|
Pennsylvania
|
| |
6311
|
| |
82-4944172
|
|
|
(State or other jurisdiction of
incorporation or organization) |
| |
(Primary Standard Industrial
Classification Code Number) |
| |
(I.R.S. Employer
Identification Number) |
|
|
Wesley R. Kelso, Esq.
Stevens & Lee, P.C. 111 North Sixth Street Reading, Pennsylvania 19603 (610) 478-2242 |
| |
James M. Connolly, Esq.
Griffin Financial Group LLC 100 Lennox Drive, Suite 200 Lawrenceville, NJ 08648 (609) 987-6677 |
|
| Large accelerated filer ☐ | | | Accelerated filer ☐ | |
| Non-accelerated filer ☐ | | | Smaller reporting company ☐ | |
| | | | Emerging growth company ☒ | |
Calculation of Registration Fee
|
| ||||||||||||||||||||||||
Title of Each Class of Securities to be Registered
|
| |
Amount to be
Registered(1) |
| |
Proposed
Maximum Offering Price Per Share(2) |
| |
Proposed
Maximum Aggregate Offering Price |
| |
Amount of
Registration Fee |
| ||||||||||||
Common Stock, par value $0.01 per share
|
| | | | 4,600,000 | | | | | $ | 10.00 | | | | | $ | 46,000,000 | | | | | $ | 5,576 | | |
|
| | |
Minimum
|
| |
Maximum
|
| ||||||
Number of shares offered
|
| | | | 3,400,000 | | | | | | 4,600,000 | | |
Gross offering proceeds
|
| | | $ | 34,000,000 | | | | | $ | 46,000,00 | | |
Estimated offering expenses
|
| | | $ | 1,000,000 | | | | | $ | 1,000,000 | | |
Commissions(1)(2) | | | | $ | 1,895,000 | | | | | $ | 2,135,000 | | |
Net proceeds
|
| | | $ | 31,105,000 | | | | | $ | 42,865,000 | | |
Net proceeds per share
|
| | | $ | 9.15 | | | | | $ | 9.32 | | |
| | | | | 1 | | | |
| | | | | 15 | | | |
| | | | | 30 | | | |
| | | | | 31 | | | |
| | | | | 33 | | | |
| | | | | 34 | | | |
| | | | | 34 | | | |
| | | | | 35 | | | |
| | | | | 36 | | | |
| | | | | 42 | | | |
| | | | | 68 | | | |
| | | | | 84 | | | |
| | | | | 105 | | | |
| | | | | 109 | | | |
| | | | | 119 | | | |
| | | | | 120 | | | |
| | | | | 124 | | | |
| | | | | 124 | | | |
| | | | | 124 | | | |
| | | | | F-1 | | |
Stock Based Incentive Plan
|
| |
Individuals
Eligible to Receive Awards |
| |
Number of
Shares |
| |
Percentage of
shares issued in the offering |
| |
Value of shares
Based on $10.00 Share Price |
| |||||||||
Shares available for restricted stock awards
|
| | Selected officers | | | | | 140,000 | | | | | | 4.12% | | | | | $ | 1,400,000 | | |
Shares available for stock options
|
| |
Directors and selected officers
|
| | | | 340,000 | | | | | | 10.0% | | | | |
|
(1)
|
| |
| | |
Six Months Ended June 30,
|
| |
Years Ended December 31,
|
| ||||||||||||||||||
(dollars in thousands)
|
| |
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||
Statement of Operations Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Premiums written
|
| | | $ | 7,593 | | | | | $ | 7,564 | | | | | $ | 14,133 | | | | | $ | 16,299 | | |
Ceded premiums
|
| | | | (1,335) | | | | | | (968) | | | | | | (2,075) | | | | | | (1,872) | | |
Insurance revenues
|
| | | | 6,258 | | | | | | 6,596 | | | | | $ | 12,058 | | | | | $ | 14,427 | | |
Net investment income
|
| | | | 4,218 | | | | | | 4,292 | | | | | | 8,523 | | | | | | 8,821 | | |
Net realized investment gains
|
| | | | 324 | | | | | | 904 | | | | | | 2,228 | | | | | | 1,783 | | |
Other revenues
|
| | | | 97 | | | | | | 85 | | | | | | 194 | | | | | | 173 | | |
Total revenues
|
| | | | 10,897 | | | | | | 11,877 | | | | | | 23,003 | | | | | | 25,204 | | |
Benefits and expenses | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | 7,018 | | | | | | 7,215 | | | | | | 13,712 | | | | | | 16,069 | | |
Interest credit to policyholder balances
|
| | | | 207 | | | | | | 114 | | | | | | 386 | | | | | | 315 | | |
Operating costs and expenses
|
| | | | 4,331 | | | | | | 3,994 | | | | | | 7,889 | | | | | | 8,099 | | |
Amortization of deferred policy acquisition and sales inducement costs
|
| | | | 897 | | | | | | 1,124 | | | | | | 2,108 | | | | | | 1,876 | | |
Taxes, licenses and fees
|
| | | | 398 | | | | | | 392 | | | | | | 716 | | | | | | 722 | | |
Dividends to policyholders
|
| | | | 31 | | | | | | 31 | | | | | | 66 | | | | | | 86 | | |
Total benefits and expenses
|
| | | | 12,882 | | | | | | 12,870 | | | | | | 24,877 | | | | | | 27,167 | | |
Net loss before taxes
|
| | | | (1,985) | | | | | | (993) | | | | | | (1,874) | | | | | | (1,963) | | |
Tax expense
|
| | | | 9 | | | | | | 14 | | | | | | 34 | | | | | | 34 | | |
Net loss
|
| | | $ | (1,994) | | | | | $ | (1,007) | | | | | $ | (1,908) | | | | | $ | (1,997) | | |
|
| | |
June 30,
|
| |
Years Ended December 31,
|
| ||||||||||||
(dollars in thousands)
|
| |
2018
|
| |
2017
|
| |
2016
|
| |||||||||
Balance Sheet Data: | | | | | |||||||||||||||
Total investments, cash and cash equivalents
|
| | | $ | 203,640 | | | | | $ | 208,993 | | | | | $ | 201,314 | | |
Deferred policy acquisition costs, net
|
| | | | 13,320 | | | | | | 12,179 | | | | | | 11,940 | | |
Deferred sales inducement costs, net
|
| | | | 1,076 | | | | | | 867 | | | | | | 315 | | |
Reinsurance recoverables
|
| | | | 3,622 | | | | | | 3,727 | | | | | | 2,107 | | |
Accrued investment income
|
| | | | 1,929 | | | | | | 1,886 | | | | | | 1,832 | | |
Accounts receivable
|
| | | | 2,417 | | | | | | 538 | | | | | | 575 | | |
Prepaid reinsurance premiums
|
| | | | 1,379 | | | | | | 1,358 | | | | | | 924 | | |
Deferred tax asset, net
|
| | | | 495 | | | | | | 458 | | | | | | 664 | | |
Other assets
|
| | | | 296 | | | | | | 202 | | | | | | 254 | | |
Separate account asset
|
| | | | 23,690 | | | | | | 24,779 | | | | | | 21,513 | | |
Real estate, property and equipment
|
| | | | 2,166 | | | | | | 2,151 | | | | | | 2,297 | | |
Total Assets
|
| | | $ | 254,030 | | | | | $ | 257,138 | | | | | $ | 243,735 | | |
Future life policy benefits
|
| | | $ | 72,608 | | | | | $ | 71,927 | | | | | $ | 73,097 | | |
Policyholder account balance
|
| | | | 113,654 | | | | | | 109,823 | | | | | | 99,440 | | |
Future accident and health policy benefits
|
| | | | 343 | | | | | | 386 | | | | | | 351 | | |
Reserve for deposit type contracts
|
| | | | 11,222 | | | | | | 10,850 | | | | | | 10,529 | | |
Other policyholder funds
|
| | | | 2,733 | | | | | | 1,970 | | | | | | 1,889 | | |
Separate account liability
|
| | | | 23,690 | | | | | | 24,779 | | | | | | 21,513 | | |
Unearned revenue
|
| | | | 1,357 | | | | | | 1,387 | | | | | | 1,396 | | |
Deferred reinsurance settlements
|
| | | | 2,826 | | | | | | 2,949 | | | | | | 1,512 | | |
Other liabilities
|
| | | | 2,080 | | | | | | 1,710 | | | | | | 1,146 | | |
Total Liabilities
|
| | | $ | 230,513 | | | | | $ | 225,781 | | | | | $ | 210,873 | | |
Retained earnings
|
| | | $ | 24,606 | | | | | $ | 26,600 | | | | | $ | 29,313 | | |
Accumulated other comprehensive income
|
| | | | (1,089) | | | | | | 4,757 | | | | | | 3,549 | | |
Total equity
|
| | | $ | 23,517 | | | | | $ | 31,357 | | | | | $ | 32,862 | | |
|
| | | | | | | | |
Pro Forma Capitalization
of Federal Life Group, Inc. as of June 30, 2018(2) |
| |||||||||
| | | | | | | | |
(dollars in thousands except share
and per share data) |
| |||||||||
| | |
Historical
Consolidated Capitalization of FLMHC at June 30, 2018 |
| |
Minimum
|
| |
Maximum
|
| |||||||||
Shareholders’ equity(1): | | | | | | | | | | | | | | | | | | | |
Common Stock, par value $0.01 per share; authorized 10,000,000 shares; shares to be outstanding – as
shown(2)(3) |
| | | $ | — | | | | | $ | 34 | | | | | $ | 46 | | |
Additional paid-in capital(2)(3)
|
| | | $ | — | | | | | $ | 31,071 | | | | | $ | 42,865 | | |
Retained earnings
|
| | | | 24,606 | | | | | | 24,606 | | | | | | 24,606 | | |
Accumulated other comprehensive income (loss),
net of tax |
| | | $ | (1,089) | | | | | $ | (1,089) | | | | | $ | (1,089) | | |
Total shareholders’ equity
|
| | | $ | 23,517 | | | | | $ | 54,622 | | | | | $ | 66,428 | | |
|
| | |
FLMHC
Historical Consolidated |
| |
Pro Forma
Adjustments |
| |
Federal Life
Group, Inc. Pro Forma Consolidated |
||||||||
Assets | | | | | | | | | | | | | | | | | |
Cash and investments
|
| | | $ | 203,640 | | | | | $ | 31,105 | | | | | $ | 234,745 |
Deferred policy acquisition costs, net
|
| | | | 13,320 | | | | | | — | | | | | | 13,320 |
Deferred sales inducement costs, net
|
| | | | 1,076 | | | | | | — | | | | | | 1,076 |
Accrued investment income
|
| | | | 1,929 | | | | | | — | | | | | | 1,929 |
Accounts receivable
|
| | | | 2,417 | | | | | | — | | | | | | 2,417 |
Prepaid reinsurance premiums
|
| | | | 1,379 | | | | | | — | | | | | | 1,379 |
Real estate, property and equipment
|
| | | | 2,166 | | | | | | — | | | | | | 2,166 |
Reinsurance recoverables
|
| | | | 3,622 | | | | | | — | | | | | | 3,622 |
Separate account asset
|
| | | | 23,690 | | | | | | — | | | | | | 23,690 |
Deferred tax asset, net
|
| | | | 495 | | | | | | — | | | | | | 495 |
Other assets
|
| | | | 296 | | | | | | — | | | | | | 296 |
Total assets
|
| | | $ | 254,030 | | | | | $ | 31,105 | | | | | $ | 285,135 |
|
| | |
FLMHC
Historical Consolidated |
| |
Pro Forma
Adjustments |
| |
Federal Life
Group, Inc. Pro Forma Consolidated |
||||||||
Liabilities | | | | | | | | | | | | | | | | | |
Policyholder account balance
|
| | | $ | 113,654 | | | | | | — | | | | | $ | 113,654 |
Separate account liability
|
| | | | 23,690 | | | | | | — | | | | | | 23,690 |
Future policy benefits
|
| | | | 72,951 | | | | | | — | | | | | | 72,951 |
Reserve for deposit accounts
|
| | | | 11,222 | | | | | | — | | | | | | 11,222 |
Other policyholder funds
|
| | | | 2,733 | | | | | | — | | | | | | 2,733 |
Deferred reinsurance settlements
|
| | | | 2,826 | | | | | | | | | | | | 2,826 |
Unearned revenue
|
| | | | 1,357 | | | | | | — | | | | | | 1,357 |
Other liabilities
|
| | | | 2,080 | | | | | | — | | | | | | 2,080 |
Total liabilities
|
| | | $ | 230,513 | | | | | | — | | | | | $ | 230,513 |
Common stock
|
| | | | — | | | | | | 34(2)(3) | | | | | $ | 34 |
Additional paid in capital
|
| | | | — | | | | | | 31,071 | | | | | | 31,071 |
Retained earnings
|
| | | $ | 24,606 | | | | | | — | | | | | | 24,606 |
Accumulated other comprehensive income
|
| | | | (1,089) | | | | | | — | | | | | | (1,089) |
Total equity
|
| | | | 23,517 | | | | | | 31,105 | | | | | | 54,622 |
Total liabilities and equity
|
| | | $ | 254,030 | | | | | $ | 31,105 | | | | | $ | 285,135 |
|
|
Sale of 3,400,000 shares at $10 per share
|
| | | $ | 34,000,000 | | |
|
Conversion and offering expenses
|
| | | | 1,000,000 | | |
|
Commissions
|
| | | | 1,895,000 | | |
|
Total
|
| | | $ | 31,105,000 | | |
|
Common stock
|
| | | $ | 34,000 | | |
|
Additional paid in capital
|
| | | $ | 31,071,000 | | |
|
Total
|
| | | $ | 31,105,000 | | |
|
(dollars in thousands)
|
| |
FLMHC
Historical Consolidated |
| |
Pro Forma
Adjustments |
| |
Federal Life
Group, Inc. Pro Forma Consolidated |
| |||||||||
Revenues | | | | | | | | | | | | | | | | | | | |
Insurance revenues
|
| | | $ | 12,058 | | | | | $ | — | | | | | $ | 12,058 | | |
Net investment income
|
| | | | 8,523 | | | | | | —(1) | | | | | | 8,523 | | |
Net realized investment gains
|
| | | | 2,228 | | | | | | —(1) | | | | | | 2,228 | | |
Other revenues
|
| | | | 194 | | | | | | — | | | | | | 194 | | |
Total revenues
|
| | | $ | 23,003 | | | | | $ | — | | | | | $ | 23,003 | | |
Benefits and Expenses | | | | | | | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | 13,712 | | | | | | — | | | | | | 13,712 | | |
Interest credit to policyholders
|
| | | | 386 | | | | | | — | | | | | | 386 | | |
Operating costs and expenses
|
| | | | 7,889 | | | | | | 350(2) | | | | | | 8,239 | | |
Amortization of deferred policy acquisition and sales inducement
costs |
| | | | 2,108 | | | | | | — | | | | | | 2,108 | | |
Taxes, licenses and fees
|
| | | | 716 | | | | | | — | | | | | | 716 | | |
Dividends to policyholders
|
| | | | 66 | | | | | | — | | | | | | 66 | | |
Total benefits and expenses
|
| | | | 24,877 | | | | | | 350 | | | | | | 25,227 | | |
Loss before income taxes
|
| | | | (1,874) | | | | | | (350) | | | | | | (2,224) | | |
Tax expense (benefit)
|
| | | | 34 | | | | |
|
(3)
|
| | | | | 34 | | |
Net loss
|
| | | $ | (1,908) | | | | | $ | (350) | | | | | $ | (2,258) | | |
Earnings per share data | | | | | | | | | | | | | | | | | | | |
Basic and diluted earnings per common share
|
| | | | | | | | | | | | | | | $ | (0.66) | | |
Weighted average basic and diluted shares outstanding
|
| | | | | | | | | | | | | | | | 3,435,000(4) | | |
(dollars in thousands)
|
| |
FLMHC
Historical Consolidated |
| |
Pro Forma
Adjustments |
| |
Federal Life
Group, Inc. Pro Forma Consolidated |
| |||||||||
Revenues | | | | | | | | | | | | | | | | | | | |
Insurance revenues
|
| | | $ | 6,258 | | | | | $ | — | | | | | $ | 6,258 | | |
Net investment income
|
| | | | 4,218 | | | | | | —(1) | | | | | | 4,218 | | |
Net realized investment gains
|
| | | | 324 | | | | | | —(1) | | | | | | 324 | | |
Other revenues
|
| | | | 97 | | | | | | — | | | | | | 97 | | |
Total revenues
|
| | | $ | 10,897 | | | | | $ | — | | | | | $ | 10,897 | | |
Benefits and Expenses | | | | | | | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | 7,018 | | | | | | — | | | | | | 7,018 | | |
Interest credit to policyholders
|
| | | | 207 | | | | | | — | | | | | | 207 | | |
Operating costs and expenses
|
| | | | 4,331 | | | | | | 350(2) | | | | | | 4,681 | | |
Amortization of deferred policy acquisition and sales inducement
costs |
| | | | 897 | | | | | | — | | | | | | 897 | | |
Taxes, licenses and fees
|
| | | | 398 | | | | | | | | | | | | 398 | | |
Dividends to policyholders
|
| | | | 31 | | | | | | — | | | | | | 31 | | |
Total benefits and expenses
|
| | | | 12,882 | | | | | | 350 | | | | | | 13,232 | | |
Loss before income taxes
|
| | | | (1,985) | | | | | | (350) | | | | | | (2,335) | | |
Tax expense (benefit)
|
| | | | 9 | | | | | | —(3) | | | | | | 9 | | |
Net loss
|
| | | $ | (1,994) | | | | | $ | (350) | | | | | $ | (2,344) | | |
Loss per share data | | | | | | | | | | | | | | | | | | | |
Basic loss per common share
|
| | | | | | | | | | | | | | | $ | (0.59)(4) | | |
Diluted loss per common share
|
| | | | | | | | | | | | | | | | (0.68) | | |
Weighted average basic shares outstanding
|
| | | | | | | | | | | | | | | | 3,400,000 | | |
Weighted average diluted shares outstanding
|
| | | | | | | | | | | | | | | | 3,540,000 | | |
| | |
At or for the Year Ended June 30, 2018
|
| |||||||||||||||
| | |
3,400,000
Shares Sold at $10.00 per Share (Minimum of Range) |
| |
4,000,000
Shares Sold at $10.00 per Share (Midpoint of Range) |
| |
4,600,000
Shares Sold at $10.00 per Share (Maximum of Range) |
| |||||||||
| | |
(dollars in thousands, except share and per share data)
|
| |||||||||||||||
Pro forma offering proceeds | | | | | | | | | | | | | | | | | | | |
Gross proceeds of public offering
|
| | | $ | 34,000 | | | | | $ | 40,000 | | | | | $ | 46,000 | | |
Less offering expenses and commissions
|
| | | $ | 2,895 | | | | | $ | 3,060 | | | | | $ | 3,135 | | |
Net Proceeds
|
| | | $ | 31,105 | | | | | $ | 36,940 | | | | | $ | 42,865 | | |
Pro forma shareholders’ equity | | | | | | | | | | | | | | | | | | | |
Historical Equity
|
| | | $ | 23,517 | | | | | $ | 23,517 | | | | | $ | 23,517 | | |
Net proceeds
|
| | | $ | 31,105 | | | | | $ | 36,940 | | | | | $ | 42,865 | | |
Pro forma shareholders’ equity(1)
|
| | | $ | 54,622 | | | | | $ | 60,457 | | | | | $ | 66,382 | | |
Pro forma per share data | | | | | | | | | | | | | | | | | | | |
Total shares outstanding after the offering
|
| | | | 3,400,000 | | | | | | 4,000,000 | | | | | | 4,600,000 | | |
Pro forma book value per share
|
| | | $ | 16.06 | | | | | $ | 15.11 | | | | | $ | 14.43 | | |
Pro forma price-to-book value per share
|
| | | | 62.3% | | | | | | 66.2% | | | | | | 69.3% | | |
Pro forma net income | | | | | | | | | | | | | | | | | | | |
Historical net loss
|
| | | | (1,994) | | | | | $ | (1,994) | | | | | $ | (1,994) | | |
Pro forma loss
|
| | | $ | (2,344) | | | | | $ | (2,344) | | | | | $ | (2,344) | | |
Weighted average shares outstanding(2)
|
| | | | 3,435,000 | | | | | | 4,035,000 | | | | | | 4,635,000 | | |
Pro forma loss per share
|
| | | $ | (0.68) | | | | | $ | (0.58) | | | | | $ | (0.51) | | |
| | |
Expected Cash Flows
|
| |||||||||
Year
|
| |
From
Maturities |
| |
Average
Interest rate |
| ||||||
2018
|
| | | $ | 2,300,000 | | | | | | 6.73% | | |
2019
|
| | | $ | 7,500,000 | | | | | | 5.21% | | |
2020
|
| | | $ | 11,700,000 | | | | | | 4.84% | | |
| | |
(dollars in thousands)
|
| |||
Guaranteed Minimum Crediting Rates December 31, 2017
|
| |
Account Value at Minimum
Guaranteed Rate |
| |||
Policyholder account balances(1)
|
| | | | | | |
Greater than 0% to 1%
|
| | | $ | — | | |
Greater than 1% to 3%
|
| | | | 17,375 | | |
Greater than 3% to 4%
|
| | | | 42,808 | | |
Greater than 4%
|
| | | | 21,163 | | |
| | | | $ | 81,346 | | |
|
|
Fair Value of Investments as of December 31, 2017
(dollars in thousands) |
| ||||||||||||||||||
|
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
Fair Value |
| |||||||||
|
$37,448
|
| | | $ | 184,290 | | | | | $ | 2,182 | | | | | $ | 223,920 | | |
|
16.72%
|
| | | | 82.30% | | | | | | 0.98% | | | | | | 100.0% | | |
Deferred Tax Liability (in thousands) |
| |
December 31, 2017
|
| |
December 31, 2016
|
| ||||||
Total deferred tax assets
|
| | | $ | 9,139 | | | | | $ | 13,939 | | |
Total deferred tax liabilities
|
| | | | (4,668) | | | | | | (7,127) | | |
Deferred tax asset (liability) before valuation allowance
|
| | | | 4,471 | | | | | | 6,812 | | |
Valuation allowance
|
| | | | (4,013) | | | | | | (6,148) | | |
Deferred income tax liability
|
| | | $ | 458 | | | | | $ | 664 | | |
|
| | |
Six Months Ended June 30,
|
| |
Year Ended December 31,
|
| ||||||||||||||||||
| | |
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||
REVENUES | | | | | | | | | | | | | | | | | | | | | | | | | |
Net insurance revenues
|
| | | $ | 6,258 | | | | | $ | 6,596 | | | | | $ | 12,058 | | | | | $ | 14,427 | | |
Net investment income
|
| | | | 4,218 | | | | | | 4,292 | | | | | | 8,523 | | | | | | 8,821 | | |
Net realized investment gains
|
| | | | 324 | | | | | | 904 | | | | | | 2,228 | | | | | | 1,783 | | |
Other income
|
| | | | 97 | | | | | | 85 | | | | | | 194 | | | | | | 173 | | |
Total revenues
|
| | | | 10,897 | | | | | | 11,877 | | | | | | 23,003 | | | | | | 25,204 | | |
BENEFITS AND EXPENSES | | | | | | | | | | | | | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | 7,018 | | | | | | 7,215 | | | | | | 13,712 | | | | | | 16,069 | | |
Interest credit to policyholders
|
| | | | 207 | | | | | | 114 | | | | | | 386 | | | | | | 315 | | |
Operating costs and expenses
|
| | | | 4,331 | | | | | | 3,994 | | | | | | 7,889 | | | | | | 8,099 | | |
Amortization of deferred policy acquisition and sales inducement costs
|
| | | | 897 | | | | | | 1,124 | | | | | | 2,108 | | | | | | 1,876 | | |
Taxes, licenses and fees
|
| | | | 398 | | | | | | 392 | | | | | | 716 | | | | | | 722 | | |
Dividends to policyholders
|
| | | | 31 | | | | | | 31 | | | | | | 66 | | | | | | 86 | | |
Total benefits and expenses
|
| | | | 12,882 | | | | | | 12,870 | | | | | | 24,877 | | | | | | 27,167 | | |
Loss before income taxes
|
| | | | (1,985) | | | | | | (993) | | | | | | (1,874) | | | | | | (1,963) | | |
Tax expense
|
| | | | 9 | | | | | | 14 | | | | | | 34 | | | | | | 34 | | |
NET LOSS
|
| | | $ | (1,994) | | | | | $ | (1,007) | | | | | $ | (1,908) | | | | | $ | (1,997) | | |
|
| | |
Year Ended December 31,
|
| |||||||||
| | |
2017
|
| |
2016
|
| ||||||
| | |
(dollars in thousands)
|
| |||||||||
Call options: | | | | | | | | | | | | | |
Gain (loss) on option expiration
|
| | | $ | 94 | | | | | $ | 0 | | |
Change in unrealized gains (losses)
|
| | | | 140 | | | | | | — | | |
| | |
Year Ended December 31,
|
| |||
| | |
2017
|
| |
2016
|
|
S&P 500 Index
|
| |
16.04 – 18.50%
|
| |
12.59 – 12.59%
|
|
Annual point-to-point strategy | | | | | | | |
Cap
|
| |
3.00 – 3.75%
|
| |
3.50 – 3.50%
|
|
Participation Rate
|
| |
30.0 – 35.0%
|
| |
30.0 – 30.0%
|
|
| | |
Year Ended December 31,
|
| |||||||||
| | |
2017
|
| |
2016
|
| ||||||
| | |
(dollars in thousands)
|
| |||||||||
Surrender charges
|
| | | $ | 69 | | | | | $ | 22 | | |
Lifetime income benefit riders (LIBR) fees
|
| | | $ | 34 | | | | | $ | 1 | | |
| | | | $ | 103 | | | | | $ | 23 | | |
Withdrawals from annuity policies subject to surrender charges
|
| | | $ | 1,091 | | | | | $ | 624 | | |
Average surrender charge collected on withdrawals subject to surrender charges
|
| | | | 6.32% | | | | | | 3.60% | | |
Fund values on policies subject to LIBR fees
|
| | | $ | 4,496 | | | | | $ | 114 | | |
Weighted average per policy LIBR fee
|
| | | | 0.75% | | | | | | 0.76% | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2017
|
| |
2016
|
| ||||||
| | |
(dollars in thousands)
|
| |||||||||
Index credits on index policies
|
| | | $ | 145 | | | | | $ | 5 | | |
Interest credited (including interest credited on fixed allocation for fixed index annuities)
|
| | | $ | 4,209 | | | | | $ | 3,927 | | |
Lifetime income benefit riders
|
| | | | (34) | | | | | | (1) | | |
| | | | $ | 4,320 | | | | | $ | 3,931 | | |
| | |
Six Months Ended June 30,
|
| |||||||||
| | |
2018
|
| |
2017
|
| ||||||
| | |
(dollars in thousands)
|
| |||||||||
Call options: | | | | | | | | | | | | | |
Gain (loss) on option expiration
|
| | | $ | 116 | | | | | $ | 2 | | |
Change in unrealized gains/losses
|
| | | $ | (108) | | | | | $ | 51 | | |
| | |
Six Months Ended June 30,
|
| |||||||||
| | |
2018
|
| |
2017
|
| ||||||
S&P 500 Index
|
| | | | 14.24 – 15.72% | | | | | | 16.04 – 17.47% | | |
Annual point-to-point strategy | | | | ||||||||||
Cap
|
| | | | 3.50 – 3.50% | | | | | | 3.50 – 3.75% | | |
Participation rate
|
| | | | 35.0 – 35.0% | | | | | | 33.0 – 35.0% | | |
| | |
Six Months Ended June 30,
|
| |||||||||
| | |
2018
|
| |
2017
|
| ||||||
| | |
(dollars in thousands)
|
| |||||||||
Surrender charges
|
| | | $ | 21 | | | | | $ | 5 | | |
Lifetime income benefit riders (LIBR) fees
|
| | | $ | 36 | | | | | $ | 12 | | |
| | | | $ | 57 | | | | | $ | 17 | | |
Withdrawals from annuity policies subject to surrender charges
|
| | | $ | 346 | | | | | $ | 343 | | |
Average surrender charge collected on withdrawals subject to surrender charges
|
| | | | 6.03% | | | | | | 1.36% | | |
Fund values on policies subject to LIBR fees
|
| | | $ | 4,734 | | | | | $ | 1,571 | | |
Weighted average per policy LIBR fee
|
| | | | 0.75% | | | | | | 0.75% | | |
| | |
Six Months Ended June 30,
|
| |||||||||
| | |
2018
|
| |
2017
|
| ||||||
| | |
(Dollars in thousands)
|
| |||||||||
Index credits on index policies
|
| | | $ | 187 | | | | | $ | 5 | | |
Interest credited (including interest credited on fixed allocation for fixed index annuities)
|
| | | $ | 2,027 | | | | | $ | 2,583 | | |
Lifetime income benefit riders
|
| | | | (36) | | | | | | (12) | | |
| | | | $ | 2,178 | | | | | $ | 2,576 | | |
|
| | |
Estimated Fair Value
|
| |||||||||||||||||||||||||||||||||
(dollars in thousands) S&P Rating |
| |
June 30, 2018
|
| |
December 31, 2017
|
| |
December 31, 2016
|
| |||||||||||||||||||||||||||
AAA
|
| | | $ | 7,151 | | | | | | 3.9% | | | | | $ | 7,176 | | | | | | 3.8% | | | | | $ | 9,669 | | | | | | 5.5% | | |
AA
|
| | | | 74,402 | | | | | | 40.6% | | | | | | 77,195 | | | | | | 41.0% | | | | | | 64,354 | | | | | | 36.8% | | |
A
|
| | | | 32,496 | | | | | | 17.7% | | | | | | 35,668 | | | | | | 18.9% | | | | | | 36,714 | | | | | | 21.0% | | |
BBB
|
| | | | 60,055 | | | | | | 32.8% | | | | | | 58,921 | | | | | | 31.3% | | | | | | 54,538 | | | | | | 31.2% | | |
Total investment grade
|
| | | $ | 174,104 | | | | | | 95.0% | | | | | $ | 178,960 | | | | | | 95.0% | | | | | $ | 165,275 | | | | | | 94.5% | | |
BB
|
| | | $ | 6,750 | | | | | | 3.7% | | | | | $ | 6,575 | | | | | | 3.8% | | | | | $ | 5,919 | | | | | | 3.4% | | |
B
|
| | | | 1,918 | | | | | | 1.1% | | | | | | 2,381 | | | | | | 1.3% | | | | | | 2,649 | | | | | | 1.5% | | |
CCC
|
| | | | 408 | | | | | | 0.2% | | | | | | 459 | | | | | | 0.2% | | | | | | 1,030 | | | | | | 0.6% | | |
CC
|
| | | | 0 | | | | | | 0.0% | | | | | | 0 | | | | | | 0.0% | | | | | | 0 | | | | | | 0.0% | | |
C
|
| | | | 69 | | | | | | 0.0% | | | | | | 77 | | | | | | 0.0% | | | | | | 3 | | | | | | 0.0% | | |
D
|
| | | | 0 | | | | | | 0.0% | | | | | | 0 | | | | | | 0.0% | | | | | | 4 | | | | | | 0.0% | | |
Total below investment grade
|
| | | | 9,145 | | | | | | 5.0% | | | | | | 9,492 | | | | | | 5.0% | | | | | | 9,605 | | | | | | 5.5% | | |
Not rated
|
| | | | 0 | | | | | | 0.0% | | | | | | 0 | | | | | | 0.0% | | | | | | 0 | | | | | | 0.0% | | |
Total
|
| | | $ | 183,249 | | | | | | 100.0% | | | | | $ | 188,452 | | | | | | 100.0% | | | | | $ | 174,880 | | | | | | 100.0% | | |
|
| | |
June 30, 2018
|
| |
December 31, 2017
|
| |
December 31, 2016
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(dollars in thousands)
|
| |
Amortized
Cost |
| |
%
|
| |
Fair
Value |
| |
%
|
| |
Amortized
Cost |
| |
%
|
| |
Fair
Value |
| |
%
|
| |
Amortized
Cost |
| |
%
|
| |
Fair
Value |
| |
%
|
| ||||||||||||||||||||||||||||||||||||
Due in one year or less
|
| | | $ | 3,499 | | | | | | 1.9% | | | | | $ | 3,554 | | | | | | 1.9% | | | | | $ | 2,247 | | | | | | 1.2% | | | | | $ | 2,288 | | | | | | 1.2% | | | | | $ | 5,038 | | | | | | 3.0% | | | | | $ | 5,161 | | | | | | 3.0% | | |
Due after one year through five years
|
| | | $ | 41,230 | | | | | | 22.3% | | | | | $ | 41,801 | | | | | | 22.8% | | | | | $ | 40,926 | | | | | | 22.3% | | | | | $ | 42,809 | | | | | | 22.7% | | | | | $ | 34,101 | | | | | | 20.0% | | | | | $ | 36,605 | | | | | | 20.9% | | |
Due after five years through ten years
|
| | | $ | 68,467 | | | | | | 37.0% | | | | | $ | 66,976 | | | | | | 36.6% | | | | | $ | 66,739 | | | | | | 36.4% | | | | | $ | 68,151 | | | | | | 36.2% | | | | | $ | 66,029 | | | | | | 38.7% | | | | | $ | 66,648 | | | | | | 38.1% | | |
Due after ten years
|
| | | $ | 26,216 | | | | | | 14.1% | | | | | $ | 25,576 | | | | | | 14.0% | | | | | $ | 27,492 | | | | | | 15.0% | | | | | $ | 27,923 | | | | | | 14.8% | | | | | $ | 20,244 | | | | | | 11.9% | | | | | $ | 20,089 | | | | | | 11.5% | | |
Mortgage-backed securities
|
| | | $ | 45,835 | | | | | | 24.7% | | | | | $ | 45,342 | | | | | | 24.7% | | | | | $ | 46,028 | | | | | | 25.1% | | | | | $ | 47,281 | | | | | | 25.1% | | | | | $ | 45,103 | | | | | | 26.4% | | | | | $ | 46,377 | | | | | | 26.5% | | |
Total debt securities
|
| | | $ | 185,247 | | | | | | 100.0% | | | | | $ | 183,249 | | | | | | 100.0% | | | | | $ | 183,432 | | | | | | 100.0% | | | | | $ | 188,452 | | | | | | 100.0% | | | | | $ | 170,515 | | | | | | 100% | | | | | $ | 174,880 | | | | | | 100% | | |
|
| | |
Six Months Ended
June 30, |
| |
Year Ended
December 31, |
| ||||||||||||||||||
| | |
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||
Book yield on fixed maturity securities available for sale(1)
|
| | | | 3.97% | | | | | | 4.14% | | | | | | 3.98% | | | | | | 4.35% | | |
| | |
As of June 30, 2018
|
| |||||||||||||||
(dollars in thousands)
|
| |
Ending
Balance |
| |
Year to Date
Interest Credited |
| |
Average
Crediting Rate |
| |||||||||
Annuity Contract Holder Deposits
|
| | | $ | 50,078 | | | | | $ | 823 | | | | | | 1.65% | | |
Dividends Left on Deposit
|
| | | | 6,898 | | | | | | 85 | | | | | | 1.22% | | |
Other
|
| | | | 620 | | | | | | 11 | | | | | | 1.79% | | |
| | | | $ | 57,596 | | | | | $ | 919 | | | | | | | | |
|
| | |
December 31, 2017
|
| |
December 31, 2016
|
| ||||||||||||||||||||||||||||||
(dollars in thousands)
|
| |
Ending
Balance |
| |
Year to Date
Interest Credit |
| |
Average
Crediting Rate |
| |
Ending
Balance |
| |
Year to Date
Interest Credit |
| |
Average
Crediting Rate |
| ||||||||||||||||||
Annuity Contract Holder Deposits
|
| | | $ | 50,728 | | | | | $ | 1,763 | | | | | | 3.47% | | | | | $ | 52,528 | | | | | $ | 1,820 | | | | | | 3.45% | | |
Dividends Left on Deposit
|
| | | | 7,067 | | | | | | 171 | | | | | | 2.40% | | | | | | 7,405 | | | | | | 184 | | | | | | 2.47% | | |
Other
|
| | | | 570 | | | | | | 18 | | | | | | 3.50% | | | | | | 461 | | | | | | 21 | | | | | | 4.66% | | |
| | | | $ | 58,365 | | | | | $ | 1,952 | | | | | | | | | | | $ | 60,394 | | | | | $ | 2,025 | | | | | | | | |
|
Net Realized Investment Gains (Losses)
(dollars in thousands) |
| |
As of June 30,
|
| |
Years Ended
December 31, |
| ||||||||||||||||||
|
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||||
Sales of Investments: | | | | | | | | | | | | | | | | | | | | | | | | | |
Fixed maturity securities, available for sale
|
| | | $ | 36 | | | | | | 124 | | | | | $ | 177 | | | | | $ | 130 | | |
Equity securities
|
| | | | 0 | | | | | | 420 | | | | | | 897 | | | | | | 1,073 | | |
Oil and gas interests
|
| | | | 261 | | | | | | 358 | | | | | | 1,060 | | | | | | 580 | | |
Real estate
|
| | | | — | | | | | | — | | | | | | 0 | | | | | | 0 | | |
Derivatives
|
| | | | 116 | | | | | | 2 | | | | | | 94 | | | | | | 0 | | |
Other-than-temporary impairment losses on fixed maturity securities, available for sale-net
|
| | | | (89) | | | | | | 0 | | | | | | 0 | | | | | | 0 | | |
Trading securities-gains and losses: | | | | | | | | | | | | | | | | | | | | | | | | | |
Fixed maturity securities
|
| | | | — | | | | | | — | | | | | | 0 | | | | | | 0 | | |
Equity securities
|
| | | | 0 | | | | | | 0 | | | | | | 0 | | | | | | 0 | | |
Investment expenses
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Mortgage loans impairments
|
| | | | 0 | | | | | | 0 | | | | | | 0 | | | | | | 0 | | |
Total net realized investment gains (losses)
|
| | | | 324 | | | | | | 904 | | | | | $ | 2,228 | | | | | $ | 1,783 | | |
|
Accumulated Other Comprehensive Income
(dollars in thousands) |
| |
Six Months Ended
June 30, |
| |
Years Ended
December 31, |
| ||||||||||||||||||
|
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||||
Unrealized holding gains (losses) from changes in the market
value of securities, including the related impact to future policy benefit liabilities, the policyholder dividend obligation, and deferred policy acquisition cost balances |
| | | $ | (5,884) | | | | | $ | 1,273 | | | | | $ | 611 | | | | | $ | (539) | | |
Income tax effect
|
| | | | 38 | | | | | | (433) | | | | | | (208) | | | | | | 183 | | |
Cumulative effect of adoption of new accounting principle
|
| | | | 0 | | | | | | 0 | | | | | | 805 | | | | | | 0 | | |
Net increase in accumulated other comprehensive income
|
| | | $ | (5,846) | | | | | $ | 840 | | | | | $ | 1,208 | | | | | $ | (356) | | |
|
| | |
Six Months Ended
|
| |
Year Ended December 31,
|
| ||||||||||||||||||
Consolidated Summary of Cash Flow (in thousands) |
| |
June 30,
2018 |
| |
June 30,
2017 |
| |
2017
|
| |
2016
|
| ||||||||||||
Cash flows provided by (used for) operating activities
|
| | | $ | (3,883) | | | | | $ | (1,362) | | | | | $ | (5,779) | | | | | $ | (5,056) | | |
Cash flows from investing activities
|
| | | | (493) | | | | | | (4,461) | | | | | | (9,228) | | | | | | 1,653 | | |
Cash flows provided by (used for) financing activities
|
| | | | 4,204 | | | | | | 4,615 | | | | | | 10,703 | | | | | | 5,239 | | |
Net increase (decrease) in cash
|
| | | | (172) | | | | | $ | (1,208) | | | | | $ | (4,304) | | | | | $ | 1,836 | | |
|
Contractual Cash Obligations (dollars in thousands) |
| |
Total
|
| |
Less than
1 year |
| |
1 – 3 years
|
| |
3 – 5 years
|
| |
More than
5 years |
| |||||||||||||||
Future policy benefits and claims(1)
|
| | | $ | 159,093 | | | | | $ | 7,075 | | | | | $ | 14,145 | | | | | $ | 20,949 | | | | | $ | 116,924 | | |
Policyholder account balances(2)
|
| | | | 162,087 | | | | | | 9,086 | | | | | | 16,875 | | | | | | 21,767 | | | | | | 114,359 | | |
Other policyholder liabilities(3)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Commissions(4) | | | | | 6,023 | | | | | | 680 | | | | | | 958 | | | | | | 1,148 | | | | | | 3,237 | | |
Reinsurance liabilities and payables(5)
|
| | | | 5,162 | | | | | | 173 | | | | | | 487 | | | | | | 863 | | | | | | 3,369 | | |
Total contractual obligations
|
| | | $ | 332,365 | | | | | $ | 17,014 | | | | | $ | 32,465 | | | | | $ | 44,727 | | | | | $ | 238,159 | | |
|
| | |
Net Premium Revenue and Annuity Deposits
|
| |||||||||||||||||||||
| | |
Six Months Ended June 30,
|
| |
Years Ended December 31,
|
| ||||||||||||||||||
(dollars in thousands)
|
| |
2018
|
| |
2017
|
| |
2017
|
| |
2016
|
| ||||||||||||
Life
|
| | | $ | 6,258 | | | | | $ | 6,596 | | | | | $ | 12,058 | | | | | $ | 14,427 | | |
Annuity deposits
|
| | | | 5,206 | | | | | | 6,184 | | | | | | 12,969 | | | | | | 8,107 | | |
Total
|
| | | $ | 11,464 | | | | | $ | 12,780 | | | | | $ | 25,027 | | | | | $ | 22,534 | | |
|
| | |
For the Year Ended December 31,
|
| |||||||||||||||||||||||||||
| | |
2015
|
| |
2014
|
| |
2013
|
| |
2012
|
| |
2011
|
| |||||||||||||||
| | |
(Dollars in thousands)
|
| |||||||||||||||||||||||||||
Total industry sales of fixed index annuities
|
| | | $ | 53,069,850 | | | | | $ | 46,896,350 | | | | | $ | 38,646,864 | | | | | $ | 33,975,442 | | | | | $ | 32,387,045 | | |
Increase from prior year
|
| | | | 6,173,500 | | | | | | 8,249,486 | | | | | | 4,671,422 | | | | | | 1,588,397 | | | | | | 41,481 | | |
Increase from prior year
|
| | | | 13.2% | | | | | | 21.3% | | | | | | 13.7% | | | | | | 4.9% | | | | | | 0.1% | | |
| | |
Year Ended December 31,
|
| |||||||||||||||||||||||||||||||||
| | |
2017
|
| |
2016
|
| |
2015
|
| |||||||||||||||||||||||||||
Product Type
|
| |
Deposits
Collected |
| |
Deposits as
a % of Total |
| |
Deposits
Collected |
| |
Deposits as
a % of Total |
| |
Deposits
Collected |
| |
Deposits as
a % of Total |
| ||||||||||||||||||
| | |
(Dollars in thousands)
|
| |||||||||||||||||||||||||||||||||
Fixed index annuities
|
| | | $ | 11,349 | | | | | | 87% | | | | | $ | 5,788 | | | | | | 71% | | | | | $ | 250 | | | | | | 7.0% | | |
Single premium fixed rate annuities
|
| | | | 231 | | | | | | 2% | | | | | | 161 | | | | | | 2% | | | | | | 1,015 | | | | | | 31% | | |
Flexible premium fixed rate annuities
|
| | | | 716 | | | | | | 6% | | | | | | 1,428 | | | | | | 18% | | | | | | 1,650 | | | | | | 50% | | |
Single premium immediate annuities
|
| | | | 672 | | | | | | 5% | | | | | | 731 | | | | | | 9% | | | | | | 401 | | | | | | 12% | | |
| | | | $ | 12,969 | | | | | | 100% | | | | | $ | 8,107 | | | | | | 100% | | | | | $ | 3,316 | | | | | | 100% | | |
|
| | |
For the Year Ended December 31,
|
| |||||||||||||||
| | |
2017
|
| |
2016
|
| |
2015
|
| |||||||||
| | |
(dollars in thousands)
|
| |||||||||||||||
Annuity Surrender Charges:
|
| | | $ | 2,666 | | | | | $ | 1,295 | | | | | $ | 603 | | |
Average years at issue
|
| | | | 8 | | | | | | 7 | | | | | | 7 | | |
Average years remaining
|
| | | | 4 | | | | | | 2 | | | | | | 1 | | |
Average surrender charge percentage remaining
|
| | | | 4.42% | | | | | | 2.59% | | | | | | 1.32% | | |
Annuity Account Value (net of coinsurance)
|
| | | $ | 60,257 | | | | | $ | 49,931 | | | | | $ | 45,498 | | |
| | |
As of December 31, 2017
|
| |||||||||||||||||||||
| | |
2017 A.M.
Best’s Rating |
| |
Ceded Future
Policy Benefits |
| |
Claims and
Other Amounts Recoverable |
| |
Total
Reinsurance Recoverables |
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Reinsurer | | | | | | | | | | | | | | | | | | | | | | | | | |
Optimum Re Insurance Company
|
| | | | A- | | | | | $ | 3,275 | | | | | $ | 77 | | | | | $ | 3,352 | | |
SCOR Global Life Americas Reins Co
|
| | | | A+ | | | | | | 444 | | | | | | — | | | | | | 444 | | |
Prudential Insurance Co of America
|
| | | | A+ | | | | | | 3 | | | | | | — | | | | | | 3 | | |
Swiss Re Life & Health America Inc.
|
| | | | A+ | | | | | | 5 | | | | | | 2 | | | | | | 7 | | |
| | | | | | | | | | $ | 3,727 | | | | | $ | 79 | | | | | $ | 3,806 | | |
|
|
Fixed maturities, available for sale, at fair value
|
| | | $ | 188,452 | | |
|
Equity securities, available for sale, at fair value
|
| | | | 6,209 | | |
|
Policy loans
|
| | | | 9,852 | | |
|
Derivative instruments
|
| | | | 395 | | |
|
Total Investments
|
| | | | 204,908 | | |
|
Cash and cash equivalents
|
| | | | 4,085 | | |
|
Total Cash and Investments
|
| | | $ | 208,993 | | |
|
| | |
% of Stock owned
|
| |||||||||||||||||||||
Name
|
| |
Amount ($)
|
| |
Number of
shares |
| |
Minimum
|
| |
Adjusted
Maximum |
| ||||||||||||
Directors | | | | | | | | | | | | | | | | | | | | | | | | | |
Joseph D. Austin
|
| | | $ | 1,700,000 | | | | | | 170,000 | | | | | | 5.0% | | | | | | 3.7% | | |
William S. Austin
|
| | | | 610,000 | | | | | | 61,000 | | | | | | 1.8% | | | | | | 1.3% | | |
Michael Austin
|
| | | | 500,000 | | | | | | 50,000 | | | | | | 1.5% | | | | | | 1.1% | | |
Wayne R. Ebersberger
|
| | | | 50,000 | | | | | | 5,000 | | | | | | * | | | | | | * | | |
William H. Springer
|
| | | | 50,000 | | | | | | 5,000 | | | | | | * | | | | | | * | | |
James H. Stacke
|
| | | | 50,000 | | | | | | 5,000 | | | | | | * | | | | | | * | | |
Executive Officers (who are not also directors) Anders Raaum
|
| | | | 100,000 | | | | | | 10,000 | | | | | | * | | | | | | * | | |
All Directors and Executive Officers as a Group (7 persons)
|
| | | $ | 3,060,000 | | | | | | 306,000 | | | | | | 9.0% | | | | | | 6.7% | | |
|
| | | | | | | | | | | |
Trailing 12 Months
|
| |
As of 12/22/2017
|
| ||||||||||||||||||
Ticker
|
| |
Company
|
| |
Total
Assets ($Mil) |
| |
Policy
Revenues ($Mil) |
| |
Total
Revenues ($Mil) |
| |
Common
Stock Price ($) |
| |
Market
Value ($Mil) |
| |||||||||||||||
| | |
Federal Life Insurance Company(1)
|
| | | $ | 258 | | | | | $ | 13 | | | | | $ | 24 | | | | | | NA | | | | | | NA | | |
AEL | | |
American Equity Investment Life Holding Company
|
| | | $ | 60,380 | | | | | $ | 230 | | | | | $ | 3,275 | | | | | $ | 32.13 | | | | | $ | 2,863 | | |
CIA | | |
Citizens, Inc.
|
| | | $ | 1,651 | | | | | $ | 199 | | | | | $ | 253 | | | | | $ | 7.48 | | | | | $ | 375 | | |
CNO | | |
CNO Financial Group, Inc.
|
| | | $ | 32,705 | | | | | $ | 2,641 | | | | | $ | 4,212 | | | | | $ | 24.87 | | | | | $ | 4,172 | | |
FFG | | |
FBL Financial Group, Inc.
|
| | | $ | 9,892 | | | | | $ | 311 | | | | | $ | 737 | | | | | $ | 71.80 | | | | | $ | 1,790 | | |
IHC | | |
Independence Holding Company
|
| | | $ | 1,039 | | | | | $ | 278 | | | | | $ | 317 | | | | | $ | 27.95 | | | | | $ | 415 | | |
KCLI | | |
Kansas City Life Insurance Company
|
| | | $ | 4,511 | | | | | $ | 292 | | | | | $ | 450 | | | | | $ | 45.10 | | | | | $ | 437 | | |
NWLI | | |
National Western Life Group, Inc.
|
| | | $ | 12,138 | | | | | $ | 181 | | | | | $ | 811 | | | | | $ | 337.03 | | | | | $ | 1,158 | | |
SNFCA | | |
Security National Financial Corporation
|
| | | $ | 1,008 | | | | | $ | 69 | | | | | $ | 288 | | | | | $ | 5.40 | | | | | $ | 82 | | |
UTGN | | |
UTG, Inc.
|
| | | $ | 405 | | | | | $ | 6 | | | | | $ | 21 | | | | | $ | 25.00 | | | | | $ | 83 | | |
| | |
Market Prices
As of 12/22/2017 |
| |
Financial Data as of
September 30, 2017 |
| |
Key Pricing Ratios as of
December 22, 2017 |
| | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Name
|
| |
Closing
Price ($) |
| |
Market
Value ($Mil) |
| |
Assets
($Mil) |
| |
Equity/
Assets (%) |
| |
ROAA
(%) |
| |
ROAE
(%) |
| |
Price/
Book (%) |
| |
Price/
Tangible Book (%) |
| |
Price/
TTM Earnings (x) |
| |
Price/
TTM Revenue (x) |
| | | ||||||||||||||||||||||||||||||||||
Federal Life Insurance Company | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||
Maximum
|
| | | $ | 10.00 | | | | | $ | 46.00 | | | | | $ | 300 | | | | | | 26.10% | | | | | | 0.06% | | | | | | -0.22% | | | | | | 58.8% | | | | | | 58.8% | | | | | | NM | | | | | | 1.83x | | | | | ||||
Midpoint
|
| | | $ | 10.00 | | | | | $ | 40.00 | | | | | $ | 294 | | | | | | 24.69% | | | | | | 0.12% | | | | | | -0.48% | | | | | | 55.1% | | | | | | 55.1% | | | | | | NM | | | | | | 1.60x | | | | | ||||
Minimum
|
| | | $ | 10.00 | | | | | $ | 34.00 | | | | | $ | 288 | | | | | | 23.23% | | | | | | 0.18% | | | | | | -0.78% | | | | | | 50.8% | | | | | | 50.8% | | | | | | NM | | | | | | 1.37x | | | | | ||||
Peer Group | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||
Average
|
| | | $ | 64.08 | | | | | $ | 1,264.1 | | | | | $ | 13,748 | | | | | | 17.52% | | | | | | 0.88% | | | | | | 5.65% | | | | | | 93.9% | | | | | | 97.4% | | | | | | 19.56x | | | | | | 1.52x | | | | | ||||
Median
|
| | | $ | 27.95 | | | | | $ | 436.7 | | | | | $ | 4,511 | | | | | | 14.93% | | | | | | 0.62% | | | | | | 5.38% | | | | | | 85.8% | | | | | | 85.8% | | | | | | 14.16x | | | | | | 1.31x | | | | | ||||
All Public Life Insurance Companies | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||||
Average
|
| | | $ | 66.40 | | | | | $ | 10,482.5 | | | | | $ | 130,630 | | | | | | 12.98% | | | | | | 0.42% | | | | | | 1.29% | | | | | | 112.3% | | | | | | 119.8% | | | | | | 17.51x | | | | | | 1.35x | | | | | ||||
Median
|
| | | $ | 51.48 | | | | | $ | 4,373.7 | | | | | $ | 45,699 | | | | | | 13.36% | | | | | | 0.59% | | | | | | 8.35% | | | | | | 98.6% | | | | | | 117.9% | | | | | | 12.81x | | | | | | 1.16x | | | | |
Name
|
| |
Age(1)
|
| |
Position
|
|
Joseph D. Austin | | |
90
|
| | Director and Executive Chairman | |
William S. Austin | | |
54
|
| | Director, President, and Chief Executive Officer | |
Anders Raaum | | |
53
|
| | Chief Financial Officer | |
Michael Austin | | |
60
|
| |
Director, Executive Vice President, and Chief of Marketing Officer
|
|
Wayne R. Ebersberger | | |
63
|
| | Director | |
William H. Springer | | |
88
|
| | Director | |
James H. Stacke | | |
79
|
| | Director | |
Name and Principal Position
|
| |
Year
|
| |
Salary
($) |
| |
Non-Equity
Incentive Plan Compensation ($) |
| |
All Other
Compensation ($)(1) |
| |
Total
($) |
| ||||||||||||
Joseph D. Austin
Chairman and Chief Executive Officer |
| |
2017
|
| | | $ | 418,140 | | | | | | — | | | | | $ | 25,333 | | | | | $ | 443,473 | | |
|
2016
|
| | | | 404,000 | | | | | | — | | | | | | 23,713 | | | | | | 427,713 | | | ||
William S. Austin
President and Chief Operating Officer |
| |
2017
|
| | | | 265,000 | | | | | | — | | | | | | 33,184 | | | | | | 298,184 | | |
|
2016
|
| | | | 254,702 | | | | | | — | | | | | | 32,897 | | | | | | 287,599 | | | ||
Anders Raaum
Chief Financial Officer |
| |
2017
|
| | | | 194,953 | | | | | | — | | | | | | 5,813 | | | | | | 200,766 | | |
|
2016
|
| | | | 190,740 | | | | | | — | | | | | | 5,722 | | | | | | 196,462 | | | ||
Michael Austin
Executive Vice President and Chief Marketing Officer |
| |
2017
|
| | | | 245,861 | | | | | | — | | | | | | 24,892 | | | | | | 270,753 | | |
|
2016
|
| | | | 238,700 | | | | | | — | | | | | | 24,914 | | | | | | 263,614 | | |
Name
|
| |
Title
|
| |
Equity Award(1)(2)
|
|
Joseph D. Austin | | | Chairman | | | Options to purchase [•] shares and [•] shares of restricted stock | |
William S. Austin | | | President and Chief Operating Officer | | | Options to purchase [•] shares and [•] shares of restricted stock | |
Anders Raaum | | | Chief Financial Officer | | | Options to purchase [•] shares and [•] shares of restricted stock | |
Michael Austin | | | Executive Vice President and Chief Marketing Officer | | | Options to purchase [•] shares and [•]shares of restricted stock | |
Wayne R. Ebersberger | | | Director | | | Options to purchase [•] shares | |
William H. Springer | | | Director | | | Options to purchase [•] shares | |
James H. Stacke | | | Director | | | Options to purchase [•] shares | |
Name
|
| |
Fees Earned
or Paid in Cash |
| |
Non-Equity
Incentive Plan Compensation(1) |
| |
Total
|
| |||||||||
Wayne R. Ebersberger
|
| | | $ | 38,350 | | | | | $ | -0- | | | | | $ | 38,350 | | |
William H. Springer
|
| | | $ | 36,950 | | | | | $ | -0- | | | | | $ | 36,950 | | |
James H. Stacke
|
| | | $ | 36,950 | | | | | $ | -0- | | | | | $ | 36,950 | | |
| | |
Page
|
| |||
Audited Consolidated Financial Statements | | | | | | | |
| | | | F-2 | | | |
| | | | F-3 | | | |
| | | | F-4 | | | |
| | | | F-5 | | | |
| | | | F-6 | | | |
| | | | F-7 | | | |
Unaudited Consolidated Financial Statements | | | | | | | |
| | | | F-31 | | | |
| | | | F-32 | | | |
| | | | F-33 | | | |
| | | | F-34 | | | |
| | | | F-35 | | |
(in thousands of dollars)
|
| |
2017
|
| |
2016
|
| ||||||
Assets | | | | | | | | | | | | | |
Investments | | | | | | | | | | | | | |
Securities available for sale, at fair value:
|
| | | | | | | | | | | | |
Fixed maturities (amortized cost; 2017, $183,432; 2016, $170,515)
|
| | | $ | 188,452 | | | | | $ | 174,880 | | |
Equity securities
|
| | | | 6,209 | | | | | | 7,927 | | |
Policy loans
|
| | | | 9,852 | | | | | | 10,059 | | |
Derivative instruments, at fair value
|
| | | | 395 | | | | | | 59 | | |
Total investments
|
| | | | 204,908 | | | | | | 192,925 | | |
Cash and cash equivalents
|
| | | | 4,085 | | | | | | 8,389 | | |
Real estate, property and equipment
|
| | | | 2,151 | | | | | | 2,297 | | |
Accrued investment income
|
| | | | 1,886 | | | | | | 1,832 | | |
Accounts receivable
|
| | | | 538 | | | | | | 575 | | |
Reinsurance recoverables
|
| | | | 3,727 | | | | | | 2,107 | | |
Prepaid reinsurance premiums
|
| | | | 1,358 | | | | | | 924 | | |
Deferred policy acquisition costs, net
|
| | | | 12,179 | | | | | | 11,940 | | |
Deferred sales inducement costs, net
|
| | | | 867 | | | | | | 315 | | |
Deferred tax asset, net
|
| | | | 458 | | | | | | 664 | | |
Other assets
|
| | | | 202 | | | | | | 254 | | |
Separate account asset
|
| | | | 24,779 | | | | | | 21,513 | | |
Total Assets
|
| | | | 257,138 | | | | | | 243,735 | | |
Liabilities | | | | | | | | | | | | | |
Policy liabilities and accruals | | | | | | | | | | | | | |
Policyholder account balance
|
| | | | 109,823 | | | | | | 99,440 | | |
Future life policy benefits
|
| | | | 71,927 | | | | | | 73,097 | | |
Future accident and health policy benefits
|
| | | | 386 | | | | | | 351 | | |
Reserve for deposit type contracts
|
| | | | 10,850 | | | | | | 10,529 | | |
Other policyholder funds
|
| | | | 1,970 | | | | | | 1,889 | | |
Unearned revenue
|
| | | | 1,387 | | | | | | 1,396 | | |
Deferred reinsurance settlements
|
| | | | 2,949 | | | | | | 1,512 | | |
Taxes payable
|
| | | | 7 | | | | | | 6 | | |
Other liabilities
|
| | | | 1,703 | | | | | | 1,140 | | |
Separate account liability
|
| | | | 24,779 | | | | | | 21,513 | | |
Total Liabilities
|
| | | | 225,781 | | | | | | 210,873 | | |
Equity | | | | | | | | | | | | | |
Retained earnings
|
| | | | 26,600 | | | | | | 29,313 | | |
Accumulated other comprehensive income
|
| | | | 4,757 | | | | | | 3,549 | | |
Total Equity
|
| | | | 31,357 | | | | | | 32,862 | | |
Total Liabilities and Equity
|
| | | $ | 257,138 | | | | | $ | 243,735 | | |
|
(in thousands of dollars)
|
| |
2017
|
| |
2016
|
| ||||||
Revenues | | | | | | | | | | | | | |
Insurance revenues
|
| | | $ | 12,058 | | | | | $ | 14,427 | | |
Net investment income
|
| | | | 8,523 | | | | | | 8,821 | | |
Net realized investment gains
|
| | | | 2,228 | | | | | | 1,783 | | |
Other revenues
|
| | | | 194 | | | | | | 173 | | |
Total Revenues
|
| | | | 23,003 | | | | | | 25,204 | | |
Benefits and expenses | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | 13,712 | | | | | | 16,069 | | |
Interest credit to policyholders
|
| | | | 386 | | | | | | 315 | | |
Operating costs and expenses
|
| | | | 7,889 | | | | | | 8,099 | | |
Amortization of deferred acquisition and sales inducement costs
|
| | | | 2,108 | | | | | | 1,876 | | |
Taxes, licenses and fees
|
| | | | 716 | | | | | | 722 | | |
Dividends to policyholders
|
| | | | 66 | | | | | | 86 | | |
Total Benefits and Expenses
|
| | | | 24,877 | | | | | | 27,167 | | |
Net loss before taxes
|
| | | | (1,874) | | | | | | (1,963) | | |
Tax expense
|
| | | | 34 | | | | | | 34 | | |
Net loss
|
| | | $ | (1,908) | | | | | $ | (1,997) | | |
Other Comprehensive Income (Loss), net of tax: | | | | | | | | | | | | | |
Unrealized holding gains (losses) arising during the year (net of tax expense (benefit) of: 2017 $236; 2016 ($185))
|
| | | | 458 | | | | | | (359) | | |
Adjustment to deferred acquisition costs (net of tax expense (benefit) of: 2017 ($28); 2016 $1)
|
| | | | (55) | | | | | | 3 | | |
Other Comprehensive Income (Loss)
|
| | | | 403 | | | | | | (356) | | |
Comprehensive Loss
|
| | | $ | (1,505) | | | | | $ | (2,353) | | |
|
(in thousands of dollars)
|
| |
Accumulated Other
Comprehensive Income |
| |
Retained
Earnings |
| |
Total
|
| |||||||||
Balance, January 1, 2016
|
| | | $ | 3,905 | | | | | $ | 31,310 | | | | | $ | 35,215 | | |
Net loss
|
| | | | — | | | | | | (1,997) | | | | | | (1,997) | | |
Other Comprehensive Loss
|
| | | | (356) | | | | | | — | | | | | | (356) | | |
Balance, December 31, 2016
|
| | | $ | 3,549 | | | | | $ | 29,313 | | | | | $ | 32,862 | | |
|
(in thousands of dollars)
|
| |
Accumulated Other
Comprehensive Income |
| |
Retained
Earnings |
| |
Total
|
| |||||||||
Balance, January 1, 2017
|
| | | $ | 3,549 | | | | | $ | 29,313 | | | | | $ | 32,862 | | |
Net loss
|
| | | | — | | | | | | (1,908) | | | | | | (1,908) | | |
Other Comprehensive Income
|
| | | | 403 | | | | | | — | | | | | | 403 | | |
Cumulative effect of adoption of new accounting principle (see Note 3)
|
| | | | 805 | | | | | | (805) | | | | | | — | | |
Balance, December 31, 2017
|
| | | $ | 4,757 | | | | | $ | 26,600 | | | | | $ | 31,357 | | |
|
(in thousands of dollars)
|
| |
2017
|
| |
2016
|
| ||||||
Cash flows from operating activities: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (1,908) | | | | | $ | (1,997) | | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
| | | | | | | | | | | | |
Realized investment gains, net
|
| | | | (2,228) | | | | | | (1,783) | | |
Amortization on investments
|
| | | | (42) | | | | | | (180) | | |
Depreciation
|
| | | | 271 | | | | | | 263 | | |
Deferred taxes
|
| | | | (1) | | | | | | 1 | | |
Deferred insurance acquisition costs
|
| | | | (2,354) | | | | | | (2,267) | | |
Deferred sales inducement costs
|
| | | | (545) | | | | | | (246) | | |
Interest and amortization of deferred acquisition and sales inducement costs
|
| | | | 2,108 | | | | | | 1,876 | | |
Change in accrued investment income
|
| | | | (54) | | | | | | 119 | | |
Change in receivables
|
| | | | 37 | | | | | | (23) | | |
Change in reinsurance recoverable
|
| | | | (1,620) | | | | | | (1,696) | | |
Change in prepaid reinsurance premiums
|
| | | | (434) | | | | | | (821) | | |
Change in policy benefits
|
| | | | (1,053) | | | | | | 349 | | |
Change in unearned revenue
|
| | | | (8) | | | | | | 162 | | |
Change in deferred reinsurance settlements
|
| | | | 1,437 | | | | | | 1,512 | | |
Change in other assets and liabilities
|
| | | | 615 | | | | | | (325) | | |
Net cash used in operating activities
|
| | | $ | (5,779) | | | | | $ | (5,056) | | |
Cash flows from investing activities: | | | | | | | | | | | | | |
Proceeds from investments sold or matured:
|
| | | | | | | | | | | | |
Fixed maturity securities
|
| | | | 23,130 | | | | | | 26,986 | | |
Equity securities
|
| | | | 4,043 | | | | | | 3,974 | | |
Derivatives
|
| | | | 154 | | | | | | 0 | | |
Policy loans
|
| | | | 206 | | | | | | 70 | | |
Costs of investments purchased:
|
| | | | | | | | | | | | |
Fixed maturity securities
|
| | | | (35,816) | | | | | | (28,479) | | |
Equity securities
|
| | | | (327) | | | | | | (486) | | |
Derivatives
|
| | | | (255) | | | | | | (60) | | |
Real estate additions
|
| | | | (84) | | | | | | (226) | | |
Other investing activities
|
| | | | (238) | | | | | | (17) | | |
Purchase of property and equipment
|
| | | | (41) | | | | | | (109) | | |
Net cash (used in) provided by investing activities
|
| | | | (9,228) | | | | | | 1,653 | | |
Cash flows from financing activities: | | | | | | | | | | | | | |
Policyholder account balances:
|
| | | | | | | | | | | | |
Deposits
|
| | | | 19,300 | | | | | | 14,559 | | |
Withdrawals
|
| | | | (8,482) | | | | | | (9,366) | | |
Net transfers (to) from separate accounts
|
| | | | (115) | | | | | | 46 | | |
Net cash provided by financing activities
|
| | | | 10,703 | | | | | | 5,239 | | |
Net (decrease) increase in cash
|
| | | | (4,304) | | | | | | 1,836 | | |
Cash, beginning of year
|
| | | | 8,389 | | | | | | 6,553 | | |
Cash, end of year
|
| | | $ | 4,085 | | | | | $ | 8,389 | | |
|
| | |
December 31, 2017
|
| |||||||||||||||||||||
| | |
Amortized
Cost |
| |
Gross Unrealized
|
| |
Fair
Value |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
U.S. government
|
| | | $ | 4,075 | | | | | $ | 207 | | | | | $ | (120) | | | | | $ | 4,162 | | |
States, political subdivisions, other
|
| | | | 26,850 | | | | | | 876 | | | | | | (112) | | | | | | 27,614 | | |
Corporate
|
| | | | 106,479 | | | | | | 3,459 | | | | | | (543) | | | | | | 109,395 | | |
Residential mortgage-backed securities
|
| | | | 41,818 | | | | | | 1,480 | | | | | | (212) | | | | | | 43,086 | | |
Commercial mortgage-backed securities
|
| | | | 4,210 | | | | | | 26 | | | | | | (41) | | | | | | 4,195 | | |
Total fixed maturity securities
|
| | | | 183,432 | | | | | | 6,048 | | | | | | (1,028) | | | | | | 188,452 | | |
Equity securities
|
| | | | 4,443 | | | | | | 1,766 | | | | | | — | | | | | | 6,209 | | |
Total fixed maturity and equity securities
|
| | | $ | 187,875 | | | | | $ | 7,814 | | | | | $ | (1,028) | | | | | $ | 194,661 | | |
|
| | |
December 31, 2016
|
| |||||||||||||||||||||
| | |
Amortized
Cost |
| |
Gross Unrealized
|
| |
Fair
Value |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
U.S. government
|
| | | $ | 4,087 | | | | | $ | 267 | | | | | $ | (140) | | | | | $ | 4,214 | | |
States, political subdivisions, other
|
| | | | 19,627 | | | | | | 616 | | | | | | (130) | | | | | | 20,113 | | |
Corporate
|
| | | | 101,698 | | | | | | 3,452 | | | | | | (974) | | | | | | 104,176 | | |
Residential mortgage-backed securities
|
| | | | 35,282 | | | | | | 1,450 | | | | | | (314) | | | | | | 36,418 | | |
Commercial mortgage-backed securities
|
| | | | 9,821 | | | | | | 228 | | | | | | (90) | | | | | | 9,959 | | |
Total fixed maturity securities
|
| | | | 170,515 | | | | | | 6,013 | | | | | | (1,648) | | | | | | 174,880 | | |
Equity securities
|
| | | | 6,202 | | | | | | 1,745 | | | | | | (20) | | | | | | 7,927 | | |
Total fixed maturity and equity securities
|
| | | $ | 176,717 | | | | | $ | 7,758 | | | | | $ | (1,668) | | | | | $ | 182,807 | | |
|
| | |
December 31, 2017
|
| |
December 31, 2016
|
| ||||||||||||||||||
| | |
Amortized
Cost |
| |
Fair
Value |
| |
Amortized
Cost |
| |
Fair
Value |
| ||||||||||||
Due in one year or less
|
| | | $ | 2,247 | | | | | $ | 2,288 | | | | | $ | 5,038 | | | | | $ | 5,161 | | |
Due after one year through five years
|
| | | | 40,926 | | | | | | 42,809 | | | | | | 34,101 | | | | | | 36,605 | | |
Due after five years through ten years
|
| | | | 66,739 | | | | | | 68,151 | | | | | | 66,029 | | | | | | 66,648 | | |
Due after ten years
|
| | | | 27,492 | | | | | | 27,923 | | | | | | 20,244 | | | | | | 20,089 | | |
Mortgage-backed securities
|
| | | | 46,028 | | | | | | 47,281 | | | | | | 45,103 | | | | | | 46,377 | | |
Total
|
| | | $ | 183,432 | | | | | $ | 188,452 | | | | | $ | 170,515 | | | | | $ | 174,880 | | |
|
| | |
2017
|
| |||||||||||||||
| | |
Fixed
Maturities |
| |
Equity
Securities |
| |
Derivative
Instruments |
| |||||||||
Proceeds from sales or maturities
|
| | | $ | 23,130 | | | | | $ | 4,043 | | | | | $ | 154 | | |
Gross gains from sales or maturities
|
| | | | 200 | | | | | | 1,957 | | | | | | 183 | | |
Gross losses from sales or maturities
|
| | | | (23) | | | | | | — | | | | | | (89) | | |
| | |
2016
|
| |||||||||
| | |
Fixed
Maturities |
| |
Equity
Securities |
| ||||||
Proceeds from sales or maturities
|
| | | $ | 26,986 | | | | | $ | 3,974 | | |
Gross gains from sales or maturities
|
| | | | 208 | | | | | | 1,714 | | |
Gross losses from sales or maturities
|
| | | | (78) | | | | | | (61) | | |
2017
|
| |
Less than 12 months
|
| |
12 months or longer
|
| |
Total
|
| |||||||||||||||||||||||||||
Description of Securities
|
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| ||||||||||||||||||
U.S. government
|
| | | $ | 1,161 | | | | | $ | (31) | | | | | $ | 1,782 | | | | | $ | (89) | | | | | $ | 2,943 | | | | | $ | (120) | | |
States, political subdivisions, other
|
| | | | 8,773 | | | | | | (86) | | | | | | 714 | | | | | | (26) | | | | | | 9,487 | | | | | | (112) | | |
Corporate
|
| | | | 10,935 | | | | | | (169) | | | | | | 6,853 | | | | | | (374) | | | | | | 17,788 | | | | | | (543) | | |
Residential mortgage-backed securities
|
| | | | 11,517 | | | | | | (126) | | | | | | 2,263 | | | | | | (86) | | | | | | 13,780 | | | | | | (212) | | |
Commercial mortgage-backed securities
|
| | | | 2,039 | | | | | | (27) | | | | | | 77 | | | | | | (14) | | | | | | 2,116 | | | | | | (41) | | |
Equity securities
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Total
|
| | | $ | 34,425 | | | | | $ | (439) | | | | | $ | 11,689 | | | | | $ | (589) | | | | | $ | 46,114 | | | | | $ | (1,028) | | |
|
2016
|
| |
Less than 12 months
|
| |
12 months or longer
|
| |
Total
|
| |||||||||||||||||||||||||||
Description of Securities
|
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| ||||||||||||||||||
U.S. government
|
| | | $ | 2,932 | | | | | $ | (140) | | | | | $ | — | | | | | $ | — | | | | | $ | 2,932 | | | | | $ | (140) | | |
States, political subdivisions, other
|
| | | | 5,983 | | | | | | (130) | | | | | | — | | | | | | — | | | | | | 5,983 | | | | | | (130) | | |
Corporate
|
| | | | 25,055 | | | | | | (791) | | | | | | 3,239 | | | | | | (183) | | | | | | 28,294 | | | | | | (974) | | |
Residential mortgage-backed securities
|
| | | | 11,367 | | | | | | (314) | | | | | | — | | | | | | — | | | | | | 11,367 | | | | | | (314) | | |
Commercial mortgage-backed securities
|
| | | | 979 | | | | | | (25) | | | | | | 538 | | | | | | (65) | | | | | | 1,517 | | | | | | (90) | | |
Equity securities
|
| | | | 183 | | | | | | (3) | | | | | | 180 | | | | | | (17) | | | | | | 363 | | | | | | (20) | | |
Total
|
| | | $ | 46,499 | | | | | $ | (1,403) | | | | | $ | 3,957 | | | | | $ | (265) | | | | | $ | 50,456 | | | | | $ | (1,668) | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Fixed maturity securities
|
| | | $ | 7,350 | | | | | $ | 7,818 | | |
Equity securities
|
| | | | 181 | | | | | | 253 | | |
Real estate
|
| | | | 149 | | | | | | 122 | | |
Cash equivalents
|
| | | | 32 | | | | | | 9 | | |
Policy loans
|
| | | | 723 | | | | | | 737 | | |
Other
|
| | | | 685 | | | | | | 470 | | |
Subtotal
|
| | | | 9,120 | | | | | | 9,409 | | |
Investment expense
|
| | | | (597) | | | | | | (588) | | |
Net investment income
|
| | | $ | 8,523 | | | | | $ | 8,821 | | |
|
| | |
December 31, 2017
|
| |||||||||||||||||||||
| | |
Fair
Value |
| |
Gross Unrealized
|
| |
Net
Unrealized Gain (Loss) |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
Fixed income securities
|
| | | $ | 188,452 | | | | | $ | 6,048 | | | | | $ | (1,028) | | | | | $ | 5,020 | | |
Equity securities
|
| | | | 6,209 | | | | | | 1,766 | | | | | | — | | | | | | 1,766 | | |
Net unrealized capital gains
|
| | | | | | | | | | | | | | | | | | | | | $ | 6,786 | | |
|
| | |
December 31, 2016
|
| |||||||||||||||||||||
| | |
Fair
Value |
| |
Gross Unrealized
|
| |
Net
Unrealized Gain (Loss) |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
Fixed income securities
|
| | | $ | 174,880 | | | | | $ | 6,013 | | | | | $ | (1,648) | | | | | $ | 4,365 | | |
Equity securities
|
| | | | 7,927 | | | | | | 1,745 | | | | | | (20) | | | | | | 1,725 | | |
Net unrealized capital gains
|
| | | | | | | | | | | | | | | | | | | | | $ | 6,090 | | |
|
| | |
Carrying/Fair
Value 12/31/2017 |
| |
Carrying/Fair
Value 12/31/2016 |
| ||||||
Financial instruments recorded as assets: | | | | | | | | | | | | | |
Fixed maturity securities
|
| | | $ | 188,452 | | | | | $ | 174,880 | | |
Equity securities
|
| | | | 6,209 | | | | | | 7,927 | | |
Policy loans
|
| | | | 9,852 | | | | | | 10,059 | | |
Derivative instruments
|
| | | | 395 | | | | | | 59 | | |
Cash and cash equivalents
|
| | | | 4,085 | | | | | | 8,389 | | |
Separate account
|
| | | | 24,779 | | | | | | 21,513 | | |
Financial Instruments recorded as liabilities: | | | | | | | | | | | | | |
Policyholder account balance:
|
| | | | | | | | | | | | |
Interest sensitive life contracts
|
| | | | 41,078 | | | | | | 40,508 | | |
Annuities
|
| | | | 68,745 | | | | | | 58,932 | | |
Dividend accumulations and other(1)
|
| | | | 7,076 | | | | | | 7,413 | | |
Separate account
|
| | | | 24,779 | | | | | | 21,513 | | |
| | |
Recurring Fair Value Measurements
at December 31, 2017 Using: |
| |||||||||||||||||||||
Description
|
| |
Fair Values
|
| |
Quoted Prices
in Active Markets for Identical Assets (Level 1) |
| |
Significant
Other Observable Inputs (Level 2) |
| |
Significant
Unobservable Inputs (Level 3) |
| ||||||||||||
Fixed maturity securities: | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. government
|
| | | $ | 4,162 | | | | | $ | 4,162 | | | | | $ | — | | | | | $ | — | | |
States, political subdivisions, other
|
| | | | 27,614 | | | | | | — | | | | | | 27,614 | | | | | | — | | |
Corporate
|
| | | | 109,395 | | | | | | — | | | | | | 109,395 | | | | | | — | | |
Residential mortgage-backed securities
|
| | | | 43,086 | | | | | | — | | | | | | 43,086 | | | | | | — | | |
Commercial mortgage-backed securities
|
| | | | 4,195 | | | | | | — | | | | | | 4,195 | | | | | | — | | |
Total fixed maturities
|
| | | | 188,452 | | | | | | 4,162 | | | | | | 184,290 | | | | | | — | | |
Equities
|
| | | | 6,209 | | | | | | 4,027 | | | | | | — | | | | | | 2,182 | | |
Derivative instruments
|
| | | | 395 | | | | | | 395 | | | | | | — | | | | | | — | | |
Cash equivalents(1)
|
| | | | 4,085 | | | | | | 4,085 | | | | | | — | | | | | | — | | |
Separate accounts(2)
|
| | | | 24,779 | | | | | | 24,779 | | | | | | — | | | | | | — | | |
Total
|
| | | $ | 223,920 | | | | | $ | 37,448 | | | | | $ | 184,290 | | | | | $ | 2,182 | | |
|
| | |
Recurring Fair Value Measurements
at December 31, 2016 Using: |
| |||||||||||||||||||||
Description
|
| |
Fair Values
|
| |
Quoted Prices
in Active Markets for Identical Assets (Level 1) |
| |
Significant
Other Observable Inputs (Level 2) |
| |
Significant
Unobservable Inputs (Level 3) |
| ||||||||||||
Fixed maturity securities: | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. government
|
| | | $ | 4,214 | | | | | $ | 4,214 | | | | | $ | — | | | | | $ | — | | |
States, political subdivisions, other
|
| | | | 20,113 | | | | | | — | | | | | | 20,113 | | | | | | — | | |
Corporate
|
| | | | 104,176 | | | | | | — | | | | | | 104,176 | | | | | | — | | |
Residential mortgage-backed securities
|
| | | | 36,418 | | | | | | — | | | | | | 36,418 | | | | | | — | | |
Commercial mortgage-backed securities
|
| | | | 9,959 | | | | | | — | | | | | | 9,959 | | | | | | — | | |
Total fixed maturities
|
| | | | 174,880 | | | | | | 4,214 | | | | | | 170,666 | | | | | | — | | |
Equities
|
| | | | 7,927 | | | | | | 4,758 | | | | | | — | | | | | | 3,169 | | |
Derivative instruments
|
| | | | 59 | | | | | | 59 | | | | | | — | | | | | | — | | |
Cash equivalents(1)
|
| | | | 5,670 | | | | | | 5,670 | | | | | | — | | | | | | — | | |
Separate accounts(2)
|
| | | | 21,513 | | | | | | 21,513 | | | | | | — | | | | | | — | | |
Total
|
| | | $ | 210,049 | | | | | $ | 36,214 | | | | | $ | 170,666 | | | | | $ | 3,169 | | |
|
Fair value at December 31, 2017
|
| | | | | | | |
Primary Valuation
Technique(s) |
| |
Significant
Unobservable Inputs |
| |
Range
|
| |
Weighted
Average |
| ||||||||||||
|
Min
|
| |
Max
|
| ||||||||||||||||||||||||||
Rreef America REIT II
|
| | | $ | 2,150 | | | |
Discounted Cash Flows
|
| | Discounted Rate | | | | | 5.50% | | | | | | 9.00% | | | | | | 6.61% | | |
| | | | | | | | | | | |
Term capitalization rate
|
| | | | 4.00% | | | | | | 8.25% | | | | | | 5.62% | | |
Fair value at December 31, 2016
|
| | | | | | | |
Primary Valuation
Technique(s) |
| |
Significant
Unobservable Inputs |
| |
Range
|
| |
Weighted
Average |
| ||||||||||||
|
Min
|
| |
Max
|
| ||||||||||||||||||||||||||
Rreef America REIT II
|
| | | $ | 3,074 | | | |
Discounted cash flows
|
| | Discounted Rate | | | | | 5.50% | | | | | | 10.75% | | | | | | 6.71% | | |
| | | | | | | | | | | |
Term capitalization rate
|
| | | | 4.00% | | | | | | 9.50% | | | | | | 5.70% | | |
| | |
2017
|
| |
2016
|
| ||||||
Balance, beginning of year
|
| | | $ | 3,169 | | | | | $ | 6,006 | | |
Gains included in net income
|
| | | | 396 | | | | | | 1,131 | | |
Settlements
|
| | | | (1,000) | | | | | | (3,000) | | |
Unrealized gains (losses) in OCI
|
| | | | (383) | | | | | | (968) | | |
Balance, end of year
|
| | | $ | 2,182 | | | | | $ | 3,169 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Balance, beginning of year
|
| | | $ | 11,940 | | | | | $ | 12,288 | | |
Capitalization of commissions, sales and issue expenses
|
| | | | 2,437 | | | | | | 2,263 | | |
Accrual of interest
|
| | | | 544 | | | | | | 530 | | |
Amortization
|
| | | | (2,659) | | | | | | (2,462) | | |
Change in Shadow DAC
|
| | | | (83) | | | | | | (679) | | |
Balance end of year
|
| | | $ | 12,179 | | | | | $ | 11,940 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Balance, beginning of year
|
| | | $ | 315 | | | | | $ | 13 | | |
Capitalization of commissions and issue expenses
|
| | | | 545 | | | | | | 246 | | |
Accrual of interest
|
| | | | 18 | | | | | | — | | |
Amortization
|
| | | | (11) | | | | | | 56 | | |
Balance end of year
|
| | | $ | 867 | | | | | $ | 315 | | |
|
| | |
Unrealized
Investment Gains (losses) |
| |
Shadow DAC
|
| |
Accumulated
Other Comprehensive Income (loss) |
| |||||||||
Balance, December 31, 2015
|
| | | $ | 4,356 | | | | | $ | (451) | | | | | $ | 3,905 | | |
Available-for-sale investment gains (losses) arising during the year:
|
| | | | | | | | | | | | | | | | | | |
Fixed maturity securities net of tax benefit of $29
|
| | | | (56) | | | | | | | | | | | | (56) | | |
Equity securities net of tax benefit of $156
|
| | | | (303) | | | | | | | | | | | | (303) | | |
Change in Shadow DAC net of tax of $1
|
| | | | | | | | | | 3 | | | | | | 3 | | |
Balance, December 31, 2016
|
| | | $ | 3,997 | | | | | $ | (448) | | | | | $ | 3,549 | | |
Available-for-sale investment gains (losses) arising during the year:
|
| | | | | | | | | | | | | | | | | | |
Fixed maturity securities net of tax of $227
|
| | | | 440 | | | | | | | | | | | | 440 | | |
Equity securities net of tax of $9
|
| | | | 18 | | | | | | | | | | | | 18 | | |
Change in Shadow DAC net of tax benefit of $28
|
| | | | | | | | | | (55) | | | | | | (55) | | |
Cumulative effect of adoption of new accounting principle (see Note 3)
|
| | | | 904 | | | | | | (99) | | | | | | 805 | | |
Balance, December 31, 2017
|
| | | $ | 5,359 | | | | | $ | (602) | | | | | $ | 4,757 | | |
| | |
December 31, 2017
|
| |
December 31, 2016
|
| ||||||
Balance, beginning of year
|
| | | $ | 21,513 | | | | | $ | 23,335 | | |
Cost of bonds and stocks acquired
|
| | | | 299 | | | | | | 80 | | |
Unrealized valuation increase
|
| | | | 3,275 | | | | | | 91 | | |
Total gain on disposals
|
| | | | 186 | | | | | | 1,820 | | |
Deduction consideration for bonds and stocks disposed of
|
| | | | (562) | | | | | | (3,813) | | |
Other assets
|
| | | | 68 | | | | | | — | | |
Balance end of year
|
| | | $ | 24,779 | | | | | $ | 21,513 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Traditional life contracts
|
| | | $ | 62,311 | | | | | $ | 63,141 | | |
Immediate annuities and pension plan
|
| | | | 6,774 | | | | | | 7,135 | | |
Supplemental contracts with life contingencies
|
| | | | 2,522 | | | | | | 2,500 | | |
Accident and health
|
| | | | 386 | | | | | | 351 | | |
Accident death benefits
|
| | | | 132 | | | | | | 130 | | |
Disability
|
| | | | 188 | | | | | | 191 | | |
| | | | $ | 72,313 | | | | | $ | 73,448 | | |
|
Product
|
| |
Mortality
|
| |
Interest Rate
|
| |
Estimation Method
|
|
Immediate fixed annuities | | | 1971, 1983, 2000, and 2012 annuity mortality tables |
| | Rates range from 4% to 6.5% |
| | Present value of expected future benefits based on historical experience | |
Traditional life insurance | | | Actual company experience plus loading |
| | Rates range from 2.5% to 5.75% |
| | Net level premium reserve method using the Company’s withdrawal experience |
|
Accident and health | | | Actual company experience plus loading |
| | n/a | | | Unearned premium; additional contract reserves for mortality risk |
|
| | |
2017
|
| |
2016
|
| ||||||
Interest sensitive life contracts
|
| | | $ | 41,078 | | | | | $ | 40,508 | | |
Annuities
|
| | | | 68,745 | | | | | | 58,932 | | |
| | | | $ | 109,823 | | | | | $ | 99,440 | | |
|
Product
|
| |
Interest Rate
|
| |
Withdrawal/surrender charges
|
|
Interest-sensitive life insurance | | | Rates range from 3% to 7% | | | Either a percentage of account balance or a dollar amount grading off generally over 20 years | |
Fixed annuities | | | Rates range from 0% to 8% | | | Either a declining or level charge generally over 9 years or less | |
Other investment contracts | | | Rates range from 2% to 6% | | | No explicit charge assumed | |
| | |
2017
|
| |
2016
|
| ||||||
Balance, beginning of year
|
| | | $ | 99,440 | | | | | $ | 94,691 | | |
Deposits
|
| | | | 17,994 | | | | | | 13,005 | | |
Interests credited
|
| | | | 4,353 | | | | | | 3,932 | | |
Benefits
|
| | | | (2,734) | | | | | | (2,446) | | |
Surrenders and partial withdrawals
|
| | | | (4,835) | | | | | | (5,769) | | |
COI charges
|
| | | | (2,973) | | | | | | (2,852) | | |
Contract charges
|
| | | | (1,307) | | | | | | (1,167) | | |
Net transfers from separate accounts
|
| | | | (115) | | | | | | 46 | | |
Balance, end of year
|
| | | $ | 109,823 | | | | | $ | 99,440 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Payout annuities without life contingencies
|
| | | $ | 3,774 | | | | | $ | 3,116 | | |
Dividend accumulations and other
|
| | | | 7,076 | | | | | | 7,413 | | |
| | | | $ | 10,850 | | | | | $ | 10,529 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Land
|
| | | $ | 405 | | | | | $ | 405 | | |
Building and other
|
| | | | 8,378 | | | | | | 8,294 | | |
| | | | | 8,783 | | | | | | 8,699 | | |
Accumulated depreciation
|
| | | | (6,828) | | | | | | (6,712) | | |
Real Estate, net
|
| | | $ | 1,955 | | | | | $ | 1,987 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
EDP equipment
|
| | | $ | 3,955 | | | | | $ | 3,963 | | |
Furniture
|
| | | | 1,522 | | | | | | 1,501 | | |
EDP equipment & furniture cost
|
| | | | 5,477 | | | | | | 5,464 | | |
Accumulated depreciation
|
| | | | (5,281) | | | | | | (5,154) | | |
Property and Equipment, net
|
| | | $ | 196 | | | | | $ | 310 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Current
|
| | | $ | 34 | | | | | $ | 34 | | |
Deferred
|
| | | | — | | | | | | — | | |
Provision for income tax
|
| | | $ | 34 | | | | | $ | 34 | | |
|
| | |
2017
|
| |
2016
|
| ||||||
Income taxes at statutory rate
|
| | | $ | (637) | | | | | $ | (667) | | |
Dividends received deduction
|
| | | | — | | | | | | — | | |
Tax effect from change in enacted tax rate
|
| | | | 805 | | | | | | — | | |
Other
|
| | | | (134) | | | | | | (701) | | |
Income tax (benefit) expense
|
| | | $ | 34 | | | | | $ | 34 | | |
Effective tax rate
|
| | | | -1.8% | | | | | | -1.7% | | |
| | |
2017
|
| |
2016
|
| ||||||
Deferred federal tax assets: | | | | | | | | | | | | | |
Difference between financial reporting and the tax basis of: | | | | | | | | | | | | | |
Operating loss carry forward
|
| | | $ | 5,859 | | | | | $ | 9,567 | | |
Other than temporary impairments
|
| | | | 947 | | | | | | 1,545 | | |
Deferred premiums
|
| | | | 734 | | | | | | 1,465 | | |
Life policy reserves
|
| | | | 600 | | | | | | 103 | | |
Other
|
| | | | 380 | | | | | | 745 | | |
Deferred reinsurance settlements
|
| | | | 619 | | | | | | 514 | | |
Total deferred tax assets
|
| | | $ | 9,139 | | | | | | 13,939 | | |
Deferred federal tax liabilities: | | | | | | | | | | | | | |
Difference between financial reporting and the tax basis of: | | | | | | | | | | | | | |
Deferred acquisition costs and sales inducements
|
| | | $ | 2,147 | | | | | | 3,215 | | |
Net unrealized gains
|
| | | | 1,421 | | | | | | 2,064 | | |
Reinsurance recoverable
|
| | | | 766 | | | | | | 716 | | |
Amortized discount on bonds
|
| | | | 138 | | | | | | 527 | | |
Other
|
| | | | 143 | | | | | | 516 | | |
Fixed assets
|
| | | | 53 | | | | | | 89 | | |
Total deferred tax liabilities
|
| | | | 4,668 | | | | | | 7,127 | | |
Net
|
| | | | 4,471 | | | | | | 6,812 | | |
Less valuation allowance
|
| | | | (4,013) | | | | | | (6,148) | | |
Net deferred tax asset
|
| | | $ | 458 | | | | | $ | 664 | | |
|
Expiring
|
| | |||||
2018
|
| | | $ | 167 | | |
2019
|
| | | | 1,590 | | |
2020
|
| | | | 2,296 | | |
2021
|
| | | | 651 | | |
2022
|
| | | | 520 | | |
2023
|
| | | | 861 | | |
2024
|
| | | | 1,762 | | |
2025
|
| | | | 7,836 | | |
2026
|
| | | | 2,188 | | |
2027
|
| | | | 1,353 | | |
2028
|
| | | | 2,664 | | |
2029
|
| | | | 509 | | |
2030
|
| | | | 2,240 | | |
2031
|
| | | | 1,119 | | |
2032
|
| | | | 596 | | |
Total
|
| | | $ | 26,352 | | |
|
(in thousands of dollars)
|
| |
6/30/2018
|
| |
12/31/2017
|
| ||||||
| | |
(unaudited)
|
| | ||||||||
Assets | | | | | | | | | | | | | |
Investments | | | | | | | | | | | | | |
Securities available for sale, at fair value:
|
| | | | | | | | | | | | |
Fixed maturities (amortized cost; 2018, $185,247; 2017, $183,432)
|
| | | $ | 183,249 | | | | | $ | 188,452 | | |
Equity securities
|
| | | | 6,362 | | | | | | 6,209 | | |
Policy loans
|
| | | | 9,718 | | | | | | 9,852 | | |
Derivative instruments, at fair value
|
| | | | 398 | | | | | | 395 | | |
Total investments
|
| | | | 199,727 | | | | | | 204,908 | | |
Cash and cash equivalents
|
| | | | 3,913 | | | | | | 4,085 | | |
Real estate, property and equipment
|
| | | | 2,166 | | | | | | 2,151 | | |
Accrued investment income
|
| | | | 1,929 | | | | | | 1,886 | | |
Accounts receivable
|
| | | | 2,417 | | | | | | 538 | | |
Reinsurance recoverables
|
| | | | 3,622 | | | | | | 3,727 | | |
Prepaid reinsurance premiums
|
| | | | 1,379 | | | | | | 1,358 | | |
Deferred policy acquisition costs, net
|
| | | | 13,320 | | | | | | 12,179 | | |
Deferred sales inducement costs, net
|
| | | | 1,076 | | | | | | 867 | | |
Deferred tax asset, net
|
| | | | 495 | | | | | | 458 | | |
Other assets
|
| | | | 296 | | | | | | 202 | | |
Separate account asset
|
| | | | 23,690 | | | | | | 24,779 | | |
Total Assets
|
| | | | 254,030 | | | | | | 257,138 | | |
Liabilities | | | | | | | | | | | | | |
Policy liabilities and accruals | | | | | | | | | | | | | |
Policyholder account balance
|
| | | | 113,654 | | | | | | 109,823 | | |
Future life policy benefits
|
| | | | 72,608 | | | | | | 71,927 | | |
Future accident and health policy benefits
|
| | | | 343 | | | | | | 386 | | |
Reserve for deposit type contracts
|
| | | | 11,222 | | | | | | 10,850 | | |
Other policyholder funds
|
| | | | 2,733 | | | | | | 1,970 | | |
Unearned revenue
|
| | | | 1,357 | | | | | | 1,387 | | |
Deferred reinsurance settlements
|
| | | | 2,826 | | | | | | 2,949 | | |
Taxes payable
|
| | | | 7 | | | | | | 7 | | |
Other liabilities
|
| | | | 2,073 | | | | | | 1,703 | | |
Separate account liability
|
| | | | 23,690 | | | | | | 24,779 | | |
Total Liabilities
|
| | | | 230,513 | | | | | | 225,781 | | |
Equity | | | | | | | | | | | | | |
Retained earnings
|
| | | | 24,606 | | | | | | 26,600 | | |
Accumulated other comprehensive income (loss)
|
| | | | (1,089) | | | | | | 4,757 | | |
Total Equity
|
| | | | 23,517 | | | | | | 31,357 | | |
Total Liabilities and Equity
|
| | | $ | 254,030 | | | | | $ | 257,138 | | |
|
| | |
for the six-month periods ended
|
| |||||||||
(in thousands of dollars)
|
| |
6/30/2018
|
| |
6/30/2017
|
| ||||||
Revenues | | | | | | | | | | | | | |
Insurance revenues
|
| | | $ | 6,258 | | | | | $ | 6,596 | | |
Net investment income
|
| | | | 4,218 | | | | | | 4,292 | | |
Net realized investment gains
|
| | | | 324 | | | | | | 904 | | |
Other revenues
|
| | | | 97 | | | | | | 85 | | |
Total Revenues
|
| | | | 10,897 | | | | | | 11,877 | | |
Benefits and expenses | | | | | | | | | | | | | |
Policyholder benefits
|
| | | | 7,018 | | | | | | 7,215 | | |
Interest credit to policyholders
|
| | | | 207 | | | | | | 114 | | |
Operating costs and expenses
|
| | | | 4,331 | | | | | | 3,994 | | |
Amortization of deferred acquisition and sales inducement costs
|
| | | | 897 | | | | | | 1,124 | | |
Taxes, licenses and fees
|
| | | | 398 | | | | | | 392 | | |
Dividends to policyholders
|
| | | | 31 | | | | | | 31 | | |
Total Benefits and Expenses
|
| | | | 12,882 | | | | | | 12,870 | | |
Net loss before taxes
|
| | | | (1,985) | | | | | | (993) | | |
Tax expense
|
| | | | 9 | | | | | | 14 | | |
Net loss
|
| | | $ | (1,994) | | | | | $ | (1,007) | | |
Other Comprehensive Income (Loss), net of tax: | | | | | | | | | | | | | |
Unrealized holding gains (losses) arising during the year (net of
tax expense (benefit) of: 2018 ($255); 2017 $506) |
| | | | (6,663) | | | | | | 982 | | |
Adjustment to deferred acquisition costs (net of tax expense
(benefit) of: 2018 $217; 2017 ($73)) |
| | | | 817 | | | | | | (142) | | |
Other Comprehensive Income (Loss)
|
| | | | (5,846) | | | | | | 840 | | |
Comprehensive Loss
|
| | | $ | (7,840) | | | | | $ | (167) | | |
|
(in thousands of dollars)
|
| |
Accumulated Other
Comprehensive Income (Loss) |
| |
Retained
Earnings |
| |
Total
|
| |||||||||
Balance, January 1, 2018
|
| | | $ | 4,757 | | | | | $ | 26,600 | | | | | $ | 31,357 | | |
Net loss
|
| | | | — | | | | | | (1,994) | | | | | | (1,994) | | |
Other Comprehensive Loss
|
| | | | (5,846) | | | | | | — | | | | | | (5,846) | | |
Balance, June 30, 2018
|
| | | $ | (1,089) | | | | | $ | 24,606 | | | | | $ | 23,517 | | |
|
| | |
for the six-month periods ended
|
| |||||||||
(in thousands of dollars)
|
| |
6/30/2018
|
| |
6/30/2017
|
| ||||||
Cash flows from operating activities: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (1,994) | | | | | $ | (1,007) | | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
| | | | | | | | | | | | |
Realized investment gains, net
|
| | | | (324) | | | | | | (904) | | |
Amortization on investments
|
| | | | (40) | | | | | | (46) | | |
Depreciation
|
| | | | 137 | | | | | | 137 | | |
Deferred taxes
|
| | | | 1 | | | | | | — | | |
Deferred insurance acquisition costs
|
| | | | (2,046) | | | | | | (1,039) | | |
Deferred sales inducement costs
|
| | | | (201) | | | | | | (263) | | |
Interest and amortization of deferred acquisition and sales inducement costs
|
| | | | 897 | | | | | | 1,124 | | |
Change in accrued investment income
|
| | | | (42) | | | | | | (13) | | |
Change in receivables
|
| | | | (1,879) | | | | | | (1,455) | | |
Change in reinsurance recoverable
|
| | | | 105 | | | | | | 4 | | |
Change in prepaid reinsurance premiums
|
| | | | (21) | | | | | | (36) | | |
Change in policy benefits
|
| | | | 1,401 | | | | | | 1,650 | | |
Change in unearned revenue
|
| | | | (30) | | | | | | (8) | | |
Change in deferred reinsurance settlements
|
| | | | (123) | | | | | | (108) | | |
Change in other assets and liabilities
|
| | | | 276 | | | | | | 602 | | |
Net cash used in operating activities
|
| | | $ | (3,883) | | | | | $ | (1,362) | | |
Cash flows from investing activities: | | | | | | | | | | | | | |
Proceeds from investments sold or matured:
|
| | | | | | | | | | | | |
Fixed maturity securities
|
| | | | 8,197 | | | | | | 13,346 | | |
Equity securities
|
| | | | 261 | | | | | | 1,541 | | |
Derivatives
|
| | | | 206 | | | | | | 3 | | |
Policy loans
|
| | | | 134 | | | | | | 151 | | |
Costs of investments purchased:
|
| | | | | | | | | | | | |
Fixed maturity securities
|
| | | | (10,026) | | | | | | (18,938) | | |
Equity securities
|
| | | | (41) | | | | | | (167) | | |
Derivatives
|
| | | | (202) | | | | | | (90) | | |
Real estate additions
|
| | | | (61) | | | | | | (3) | | |
Other investing activies
|
| | | | 1,131 | | | | | | (277) | | |
Purchase of property and equipment
|
| | | | (92) | | | | | | (27) | | |
Net cash used in investing activities
|
| | | | (493) | | | | | | (4,461) | | |
Cash flows from financing activites: | | | | | | | | | | | | | |
Policyholder account balances:
|
| | | | | | | | | | | | |
Deposits
|
| | | | 8,388 | | | | | | 9,104 | | |
Withdrawals
|
| | | | (4,184) | | | | | | (4,749) | | |
Net transfers from separate acounts
|
| | | | 0 | | | | | | 260 | | |
Net cash provided by financing activities
|
| | | | 4,204 | | | | | | 4,615 | | |
Net decrease in cash
|
| | | | (172) | | | | | | (1,208) | | |
Cash, beginning of year
|
| | | | 4,085 | | | | | | 8,389 | | |
Cash, end of period
|
| | | $ | 3,913 | | | | | $ | 7,181 | | |
|
| | |
June 30, 2018
|
| |||||||||||||||||||||
| | |
Amortized
Cost |
| |
Gross Unrealized
|
| |
Fair
Value |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
U.S. government
|
| | | $ | 4,070 | | | | | $ | 162 | | | | | $ | (202) | | | | | $ | 4,030 | | |
States, political subdivisions, other
|
| | | | 28,262 | | | | | | 493 | | | | | | (534) | | | | | | 28,221 | | |
Corporate
|
| | | | 107,080 | | | | | | 1,034 | | | | | | (2,458) | | | | | | 105,656 | | |
Residential mortgage-backed securities
|
| | | | 42,039 | | | | | | 670 | | | | | | (1,046) | | | | | | 41,663 | | |
Commercial mortgage-backed securities
|
| | | | 3,796 | | | | | | 11 | | | | | | (128) | | | | | | 3,679 | | |
Total fixed maturity securities
|
| | | | 185,247 | | | | | | 2,370 | | | | | | (4,368) | | | | | | 183,249 | | |
Equity securities
|
| | | | 4,484 | | | | | | 1,878 | | | | | | — | | | | | | 6,362 | | |
Total fixed maturity and equity securities
|
| | | $ | 189,731 | | | | | $ | 4,248 | | | | | $ | (4,368) | | | | | $ | 189,611 | | |
|
| | |
December 31, 2017
|
| |||||||||||||||||||||
| | |
Amortized
Cost |
| |
Gross Unrealized
|
| |
Fair
Value |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
U.S. government
|
| | | $ | 4,075 | | | | | $ | 207 | | | | | $ | (120) | | | | | $ | 4,162 | | |
States, political subdivisions, other
|
| | | | 26,850 | | | | | | 876 | | | | | | (112) | | | | | | 27,614 | | |
Corporate
|
| | | | 106,479 | | | | | | 3,459 | | | | | | (543) | | | | | | 109,395 | | |
Residential mortgage-backed securities
|
| | | | 41,818 | | | | | | 1,480 | | | | | | (212) | | | | | | 43,086 | | |
Commercial mortgage-backed securities
|
| | | | 4,210 | | | | | | 26 | | | | | | (41) | | | | | | 4,195 | | |
Total fixed maturity securities
|
| | | | 183,432 | | | | | | 6,048 | | | | | | (1,028) | | | | | | 188,452 | | |
Equity securities
|
| | | | 4,443 | | | | | | 1,766 | | | | | | — | | | | | | 6,209 | | |
Total fixed maturity and equity securities
|
| | | $ | 187,875 | | | | | $ | 7,814 | | | | | $ | (1,028) | | | | | $ | 194,661 | | |
|
| | |
June 30, 2018
|
| |
December 31, 2017
|
| ||||||||||||||||||
| | |
Amortized
Cost |
| |
Fair
Value |
| |
Amortized
Cost |
| |
Fair
Value |
| ||||||||||||
Due in one year or less
|
| | | $ | 3,499 | | | | | $ | 3,554 | | | | | $ | 2,247 | | | | | $ | 2,288 | | |
Due after one year through five years
|
| | | | 41,230 | | | | | | 41,801 | | | | | | 40,926 | | | | | | 42,809 | | |
Due after five years through ten years
|
| | | | 68,467 | | | | | | 66,976 | | | | | | 66,739 | | | | | | 68,151 | | |
Due after ten years
|
| | | | 26,216 | | | | | | 25,576 | | | | | | 27,492 | | | | | | 27,923 | | |
Mortgage-backed securities
|
| | | | 45,835 | | | | | | 45,342 | | | | | | 46,028 | | | | | | 47,281 | | |
Total
|
| | | $ | 185,247 | | | | | $ | 183,249 | | | | | $ | 183,432 | | | | | $ | 188,452 | | |
|
| | |
for the six-month period ended
|
| |||||||||||||||
| | |
June 30, 2018
|
| |||||||||||||||
| | |
Fixed
Maturities |
| |
Equity
Securities |
| |
Derivative
Instruments |
| |||||||||
Proceeds from sales or maturities
|
| | | $ | 8,197 | | | | | $ | 261 | | | | | $ | 206 | | |
Gross gains from sales or maturities
|
| | | | 75 | | | | | | 261 | | | | | | 339 | | |
Other-than-temporary-impairment (OTTI) losses
|
| | | | (89) | | | | | | — | | | | | | — | | |
Gross losses from sales or maturities
|
| | | | (39) | | | | | | — | | | | | | (223) | | |
| | |
for the six-month period ended
|
| |||||||||||||||
| | |
June 30, 2017
|
| |||||||||||||||
| | |
Fixed
Maturities |
| |
Equity
Securities |
| |
Derivative
Instruments |
| |||||||||
Proceeds from sales or maturities
|
| | | $ | 13,346 | | | | | $ | 1,541 | | | | | $ | 3 | | |
Gross gains from sales or maturities
|
| | | | 143 | | | | | | 778 | | | | | | 9 | | |
Gross losses from sales or maturities
|
| | | | (19) | | | | | | — | | | | | | (7) | | |
| | |
for the
six-month period ended June 30, 2018 |
| |||
Balance at beginning of period
|
| | | $ | — | | |
Additions for credit related OTTI not previously reported
|
| | | | 89 | | |
Additions for increases in OTTI amounts previously recognized
|
| | | | — | | |
Balance at end of period
|
| | | $ | 89 | | |
June 30, 2018
|
| |
Less than 12 months
|
| |
12 months or longer
|
| |
Total
|
| |||||||||||||||||||||||||||
Description of securities
|
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| ||||||||||||||||||
U.S. government
|
| | | $ | 1,406 | | | | | $ | (85) | | | | | $ | 1,451 | | | | | $ | (117) | | | | | $ | 2,857 | | | | | $ | (202) | | |
States, political subdivisions, other
|
| | | | 16,345 | | | | | | (486) | | | | | | 694 | | | | | | (48) | | | | | | 17,039 | | | | | | (534) | | |
Corporate
|
| | | | 53,853 | | | | | | (1,921) | | | | | | 5,671 | | | | | | (537) | | | | | | 59,524 | | | | | | (2,458) | | |
Residential mortgage-backed securities
|
| | | | 19,331 | | | | | | (881) | | | | | | 1,795 | | | | | | (165) | | | | | | 21,126 | | | | | | (1,046) | | |
Commercial mortgage-backed securities
|
| | | | 3,611 | | | | | | (128) | | | | | | — | | | | | | — | | | | | | 3,611 | | | | | | (128) | | |
Total
|
| | | $ | 94,546 | | | | | $ | (3,501) | | | | | $ | 9,611 | | | | | $ | (867) | | | | | $ | 104,157 | | | | | $ | (4,368) | | |
|
2017
|
| |
Less than 12 months
|
| |
12 months or longer
|
| |
Total
|
| |||||||||||||||||||||||||||
Description of securities
|
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| |
Fair
Value |
| |
Gross
Unrealized Loss |
| ||||||||||||||||||
U.S. government
|
| | | $ | 1,161 | | | | | $ | (31) | | | | | $ | 1,782 | | | | | $ | (89) | | | | | $ | 2,943 | | | | | $ | (120) | | |
States, political subdivisions, other
|
| | | | 8,773 | | | | | | (86) | | | | | | 714 | | | | | | (26) | | | | | | 9,487 | | | | | | (112) | | |
Corporate
|
| | | | 10,935 | | | | | | (169) | | | | | | 6,853 | | | | | | (374) | | | | | | 17,788 | | | | | | (543) | | |
Residential mortgage-backed securities
|
| | | | 11,517 | | | | | | (126) | | | | | | 2,263 | | | | | | (86) | | | | | | 13,780 | | | | | | (212) | | |
Commercial mortgage-backed securities
|
| | | | 2,039 | | | | | | (27) | | | | | | 77 | | | | | | (14) | | | | | | 2,116 | | | | | | (41) | | |
Total
|
| | | $ | 34,425 | | | | | $ | (439) | | | | | $ | 11,689 | | | | | $ | (589) | | | | | $ | 46,114 | | | | | $ | (1,028) | | |
|
| | |
for the six-month
periods ended |
| |||||||||
| | |
6/30/2018
|
| |
6/30/2017
|
| ||||||
Fixed maturity securities
|
| | | $ | 3,689 | | | | | $ | 3,752 | | |
Equity securities
|
| | | | 82 | | | | | | 94 | | |
Real estate
|
| | | | 72 | | | | | | 74 | | |
Cash equivalents
|
| | | | 19 | | | | | | 12 | | |
Policy loans
|
| | | | 356 | | | | | | 362 | | |
Other
|
| | | | 285 | | | | | | 300 | | |
Subtotal
|
| | | | 4,503 | | | | | | 4,594 | | |
Investment expense
|
| | | | (285) | | | | | | (302) | | |
Net investment income
|
| | | $ | 4,218 | | | | | $ | 4,292 | | |
|
| | |
June 30, 2018
|
| |||||||||||||||||||||
| | |
Fair
Value |
| |
Gross Unrealized
|
| |
Net
Unrealized Gain (Loss) |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
Fixed income securities
|
| | | $ | 183,249 | | | | | $ | 2,370 | | | | | $ | (4,368) | | | | | $ | (1,998) | | |
Equity securities
|
| | | | 6,362 | | | | | | 1,878 | | | | | | — | | | | | | 1,878 | | |
Net unrealized capital gains
|
| | | | | | | | | | | | | | | | | | | | | $ | (120) | | |
|
| | |
December 31, 2017
|
| |||||||||||||||||||||
| | |
Fair Value
|
| |
Gross Unrealized
|
| |
Net
Unrealized Gain (Loss) |
| |||||||||||||||
| | |
Gains
|
| |
Losses
|
| ||||||||||||||||||
Fixed income securities
|
| | | $ | 188,452 | | | | | $ | 6,048 | | | | | $ | (1,028) | | | | | $ | 5,020 | | |
Equity securities
|
| | | | 6,209 | | | | | | 1,766 | | | | | | — | | | | | | 1,766 | | |
Net unrealized capital gains
|
| | | | | | | | | | | | | | | | | | | | | $ | 6,786 | | |
|
| | |
Carrying\Fair
Value 06/30/2018 |
| |
Carrying\Fair
Value 12/31/2017 |
| ||||||
Financial instruments recorded as assets: | | | | | | | | | | | | | |
Fixed maturity securities
|
| | | $ | 183,249 | | | | | $ | 188,452 | | |
Equity securities
|
| | | | 6,362 | | | | | | 6,209 | | |
Policy loans
|
| | | | 9,718 | | | | | | 9,852 | | |
Derivative instruments
|
| | | | 398 | | | | | | 395 | | |
Cash and cash equivalents
|
| | | | 3,913 | | | | | | 4,085 | | |
Separate account
|
| | | | 23,690 | | | | | | 24,779 | | |
Financial instruments recorded as liabilities: | | | | | | | | | | | | | |
Policyholder account balance:
|
| | | | | | | | | | | | |
Interest sensitive life contracts
|
| | | | 41,217 | | | | | | 41,078 | | |
Annuities
|
| | | | 72,437 | | | | | | 68,745 | | |
Dividend accumulations and other(1)
|
| | | | 6,906 | | | | | | 7,076 | | |
Separate account
|
| | | | 23,690 | | | | | | 24,779 | | |
| | |
Recurring Fair Value Measurements
at June 30, 2018 Using: |
| |||||||||||||||||||||
Description
|
| |
Fair Values
|
| |
Quoted Prices
in Active Markets for Identical Assets (Level 1) |
| |
Significant
Other Obeservable Inputs (Level 2) |
| |
Significant
Unobservable Inputs (Level 3) |
| ||||||||||||
Fixed maturity securities: | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. government
|
| | | $ | 4,030 | | | | | $ | 4,030 | | | | | $ | — | | | | | $ | — | | |
States, political subdivisions, other
|
| | | | 28,221 | | | | | | — | | | | | | 28,221 | | | | | | — | | |
Corporate
|
| | | | 105,656 | | | | | | — | | | | | | 105,656 | | | | | | — | | |
Residential mortgage-backed securities
|
| | | | 41,663 | | | | | | — | | | | | | 41,663 | | | | | | — | | |
Commercial mortgage-backed securities
|
| | | | 3,679 | | | | | | — | | | | | | 3,679 | | | | | | — | | |
Total fixed maturiities
|
| | | | 183,249 | | | | | | 4,030 | | | | | | 179,219 | | | | | | — | | |
Equities
|
| | | | 6,362 | | | | | | 4,123 | | | | | | — | | | | | | 2,239 | | |
Derivative instruments
|
| | | | 398 | | | | | | 398 | | | | | | — | | | | | | — | | |
Cash equivalents(1)
|
| | | | 3,913 | | | | | | 3,913 | | | | | | — | | | | | | — | | |
Separate accounts(2)
|
| | | | 23,690 | | | | | | 23,690 | | | | | | — | | | | | | — | | |
Total
|
| | | $ | 217,612 | | | | | $ | 36,154 | | | | | $ | 179,219 | | | | | $ | 2,239 | | |
|
| | |
Recurring Fair Value Measurements
at December 31, 2017 Using: |
| |||||||||||||||||||||
Description
|
| |
Fair Values
|
| |
Quoted Prices
in Active Markets for Identical Assets (Level 1) |
| |
Significant
Other Obeservable Inputs (Level 2) |
| |
Significant
Unobservable Inputs (Level 3) |
| ||||||||||||
Fixed maturity securities: | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. government
|
| | | $ | 4,162 | | | | | $ | 4,162 | | | | | $ | — | | | | | $ | — | | |
States, political subdivisions, other
|
| | | | 27,614 | | | | | | — | | | | | | 27,614 | | | | | | — | | |
Corporate
|
| | | | 109,395 | | | | | | — | | | | | | 109,395 | | | | | | — | | |
Residential mortgage-backed securities
|
| | | | 43,086 | | | | | | — | | | | | | 43,086 | | | | | | — | | |
Commercial mortgage-backed securities
|
| | | | 4,195 | | | | | | — | | | | | | 4,195 | | | | | | — | | |
Total fixed maturiities
|
| | | | 188,452 | | | | | | 4,162 | | | | | | 184,290 | | | | | | — | | |
Equities
|
| | | | 6,209 | | | | | | 4,027 | | | | | | — | | | | | | 2,182 | | |
Derivative instruments
|
| | | | 395 | | | | | | 395 | | | | | | — | | | | | | — | | |
Cash equivalents(1)
|
| | | | 4,085 | | | | | | 4,085 | | | | | | — | | | | | | — | | |
Separate accounts(2)
|
| | | | 24,779 | | | | | | 24,779 | | | | | | — | | | | | | — | | |
Total
|
| | | $ | 223,920 | | | | | $ | 37,448 | | | | | $ | 184,290 | | | | | $ | 2,182 | | |
|
Fair value at June 30, 2018
|
| | | | | | | |
Primary Valuation
Technique(s) |
| |
Significant
Unobservable Inputs |
| |
Range
|
| |
Weighted
Average |
| ||||||||||||
|
Min
|
| |
Max
|
| ||||||||||||||||||||||||||
Rreef America REIT II
|
| | | $ | 2,202 | | | |
Discounted cash Flows
|
| | Discount Rate | | | | | 5.00% | | | | | | 9.00% | | | | | | 6.50% | | |
| | | | | | | | | | | |
Terminal capitalization rate
|
| | | | 3.75% | | | | | | 8.00% | | | | | | 5.48% | | |
Fair value at December 31, 2017
|
| | | | | | | |
Primary Valuation
Technique(s) |
| |
Significant Unobservable Inputs
|
| |
Range
|
| |
Weighted
Average |
| ||||||||||||
|
Min
|
| |
Max
|
| ||||||||||||||||||||||||||
Rreef America REIT II
|
| | | $ | 2,150 | | | |
Discounted cash Flows
|
| | Discount Rate | | | | | 5.00% | | | | | | 9.00% | | | | | | 6.61% | | |
| | | | | | | | | | | |
Terminal capitalization rate
|
| | | | 4.00% | | | | | | 8.25% | | | | | | 5.62% | | |
| | |
for the six-month
periods ended |
| |||||||||
| | |
6/30/2018
|
| |
6/30/2017
|
| ||||||
Balance, beginning of year
|
| | | $ | 2,182 | | | | | $ | 3,169 | | |
Gains included in net income
|
| | | | — | | | | | | 396 | | |
Settlements
|
| | | | — | | | | | | (1,000) | | |
Unrealized gains (losses) in OCI
|
| | | | 57 | | | | | | (424) | | |
Balance, end of period
|
| | | $ | 2,239 | | | | | $ | 2,141 | | |
|
| | |
6/30/2018
|
| |
12/31/2017
|
| ||||||
Balance, beginning of year
|
| | | $ | 12,179 | | | | | $ | 11,940 | | |
Capitalization of commissions, sales and issue expenses
|
| | | | 1,011 | | | | | | 2,437 | | |
Accrual of interest
|
| | | | 275 | | | | | | 544 | | |
Amortization
|
| | | | (1,180) | | | | | | (2,659) | | |
Change in Shadow DAC
|
| | | | 1,035 | | | | | | (83) | | |
Balance end of period
|
| | | $ | 13,320 | | | | | $ | 12,179 | | |
|
| | |
6/30/2018
|
| |
12/31/2017
|
| ||||||
Balance, beginning of year
|
| | | $ | 867 | | | | | $ | 315 | | |
Capitalization of commissions and issue expenses
|
| | | | 201 | | | | | | 545 | | |
Accrual of interest
|
| | | | 15 | | | | | | 18 | | |
Amortization
|
| | | | (7) | | | | | | (11) | | |
Balance end of period
|
| | | $ | 1,076 | | | | | $ | 867 | | |
|
| | |
Unrealized
Investment Gains (losses) |
| |
Shadow DAC
|
| |
Accumulated
Other Comprehensive Income (loss) |
| |||||||||
Balance, December 31, 2016
|
| | | $ | 3,997 | | | | | $ | (448) | | | | | $ | 3,549 | | |
Available-for-sale investment gains (losses) arising during the year:
|
| | | | | | | | | | | | | | | | | | |
Fixed maturity securities net ot tax of $227
|
| | | | 440 | | | | | | | | | | | | 440 | | |
Equity securities net of tax of $9
|
| | | | 18 | | | | | | | | | | | | 18 | | |
Change in Shadow DAC net of tax benefit of $28
|
| | | | | | | | | | (55) | | | | | | (55) | | |
Cumulative effect of adoption of new accounting principle (see Note 3)
|
| | | | 904 | | | | | | (99) | | | | | | 805 | | |
Balance, December 31, 2017
|
| | | $ | 5,359 | | | | | $ | (602) | | | | | $ | 4,757 | | |
Available-for-sale investment gains (losses) arising during the year:
|
| | | | | | | | | | | | | | | | | | |
Fixed maturity securities net ot tax benefit of $276
|
| | | | (6,742) | | | | | | | | | | | | (6,742) | | |
Equity securities net of tax of $21
|
| | | | 79 | | | | | | | | | | | | 79 | | |
Change in Shadow DAC net of tax of $217
|
| | | | | | | | | | 817 | | | | | | 817 | | |
Balance, June 30, 2018
|
| | | $ | (1,304) | | | | | $ | 215 | | | | | $ | (1,089) | | |
|
| | |
June 30,
2018 |
| |
December 31,
2017 |
| ||||||
Balance, beginning of year
|
| | | $ | 24,779 | | | | | $ | 21,513 | | |
Cost of bonds and stocks acquired
|
| | | | — | | | | | | 299 | | |
Net realized and unrealized increase (decrease)
|
| | | | (200) | | | | | | 3,467 | | |
Deduction consideration for bonds and stocks disposed of
|
| | | | (952) | | | | | | (562) | | |
Change in other assets
|
| | | | 63 | | | | | | 62 | | |
Balance, end of period
|
| | | $ | 23,690 | | | | | $ | 24,779 | | |
|
| | |
6/30/2018
|
| |
12/31/2017
|
| ||||||
Traditional life contracts
|
| | | $ | 62,404 | | | | | $ | 62,311 | | |
Immediate annuities and pension plan
|
| | | | 6,704 | | | | | | 6,774 | | |
Supplemental contracts with life contingencies
|
| | | | 3,186 | | | | | | 2,522 | | |
Accident and health
|
| | | | 343 | | | | | | 386 | | |
Accident death benefits
|
| | | | 133 | | | | | | 132 | | |
Disability
|
| | | | 181 | | | | | | 188 | | |
| | | | $ | 72,951 | | | | | $ | 72,313 | | |
|
Product
|
| |
Mortality
|
| |
Interest Rate
|
| |
Estimation Method
|
|
Immediate fixed annuities | | | 1971, 1983, 2000, and 2012 annuity mortality tables | | | Rates range from 4% to 6.5% | | | Present value of expected future benefits based on historical experience | |
Traditional life insurance | | | Actual company experience plus loading | | | Rates range from 2.5% to 5.75% | | | Net level premium reserve method using the Company’s withdrawal experience | |
Accident and health | | | Actual company experience plus loading | | | n/a | | | Unearned premium; additional contract reserves for mortality risk | |
| | |
6/30/2018
|
| |
12/31/2017
|
| ||||||
Interest sensitive life contracts
|
| | | $ | 41,217 | | | | | $ | 41,078 | | |
Annuities
|
| | | | 72,437 | | | | | | 68,745 | | |
| | | | $ | 113,654 | | | | | $ | 109,823 | | |
|
Product
|
| |
Interest Rate
|
| |
Withdrawal/surrender charges
|
|
Interest-sensitive life insurance | | | Rates range from 3% to 7% | | | Either a percentage of account balance or a dollar amount grading off generally over 20 years | |
Fixed annuities | | | Rates range from 0% to 8% | | | Either a declining or level charge generally over 9 years or less | |
Other investment contracts | | | Rates range from 2% to 6% | | | No explicit charge assumed | |
| | |
6/30/2018
|
| |
12/31/2017
|
| ||||||
Balance, beginning of year
|
| | | $ | 109,823 | | | | | $ | 99,440 | | |
Deposits
|
| | | | 7,439 | | | | | | 17,994 | | |
Interest credited
|
| | | | 2,214 | | | | | | 4,353 | | |
Benefits
|
| | | | (1,432) | | | | | | (2,734) | | |
Surrenders and partial withdrawals
|
| | | | (2,279) | | | | | | (4,835) | | |
COI charges
|
| | | | (1,459) | | | | | | (2,973) | | |
Contract charges
|
| | | | (652) | | | | | | (1,307) | | |
Net transfers from separate accounts
|
| | | | — | | | | | | (115) | | |
Balance, end of period
|
| | | $ | 113,654 | | | | | $ | 109,823 | | |
|
| | |
6/30/2018
|
| |
12/31/2017
|
| ||||||
Payout annuities without life contingencies
|
| | | $ | 4,316 | | | | | $ | 3,774 | | |
Dividend accumulations and other
|
| | | | 6,906 | | | | | | 7,076 | | |
| | | | $ | 11,222 | | | | | $ | 10,850 | | |
|
| | |
6/30/2018
|
| |
12/31/2017
|
| ||||||
Land
|
| | | $ | 405 | | | | | $ | 405 | | |
Building and other
|
| | | | 8,439 | | | | | | 8,378 | | |
| | | | | 8,844 | | | | | | 8,783 | | |
Accumulated depreciation
|
| | | | (6,887) | | | | | | (6,828) | | |
Real Estate, net
|
| | | $ | 1,957 | | | | | $ | 1,955 | | |
|
| | |
6/30/2018
|
| |
12/31/2017
|
| ||||||
EDP equipment
|
| | | $ | 3,973 | | | | | $ | 3,955 | | |
Furniture
|
| | | | 1,592 | | | | | | 1,522 | | |
EDP equipment & furniture cost
|
| | | | 5,565 | | | | | | 5,477 | | |
Accumulated depreciation
|
| | | | (5,356) | | | | | | (5,281) | | |
Property and Equipment, net
|
| | | $ | 209 | | | | | $ | 196 | | |
|
| | |
for the six-month
periods ended |
| |||||||||
| | |
6/30/2018
|
| |
6/30/2017
|
| ||||||
Current
|
| | | $ | 9 | | | | | $ | 14 | | |
Deferred
|
| | | | — | | | | | | — | | |
Provision for income tax
|
| | | $ | 9 | | | | | $ | 14 | | |
|
| | |
for the six-month
periods ended |
| |||||||||
| | |
6/30/2018
|
| |
6/30/2017
|
| ||||||
Income tax benefits at statutory rate
|
| | | $ | (417) | | | | | $ | (338) | | |
Dividends received deduction
|
| | | | — | | | | | | — | | |
Other
|
| | | | 426 | | | | | | 352 | | |
Income tax (benefit) expense
|
| | | $ | 9 | | | | | $ | 14 | | |
Effective tax rate
|
| | | | 0.5% | | | | | | 1.4% | | |
| | |
6/30/2018
|
| |
12/31/2017
|
| ||||||
Deferred federal tax assets: | | | | | | | | | | | | | |
Difference between financial reporting and the tax basis of: | | | | | | | | | | | | | |
Operating loss carryforward
|
| | | $ | 6,180 | | | | | $ | 5,859 | | |
Other than temporary impairments
|
| | | | 966 | | | | | | 947 | | |
Deferred premiums
|
| | | | 850 | | | | | | 734 | | |
Life policy reserves
|
| | | | 702 | | | | | | 600 | | |
Other
|
| | | | 299 | | | | | | 380 | | |
Deferred reinsurance settlements
|
| | | | 594 | | | | | | 619 | | |
Total deferred tax assets
|
| | | | 9,591 | | | | | | 9,139 | | |
Deferred federal tax liabilities: | | | | | | | | | | | | | |
Difference between financial reporting and the tax basis of: | | | | | | | | | | | | | |
Deferred acquisition costs and sales inducements
|
| | | | 2,430 | | | | | | 2,147 | | |
Net unrealized gains
|
| | | | (32) | | | | | | 1,421 | | |
Reinsurance recoverable
|
| | | | 761 | | | | | | 766 | | |
Amortized discount on bonds
|
| | | | 123 | | | | | | 138 | | |
Other
|
| | | | 216 | | | | | | 143 | | |
Fixed assets
|
| | | | (12) | | | | | | 53 | | |
Total deferred tax liabilities
|
| | | | 3,486 | | | | | | 4,668 | | |
Net
|
| | | | 6,105 | | | | | | 4,471 | | |
Less valuation allowance
|
| | | | (5,610) | | | | | | (4,013) | | |
Net deferred tax asset
|
| | | $ | 495 | | | | | $ | 458 | | |
|
Expiring
|
| | |||||
2018
|
| | | $ | 167 | | |
2019
|
| | | | 1,590 | | |
2020
|
| | | | 2,296 | | |
2021
|
| | | | 651 | | |
2022
|
| | | | 520 | | |
2023
|
| | | | 861 | | |
2024
|
| | | | 1,762 | | |
2025
|
| | | | 7,836 | | |
2026
|
| | | | 2,188 | | |
2027
|
| | | | 1,353 | | |
2028
|
| | | | 2,664 | | |
2029
|
| | | | 509 | | |
2030
|
| | | | 2,240 | | |
2031
|
| | | | 1,119 | | |
2032
|
| | | | 596 | | |
Total
|
| | | $ | 26,352 | | |
|
|
SEC Registration Fee
|
| | | $ | 5,576 | | |
|
Printing, Postage and Mailing Expenses
|
| | | $ | 225,000 | | |
|
FINRA Filing Fees
|
| | | | 7,400 | | |
|
NASDAQ Listing Fee
|
| | | | 45,000 | | |
|
Legal Fees and Expenses
|
| | | | 175,000 | | |
|
Accounting Fees and Expenses
|
| | | | 255,000 | | |
|
Valuation Expenses
|
| | | | 124,000 | | |
|
Transfer and Offering Agent Fees and Expenses
|
| | | | 5,000 | | |
|
Underwriters’ Expense Reimbursement
|
| | | | 10,000 | | |
|
Blue Sky Fees and Expenses
|
| | | | 0 | | |
|
Miscellaneous Expenses
|
| | | | 3,024 | | |
|
Total
|
| | | $ | 855,000 | | |
|
Signature
|
| |
Title
|
| |
Date
|
|
/s/ Joseph D. Austin
Joseph D. Austin
|
| | Chairman and Chief Executive Officer (Principal Executive Officer), Director |
| |
October 9, 2018
|
|
/s/ William S. Austin
William S. Austin
|
| | President and Chief Operating Officer, Director | | |
October 9, 2018
|
|
/s/ Anders Raaum
Anders Raaum
|
| | Chief Financial Officer (Principal Financial Officer) |
| |
October 9, 2018
|
|
/s/ Michael Austin
Michael Austin
|
| | Director | | |
October 9, 2018
|
|
/s/ Wayne R. Ebersberger
Wayne R. Ebersberger
|
| | Director | | |
October 9, 2018
|
|
/s/ William H. Springer
William H. Springer
|
| | Director | | |
October 9, 2018
|
|
/s/ James H. Stacke
James H. Stacke
|
| | Director | | |
October 9, 2018
|
|
Exhibit 1.1
Federal Life Group, Inc.
Up to 4,600,000 Shares
COMMON STOCK
($0.01 Par Value)
Subscription Price $10.00 Per Share
AGENCY AGREEMENT
___________, 2018
Griffin Financial Group, LLC
620 Freedom Business Center
2nd Floor
King of Prussia, Pennsylvania 10019
Ladies and Gentlemen:
Federal Life Group, Inc., a Pennsylvania business corporation (“HoldCo”), Federal Life Mutual Holding Company, an Illinois mutual holding company (“Federal Life Mutual”), and Federal Life Insurance Company, an Illinois insurance company (“Federal Life” and together with HoldCo and Federal Life Mutual, the “Federal Life Parties”), hereby confirm, jointly and severally, their agreement (the “Agreement”) with Griffin Financial Group, LLC (the “Agent”), as follows:
1. The Offering. On March 8, 2018, the board of directors of Federal Life Mutual adopted a Plan of Conversion (the “Plan”). The Plan provides for the conversion of Federal Life Mutual from mutual to stock form (the “Conversion”). The Plan also provides for (a) the issuance of all of the outstanding common stock of Federal Life Mutual upon completion of the Conversion to HoldCo, and (b) the formation of HoldCo as a stock holding company that will own 100% of the common stock of Federal Life Mutual.
In connection with the Conversion, HoldCo is offering up to 4,600,000 shares (the “Shares”) of its common stock, $0.01 par value (the “Common Stock”), in (i) a subscription offering (the “Subscription Offering”), and, if necessary, (ii) a direct community offering (the “Community Offering”), and (iii) if necessary, a syndicated offering (the “Syndicated Offering”). The Subscription Offering, the Community Offering and the Syndicated Offering are herein sometimes collectively referred to as the “Offering.” Except for any shares of Common Stock issued under any stock incentive plan adopted by HoldCo, the Shares will constitute 100% of the outstanding common stock of HoldCo after completion of the Offering.
HoldCo will issue the Shares at a purchase price of $10.00 per share (the “Purchase Price”). If the number of Shares is increased or decreased in accordance with the Plan, the term “Shares” shall mean such greater or lesser number, where applicable.
1 |
The shares of Common Stock to be offered in the Subscription Offering will be offered pursuant to nontransferable subscription rights (subject to limitations set forth in the Plan) in the following order of priority
· | to eligible members of Federal Life, who are the named insureds under policies of insurance and holders of annuity contracts issued by Federal Life and in force on March 8, 2018 (the “Eligible Members”); and |
· | directors and officers of HoldCo. |
HoldCo may offer shares of Common Stock for which subscriptions have not been received in the Subscription Offering to the following categories of purchasers (listed in order of priority) in the Community Offering before offering them to the general public:
· | employees of Federal Life; |
· | Insurance Capital Group LLC (“ICG”); and |
· | Up to four strategic investors. |
In the event a Community Offering is held, it may be held at any time during or immediately after the Subscription Offering. Depending on market conditions, shares not subscribed for in the Subscription Offering or in the Community Offering may be offered in the Syndicated Offering to selected members of the general public on a best-efforts basis through a syndicate of registered broker-dealers who are members of the Financial Industry Regulatory Authority (“FINRA”). The Syndicated Offering will be managed by the Agent.
It is acknowledged that the number of Shares to be sold in the Offering may be increased or decreased as described in the Prospectus (as hereinafter defined), that the purchase of Shares in the Offering is subject to maximum and minimum purchase limitations as described in the Prospectus, and that HoldCo may reject, in whole or in part, any subscription received in the Community Offering or Syndicated Offering.
HoldCo has filed with the U.S. Securities and Exchange Commission (the “Commission”) a Registration Statement on Form S-1 (File No. 377-02185) in order to register the Shares under the Securities Act of 1933, as amended (the “1933 Act”), and the regulations promulgated thereunder (the “1933 Act Regulations”) and has filed such amendments thereto as have been required to the date hereof (the “Registration Statement”). The term “Registration Statement” shall include any documents incorporated by reference therein and all financial schedules and exhibits thereto, including post-effective amendments. The prospectus, as amended, included in the Registration Statement at the time it initially becomes effective is hereinafter called the “Prospectus,” except that if any prospectus is filed by HoldCo pursuant to Rule 424(b) or (c) of the 1933 Act Regulations differing from the prospectus included in the Registration Statement at the time it initially becomes effective, the term “Prospectus” shall refer to the prospectus filed pursuant to Rule 424(b) or (c) from and after the time such prospectus is filed with the Commission and shall include any supplements and amendments thereto from and after their dates of effectiveness or use, respectively.
2 |
Concurrently with the execution of this Agreement, HoldCo is delivering to the Agent copies of the Prospectus, dated [●], 2018, of HoldCo to be used in the Subscription Offering and Community Offering (if any), and, if necessary, will deliver copies of the Prospectus and any prospectus supplement for use in a Syndicated Offering as defined in the Prospectus.
In accordance with Section 59.1 of the Illinois Insurance Code, 215 ILCS 5/59.1 (the “Insurance Code”), Federal Life Mutual has filed with the Illinois Department of Insurance (the “Department”) an application for conversion and has filed such amendments thereto and supplementary materials as may have been required to the date hereof (such application, as amended to date, is hereinafter referred to as the “Conversion Application”), including a copy of the Proxy Statement for a Special Meeting of the voting members of Federal Life Mutual relating to the Conversion (the “Proxy Statement”), the Pro Forma Valuation Report prepared by RP Financial, LC (the “Appraisal”), and the Prospectus.
2. Appointment of the Agent. Subject to the terms and conditions of this Agreement, the Federal Life Parties hereby appoint the Agent as their exclusive financial advisor (i) to consult with and to advise and assist the Federal Life Parties with respect to the sale of the Shares in the Offering, (ii) to utilize its best efforts to solicit subscriptions for the Shares and to advise and assist HoldCo with respect to the sale of the Shares in the Offering, and (iii) to participate in the Offering in the areas of market making and in syndicate formation (if necessary).
It is acknowledged by the Federal Life Parties that the Agent shall not be obligated to purchase any Shares and shall not be obligated to take any action that is inconsistent with any applicable law, regulation, decision or order. Except as provided in the last Paragraph of this Section 2 and Section 13, the appointment of the Agent hereunder shall terminate upon consummation of the Offering, but in no event later than forty-five (45) days after completion of the Subscription Offering (the “End Date”). All fees or expenses due to the Agent but unpaid will be payable to the Agent in same day funds at the earlier of the Closing Date (as hereinafter defined) or the End Date. In the event the Offering is extended beyond the End Date, the Federal Life Parties and the Agent may agree to renew this Agreement under mutually acceptable terms.
If selected broker-dealers are used to assist in the sale of Shares in the Syndicated Offering, the Federal Life Parties hereby, subject to the terms and conditions of this Agreement, appoint the Agent to manage such broker-dealers in the Syndicated Offering. On the basis of the representations, warranties, and agreements of the Federal Life Parties contained in, and subject to the terms and conditions of, this Agreement, the Agent accepts such appointment and agrees to manage the selling group of broker-dealers in the Syndicated Offering.
3. Refund of Purchase Price. In the event that the Offering is not consummated for any reason, including but not limited to the inability of HoldCo to sell a minimum of 3,400,000 Shares during the Offering (including any permitted extension thereof) or such other minimum number of Shares as shall be established consistent with the Plan, this Agreement shall terminate and any persons who have subscribed for or placed orders for any of the Shares shall have refunded to them the full amount that has been received from such person, without interest, as provided in the Prospectus. In the event the Offering is terminated for any reason not attributable to the action or inaction of the Agent, the Agent shall be paid the fees due to the date of such termination pursuant to Section 4(a) and (b) hereof.
3 |
4. Fees. In addition to the expenses specified in Section 9 hereof, as compensation for the Agent’s services under this Agreement, the Agent has received or will receive the following fees from the Federal Life Parties:
(a) | A success fee of 2.0% shall be paid based on the aggregate purchase price of Shares (i) sold in the Offering to Eligible Members, directors, officers and employees of Federal Life Mutual and its subsidiaries or to any strategic investor identified by Federal Life in accordance with the Plan, (ii) issued pursuant to the terms of the Exchangeable Note, or (iii) sold to persons for the purpose of satisfying the NASDAQ listing requirement of having at least 300 round lot holders of Common Stock. Any amounts paid to the Agent and related persons shall be repaid to the Federal Life Parties to the extent any portion thereof is not actually incurred in compliance with FINRA Rule 5110(f)(2)(C). |
(b) | A success fee of 6.5% shall be paid based on the aggregate purchase price of Shares sold in the Offering to Insurance Capital Group LLC or any of its affiliates or assignees. Any amounts paid to the Agent and related persons shall be repaid to the Federal Life Parties to the extent any portion thereof is not actually incurred in compliance with FINRA Rule 5110(f)(2)(C). |
(c) | If any of the Shares remain available after the Subscription Offering and Community Offering, at the request of the Federal Life Parties, the Agent will seek to form a group of approved registered broker-dealer firms (the “Assisting Brokers”) to assist in the sale of such available Shares on a best-efforts basis, subject to the terms and conditions set forth in a selected dealers agreement to be entered into between HoldCo and the Agent. Agent will endeavor to distribute the Shares among dealers in a fashion which best meets the distribution objectives of HoldCo and the Plan. The Federal Life Parties, in consultation with the Agent, will determine which FINRA member firms will participate in the Syndicated Offering and the extent of their participation. The Agent will be paid a fee pursuant to this Section 4(c) equal to 6.5% of the aggregate Purchase Price of the Shares sold in the Syndicated Offering. From this fee, Agent will pass onto selected broker-dealers who assist in the Syndicated Offering an amount competitive with gross underwriting discounts charged at such time for comparable amounts of stock sold at a comparable price per share in a similar market environment. Fees with respect to purchases affected with the assistance of a broker/dealer other than the Agent shall be transmitted by the Agent to such broker/dealer. The decision to utilize selected broker-dealers will be made by Agent upon consultation with the HoldCo. All such fees payable under this Section 4(b) shall be in addition to all fees payable under Section 4(a) and shall be paid at Closing (as defined in Section 5). The fees paid under paragraphs (a), (b), and (c) of this Section 4 are collectively referred to as the “Success Fee.” |
4 |
(d) | The Federal Life Parties will reimburse the Agent, upon request made from time to time, for its reasonable out-of-pocket expenses incurred in connection with its conversion agent services not to exceed $15,000 without the written approval of Federal Life, with the exclusion of any legal and travel expenses, which shall not be included in such $15,000 limit. Any amounts paid to the Agent and related persons shall be repaid to the Federal Life Parties to the extent any portion thereof is not actually incurred in compliance with FINRA Rule 5110(f)(2)(C). |
If this Agreement is terminated in accordance with the provisions of Sections 3, 10, or 14, and the sale of Shares is not consummated, the Agent shall not be entitled to receive the fees set forth in Sections 4(a), (b), and (c), and the Agent will return to the Federal Life Parties any amounts advanced to the Agent to the extent not actually incurred by the Agent in accordance with FINRA Rule 5110(f)(2)(C).
5. Closing. If the minimum number of Shares required to be sold in the Offering pursuant to the Plan are subscribed for or ordered at or before the termination of the Offering, and the other conditions to the completion of the Offering are satisfied, HoldCo agrees to issue the Shares at the Closing Time (as hereinafter defined) against payment therefor by the means authorized by the Plan; provided, however, that no funds shall be released to HoldCo until the conditions specified in Section 10 hereof have been complied with to the reasonable satisfaction of the Agent. HoldCo shall deliver written notice of the issuance of the Shares in accordance with Section 59.1 of the Insurance Code (the “Conversion Act”) in such authorized denominations and registered in such names as may be indicated on the subscription order forms directly to the purchasers thereof as promptly as practicable after the Closing Time. The Closing (the “Closing”) shall be held at the offices of Stevens & Lee, PC, 620 Freedom Business Center, King of Prussia, Pennsylvania, or at such other place as shall be agreed upon among the Federal Life Parties and the Agent, at 9:00 a.m., Central Time, on the business day selected by HoldCo (the “Closing Date”), which business day shall be no less than two business days following the giving of prior notice by HoldCo to the Agent or at such other time as shall be agreed upon by HoldCo and the Agent. At the Closing, HoldCo shall deliver to the Agent by wire transfer in same-day funds the commissions, fees and expenses owing as set forth in Sections 4 and 9 hereof and the opinions and other documents required hereby shall be executed and delivered to effect the sale of the Shares as contemplated hereby and pursuant to the terms of the Prospectus; provided, however, that all out-of-pocket expenses to which the Agent is entitled under Section 9 hereof shall be due and payable upon receipt by HoldCo of a written accounting therefor setting forth in reasonable detail the expenses incurred by the Agent. The hour and date upon which HoldCo shall release the Shares for delivery in accordance with the terms hereof is referred to herein as the “Closing Time.”
The Agent shall have no liability to any party for the records or other information provided by the Federal Life Parties (or their agents) to the Agent for use in allocating the Shares. Subject to the limitations of Section 11 hereof, the Federal Life Parties shall indemnify and hold harmless the Agent for any liability arising out of the allocation of the Shares in accordance with (i) the Plan generally, and (ii) the records or other information provided to the Agent by the Federal Life Parties (or their respective agents).
5 |
6. Representations and Warranties of the Federal Life Parties. The Federal Life Parties jointly and severally represent and warrant to the Agent that, except as disclosed in the Prospectus:
(a) | Each of the Federal Life Parties has and, as of the Closing Time, will have all such power, authority, authorizations, approvals and orders as may be required to enter into this Agreement, to carry out the provisions and conditions hereof and to issue and sell the Shares as provided herein and as described in the Prospectus. Subject to the receipt of regulatory approval, the execution, delivery and performance of this Agreement and the consummation of the transactions herein contemplated have been duly and validly authorized by all necessary corporate action on the part of each of the Federal Life Parties that is a party thereto. This Agreement has been validly executed and delivered by each of the Federal Life Parties and is a valid, legal and binding obligation of each of the Federal Life Parties, enforceable in accordance with its terms, except as the legality, validity, binding nature and enforceability thereof may be limited by (i) bankruptcy, insolvency, moratorium, conservatorship, receivership or other similar laws relating to or affecting the enforcement of creditors’ rights generally; (ii) general equity principles regardless of whether such enforceability is considered in a proceeding in equity or at law; and (iii) the extent, if any, that the provisions of Sections 11 or 12 hereof may be unenforceable as against public policy. |
(b) | The Registration Statement, which was prepared by the Federal Life Parties and filed with the Commission, was declared effective by the Commission on ___________, 2018, and no stop order has been issued with respect thereto and no proceedings therefor have been initiated or, to the knowledge of the Federal Life Parties, threatened by the Commission. At the time the Registration Statement, including the Prospectus contained therein (including any amendment or supplement), became effective, at the Applicable Time (as defined in Section 6(d) hereof) and at the Closing Date, (x) the Registration Statement (including the Prospectus contained therein) complied and will comply in all material respects with the 1933 Act and the 1933 Act Regulations, and (y) the Registration Statement, including the Prospectus contained therein (including any amendment or supplement), and any information regarding the Federal Life Parties contained in any Sales Information (as defined in Section 11(a) hereof) authorized by the Federal Life Parties for use in connection with the Offering, (i) contained and will contain all statements required to be included therein in accordance with the 1933 Act and the 1933 Act Regulations, and (ii) did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. At the time any Rule 424(b) or (c) Prospectus was or is filed with the Commission and at the Closing Time referred to in Section 5, the Registration Statement, including the Prospectus contained therein (including any amendment or supplement thereto), and any state securities law application or any Sales Information authorized by the Federal Life Parties for use in connection with the Offering did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that the representations and warranties in this Section 6(b) shall not apply to statements or omissions made in reliance upon and in conformity with written information furnished to the Federal Life Parties by the Agent regarding the Agent or the method of conducting the Offering expressly for use in the Registration Statement or Prospectus, which the parties hereto agree is limited to the information contained in the first three paragraphs under the caption “The Conversion and the Offering—Marketing and Underwriting Arrangements.” |
6 |
(c) | At the time of filing of the Registration Statement and at the date hereof, HoldCo was not, and is not, an ineligible issuer, as defined in Rule 405. At the time of the filing of the Registration Statement and at the time of the use of any Issuer Free Writing Prospectus, as defined in Rule 433(h), HoldCo met the conditions required by Rules 164 and 433 for the use of a free writing prospectus. If required to be filed, HoldCo has filed any Issuer Free Writing Prospectus related to the offered Shares at the time it is required to be filed under Rule 433 and, if not required to be filed, will retain such free writing prospectus in HoldCo’s records pursuant to Rule 433(g), and if any Issuer Free Writing Prospectus is used after the date hereof in connection with the offering of the Shares, HoldCo will file or retain such free writing prospectus as required by Rule 433. |
(d) | As of the Applicable Time (as hereinafter defined), neither (i) the Issuer General Free Writing Prospectus(es) issued at or prior to the Applicable Time and the Statutory Prospectus, all considered together (collectively, the “General Disclosure Package”), nor (ii) any individual Issuer Limited-Use Free Writing Prospectus, when considered together with the General Disclosure Package, included any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to statements in or omissions from any Prospectus included in the Registration Statement relating to the offered Shares or any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to any of the Federal Life Parties by the Agent specifically for use therein. As used in this Paragraph and elsewhere in this Agreement: |
(i) | “Applicable Time” means each and every date when a potential purchaser submitted a subscription or otherwise committed to purchase Shares. |
(ii) | “Statutory Prospectus” as of any time, means the Prospectus relating to the offered Shares that is included in the Registration Statement immediately prior to the Applicable Time, including any document incorporated by reference therein. |
(iii) | “Issuer Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in Rule 433(h), relating to the offered Shares that is filed or is required to be filed with the Commission by HoldCo, or, if not required to be filed with the Commission, that is retained in HoldCo’s records pursuant to Rule 433(g). The term does not include any writing exempted from the definition of prospectus pursuant to clause (g) of Section 2(a)(10) of the 1933 Act, without regard to Rule 172 or Rule 173 under the 1933 Act Regulations. |
7 |
(iv) | “Issuer General Free Writing Prospectus” means any Issuer Free Writing Prospectus that is intended for general distribution to prospective investors. |
(v) | “Issuer Limited-Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is not an Issuer General Free Writing Prospectus. The term Issuer Limited-Use Free Writing Prospectus also includes any “bona fide electronic road show,” as defined in Rule 433 under the 1933 Act Regulations, that is made available without restriction pursuant to Rule 433(d)(8)(ii) under the 1933 Act Regulations or otherwise, even though not required to be filed with the Commission. |
(vi) | “Permitted Free Writing Prospectus” means any free writing prospectus as defined in Rule 405 of the 1933 Act Regulations that is consented to by HoldCo and the Agent. |
(e) | None of the Federal Life Parties has directly or indirectly distributed or otherwise used and will not directly or indirectly distribute or otherwise use any prospectus, any “free writing prospectus” (as defined in Rule 405 of the 1933 Act Regulations) or other offering material (including, without limitation, content on HoldCo’s website that may be deemed to be a prospectus, free writing prospectus or other offering material) in connection with the offering and sale of the Shares other than any Permitted Free Writing Prospectus or the Prospectus or other materials permitted by the 1933 Act and the 1933 Act Regulations distributed by HoldCo and reviewed and approved in advance for distribution by the Agent. HoldCo has not, directly or indirectly, prepared or used and will not directly or indirectly, prepare or use, any Permitted Free Writing Prospectus except in compliance with the filing and other requirements of Rules 164 and 433 of the 1933 Act Regulations; assuming that such Permitted Free Writing Prospectus is so sent or given after the Registration Statement was filed with the Commission (and after such Permitted Free Writing Prospectus was, if required pursuant to Rule 433(d) under the Act, filed with the Commission), the sending or giving, by the Agent, of any Permitted Free Writing Prospectus will satisfy the provisions of Rules 164 and 433 (without reliance on subsections (b), (c) and (d) for Rule 164). |
(f) | Each Issuer Free Writing Prospectus, as of its date of first use and at all subsequent times through the completion of the Offering and sale of the offered Shares or until any earlier date that HoldCo notified or notifies the Agent (as described in the next sentence), did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement, including any document incorporated by reference therein that has not been superseded or modified. If at any time following the date of first use of an Issuer Free Writing Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement relating to the offered Shares or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at that subsequent time, not misleading, HoldCo has notified or will notify promptly the Agent so that any use of such Issuer Free-Writing Prospectus may cease until it is amended or supplemented, and HoldCo has promptly amended or will promptly amend or supplement such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission. The foregoing two sentences do not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to any of the Federal Life Parties by the Agent specifically for use therein. |
8 |
(g) | HoldCo will promptly file the Prospectus and any supplemental sales literature with the Commission. The Prospectus and all supplemental sales literature, as of the date the Registration Statement became effective and at the Closing Time referred to in Section 5, will have received all required authorizations for use in final form. |
(h) | The Conversion Application, which was prepared by the Federal Life Parties and filed with the Department, has been approved by the Department and the related Prospectus and Proxy Statement delivered or to be delivered to eligible voters of Federal Life have been authorized for use by the Department. The Conversion Application complies in all material respects with the Conversion Act, except to the extent waived in writing by the Department, and did not and does not include any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. |
(i) | No order has been issued by the Department, the Commission, or any other state or federal regulatory authority, preventing or suspending the use of the Registration Statement, the Prospectus, the Proxy Statement or any supplemental sales literature, and no action by or before any such government entity to revoke any approval, authorization or order of effectiveness related to the Offering is pending or, to the knowledge of the Federal Life Parties, threatened. |
(j) | The Plan has been duly adopted by the Board of Directors of Federal Life, and the offer and sale of the Shares will have been conducted in all material respects in accordance with the Plan, the Insurance Code (except to the extent waived or otherwise approved by the Department), and all other applicable laws, regulations, decisions and orders, including all terms, conditions, requirements and provisions precedent to the Offering imposed upon the Federal Life Parties by the Department or the Commission and in the manner described in the Prospectus. To the knowledge of the Federal Life Parties, no person has, or at the Closing Time will have, sought to obtain review of the final action of any state or federal regulatory authority with respect to the Plan or the Offering. |
9 |
(k) | RP Financial, LC, which prepared the Appraisal in connection with the Offering, has advised the Federal Life Parties in writing that it is independent with respect to each of the Federal Life Parties. The Federal Life Parties believe that RP Financial, LC is an expert in preparing appraisals of insurance companies. |
(l) | BKD, LLP, which certified the financial statements included in the Registration Statement, has advised the Federal Life Parties that it is an independent registered public accounting firm within the meaning of the Code of Ethics of the American Institute of Certified Public Accountants (the “AICPA”), that it is registered with the Public Company Accounting Oversight Board (“PCAOB”), and that it is, with respect to each of the Federal Life Parties, an independent certified public accountant within the meaning of, and is not in violation of the auditor independence requirements of the 1933 Act, the 1933 Act Regulations, the regulations of the PCAOB and the Sarbanes Oxley Act of 2002 (the “Sarbanes-Oxley Act”). |
(m) | The consolidated financial statements, schedules and notes thereto that are included in the Registration Statement and that are a part of the Prospectus present fairly the consolidated financial condition and retained earnings of Federal Life and its subsidiaries as of the dates indicated and the consolidated results of operations and cash flows for the periods specified. The financial statements comply in all material respects with the applicable accounting requirements of the 1933 Act Regulations, Regulation S-X of the Commission, and accounting principles generally accepted in the United States of America (“GAAP”) applied on a consistent basis during the periods presented except as otherwise noted therein, and present fairly in all material respects the information required to be stated therein. The other financial, statistical and pro forma information and related notes included in the Prospectus present fairly the information shown therein on a basis consistent with the audited and unaudited financial statements included in the Prospectus, and as to the pro forma adjustments, the adjustments made therein have been properly applied on the basis described therein. |
(n) | Since the respective dates as of which information is given in the Registration Statement, including the Prospectus, other than disclosed therein: (i) there has not been any material adverse change in the financial condition or in the earnings, capital, properties, business affairs or prospects of any of the Federal Life Parties or of the Federal Life Parties taken as a whole, whether or not arising in the ordinary course of business (“Material Adverse Effect”); (ii) there has not been any material change in total assets of the Federal Life Parties, nor have any of the Federal Life Parties issued any securities or incurred any liability or obligation for borrowings other than in the ordinary course of business; and (iii) there have not been any material transactions entered into by any of the Federal Life Parties, other than those in the ordinary course of business. The capitalization, liabilities, assets, properties and business of the Federal Life Parties conform in all material respects to the descriptions thereof contained in the Prospectus, and none of the Federal Life Parties has any material liabilities of any kind, contingent or otherwise, except as disclosed in the Registration Statement or the Prospectus. |
10 |
(o) | HoldCo is a corporation duly incorporated and validly existing under the laws of the Commonwealth of Pennsylvania, with corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement and the Prospectus, and is, and as of the Closing Date will be, qualified to transact business and in good standing in each jurisdiction in which the conduct of its business requires such qualification unless the failure to qualify in one or more of such jurisdictions would not have a Material Adverse Effect. As of the Closing Time, HoldCo will be in good standing under the laws of the Commonwealth of Pennsylvania and will have obtained all licenses, permits and other governmental authorizations required for the conduct of its business, except those that individually or in the aggregate would not have a Material Adverse Effect; and all such licenses, permits and governmental authorizations are in full force and effect, and HoldCo is, and as of the Closing Date will be, in compliance therewith in all material respects. There are no outstanding options, warrants or other rights to purchase any securities of HoldCo or any of the Federal Life Parties except as disclosed in the Prospectus. |
(p) | Federal Life Mutual is a mutual insurance holding company organized under the laws of the State of Illinois and validly existing under the laws of the State of Illinois, with power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement and the Prospectus, and is, and as of the Closing Date will be, qualified to transact business and in good standing in each jurisdiction in which the conduct of its business requires such qualification unless the failure to qualify in one or more of such jurisdictions would not have a Material Adverse Effect. As of the Closing Time, Federal Life Mutual will be in good standing under the laws of the State of Illinois and will have obtained all licenses, permits and other governmental authorizations required for the conduct of its business, except those that individually or in the aggregate would not have a Material Adverse Effect; and all such licenses, permits and governmental authorizations are in full force and effect, and Federal Life Mutual is, and at the Closing Date will be, in compliance therewith in all material respects. Federal Life Mutual directly owns all of the outstanding equity interests of Federal Life free and clear of any mortgage, pledge, lien, encumbrance, claim or restriction. |
(q) | Federal Life is a stock insurance company organized and validly existing under the laws of the State of Illinois, with power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement and the Prospectus, and is, and as of the Closing Date will be, qualified to transact business and in good standing in each jurisdiction in which the conduct of its business requires such qualification unless the failure to qualify in one or more of such jurisdictions would not have a Material Adverse Effect. As of the Closing Time, Federal Life will be in good standing under the laws of the State of Illinois and will have obtained all licenses, permits and other governmental authorizations required for the conduct of its business, except those that individually or in the aggregate would not have a Material Adverse Effect; and all such licenses, permits and governmental authorizations are in full force and effect, and Federal Life is, and at the Closing Date will be, in compliance therewith in all material respects. Federal Life directly owns all of the outstanding equity interests of FED Mutual Financial Services, Inc. and Americana Realty Company free and clear of any mortgage, pledge, lien, encumbrance, claim or restriction. |
11 |
(r) | The authorized capital stock of HoldCo consists of 10,000,000 shares of Common Stock, $0.01 par value per share. Upon consummation of the Offering, the issued and outstanding Common Stock of HoldCo will be within the range set forth in the Prospectus under the caption “Capitalization” (except for subsequent issuances, if any, pursuant to reservations, agreements or employee benefit plans referred to in the Prospectus); and the shares of Common Stock to be subscribed for in the Offering have been duly and validly authorized for issuance and, when issued and delivered by HoldCo pursuant to the Plan against payment of the consideration calculated as set forth in the Plan and the Prospectus, will be duly and validly issued and fully paid and nonassessable; the issuance of the Shares is not subject to preemptive rights, except for the Subscription Rights granted pursuant to the Plan; and the terms and provisions of the Shares will conform in all material respects to the description thereof contained in the Prospectus. Upon issuance of the Shares against payment therefor in the Offering as set forth in the Plan and the Prospectus such shares will be duly authorized, fully paid, and nonassessable. No holder of Shares will be subject to personal liability by reason of being such a holder. |
(s) | Upon consummation of the Conversion, the authorized capital stock of Federal Life Mutual will be 100,000 shares of common stock, no par value (the “Federal Life Mutual Common Stock”), and no shares of Federal Life Mutual Common Stock have been or will be issued prior to the Closing Time. The shares of Federal Life Mutual Common Stock to be issued to HoldCo will have been duly authorized for issuance and, when issued and delivered by Federal Life Mutual, will be duly and validly issued and fully paid and nonassessable, and all such Federal Life Mutual Common Stock will be owned beneficially and of record by HoldCo, free and clear of any security interest, mortgage, pledge, lien, encumbrance or legal or equitable claim; the certificates representing the shares of Federal Life Mutual Common Stock will conform with the requirements of applicable laws and regulations. |
(t) | None of the Federal Life Parties is and, as of the Closing Time, none of the Federal Life Parties will be, in violation of its respective declaration of organization, charter, certificate or articles of incorporation, certificate of organization, operating agreement or bylaws (collectively, the “Organizational Documents”), or in material default in the performance or observance of any obligation, agreement, covenant, or condition contained in any contract, lease, loan agreement, indenture or other instrument to which any of them is a party or by which any of them, or any of their respective properties, may be bound that would result in a Material Adverse Effect. The consummation of the transactions herein contemplated will not (i) conflict with or constitute a breach of, or default under, the Organizational Documents of any of the Federal Life Parties, or materially conflict with or constitute a material breach of, or default under, any material contract, lease or other instrument to which any of the Federal Life Parties is a party or bound, or any applicable law, rule, regulation or order that is material to the financial condition of the Federal Life Parties, on a consolidated basis; (ii) violate any authorization, approval, judgment, decree, order, statute, rule or regulation applicable to the Federal Life Parties except for such violations that would not have a Material Adverse Effect; or (iii) result in the creation of any material lien, charge or encumbrance upon any property of any of the Federal Life Parties. |
12 |
(u) | No default exists, and no event has occurred that with notice or lapse of time, or both, would constitute a material default on the part of any of the Federal Life Parties, in the due performance and observance of any term, covenant or condition of any indenture, mortgage, deed of trust, note, bank loan or credit agreement or any other material instrument or agreement to which any of the Federal Life Parties is a party or by which any of them or any of their property is bound or affected in any respect that, in any such case, is material to the Federal Life Parties individually or considered as one enterprise, and such agreements are in full force and effect; and no other party to any such agreements has instituted or, to the knowledge of the Federal Life Parties, threatened any action or proceeding wherein any of the Federal Life Parties is alleged to be in default thereunder under circumstances where such action or proceeding, if determined adversely to any of the Federal Life Parties, would have a Material Adverse Effect. |
(v) | The Federal Life Parties have good and marketable title to all assets that are material to the businesses of the Federal Life Parties and to those assets described in the Prospectus as owned by them, free and clear of all material liens, charges, encumbrances, restrictions or other claims, except such as are described in the Prospectus or which do not have a Material Adverse Effect, and all of the leases and subleases that are material to the businesses of the Federal Life Parties, as described in the Registration Statement or Prospectus, are in full force and effect. |
(w) | The Federal Life Parties are not in material violation of any directive from the Department, the Commission, or any other agency to make any material change in the method of conducting their respective businesses; the Federal Life Parties have conducted and are conducting their respective businesses so as to comply in all respects with all applicable statutes and regulations (including, without limitation, regulations, decisions, directives and orders of the Department and the Commission), except where the failure to so comply would not reasonably be expected to result in any Material Adverse Effect, and there is no charge, investigation, action, suit or proceeding before or by any court, regulatory authority or governmental agency or body pending or, to the knowledge of any of the Federal Life Parties, threatened, that would reasonably be expected to materially and adversely affect the Offering, the performance of this Agreement, or the consummation of the transactions contemplated in the Plan as described in the Registration Statement, or that would reasonably be expected to result in a Material Adverse Effect. |
13 |
(x) | The Federal Life Parties have received an opinion of their counsel, Stevens & Lee P.C., with respect to the legality of the Shares and an opinion of Stevens & Lee, P.C. with respect to the federal income tax consequences of the Conversion and the Offering, as described in the Registration Statement and the Prospectus, and the facts and representations upon which such opinions are based are truthful, accurate and complete, and none of the Federal Life Parties will take any action inconsistent therewith. All material aspects of the aforesaid opinions are accurately summarized in the Prospectus. None of the Federal Life Parties has taken or will take any action inconsistent with such opinions. |
(y) | The Federal Life Parties have timely filed all required federal and state tax returns, have paid all taxes that have become due and payable in respect of such returns, except where permitted to be extended, have made adequate reserves for similar future tax liabilities, and no deficiency has been asserted with respect thereto by any taxing authority. |
(z) | No approval, authorization, consent or other order of any regulatory, supervisory or other public authority is required for the execution and delivery by the Federal Life Parties of this Agreement and the issuance of the Shares, except (i) for the approval of the Department (which will have been received as of the Closing Time), (ii) the non-objection of FINRA, and (iii) any necessary qualification, notification, or registration or exemption under the securities or blue sky laws of the various states in which the Shares are to be offered for sale. |
(aa) | None of the Federal Life Parties has: (i) issued any securities within the last 18 months (except for notes to evidence bank loans or other liabilities in the ordinary course of business or as described in the Prospectus); (ii) had any dealings with respect to sales of securities within the 18 months prior to the date hereof with any member of FINRA except the Agent, or any person related to or associated with such member, other than discussions and meetings relating to the Offering and purchases and sales of U.S. government and agency and other securities in the ordinary course of business; (iii) entered into a financial or management consulting agreement; or (iv) engaged any intermediary between the Agent and the Federal Life Parties in connection with the Offering, and no person is being compensated in any manner for such services. |
(bb) | None of the Federal Life Parties nor, to the knowledge of the Federal Life Parties, any employee of the Federal Life Parties, has made any payment of funds of the Federal Life Parties as a loan to any person for the purchase of Shares or has made any other payment of funds prohibited by law, and no funds have been set aside to be used for any payment prohibited by law. |
14 |
(cc) | The Federal Life Parties and their respective subsidiaries comply in all material respects with any applicable financial record keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, and the regulations and rules thereunder. The Federal Life Parties have established compliance programs and are in compliance in all material respects with the requirements of the USA PATRIOT Act and all applicable regulations promulgated thereunder, and there is no charge, investigation, action, suit or proceeding by or before any court, regulatory authority or governmental entity or body pending or, to the knowledge of the Federal Life Parties, threatened regarding compliance by the Federal Life Parties with the USA PATRIOT Act or any regulations promulgated thereunder. |
(dd) | The membership records of Federal Life, including, without limitation, as to Eligible Members, are accurate and complete in all material respects. |
(ee) | The Federal Life Parties comply in all material respects with all laws, rules and regulations relating to environmental protection, and none of them has been notified or is otherwise aware that any of them is potentially liable, or is considered potentially liable, under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, or any other federal, state or local environmental laws and regulations; no action, suit, regulatory investigation or other proceeding is pending or, to the knowledge of the Federal Life Parties, threatened against the Federal Life Parties relating to environmental protection, nor do the Federal Life Parties have any reason to believe any such proceedings may be brought against any of them; and no disposal, release or discharge of hazardous or toxic substances, pollutants or contaminants, including petroleum and gas products, as any of such terms may be defined under federal, state or local law, has occurred on, in, at or about any facilities or properties owned or leased by any of the Federal Life Parties. |
(ff) | None of the Federal Life Parties maintains any “pension plan,” as defined in the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). In addition, (A) the employee benefit plans, including employee welfare benefit plans, of the Federal Life Parties (the “Employee Plans”) have been operated in compliance with the applicable provisions of ERISA, the Internal Revenue Code of 1986, as amended (the “Code”), all regulations, rulings and announcements promulgated or issued thereunder and all other applicable laws and governmental regulations, (B) no reportable event under Section 4043(c) of ERISA has occurred with respect to any Employee Plan of the Federal Life Parties for which the reporting requirements have not been waived, (C) no prohibited transaction under Section 406 of ERISA, for which an exemption does not apply, has occurred with respect to any Employee Plan of the Federal Life Parties and (D) all Employee Plans that are group health plans have been operated in compliance with the group health plan continuation coverage requirements of Section 4980B of the Code, except to the extent such noncompliance, reportable event or prohibited transaction would not have, individually or in the aggregate, a Material Adverse Effect. There are no pending or, to the knowledge of the Federal Life Parties, threatened, claims by or on behalf of any Employee Plan, by any employee or beneficiary covered under any such Employee Plan or by any governmental authority, or otherwise involving such Employee Plans or any of their respective fiduciaries (other than for routine claims for benefits). Each of the Federal Life Parties has fulfilled, in all material respects, its obligations, if any, under the minimum funding standards of Section 302 of the United States Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and the regulations promulgated thereunder with respect to any “plan” (as defined in Section 3(3) of ERISA and the regulations thereunder), that is maintained by any of the Federal Life Parties for their employees, and any such plan is in compliance in all material respects with the presently applicable provisions of ERISA and the regulations thereunder. None of the Federal Life Parties has incurred any unpaid liability under Title IV of ERISA to the Pension Benefit Guaranty Corporation (other than for the payment of premiums in the ordinary course) or to any such plan. |
15 |
(gg) | HoldCo has applied for approval, subject to completion of the Offering, to have the Shares listed on the NASDAQ Capital Market effective as of the Closing Time. |
(hh) | Except as disclosed in the Prospectus, all material reinsurance treaties or agreements to which Federal Life is a party or is a named reinsured are in full force and effect. To the knowledge of Federal Life, neither Federal Life nor any other party thereto, is in default under any such agreement, and no party may terminate any such agreement by reason of the transactions contemplated by the Plan. |
(ii) | HoldCo has filed a registration statement on Form 8-A to register the Common Stock under Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and pursuant to Form 8-A such registration statement shall be effective concurrent with the effectiveness of the Registration Statement. |
(jj) | There is no contract or other document of a character required to be described in the Registration Statement or the Prospectus or to be filed as an exhibit to the Registration Statement which is not described or filed as required. |
(kk) | The Federal Life Parties maintain a system of internal accounting controls sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain accountability for assets, (iii) access to cash and other liquid assets is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded ledger assets are compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The books, records and accounts and systems of internal accounting control of Federal Life and its subsidiaries comply in all material respects with the requirements of Section 13(b)(2) of the Securities Exchange Act of 1934, as amended (the “1934 Act”). HoldCo has established and maintains “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the 1934 Act) that are effective in ensuring that the information it will be required to disclose in the reports it files or submits under the 1934 Act is accumulated and communicated to HoldCo’ management (including HoldCo’s chief executive officer and chief financial officer) in a timely manner and recorded, processed, summarized and reported within the periods specified in the Commission’s rules and forms. To the knowledge of the Federal Life Parties, BKD LLP and the Audit Committee of the Board of Directors have been advised of: (A) any significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that could adversely affect HoldCo’s ability to record, process, summarize, and report financial data; and (B) any fraud, whether or not material, that involves management or other employees who have a significant role in the internal accounting controls of Federal Life and its subsidiaries. |
16 |
(ll) | Except as described in the Prospectus, (i) there are no contractual encumbrances or contractual restrictions or regulatory restrictions on the ability of any of the Federal Life Parties to pay dividends or make any other distributions on its capital stock, and (ii) there are no contractual encumbrances or contractual restrictions on the ability of the Federal Life Parties (A) to pay any indebtedness owed to any of the Federal Life Parties or (B) to make any loans or advances to, or investments in, any of the Federal Life Parties, or (C) to transfer any of its property or assets to any of the Federal Life Parties. |
(mm) | None of the Federal Life Parties is required to be registered as an “investment company” under the Investment Company Act of 1940, as amended, or as an “investment advisor” under the Investment Advisor Act of 1940, as amended. |
(nn) | The Federal Life Parties have taken all actions necessary to obtain at the Closing Time a blue sky memorandum from Stevens & Lee, PC. |
(oo) | The Federal Life Parties carry, or are covered by, insurance in such amounts and covering such risks as the Federal Life Parties deem reasonably adequate for the conduct of their respective businesses and the value of their respective properties. |
(pp) | The Federal Life Parties have not relied upon the Agent for any legal, tax or accounting advice in connection with the Conversion. |
(qq) | The Standby Stock Purchase Agreement dated as of March 8, 2018, among HoldCo, Federal Life Mutual, Federal Life and ICG (the “Standby Stock Purchase Agreement”) is in full force and effect. |
(rr) | The statistical and market related data contained in any Permitted Free Writing Prospectus, the Prospectus and the Registration Statement are based on or derived from sources that the Federal Life Parties believe were reliable and accurate at the time they were filed with the Commission. No forward-looking statement (within the meaning of Section 27A of the 1933 Act and Section 21E of the 1934 Act) contained in the Registration Statement, the Prospectus, or any Permitted Free Writing Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. |
17 |
(ss) | None of the Federal Life Parties, or any of their subsidiaries nor, to the knowledge of the Federal Life Parties, any other person associated with or acting on behalf of the Federal Life Parties or any of their subsidiaries has violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder. |
(tt) | Except for rights of ICG under the Standby Stock Purchase Agreement, there are no persons with registration rights or other similar rights to have any securities of HoldCo registered for sale under the 1933 Act or otherwise registered for sale or sold by HoldCo under the 1933 Act. |
(uu) | There are no contracts or documents that are required to be described in the Registration Statement, the General Disclosure Package or the Prospectus or to be filed as exhibits to the Registration Statement that have not been so described or filed as required. |
(vv) | The Federal Life Parties and their subsidiaries own or possess all material patents, copyrights, trademarks, service marks, inventions, trade names or other intellectual property (collectively, “Intellectual Property”), or have valid licenses to use such Intellectual Property necessary to carry on the business now operated by them, except where the failure to own or have the right to use such Intellectual Property, singularly or in the aggregate, would not reasonably be expected to have a Material Adverse Effect. None of the Federal Life Parties nor any of their subsidiaries has received any notice or is otherwise aware of any infringement of or conflict with asserted rights of others with respect to any Intellectual Property. |
(ww) | None of the Federal Life Parties nor any of their subsidiaries or, to the knowledge of the Federal Life Parties, any director, officer, or employee of any of them is an individual or entity currently the subject or target of any sanctions administered or enforced by the United States Government, including without limitation the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”). |
Any certificates signed by an officer of any of the Federal Life Parties and delivered to the Agent or its counsel that refer to this Agreement shall be deemed to be a representation and warranty by the Federal Life Parties to the Agent as to the matters covered thereby with the same effect as if such representation and warranty were set forth herein.
7. Representations and Warranties of the Agent. The Agent represents and warrants to the Federal Life Parties that:
(a) | The Agent is a limited liability company and is validly existing in good standing under the laws of the Commonwealth of Pennsylvania, with full power and authority to provide the services to be furnished to the Federal Life Parties hereunder. |
18 |
(b) | The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly and validly authorized by all necessary action on the part of the Agent, and this Agreement is a legal, valid and binding agreement of the Agent, enforceable in accordance with its terms except as the legality, validity, binding nature and enforceability thereof may be limited by (i) bankruptcy, insolvency, moratorium, conservatorship, receivership or other similar laws relating to or affecting the enforcement of creditors’ rights generally; (ii) general equity principles regardless of whether such enforceability is considered in a proceeding in equity or at law; and (iii) the extent, if any, that the provisions of Sections 11 or 12 hereof may be unenforceable as against public policy. |
(c) | Each of the Agent and its employees, agents and representatives who shall perform any of the services hereunder has, and until the Offering is completed or terminated shall maintain, all licenses, approvals and permits necessary to perform such services. |
(d) | No action, suit, charge or proceeding before the Commission, FINRA, any state securities commission or any court is pending, or to the knowledge of Agent threatened, against the Agent that, if determined adversely to Agent, would have a material adverse effect upon the ability of the Agent to perform its obligations under this Agreement. |
(e) | The Agent is registered as a broker/dealer pursuant to Section 15(b) of the 1934 Act and is a member of FINRA. |
(f) | Any funds received in the Offering by the Agent from prospective purchasers of the Shares shall be delivered by the Agent to Computershare Trust Company, N. A., as escrow agent (the “Escrow Agent”) for deposit in the escrow account established under the Escrow Agreement dated September 12, 2018, by and among Federal Life, HoldCo, the Agent, and the Escrow Agent (the “Escrow Agreement”), by noon of the next business day after receipt by the Agent, together with a written account of each purchaser that sets forth, among other things, the name and address of the purchaser, the number of Shares purchased and the amount paid therefor. Any checks received by the Agent that are made payable to any party other than the Escrow Agent shall be returned to the purchaser who submitted the check and shall not be accepted. The Agent shall require any selected dealers agreements with Assisting Brokers to include provisions requiring such Assisting Brokers to comply with Rule 15c2-4 under the 1934 Act. |
19 |
8. Covenants of the Federal Life Parties. The Federal Life Parties hereby jointly and severally covenant with the Agent as follows:
(a) | HoldCo will not, at any time after the date the Registration Statement is declared effective, file any amendment or supplement to the Registration Statement without providing the Agent and its counsel an opportunity to review such amendment or supplement or, except as may be required by law, file any amendment or supplement to which the Agent shall reasonably object. HoldCo will furnish promptly to the Agent and its counsel copies of all correspondence from the Commission with respect to the Registration Statement and HoldCo’s responses thereto. |
(b) | HoldCo represents and agrees that, unless it obtains the prior consent of the Agent, and the Agent represents and agrees that, unless it obtains the prior consent of HoldCo, it has not made and will not make any offer relating to the offered Shares that would constitute an “issuer free writing prospectus,” as defined in Rule 433, or that would constitute a “free writing prospectus,” as defined in Rule 405, required to be filed with the Commission. Any such free writing prospectus consented to by HoldCo and the Agent is hereinafter referred to as a “Permitted Free Writing Prospectus.” HoldCo represents that it has treated or agrees that it will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus,” as defined in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely Commission filing where required, legending and record keeping. HoldCo need not treat any communication as a free writing prospectus if it is exempt from the definition of prospectus pursuant to Clause (a) of Section 2(a)(10) of the 1933 Act without regard to Rule 172 or 173. |
(c) | The Federal Life Parties will use commercially reasonable efforts to cause any post-effective amendment to the Registration Statement to be declared effective by the Commission and will immediately upon receipt of any information concerning the events listed below notify the Agent (i) when the Registration Statement, as amended, has become effective; (ii) of any request by the Commission or any other governmental entity for any amendment or supplement to the Registration Statement, or of any request for additional information; (iii) of the issuance by the Commission or any other governmental agency of any order or other action suspending the Offering or the use of the Registration Statement or the Prospectus or any other filing of the Federal Life Parties under the 1933 Act, the 1933 Act Regulations, the 1934 Act, and the rules and regulations of the Commission promulgated under the 1934 Act (the “1934 Act Regulations”), the Insurance Code or any other applicable law, or the threat of any such action; or (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or of the initiation or threat of initiation of any proceedings for that purpose. |
20 |
(d) | For a period of eighteen (18) months after the Closing Time, the Federal Life Parties will comply in all material respects with any and all terms, conditions, requirements and provisions with respect to the Offering and the transactions contemplated thereby imposed by the Commission or the Department, by applicable state law and regulations (including without limitation the Insurance Code), and by the 1933 Act, the 1933 Act Regulations, the 1934 Act, and 1934 Act Regulations, FINRA, and the NASDAQ Stock Market, to be complied with prior to or subsequent to the Closing Time; and when the Prospectus is required to be delivered, the Federal Life Parties will comply in all material respects, at their own expense, with all material requirements imposed upon them by the Commission or the Department, by applicable state law and regulations and by the 1933 Act, the 1933 Act Regulations, the 1934 Act, and the 1934 Act Regulations, in each case as from time to time in force, so far as necessary to permit the continuance of sales or dealing in the Shares during such period in accordance with the provisions hereof and the Prospectus. If the most recent updated valuation of the Company prepared by RP Financial, LC is not within the valuation range set forth in the Prospectus at the time of effectiveness and HoldCo decides to resolicit subscriptions, HoldCo will promptly prepare and file with the Commission a post-effective amendment to the Registration Statement relating to the results of the updated valuation prior to any resolicitation of subscriptions. |
(e) | Each of the Federal Life Parties will inform the Agent of any event or circumstances of which it is or becomes aware as a result of which the Registration Statement and/or Prospectus, as then supplemented or amended, would include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading. If it is necessary, in the reasonable opinion of counsel for the Federal Life Parties and in the reasonable opinion of the Agent, to amend or supplement the Registration Statement or the Prospectus in order to correct such untrue statement of a material fact or to make the statements therein not misleading in light of the circumstances existing at the time of their use, the Federal Life Parties will, at their expense, prepare and file with the Commission, as necessary under applicable federal and state rules and regulations, and furnish to the Agent a reasonable number of copies of an amendment or amendments of, or a supplement or supplements to, the Registration Statement and the Prospectus (in form and substance reasonably satisfactory to the Agent after a reasonable time for review) that will amend or supplement the Registration Statement and/or the Prospectus so that as amended or supplemented it will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances existing at the time, not misleading. For the purpose of this subsection, each of the Federal Life Parties will furnish such information with respect to itself as the Agent may from time to time reasonably request. |
21 |
(f) | Pursuant to the terms of the Plan, HoldCo will endeavor in good faith, in cooperation with the Agent, to register or to qualify the Shares for offer and sale or to exempt such Shares from registration and to exempt HoldCo and its officers, directors and employees from registration as broker-dealers, under the applicable securities laws of the jurisdictions in which the Offering will be conducted; provided, however, that HoldCo shall not be obligated to file any general consent to service of process, to qualify as a foreign corporation to do business in any jurisdiction in which it is not so qualified, or to register its directors or officers as brokers, dealers, salesmen, or agents in any jurisdiction. In each jurisdiction where any of the Shares shall have been registered or qualified as above provided, HoldCo will make and file such statements and reports as are or may be required by the laws of such jurisdiction as a result of, or in connection with, such registration or qualification. |
(g) | HoldCo will not sell or issue, contract to sell or otherwise dispose of, for a period of 180 days after the date hereof, without the Agent’s prior written consent, which consent shall not be unreasonably withheld, any shares of Common Stock, any option, warrant, contract or other right to purchase shares of Common Stock, or any security convertible into or exercisable or exchangeable for shares of Common Stock, other than in connection with any plan or arrangement described in the Prospectus. |
(h) | For the period of three years from the date of this Agreement, HoldCo will furnish to the Agent upon request (i) a copy of each report of HoldCo furnished to or filed with the Commission under the 1934 Act or any national securities exchange or system or the NASDAQ Stock Market on which any class of securities of HoldCo is listed or quoted, (ii) a copy of each report of HoldCo mailed to holders of Common Stock or non-confidential report filed with the Commission, the Department, or any other supervisory or regulatory authority or any national securities exchange or system or the NASDAQ Stock Market on which any class of the securities of HoldCo is listed or quoted, (iii) each press release and material news item and article released by the Federal Life Parties, and (iv) from time-to-time, such other publicly available information concerning the Federal Life Parties as the Agent may reasonably request; provided that, any information or documents available on the Commission’s Electronic Data Gathering, Analysis and Retrieval System shall be considered furnished for purposes of this Section 8(h). |
(i) | The Federal Life Parties will use the net proceeds from the sale of the Shares in the manner set forth in the Prospectus under the caption “USE OF PROCEEDS.” |
(j) | HoldCo will distribute the Prospectus or other offering materials in connection with the offering and sale of the Common Stock only in accordance with the 1933 Act, the 1933 Act Regulations, the 1934 Act and the 1934 Act Regulations, and the laws of any state in which the shares are qualified for sale. |
(k) | Prior to the Closing Time, HoldCo shall register its Common Stock under Section 12(b) of the 1934 Act, as amended, and will request that such registration statement be effective as of the Closing Time. HoldCo will use commercially reasonable efforts to list, subject to notice of issuance, the Shares on the NASDAQ Capital Market. |
22 |
(l) | [Intentionally Omitted]. |
(m) | HoldCo will report the use of proceeds of the Offering in accordance with Rule 463 under the 1933 Act. |
(n) | The Federal Life Parties will maintain appropriate arrangements for depositing with the Escrow Agent all funds received from persons mailing subscriptions for or orders to purchase Shares on a non-interest bearing basis as described in the Prospectus until the Closing Time and satisfaction of all conditions precedent to the release of HoldCo’s obligation to refund payments received from persons subscribing for or ordering Shares in the Offering, in accordance with the Plan as described in the Prospectus, or until refunds of such funds have been made to the persons entitled thereto. The Federal Life Parties will maintain, together with the Agent, such records of all funds received to permit the funds of each subscriber to be separately insured by the FDIC (to the maximum extent allowable) and to enable the Federal Life Parties to make the appropriate refunds of such funds in the event that such refunds are required to be made in accordance with the Plan and as described in the Prospectus. |
(o) | Until the Closing Time, the Federal Life Parties will take such actions and furnish such information as are reasonably requested by the Agent in order for the Agent to ensure compliance with Rule 5130 of FINRA. |
(p) | The Federal Life Parties will conduct their businesses in compliance in all material respects with all applicable federal and state laws, rules, regulations, decisions, directives and orders, including all decisions, directives and orders of the Commission and the Department. |
(q) | The Federal Life Parties shall comply with any and all terms, conditions, requirements and provisions with respect to the Plan and the transactions contemplated thereby imposed by the Commission, the 1933 Act, the 1933 Act Regulations, the 1934 Act and the 1934 Act Regulations to be complied with subsequent to the Closing Time for so long as such terms, conditions, requirements and provisions are applicable. HoldCo will comply with all provisions of all undertakings contained in the Registration Statement until such undertakings are performed in full or are no longer applicable. |
(r) | The Federal Life Parties will not amend the Plan without the consent of the Agent, which consent shall not be unreasonably withheld or delayed. |
(s) | HoldCo shall provide the Agent with any information necessary to assist with the allocation of the Shares in the Offering in the event of an oversubscription, and such information shall be accurate and reliable in all material respects. |
(t) | HoldCo will not deliver the Shares until the Federal Life Parties have satisfied or caused to be satisfied each condition set forth in Section 10 hereof, unless such condition is waived in writing by the Agent. |
23 |
(u) | Immediately upon completion of the sale by HoldCo of the Shares contemplated by the Plan and the Prospectus, all of the issued and outstanding shares of capital stock of Federal Life Mutual shall be owned by HoldCo. |
(v) | Prior to the Closing Time, the Plan shall have been approved by the voting members of Federal Life in accordance with the provisions of the Insurance Code. |
(w) | On or before the Closing Time, the Federal Life Parties will have completed all conditions precedent to the Offering specified in the Plan and the offer and sale of the Shares will have been conducted in all material respects in accordance with the Plan and with all other applicable laws, regulations, decisions and orders, including all terms, conditions, requirements and provisions precedent to the Offering imposed upon any of the Federal Life Parties by the Department, the Commission or any other regulatory authority and in the manner described in the Prospectus. |
(x) | HoldCo shall notify the Agent when funds shall have been received for the minimum number of Shares. |
(y) | The Federal Life Parties shall cause each of the Persons listed on Schedule A attached hereto to execute and deliver to the Agent a lockup agreement substantially in the form of Exhibit B attached hereto. |
9. Payment of Expenses. The Federal Life Parties will pay for all expenses incident to the performance of this Agreement, including without limitation: (a) the preparation, printing, filing, delivery and shipment of the Registration Statement, including the Prospectus, and all amendments and supplements thereto, and all filing fees related thereto; (b) all filing fees and expenses in connection with the qualification or registration of the Shares for offer and sale by HoldCo under the securities or “blue sky” laws, including without limitation filing fees, reasonable legal fees and disbursements of counsel in connection therewith, and in connection with the preparation of a blue sky law survey; (c) the filing fees of FINRA related to the Agent’s fairness filing under Rule 5110 (or any successor rule of FINRA); (e) fees and expenses related to the preparation of the Appraisal; (f) fees and expenses related to auditing and accounting services; (g) all expenses relating to advertising, postage, temporary personnel, investor meetings and the operation of the stock information center; (h) transfer agent fees and costs of preparation and distribution of written notices under Conversion Act; and (i) fees and expenses of the Federal Life Parties relating to presentations or meetings undertaken in connection with the marketing of the Syndicated Offering and sale of the Shares in the Syndicated Offering to prospective investors and the Agent’s sales forces, including expenses associated with travel, lodging, and other expenses incurred by the officers of the Federal Life Parties; provided, however, that the Agent shall pay the fees and expenses of the Agent and any of its affiliates relating to presentations or meetings undertaken in connection with the marketing and sale of the Shares to prospective investors and the Agent’s sales forces, including expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations, travel, lodging and other expenses incurred by the officers of the Agent and any such consultants. In the event that the Agent incurs any expenses on behalf of the Federal Life Parties, the Federal Life Parties will pay or reimburse the Agent for such expenses in an amount not to exceed $15,000 (except for travel and legal expenses, which will not be included in such $15,000 limit, and except as approved in writing by Federal Life) regardless of whether the Offering is successfully completed. Not later than two days prior to the Closing Time, the Agent will provide the Federal Life Parties with a detailed accounting of all reimbursable expenses to be paid at the Closing.
24 |
10. Conditions to the Agent’s Obligations. The obligations of the Agent hereunder and the occurrence of the Closing are subject to the conditions that (i) all representations and warranties and other statements of the Federal Life Parties herein contained are, at and as of the commencement of the Offering and at and as of the Closing Time, true and correct in all material respects, and (ii) the Federal Life Parties shall have performed all of their obligations hereunder to be performed on or before such dates, and to the following further conditions:
(a) | The Registration Statement shall have been declared effective by the Commission, and no stop order or other action suspending the effectiveness of the Registration Statement shall have been issued under the 1933 Act or proceedings therefor initiated or, to any of the Federal Life Parties’ knowledge, threatened by the Commission or any state authority and no order or other action suspending the authorization for use of the Prospectus or the consummation of the Conversion shall have been issued or proceedings therefor initiated or, to any of the Federal Life Parties’ knowledge, threatened by the Department, the Commission, or any other governmental body. The Conversion Application shall have been approved by the Department. |
(b) | At the Closing Time, the Agent shall have received: |
(1) An opinion or opinions, dated as of the Closing Time, of Stevens & Lee, P.C., as counsel to the Federal Life Parties, in form and substance satisfactory to counsel for the Agent, to the effect that:
(i) | HoldCo is a corporation duly incorporated and validly subsisting under the laws of the Commonwealth of Pennsylvania, with corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Prospectus, and, to its knowledge, is duly qualified to transact business and will be in good standing in each jurisdiction in which the conduct of its business requires such qualification and in which the failure to qualify would have a Material Adverse Effect. |
(ii) | Prior to the Closing Time Federal Life Mutual was a mutual insurance holding company, and, after the Closing Time, Federal Life will be a duly incorporated and validly subsisting Illinois stock insurance holding company with corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Prospectus and to enter into this Agreement and perform its obligations hereunder, and, to its knowledge, is duly qualified to transact business and in good standing in each jurisdiction in which the conduct of its business requires such qualification and in which the failure to qualify would have a Material Adverse Effect. |
25 |
(iii) | Federal Life is a corporation duly incorporated and validly subsisting under the laws of the State of Illinois, with corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Prospectus, and, to its knowledge, is duly qualified to transact business and will be in good standing in each jurisdiction in which the conduct of its business requires such qualification and in which the failure to qualify would have a Material Adverse Effect. |
(iv) | The authorized capital stock of HoldCo consists of 10,000,000 shares of Common Stock, $0.01 par value per share, and HoldCo has no shares of capital stock issued and outstanding. Immediately upon consummation of the Offering, (a) the shares of Common Stock of HoldCo to be subscribed for or for which orders are placed in the Offering will have been duly and validly authorized for issuance, and when issued and delivered by HoldCo pursuant to the Plan against payment of the consideration calculated as set forth in the Plan, will be fully paid and nonassessable; and (b) the issuance of the shares of Common Stock of HoldCo will not be subject to preemptive rights under the articles of incorporation or bylaws of HoldCo, or arising or outstanding by operation of law or, to the knowledge of such counsel, under any contract, indenture, agreement, instrument or other document, except for the subscription rights under the Plan and the provisions of the Standby Stock Purchase Agreement dated as of March 8, 2018 between the Federal Life Parties and Insurance Capital Group LLC. |
(v) | The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the part of the Federal Life Parties; and this Agreement constitutes a valid and legal obligation of each of the Federal Life Parties. |
(vi) | The Plan has been duly adopted by the Board of Directors of Federal Life Mutual in the manner required by the Insurance Code. |
(vii) | Upon consummation of the Offering, to the knowledge of such counsel, (a) the Offering was made in all material respects in accordance with the Plan, (b) all terms, conditions, requirements and provisions with respect to the Conversion and Offering imposed by the Commission or the Department were complied with by the Federal Life Parties in all material respects or appropriate waivers were obtained, and (c) all notice and waiting periods were satisfied or waived; provided, however, that no opinion need be expressed concerning the state securities or blue sky laws or foreign securities laws of various jurisdictions in which the Shares will be offered. |
26 |
(viii) | The Registration Statement has become effective under the 1933 Act and, to such counsel’s knowledge after making inquiry of the Commission, and based upon representations made by staff of the Commission, no stop order suspending the effectiveness of the Registration Statement has been issued, and, to such counsel’s knowledge, no proceedings for that purpose have been instituted or threatened. |
(ix) | The description of the shares of Common Stock of HoldCo contained in the Registration Statement and the Prospectus, insofar as such statements purport to summarize certain provisions of the articles of incorporation and bylaws of HoldCo, provide a fair summary thereof. |
(x) | At the time that the Registration Statement became effective, the Registration Statement, including the Prospectus contained therein, as amended or supplemented (other than the financial statements, notes to financial statements, financial tables or other financial and statistical data included therein and the appraisal valuation, as to which counsel need express no opinion), complied as to form in all material respects with the requirements of the 1933 Act and the 1933 Act Regulations. |
(xi) | To such counsel’s knowledge, there are no legal or governmental proceedings pending or threatened (i) asserting the invalidity of this Agreement or (ii) seeking to prevent the offer, sale or issuance of the Shares. |
(xii) | The information in the Prospectus under the captions “BUSINESS — Regulation,” and “DESCRIPTION OF OUR CAPITAL STOCK,” to the extent that it constitutes summaries of legal matters, documents or proceedings, or legal conclusions, fairly presents in all material respects the information required to be presented in Form S-1. |
(xiii) | None of the Federal Life Parties is required to be registered as an investment company under the Investment Company Act of 1940, as amended. |
(xiv) | To such counsel’s knowledge, none of the Federal Life Parties is in violation of its Organizational Documents as in effect at the Closing Time. In addition, to such counsel’s knowledge, the execution and delivery of and performance under this Agreement by the Federal Life Parties, the incurrence of the obligations set forth herein and the consummation of the transactions contemplated herein will not result in any material violation of the provisions of the Organizational Documents of any of the Federal Life Parties or any material violation of any applicable law, act, regulation, or to such counsel’s knowledge, order or court order, writ, injunction or decree. |
27 |
In rendering such opinion, such counsel may rely as to matters of fact, without independent investigation, on certificates of responsible officers of the Federal Life Parties (to the extent relevant) and public officials, provided copies of any such certificates are delivered to Agent together with the opinion to be rendered hereunder. Such opinion may be limited to the laws of the Commonwealth of Pennsylvania and the federal securities laws of the United States of America, and such opinion will not be deemed to be rendering any opinion or any other statements regarding the regulatory laws of any other state.
(2) A letter of Stevens & Lee, PC addressed to the Agent to the effect that during the preparation of the Registration Statement and the Prospectus, representatives of Stevens & Lee, PC participated in conferences with certain officers of and other representatives of the Federal Life Parties, representatives of the independent public accounting firm for the Federal Life Parties and representatives of the Agent at which the contents of the Registration Statement and the Prospectus and related matters were discussed, and although (without limiting the opinions provided pursuant to Section 10(b)(1)) Stevens & Lee, PC has not independently verified the accuracy, completeness or fairness of the statements contained in the Registration Statement and Prospectus, on the basis of the information obtained in the course of engagement as counsel, nothing has come to the attention of the representatives of Stevens & Lee, PC providing services to the Federal Life Parties that caused them to believe that (i) the Registration Statement at the time it was ordered effective by the Commission, (ii) the General Disclosure Package as of the Closing Time, or (iii) the Prospectus, as of its date and as of the Closing Time, contained or contains any untrue statement of a material fact or omitted to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading (it being understood that counsel need not assume any responsibility for the accuracy, completeness or fairness of the statements contained in the Registration Statement, the General Disclosure Package and the Prospectus, and counsel need not express any belief with respect to the financial statements, schedules and other financial and statistical data included, statistical or appraisal or valuation methodology employed, or information concerning internal controls over financial reporting contained in, the Registration Statement, Prospectus or General Disclosure Package).
(3) A blue sky memorandum from Stevens & Lee, PC addressed to the Federal Life Parties and the Agent relating to the Offering, including the Agent’s participation therein. The Blue Sky Memorandum will address the necessity of obtaining or confirming exemptions, qualifications or the registration of the Shares under applicable state securities law.
(a) | Concurrently with the execution of this Agreement, the Agent shall receive a letter from BKD LLP, dated the date hereof and addressed to the Agent, in the form set forth in Exhibit A hereto. |
(b) | At the Closing Time, the Agent shall receive a letter from BKD LLP dated the Closing Time, addressed to the Agent, confirming the statements made by its letter delivered by it pursuant to subsection (c) above, the “specified date” referred to in clause (iii)(C) and (D) thereof to be a date specified in such letter, which shall not be more than six business days prior to the Closing Time. |
28 |
(c) | At the Closing Time, the Agent shall receive a certificate of the Chief Executive Officer and Chief Financial Officer of each of the Federal Life Parties, dated as of the Closing Time, in form and substance satisfactory to the Agent to the effect that: (i) they have examined the Prospectus and at the time the Prospectus became authorized for final use, the Prospectus did not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; (ii) since the date the Prospectus became authorized for final use, no event has occurred that should have been set forth in an amendment or supplement to the Prospectus that has not been so set forth, including specifically, but without limitation, any material adverse change in the condition, financial or otherwise, or in the earnings, capital, properties or business of the Federal Life Parties; (iii) since the respective dates as of which information is given in the Registration Statement, the General Disclosure Package and the Prospectus, there has been no material adverse change in the condition, financial or otherwise, or in the earnings, capital, properties or business of the Federal Life Parties independently, or of the Federal Life Parties considered as one enterprise, whether or not arising in the ordinary course of business; (iv) the representations and warranties contained in Section 6 of this Agreement are true and correct with the same force and effect as though made at and as of the Closing Time; (v) each of the Federal Life Parties has complied in all material respects with all agreements and satisfied all conditions on its part to be performed or satisfied at or prior to the Closing Time including the conditions contained in this Section 10; (vi) no stop order suspending the effectiveness of the Registration Statement has been issued or, to their knowledge, is threatened, by the Commission or any other governmental body; (vii) no order suspending the Offering, the Conversion or the use of the Prospectus has been issued and, to their knowledge, no proceedings for any such purpose have been initiated or threatened by the Department, the Commission, or any other federal or state authority; and (viii) to their knowledge, no person has sought to obtain review of the final action of the Director with respect to the Conversion Application. |
(d) | Prior to and at the Closing Time, none of the Federal Life Parties shall have sustained, since the date of the latest audited financial statements included in the Registration Statement and Prospectus, any material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth in the Registration Statement and the Prospectus, and since the respective dates as of which information is given in the Registration Statement and the Prospectus, there shall not have been any material change, or any development involving a prospective Material Adverse Effect, otherwise than as set forth or contemplated in the Registration Statement and the Prospectus, the effect of which, in any such case described above, is in the Agent’s reasonable judgment sufficiently material and adverse as to make it impracticable or inadvisable to proceed with the Offering or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus. |
29 |
(e) | At or prior to the Closing Time, the Department shall have issued a letter or order to Federal Life, which shall have the force of approving the Conversion and Offering. |
(f) | Subsequent to the date hereof, there shall not have occurred any of the following: (i) a suspension or limitation in trading in securities generally on the New York Stock Exchange or American Stock Exchange or in the over-the-counter market, or quotations halted generally on the Nasdaq Stock Market, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices for securities have been required by either of such exchanges or FINRA or by order of the Commission or any other governmental authority other than temporary trading halts (A) imposed as a result of intraday changes in the Dow Jones Industrial Average, (B) lasting no longer than until the regularly scheduled commencement of trading on the next succeeding business-day, and (C) which, when combined with all other such halts occurring during the previous five business days, total less than three; (ii) a general moratorium on the operations of federally-insured financial institutions or general moratorium on the withdrawal of deposits from federally-insured financial institutions declared by either federal or state authorities; or (iii) any outbreak of hostilities or escalation thereof or other calamity or crisis, including, without limitation, terrorist activities after the date hereof, the effect of any of (i) through (iii) herein, in the judgment of the Agent, is so material and adverse as to make it impracticable to market the Shares or to enforce contracts, including subscriptions or purchase orders, for the sale of the Shares. |
All such opinions, certificates, letters and documents will be in compliance with the provisions hereof only if they are reasonably satisfactory in form and substance to the Agent. Any certificate signed by an officer of any of the Federal Life Parties and delivered to the Agent shall be deemed a representation and warranty by the Federal Life Parties to the Agent as to the statements made therein. If any condition to the Agent’s obligations hereunder to be fulfilled prior to or at the Closing Time is not fulfilled, the Agent may terminate this Agreement (provided that if this Agreement is so terminated but the sale of Shares is nevertheless consummated, the Agent shall be entitled to the reimbursement of all expenses to the extent contemplated by Section 14 hereof but shall not be entitled to any compensation provided for in Section 4(a) or (b) hereof) or, if the Agent so elects, may waive any such conditions which have not been fulfilled or may extend the time of their fulfillment.
30 |
11. Indemnification.
(a) | The Federal Life Parties jointly and severally agree to indemnify and hold harmless the Agent, its officers, directors, agents, and employees and each person, if any, who controls the Agent within the meaning of Section 15 of the 1933 Act or Section 20(a) of the 1934 Act, against any and all loss, liability, claim, damage or expense whatsoever (including but not limited to settlement expenses, subject to the limitation set forth in the last sentence of Paragraph (c) below), joint or several, that the Agent or any of such officers, directors, agents, employees and controlling Persons (collectively, the “Related Persons”) may suffer or to which the Agent or the Related Persons may become subject under all applicable federal and state laws or otherwise, and to promptly reimburse the Agent and any Related Persons upon written demand for any reasonable expenses (including reasonable fees and disbursements of counsel) incurred by the Agent or any Related Persons in connection with investigating, preparing or defending any actions, proceedings or claims (whether commenced or threatened) to the extent such losses, claims, damages, liabilities or actions: (i) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment or supplement thereto), the Prospectus (or any amendment or supplement thereto), the General Disclosure Package, the Conversion Application, any Issuer Free Writing Prospectus or any blue sky application or other instrument or document executed by any of the Federal Life Parties or based upon written information supplied by any of the Federal Life Parties filed in any state or jurisdiction to register or qualify any or all of the Shares under the securities laws thereof of to claim an exemption therefrom (collectively, the “Blue Sky Applications”), or any application or other document, advertisement, or communication (“Sales Information”) prepared, made or executed by or on behalf of any of the Federal Life Parties with its consent or based upon written or oral information furnished by or on behalf of any of the Federal Life Parties, whether or not filed in any jurisdiction in order to qualify or register the Shares under the securities laws thereof or to claim an exemption therefrom, (ii) arise out of or are based upon the omission or alleged omission to state in any of the foregoing documents or information, a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; (iii) arise from any theory of liability whatsoever relating to or arising from or based upon the Registration Statement (or any amendment or supplement thereto), the Prospectus (or any amendment or supplement thereto), any Issuer Free Writing Prospectus, or any Blue Sky Applications or Sales Information or other documentation distributed in connection with the Offering; or (iv) result from any claims made with respect to the accuracy, reliability and completeness of the records of policyholders, including without limitation, Eligible Members, or for any denial or reduction of a subscription or order to purchase Common Stock, whether as a result of a properly calculated allocation pursuant to the Plan or otherwise, based upon such records; provided, however, that no indemnification is required under this Paragraph (a) to the extent such losses, claims, damages, liabilities or actions arise out of or are based upon any untrue material statements or alleged untrue material statements in, or material omission or alleged material omission from, the Registration Statement (or any amendment or supplement thereto) or the Prospectus (or any amendment or supplement thereto), any Issuer Free Writing Prospectus, the Blue Sky Applications or Sales Information or other documentation distributed in connection with the Offering made in reliance upon and in conformity with written information furnished to the Federal Life Parties by the Agent or its representatives with respect to the Agent expressly for use in any such document (or any amendment or supplement thereto); provided, that it is agreed and understood that the only information furnished in writing to the Federal Life Parties, by the Agent regarding the Agent is set forth in the Prospectus in the first three paragraphs under the caption “The Conversion and the Offering—Marketing and Underwriting Arrangements”. |
31 |
(b) | The Agent agrees to indemnify and hold harmless the Federal Life Parties, their directors and officers, agents, and employees and each person, if any, who controls any of the Federal Life Parties within the meaning of Section 15 of the 1933 Act or Section 20(a) of the 1934 Act against any and all loss, liability, claim, damage or expense whatsoever (including but not limited to settlement expenses, subject to the limitation set forth in the last sentence of Paragraph (c) below), joint or several which they, or any of them, may suffer or to which they, or any of them, may become subject under all applicable federal and state laws or otherwise, and to promptly reimburse the Federal Life Parties and any such persons upon written demand for any reasonable expenses (including reasonable fees and disbursements of counsel) incurred by them in connection with investigating, preparing or defending any actions, proceedings or claims (whether commenced or threatened) to the extent such losses, claims, damages, liabilities or actions (i) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment of supplement thereto), the Prospectus (or any amendment of supplement thereto), any Issuer Free Writing Prospectus, or any Blue Sky Applications or Sales Information, or (ii) are based upon the omission or alleged omission to state in any of the foregoing documents a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Agent’s obligations under this Paragraph (b) shall exist only if and only to the extent that such untrue statement or alleged untrue statement was made in, or such material fact or alleged material fact was omitted from, the Registration Statement (or any amendment or supplement thereto), the Prospectus (or any amendment or supplement thereto), the Blue Sky Applications or Sales Information in reliance upon and in conformity with written information furnished to any of the Federal Life Parties by the Agent or its representatives (including counsel) with respect to the Agent expressly for use therein; provided, that it is agreed and understood that the only information furnished in writing to the Federal Life Parties, by the Agent regarding the Agent is set forth in the Prospectus in the first three paragraphs under the caption “The Conversion and the Offering—Marketing and Underwriting Arrangements”. |
32 |
(c) | Each indemnified party shall give prompt written notice to each indemnifying party of any action, proceeding, claim (whether commenced or threatened), or suit instituted against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve it from any liability which it may have on account of this Section, Section 12 or otherwise, except to the extent that such failure or delay causes actual harm to the indemnifying party with respect to such action, proceeding, claim or suit. An indemnifying party may participate at its own expense in the defense of such action. In addition, if it so elects within a reasonable time after receipt of such notice, an indemnifying party, jointly with any other indemnifying parties receiving such notice, may assume the defense of such action with counsel chosen by it reasonably acceptable to the indemnified parties that are defendants in such action, unless such indemnified parties reasonably object to such assumption on the ground that there may be legal defenses available to them that are different from or in addition to those available to such indemnifying party. If an indemnifying party assumes the defense of such action, the indemnifying parties shall not be liable for any fees and expenses of counsel for the indemnified parties incurred thereafter in connection with such action, proceeding or claim, other than reasonable costs of investigation unless such indemnified parties reasonably object to such assumption on the ground that there may be legal defenses available to them that are different from or in addition to those available to such indemnifying party. In no event shall the indemnifying parties be liable for the fees and expenses of more than one separate firm of attorneys for all indemnified parties in connection with any one action, proceeding or claim or separate but similar or related actions, proceedings or claims in the same jurisdiction arising out of the same general allegations or circumstances. The indemnifying party shall be liable for any settlement of any claim against the indemnified party (or its directors, officers, employees, affiliates or controlling persons) made with the indemnifying party’s consent, which consent shall not be unreasonably withheld. The indemnifying party shall not, without the written consent of the indemnified party, settle or compromise any claim against the indemnified party based upon circumstances giving rise to an indemnification claim against the indemnifying party hereunder unless such settlement or compromise provides that indemnified party and the other indemnified parties shall be unconditionally and irrevocably released from all liability in respect of such claim. |
33 |
12. Contribution. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in Section 11 is due in accordance with its terms but is found in a final judgment by a court to be unavailable from the Federal Life Parties or the Agent, the Federal Life Parties and the Agent shall contribute to the aggregate losses, claims, damages and liabilities of the nature contemplated by such indemnification (including any investigation, legal and other expenses incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding, but after deducting any contribution received by the Federal Life Parties or the Agent from persons other than the other parties thereto, who may also be liable for contribution) in such proportion so that (i) the Agent is responsible for that portion represented by the percentage that the fees paid to the Agent pursuant to Section 4 of this Agreement (not including expenses) (“Agent’s Fees”) bear to the total proceeds received by the Federal Life Parties from the sale of the Shares in the Offering, net of the Agent’s Fees, and (ii) the Federal Life Parties shall be responsible for the balance. If, however, the allocation provided above is not permitted by applicable law, then each indemnifying party shall contribute to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative fault of the Federal Life Parties on the one hand and the Agent on the other in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions, proceedings or claims in respect thereof), but also the relative benefits received by the Federal Life Parties on the one hand and the Agent on the other from the Offering, as well as any other relevant equitable considerations. The relative benefits received by the Federal Life Parties on the one hand and the Agent on the other hand shall be deemed to be in the same proportion as the total proceeds from the Offering, net of the Agent’s Fees, received by the Federal Life Parties bear to the Agent’s Fees. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Federal Life Parties on the one hand or the Agent on the other and the parties relative intent, good faith, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Federal Life Parties and the Agent agree that it would not be just and equitable if contribution pursuant to this Section 12 were determined by pro-rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 12. The amount paid or payable by an indemnified party as a result of the losses, claims, damages or liabilities (or action, proceedings or claims in respect thereof) referred to above in this Section 12 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action, proceeding or claim. It is expressly agreed that the Agent shall not be liable for any loss, liability, claim, damage or expense or be required to contribute any amount that in the aggregate exceeds the amount paid (excluding reimbursable expenses) to the Agent under this Agreement. It is understood and agreed that the above-stated limitation on the Agent’s liability is essential to the Agent and that the Agent would not have entered into this Agreement if such limitation had not been agreed to by the parties to this Agreement. No person found guilty of any fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any person who was not found guilty of such fraudulent misrepresentation. For purposes of this Section 12, each of the Agent’s and the Federal Life Parties’ officers and directors and each person, if any, who controls the Agent or any of the Federal Life Parties within the meaning of the 1933 Act and the 1934 Act shall have the same rights to contribution as the Federal Life Parties and the Agent. Any party entitled to contribution, promptly after receipt of notice of commencement of any action, suit, claim or proceeding against such party in respect of which a claim for contribution may be made against another party under this Section 12, will notify such party from whom contribution may be sought, but the omission to so notify such party shall not relieve the party from whom contribution may be sought from any other obligation it may have hereunder or otherwise than under this Section 12, except to the extent that such failure or delay causes actual harm to the indemnifying party with respect to such action, proceeding, claim or suit. The obligations of the Federal Life Parties under this Section 12 and under Section 11 shall be in addition to any liability which the Federal Life Parties and the Agent may otherwise have.
13. Survival. All representations, warranties and indemnities and other statements contained in this Agreement or contained in certificates of officers of the Federal Life Parties or the Agent submitted pursuant hereto, shall remain operative and in full force and effect, regardless of any termination or cancellation of this Agreement or any investigation made by or on behalf of the Agent or its controlling persons, or by or on behalf of the Federal Life Parties and shall survive the issuance of the Shares, and any legal representative, successor or assign of the Agent, any of the Federal Life Parties, and any indemnified person shall be entitled to the benefit of the respective agreements, indemnities, warranties and representations.
34 |
14. Termination.
(a) | Agent may terminate this Agreement by giving the notice indicated below in this Section at any time after this Agreement becomes effective as follows: |
(i) | If any domestic or international event or act or occurrence has materially disrupted the United States securities markets such as to make it, in the Agent’s reasonable opinion, impracticable to proceed with the offering of the Shares; or if trading on the NYSE shall have suspended (except that this shall not apply to the imposition of NYSE trading collars imposed on program trading); or if the United States shall have become involved in a war or major hostilities or escalation thereof; or if a general banking moratorium has been declared by a state or federal authority which has a material effect on the Federal Life Parties on a consolidated basis; or if a moratorium in foreign exchange trading by major international banks or persons has been declared; or if any of the Federal Life Parties shall have sustained a material or substantial loss by fire, flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act, whether or not such loss shall have been insured; or, if there shall have been a material adverse change in the financial condition, results of operations or business of the Federal Life Parties taken as a whole. |
(ii) | In the event that (x) the Plan is abandoned or terminated by Federal Life, (y) HoldCo fails to consummate the sale of the minimum number of the Shares by _____, 2019, in accordance with the provisions of the Plan, or (z) the Agent terminates this relationship because there has been a Material Adverse Effect, this Agreement shall terminate and no party to this Agreement shall have any obligation to the other hereunder, except that (1) the Federal Life Parties shall remain liable for any amounts due pursuant to Sections 3, 4, 9, 11 and 12 hereof, unless the transaction is not consummated due to the breach by the Agent of a warranty, representation or covenant and (2) the Agent shall remain liable for any amount due pursuant to Sections 11 and 12 hereof, unless the transaction is not consummated due to the breach by the Federal Life Parties of a warranty representation or covenant. |
(iii) | If any of the conditions specified in Section 10 shall not have been fulfilled when and as required by this Agreement, or by the Closing Time, or waived in writing by the Agent, this Agreement and all of the Agent’s obligations hereunder may be canceled by the Agent by notifying the Federal Life Parties of such cancellation in writing at any time at or prior to the Closing Time, and any such cancellation shall be without liability of any party to any other party except that (x) the Federal Life Parties shall remain liable for any amounts due pursuant to Sections 3, 4, 9, 11 and 12 hereof, unless the transaction is not consummated due to breach by the Agent of a warrant, representation or covenant, and (y) the Agent shall remain liable for any amount due pursuant to Sections 11 and 12 hereof, unless the transaction is not consummated due to the breach by the Federal Life Parties of a warranty representation or covenant. |
35 |
(b) | If Agent elects to terminate this Agreement as provided in this Section, the Federal Life Parties shall be notified by the Agent as provided in Section 15 hereof. |
(c) | If this Agreement is terminated in accordance with the provisions of this Agreement, the Federal Life Parties shall pay the Agent the fees earned pursuant to Section 4 and will reimburse the Agent for its reasonable expenses pursuant to Section 9. |
(d) | Any of the Federal Life Parties may terminate this Agreement in the event the Agent is in material breach of the representations and warranties or covenants contained in Section 5 and such breach has not been cured within a reasonable time period after the Federal Life Parties have provided the Agent with notice of such breach. |
(e) | This Agreement may also be terminated by mutual written consent of the parties hereto. |
15. Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed by United States certified mail, return receipt requested, or sent by a nationally recognized commercial courier promising next business day delivery (such as Federal Express) or transmitted by any standard form of telecommunication (such as facsimile or email) with confirming copy sent by regular U.S. mail. Notices shall be sent as follows:
If to Agent: | Griffin Financial Group, LLC | |
620 Freedom Business Center | ||
2nd Floor | ||
King of Prussia, Pennsylvania 10019 | ||
Attention: Jeffrey P. Waldron, Senior Managing Director | ||
Facsimile: (610) 371-7974 | ||
Email: jpw@griffinfingroup.com | ||
If to the Federal Life Parties | Federal Life Company | |
3759 Deerfield Road | ||
Riverwoods, Illinois 60015 | ||
Attention: William S. Austin | ||
Facsimile: | ||
Email: waustin@federallife.com | ||
With a copy to: | Stevens & Lee, PC | |
111 North 6th Street | ||
Reading, Pennsylvania 19603 | ||
Attention: Wesley R. Kelso, Esquire | ||
Facsimile: (610) 236-4176 | ||
Email: wrk@stevenslee.com |
36 |
Any party may change the address or other information for notices set forth above by written notice to the other parties, which notice shall be given in accordance with this Section 15.
16. Parties. This Agreement shall inure to the benefit of and be binding upon the Agent and the Federal Life Parties and their respective successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or corporation, other than the parties hereto and their respective successors and the controlling persons and officers, directors, agents and employees referred to in Sections 11 and 12 and their heirs and legal representatives, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provisions herein contained.
17. Partial Invalidity. In the event that any term, provision or covenant herein or the application thereof to any circumstances or situation shall be invalid or unenforceable, in whole or in part, the remainder hereof and the application of said term, provision or covenant to any other circumstance or situation shall not be affected thereby, and each term, provision or covenant herein shall be valid and enforceable to the full extent permitted by law.
18. Governing Law and Construction. This Agreement shall be construed in accordance with the laws of the Commonwealth of Pennsylvania applicable to contracts executed and to be wholly performed therein without giving effects to its conflicts of laws principles or rules.
19. Counterparts. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument and any of the parties hereto may execute this Agreement by signing any such counterpart. Any signature delivered by facsimile or email (including any delivery by PDF) shall bind the parties hereto with the same effect as the delivery of a manually signed signature page.
20. Entire Agreement. This Agreement, including schedules and exhibits hereto, which are integral parts hereof and incorporated as though set forth in full, constitutes the entire agreement between the parties pertaining to the subject matter hereof superseding any and all prior or contemporaneous oral or prior written agreements, proposals, letters of intent and understandings, and cannot be modified, changed, waived or terminated except by a writing which expressly states that it is an amendment, modification or waiver, refers to this Agreement and is signed by the party to be charged. No course of conduct or dealing shall be construed to modify, amend or otherwise affect any of the provisions hereof.
21. Waiver of Trial by Jury. Each of the Agent and the Federal Life Parties waives all right to trial by jury in any action, proceeding, claim or counterclaim (whether based on contract, tort or otherwise) related to or arising out of this Agreement.
37 |
If the foregoing is in accordance with your understanding of our agreement, please sign and return to us a counterpart hereof, whereupon this instrument along with all counterparts will become a binding agreement between you and us in accordance with its terms.
Very truly yours, | ||
FEDERAL LIFE GROUP, INC. | ||
By: | ||
William S. Austin, President and | ||
Chief Operating Officer | ||
FEDERAL LIFE INSURANCE COMPANY | ||
By: | ||
William S. Austin, President and | ||
Chief Operating Officer | ||
FEDERAL LIFE MUTUAL HOLDING COMPANY | ||
By: | ||
William S. Austin, President and | ||
Chief Operating Officer |
[COUNTERPART SIGNATURE OF GRIFFIN ON FOLLOWING PAGE]
38 |
The foregoing Agency Agreement is hereby confirmed and accepted as of the date first set and above written.
GRIFFIN FINANCIAL GROUP, LLC | ||
By: | ||
Jeffrey P. Waldron, Senior Managing | ||
Director |
39 |
Schedule A
Persons Required to Enter into Lock-up Agreements
NONE
Exhibit A
Form of Comfort Letter from BKD LLP
Exhibit B
Form of Lockup Agreement
Exhibit 2.1
PLAN OF CONVERSION
OF
FEDERAL LIFE MUTUAL HOLDING COMPANY
Under Section 59.1 of the
Illinois Insurance Code, 215 ILCS 5/59.1
As Approved on March 8, 2018
by the Board of Directors
Table of Contents
Page | |
ARTICLE 1 | |
REASONS FOR THE CONVERSION | 1 |
ARTICLE 2 | |
DEFINITIONS | 2 |
2.01 Certain Terms | 2 |
2.02 Terms Generally | 5 |
ARTICLE 3 | |
ADOPTION BY THE BOARD OF DIRECTORS | 6 |
3.01 Adoption by the Board | 6 |
ARTICLE 4 | |
APPROVAL BY THE DIRECTOR | 6 |
4.01 Application for Approval | 6 |
4.02 Director Approval | 6 |
ARTICLE 5 | |
TOTAL NUMBER OF SHARES AND PURCHASE PRICE OF COMMON STOCK | 7 |
5.01 Independent Appraiser | 7 |
5.02 Purchase Price | 7 |
5.03 Number of Shares of Common Stock to be Offered | 7 |
5.04 Number of Shares of Common Stock to be Sold | 7 |
5.05 Results of Offering | 7 |
ARTICLE 6 | |
GENERAL PROCEDURE FOR THE OFFERINGS | 9 |
6.01 Commencement of Offerings | 9 |
ARTICLE 7 | |
SUBSCRIPTION OFFERING | 9 |
7.01 Allocation of Subscription Rights | 9 |
ARTICLE 8 | |
COMMUNITY OFFERING AND PUBLIC OFFERING | 11 |
8.01 Community Offering | 11 |
8.02 Preference in Community Offering | 11 |
8.03 Delivery of Offering Materials | 11 |
8.04 Commencement of Community Offering | 11 |
8.05 Public Offering | 11 |
8.06 Alternative Offering Procedures | 12 |
ARTICLE 9 | |
STANDBY PURCHASER | 12 |
9.01 Sale of Shares to Standby Purchaser | 12 |
i
Table of Contents
Page | |
ARTICLE 10 | |
LIMITATIONS ON SUBSCRIPTIONS AND PURCHASES OF COMMON STOCK | 12 |
10.01 Maximum Number of Shares That May be Purchased | 12 |
ARTICLE 11 | |
TIMING OF THE OFFERINGS, MANNER OF PURCHASING COMMON STOCK AND ORDER FORMS | 14 |
11.01 Commencement of the Offering | 14 |
11.02 Right to Reject Orders | 14 |
11.03 Policyholders Outside the United States | 14 |
ARTICLE 12 | |
PAYMENT FOR COMMON STOCK | 15 |
12.01 Purchase Price for Shares | 15 |
12.02 Shares Nonassessable | 15 |
ARTICLE 13 | |
CONDITIONS of THE OFFERING | 15 |
13.01 Closing Conditions | 15 |
ARTICLE 14 | |
APPROVAL BY ELIGIBLE MEMBERS | 15 |
14.01 Special Meeting | 15 |
14.02 Notice of the Special Meeting | 16 |
ARTICLE 15 | |
THE CONVERSION | 16 |
15.01 Effect on FLMHC | 16 |
15.02 Effect on Existing Policies | 17 |
15.03 Closed Block of Participating Policies | 17 |
15.04 Filing of Plan of Conversion and Amended and Restated Articles | 17 |
15.05 Effectiveness of Plan of Conversion | 18 |
15.06 Tax Considerations | 18 |
ARTICLE 16 | |
POLICIES | 19 |
16.01 Policies | 19 |
16.02 Determination of Ownership | 19 |
16.03 In Force | 20 |
ARTICLE 17 | |
SUBSEQUENT POLICYHOLDERS | 20 |
17.01 Notice to Subsequent Policyholders | 20 |
17.02 Option to Rescind | 20 |
ii
Table of Contents
Page | |
ARTICLE 18 | |
OFFICERS AND BOARD OF DIRECTORS | 21 |
18.01 Directors | 21 |
18.02 Officers | 21 |
ARTICLE 19 | |
ADDITIONAL PROVISIONS | 21 |
19.01 Continuation of Corporate Existence | 21 |
19.02 Conflict of Interest | 21 |
19.03 Registration of Shares; Listing of Shares on Stock Exchange | 22 |
19.04 Restrictions on Transfer of Common Stock | 22 |
19.05 No Preemptive Rights | 22 |
19.06 Amendment or Withdrawal of Plan of Conversion | 22 |
19.07 Corrections | 23 |
19.08 Notices | 23 |
19.09 Limitation of Actions | 23 |
19.10 Costs and Expenses | 23 |
19.11 Headings | 23 |
19.12 Governing Law | 23 |
iii
PLAN OF CONVERSION
OF
FEDERAL LIFE MUTUAL HOLDING COMPANY
Under Section 59.1 of the
Illinois Insurance Code, 215 ILCS 5/59.1
This Plan of Conversion provides for the conversion of Federal Life Mutual Holding Company, a mutual holding company organized under the laws of Illinois (such entity, both before and after the Conversion, being referred to as “FLMHC”), from a mutual holding company into a stock company (the “Conversion”) and the issuance by FLMHC of newly-issued shares of common stock of FLMHC to Federal Life Group, Inc., a Pennsylvania corporation (“HoldCo”), as authorized by Section 59.1 of the Illinois Insurance Code, 215 ILCS 5/59.1 (the “Conversion Act”). In the Conversion, all Eligible Members will receive subscription rights to purchase shares of common stock of HoldCo, in exchange for the extinguishment of their Membership Interests in FLMHC. As required by Section 59.1(2) of the Illinois Insurance Code, this Plan of Conversion was originally approved and adopted by at least two-thirds of the members of the Board of Directors (the “Board”) of FLMHC, at a meeting duly called and held on March 8, 2018 (the “Adoption Date”). Capitalized terms used herein without definition have the meaning set forth in Article 2 hereof.
ARTICLE 1
REASONS FOR THE CONVERSION
The principal purpose of the Conversion is to convert FLMHC from a mutual insurance holding company into a stock holding company in order to enhance its strategic and financial flexibility and to provide the Eligible Members with the right to acquire an equity interest in HoldCo. The Board believes that the Conversion is in the best interest of FLMHC because the additional capital resulting from the Conversion should: (i) support further organic growth in life insurance premiums written and annuity deposits; (ii) provide the capital necessary to permit increased sales of life insurance and annuities by Federal Life; and (iii) enable HoldCo to attract institutional investors and engage in strategic transactions advantageous to HoldCo and its subsidiaries. The Board further believes that the transaction is fair and equitable, is consistent with the purpose and intent of Section 59.1 and will not prejudice the interests of the Members.
In its present structure as a mutual holding company, FLMHC can increase the statutory capital of Federal Life only through earnings generated by the businesses of Federal Life and its subsidiaries, the issuance of surplus notes by Federal Life, or the sale of a minority interest in Federal Life with or without the granting of subscription rights. Reliance on earnings to provide a long-term source of permanent capital, however, limits Federal Life’s ability to develop new business, issue new insurance and annuity products, and provide greater stability and protection for its policyholders. Surplus notes do not provide permanent capital and must be repaid out of the company’s earnings. The sale of a minority interest in Federal Life is unlikely to provide a meaningful amount of capital, especially in relation to the costs incurred to raise this capital.
1
ARTICLE 2
DEFINITIONS
2.01 Certain Terms. As used in this Plan of Conversion, the following terms have the meanings set forth below:
“Adoption Date” has the meaning specified in the preamble.
“Affiliate” means a Person who, directly or indirectly, through one or more intermediaries, controls or is controlled by or is under common control with the Person specified or who is acting in concert with the Person specified.
“Amended and Restated Articles of Incorporation” has the meaning specified in Section 14.01(a).
“Amended and Restated Bylaws” has the meaning specified in Section 15.04(a).
“Application” has the meaning specified in Section 4.01.
“Appraised Value” means the estimated pro forma market value of FLMHC, as determined by RP Financial, LC.
“Board” has the meaning specified in the preamble.
“Code” means the Internal Revenue Code of 1986, as amended.
“Common Stock” means the common stock of HoldCo, par value $0.01 per share.
“Community Offering” means the offering for sale by HoldCo of any shares of Common Stock not subscribed for in the Subscription Offering as set forth in Article 8 hereof, and includes any Public Offering. HoldCo may retain the assistance of a broker-dealer or syndicate of broker-dealers to assist it in connection with the sale of Common Stock in the Community Offering.
“Conversion” has the meaning specified in the preamble.
“Decision and Order” means the final and effective decision and order issued by the Director and evidencing the Director’s approval of the Application and of this Plan of Conversion.
“Department” means the Illinois Department of Insurance.
“Director” means the Director of the Illinois Department of Insurance.
“Effective Date Filing” has the meaning specified in Section 15.04.
“Effective Time” means 12:01 a.m., Illinois time, on the Plan Effective Date. This is the time that this Plan of Conversion is deemed to be effective.
2
“Eligible Member” means a Member on the Adoption Date; provided that a person insured under a group policy is not an Eligible Member unless all of the conditions in 215 ILCS 5/59.1(1)(a)(i)-(iv) are satisfied.
“Eligible Policy” means any Policy that is In Force on the Adoption Date.
“Employee” means any natural person who is a full or part-time employee of Federal Life.
“Federal Life” means Federal Life Insurance Company, an Illinois chartered stock insurance company.
“Federal Life Records” means the books, records and accounts of Federal Life.
“FLMHC Shares” means the duly authorized shares of common stock of FLMHC to be issued to HoldCo on the Plan Effective Date in accordance with this Plan of Conversion.
“Gross Proceeds” means the product of (x) the Purchase Price and (y) the number of shares for which subscriptions and orders are received in the Offering and accepted by HoldCo.
“HoldCo” means Federal Life Group, Inc., a Pennsylvania corporation that will become the sole stockholder of FLMHC, and which will issue shares of Common Stock in the Offering.
“Illinois Insurance Code” means 215 ILCS 5.
“In Force” has the meaning specified in Section 16.03(a).
“Insider” means any Officer or director of Federal Life.
“Maximum of the Valuation of Range” has the meaning specified in Section 5.01.
“Member” means a person who, according to the Federal Life Records and pursuant to its bylaws and in accordance with Article 16 hereof, is deemed to be a holder of a Membership Interest in FLMHC.
“Membership Interests” means, with respect to FLMHC, the interests of Members arising under Illinois law and the articles of incorporation and bylaws of FLMHC prior to the Conversion, including the right to vote and the right to participate in any distribution of surplus in the event that FLMHC is liquidated.
“Minimum of the Valuation of Range” has the meaning specified in Section 5.01.
“Notice of Special Meeting” has the meaning specified in Section 14.02(a).
“Offering” means the offering of shares of Common Stock pursuant to this Plan in the Subscription Offering and the Community Offering or any Public Offering.
3
“Officer” means the people elected to serve as an officer by the Board of Directors of Federal Life, FLMHC, or HoldCo.
“Order Form” means the form provided on behalf of HoldCo by which Common Stock may be ordered in the Offering.
“Owner” means, with respect to any Policy, the Person or Persons specified or determined pursuant to the provisions of Section 16.02.
“Participant” means a Person to whom Common Stock is offered in the Subscription Offering.
“Person” means an individual, partnership, firm, association, corporation, joint-stock company, limited liability company, trust, government or governmental agency, state or political subdivision of a state, public or private corporation, board, association, estate, trustee, or fiduciary, or any similar entity.
“Plan Effective Date” has the meaning specified in Section 15.05(a).
“Plan of Conversion” means this Plan of Conversion, as it may be amended from time to time in accordance with Section 19.06 or corrected in accordance with Section 19.07. Any reference to the term “Plan of Conversion” shall be deemed to incorporate by reference all of the Exhibits thereto.
“Policy” or “Policies” has the meaning specified in Section 16.01(a).
“Prospectus” means the one or more documents to be used in offering the Common Stock in the Offering and for providing information to Persons in connection with the Offering.
“Public Offering” means an underwritten firm commitment or best efforts offering to the public through one or more underwriters or registered broker-dealers
“Purchase Price” has the meaning specified in Section 5.02.
“Registration Statement” means the registration statement filed or to be filed with the SEC by HoldCo under the Securities Act with respect to the offer and sale of shares of HoldCo common stock in the Offering.
“RP Financial” means RP Financial, LC.
“SEC” means the United States Securities and Exchange Commission.
“Securities Act” means the Securities Act of 1933, as amended.
“Special Meeting” has the meaning specified in Section 14.01.
4
“Standby Purchaser” means one or more Persons that enter into a Stock Purchase Agreement to purchase stock in the Offering in an amount in excess of five percent (5%) of the number of shares issued in the Offering.
“Strategic Investors” means the Persons (which shall not exceed four (4) in number) identified in a resolution adopted by the Board and granted preference by HoldCo and FLMHC in the Community Offering.
“Stock Compensation Plan” means any executive stock incentive plan that may be established by HoldCo and under which stock options, shares of restricted stock, or restricted stock units may be granted to directors and employees of HoldCo or any of its subsidiaries.
“Stock Purchase Agreement” means any Stock Purchase Agreement entered into between HoldCo and a Standby Purchaser.
“Subscription Offering” means the offering of the Common Stock that is described in Section 7.01 hereof.
“Subscription Rights” means nontransferable rights to subscribe for Common Stock in the Subscription Offering granted to Participants as described in Section 7.01 hereof.
“Valuation Range” means the range of the estimated pro forma market value of FLMHC as converted to a stock insurance holding company as determined by RP Financial in accordance with Section 5.01 hereof.
2.02 Terms Generally. As used in this Plan of Conversion, except to the extent that the context otherwise requires:
(a) when a reference is made in this Plan of Conversion to an Article, Section or Exhibit, such reference is to an Article or Section of, or an Exhibit to, this Plan of Conversion unless otherwise indicated;
(b) the words “hereby”, “herein”, “hereof”, “hereunder” and words of similar import refer to this Plan of Conversion as a whole (including any Exhibits hereto) and not merely to the specific section, paragraph or clause in which such word appears;
(c) whenever the words “include,” “includes,” or “including” (or similar terms) are used in this Plan of Conversion, they are deemed to be followed by the words “without limitation”;
(d) the definitions contained in this Plan of Conversion are applicable to the singular as well as the plural forms of such terms; and
(e) whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms.
5
ARTICLE 3
ADOPTION BY THE BOARD OF DIRECTORS
3.01 Adoption by the Board. This Plan of Conversion has been approved and adopted by at least two-thirds of the members of the Board at a meeting duly called and held on March 8, 2018. This Plan of Conversion provides for the conversion of FLMHC into a stock insurance holding company in accordance with the requirements of Section 59.1(2) of the Illinois Insurance Code.
ARTICLE 4
APPROVAL BY THE DIRECTOR
4.01 Application for Approval. Following the adoption of this Plan of Conversion by the Board, FLMHC shall file an application (the “Application”) with the Director for approval of this Plan of Conversion in accordance with Section 59.1(3) of the Illinois Insurance Code. The Application shall include true and complete copies of the following documents:
(a) this Plan of Conversion;
(b) the independent appraisal of market value of FLMHC provided by RP Financial in accordance with Section 5.01 and required by Section 59.1(6)(f) of the Illinois Insurance Code;
(c) the form of notice of the Special Meeting, required by Section 59.1(4)(b) of the Illinois Insurance Code;
(d) the form of information statement and proxy to be solicited from Eligible Members, required by Section 59.1(4)(c)(ii) of the Illinois Insurance Code;
(e) the form of notice to persons whose Policies are issued after the Adoption Date but before the Plan Effective Date, required by Section 59.1(10)(a) of the Illinois Insurance Code;
(f) the proposed amended and restated articles of incorporation and amended and restated bylaws of FLMHC; and
(g) any other information or documentation as the Director may request.
If the Director requires modifications to this Plan of Conversion, the Board shall submit any amended Plan of Conversion to the Director for his review and approval.
4.02 Director Approval. This Plan of Conversion is subject to the approval of the Director.
6
ARTICLE 5
TOTAL NUMBER OF SHARES AND PURCHASE PRICE OF COMMON STOCK.
The number of shares of Common Stock required to be offered and sold by HoldCo in the Offering will be determined as follows:
5.01 Independent Appraiser. RP Financial has been retained by FLMHC to determine the Valuation Range. The Valuation Range will consist of a midpoint valuation, a valuation fifteen percent (15%) above the midpoint valuation (the “Maximum of the Valuation Range”) and a valuation fifteen percent (15%) below the midpoint valuation (the “Minimum of the Valuation Range”). The Valuation Range will be based upon the consolidated financial condition and results of operations of FLMHC, the consolidated pro forma book value and earnings per share of FLMHC as converted to a stock company, a comparison of FLMHC with comparable publicly-held insurance companies and insurance holding companies, and such other factors as RP Financial may deem to be relevant, including that value which RP Financial estimates to be necessary to attract a full subscription for the Common Stock. RP Financial will submit to FLMHC the Valuation Range and a related report that describes the data and methodology used to determine the Valuation Range.
5.02 Purchase Price. The Purchase Price for Common Stock in the Offering (the “Purchase Price”) will be $10.00 per share and will be uniform as to all purchasers in the Offering.
5.03 Number of Shares of Common Stock to be Offered. The maximum number of shares of Common Stock to be offered in the Offering shall be equal to the Maximum of the Valuation Range divided by the Purchase Price.
5.04 Number of Shares of Common Stock to be Sold. RP Financial will submit to FLMHC the Appraised Value as of the end of the latest calendar quarter for which financial statements of FLMHC are available prior to the initial filing of a draft Registration Statement with the SEC. If the Gross Proceeds of the Offering do not equal or exceed the Minimum of the Valuation Range, then FLMHC may cancel the Offering and terminate this Plan, establish a new Valuation Range and extend, reopen or hold a new Offering, or take such other action as it deems to be reasonably necessary.
5.05 Results of Offering.
(a) If the Gross Proceeds of the Offering equal or exceed the Minimum of the Valuation Range, the following steps will be taken:
(i) Subscription Offering Exceeds Maximum. If the number of shares to which Participants subscribe in the Subscription Offering multiplied by the Purchase Price is greater than the Maximum of the Valuation Range, then HoldCo on the Effective Date shall issue shares of Common Stock to the subscribing Participants; which shares shall be allocated among the subscribing Participants as provided in Section 7.01; provided, however, that the number of shares of Common Stock issued shall not exceed the number of shares of Common Stock offered in the Offering as provided in Section 5.03; and provided further, that no fractional shares of Common Stock shall be issued.
7
(ii) Subscription Offering Meets or Exceeds Minimum, but does not Exceed Maximum. If the number of shares of Common Stock subscribed for by Participants in the Subscription Offering multiplied by the Purchase Price is equal to or greater than the Minimum of the Valuation Range, but less than or equal to the Maximum of the Valuation Range, then HoldCo on the Effective Date shall issue shares of Common Stock to the subscribing Participants in an amount sufficient to satisfy the subscriptions of such Participants in full. To the extent that shares of Common Stock remain unsold after the subscriptions of all Participants in the Subscription Offering have been satisfied in full, HoldCo shall have the right in its absolute discretion to accept, in whole or in part, orders received from purchasers in the Community Offering, including without limitation orders from Standby Purchasers pursuant to any Stock Purchase Agreement; provided, however, that the number of shares of Common Stock issued shall not exceed the Maximum of the Valuation Range; and, provided further, that no fractional shares of Common Stock shall be issued.
(iii) Subscription Offering Does Not Meet Minimum. If the number of shares of Common Stock subscribed for by Participants in the Subscription Offering multiplied by the Purchase Price is less than the Minimum of the Valuation Range, then in such event HoldCo may accept orders received from purchasers in the Community Offering, including without limitation orders from Standby Purchasers pursuant to any Stock Purchase Agreement. If the aggregate number of shares of Common Stock subscribed for in the Subscription Offering together with the orders for shares accepted in the Community Offering multiplied by the Purchase Price is equal to or greater than the Minimum of the Valuation Range, then on the Effective Date HoldCo shall: (A) issue shares of Common Stock to subscribing Participants in an amount sufficient to satisfy the subscriptions of such Participants in full, and (B) issue to purchasers in the Community Offering whose orders have been accepted such additional number of shares of Common Stock such that the aggregate number of shares of Common Stock to be issued to subscribing Participants and to purchasers in the Community Offering multiplied by the Purchase Price shall be equal to the Minimum of the Valuation Range; provided, however, that no fractional shares of Common Stock shall be issued. HoldCo may in its absolute discretion elect to issue shares of Common Stock to purchasers in the Community Offering in excess of the number determined by reference to clause (B) of the preceding sentence; provided, however, that the number of shares of Common Stock issued shall not exceed the Maximum of the Valuation Range.
(b) Offering Does Not Meet Minimum. If the aggregate number of shares of Common Stock subscribed for in the Subscription Offering together with the orders for shares accepted in the Community Offering multiplied by the Purchase Price is less than the Minimum of the Valuation Range, then in such event HoldCo and FLMHC may (w) cancel the Offering and terminate this Plan, (x) establish a new Valuation Range, (y) extend, reopen or hold a new Offering, or (z) take such other action as they deem reasonably necessary. If a new Valuation Range is established and the Offering is extended, reopened or continued as part of a new Offering, Persons who previously submitted subscriptions or orders will be required to confirm, revise or cancel their original subscriptions or orders. If original subscriptions or orders are canceled, any related payment will be refunded (without interest).
8
If, following a reduction in the Valuation Range, the aggregate number of shares of Common Stock for which subscriptions and orders have been accepted in the Offering multiplied by the Purchase Price is equal to or greater than the Minimum of the Valuation Range (as such Valuation Range has been reduced), then HoldCo on the Effective Date shall: (i) issue shares of Common Stock to Participants in the Subscription Offering in an amount sufficient to satisfy the subscriptions of such subscribers in full, and (ii) issue to purchasers in the Community Offering whose orders have been accepted such additional number of shares of Common Stock such that the aggregate number of shares of Common Stock to be issued multiplied by the Purchase Price shall be at least equal to the Minimum of the Valuation Range (as such Valuation Range has been reduced).
(c) Allocation of Shares. In determining the allocation of shares of Common Stock to purchasers in the Offering: (i) only those orders and subscriptions accepted by FLMHC and HoldCo shall be counted; (ii) any orders and subscriptions for shares in excess of the limitations on purchases set forth in Article 10 hereof shall be accepted only up to the applicable limitation on purchases set forth in Article 10 hereof; and (iii) any order or subscription for shares of Common Stock shall only be accepted to the extent of the payment of the Purchase Price for such shares actually received prior to the termination of the Offering.
(d) Participant Eligibility. Notwithstanding anything to the contrary set forth in this Plan, FLMHC and HoldCo shall have the right in their absolute discretion and without liability to any subscriber, purchaser, underwriter, broker-dealer, or any other Person to determine which proposed Persons and which subscriptions and orders in the Offering meet the criteria provided in this Plan for eligibility to purchase Common Stock and the number of shares eligible for purchase by any Person. The determination of these matters by HoldCo and FLMHC shall be final and binding on all parties and all Persons. Except for orders submitted by any Standby Purchaser in accordance with the provisions of a Stock Purchase Agreement, FLMHC and HoldCo shall have absolute and sole discretion to accept or reject, in whole or in part, any offer to purchase that is made or received in the course of the Community Offering, irrespective of a Person’s eligibility under this Plan to participate in the Community Offering.
ARTICLE 6
GENERAL PROCEDURE FOR THE OFFERINGS.
6.01 Commencement of Offerings. As soon as practicable after the registration of the Common Stock under the Securities Act, and after the receipt of all required regulatory approvals, the Common Stock shall be first offered for sale in the Subscription Offering. It is anticipated that any shares of Common Stock remaining unsold after the Subscription Offering will be sold through a Community Offering. The purchase price per share for the Common Stock shall be a uniform price determined in accordance with Section 5.02 hereof.
ARTICLE 7
SUBSCRIPTION OFFERING.
7.01 Allocation of Subscription Rights. Rights to purchase shares of Common Stock at the Purchase Price (the “Subscription Rights”) will be distributed by HoldCo to the Participants in the following priorities:
9
(a) Eligible Members (First Priority). Each Eligible Member shall receive, without payment, nontransferable Subscription Rights to purchase up to 50,000 shares of Common Stock in the Subscription Offering; provided, however, that the maximum number of shares that may be purchased by Eligible Members in the aggregate shall be equal to the Maximum of the Valuation Range divided by the Purchase Price.
In the event of an oversubscription for shares of Common Stock pursuant to this Section 7.01(a), available shares shall be allocated among subscribing Eligible Members so as to permit each such Eligible Member, to the extent possible, to purchase a number of shares that will make his or her total allocation equal to the lesser of (i) the number of shares that he or she subscribed for or (ii) 1,000 shares. Any shares of Common Stock remaining after such initial allocation will be allocated among the subscribing Eligible Members whose subscriptions remain unsatisfied in the proportion in which (i) the aggregate number of shares as to which each such Eligible Member’s subscription remains unsatisfied bears to (ii) the aggregate number of shares as to which all such Eligible Members’ subscriptions remain unsatisfied; provided, however, that no fractional shares of Common Stock shall be issued. If, because of the magnitude of the oversubscription, shares of Common Stock cannot be allocated among subscribing Eligible Members so as to permit each such Eligible Member to purchase the lesser of 1,000 shares or the number of shares subscribed for, then shares of Common Stock will be allocated among the subscribing Eligible Members in the proportion in which: (i) the aggregate number of shares subscribed for by each such Eligible Member bears to (ii) the aggregate number of shares subscribed for by all Eligible Members; provided, however, that no fractional shares of Common Stock shall be issued.
(b) Directors and Officers of FLMHC (Second Priority). Each director and Officer of FLMHC shall receive, without payment, nontransferable Subscription Rights to purchase shares of Common Stock in the Subscription Offering; provided, however, that such Subscription Rights shall be subordinated to the Subscription Rights of the Eligible Members; and provided, further, that such Subscription Rights may be exercised only to the extent that there are shares of Common Stock that could have been purchased by Eligible Members, but which remain unsold after satisfying the subscriptions of all Eligible Members. In the event of an oversubscription among the directors and Officers, the number of shares issued to any one director or Officer shall be equal to the product of (i) the number of shares available for issuance to all directors and Officers, and (ii) a fraction, expressed as a percentage, the numerator of which is the number of shares to which the subscribing director or Officer subscribed and the denominator of which is the total number of shares subscribed by all directors and Officers. The aggregate number of shares purchased by the directors and Officers, whether purchased in the Subscription Offering in their capacity as Eligible Members, in the Community Offering, or otherwise, shall be limited as provided in Section 10.1 hereof.
A director or Officer who subscribes to purchase shares of Common Stock and who also is eligible to purchase shares of Common Stock as an Eligible Member will be deemed to purchase Common Stock first in his or her capacity as an Eligible Member.
(c) Limitations on Subscription Rights. Subscription rights granted under this Plan will be nontransferable, nonnegotiable personal rights to subscribe for and purchase shares of Common Stock at the Purchase Price. Subscription Rights under this Plan will be granted without payment, but subject to all the terms, conditions and limitations of this Plan. Any Person purchasing Common Stock hereunder will be deemed to represent and affirm to HoldCo and FLMHC that such Person is purchasing for his or her own account and not on behalf of any other Person.
10
ARTICLE 8
COMMUNITY OFFERING AND PUBLIC OFFERING.
8.01 Community Offering. If less than the total number of shares of Common Stock offered by HoldCo in connection with the Conversion are sold in the Subscription Offering, it is anticipated that remaining shares of Common Stock shall, if practicable, be sold by HoldCo in the Community Offering.
8.02 Preference in Community Offering. In the Community Offering, subject to the terms of any Stock Purchase Agreement, HoldCo may accept, in its sole and absolute discretion, orders received, in the following order of priority, from (i) Employees, (ii) any Standby Purchaser, (iii) the Federal Life 401-K plan, and (iv) Strategic Investors, before accepting orders from the general public; provided, however, that notwithstanding the foregoing, HoldCo may accept such number of orders as are necessary for HoldCo to qualify for listing on the NASDAQ Capital Market.
8.03 Delivery of Offering Materials. A Prospectus and an Order Form shall be furnished to such Persons as FLMHC and HoldCo may select in connection with the Community Offering. Except to the extent provided in any Stock Purchase Agreement with a Standby Purchaser, each order for Common Stock in the Community Offering shall be subject to the absolute right of HoldCo to accept or reject any such order in whole or in part either at the time of receipt of an order or as soon as practicable following completion of the Community Offering. In the event of an oversubscription, subject to the preferences described above, the terms of the Standby Purchase Agreement, and the right of HoldCo to accept or reject, in its sole discretion, any order received in the Community Offering, any available shares will be allocated so as to permit each purchaser whose order is accepted in the Community Offering to purchase, to the extent possible, the lesser of 1,000 shares and the number of shares subscribed for by such person. Thereafter, any shares remaining will be allocated among purchasers whose orders have been accepted but remain unsatisfied on a pro rata basis, provided no fractional shares shall be issued.
8.04 Commencement of Community Offering. HoldCo may commence the Community Offering concurrently with, at any time during, or as soon as practicable after the end of, the Subscription Offering, and the Community Offering must be completed within 45 days after the completion of the Subscription Offering, unless extended by HoldCo.
8.05 Public Offering. HoldCo may sell any shares of Common Stock remaining following the Subscription Offering and Community Offering in a Public Offering, if desired. The provisions of Section 10.01 hereof shall not be applicable to the sales to underwriters for purposes of the Public Offering, but shall be applicable to sales by the underwriters to the public. The price to be paid by the underwriters in such an offering shall be equal to the Purchase Price less an underwriting discount to be negotiated among such underwriters and HoldCo, subject to any required regulatory approval or consent.
11
8.06 Alternative Offering Procedures. If for any reason a Public Offering of shares of Common Stock not sold in the Subscription Offering and the Community Offering cannot be effected, or if the number of shares of Common Stock remaining to be sold after the Subscription Offering and Community Offering is so small that a Public Offering of those remaining shares would be impractical, HoldCo shall use its best efforts to obtain other purchases in such manner and upon such condition as may be necessary, including without limitation selling shares of Common Stock to any Standby Purchaser as described in Section 9.01 hereof.
ARTICLE 9
STANDBY PURCHASER.
9.01 Sale of Shares to Standby Purchaser. If the aggregate number of shares of Common Stock subscribed for in the Subscription Offering multiplied by the Purchase Price is less than the Maximum of the Valuation Range, then in such event HoldCo may sell shares of Common Stock to Standby Purchasers at the Purchase Price, provided that the total number of shares sold in the Offering multiplied by the Purchase Price do not exceed the Maximum of the Valuation Range. Subject to the terms of any Stock Purchase Agreement, any order submitted by Standby Purchasers in the Community Offering may be accepted by HoldCo prior to accepting any other order received in the Community Offering. The Standby Purchaser has purchased an exchangeable promissory note issued by FLMHC in the principal amount of up to $2,000,000 (the “Exchangeable Note”). The outstanding principal balance of the Exchangeable Note will be converted into shares of Common Stock at the Effective Time at a price per share equal to the Purchase Price. The shares of Common Stock issuable upon conversion of the Exchangeable Note shall be issued outside of the Offering and will have no effect on the number of shares issuable in the Offering.
ARTICLE 10
LIMITATIONS ON SUBSCRIPTIONS AND PURCHASES OF COMMON STOCK.
10.01 Maximum Number of Shares That May be Purchased. The following additional limitations and exceptions shall apply to all purchases of Common Stock in the Offering:
(a) To the extent that shares are available, no Person may purchase fewer than the lesser of (i) 50 shares of Common Stock or (ii) shares of Common Stock having an aggregate purchase price of $500.00 in the Offering.
(b) Except for an Officer or director, no employee may purchase more than 50,000 shares of Common Stock in the Offering.
(c) No Strategic Investor may purchase more than 50,000 shares of Common Stock in the Offering.
12
(d) In addition to the other restrictions and limitations set forth herein, except for purchases by a director or Officer, the maximum amount of Common Stock which any Person together with any Affiliate may, directly or indirectly, subscribe for or purchase in the Offering (including without limitation the Subscription Offering and/or Community Offering), shall not exceed 50,000 shares, except that any Standby Purchaser may purchase such number of shares of Common Stock as provided in Section 9.01; and provided further, that any purchase in excess of five percent (5%) of the total shares of Common Stock sold in the Offering must be approved by the Director as otherwise provided under the Illinois Insurance Code. The limit set forth in this section shall not be construed to increase any other purchase limit provided herein. Purchases of shares of Common Stock in the Offering by any Person other than any Standby Purchaser shall not exceed five percent (5%) of the total shares of Common Stock sold in the Offering irrespective of the different capacities in which such person may have received Subscription Rights or other rights or options to place orders for shares of Common Stock under this Plan. The aggregate number of shares purchased in the Offering by the Strategic Investors, employees, the Federal Life 401-K Plan, and the directors and Officers as a group may not exceed 700,000 shares.
(e) For purposes of the foregoing limitations and the determination of Subscription Rights, (i) directors, Officers, and Employees shall not be deemed to be Affiliates or a group acting in concert solely as a result of their capacities as such, (ii) shares of Common Stock purchased by any plan participant in any tax-qualified retirement account using personal funds or funds held in any tax-qualified retirement account (including, for avoidance of doubt, the Federal Life 401-K Plan) pursuant to the exercise of Subscription Rights granted to such plan participant in his individual capacity as an Eligible Member or as a director or Officer and/or purchases by such plan participant in the Community Offering in such plan participant’s capacity as an employee, director or Officer shall not be deemed to be purchases by the tax-qualified retirement account for purposes of calculating the maximum amount of Common Stock that the tax-qualified retirement account may purchase, but shall count towards the individual limitations on purchases set forth in this Plan, and (iii) no Person shall be deemed to be an Affiliate of any Standby Purchaser.
(f) HoldCo may increase or decrease any of the purchase limitations set forth herein at any time; provided that in no event shall the maximum purchase limitation applicable to Eligible Members be less than the maximum purchase limitation percentage applicable to any other class of subscribers or purchasers in the Offering other than the directors and Officers and any Standby Purchaser. In the event that either an individual or aggregate purchase limitation is increased after commencement of the Offering, any Person who ordered the maximum number of shares of Common Stock shall be permitted to purchase an additional number of shares such that such Person may subscribe for or order the then maximum number of shares permitted to be subscribed for or ordered by such Person, subject to the rights and preferences of any person who has priority rights to purchase shares of Common Stock in the Offering. In the event that either an individual or the aggregate purchase limitation is decreased after commencement of the Offering, the orders of any Person who subscribed for or submitted an order for the maximum number of shares of Common Stock shall be decreased by the minimum amount necessary so that such Person shall be in compliance with the then maximum number of shares permitted to be subscribed for or ordered by such Person.
13
(g) Each Person who purchases Common Stock in the Offering shall be deemed to confirm that such purchase does not conflict with the purchase limitations under this Plan or otherwise imposed by law. FLMHC shall have the right to take any action as it may, in its sole discretion, deem necessary, appropriate or advisable in order to monitor and enforce the terms, conditions, limitations and restrictions contained in this Section and elsewhere in this Plan and the terms, conditions and representations contained in the Order Form, including, but not limited to, the absolute right of FLMHC and HoldCo to reject, limit or revoke acceptance of any order and to delay, terminate or refuse to consummate any sale of Common Stock that they believe might violate, or is designed to, or is any part of a plan to, evade or circumvent such terms, conditions, limitations, restrictions and representations. Any such action shall be final, conclusive and binding on all Persons, and HoldCo and FLMHC shall be free from any liability to any Person on account of any such action.
ARTICLE 11
TIMING OF THE OFFERINGS, MANNER OF
PURCHASING COMMON STOCK AND ORDER FORMS.
11.01 Commencement of the Offering. The exact timing of the commencement of the Offering shall be determined by HoldCo in consultation with any financial advisory or investment banking firm retained by it in connection with the Offering. HoldCo may consider a number of factors in determining the exact timing of the commencement of the Offering, including, but not limited to, its pro forma current and projected future earnings, local and national economic conditions and the prevailing market for stocks in general and stocks of insurance companies in particular. HoldCo shall have the right to withdraw, terminate, suspend, delay, revoke or modify the Offering at any time and from time to time, as it in its sole discretion may determine, without liability to any Person, subject to any necessary regulatory approval or concurrence.
11.02 Right to Reject Orders. Subject to the terms of any Stock Purchase Agreement, FLMHC and HoldCo shall have the absolute right, in their sole discretion and without liability to any Person, to reject any Order Form, including, but not limited to, any Order Form that is (i) improperly completed or executed, (ii) not timely received, (iii) not accompanied by the proper payment, or (iv) submitted by a Person whose representations FLMHC or HoldCo believes to be false or who it otherwise believes, either alone, or acting in concert with others, is violating, evading or circumventing, or intends to violate, evade or circumvent, the terms and conditions of this Plan. HoldCo and FLMHC may, but will not be required to, waive any irregularity on any Order Form or may require the submission of corrected Order Forms or the remittance of full payment for shares of Common Stock by such date as FLMHC and HoldCo may specify. The interpretation of FLMHC and HoldCo of the terms and conditions of the Order Forms shall be final and conclusive. Once HoldCo receives an Order Form, the order shall be deemed placed and will be irrevocable; provided, however, that no Order Form shall be accepted until the Prospectus has been filed with the SEC and mailed or otherwise made available to the Persons entitled to Subscription Rights in the Offering, and any Order Form received prior to that time shall be rejected and no sale of Common Stock shall be made in respect thereof.
11.03 Policyholders Outside the United States. HoldCo shall make reasonable efforts to comply with the securities laws of all jurisdictions in the United States in which Persons entitled to subscribe reside. However, HoldCo has no obligation to offer or sell shares to any Person under the Plan if such Person resides in a foreign country or in a jurisdiction of the United States with respect to which (i) there are few Persons otherwise eligible to subscribe for shares under this Plan who reside in such jurisdiction, (ii) the granting of Subscription Rights or the offer or sale of shares of Common Stock to such Persons would require HoldCo or its directors, Officers or employees, under the laws of such jurisdiction, to register as a broker or dealer, salesman or selling agent or to register or otherwise qualify the Common Stock for sale in such jurisdiction, or HoldCo would be required to qualify as a foreign corporation or file a consent to service of process in such jurisdiction, or (iii) such registration or qualification in the judgment of HoldCo would be impracticable or unduly burdensome for reasons of cost or otherwise.
14
ARTICLE 12
PAYMENT FOR COMMON STOCK.
12.01 Purchase Price for Shares. Payment for shares of Common Stock ordered by Persons in the Offering shall be equal to the Purchase Price per share multiplied by the number of shares that are being ordered. Payment for shares subscribed for or ordered in the Subscription Offering or the Community Offering shall be made by bank draft, check, or money order at the time the Order Form is delivered to HoldCo, or in HoldCo’s sole and absolute discretion by delivery of a wire transfer of immediately available funds. Payment for all shares of Common Stock subscribed for must be received in full and collected by HoldCo or by any subscription agent engaged by HoldCo. All subscription payments will be deposited by HoldCo in an escrow account at a bank designated by HoldCo and FLMHC and any wire transfers will be delivered directly to such escrow account. Payment for shares ordered by a Standby Purchaser or through a broker-dealer or underwriter in the Community Offering or any Public Offering may be made by delivery of a wire transfer of immediately available funds to such escrow account.
12.02 Shares Nonassessable. Each share of Common Stock issued in the Offering shall be nonassessable upon payment in full of the Purchase Price.
ARTICLE 13
CONDITIONS of THE OFFERING
13.01 Closing Conditions. Consummation of the Offering is subject to (i) the receipt of all required federal and state approvals for the issuance of Common Stock in the Offering, (ii) approval of the Plan by the members of FLMHC as provided in Section 59.1(4)(c)(i) of the Conversion Act, and (iii) the sale in the Offering (including any shares sold to a Standby Purchaser) of such minimum number of shares of Common Stock within the Valuation Range as may be determined by the Board of Directors of FLMHC.
ARTICLE 14
APPROVAL BY ELIGIBLE MEMBERS
14.01 Special Meeting.
(a) After the approval of the Application by the Director, FLMHC shall hold a special meeting of Eligible Members to vote on this Plan of Conversion (the “Special Meeting”). At the Special Meeting, each Eligible Member shall be entitled to vote on a single proposal (the “Proposal”) to (i) adopt and approve this Plan of Conversion and the other transactions contemplated by this Plan of Conversion, and (ii) amend and restate the articles of incorporation of FLMHC to read in the form attached as Exhibit A (the “Amended and Restated Articles of Incorporation”). The number of votes that each Eligible Member is entitled to cast at the Special Meeting shall be governed by the Bylaws of FLMHC.
15
(b) Adoption of this Plan of Conversion and the Amended and Restated Articles of Incorporation, pursuant to Section 59.1(4)(c)(i) of the Illinois Insurance Code, is subject to the approval of at least two-thirds of the votes cast by Eligible Members in person or by proxy at the Special Meeting.
14.02 Notice of the Special Meeting.
(a) FLMHC shall mail notice of the Special Meeting in a form satisfactory to the Department (the “Notice of Special Meeting”). The Notice of Special Meeting shall be mailed within forty-five (45) days following the Director’s approval of this Plan of Conversion. Such notice shall inform each Eligible Member of such Eligible Member’s right to vote upon the Proposal and the place, the day, and the hour of the Special Meeting. Such notice and other materials set forth in Sections 14.02(b) shall be mailed by first class or priority mail or an equivalent of first class or priority mail, to the last-known address of each Eligible Member as it appears on the Federal Life Records, at least thirty (30) days prior to the date of the Special Meeting, and shall be in a form satisfactory to the Director.
Beginning on the date that the first Notice of Special Meeting is mailed pursuant to Section 14.02(a) and continuing until the Plan Effective Date, FLMHC shall also make available at its statutory home office located at 3750 Deerfield Road, Riverwoods, Illinois, 60015, during regular business hours, copies of the Notice of Special Meeting, this Plan of Conversion and its Exhibits, each in its entirety, for inspection by Eligible Members.
(b) The Notice of the Special Meeting shall be accompanied by information relevant to the Special Meeting, including a copy or summary of this Plan of Conversion, a form of proxy allowing the Eligible Members to vote for or against the Plan of Conversion, a policyholder information statement regarding this Plan of Conversion, and such other explanatory information that the Director approves or requires, all of which shall be in a form satisfactory to the Director. With the prior approval of the Director, FLMHC may also send supplemental information relating to this Plan of Conversion to Eligible Members either before or after the date of the Special Meeting.
ARTICLE 15
THE CONVERSION
15.01 Effect on FLMHC. On the Plan Effective Date, FLMHC shall be converted from a mutual insurance holding company into a stock insurance holding company in accordance with Section 59.1 and the closing of the Offering shall occur in accordance with this Plan of Conversion. Under the terms of this Plan of Conversion, HoldCo will acquire all of the FLMHC Shares. HoldCo thereupon will become the sole shareholder of FLMHC and will have all the rights, privileges, immunities and powers and will be subject to all of the duties and liabilities to the extent provided by law of a shareholder of a corporation organized under the laws of the State of Illinois.
16
15.02 Effect on Existing Policies.
(a) Any Policy In Force on the Plan Effective Date will remain In Force under the terms of such Policy, except that the following rights, to the extent they existed in FLMHC, shall be extinguished on the Plan Effective Date:
(i) any voting rights of the policyholder provided under or as a result of the Policy;
(ii) any right to share in the surplus of FLMHC, except as provided in Section 15.02(b).
(b) Except as otherwise provided in Section 15.02(c), an Owner of a participating Policy In Force on the Plan Effective Date will continue to have a right to receive policyholder dividends as provided in the participating Policy, if any, consistent with Federal Life’s dividend principles and policies practice prior to the Plan Effective Date. Nothing in this Plan shall be construed to guarantee the future payment of any policy dividend for any Policy, whether issued by Federal Life prior to the Plan Effective Date or after the Plan Effective Date. Policy dividends may increase or decrease. The declaration and crediting of future policy dividends, if any, shall remain within the sole discretion of the Board of Directors of Federal Life, except as provided by law. Federal Life may modify the dividend principles and policy in effect on June 1, 2015, with the approval of the Director.
(c) Except for life insurance policies, guaranteed renewable accident and health policies and non-cancellable accident and health policies, after the Plan Effective Date Federal Life may issue the Owner a nonparticipating Policy as a substitute for the participating Policy upon the renewal date of any Policy.
15.03 Closed Block of Participating Policies. Federal Life believes that the size of the block of Policies in Force on the Adoption Date that are participating policies and eligible to receive dividends is insignificant and that the reserve supporting such policies is adequate to continue to support Federal Life’s obligations under such Policies. Accordingly, subject to the Director’s approval of this Plan, Federal Life does not intend to establish a closed block for such policies.
15.04 Filing of Plan of Conversion and Amended and Restated Articles. As soon as practicable following (i) the receipt of the Decision and Order, (ii) the Director’s determination that all conditions to such approval contained in the Decision and Order have been satisfied, except for those conditions required by the Decision and Order to be satisfied after the Plan Effective Date and with respect to which the Director has received commitments, acceptable to the Director, from FLMHC and/or HoldCo to satisfy after the Plan Effective Date, (iii) the adoption of this Plan of Conversion and the Amended and Restated Articles of Incorporation by the Eligible Members as provided in this Plan of Conversion, and (iv) the satisfaction or waiver of all of the conditions contained in this Plan of Conversion, FLMHC shall file with the Director (A) the minutes of the Special Meeting, (B) a certificate of the Secretary of FLMHC setting forth the results of the vote on the Plan of Conversion and the Amended and Restated Articles of Incorporation and certifying as to whether or not it was approved by not less than two-thirds of the votes cast by the Eligible Members voting in person or by proxy at the Special Meeting, and (C) the Amended and Restated Articles of Incorporation and the Amended and Restated Bylaws of FLMHC (the filing described in clauses (A), (B) and (C) above, the “Effective Date Filing”).
17
15.05 Effectiveness of Plan of Conversion.
(a) The “Plan Effective Date” of the Plan of Conversion shall be the date and time as of which all of the following steps have been completed: (i) the Plan of Conversion has been approved by the Director, (ii) the Eligible Members have approved the Plan of Conversion by the requisite vote, (iii) the Amended and Restated Articles of Incorporation have been duly adopted, (iv) the Effective Date Filing shall have been made by FLMHC, and (v) the Articles of Incorporation of HoldCo have been filed with the Illinois Secretary of State. Subsequent to the Plan Effective Date, the bylaws of FLMHC shall be substantially in the form attached hereto as Exhibit B (the “Amended and Restated Bylaws”). This Plan of Conversion shall be deemed to have become effective at the Effective Time.
(b) At the Effective Time:
(i) FLMHC shall by operation of Section 59.1 of the Illinois Insurance Code become a stock insurance holding company;
(ii) the Amended and Restated Articles of Incorporation and the Amended and Restated Bylaws shall without further action become effective; and
(iii) all of the Membership Interests shall be extinguished.
(c) On the Plan Effective Date:
(i) FLMHC shall issue all of the authorized FLMHC Shares to HoldCo, representing all of the issued and outstanding common stock of FLMHC; and
(ii) HoldCo shall issue shares of Common Stock to Persons whose subscriptions and orders were accepted in the Offering.
15.06 Tax Considerations. This Plan of Conversion shall not become effective and the Conversion shall not occur unless, on or prior to the Plan Effective Date, FLMHC shall have received a favorable opinion of Stevens & Lee, P.C., special counsel to FLMHC, or other nationally-recognized independent tax counsel to FLMHC, dated as of the Plan Effective Date, addressed to the Board and in form and substance satisfactory to FLMHC, which, notwithstanding any qualifications expressed therein, is substantially to the effect that FLMHC will not recognize any gain or loss for U.S. federal income tax purposes as a result of the Conversion.
18
ARTICLE 16
POLICIES
16.01 Policies.
(a) For the purposes of this Plan of Conversion, the term “Policy” means each insurance policy and annuity contract that has been issued or will be issued or assumed through assumption reinsurance, if any, by Federal Life.
(b) The following policies and contracts shall be deemed not to be Policies for purposes of this Plan of Conversion:
(i) any reinsurance assumed by Federal Life as a reinsurer on an indemnity basis (but assumption certificates may constitute Policies if they otherwise fall within the definition of Policies as provided in Section 16.01(a));
(ii) all administrative services agreements; and
(iii) any policy or contract issued by Federal Life and ceded to another insurance company through assumption reinsurance.
16.02 Determination of Ownership. Unless otherwise stated herein, the Owner of any Policy as of any date shall be determined on the basis of the Federal Life Records as of such date in accordance with the following provisions:
(a) the Owner shall be the owner of the Policy as shown on the Federal Life Records;
(b) an additional insured under a Policy shall not be an Owner of the Policy and shall not be a Member;
(c) except as otherwise set forth in this Section 16.02, the identity of the Owner of a Policy shall be determined without giving effect to any interest of any other Person in such Policy;
(d) in any situation not expressly covered by the foregoing provisions of this Section 16.02, the owner of the Policy, as reflected on the Federal Life Records, and as determined in good faith by FLMHC, shall conclusively be presumed to be the Owner of such Policy for purposes of this Section 16.02, and except for administrative errors, FLMHC shall not be required to examine or consider any other facts or circumstances;
(e) the mailing address of an Owner as of any date for purposes of this Plan of Conversion shall be the Owner’s last known address as shown on the Federal Life Records as of such date;
(f) in no event may there be more than one Owner of a Policy, although more than one Person may constitute a single Owner. If a Person owns a Policy with one or more other Persons, they will constitute a single Owner with respect to the Policy; and
19
(g) any dispute as to the identity of the Owner of a Policy or the right to vote shall be resolved in accordance with the foregoing and such other procedures as FLMHC may determine. Any determinations made by FLMHC shall be conclusive as between FLMHC and any Owner of a Policy or any other Person with an interest therein but shall not preclude any actions among such Persons.
16.03 In Force.
(a) A Policy shall be deemed to be in force (“In Force”) as of any date if, as shown in the Federal Life Records:
(i) the Policy has been issued or coverage has been bound by Federal Life or assumed by Federal Life through assumption reinsurance as of such date; and
(ii) such Policy has not expired, cancelled, non-renewed or otherwise terminated, provided that a Policy shall be deemed to be In Force after lapse for nonpayment of premiums until expiration of any applicable grace period (or similar period however designated in such Policy) during which the Policy is in full force for its basic benefits.
(b) The date of expiration, cancellation or termination of a Policy shall be as shown on the Federal Life Records.
(c) A Policy shall not be deemed to be In Force as of a given date if the Policy is returned to Federal Life and all premiums are refunded within thirty (30) days of such date.
(d) Any dispute as to whether a Policy is In Force shall be resolved in accordance with the foregoing.
ARTICLE 17
SUBSEQUENT POLICYHOLDERS
17.01 Notice to Subsequent Policyholders. Upon the issuance of a Policy that becomes effective after the Adoption Date and before the Plan Effective Date (excluding renewals of Policies In Force on the Adoption Date), Federal Life shall send to the Owner of such Policy (a “Subsequent Policyholder”) a written notice regarding this Plan of Conversion in accordance with 215 ILCS 5/59.1(10). Such notice shall specify such Subsequent Policyholder’s right to rescind such Policy as provided in Section 17.02 within forty-five (45) days after the Plan Effective Date and shall be accompanied by a copy or summary of this Plan of Conversion. The form of such notice shall be filed with and approved by the Director.
17.02 Option to Rescind. Each Subsequent Policyholder shall be entitled to rescind his Policy and receive a full refund of any amounts paid for the Policy within ten (10) days after the receipt by Federal Life of the notice of rescission by such Subsequent Policyholder. No Subsequent Policyholder, the estate of such Subsequent Policyholder, or any beneficiary under such policy that has made or filed a claim under a Policy will be entitled to rescission or refund of any premiums paid for such policy. If a Subsequent Policyholder rescinds its Policy pursuant to the right described in this Section 17.02, such Subsequent Policyholder, the estate of such Subsequent Policyholder, or any beneficiary under such policy will have no insurance coverage under such Policy and may not make or file a claim under such Policy.
20
ARTICLE 18
OFFICERS AND BOARD OF DIRECTORS
18.01 Directors. Each of the members of FLMHC’s Board immediately prior to the Effective Time shall remain as a director of FLMHC as of the Effective Time, and thereafter, HoldCo, as the sole shareholder of FLMHC, shall have the right to elect the directors of FLMHC.
18.02 Officers. The officers of FLMHC immediately prior to the Effective Time shall serve as officers of FLMHC after the Effective Time until new officers are duly elected pursuant to the Amended and Restated Articles of Incorporation and the Amended and Restated Bylaws.
ARTICLE 19
ADDITIONAL PROVISIONS
19.01 Continuation of Corporate Existence. Upon the conversion of FLMHC to a stock insurance holding company in accordance with the terms of this Plan of Conversion and the provisions of Section 59.1(11):
(a) the corporate existence of FLMHC as a mutual insurance holding company shall be continued in FLMHC’s corporate existence as a stock insurance holding company;
(b) all the rights, franchises and interests of FLMHC as a mutual insurance holding company in and to every type of property, real, personal and mixed, and things in action thereunto belonging, shall be deemed transferred to and vested in FLMHC as a stock insurance holding company without any deed or transfer;
(c) FLMHC (as converted to a stock insurance holding company) shall be deemed to have assumed all the obligations and liabilities of FLMHC (as the former mutual insurance holding company);
(d) Except to the extent any surplus note or other convertible instrument is converted to shares of HoldCo common stock in accordance with its terms, all outstanding surplus notes, guaranty fund interests or other surplus debentures issued by Federal Life prior to the Effective Time shall remain in full force and effect following the Conversion.
19.02 Conflict of Interest. No director, officer, agent or employee of FLMHC, or any of its subsidiaries or affiliates or any other person shall receive any fee, commission or other valuable consideration whatsoever, other than his or her usual regular salary and compensation, for in any manner aiding, promoting or assisting in the transactions contemplated by this Plan of Conversion; provided, that FLMHC may pay reasonable fees and compensation to attorneys, accountants and actuaries for services performed in the independent practice of their professions, even if such attorney, accountant or actuary is also a director or agent of FLMHC or any of its subsidiaries.
21
19.03 Registration of Shares; Listing of Shares on Stock Exchange.
HoldCo shall register the Common Stock pursuant to the Securities Exchange Act of 1934, as amended. HoldCo shall use its best efforts to (i) encourage and assist a market maker to establish and maintain a market for that class of stock and (ii) list that class of stock on a national or regional securities exchange or to have quotations for that class of stock disseminated on The Nasdaq Stock Market.
19.04 Restrictions on Transfer of Common Stock.
(a) All shares of the Common Stock which are purchased in the Offering by Persons other than directors and officers of FLMHC shall be transferable without restriction. Shares of Common Stock purchased by directors and officers of FLMHC in the Offering shall be subject to the restriction that such shares shall not be sold for a period of one year following the date of purchase. The shares of Common Stock issued by HoldCo to officers and directors of FLMHC shall bear the following legend giving appropriate notice of such one year restriction:
The shares represented by this Certificate may not be sold by the registered holder hereof for a period of one year from the date of the issuance printed hereon. This restrictive legend shall be deemed null and void after one year from the date of this Certificate.
(b) In addition, HoldCo shall give appropriate instructions to the transfer agent for its Common Stock with respect to the applicable restrictions relating to the transfer of restricted stock. Any shares issued at a later date as a stock dividend, stock split or otherwise with respect to any such restricted stock shall be subject to the same holding period restrictions as may then be applicable to such restricted stock.
(c) The foregoing restriction on transfer shall be in addition to any restrictions on transfer that may be imposed by federal and state securities laws.
19.05 No Preemptive Rights. No Member or other Person shall have any preemptive right to acquire FLMHC shares in connection with this Plan of Conversion.
19.06 Amendment or Withdrawal of Plan of Conversion.
(a) At any time prior to the Plan Effective Date, FLMHC may, by resolution of not less than two-thirds of the Board, amend or withdraw this Plan of Conversion (including the Exhibits hereto). Any amendment shall require the written consent of the Director. No amendment may change the Plan of Conversion after its approval by the Eligible Members in a manner that the Director determines is material unless the Plan of Conversion, as amended, is submitted for reconsideration by the Eligible Members of FLMHC pursuant to the provisions of Sections 14.01 and 14.02. No amendment may change the Adoption Date of the Plan of Conversion.
(b) After the Plan Effective Date, the Amended and Restated Articles of Incorporation adopted pursuant to this Plan of Conversion may be amended pursuant to the provisions of such articles of incorporation, the Illinois Insurance Code and the statutory provisions generally applicable to the amendment of the articles of incorporation of insurance holding companies, or such other statutory provisions as may be applicable at the time of the amendment.
22
19.07 Corrections. Prior to the Plan Effective Date, FLMHC, with the prior consent of the Director, may make such modifications as are appropriate to correct errors, cure ambiguities, clarify existing items or make additions to correct manifest omissions in this Plan of Conversion or any exhibits hereto.
19.08 Notices. If FLMHC complies substantially and in good faith with the notice requirements of Section 59.1 of the Illinois Insurance Code with respect to the giving of any required notice to Members, the failure of FLMHC to give any Member any required notice does not impair the validity of any action taken under Section 59.1 of the Illinois Insurance Code.
19.09 Limitation of Actions. Any action or proceeding challenging the validity of or arising out of acts taken or proposed to be taken pursuant to Section 59.1 of the Illinois Insurance Code shall be commenced within 30 days after the Plan Effective Date. No Person shall have any rights or claims against FLMHC or its Board based upon the withdrawal or termination of this Plan of Conversion.
19.10 Costs and Expenses. All the costs and expenses related to the Plan of Conversion, including the costs of outside advisors and consultants of the regulatory agencies, shall be borne, directly or indirectly, by FLMHC or its subsidiaries.
19.11 Headings. Article and Section headings contained in this Plan of Conversion are for convenience only and shall not be considered in construing or interpreting any of the provisions hereof.
19.12 Governing Law. The Plan of Conversion shall be governed by and construed in accordance with the laws of the State of Illinois, without regard to such State’s principles of conflicts of law.
19.13 Limitation on Acquisition of Shares of Common Stock. In accordance with Section 59.1(6)(i) of the Conversion Act, no person or group of persons acting in concert may acquire more than 5% of the outstanding shares of Common Stock, through a public offering or subscription rights, for a period of five (5) years after the Effective Time without the prior approval of the Director.
[Remainder of this page intentionally left blank]
23
IN WITNESS WHEREOF, FLMHC by authority of its Board, has caused this Plan of Conversion to be duly executed as of the day and year first above written.
Federal Life Mutual Holding Company | ||
By: | /s/ William S. Austin | |
Name: William S. Austin | ||
Title: President |
24
AMENDMENT TO
PLAN OF CONVERSION
OF
FEDERAL LIFE MUTUAL HOLDING COMPANY
Under Section 59.1 of the
Illinois Insurance Code, 215 ILCS 5/59.1
As Approved on August 16, 2018
by the Board of Directors
AMENDMENT TO
PLAN OF CONVERSION
OF
FEDERAL LIFE MUTUAL HOLDING COMPANY
Under Section 59.1 of the
Illinois Insurance Code, 215 ILCS 5/59.1
The Board of Directors (the “Board”) of Federal Life Mutual Holding Company (“FLMHC”) adopted a Plan of Conversion on March 8, 2018 (the “Plan”). This Amendment to the Plan of Conversion was approved and adopted by the Board by at least two-thirds of the members of the Board of Directors, at a meeting duly called and held on August 16, 2018. Capitalized terms used herein without definition have the meaning set forth in the Plan.
1. | Section 5.04 of the Plan is amended and restated to read as follows: |
“5.04 Number of Shares of Common Stock to be Sold. RP Financial will submit to FLMHC the Appraised Value as of December 22, 2017. If the Gross Proceeds of the Offering do not equal or exceed the Minimum of the Valuation Range, then FLMHC may cancel the Offering and terminate this Plan, establish a new Valuation Range and extend, reopen or hold a new Offering, or take such other action as it deems to be reasonably necessary.”
2. | Section 9.01 of the Plan is amended and restated to read as follows: |
“9.01 Sale of Shares to Standby Purchaser. If the aggregate number of shares of Common Stock subscribed for in the Subscription Offering multiplied by the Purchase Price is less than the Maximum of the Valuation Range, then in such event HoldCo may sell shares of Common Stock to Standby Purchasers at the Purchase Price, provided that the total number of shares sold in the Offering multiplied by the Purchase Price do not exceed the Maximum of the Valuation Range. Subject to the terms of any Stock Purchase Agreement, any order submitted by Standby Purchasers in the Community Offering may be accepted by HoldCo prior to accepting any other order received in the Community Offering. The Standby Purchaser has purchased an exchangeable promissory note issued by FLMHC in the principal amount of up to $2,000,000 (the “Exchangeable Note”). The outstanding principal balance of the Exchangeable Note will be converted into shares of Common Stock at the Effective Time at a price per share equal to the Purchase Price. The shares of Common Stock issuable upon conversion of the Exchangeable Note shall be counted towards the number of shares purchased by the Standby Purchasers and included in the number of shares issuable in the Offering.”
1 |
IN WITNESS WHEREOF, FLMHC by authority of its Board, has caused this Amendment to Plan of Conversion to be duly executed as of this August 16, 2018.
Federal Life Mutual Holding Company | ||
By: | /s/ William S. Austin | |
Name: William S. Austin | ||
Title: President |
2 |
Final, As Adopted
SECOND AMENDMENT TO
PLAN OF CONVERSION
OF
FEDERAL LIFE MUTUAL HOLDING COMPANY
Under Section 59.1 of the
Illinois Insurance Code, 215 ILCS 5/59.1
As Approved on October 4, 2018
by the Board of Directors
SECOND AMENDMENT TO
PLAN OF CONVERSION
OF
FEDERAL LIFE MUTUAL HOLDING COMPANY
Under Section 59.1 of the
Illinois Insurance Code, 215 ILCS 5/59.1
The Board of Directors (the “Board”) of Federal Life Mutual Holding Company (“FLMHC”) adopted a Plan of Conversion on March 8, 2018, as subsequently amended on August 16, 2018 (as amended, the “Plan”). This Second Amendment to the Plan of Conversion was approved and adopted by unanimous written consent of the Board of Directors, effective October 4, 2018. Capitalized terms used herein without definition have the meaning set forth in the Plan.
1. | Section 15.02(b) of the Plan is amended by adding the following language at the end of the existing text: |
“Federal Life shall increase the dividend scale, if experience warrants, using the dividend criteria that were in effect on June 1, 2015. In addition, Federal Life shall include a discussion of the dividend scale assumption review in its annual Actuarial Opinion and Memorandum for the Dividend Paying Block submitted to the Illinois Department of Insurance.“
IN WITNESS WHEREOF, FLMHC by authority of its Board has caused this Second Amendment to Plan of Conversion to be duly executed as of this October 4, 2018.
Federal Life Mutual Holding Company | |||
By: | /s/ William S. Austin | ||
Name: William S. Austin | |||
Title: President |
1
Exhibit 3.1
AMENDED AND RESTATED
ARTICLES OF INCORPORATION
OF
FEDERAL LIFE GROUP, INC.
A Business-Stock Domestic Corporation
The Articles of Incorporation of Federal Life Group, Inc., a Pennsylvania corporation, are hereby amended and restated to read as follows:
First: The name of the corporation is: Federal Life Group, Inc. (the “Corporation”).
Second: The location and address of the Corporation’s registered office in this Commonwealth of Pennsylvania and the county of venue is: c/o: Corporation Service Company, 2595 Interstate Drive, Suite 103, Harrisburg, Pennsylvania 17110, Dauphin County.
Third: The purpose of the Corporation is to have unlimited power to engage in, and do any lawful act concerning, any or all lawful business for which corporations may be incorporated under the provisions of the Pennsylvania Business Corporation Law of 1988, as amended (15 Pa. C.S. §§ 1101, et seq.) (the “Business Corporation Law”), specifically to act as an insurance holding company.
Fourth: The term for which the Corporation is to exist is perpetual.
Fifth:
A. Authorized Shares. The total number of shares of capital stock which the Corporation has authority to issue is 10,000,000 shares of Common Stock, par value $0.01 per share (the “Common Stock”).
The Corporation shall be entitled to treat the person in whose name any share of its stock is registered as the owner thereof for all purposes and shall not be bound to recognize any equitable or other claim to, or interest in, such share on the part of any other person, whether or not the Corporation shall have notice thereof, except as expressly provided by applicable law.
B. Preemptive Rights. No holder of capital stock of the Corporation shall have any preemptive, subscription, redemption, conversion or sinking fund rights with respect to the capital stock, or to any obligations convertible (directly or indirectly) into stock of the Corporation, whether now or hereafter authorized.
C. Voting Rights. Each holder of Common Stock shall have one vote for each share held by such holder on all matters voted upon by the shareholders of the Corporation.
D. Uncertificated Shares. Any and all classes or series of shares of capital stock of the Corporation, or any part thereof, may be represented by uncertificated shares to the extent determined by the Board, except as required by applicable law, including that shares represented by a certificate that is issued and outstanding shall continue to be represented thereby until the certificate is surrendered to the Corporation. Within a reasonable time after the issuance or transfer of uncertificated shares, the Corporation shall send to the registered owner thereof a written notice containing the information required by applicable law to be set forth or stated on certificates. Except as otherwise expressly provided by law, the rights and obligations of the holders of uncertificated shares of the same class and series shall be identical.
1 |
Sixth: In furtherance and not in limitation of the powers conferred by statute, the Board is expressly authorized to make, alter, amend or repeal the Bylaws of the Corporation.
Seventh: The shareholders of the Corporation shall not be entitled to cumulate their votes for the election of directors.
Eighth: Shareholders of the Corporation may take action by written consent provided that the holders of at least such number of shares of capital stock of the Corporation having the right to vote with respect to such action as is necessary to approve such action have signed consents approving such action.
Ninth: If the Corporation solicits proxies generally with respect to a meeting of shareholders, the Corporation need not give notices of the meeting, or any material that accompanies the notice, to any shareholder to whom the Corporation is not required to send a proxy statement pursuant to the rules of the Securities and Exchange Commission.
Tenth: The Corporation expressly elects not to be governed by the provisions contained in Subchapters E (Control Transactions), F (Business Combinations), G (Control-Share Acquisitions), H (Disgorgement by Certain Controlling Shareholders Following Attempts to Acquire Control), I (Severance Compensation for Employees Terminated Following Certain Control-Share Acquisitions) and J (Business Combination Transactions – Labor Contracts) of Chapter 25 of the Business Corporation Law.
Eleventh: The Corporation reserves the right to amend, alter, change or repeal any provision contained in these Articles, or any amendment hereof, in the manner now or hereafter prescribed herein and by the laws of the Commonwealth of Pennsylvania upon the approval of the holders of at least a majority of the outstanding shares of capital stock of the Corporation, and all rights conferred upon shareholders herein are granted subject to this reservation.
Twelfth: Directors.
A. The business affairs of the Corporation shall be managed by or under the direction of the Board of Directors (the “Board”). The election of the directors need not be by ballot unless required by the Bylaws of the Corporation. The number of directors of the Corporation shall be fixed from time to time exclusively by the Board pursuant to a resolution adopted by a majority of the whole Board, but shall not be less than three and not more than fifteen.
B. (i) During the Standstill Period (as defined in the Standby Stock Purchase Agreement dated as of March 8, 2018, by and among Federal Life Insurance Company, Federal Life Mutual Holding Company, and Insurance Capital Group, LLC), the directors shall be divided into three classes, as nearly equal in number as possible. Members of each class shall hold office until their successors are duly elected and qualified, subject to their earlier death, resignation, disqualification or removal. At each annual meeting of the shareholders of the Corporation, the successors of the class of directors whose term expires at that meeting shall be elected by the shareholders in the manner set forth in the Bylaws of the Corporation, to hold office for a term expiring at the annual meeting of shareholders held in the third year following the year of their election. If the number of directors is changed, any increase or decrease shall be apportioned among the classes so as to maintain the number of directors in each class as nearly equal as possible, but in no case will a decrease in the number of authorized directors constituting the whole Board shorten the term of any incumbent director.
2 |
(ii) After the end of the Standstill Period, all of the directors shall hold office until their successors are duly elected and qualified at an annual meeting of the shareholders of the Corporation, subject to their earlier death, resignation, disqualification or removal. At each annual meeting of the shareholders of the Corporation, all of the directors shall be elected by the shareholders in the manner set forth in the Bylaws of the Corporation, to hold office for a term expiring at the next annual meeting of shareholders.
C. (i) During the Standstill Period, unless the Board otherwise determines, newly created directorships resulting from any increase in the authorized number of directors or any vacancies on the Board resulting from death, resignation, retirement, disqualification, removal from office or other cause may be filled only by a majority vote of the directors then in office, though less than a quorum, and shall not be filled by the shareholders unless there are no directors remaining on the Board. Any director so chosen, if chosen to fill a vacancy, shall be a director of the same class as the director whose vacancy he or she fills.
(ii) After the end of the Standstill Period, unless the Board otherwise determines, newly created directorships resulting from any increase in the authorized number of directors or any vacancies on the Board resulting from death, resignation, retirement, disqualification, removal from office or other cause may be filled only by a vote of the shareholders. Any director so chosen, if chosen to fill a vacancy, shall hold office for a term expiring at the next annual meeting of shareholders.
Thirteenth: A director of the Corporation shall not be personally liable for monetary damages (including, without limitation, any judgment, amount paid in settlement, penalty, punitive damages or expense of any nature (including, without limitation, attorneys’ fees and disbursements)) for any action taken, or any failure to take any action, unless the director has breached or failed to perform the duties of his or her office and the breach or failure to perform constitutes self-dealing, willful misconduct or recklessness.
Fourteenth: The Corporation shall indemnify any officer or director of the Corporation against any and all expenses, judgments, fines, amounts paid in settlement, and any other liabilities to the fullest extent permitted by the Business Corporation Law and may, at the discretion of the Board, purchase and maintain insurance, at the Corporation’s expense, to protect itself, the directors and officers of the Corporation, and any other persons against any such expense, judgment, fine, amount paid in settlement, or other liability, whether or not the Corporation would have the power to so indemnify such person under the Business Corporation Law.
Fifteenth: The name and post office address of the incorporator of the Corporation is: Melissa M. Zeiders, 17 North Second Street, 16th Floor, Harrisburg, PA 17101.
IN WITNESS WHEREOF, Federal Life Group, Inc. has caused these Amended and Restated Articles of Incorporation to be executed in its name by its duly authorized officer and this September 12, 2018.
/s/ Melissa M. Zeiders | |
Melissa M. Zeiders, Incorporator |
3 |
Exhibit 3.2
BYLAWS
OF
FEDERAL LIFE GROUP, INC.
ARTICLE
1
OFFICES
Section 1.1. Registered Office. The registered office of Federal Life Group, Inc. (the “Corporation”) in the Commonwealth of Pennsylvania shall be as specified in the Articles of Incorporation of the Corporation, as they may be amended from time to time (the “Articles”), or at such other place as the Board of Directors of the Corporation (the “Board”) may specify in a statement of change of registered office filed with the Department of State of the Commonwealth of Pennsylvania.
Section 1.2. Other Offices. The Corporation may also have an office or offices at such other place or places either within or without the Commonwealth of Pennsylvania as the Board may from time to time determine or as the business of the Corporation requires.
ARTICLE
2
MEETINGS OF THE SHAREHOLDERS
Section 2.1. Place. All meetings of the shareholders shall be held at such places, within or without the Commonwealth of Pennsylvania, as the Board may from time to time determine. If, as permitted by the Board pursuant to Section 2.15 hereof, a meeting of the shareholders is held by means of the Internet or other electronic communications technology in a fashion pursuant to which the shareholders have the opportunity to read or hear the proceedings substantially concurrently with their occurrence, vote on matters submitted to the shareholders and pose questions to the directors, the meeting need not be held at a particular geographic location.
Section 2.2. Annual Meetings.
(1) A meeting of the shareholders for the election of directors and the transaction of such other business as may properly be brought before the meeting shall be held once each calendar year on such date and at such time as may be fixed by the Board not less than 90 days prior to the date of such meeting..
(2) Nominations of persons for election to the Board and the proposal of business to be considered by the shareholders at an annual meeting of shareholders may be made (A) pursuant to the Corporation’s notice of meeting, (B) by or at the direction of the Board, or (C) by any shareholder of the Corporation who was a shareholder of record at the time of giving of notice provided for in this Article 2, who is entitled to vote at the meeting and who complies with the notice procedures set forth in this Article 2.
1 |
(3) For nominations or other business to be properly brought before an annual meeting by a shareholder pursuant to clause (C) of paragraph (2) of this Section 2.2, the shareholder must have given timely notice thereof in writing to the Secretary of the Corporation (the “Secretary”) and such other business must otherwise be a proper matter for shareholder action. To be timely, a shareholder’s notice must be received by the Secretary at the principal executive offices of the Corporation not later than the 60th day prior to the first anniversary of the preceding year’s annual meeting; provided, however, that in the event that the date of the annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the shareholder must be so received not later than the later of the 60th day prior to the annual meeting or the 15th day following the day on which public announcement of the date of the meeting is first made by the Corporation. In no event shall the public announcement of an adjournment or postponement of an annual meeting commence a new time period for the giving of a shareholder’s notice as described above. Notwithstanding the foregoing, if the Corporation is required under Rule 14a-8 under the Securities Exchange Act of 1934 (the “Exchange Act”) to include a shareholder’s proposal in its proxy statement, such shareholder shall be deemed to have given timely notice for purposes of this paragraph (3) of Section 2.2 with respect to such proposal. A shareholder’s notice shall set forth (A) as to each person whom the shareholder proposes to nominate for election or reelection as a director: (i) all information relating to such person that is required to be disclosed in solicitations of proxies for election of directors in an election contest or is otherwise required pursuant to Regulation 14A under the Exchange Act, (ii) a description of any arrangements or understandings among the shareholder and each such person and any other person with respect to such nomination, and (iii) the consent of each such person to being named in the proxy statement as a nominee and to serving as a director of the Corporation if so elected; (B) as to any other business that the shareholder proposes to bring before the meeting, a brief description of the business desired to be brought before the meeting, the reasons for conducting such business at the meeting and any material interest in such business of such shareholder and the beneficial owner, if any, on whose behalf the proposal is made; and (C) as to the shareholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made (i) the name and address of such shareholder, as they appear on the Corporation’s books, and of such beneficial owner; (ii) the class and number of shares of the Corporation which are owned beneficially and of record by such shareholder and such beneficial owner; and (iii) a representation that such shareholder and beneficial owner intend to appear in person or by proxy at the meeting. At the request of the Corporation, any person nominated by a shareholder for election as a director must furnish to the Secretary such other information as may reasonably be required by the Corporation to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation or that could be material to a reasonable shareholder’s understanding of the independence, or lack thereof, of such nominee; in the absence of the furnishing of such information if requested, such shareholder’s nomination shall not be considered in proper form pursuant to this Section 2.2.
(4) Notwithstanding anything in paragraph (3) of this Section 2.2 to the contrary, in the event that the number of directors to be elected to the Board at the annual meeting is increased pursuant to an act of the Board and there is no public announcement by the Corporation naming all of the nominees for director or specifying the size of the increased Board on or before the date which is 15 days before the latest date by which a shareholder may timely notify the Corporation of nominations or other business to be brought by a shareholder in accordance with paragraph (3) of this Section 2.2, a shareholder’s notice required by this Section 2.2 shall also be considered timely, but only with respect to nominees for any new positions created by such increase, if it shall be received by the Secretary at the principal executive offices of the Corporation not later than the 15th day following the day on which such public announcement is first made by the Corporation.
2 |
(5) In addition to the requirements of this Section 2.2 and Section 2.3, a shareholder must also comply with all applicable requirements of state law and of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth in this Section 2.2 and Section 2.3; provided, however, that any references in this Section 2.2 to the Exchange Act or the rules and regulations promulgated thereunder are not intended to and shall not limit the requirements applicable to proposals as to any other business to be considered pursuant to this Section 2.2 or Section 2.3.
Section 2.3. Special Meetings of Shareholders. A special meeting of the shareholders for any purpose or purposes shall be called only by the Executive Chairman, the Chief Executive Officer, the Secretary of the Corporation, or the holders of at least a majority of the outstanding shares of capital stock of the Corporation. Only such business shall be conducted at a special meeting of shareholders as shall have been brought before the meeting pursuant to the Corporation’s notice of meeting. Nominations of persons for election to the Board may be made at a special meeting of shareholders at which directors are to be elected pursuant to the Corporation’s notice of meeting (1) by or at the direction of the Board or (2) provided that the Board or the holders of at least a majority of the outstanding shares of capital stock of the Corporation have determined that directors shall be elected at such meeting, by any shareholder of the Corporation who is a shareholder of record at the time of giving of notice provided for in this Section 2.3, who shall be entitled to vote at the meeting and who complies with the notice procedures set forth in this Section 2.3. In the event the Corporation calls a special meeting of shareholders for the purpose of electing one or more directors to the Board, any such shareholder may nominate a person or persons (as the case may be), for election to such position(s) as specified in the Corporation’s notice of meeting, if the shareholder’s notice required by paragraph (3) of Section 2.2 shall be received by the Secretary at the principal executive offices of the Corporation not later than the later of the 60th day prior to such special meeting or the 15th day following the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board to be elected at such meeting. In no event shall the public announcement of an adjournment or postponement of a special meeting commence a new time period for the giving of a shareholder’s notice as described above.
Section 2.4. Written Ballot. Unless required by vote of the shareholders before the voting begins, elections of directors need not be by written ballot.
Section 2.5. Conduct of Shareholders Meeting. The Executive Chairman shall preside at all meetings of shareholders and of the Board of Directors. In the absence of the Executive Chairman, the Chief Executive Officer shall preside at such meetings. The Secretary of the Corporation shall act as secretary of the meeting, but in his absence the chairman of the meeting may appoint any person to act as secretary of the meeting. The presiding officer shall determine the order of business and shall have the authority to establish rules for the conduct of the meeting of the shareholders. Any action by the presiding officer in adopting rules for, and in conducting, a meeting of the shareholders shall be fair to the shareholders. The presiding officer shall announce at the meeting when the polls close for each matter voted upon. If no announcement is made, the polls shall be deemed to have closed upon the final adjournment of the meeting. After the polls close, no ballots, proxies or votes, nor any revocations or changes thereto, may be accepted.
3 |
Section 2.6. General.
(1) Only such persons who are nominated in accordance with the procedures set forth in this Article 2 and Section 3.5 shall be eligible to serve as directors to the Board and only such business shall be conducted at a meeting of shareholders as shall have been brought before the meeting in accordance with the procedures set forth in this Article 2. Except as otherwise provided by law, the Articles or the Bylaws of the Corporation (the “Bylaws”), the presiding officer at the meeting, acting reasonably, shall have the power and duty to determine whether a nomination or any business proposed to be brought before the meeting was made or proposed, as the case may be, in accordance with the procedures set forth in this Article 2 and, if any proposed nomination or business is not in compliance with this Article 2, to declare that such defective proposal or nomination shall be disregarded.
(2) For purposes of this Article 2, “public announcement” shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press or comparable national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Sections 13, 14 or 15(d) of the Exchange Act.
Section 2.7. Notice of Meetings. Written notice of every meeting of the shareholders, stating the place, the date and hour thereof and, in the case of a special meeting of the shareholders, the general nature of the business to be transacted thereat, shall be given in a manner consistent with the provisions of Section 11.4 of these Bylaws at the direction of the Secretary or, in the absence of the Secretary, the Executive Chairman or the Chief Executive Officer, at least ten (10) days prior to the day named for a meeting called to consider a fundamental change under Chapter 19 of the Pennsylvania Business Corporation Law of 1988, as it may from time to time be amended (the “1988 BCL”), or five (5) days prior to the day named for the meeting in any other case, to each shareholder entitled to vote thereat on the date fixed as a record date in accordance with Section 7.1 of these Bylaws or, if no record date be fixed, then of record at the close of business on the tenth (10th) day next preceding the day on which notice is given or, if notice is waived, at the close of business on the day immediately preceding the day of the meeting, at such address (or facsimile, electronic mail address or telephone number), as appears on the transfer books of the Corporation. Any notice of any meeting of shareholders may state that, for purposes of any meeting that has been previously adjourned for one or more periods aggregating at least fifteen (15) days because of an absence of a quorum, the shareholders entitled to vote who attend such a meeting, although less than a quorum pursuant to Section 2.8 of these Bylaws, shall nevertheless constitute a quorum for the purpose of acting upon any matter set forth in the original notice of the meeting that was so adjourned.
Section 2.8. Quorum.
(1) The shareholders present in person or by proxy, entitled to cast at least a majority of the votes that all shareholders are entitled to cast on any particular matter to be acted upon at the meeting, shall constitute a quorum for the purposes of consideration of, and action on, such matter. Treasury shares shall not be counted in determining the total number of outstanding shares for voting purposes at any given time. The shareholders present in person or by proxy at a duly organized meeting can continue to do business until the adjournment thereof notwithstanding the withdrawal of enough shareholders to leave less than a quorum. If a meeting cannot be organized because a quorum has not been achieved, the shareholders present in person or by proxy may, except as otherwise provided by the 1988 BCL and subject to the provisions of Section 2.9 of these Bylaws, adjourn the meeting to such time and place as they may determine.
4 |
(2) Abstentions and broker votes and broker nonvotes (only when accompanied by broker votes with respect to at least one matter at the meeting) are considered present and entitled to vote for purposes of establishing a quorum for the transaction of business at a meeting of shareholders. A “broker vote” occurs when a broker votes the shares on any matter pursuant to either (i) the voting instructions and authority received from its client who is the beneficial owner of the shares or (ii) the broker’s discretionary authority to vote the shares under the applicable rules and regulations of the NASDAQ Stock Market LLP (“NASDAQ”) or other national securities exchange governing the voting authority of brokers. A “broker nonvote” occurs when a broker has not received voting instructions from its client who is the beneficial owner of the shares and the broker is barred from exercising its discretionary authority to vote the shares under the applicable rules and regulations of NASDAQ or other securities exchange governing the voting authority of brokers.
Section 2.9. Adjournments and Postponements.
(1) Any meeting of the shareholders, including one at which directors are to be elected, may be adjourned for such period as the shareholders present in person or by proxy and entitled to vote shall direct. Notice of the adjourned meeting or the business to be transacted thereat need not be given, other than announcement at the meeting at which adjournment is taken, unless the Board fixes a new record date for the adjourned meeting or the 1988 BCL requires notice of the business to be transacted and such notice has not previously been given. At any adjourned meeting at which a quorum is present, any business may be transacted that might have been transacted at the meeting as originally noticed. Those shareholders entitled to vote present in person or by proxy, although less than a quorum pursuant to Section 2.8 of these Bylaws, shall nevertheless constitute a quorum for the purpose of (a) electing directors at a meeting called for the election of directors that has been previously adjourned for lack of a quorum, and (b) acting, at a meeting that has been adjourned for one or more periods aggregating fifteen (15) days because of an absence of a quorum, upon any matter set forth in the original notice of such adjourned meeting, provided that such original notice shall have complied with the last sentence of Section 2.7 of these Bylaws.
(2) Any meeting of the shareholders, including one at which directors are to be elected, may be postponed for any proper purpose for such period as the Board shall determine.
Section 2.10. Action at a Meeting. Subject to the provisions of Section 3.3, any matter brought before a duly organized meeting for a vote of the shareholders, including, without limitation, the amendment of any provision of these Bylaws, shall be decided by a majority of the votes cast at such meeting by the shareholders present in person or by proxy and entitled to vote thereon, unless the matter is one for which a different vote is required by express provision of the 1988 BCL, the Articles or a provision of these Bylaws adopted by the shareholders, in any of which case(s) such express provision shall govern and control the decision on such matter. For clarification purposes, abstentions and broker nonvotes will not be counted as votes cast.
5 |
Section 2.11. Voting Rights. Except as otherwise provided in the Articles, at every meeting of the shareholders, every shareholder entitled to vote shall have the right to one vote for each share having voting power standing in his or her name on the books of the Corporation. Shares of the Corporation owned by it, directly or indirectly, including treasury shares, shall not be voted.
Section 2.12. Proxies. Every shareholder entitled to vote at a meeting of the shareholders or to express consent or dissent to a corporate action in writing may authorize another person to act for him or her by proxy appointed by an instrument in writing executed (or transmitted by electronic means which results in a writing) by such shareholder or by the shareholder’s attorney thereunto authorized, and delivered to the Secretary or its designated agent. The presence of, or vote or other action at a meeting of shareholders, or the expression of consent or dissent to corporate action in writing, by a proxy of a shareholder, shall constitute the presence of, or vote or action by, or written consent or dissent of the shareholder. Every proxy shall be executed in writing by the shareholder or by the shareholder’s duly authorized attorney-in-fact and filed with the Secretary or its designated agent. A proxy, unless coupled with an interest, shall be revocable at will, notwithstanding any other agreement or any provision in the proxy to the contrary, but the revocation of a proxy shall not be effective until written notice of revocation has been given to the Secretary or its designated agent in writing. An unrevoked proxy shall not be valid after three (3) years from the date of its execution, unless a longer time is expressly provided therein. A proxy shall not be revoked by the death or incapacity of the maker unless, before the vote is counted or the authority is exercised, written notice of such death or incapacity is given to the Secretary or its designated agent.
Section 2.13. Voting Lists. The officer or agent having charge of the transfer books for securities of the Corporation shall make a complete list of the shareholders entitled to vote at a meeting of the shareholders, arranged in alphabetical order, with the address of and the number of shares held by each shareholder, which list shall be produced and kept open at the time and place of the meeting and shall be subject to the inspection of any shareholder during the whole time of the meeting. Failure to comply with the requirements of this Section shall not affect the validity of any action taken at a meeting prior to a demand at the meeting by any shareholder entitled to vote thereat to examine the list. If the Corporation has 5,000 or more shareholders, it may make such information available at the meeting by any other means.
Section 2.14. Judges of Election. In advance of any meeting of the shareholders, the Board may appoint judges of election, who need not be shareholders, to act at such meeting or any adjournment thereof. If judges of election are not so appointed, the presiding officer of any such meeting may, and on the request of any shareholder shall, appoint judges of election at the meeting. The number of judges shall be either one (1) or three (3), as determined by the Board or presiding officer, as the case may be, to be appropriate under the circumstances. No person who is a candidate for office to be filled at the meeting shall act as a judge at the meeting. The judges of election shall do all such acts as may be proper to conduct the election or vote with fairness to all shareholders, and shall make a written report of any matter determined by them and execute a certificate of any fact found by them, if requested by the presiding officer of the meeting or any shareholder or the proxy of any shareholder. If there are three (3) judges of election, the decision, act or certificate of a majority shall be effective in all respects as the decision, act or certificate of all.
6 |
Section 2.15. Participation by Electronic Means. The right of any shareholder to participate in any shareholders’ meeting by means of conference telephone, the Internet or other electronic means by which all persons participating in the meeting may hear each other and, in which event, all shareholders so participating shall be deemed present at such meeting, shall be granted solely in the discretion of the Board.
ARTICLE
3
DIRECTORS
Section 3.1. Powers. The business and affairs of the Corporation shall be managed under the direction of the Board, which may exercise all powers of the Corporation and do all such lawful acts and things as are not by statute or by the Articles or these Bylaws directed or required to be exercised and done by the shareholders.
Section 3.2. Number, Elections and Term of Office.
(1) Subject to the provisions of the Articles (including, but not limited to, for purposes of these Bylaws, pursuant to any duly authorized certificate of designation), the number of directors of the Corporation shall be fixed from time to time exclusively by the Board pursuant to a resolution adopted by a majority of the whole Board, but the size of the Board shall not be less than three or greater than fifteen. During the Standstill Period (as defined in the Standby Stock Purchase Agreement dated as of March 8, 2018, by and among Federal Life Insurance Company, Federal Life Mutual Holding Company, and Insurance Capital Group, LLC ), the directors, other than those who may be elected by the holders of any series or class of stock, as provided in the Articles, shall be divided into three (3) classes, as nearly equal in term as possible, shall be elected to serve a term of three (3) years and shall hold office until his or her successor shall have been duly elected and qualified, subject to his earlier death, resignation, disqualification or removal. No decrease in the number of authorized directors constituting the whole Board shall shorten the term of any incumbent director. At each annual meeting of the shareholders of the Corporation, commencing with the 2019 annual meeting, the successors of the class of directors whose term expires at that meeting shall be elected by a plurality vote of all votes cast at such meeting to hold office for a term expiring at the annual meeting of shareholders held in the third year following the year of their election.
(2) After the end of the Standstill Period, the directors shall be elected at each annual meeting of the shareholders of the Corporation by a plurality vote of all votes cast at such meeting to hold office for a term expiring at the next annual meeting of shareholders.
Section 3.3. Plurality Voting. When directors are to be elected at a meeting of shareholders, the directors shall be elected by a plurality of the votes of the shares present in person or represented by proxy at the meeting and entitled to vote in the election of directors; provided that, whenever the holders of any class or series of common stock of the Corporation are entitled to elect one or more directors pursuant to the provisions of the Articles, such directors shall be elected by a plurality of the votes of such class or series present in person or represented by proxy at the meeting and entitled to vote in the election of such directors.
7 |
Section 3.4. Qualifications. Directors shall be natural persons, shall be 18 years or older, and need not be residents of the Commonwealth of Pennsylvania or security holders of the Corporation.
Section 3.5. Nominations of Directors. Nominees for election to the Board shall be selected by the Board or a committee of the Board to which the Board has delegated the authority to make such selections pursuant to Section 3.13 of these Bylaws. Nominees for election to the Board may also be selected by shareholders, provided that such nominations are made in accordance with, and accompanied by the information required by, Section 2.2 and Section 2.3. Only persons duly nominated for election to the Board in accordance with this Section 3.5, Section 2.2 or Section 2.3 and for whose election proxies have been solicited pursuant to a proxy statement filed pursuant to the Exchange Act shall be eligible for election to the Board.
Section 3.6. Vacancies.
(1) During the Standstill Period, subject to the rights of the holders of any capital stock of the Corporation, as specified in the Articles, and unless the Board otherwise determines, newly created directorships resulting from any increase in the authorized number of directors or any vacancies on the Board resulting from death, resignation, retirement, disqualification, removal from office or other cause may be filled only by a majority vote of the directors then in office, though less than a quorum, and shall not be filled by the shareholders unless there are no directors remaining on the Board. Any director so chosen, if chosen to fill a vacancy, shall be a director of the same class as the director whose vacancy he or she fills.
(2) After the end of the Standstill Period, subject to the rights of the holders of any capital stock of the Corporation, as specified in the Articles, newly created directorships resulting from any increase in the authorized number of directors or any vacancies on the Board resulting from death, resignation, retirement, disqualification, removal from office or other cause shall be filled only by a vote of the shareholders at a special meeting called for such purpose (or by written consent in accordance with the Corporation’s articles and bylaws). Any director so chosen, if chosen to fill a vacancy, shall have a term that expires at the next annual meeting of the shareholders of the Corporation.
Section 3.7. Removal.
(a) Removal by the Shareholders. Subject to the rights of the holders of any series or class of capital stock pursuant to provisions of the Articles, prior to the end of the Standstill Period, any director may be removed from office at any time, but only for cause and by the affirmative vote of the holders of at least eighty percent (80%) of the voting power of the then outstanding capital stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class. After the end of the Standstill Period, subject to the rights of the holders of any series or class of capital stock pursuant to provisions of the Articles, any director may be removed from office at any time, but only for cause and by the affirmative vote of the holders of at least sixty-five percent (65%) of the voting power of the then outstanding capital stock of the Corporation entitled to vote generally in the election of directors, voting together as a single class.
8 |
(b) Removal by the Board. The Board may declare vacant the office of a director who has been judicially declared of unsound mind or who has been convicted of an offense punishable by imprisonment for a term of more than one year, or if, within one hundred twenty days after notice of election, the director does not accept such office either in writing or by attending a meeting of the Board.
Section 3.8. Place of Board Meetings. Meetings of the Board may be held at such place within or without the Commonwealth of Pennsylvania as the Board may from time to time appoint or as may be designated in the notice of the meeting.
Section 3.9. First Meeting of Newly Elected Board. The first meeting of each newly elected Board may be held at the same place and immediately after the meeting at which such directors were elected and no notice shall be required other than announcement at such meeting. If such first meeting of the newly elected Board is not so held, notice of such meeting shall be given in the same manner as set forth in Section 3.10 of these Bylaws with respect to notice of regular meetings of the Board.
Section 3.10. Regular Board Meetings; Notice. Regular meetings of the Board may be held at such times and places as shall be determined from time to time by the Board at a duly convened meeting, or by unanimous written consent. Notice of each regular meeting of the Board shall specify the purpose, date, place and hour of the meeting and shall be given to each director at least five (5) days before the meeting. Notice shall be given in a manner consistent with Section 11.4 of these Bylaws.
Section 3.11. Special Board Meetings; Notice. Special meetings of the Board may be called by the Executive Chairman of the Board, the Chief Executive Officer or the Secretary on one day’s notice to each director, either by telephone, or, if in writing, in accordance with the provisions of Section 11.4 of these Bylaws.
Section 3.12. Quorum of the Board; Action of the Board. At all meetings of the Board, the presence of (i) a majority of the directors then in office and (ii) the directors nominated by Insurance Capital Group, LLC pursuant to Section 6(f) of the Standby Stock Purchase Agreement dated as of March 8, 2018, by and among Federal Life Insurance Company, Federal Life Mutual Holding Company, and Insurance Capital Group, LLC, shall constitute a quorum for the transaction of business, and the acts of a majority of the directors present and voting at a meeting at which a quorum is present shall be the acts of the Board. If a quorum shall not be present at any meeting of directors, the directors present thereat may adjourn the meeting. It shall not be necessary to give any notice of the adjourned meeting or of the business to be transacted thereat other than by announcement at the meeting at which such adjournment is taken.
9 |
Section 3.13. Committees of Directors. (a) The Board may establish one or more committees, each committee to consist of one or more of the directors, and may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee or for the purposes of any written action by the committee. Any such committee, to the extent provided in such resolution of the Board or in these Bylaws, shall have and may exercise all of the powers and authority of the Board; provided, however, that no such committee shall have any power or authority to (a) submit to the shareholders any action requiring approval of the shareholders under the 1988 BCL, (b) create or fill vacancies on the Board, (c) amend or repeal these Bylaws or adopt new Bylaws, (d) amend or repeal any resolution of the Board that by its terms is amendable or repealable only by the Board, (e) act on any matter committed by these Bylaws or by resolution of the Board to another committee of the Board, (f) amend the Articles or adopt a resolution proposing an amendment to the Articles, or (g) adopt a plan or an agreement of merger or consolidation, share exchange, asset sale or division. In the absence or disqualification of a member or alternate member or members of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not a quorum is present, may unanimously appoint another director to act at the meeting in the place of any absent or disqualified member. Minutes of all meetings of any committee of the Board shall be kept by the person designated by such committee to keep such minutes. Copies of such minutes and any writing setting forth an action taken by written consent without a meeting shall be distributed to each member of the Board promptly after such meeting is held or such action is taken. Each committee of the Board shall serve at the pleasure of the Board and shall include at least one director nominated by Insurance Capital Group, LLC.
(b) The Board shall appoint an Audit Committee, and the authority of the Audit Committee shall be as follows:
(i) To recommend to the Board a firm of independent public accountants to audit the Corporation’s accounts for the year regarding which the accountants are appointed;
(ii) To meet with the independent public accountants before commencement of the audit to:
(1) discuss the evaluation by the accountants of the adequacy and effectiveness of the accounting procedures and internal controls of the Corporation;
(2) approve the overall scope of the audit to be made and the fees to be charged; and
(3) inquire regarding and discuss with the accountants recent Pennsylvania Business Corporation Law, Financial Accounting Standards Board, Securities and Exchange Commission or other regulatory agency pronouncements, if any, which might affect the Corporation's financial statements.
(iii) To meet with the independent public accountants at the conclusion of the audit to:
(1) review the audited financial statements of the Corporation;
(2) discuss the results of the audit;
(3) discuss the report by the accountants to management of the Corporation regarding the audit and the response by the management thereto; and
(4) discuss any significant recommendations by the accountants for improvement of accounting systems and controls of the Corporation.
10 |
Section 3.14. Executive Chairman of the Board. The Executive Chairman of the Board, if one is elected, shall preside at all meetings of the Board and of the shareholders. The Executive Chairman of the Board shall perform all duties incident to the office of Executive Chairman of the Board and shall have such other powers and duties as the Board assigns to that individual.
Section 3.15. Participation in Board Meetings by Electronic Means. One or more directors may participate in a meeting of the Board or of a committee of the Board by means of conference telephone or other electronic technology by means of which all persons participating in the meeting can hear each other, and all directors so participating shall be deemed present at the meeting.
Section 3.16. Action by Written Consent of Directors. Any action required or permitted to be taken at a meeting of the Board or of a committee of the Board may be taken without a meeting if, prior or subsequent to the action, a consent or consents in writing setting forth the action so taken shall be signed by all of the directors then in office or the members of the committee, as the case may be, and filed with the Secretary. For purposes of this Section 3.16, a consent may be given by means of a physical written copy or may be transmitted by facsimile transmission, e-mail or similar electronic communications technology.
Section 3.17. Compensation of Directors. The Board may, by resolution, fix the compensation of directors for their services as directors. A director may also serve the Corporation in any other capacity and receive compensation therefor.
Section 3.18. Directors’ Liability. A director of the Board shall not be personally liable for monetary damages as such (including, without limitation, any judgment, amount paid in settlement, penalty, punitive damages or expense of any nature (including, without limitation, attorneys’ fees and disbursements)) for any action taken, or any failure to take any action, unless the director has breached or failed to perform the duties of his or her office under the Articles, these Bylaws or applicable provisions of law and the breach or failure to perform constitutes self-dealing, willful misconduct or recklessness.
ARTICLE
4
OFFICERS
Section 4.1. Number, Qualifications and Designation. The officers of the Corporation shall be an Executive Chairman, a Chief Executive Officer, a President, one or more Vice Presidents (including executive or Senior Vice Presidents), a Chief Financial Officer, a Secretary and a Treasurer, and such other officers as may be elected or appointed in accordance with the provisions of this Section 4.1 or Section 4.3 of this Article. One person may hold more than one office. Officers may but need not be directors or shareholders of the Corporation. The Officers shall be natural persons of full age.
Section 4.2. Election and Term of Office. The officers of the Corporation, except those elected by delegated authority pursuant to Section 4.3 of this Article, shall be elected annually by the Board, and each such officer shall hold office until the next annual organization meeting of Board and until a successor shall have been duly chosen and qualified, or until his or her earlier death, resignation, or removal.
11 |
Section 4.3. Other and Subordinate Officers, Committees and Agents. The Board may from time to time appoint such other officers and appoint such committees, employees or other agents as the business of the Corporation may require, including one or more vice-chairmen, a chief operating officer, one or more assistant secretaries, and one or more assistant treasurers, each of whom shall hold office for such period, have such authority, and perform such duties as are provided in these Bylaws, or as the Board may from time to time determine. The Board may delegate to any officer or committee the power to appoint subordinate officers and to retain or appoint employees or other agents, or committees thereof, and to prescribe the authority and duties of such subordinate officers, committees, employees or other agents.
Section 4.4. Resignations. Any officer or agent may resign at any time by giving written notice to the Chief Executive Officer. Any such resignation shall take effect at the date of the receipt of such notice or at any later time specified therein and, unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.
Section 4.5. Removal. Any officer, committee, employee or other agent of the Corporation may be removed, either with or without cause, by the Board or other authority which elected or appointed such officer, committee or other agent. Election or appointment of an officer or employee or other agent shall not of itself create contract rights.
Section 4.6. Vacancies. A vacancy in any office because of death, resignation, removal, disqualification, or any other cause, shall be filled by the Board or by the officer or committee to which the power to fill such office has been delegated pursuant to Section 4.3 of this Article, as the case may be, and if the office is one for which these Bylaws prescribe a term, shall be filled for the unexpired portion of the term.
Section 4.7. General Powers. All officers of the Corporation as between themselves and the Corporation, shall have such authority and perform such duties in the management of the Corporation as may be provided by or pursuant to resolutions or orders of the Board, or in the absence of controlling provisions in the resolutions or orders of the Board, as may be determined by or pursuant to these Bylaws.
Section 4.8. The Chief Executive Officer. Unless otherwise determined by the Board, the Chief Executive Officer shall have general supervision, direction and management over the business and operations of the Corporation, subject, however, to the control of the Board. The Chief Executive Officer shall sign, execute, and acknowledge, in the name of the Corporation, deeds, mortgages, bonds, contracts or other instruments, authorized by the Board, except in cases where the signing and execution thereof shall be expressly delegated by the Board, or by these Bylaws, to some other officer or agent of the Corporation; and, in general, shall perform all duties incident to the office of Chief Executive Officer and such other duties as from time to time may be assigned by the Board.
In the absence of the Chief Executive Officer, the officer as designated by the Board shall perform the duties of the Chief Executive Officer and such other duties as may from time to time be assigned to him by the Board.
12 |
Section 4.9. The Secretary. The Secretary
shall record all the votes of the shareholders and of the directors and the minutes of the meetings of the shareholders and of
the Board and of committees of the Board in a book or books to be kept for that purpose; shall see that notices are given and records
and reports properly kept and filed by the Corporation as required by law; shall be the custodian of the seal of the Corporation
and see that it is affixed to all documents to be executed on behalf of the Corporation under its seal; and, in general, shall
perform all duties incident to the office of Secretary, and such other duties as may from time to time be assigned by the Board,
the Executive Chairman or the Chief Executive Officer.
In the absence of the Secretary, the Assistant Secretary or an officer as designated by the Board shall perform the duties of the
Secretary and such other duties as may from time to time be assigned to him by the Board.
Section 4.10. The Treasurer. The Treasurer or an Assistant Treasurer shall have or provide for the custody of the funds or other property of the Corporation; shall collect and receive or provide for the collection and receipt of moneys earned by or in any manner due to or received by the Corporation; shall deposit all funds in his or her custody as treasurer in such banks or other places of deposit as the Board may from time to time designate; shall, whenever so required by the Board, render an account showing all transactions as treasurer, and the financial condition of the Corporation; and, in general, shall discharge such other duties as may from time to time be assigned by the Board or the Executive Chairman or the Chief Executive Officer. The Treasurer may also be the Chief Financial Officer.
In the absence of the Treasurer, the Assistant Treasurer or an officer as designated by the Board shall perform the duties of the Treasurer and such other duties as may from time to time be assigned to him by the Board.
Section 4.11. Officers’ Bonds. Any officer shall give a bond for the faithful discharge of the duties of the officer in such sum, if any, and with such surety or sureties as the Board may require.
Section 4.12. Salaries. The salaries of the officers elected by the Board shall be fixed from time to time by the Board or by such officer as may be designated by resolution of the Board. The salaries or other compensation of any other officers, employees and other agents shall be fixed from time to time by the officer or committee to which the power to elect such officers or to retain or appoint such employees or other agents has been delegated pursuant to Section 4.1 of this Article. No officer shall be prevented from receiving such salary or other compensation by reason of the fact that the officer is also a director of the Corporation.
13 |
ARTICLE
5
CERTIFICATES FOR SHARES
Section 5.1. Share Certificates. Any or all classes and series of shares of the Corporation, or any part thereof, may be represented by uncertificated shares to the extent determined by the Board, except as otherwise required by law or the Articles. To the extent that certificates for shares of the Corporation are issued, such certificates shall be numbered and registered in a share register as they are issued. The share register shall exhibit the names and addresses of all registered holders and the number and class of shares and the series, if any, held by each. To the extent that certificates for shares of the Corporation are issued, each such certificate shall state that the Corporation is incorporated under the laws of the Commonwealth of Pennsylvania, the name of the registered holder and the number and class of shares and the series, if any, represented thereby. If, under its Articles, the Corporation is authorized to issue shares of the Corporation of more than one class or series and certificates for such shares are issued, each such certificate shall set forth, or shall contain a statement that the Corporation will furnish to any shareholder upon request and without charge, a full or summary statement of the designations, voting rights, preferences, limitations and special rights of the shares of each class or series authorized to be issued so far as they have been fixed and determined and the authority of the Board to fix and determine such rights.
Section 5.2. Execution of Certificates. Every share certificate shall be executed, by facsimile or otherwise, by or on behalf of the Corporation, by the Executive Chairman or the Chief Executive Officer and by the Secretary. In case any officer who has signed or whose facsimile signature has been placed upon any share certificate shall have ceased to be such officer, because of death, resignation or otherwise, before the certificate is issued, it may be issued by the Corporation with the same effect as if the officer had not ceased to be such at the time of issue.
ARTICLE
6
TRANSFER OF SHARES
Section 6.1. Transfer. Transfers of shares shall be made on the share register of the Corporation only by the record holder of such shares, or by the appropriate person or accompanied by proper evidence of succession, assignment or authority to transfer, and, in the case of shares represented by a certificate, upon the presentment of the certificate therefore in the manner set forth herein. Upon presentment to the Corporation or its transfer agent of a share certificate endorsed by the appropriate person or accompanied by proper evidence of succession, assignment or authority to transfer, a new certificate shall be issued to the person entitled thereto and the old certificate canceled and the transfer registered upon the books of the Corporation, unless the Corporation has been served with a restraining order, injunction or other process from a court of competent jurisdiction enjoining it from registering the transfer.
ARTICLE
7
RECORD DATE; IDENTITY OF SHAREHOLDERS
Section 7.1. Record Date. The Board may fix a time, prior to the date of any meeting of the shareholders, as a record date for the determination of the shareholders entitled to notice of, or to vote at, the meeting, which time, except in the case of an adjourned meeting, shall not be more than ninety (90) days prior to the date of the meeting. Except as otherwise provided in Section 7.2 of these Bylaws, only the shareholders of record at the close of business on the date so fixed shall be entitled to notice of, or to vote at, such meeting, notwithstanding any transfer of securities on the books of the Corporation after any record date so fixed. The Board may similarly fix a record date for the determination of shareholders for any other purpose. When a determination of shareholders of record has been made as herein provided for purposes of a meeting, the determination shall apply to any adjournment thereof unless the Board fixes a new record date for the adjourned meeting.
14 |
ARTICLE
8
REGISTERED SHAREHOLDERS
Before due presentment for transfer of any shares, the Corporation shall treat the registered owner thereof as the person exclusively entitled to vote, to receive notifications and otherwise to exercise all the rights and powers of an owner, and shall not be bound to recognize any equitable or other claim or interest in such securities, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of the Commonwealth of Pennsylvania or Section 7.2 of these Bylaws.
ARTICLE
9
LOST CERTIFICATES
If the owner of a share certificate claims that it has been lost, destroyed, or wrongfully taken, the Corporation shall issue a new certificate in place of the original certificate if the owner so requests before the Corporation has notice that the certificate has been acquired by a bona fide purchaser, and if the owner has filed with the Corporation an indemnity bond and an affidavit of the facts satisfactory to the Board or its designated agent, and has complied with such other reasonable requirements, if any, as the Board may deem appropriate.
ARTICLE
10
DISTRIBUTIONS
Section 10.1. Distributions. Distributions upon the shares of the Corporation, whether by dividend, purchase or redemption or other acquisition of its shares subject to any provisions of the Articles related thereto, may be authorized by the Board at any regular or special meeting of the Board and may be paid directly or indirectly in cash, in property or by the incurrence of indebtedness by the Corporation.
Section 10.2. Reserves. Before the making of any distributions, there may be set aside out of any funds of the Corporation available for distributions such sum or sums as the Board from time to time, in its absolute discretion, deems proper as a reserve fund to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the Corporation, or for such other purpose as the Board shall deem conducive to the interests of the Corporation, and the Board may abolish any such reserve in the manner in which it was created.
Section 10.3. Stock Dividends/Splits. Stock dividends or splits upon the shares of the Corporation, subject to any provisions of the Articles related thereto, may be authorized by the Board at any regular or special meeting of the Board.
ARTICLE
11
GENERAL PROVISIONS
Section 11.1. Checks and Notes. All checks or demands for money and notes of the Corporation shall be signed by such officer or officers as the Board may from time to time designate.
15 |
Section 11.2. Fiscal Year. The fiscal year of the Corporation shall begin of January 1 of each year.
Section 11.3. Seal. The corporate seal, if any, shall have inscribed thereon the name of the Corporation and the words “Corporate Seal, Pennsylvania.” Such seal may be used by causing it or a facsimile thereof to be impressed or affixed or in any manner reproduced. The affixation of the corporate seal shall not be necessary to the valid execution, assignment or endorsement of any instrument or other document by the Corporation.
Section 11.4. Notices. Whenever, under the provisions of the 1988 BCL or of the Articles or of these Bylaws or otherwise, written notice is required to be given to any person, it may be given to such person either personally or by sending a copy thereof by first class or express mail, postage prepaid, telegram (with messenger service specified), courier service (with charges prepaid), electronic mail, facsimile transmission or by any other means permitted by the 1988 BCL, to his, her or its address, (or to his, her or its electronic mail address, facsimile number or other place as specified in the 1998 BCL), appearing on the books of the Corporation or, in the case of directors, supplied by the director to the Corporation for the purpose of notice. If the notice is sent by mail, telegraph or courier service, it shall be deemed to have been given to the person entitled thereto when deposited in the United States mail or with a telegraph office or courier service for delivery to that person. A notice given by electronic mail or facsimile transmission shall be deemed to have been given when dispatched. Notice or other communications need not be sent to any shareholder with whom the Corporation has been unable to communicate for more than 24 consecutive months because communications to the shareholder are returned unclaimed or the shareholder has otherwise failed to provide the Corporation with a current address. Whenever such shareholder provides the Corporation with a current address, the Corporation shall commence sending notices and other communications to such shareholder in the same manner as to other shareholders.
Section 11.5. Waiver of Notice. Whenever any notice is required to be given by the 1988 BCL or by the Articles or these Bylaws, a waiver thereof in writing, signed by the person or persons entitled to the notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of such notice. Neither the business to be transacted nor the purpose of a meeting need be specified in the waiver of notice of the meeting. Attendance of a person at any meeting shall constitute a waiver of notice of the meeting, except where any person attends a meeting for the express purpose of objecting to the transaction of any business because the meeting was not lawfully called or convened, and the person so objects at the beginning of the meeting.
ARTICLE
12
AMENDMENTS
In furtherance and not in limitation of the powers conferred by the 1988 BCL, the Board is expressly authorized to make, alter, amend, change, add to or repeal any provision of these Bylaws by the affirmative vote of a majority of the total number of directors then in office, subject to the power of the holders of the then outstanding capital stock of the Corporation to alter, amend, change, add to or repeal any provision of these Bylaws made by the Board. Subject to Article 13 of these Bylaws, any alteration, amendment, change, addition to, adoption or repeal of any provision of these Bylaws will require the affirmative vote of a majority of the total number of directors then in office, or the affirmative vote of a majority of the combined voting power of all of the then outstanding shares of the Corporation entitled to vote on such alteration, amendment, change, addition to, adoption or repeal of such provision of these Bylaws.
16 |
ARTICLE
13
INDEMNIFICATION
Section 13.1. Officers and Directors – Direct Actions. The Corporation shall indemnify any director or officer of the Corporation (as used herein, the phrase “director or officer of the Corporation” shall mean any person who is or was a director or officer of the Corporation, or is or was serving at the request of the Corporation as a director or officer of another domestic or foreign corporation for profit or not-for-profit, partnership, joint venture, trust or other enterprise), who was or is a party (other than a party plaintiff suing on his or her own behalf), or who is threatened to be made such a party, to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation) by reason of the fact that he or she is or was a director or officer of the Corporation, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding if he or she met the standard of conduct of (a) acting in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the Corporation, and (b) with respect to any criminal proceeding, having no reasonable cause to believe his or her conduct was unlawful. The termination of any action or proceeding by judgment, order, settlement or conviction or upon a plea of nolo contendere or its equivalent shall not of itself create a presumption that the person (x) did not act in good faith and in a manner that he or she reasonably believed to be in, or not opposed to, the best interests of the Corporation, and (y) with respect to any criminal proceeding, had reasonable cause to believe that his or her conduct was unlawful.
Section 13.2. Officers and Directors – Derivative Actions. The Corporation shall indemnify any director or officer of the Corporation who was or is a party (other than a party suing in the right of the Corporation), or is threatened to be made a party, to any threatened, pending or completed action, suit or proceeding by or in the right of the Corporation to procure a judgment in the Corporation’s favor by reason of the fact that he or she is or was a director or officer of the Corporation, against expenses (including attorneys’ fees) actually and reasonably incurred by him or her in connection with the defense or settlement of the action, suit or proceeding if he or she met the standard of conduct of acting in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the Corporation. Indemnification shall not be made under this Section in respect of any claim, issue or matter as to which the person has been adjudged to be liable to the Corporation unless and only to the extent that the Court of Common Pleas of the judicial district embracing the county in which the registered office of the Corporation is located or the court in which the action, suit or proceeding was brought determines upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for the expenses that the Court of Common Pleas or other court deems proper.
17 |
Section 13.3. Employees and Agents. The Corporation may, to the extent permitted by the 1988 BCL, indemnify any employee or agent of the Corporation (as used in this Article 13, the phrase “employee or agent of the Corporation” shall mean any person who is or was an employee or agent of the Corporation, other than an officer, or is or was serving at the request of the Corporation as an employee or agent of another domestic or foreign corporation for profit or not-for-profit, partnership, joint venture, trust or other enterprise) who was or is a party, or who is threatened to be made such a party, to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding by reason of the fact that he or she is or was an employee or agent of the Corporation, provided he or she has met the standard of conduct set forth in Sections 13.1 and 13.2, subject to the limitations set forth in Section 13.2 in the case of an action, suit or proceeding by or in the right of the Corporation to procure a judgment in the Corporation’s favor.
Section 13.4. Mandatory Indemnification. To the extent that a director or officer of the Corporation or any employee or agent of the Corporation has been successful on the merits or otherwise in defense of any action or proceeding referred to in Sections 13.1, 13.2 or 13.3 of this Article 13, or in defense of any claim, issue or matter therein, he or she shall be indemnified by the Corporation against expenses (including attorneys’ fees) actually and reasonably incurred by him or her in connection therewith.
Section 13.5. Advancing Expenses. Expenses (including attorneys’ fees) incurred by a director or officer of the Corporation or an employee or agent of the Corporation in defending any action or proceeding referred to in this Article 13 may be paid by the Corporation in advance of the final disposition of the action or proceeding upon receipt of an undertaking by or on behalf of such person to repay such amount if it is ultimately determined that he or she is not entitled to be indemnified by the Corporation as authorized in this Article 13.
Section 13.6. Procedure.
(a) Unless ordered by a court, any indemnification under Section 13.1, 13.2 or 13.3 or advancement of expenses under Section 13.5 of this Article 13 shall be made by the Corporation only as authorized in a specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances because he or she has met the applicable standard of conduct set forth in Section 13.1, 13.2 or 13.3.
(b) All determinations under this Section 13.6 shall be made:
(i) With respect to indemnification under Section 13.3 and advancement of expenses to an employee or agent of the Corporation, other than an officer, by the Board.
(ii) With respect to indemnification under Section 13.1 or 13.2 and advancement of expenses to a director or officer of the Corporation,
(A) By the Board, by a majority vote of a quorum consisting of directors who were not parties to such action or proceeding, or
18 |
(B) If such a quorum is not obtainable, or, if obtainable and a majority vote of a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, or
(C) By the shareholders.
Section 13.7. Nonexclusivity of Indemnification.
(a) The indemnification and advancement of expenses provided by, or granted pursuant to, this Article 13 shall not be deemed exclusive of any other rights to which a person seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of shareholders or disinterested directors or otherwise, both as to actions in his or her official capacity and as to actions in another capacity while holding that office. Section 1728 (relating to interested directors; quorum) of the 1988 BCL, or any successor section, shall be applicable to any bylaw, contract or transaction authorized by the directors under this Section 13.7. The Corporation may create a fund of any nature, which may, but need not be, under the control of a trustee, or otherwise secure or insure in any manner its indemnification obligations, whether arising under or pursuant to this Article 13 or otherwise.
(b) Indemnification pursuant to Section 3.7(a) hereof shall not be made in any case where the act or failure to act giving rise to the claim for indemnification is determined by a court to have constituted self-dealing, willful misconduct or recklessness.
(c) Indemnification pursuant to Section 13.7(a) under any bylaw, agreement, vote of shareholders or directors or otherwise, may be granted for any action taken or any failure to take any action and may be made whether or not the Corporation would have the power to indemnify the person under any other provision of law except as provided in this Section 13.7 and whether or not the indemnified liability arises or arose from any threatened or pending or completed action by or in the right of the Corporation.
Section 13.8. Insurance. The Corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director or officer of the Corporation or an employee or agent of the Corporation, against any liability asserted against such person and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify him or her against that liability under the provisions of this Article 13 or otherwise.
Section 13.9. Past Officers and Directors. The indemnification and advancement of expenses provided by, or granted pursuant to, this Article 13 shall continue as to a person who has ceased to be a director, officer, employee or agent of the Corporation and shall inure to the benefit of the heirs and personal representatives of that person.
Section 13.10. Surviving or New Corporations. References to “the Corporation” in this Article 13 include all constituent corporations absorbed in a consolidation, merger or division, as well as the surviving or new corporation resulting therefrom, so that any director, officer, employee or agent of the constituent, surviving or new corporation shall stand in the same position under the provisions of this Article 13 with respect to the surviving or new corporation as he or she would if he or she had served the surviving or new corporation in the same capacity.
19 |
Section 13.11. Employee Benefit Plans.
(a) References in this Article 13 to “other enterprise” shall include employee benefit plans and references to “serving at the request of the Corporation” shall include any service as a director, officer, employee or agent of the Corporation that imposes duties on, or involves services by, the person with respect to an employee benefit plan, its participants or beneficiaries.
(b) Excise taxes assessed on a person with respect to an employee benefit plan pursuant to applicable law shall be deemed “fines.”
(c) Action with respect to an employee benefit plan taken or omitted in good faith by a director, officer, employee or agent of the Corporation in a manner he or she reasonably believed to be in the interest of the participants and beneficiaries of the plan shall be deemed to be action in a manner that is not opposed to the best interests of the Corporation.
Section 13.12. Amendment, Etc. Notwithstanding anything herein contained to the contrary, neither Section 3.18 nor this Article 13 may be amended or repealed, and no provision inconsistent herewith may be adopted, except by the affirmative vote of shareholders of the corporation entitled to cast at least eighty percent (80%) of the votes which all shareholders of the corporation are then entitled to cast thereon, except that, if the Pennsylvania Business Corporation Law of 1988, as amended, is amended or any other statute is enacted so as to decrease the exposure of directors to liability or increase the indemnification rights available to directors, officers or others, then Section 3. 18 and this Article 13 and any other provisions of these Bylaws inconsistent with such decreased exposure or increased indemnification rights shall be amended, automatically and without any further action on the part of the shareholders or directors, to reflect such reduced exposure or increased indemnification rights, unless such legislation expressly requires otherwise. Any repeal or modification of Section 3.18 or of this Article 13 by the shareholders of the corporation shall be prospective only, and shall not adversely affect any limitation on the personal liability of a director of the corporation or any right to indemnification from the corporation with respect to any action or failure to take any action occurring prior to the time of such repeal or modification.
Section 13.13. Severability. If, for any reason, any provision of this Article 13 shall be held invalid, such invalidity shall not affect any other provision not held so invalid, and each such other provision shall, to the full extent consistent with law, continue in full force and effect. If any provision of this Article 13 shall be held invalid in part, such invalidity shall in no way affect the remainder of such provision, and the remainder of such provision, together with all other provisions of this Article 13 shall, to the fullest extent consistent with law, continue in full force and effect.
20 |
Exhibit 4.1
CUSIP NO. ___________ | |
COMMON STOCK | COMMON STOCK |
CERTIFICATE NO. | SHARES |
FEDERAL LIFE GROUP, INC.
ORGANIZED UNDER THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA
[SPECIMEN]
is the owner of:
FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK,
$0.01 PAR VALUE, OF FEDERAL LIFE GROUP, INC.
a Pennsylvania corporation.
The shares represented by this certificate are transferable only on the stock transfer books of Federal Life Group, Inc. (the “Company”) by the holder of record hereof, or by such holder’s duly authorized attorney or legal representative, upon the surrender of this certificate properly endorsed. This certificate and the shares represented hereby are issued and shall be held subject to all the provisions contained in the Company’s official corporate papers filed with the Department of State of the Commonwealth of Pennsylvania (copies of which are on file with the Transfer Agent), to all of the provisions the holder by acceptance hereof assents.
This certificate is not valid unless countersigned and registered by the Transfer Agent and Registrar.
IN WITNESS WHEREOF, FEDERAL LIFE GROUP, INC. has caused this certificate to be executed by the signatures of its duly authorized officers and has caused its corporate seal to be hereunto affixed.
Dated: | [SEAL] |
Treasurer | President and Chief Executive Officer |
FEDERAL LIFE GROUP, INC.
Preferred stock may be issued from time to time as a class without series or, if so determined by the board of directors of the Company, either in whole or in part, in one or more series. The board of directors of the Company has the authority to fix and determine, by resolution, the voting powers, full or limited, or no voting power, and such designations, preferences and relative, participating, optional, or other special rights, if any, and the qualifications, limitations, or restrictions thereof, if any, including specifically, but not limited to, the dividend rights, conversion rights, redemption rights and liquidation preferences, if any, of any wholly unissued series of preferred stock (or the entire class of preferred stock if none of such shares have been issued), the number of shares constituting any such series and the terms and conditions of the issue thereof. The Company will furnish to any shareholder upon request and without charge a full description of each class of stock and any series thereof.
The shares represented by this certificate may not be cumulatively voted in the election of directors of the Company.
The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:
TEN COM | - | as tenants in common | UNIF GIFTS MIN ACT - | __________ custodian __________ |
TEN ENT | - | as tenants by the entireties | (Cust) (Minor) | |
JT TEN | - | as joint tenants with right of | ||
survivorship and not as tenants | under Uniform Gifts to Minors Act | |||
in common | ||||
(State) |
Additional abbreviations may also be used though not in the above list.
FOR VALUE RECEIVED, __________ hereby sell, assign and transfer unto
PLEASE INSERT SOCIAL SECURITY OR
OTHER IDENTIFICATION NUMBER OF ASSIGNEE
[ ]
Please print or typewrite name and address including postal zip code of assignee. |
__________________________________________________ shares of the common stock represented by this certificate and do hereby irrevocably constitute and appoint _____________________________________________________________, attorney, to transfer the said stock on the books of the within-named corporation with full power of substitution in the premises.
DATED ______________________ | |
NOTICE: The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular without alteration or enlargement or any change whatever. | |
SIGNATURE GUARANTEED: | |
THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION, (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17Ad-15 |
Exhibit 4.2
Exchangeable PROMISSORY NOTE
Up to $2,000,000 | June 29, 2018 |
For value received Federal Life Mutual Holding Company, an Illinois corporation (the “Company”), promises to pay to Insurance Capital Group LLC or its assigns (“Holder”) the principal sum of up to TWO MILLION DOLLARS $2,000,000 (the “Maximum Amount”) together with accrued and unpaid interest thereon, each due and payable on the date and in the manner set forth below.
This exchangeable promissory note (the “Note”) is issued in connection with that certain Standby Stock Purchase Agreement (as may be amended, the “Purchase Agreement”) dated as of the date hereof, among the Company, Federal Life Group, Inc. (“ListCo”), Federal Life Insurance Company (“Federal Life”) and Holder. Capitalized terms used herein without definition shall have the meanings given to such terms in the Purchase Agreement.
1. Advances. Advances under this Note (each, an “Advance” and, collectively, the “Advances”) shall be made within five (5) Business Days of the receipt by Holder of a written request from the Company, which request shall include the amount of the requested Advance and wire details of the Company’s bank account into which such Advance shall be paid. The Company may not request an Advance, and Holder shall have no obligation to fund an Advance (a) until Holder has received evidence satisfactory to it (in its sole and absolute discretion) of the proper filing of the Registration Statement, (b) if an Event of Default shall have occurred and be continuing, or (c) if the amount requested, when added to the aggregate amount of all prior Advances, would exceed the Maximum Amount. Nothing herein shall entitle the Company to re-borrow any Advances previously repaid.
2. Payments Generally. All payments of interest and principal shall be in lawful money of the United States of America. All payments shall be applied first to accrued interest, and thereafter to principal.
(a) Payments of Interest. Unless this Note has been previously exchanged in accordance with the terms of Section 4 below (or as otherwise agreed by the Company and Holder), commencing September 30, 2018 and continuing until all amounts due under the Note are paid in full, the Company shall make interest payments in arrears at the rate described in Section 3 hereof on the last day of each calendar quarter.
(b) Payments of Principal. Unless this Note has been previously exchanged in accordance with the terms of Section 4 below (or as otherwise agreed by the Company and Holder), the Company shall repay the outstanding Advances, together with any accrued and unpaid interest on the earlier to occur of (i) the date that is two (2) years following the date hereof, (ii) the date of the issuance of Shares in connection with the Community Offering, in which case the outstanding Advances shall be exchanged for Shares in the manner described in Section 4 on such date and (iii) the date on which payment of this Note is accelerated pursuant to Section 7 hereof (the “Maturity Date”).
(c) Prepayments. The Advances may not be prepaid prior to the date of the issuance of Shares in connection with the Community Offering.
3. Interest Rate. Interest shall accrue on the amount of the outstanding Advances during each calendar quarter following the date of this Note at a rate for such quarter equal to (a) from the date of this Note to the date that is twelve months (or, if the Outside Date is extended pursuant to Section 16(a)(iv) of the Purchase Agreement, eighteen months) following the date of this Note, three and three-quarters percent (3.75%) per annum and (b) thereafter, or anytime after the occurrence and during the continuation of an Event of Default (defined below), ten percent (10%) per annum. Interest shall be calculated on the basis of a 365-day year for the actual number of days elapsed.
4. Assumption and Exchange. Upon the occurrence of the Conversion and the issuance of Shares in connection with the Community Offering, Listco shall automatically assume and be liable for the obligations of the Company hereunder and the outstanding Advances shall be exchanged and deemed to be repaid in full upon the issuance to Holder of a number of Shares equal to aggregate amount of the outstanding Advances divided by the Subscription Price.
5. Expenses. In the event of any default hereunder, the Company shall pay all reasonable attorneys’ fees and court costs incurred by Holder in enforcing and collecting this Note.
6. Covenants. Until all of the obligations to pay principal and interest under this note shall have been satisfied (whether by payment or by exchange in accordance with Section 4), the Company shall not (a) incur or permit to exist any Indebtedness other than the Indebtedness under this Note, permit Listco to incur or permit to exist any Indebtedness other than the Indebtedness under this Note, or permit Federal Life to incur or permit to exist any Indebtedness other than Indebtedness that Federal Life is permitted to incur under the Purchase Agreement (notwithstanding the termination of the Purchase Agreement), (b) declare or pay any dividends or other distributions to its shareholders, (c) sell or dispose of any of its assets or cause or permit Federal Life to, directly or indirectly, sell or dispose of any of its assets outside of the ordinary course of Federal Life’s business, or (d) without the prior written consent of Holder, make any investments or acquisitions of assets or cause or permit Federal Life to make any investments or acquisitions of assets outside of the ordinary course of its business.
7. Default. If there shall be any Event of Default hereunder, at the option and upon the declaration of Holder and upon written notice to the Company (which election and notice shall not be required in the case of an Event of Default under Section 7(c) or Section 7(d)), this Note shall accelerate and all principal and unpaid accrued interest shall become due and payable. For the purposes of this Note, an “Event of Default” shall mean the occurrence of any one or more of the following:
(a) The Company fails to pay timely any of the principal amount due under this Note on the date the same becomes due and payable or any accrued interest or other amounts due under this Note on the date the same becomes due and payable;
(b) The Company, ListCo or Federal Life shall default in its performance of any covenant under the Purchase Agreement or the Note;
(c) The Company files any petition or action for relief under any bankruptcy, reorganization, insolvency or moratorium law or any other law for the relief of, or relating to, debtors, now or hereafter in effect, or makes any assignment for the benefit of creditors or takes any corporate action in furtherance of any of the foregoing;
(d) An involuntary petition is filed against the Company (unless such petition is dismissed or discharged within 60 days under any bankruptcy statute now or hereafter in effect, or a custodian, receiver, trustee, assignee for the benefit of creditors (or other similar official) is appointed to take possession, custody or control of any property of the Company); or
8. Waiver. The Company hereby waives: (a) all presentments, demands for performance, notices of nonperformance (except to the extent required by the provisions of this Note), protests, notices of protest and notices of dishonor; (b) any requirement of diligence or promptness on the part of Holder in the enforcement of its rights hereunder; (c) any and all notices of every kind and description which may be required to be given by any statute or rule of law; and (d) any defense (other than indefeasible payment in full) which it may now or hereafter have with respect to its liability hereunder.
2 |
9. Governing Law. This Note shall be governed by and construed under the laws of the State of New York, without giving effect to conflicts of laws principles which would lead to the application of the laws of any other jurisdiction.
10. Modification; Waiver. Any term of this Note may be amended or waived with the written consent of the Company and Holder.
11. Assignment. This Note may be transferred only (i) upon its surrender to the Company for registration of transfer, duly endorsed, or accompanied by a duly executed written instrument of transfer in form reasonably satisfactory to the Company and (ii) unless the Purchase Agreement has been terminated in accordance with the terms thereof, in connection with an assignment of Holder’s rights under the Purchase Agreement in accordance with Section 19 thereof. Thereupon, this Note shall be reissued to, and registered in the name of, the transferee, or a new Note for like principal amount and interest shall be issued to, and registered in the name of, the transferee. Interest and principal shall be paid solely to the registered holder of this Note. Such payment shall constitute full discharge of the Company’s obligation to pay such interest and principal.
[Signature Page Follows]
3 |
IN WITNESS WHEREOF, the Company and ListCo have caused this Note to be duly executed and delivered as of the date first above written.
FEDERAL LIFE MUTUAL HOLDING COMPANY | ||
By: | /s/ William S. Austin | |
William S. Austin | ||
President | ||
FEDERAL LIFE GROUP, INC. | ||
By: | /s/ William S. Austin | |
William S. Austin | ||
President |
[Signature Page to Exchangeable Promissory Note]
Exhibit 5.1
Stevens & Lee
Lawyers & Consultants
111 North 6th Street
Reading, PA 16103
(610) 478-2000 Fax (610) 376-5610
www.stevenslee.com
October 11, 2018
Board of Directors
Federal Life Group, Inc.
3750 Deerfield Road
Riverwoods, IL 60015
Re: Registration Statement on Form S-1
Ladies and Gentlemen:
We have acted as counsel to Federal Life Group, Inc. (the “Company”) in connection with the Company’s proposed offering of up to 4,600,000 shares of the Company’s common stock, $0.01 par value per share (the “Common Stock”). This offering is covered by the Company’s Registration Statement on Form S-1, filed with the Securities and Exchange Commission (the “Registration Statement”). In connection with delivering this opinion, we have reviewed the following documents:
1. | The Amended and Restated Articles of Incorporation of the Company as filed with the Secretary of State of the Commonwealth of Pennsylvania on September 11, 2018, as certified by the Secretary of the Company; |
2. | The bylaws of the Company as presently in effect, as certified by the Secretary of the Company; |
3. | The resolutions of the Board of Directors of the Company adopted by an action by unanimous written consent dated October 9, 2018, as certified by the Secretary of the Company; |
4. | The Registration Statement, including the prospectus (the “Prospectus”) contained therein; |
5. | The form of the certificate representing shares of the Common Stock filed as Exhibit 4.1 to the Registration Statement. |
Philadelphia · Reading · Valley Forge · Lehigh Valley · Harrisburg · Lancaster · Scranton Wilkes-Barre · Princeton · Charleston · New York · Wilmington
A PROFESSIONAL CORPORATION |
Board of Directors October 11, 2018 Page 2 | Stevens & Lee Lawyers & Consultants |
Based upon our review of the documents listed above, it is our opinion that the shares of Common Stock covered by the Registration Statement have been duly authorized and, when issued and sold against payment therefor, pursuant to the terms described in the Registration Statement, will be legally issued by the Company and fully paid and nonassessable.
We consent to the filing of this opinion as an exhibit to the Registration Statement, and to the reference to us under the heading “Legal Matters” in the Prospectus. In giving this consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder.
Very truly yours,
STEVENS & LEE
/s/ Stevens & Lee
/mm
Exhibit 8.1
Stevens & Lee
Lawyers & Consultants
620 Freedom Business Center, Suite 200
King of Prussia,
PA 19406
(610) 205-6000 Fax (610) 337-4374
www.stevenslee.com
October 10, 2018
Board of Directors
Federal Life Group, Inc.
3750 Deerfield Rd.
Riverwoods, IL 60015
Re: | Conversion of Federal Life Mutual Holding Company from Mutual Holding Company to Stock Company |
Ladies and Gentlemen:
We have been requested to provide this opinion concerning matters of U.S. federal income tax law in connection with (1) the proposed conversion of Federal Life Mutual Holding Company, a mutual holding company organized under the laws of Illinois (“Federal Life Mutual”) to a stock company (the “Conversion”) pursuant to the Plan of Conversion of Federal Life Mutual approved by the Board of Directors of Federal Life Mutual on March 8, 2018 (the “Plan of Conversion”); and (2) the issuance of all of the capital stock of the converted Federal Life Mutual to Federal Life Group, Inc., a Pennsylvania corporation (the “Company”) and the issuance of shares of common stock by the Company in an initial public offering in accordance with the Form S-1 Registration Statement filed by the Company on October 10, 2018 (the “S-1 Registration Statement”), and related exhibits thereto. This opinion is being provided solely in connection with the filing of the S-1 Registration Statement with the Securities and Exchange Commission.
For purposes of this opinion letter, capitalized words and phrases that are used but not defined herein shall have the meanings given to such terms in the Plan of Conversion.
For purposes of providing this opinion, we have examined and are relying upon (without any independent verification or review thereof) the truth and accuracy, at all relevant times, of the statements, covenants, representations and warranties contained in the following documents (including all schedules and exhibits thereto):
1. | the S-1 Registration Statement; |
2. | the Plan of Conversion; |
Allentown · Bala Cynwyd · Charleston · Cleveland · Fargo · Fort Lauderdale · Harrisburg · Lancaster
A PROFESSIONAL CORPORATION |
October 10, 2018 Page 2 | Stevens & Lee Lawyers & Consultants
|
3. | the Officer’s Certificate provided to us by Federal Life Mutual; and |
4. | such other instruments and documents related to Federal Life Mutual and the Company and the Plan of Conversion as we have deemed necessary or appropriate. |
In addition, in connection with providing this opinion, we have assumed (without any independent investigation thereof) that:
1. original documents (including signatures) are authentic; documents submitted to us as copies conform to the original documents; and there has been (or will be by the Effective Date) due execution and delivery of all documents where due execution and delivery are prerequisites to the effectiveness thereof;
2. any representation or statement referred to above made “to the best of knowledge” or otherwise similarly qualified is correct without such qualification, and all statements and representations, whether or not qualified, are true and will remain true through the Effective Date and thereafter where relevant; and
3. all transactions that are related or incidental to the Conversion will be consummated pursuant to the Plan of Conversion, and will be effective under the laws of the State of Illinois and applicable federal and state insurance laws.
The opinion expressed herein is conditioned on the initial and continuing accuracy of the facts, information, representations and assumptions contained in the aforesaid documents or otherwise referred to above.
Based on the foregoing documents, materials, assumptions and information, and subject to the qualifications and assumptions set forth herein, if the Conversion is consummated in accordance with the provisions of the Plan of Conversion (and without any waiver, breach or amendment of any of the provisions thereof), it is our opinion that, under current law (i) the Conversion will constitute a “reorganization” within the meaning of Code Section 368(a), and (ii) the statements made regarding U.S. federal income tax consequences set forth in the S-1 Registration Statement under the heading “Federal Income Tax Considerations,” insofar as they constitute statements of law or legal conclusions, are correct in all material respects.
_________________________________
The opinion set forth above is based on the existing provisions of the Code, Treasury Regulations (including Temporary Treasury Regulations) promulgated under the Code, published Revenue Rulings, Revenue Procedures and other announcements of the Internal Revenue Service (the “Service”) and existing court decisions, any of which could be changed at any time. Any such changes might be retroactive with respect to transactions entered into prior to the date of such changes and could significantly modify the opinion set forth above. Nevertheless, we undertake no responsibility to advise you of any subsequent developments in the application, operation or interpretation of the U.S. federal income tax laws.
October 10, 2018 Page 3 | Stevens & Lee Lawyers & Consultants |
As you are aware, no ruling has been or will be requested from the Service concerning the U.S. federal income tax consequences of the Conversion or the Offering. In reviewing this letter, you should be aware that the opinion set forth above represents our conclusion regarding the application of existing U.S. federal income tax law to the instant transaction. If the facts vary from those relied upon (or if any representation, covenant, warranty or assumption upon which we have relied is inaccurate, incomplete, breached or ineffective), our opinion contained herein could be inapplicable in whole or in part. You should be aware that an opinion of counsel represents only counsel’s best legal judgment, and has no binding effect or official status of any kind, and that no assurance can be given that contrary positions may not be taken by the Service or that a court considering the issues would not hold otherwise.
As stated above, this opinion is being delivered to the Board of Directors of the Company solely for the purpose of being included as an exhibit to the S-1 Registration Statement. We consent to the filing of this opinion as an exhibit to the S-1 Registration Statement and to the use of our name in the S-1 Registration Statement wherever it appears. In giving this consent, however, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules or regulations promulgated thereunder
Very truly yours,
STEVENS & LEE
/s/ Stevens & Lee
Exhibit 10.4
AMENDMENT NUMBER ONE
to
REINSURANCE AGREEMENT
NUMBER 308-16AY12
between
FEDERAL LIFE INSURANCE COMPANY
3750 West Deerfield Road
Riverwoods, Illinois 60015
(hereinafter referred to as “THE COMPANY”)
and
OPTIMUM RE INSURANCE COMPANY
1345 River Bend Drive, Suite 100,
Dallas, TX 75247
(hereinafter referred to as “OPTIMUM RE”)
Respecting reinsurance of a closed in-force block of Universal Life policies reinsured on YRT basis from October 1, 2017
1. Effective October 1, 2017, this Agreement shall be amended as follows:
A. Article 1.1, Scope of Reinsurance Ceded and Accepted, shall be amended and replaced by the following to reflect the addition of a closed in-force block of Universal Life policies:
1.1 Scope of Reinsurance Ceded and Accepted
Effective July 1, 2016, OPTIMUM IRE hereby agrees to assume 100% of the amount in excess of THE COMPANY’s retention, net of the existing amount of reinsurance, on THE COMPANY’s closed in-force block of Level Term policies as per the attached in-force listing specified in Schedule E. It is understood that no additional policies are to be added to this block past the effective date of this Agreement without OPTIMUM RE’s prior written approval.
Effective October 1, 2017, OPTIMUM RE hereby agrees to assume 100% of the amount in excess of THE COMPANY’s retention, net of the existing amount of reinsurance, on THE COMPANY’s closed in-force block of Universal Life policies as per the attached in-force listing specified in Schedule H. It is understood that no additional policies are to be added to this block past the effective date of this Agreement without OPTIMUM RE’s prior written approval.
The maximum reinsurance amount per life that will be ceded to OPTIMUM RE is as described in Schedule A.
B. Article 3.2, Net Amount at Risk Basis, shall be amended and replaced by the following to reflect a change in A.2 due to the administration of the closed in-force block of Universal Life policies.
3.2 Net Amount at Risk Basis
When the reinsurer does not participate in the surrender values on a policy, as in reinsurance based on YRT or cost of insurance rates, the reinsurance amount at risk shall be based on the death benefit less a fund which represents the savings element in the policies.
The overriding principle involved is that OPTIMUM RE and THE COMPANY will each continue to insure their original proportionate share of the net amount at risk.
1 |
Net Amounts at Risk mill be defined as follows:
A. Insurance With Cash Values
1. Scheduled Face Amount and Cash Value
Amounts at risk will be projected for 10 year intervals (or until there is a scheduled change in face amount if less than 10 years). Cash, values will be used to represent the fund at the end of an interval, and amounts at risk for each intervening year will be interpolated on a straight line basis.
2. Variable Face Amount or Variable Cash Value
The amount at risk applicable to each policy year will be the projected amount at risk at the beginning of that policy year. Amounts at risk will be recalculated when THE COMPANY periodically provides updated cash values. Upon recalculation, the amount at risk will remain level until THE COMPANY provides the subsequent updated cash values. The amount at risk on which reinsurance premiums were paid will be the basis for the reinsurance claim liability.
B. Insurance Without Cash Values
This category should include policies where the cash values never exceed 10% of the face amount.
1. Scheduled Face Amount
The amount at risk applicable to each policy year will be the face amount applicable at the beginning of the policy year.
2. Variable Face Amount
The amount at risk applicable to each policy year will be the face amount projected to be applicable at the beginning of that policy year. Face amounts will be projected for five year intervals. Where actual face amounts diverge from the originally projected face amounts by more than 10%, THE COMPANY may re-establish the projected schedule at the next policy anniversary for future face amounts. If the schedule is not amended, the existing established schedule will be used for determining premium and claims liabilities.
2 |
C. Article 4. 2, Standard, Risks, shall be amended and replaced by the following to reflect the addition of a closed in-force block of Universal Life policies:
4.2 Standard Risks
TERM BLOCK
For policies issued prior to 2009, reinsurance premiums for standard risks are calculated based on the issue age and duration for that policy by applying the appropriate percentage as specified in Schedule B to the age nearest birthday mortality tables specified in Schedule C, exclusive of policy fees.
For policies issued in 2009 and afterwards, reinsurance premiums for standard risks are calculated based on the issue age and duration for that policy by applying the appropriate percentage as specified in Schedule B to the age last birthday mortality tables specified in Schedule D, exclusive of policy fees.
UNIVERSAL LIFE BLOCK
For policies issued on forms I-385, L-7620, and, L-7929, reinsurance premiums for standard risks are calculated based on the issue age and duration for that policy by applying the appropriate percentage as specified in Schedule B to the age nearest birthday mortality tables specified in Schedule F, exclusive of policy fees.
For policies issued on form L-8031, reinsurance premiums for standard risks are calculated based on the issue age and duration for that policy by applying the appropriate percentage as specified in Schedule B to the age last birthday mortality tables specified in Schedule G, exclusive of policy fees.
TERM AND UNIVERSAL LIFE BLOCKS
For the period from the effective date of the reinsurance coverage under this Agreement up to the next policy anniversary date, THE COMPANY shall pay a pro-rated reinsurance premium to OPTIMUM RE. Following the initial reinsurance premium, all reinsurance premiums shall be as described above and in Article 7.
D. Article 8.8, Recapture, shall be renumbered to Article 8.9, and a new Article 8.8, Reduced Paid Up and Extended Term, shall be included as shown below:
8 .8 Reduced Paid Up and Extended Term
If a Reduced Paid Up or Extended Term option is selected by the policyholder, OPTIMUM RE will continue to reinsure its proportionate share of the policy.
3 |
For policies where OPTIMUM RE does not participate in surrender value accumulation, reinsurance premiums will be calculated on a point-in-scale basis using the same YRT rates that applied to the policy and the calculation of the Net Amount at Risk according to Article 3.
8 9 Recapture
Recapture will not be permitted under this Agreement unless explicitly approved by OPTIMUM RE, except as stated in Article 3.3.
E. Schedule B shall be amended and replaced with the attached.
F. Schedules F, G, and H shall be included as attached.
4 |
2. Signatures
The terms and conditions of this Agreement are not changed in any way except as stated herein.
IN WITNESS of the above, this Amendment is signed in duplicate on the dates indicated.
FOR: FEDERAL LIFE INSURANCE COMPANY |
BY: | /s/ Paul R. Murphy | DATE: | 01-10-2018 | |
NAME: | Paul R. Murphy | |||
TITLE: | Actuary |
BY: | /s/ Dorothy M. Latuzek | DATE: | 01-10-2018 | |
NAME: | Dorothy M. Latuzek | |||
TITLE: | Director of Underwriting |
FOR: OPTIMUM RE INSURANCE COMPANY
BY: | /s/ Sebastien Blondeau | DATE: | 12-20-2017 | |
NAME: | Sebastien Blondeau | |||
TITLE: | President & COO | |||
BY: | /s/ Serge Goulet | DATE: | 12-20-2017 | |
NAME: | Serge Goulet | |||
TITLE: | Managing Director |
5 |
SCHEDULE B
EFFECTIVE JULY 1, 2016
REINSURANCE PREMIUM PERCENTAGES FOR THE
CLOSED IN-FORCE BLOCK OF LEVEL TERM POLICIES
PREMIUM PERCENTAGES APPLIED TO THE APPLICABLE MORTALITY
TABLES SPECIFIED IN SCHEDULE C AND SCHEDULE D
3-CLASS TERM PRODUCTS
RISK CLASS | LEVEL TERM PERIOD | POST LEVEL TERM PERIOD | ||||||
MALE PREFERRED NONTOBACCO | 43 | % | 62 | % | ||||
MALE RESIDUAL NONTOBACCO | 52 | % | 82 | % | ||||
MALE STANDARD TOBACCO | 109 | % | 169 | % | ||||
FEMALE PREFERRED NONTOBACCO | 47 | % | 68 | % | ||||
FEMALE RESIDUAL NONTOBACCO | 63 | % | 99 | % | ||||
FEMALE STANDARD TOBACCO | 140 | % | 217 | % |
2-CLASS & AGGREGATE TERM PRODUCTS,
ART ONLY | ALL OTHER TERM PLANS | |||||||||||
RISK CLASS | ALL DURATIONS | LEVEL TERM PERIOD | POST LEVEL TERM PERIOD | |||||||||
MALE STANDARD NONTOBACCO | 52 | % | 52 | % | 82 | % | ||||||
MALE STANDARD TOBACCO | 109 | % | 109 | % | 169 | % | ||||||
MALE AGGREGATE | 63 | % | 63 | % | 98 | % | ||||||
FEMALE STANDARD NONTOBACCO | 63 | % | 63 | % | 99 | % | ||||||
FEMALE STANDARD TOBACCO | 140 | % | 140 | % | 217 | % | ||||||
FEMALE AGGREGATE | 81 | % | 81 | % | 125 | % |
*AFTER APPLYING THE ABOVE PERCENTAGES TO THE MORTALITY TABLES SPECIFIED, MULTIPLY THESE BY THE NET AMOUNT AT RISK PER THOUSAND AND ROUND THE RESULTING REINSURANCE PREMIUMS TO TWO DECIMAL PLACES (I.E., NEAREST CENT).
6 |
SCHEDULE B (Continued)
EFFECTIVE JULY 1, 2016
REINSURANCE PREMIUM PERCENTAGES FOR THE
CLOSED IN-FORCE BLOCK OF LEVEL TERM POLICIES
PREMIUM PERCENTAGES APPLIED TO THE APPLICABLE MORTALITY
TABLES SPECIFIED IN SCHEDULES F AND G
RISK CLASS | ALL DURATIONS | |||
ALL CLASSES | 115 | % |
*AFTER APPLYING THE ABOVE PERCENTAGES TO THE MORTALITY TABLES SPECIFIED, MULTIPLY THESE BY THE NET AMOUNT AT RISK PER THOUSAND AND ROUND THE RESULTING REINSURANCE PREMIUMS TO TWO DECIMAL PLACES (I.E., NEAREST CENT). FOR UNIVERSAL LIFE POLICIES, THE NET AMOUNT AT RISK SHALL BE DEFINED AS THE FACE AMOUNT MINUS THE CASH VALUE.
7 |
SCHEDULE F
SOA 2008 VBT, AGE NEAREST BIRTHDAY,
SELECT & ULTIMATE, SMOKER AND
GENDER DISTINCT MORTALITY TABLES
PART 1 - MALE RATES
8 |
REINSURANCE AGREEMENT
NUMBER: 308-16AY12
Between
FEDERAL LIFE INSURANCE COMPANY (MUTUAL)
3750 West Deerfield Road
Riverwoods, Illinois 60015
(hereinafter referred to as “THE COMPANY”)
And
OPTIMUM RE INSURANCE COMPANY
1345 River Bend Drive, Suite 100
Dallas, TX 75247
(hereinafter referred to as “OPTIMUM RE”)
Respecting reinsurance of a closed in-force block of Level Term policies reinsured on an Automatic YRT basis from July 1, 2016.
TABLE OF CONTENTS
Page | |
ARTICLE 1 REINSURANCE CEDED AND ACCEPTED | 3 |
1.1. Scope of Reinsurance Ceded and Accepted | 3 |
1.2. Currency | 3 |
ARTICLE 2 LIABILITY | 4 |
ARTICLE 3 REINSURANCE AMOUNT AT RISK | 5 |
3.1. Face Amount Basis | 5 |
3.2. Net Amount at Risk Basis | 5 |
3.3. Minimum Reinsured Risk Amount | 6 |
ARTICLE 4 REINSURANCE PREMIUMS | 7 |
4.1. Life Premiums | 7 |
4.2. Standard Risks | 7 |
4.3. Substandard Risks | 7 |
ARTICLE 5 ALLOWANCES | 9 |
5.1. Allowances | 9 |
5.2. Premium Taxes | 9 |
ARTICLE 6 GENERAL PROCEDURES | 10 |
6.1. Inspection of Records | 10 |
6.2. Errors and Omissions | 10 |
6.3. Reserves | 10 |
6.4. Reporting | 10 |
6.5. Confidentiality | 11 |
ARTICLE 7 ACCOUNTING AND BILLING | 12 |
7.1. Reinsurance Premiums | 12 |
7.2. Individual Cession Billing | 12 |
7.3. Late Payment | 12 |
ARTICLE 8 CHANGES AND ADJUSTMENTS | 13 |
8.1. Change Information | 13 |
8.2. Reductions | 13 |
8.3. Reinstatements | 13 |
8.4. Conversions | 13 |
8.5. Terminations | 13 |
i |
8.6. Cash Values | 14 |
8.7. Policy loans and Dividends | 14 |
8.8. Recapture | 14 |
ARTICLE 9 CLAIMS | 15 |
9.1. Claims Liability | 15 |
9.2. Notice | 15 |
9.3. Authorization for Payment | 15 |
9.4. Adjusted Amounts | 15 |
9.5. Payment | 15 |
9.6. Contest | 15 |
9.7. Punitive Damages | 16 |
ARTICLE 10 ARBITRATION | 17 |
10.1. Principle | 17 |
10.2. Arbitrators | 17 |
10.3. Matters In Dispute | 17 |
10.4. Procedures | 17 |
10.5. Decision | 17 |
10.6. Applicable Laws | 17 |
ARTICLE 11 INSOLVENCY | 18 |
11.1. Payment of Claims | 18 |
11.2. Notice to OPTIMUM RE | 18 |
11.3. Expenses | 18 |
11.4. Right to Offset | 18 |
ARTICLE 12 DEFERRED ACQUISITION COST TAX | 19 |
ARTICLE 13 EXECUTION | 20 |
13.1. Duration | 20 |
13.2. Parties to the Agreement | 20 |
13.3. Written Agreement | 20 |
13.4. Change of Control/Assignment | 20 |
13.5. Compliance | 21 |
13.6. Signatures | 21 |
ii |
SCHEDULES
SCHEDULE A: | RETENTION AND REINSURANCE LIMITS |
SCHEDULE B: | REINSURANCE PREMIUM PERCENTAGES FOR THE CLOSED IN-FORCE BLOCK OF LEVEL TERM POLICIES |
SCHEDULE C: | US 75-80, BASIC SELECT & ULTIMATE, AGGREGATE AGE NEAREST BIRTHDAY, GENDER DISTINCT MORTALITY TABLES |
PART 1 - |
MALE RATES
| |
PART 2 - | FEMALE RATES |
SCHEDULE D: | US 75-80, BASIC SELECT & ULTIMATE, AGGREGATE AGE LAST BIRTHDAY, GENDER DISTINCT MORTALITY TABLES |
PART 1 - |
MALE RATES
| |
PART 2 - | FEMALE RATES |
SCHEDULE E: | IN-FORCE LIST OF LEVEL TERM POLICIES |
iii |
By this Agreement, FEDERAL LIFE INSURANCE COMPANY (MUTUAL), a corporation organized under the laws of the State of Illinois, hereinafter referred to as “THE COMPANY”, and OPTIMUM RE INSURANCE COMPANY, a corporation organized under the laws of the State of Texas, hereinafter referred to as “OPTIMUM RE”, mutually agree to reinsure on the following terms and conditions.
1 |
DEFINITION OF TERMS USED IN THIS AGREEMENT
Compensatory Damages | Shall mean the amounts awarded to compensate for the actual damages sustained, and not awarded as a penalty, nor fixed in amount by statute. | |
Insolvency | Shall mean the legal incapacity of a company to operate as declared by a court of competent jurisdiction. | |
Policy | Shall mean the contract(s) of insurance issued by THE COMPANY in respect of which reinsurance is applied for and/or placed in whole or in part. | |
Punitive Damages | Shall mean the damages awarded as a penalty, the amount of which is not governed, nor fixed by statute. | |
Reinsurance Cession | Shall mean the insurance transferred to OPTIMUM RE by THE COMPANY on a policy. | |
Statutory Penalties | Shall mean the amounts which are awarded as a penalty, but fixed in amount by statute. |
2 |
ARTICLE
1
REINSURANCE CEDED AND ACCEPTED
1.1. Scope of Reinsurance Ceded and Accepted
OPTIMUM RE hereby agrees to assume 100% of the amount in excess of THE COMPANY’s retention, net of the existing amount of reinsurance, on THE COMPANY’s closed in-force block of Level Term policies as per the attached in-force listing specified in Schedule E. It is understood that no additional policies are to be added to this block past the effective date of this Agreement without OPTIMUM RE’s prior written approval.
The maximum reinsurance amount per life that will be ceded to OPTIMUM RE is as described in Schedule A.
1.2. Currency
Reinsurance will be in U.S. dollars. Any other currency requires specific agreement between THE COMPANY and OPTIMUM RE.
3 |
ARTICLE
2
LIABILITY
OPTIMUM RE accepts liability for its share of the risks on eligible lives for deaths occurring on or after the effective date of the Agreement.
The liability of OPTIMUM RE on any policy shall commence on the effective date of this Agreement and end simultaneously with that of THE COMPANY.
4 |
ARTICLE
3
REINSURANCE AMOUNT AT RISK
3.1. Face Amount Basis
When the reinsurer is participating in the accumulation of surrender values on a policy, or when there are no surrender values on a policy, the reinsurance amount shall be based on the face amount of the policy.
The overriding principle involved is that OPTIMUM RE and THE COMPANY will each continue to insure their original proportionate share of the initial face amount.
3.2. Net Amount at Risk Basis
When the reinsurer does not participate in the surrender values on a policy, as in reinsurance based on YRT or cost of insurance rates, the reinsurance amount at risk shall be based on the death benefit less a fund which represents the savings element in the policies.
The overriding principle involved is that OPTIMUM RE and THE COMPANY will each continue to insure their original proportionate share of the net amount at risk.
Net Amounts at Risk will be defined as follows:
A. Insurance With Cash Values
1. Scheduled Face Amount and Cash Value
Amounts at risk will be projected for 10 year intervals (or until there is a scheduled change in face amount if less than 10 years). Cash values will be used to represent the fund at the end of an interval, and amounts at risk for each intervening year will be interpolated on a straight line basis.
2. Variable Face Amount or Variable Cash Value
The amount at risk applicable to each policy year will be the projected amount at risk at the beginning of that policy year. Amounts at risk will be projected for five year intervals. Where an actual amount at risk diverges from an originally projected amount at risk by more than 10%, THE COMPANY may re-establish the projected Schedule at the next policy anniversary for future amounts at risk. If the Schedule is not amended, the existing established Schedule will be used for determining premium and claims liabilities.
B. Insurance Without Cash Values
This category should include policies where the cash values never exceed 10% of the face amount.
5 |
1. Scheduled Face Amount
The amount at risk applicable to each policy year will be the face amount applicable at the beginning of the policy year.
2. Variable Face Amount
The amount at risk applicable to each policy year will be the face amount projected to be applicable at the beginning of that policy year. Face amounts will be projected for five year intervals. Where actual face amounts diverge from the originally projected face amounts by more than 10%, THE COMPANY may re-establish the projected Schedule at the next policy anniversary for future face amounts. If the Schedule is not amended, the existing established Schedule will be used for determining premium and claims liabilities.
3.3. Minimum Reinsured Risk Amount
The minimum reinsured risk amount shall be $1,000. In the event that the reinsured risk amount reduces below the minimum, THE COMPANY will automatically recapture the risk on that policy anniversary.
6 |
ARTICLE
4
REINSURANCE PREMIUMS
4.1. Life Premiums
Until further notice, the reinsurance premiums shall be at the rates described in Articles 4.2 and 4.3.
Although OPTIMUM RE anticipates that the reinsurance premium rates in Schedule B shall apply indefinitely, it guarantees only that the reinsurance premium rates applicable to the business reinsured hereunder will not exceed the YRT net premiums at the applicable statutory minimum valuation select and ultimate mortality table and statutory maximum interest rate.
In the event THE COMPANY increases its premiums or cost-of-insurance charges on any block of policies, OPTIMUM RE reserves the right to review and modify its reinsurance premium rates. Any such increase in the reinsurance premium rates shall be in proportion to THE COMPANY’s increase in premiums or cost-of-insurance charges.
The increase in the reinsurance premium rates shall become effective on the policy anniversary dates beginning no sooner than 30 days after OPTIMUM RE has given its written notice to THE COMPANY of its intent to increase the reinsurance premium rates and no sooner than the COMPANY’s increase in its premiums or cost-of-insurance charges.
4.2. Standard Risks
For policies issued prior to 2009, reinsurance premiums for standard risks are calculated based on the issue age and attained duration for that policy by applying the appropriate percentage as specified in Schedule B to the age nearest mortality tables specified in Schedule C, exclusive of policy fees.
For policies issued in 2Q09 and afterwards, reinsurance premiums for standard risks are calculated based on the issue age and attained duration for that policy by applying the appropriate percentage as specified in Schedule B to the age last mortality tables specified in Schedule D, exclusive of policy fees.
For the period from the effective date of this Agreement up to the next policy anniversary date, THE COMPANY shall pay a pro-rated reinsurance premium to OPTIMUM RE. Following the initial reinsurance premium, all reinsurance premiums shall be as described above and in Article 7.
4.3. Substandard Risks
Substandard reinsurance premiums shall be paid on policies which have been underwritten as a substandard risk. The substandard extra premium rate per $1,000 for one table (25% mortality) is 25% of the standard rate. The extra premium for additional tables is the corresponding multiple of the extra premium rate for one table.
7 |
When a flat extra premium is charged by THE COMPANY, a flat extra reinsurance premium is paid at the same rate and for the same period.
8 |
ARTICLE
5
ALLOWANCES
5.1. Allowances
There are no allowances payable on the standard and substandard life premiums based on the YRT rates in Schedule B.
Allowances on Flat Extra Premiums
On permanent (6 years or more) flat extra premiums:
1st year | : | 75 | % | |||
Renewals | : | 10 | % |
On temporary (5 years of less) flat extra premiums:
All years | : | 10 | % |
5.2. Premium Taxes
OPTIMUM RE shall not reimburse THE COMPANY for state premium tax or any other tax levied on THE COMPANY.
9 |
ARTICLE
6
GENERAL PROCEDURES
6.1. Inspection of Records
OPTIMUM RE shall have the right to inspect, make copies of, or reproduce, at any reasonable time, at the office of THE COMPANY, all books and documents relating to reinsurance under this Agreement.
6.2. Errors and Omissions
It is expressly understood and agreed that if failure to comply with any terms of this Agreement is shown to be unintentional and the result of administrative errors or omissions on the part of either THE COMPANY or OPTIMUM RE, both THE COMPANY and OPTIMUM RE shall be restored to the position they would have occupied had no such error or omission occurred.
This provision shall apply only to oversights, misunderstandings or clerical errors relating to the administration of reinsurance covered by this Agreement and not to the administration of the insurance provided by THE COMPANY to its insured. Any negligent or deliberate acts or omissions by THE COMPANY regarding the insurance provided are the responsibility of THE COMPANY and its liability insurer, if any, but not that of OPTIMUM RE.
Furthermore, the deviating party will undertake to identify, through a prudent review of its records all other errors and omissions of the same or similar category and correct them within a mutually negotiated time frame.
If seven (7) years have elapsed since the error or oversight occurred, there will not be rectification as above, unless both OPTIMUM RE and THE COMPANY agree to such rectification.
6.3. Reserves
OPTIMUM RE will establish appropriate reserves in accordance with the Standard Valuation Law in effect in Texas, on the portion of policies reinsured, and in force, as reported to OPTIMUM RE under this Agreement.
6.4. Reporting
THE COMPANY shall promptly report all transactions to OPTIMUM RE. In particular, but not limited to, changes and terminations.
Should THE COMPANY encounter, or expect to encounter, delays in reporting its business; it shall promptly:
1. | Notify OPTIMUM RE of the situation; and |
10 |
2. | Present OPTIMUM RE with a plan of action to correct the situation, including a time frame to solve the problem. |
OPTIMUM RE, upon receipt of the above, may request that THE COMPANY:
1. | Make modifications to the plan; |
2. | Pay estimated premiums for the duration of the reporting problem; and/or |
3. | Report larger individual exposures manually, until the situation is resolved. |
In any case where the above is not met, or if the plan is not accepted by both OPTIMUM RE and THE COMPANY, or when the plan is not adhered to, OPTIMUM RE reserves the right to deny liability on claims or limit refunds of reinsurance premiums.
6.5. Confidentiality
THE COMPANY and OPTIMUM RE agree that Customer and Proprietary Information will be treated as confidential. Customer Information includes, but is not limited to, medical, financial, and other personal information about proposed, current, and former policy owners, insureds, applicants, and beneficiaries of policies issued by THE COMPANY. Proprietary Information includes, but is not limited to, business plans, mortality and lapse studies, underwriting manuals and guidelines, applications and contract forms. Furthermore, the specific terms and conditions of this Agreement, cannot be disclosed to any other party for competitive use, unless prior written approval is obtained.
Customer and Proprietary Information will not include information that:
a. | is or becomes available to the general public through no fault of the party receiving the Customer or Proprietary Information (the “Recipient”); |
b. | is independently developed by the Recipient; |
c. | is acquired by the Recipient from a third party not covered by a confidentiality agreement; or |
d. | is disclosed under a court order, law or regulation. |
The parties will not disclose such information to any other parties unless agreed to in writing, except as necessary for retrocession purposes, as requested by external auditors, as required by court order, or as required or allowed by law or regulation.
THE COMPANY acknowledges that OPTIMUM RE can aggregate data with other companies reinsured with OPTIMUM RE as long as the data cannot be identified as belonging to THE COMPANY.
11 |
ARTICLE
7
ACCOUNTING AND BILLING
7.1. Reinsurance Premiums
For the period from the effective date of this Agreement up to the next policy anniversary date, the reinsurance premiums are due at the effective date of this Agreement. Following the initial payment of reinsurance premiums, reinsurance premiums are due on the policy anniversary date and payable to OPTIMUM RE on an annual basis regardless of how premiums are paid to THE COMPANY.
7.2. Individual Cession Billing
OPTIMUM RE will submit every month to THE COMPANY a listing of changes and terminations, and a statement of amounts payable.
The net balance is due to OPTIMUM RE within 30 days of receiving the statement. If a balance is due to THE COMPANY, OPTIMUM RE will remit its payment with the statement.
7.3. Late Payment
Any overdue balance bears interest from the end of a 30-day period following receipt of the monthly billing.
The interest for the period from 30 to 60 days will be the then current annual prime interest rate of the JP Morgan Chase Bank, Dallas, Texas calculated on a monthly basis.
For each additional month, after 60 days that a balance remains unpaid, interest will be calculated using the above annual rate plus 2%.
The payment of reinsurance premiums shall be a condition precedent to the liability of OPTIMUM RE under this Agreement. If any premium remains unpaid for more than 60 days after the due date, OPTIMUM RE may send to THE COMPANY a formal demand for immediate payment. If THE COMPANY does not comply with this demand within 30 days, then OPTIMUM RE may cancel any unpaid reinsurance cessions for nonpayment of premium; however, any unpaid premiums to the time of cancellation would be due with interest.
THE COMPANY will not force cancellation under the provisions of this Article solely to circumvent the provisions regarding recapture in Article 8.8., or to transfer the reinsured policies to another reinsurer.
12 |
ARTICLE
8
CHANGES AND ADJUSTMENTS
8.1. Change Information
THE COMPANY will keep OPTIMUM RE informed of any changes or adjustments affecting a reinsured case. If a change affects either the reinsurance premiums or allowances, or amount at risk, THE COMPANY will provide OPTIMUM RE with the necessary information to complete a modified Reinsurance Cession Form.
8.2. Reductions
If a policy is changed in any way that results in a reduction in the amount of insurance on any policy, the amount of reinsurance on that policy will be reduced proportionately.
If a Life has multiple policies and one or more are terminated or reduced, the reinsurance on remaining policies for that same Life that are reinsured under this Agreement will not be reduced to allow THE COMPANY to fill its retention.
If more than one reinsurer has a cession on that policy, each reinsurer’s cession will be reduced proportionately.
8.3. Reinstatements
If a policy reinsured with OPTIMUM RE lapses and is subsequently reinstated under THE COMPANY’s regular rules, the reinsurance will automatically be reinstated for the same amount, upon receipt by OPTIMUM RE of written notice of the reinstatement. All other reinstatement requests shall be submitted to OPTIMUM RE for its approval before THE COMPANY can reinstate such policy.
THE COMPANY shall pay all reinsurance premiums in arrears for the same period THE COMPANY received premiums in arrears under its policy, including interest, if any.
8.4. Conversions
When a conversion right is contractually available under the original plan, provided the conversion occurs before age 65, OPTIMUM RE shall continue to reinsure its share of the policy. The reinsurance premiums shall be calculated on a point-in-scale basis using the same reinsurance factor specified in Schedule B, at the time of the policy conversion, for the conversion plan. The calculation of the Net Amount at Risk shall be as described in Article 3.
8.5. Terminations
At termination of a policy, other than death, all premiums and allowances, excluding cession fees, are adjusted pro rata for the period of coverage.
In the event of termination by death, there will be no adjustment of premiums.
13 |
8.6. Cash Values
OPTIMUM RE will not participate in the payment of cash values.
8.7. Policy loans and Dividends
OPTIMUM RE will not participate in policy loans or dividends.
8.8. Recapture
Recapture will not be permitted under this Agreement unless explicitly approved by OPTIMUM RE, except as stated in Article 3.3.
14 |
ARTICLE
9
CLAIMS
9.1. Claims Liability
OPTIMUM RE will be liable to THE COMPANY for the benefits reinsured hereunder to the same extent as THE COMPANY is liable to the insured for such benefits, and all reinsurance will be subject to the terms and conditions of the policy under which THE COMPANY is liable. OPTIMUM RE will also be liable for its proportionate share of interest on payment of the claim at the usual interest rate allowed by THE COMPANY.
9.2. Notice
THE COMPANY will give OPTIMUM RE prompt notice of any claim. Copies of notification, claim papers and proofs will be furnished to OPTIMUM RE within ten (10) working days of having been received by THE COMPANY.
9.3. Authorization for Payment
On all claims, THE COMPANY must obtain the approval of OPTIMUM RE prior to acknowledgment of its liability to the claimant.
9.4. Adjusted Amounts
In the event the amount of insurance provided by a policy reinsured hereunder is increased or reduced because of a misstatement of age or sex established after the death of the insured, OPTIMUM RE will share in the increase or reduction in the proportion that the liability of OPTIMUM RE bore to the total liability under the policy immediately prior to such increase or reduction.
9.5. Payment
On death claims, OPTIMUM RE will pay its share in a lump sum to THE COMPANY without regard to the form of claim settlement. OPTIMUM RE is not responsible for usual claim expenses that THE COMPANY incurs in claim settlement such as compensation of employees and routine investigative expenses.
9.6. Contest
THE COMPANY will advise OPTIMUM RE of its intention to contest, compromise or litigate a claim or rescind a contract involving reinsurance. If after reviewing the complete file OPTIMUM RE agrees in writing with THE COMPANY’s intention, then OPTIMUM RE agrees to pay a share of the expenses incurred by THE COMPANY in contesting or investigating a claim on a reinsured policy or in rescinding a reinsured policy, in proportion to the respective liabilities of OPTIMUM RE and THE COMPANY. Compensation of officers and employees of THE COMPANY is not deemed a claim expense.
15 |
If OPTIMUM RE declines to be a party to a claim contest, OPTIMUM RE will discharge any and all liability by payment of its full share of the claim to THE COMPANY according to the terms and conditions of this Agreement.
9.7. Punitive Damages
OPTIMUM RE will not participate in punitive, compensatory or statutory damages or penalties which are awarded against THE COMPANY as a result of an act, omission or course of conduct committed solely by THE COMPANY in connection with the insurance reinsured under this Agreement.
16 |
ARTICLE
10
ARBITRATION
10.1. Principle
The parties express their formal intention to resolve any differences arising from the interpretation or execution of this Agreement in accordance with equity and usage rather than according to strict legal rules. Any difference that cannot be resolved by the parties shall be submitted to arbitration by written notice sent by one party to the other. The location for arbitration shall be Dallas, Texas.
10.2. Arbitrators
There shall be three disinterested arbitrators who shall be officers or retired officers of life insurance or reinsurance companies other than the parties to the Agreement or their subsidiaries. The arbitrators shall be disinterested parties and cannot be jurists, present or former employees of one of the parties or their affiliate or therefore related to the management of one of the parties or their affiliates. Each of the parties shall appoint one of the arbitrators and these two arbitrators shall select the third. In the event that either party should fail to choose an arbitrator within thirty days after the other party has given notice of its arbitrator appointment, that party may choose two arbitrators who shall in turn choose a third arbitrator before entering arbitration.
Any arbitrator who does not perform their duties or resigns will be replaced by the party who originally selected that arbitrator.
10.3. Matters In Dispute
The parties will state together or separately the subjects in dispute and submit them in writing to the arbitrators along with the necessary documents.
10.4. Procedures
The arbitrators must themselves establish the procedure to be followed: they are exempt from any judicial formality or rule. They can adjudicate and are empowered to act as mediators. They shall decide how the arbitration costs are apportioned.
10.5. Decision
The award rendered by the majority, must be in writing, give the reasons for the decision and be signed by each arbitrator. The parties agree to abide by the decision rendered and to consider the award as final and binding on both parties.
10.6. Applicable Laws
Should there be improprieties in the arbitration process or if one of the parties objects to the implementation of the arbitration process, the laws of the State of Texas shall then apply.
17 |
ARTICLE
11
INSOLVENCY
11.1. Payment of Claims
In the event of insolvency of THE COMPANY, all claims under this Agreement will be paid by OPTIMUM RE directly to THE COMPANY, its liquidator, receiver or statutory successor. OPTIMUM RE’s share of claims will be paid without diminution because of the insolvency of THE COMPANY, provided that all reinsurance premiums have been duly paid and subject to Article 11.4.
OPTIMUM RE shall be liable only for the claims actually paid by THE COMPANY to the insured or its beneficiary on amounts reinsured and shall not be or become liable for any amounts or reserves to be held by THE COMPANY on policies reinsured under this Agreement.
11.2. Notice to OPTIMUM RE
In the event of the insolvency of THE COMPANY, the liquidator, receiver, or statutory successor of THE COMPANY will give written notice of a pending claim against THE COMPANY on any policy reinsured, within a reasonable time after the claim is filed in the insolvency proceedings. While the claim is pending, OPTIMUM RE may investigate and interpose, at its own expense, in the proceedings where the claim is to be adjudicated, any defenses which it may deem available to THE COMPANY or its liquidator, receiver, or statutory successor.
11.3. Expenses
The expenses incurred by OPTIMUM RE will be charged, subject to court approval, against THE COMPANY as expenses of liquidation to the extent of a proportionate share of the benefit which accrues to THE COMPANY as a result of the defenses undertaken by OPTIMUM RE. Where two or more reinsurers are involved and a majority in interest elects to defend a claim, the expenses will be apportioned in accordance with the terms of the reinsurance agreements as if the expenses had been incurred by THE COMPANY.
11.4. Right to Offset
In the event of the insolvency of either OPTIMUM RE or THE COMPANY, any amounts owed by OPTIMUM RE to THE COMPANY and by THE COMPANY to OPTIMUM RE with respect to this and all other Reinsurance Agreements between OPTIMUM RE and THE COMPANY, shall be offset against each other with the balance to be paid by the appropriate party.
18 |
ARTICLE
12
DEFERRED ACQUISITION COST TAX
THE COMPANY and OPTIMUM RE mutually agree to the following pursuant to Section 1.848-2(g)(8) of the Income Tax Regulations issued December 29, 1992 of the Internal Revenue Code of 1986.
1. | The Party with net positive consideration for the Agreement(s) for each taxable year shall compute specified policy acquisition expenses without regard to the general deductions limitation of Section 848(c)(1). |
2. | THE COMPANY and OPTIMUM RE agree to exchange information pertaining to the amount of net consideration as determined for all reinsurance agreements in force between them to ensure consistency or as may otherwise be required by the Internal Revenue Service. |
3. | THE COMPANY will submit a Schedule to OPTIMUM RE by June 1st of its calculation of the net consideration for the preceding calendar year. This calculation shall be accompanied by a statement signed by an officer of THE COMPANY stating that THE COMPANY will report such net consideration in its tax return for the preceding calendar year. |
4. | OPTIMUM RE shall advise THE COMPANY if it disagrees with the amounts provided and OPTIMUM RE and THE COMPANY agree to amicably resolve any difference. The amounts provided by THE COMPANY shall be presumed correct if it does not receive a response from OPTIMUM RE at the latest 30 days after receipt by OPTIMUM RE of these amounts or by May 30th of the current year. |
19 |
ARTICLE
13
EXECUTION
13.1. Duration
This Agreement will be effective on July 1, 2016. Reinsurance for these policies shall remain in-force until termination of the original policy with THE COMPANY or as provided elsewhere within this Agreement.
13.2. Parties to the Agreement
This is an agreement solely between THE COMPANY and OPTIMUM RE. There will be no legal relationship between OPTIMUM RE and any person having an interest of any kind in any of THE COMPANY’s insurance, or between OPTIMUM RE and any other reinsurer, or between OPTIMUM RE and any other third party.
13.3. Written Agreement
A. Entirety
This Agreement shall constitute the entire agreement between THE COMPANY and OPTIMUM RE with respect to the business reinsured hereunder. There are no understandings between THE COMPANY and OPTIMUM RE other than as expressed in this Agreement.
B. Amendments
Any change or modification to the Agreement shall be null and void unless made by amendment to the Agreement and signed by both parties.
C. Waiver
A waiver of any provision(s) of this Agreement shall constitute a waiver only with respect to the particular circumstance for which it is given and not a waiver for any future circumstances.
D. Severability
If any section or provision of this Agreement is determined to be invalid or unenforceable, such determination will not impact or affect the validity or the enforceability of the remaining sections or provisions of this Agreement.
13.4. Change of Control/Assignment
Neither THE COMPANY nor its liquidator, receiver, or statutory successor will, without the prior written consent of OPTIMUM RE, sell, assign, transfer, or otherwise dispose of this Agreement, or any interest in this Agreement, by voluntary or involuntary act.
20 |
13.5. Compliance
THE COMPANY represents that to the best of its knowledge and belief it is, and shall use its best efforts to continue to be, in substantial compliance in all material respects with all laws, regulations, and judicial and administrative orders applicable to the business reinsured under this Agreement, including but not limited to, privacy laws and the maintenance of an effective anti-money laundering policy, (collectively, the “Law”). Neither THE COMPANY nor OPTIMUM RE shall be required to take any action under this Agreement that would result in it being in violation of the Law, which shall include requirements enforced by the U.S. Treasury Department Office of Foreign Assets Control and Terrorist Financing Act. THE COMPANY and OPTIMUM RE acknowledge and agree that a claim under this Agreement is not payable if payment would cause OPTIMUM RE to be in violation of the Law. Should either party discover a reinsurance payment has been made in violation of the Law, it shall notify the other party and the parties shall cooperate in order to take all necessary corrective actions.
13.6. Signatures
IN WITNESS of the above, this Agreement is signed in duplicate on the dates indicated.
FOR: FEDERAL LIFE INSURANCE COMPANY |
BY: | /s/ Paul R. Murphy | DATE: | 08-29-16 | |
NAME: | Paul R. Murphy | |||
TITLE: | Actuary |
BY: | /s/ Dorothy M. Latuszek | DATE: | 08-29-16 | |
NAME: | Dorothy M. Latuszek | |||
TITLE: | Director of Underwriting |
FOR: OPTIMUM RE INSURANCE COMPANY
BY: | /s/ Sebastien Blondeau | DATE: | 8-26-2016 | |
NAME: | Sebastien Blondeau | |||
TITLE: | President & COO | |||
BY: | /s/ Serge Goulet | DATE: | 8-26-2016 | |
NAME: | Serge Goulet | |||
TITLE: | Managing Director |
21 |
SCHEDULE
A
RETENTION AND REINSURANCE LIMITS
FEDERAL LIFE INSURANCE COMPANY (MUTUAL)
LIFE | ||
THE COMPANY’S Retention Limit per Life | 20% retained on all ceded amounts. | |
Maximum Reinsurance Amount per Life | $208,000 | |
Minimum Cession | $5,000 |
22 |
SCHEDULE
B
REINSURANCE PREMIUM PERCENTAGES FOR THE CLOSED IN-FORCE BLOCK OF LEVEL TERM POLICIES
PREMIUM PERCENTAGES APPLIED TO THE APPLICABLE
MORTALITY
TABLES SPECIFIED IN SCHEDULE C AND SCHEDULE D
3-CLASS TERM PRODUCTS
RISK CLASS | LEVEL TERM PERIOD | POST LEVEL TERM PERIOD | ||||||
MALE PREFERRED NONTOBACCO | 43 | % | 62 | % | ||||
MALE RESIDUAL NONTOBACCO | 52 | % | 82 | % | ||||
MALE STANDARD TOBACCO | 109 | % | 169 | % | ||||
FEMALE PREFERRED NONTOBACCO | 47 | % | 68 | % | ||||
FEMALE RESIDUAL NONTOBACCO | 63 | % | 99 | % | ||||
FEMALE STANDARD TOBACCO | 140 | % | 217 | % |
*AFTER APPLYING THE ABOVE PERCENTAGES TO THE MORTALITY TABLES SPECIFIED IN SCHEDULE C OR SCHEDULE D, MULTIPLY THESE BY THE NET AMOUNT AT RISK PER THOUSAND AND ROUND THE RESULTING REINSURANCE PREMIUMS TO TWO DECIMAL PLACES (I.E., NEAREST CENT).
2-CLASS & AGGREGATE TERM PRODUCTS
ART ONLY | ALL OTHER TERM PLANS | |||||||||||
RISK CLASS | ALL DURATIONS | LEVEL TERM PERIOD | POST LEVEL TERM PERIOD | |||||||||
MALE STANDARD NONTOBACCO | 52 | % | 52 | % | 82 | % | ||||||
MALE STANDARD TOBACCO | 109 | % | 109 | % | 169 | % | ||||||
MALE AGGREGATE | 63 | % | 63 | % | 98 | % | ||||||
FEMALE STANDARD NONTOBACCO | 63 | % | 63 | % | 99 | % | ||||||
FEMALE STANDARD TOBACCO | 140 | % | 140 | % | 217 | % | ||||||
FEMALE AGGREGATE | 81 | % | 81 | % | 125 | % |
*AFTER APPLYING THE ABOVE PERCENTAGES TO THE MORTALITY TABLES SPECIFIED IN SCHEDULE C OR SCHEDULE D, MULTIPLY THESE BY THE NET AMOUNT AT RISK PER THOUSAND AND ROUND THE RESULTING REINSURANCE PREMIUMS TO TWO DECIMAL PLACES (I.E., NEAREST CENT).
23 |
SCHEDULE
C
US 75-80, BASIC SELECT & ULTIMATE, AGGREGATE AGE NEAREST BIRTHDAY, GENDER DISTINCT MORTALITY TABLES
PART 1 | - | MALE RATES |
24 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
0 | 1.23 | 0.74 | 0.48 | 0.43 | 0.38 | 0.34 | 0.33 | 0.29 | 0.27 | 0.27 | 0.25 | 0.28 | 0.31 | 0.38 | 0.54 | 0.68 | 15 | |||||||||||||||||
1 | 0.49 | 0.47 | 0.42 | 0.36 | 0.28 | 0.23 | 0.22 | 0.22 | 0.24 | 0.24 | 0.27 | 0.30 | 0.38 | 0.54 | 0.68 | 1.01 | 16 | |||||||||||||||||
2 | 0.35 | 0.37 | 0.33 | 0.28 | 0.23 | 0.22 | 0.21 | 0.24 | 0.24 | 0.27 | 0.30 | 0.37 | 0.54 | 0.68 | 1.01 | 1.14 | 17 | |||||||||||||||||
3 | 0.35 | 0.29 | 0.25 | 0.23 | 0.22 | 0.20 | 0.22 | 0.24 | 0.27 | 0.30 | 0.37 | 0.53 | 0.68 | 1.01 | 1.14 | 1.22 | 18 | |||||||||||||||||
4 | 0.29 | 0.25 | 0.23 | 0.22 | 0.20 | 0.22 | 0.24 | 0.27 | 0.30 | 0.36 | 0.52 | 0.66 | 0.99 | 1.11 | 1.22 | 1.31 | 19 | |||||||||||||||||
5 | 0.25 | 0.23 | 0.22 | 0.20 | 0.22 | 0.24 | 0.27 | 0.30 | 0.36 | 0.50 | 0.66 | 0.96 | 1.09 | 1.16 | 1.31 | 1.37 | 20 | |||||||||||||||||
6 | 0.23 | 0.22 | 0.20 | 0.22 | 0.24 | 0.27 | 0.30 | 0.36 | 0.50 | 0.66 | 0.94 | 1.07 | 1.14 | 1.21 | 1.37 | 1.40 | 21 | |||||||||||||||||
7 | 0.19 | 0.20 | 0.22 | 0.24 | 0.27 | 0.30 | 0.35 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.40 | 1.41 | 22 | |||||||||||||||||
8 | 0.18 | 0.21 | 0.21 | 0.27 | 0.29 | 0.35 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.30 | 1.39 | 1.40 | 23 | |||||||||||||||||
9 | 0.19 | 0.20 | 0.24 | 0.29 | 0.35 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.30 | 1.35 | 1.36 | 1.38 | 24 | |||||||||||||||||
10 | 0.18 | 0.22 | 0.27 | 0.35 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.30 | 1.35 | 1.36 | 1.32 | 1.34 | 25 | |||||||||||||||||
11 | 0.20 | 0.25 | 0.34 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.30 | 1.35 | 1.36 | 1.30 | 1.27 | 1.29 | 26 | |||||||||||||||||
12 | 0.23 | 0.32 | 0.50 | 0.66 | 0.87 | 1.05 | 1.13 | 1.19 | 1.23 | 1.30 | 1.35 | 1.36 | 1.30 | 1.2.5 | 1.20 | 1.24 | 27 | |||||||||||||||||
13 | 0.30 | 0.46 | 0.63 | 0.87 | 1.05 | 1.12 | 1.19 | 1.22 | 1.24 | 1.28 | 1.31 | 1.30 | 1.25 | 1.20 | 1.16 | 1.20 | 28 | |||||||||||||||||
14 | 0.44 | 0.59 | 0.87 | 1.05 | 1.12 | 1.17 | 1.22 | 1.23 | 1.23 | 1.24 | 1.26 | 1.25 | 1.19 | 1.16 | 1.13 | 1.17 | 29 | |||||||||||||||||
15 | 0.58 | 0.87 | 1.05 | 1.12 | 1.17 | 1.21 | 1.23 | 1.22 | 1.20 | 1.20 | 1.19 | 1.18 | 1.13 | 1.12 | 1.11 | 1.14 | 30 | |||||||||||||||||
16 | 0.87 | 1.05 | 1.12 | 1.17 | 1.21 | 1.20 | 1.21 | 1.19 | 1.16 | 1.14 | 1.12 | 1.12 | 1.09 | 1.09 | 1.09 | 1.12 | 31 | |||||||||||||||||
17 | 1.05 | 1.12 | 1.17 | 1.21 | 1.20 | 1.18 | 1.18 | 1.15 | 1.11 | 1.07 | 1.05 | 1.06 | 1.05 | 1.06 | 1.08 | 1.11 | 32 | |||||||||||||||||
18 | 1.03 | 1.10 | 1.13 | 1.15 | 1.14 | 1.11 | 1.11 | 1.07 | 1.04 | 1.01 | 1.00 | 1.02 | 1.01 | 1.03 | 1.07 | 1.12 | 33 | |||||||||||||||||
19 | 1.00 | 1.05 | 1.06 | 1.07 | 1.05 | 1.04 | 1.02 | 0.98 | 0.96 | 0.95 | 0.97 | 0.97 | 0.98 | 1.01 | 1.07 | 1.14 | 34 | |||||||||||||||||
20 | 0.93 | 0.97 | 0.97 | 0.97 | 0.97 | 0.95 | 0.93 | 0.90 | 0.90 | 0.91 | 0.93 | 0.94 | 0.96 | 1.01 | 1.08 | 1.17 | 35 | |||||||||||||||||
21 | 0.84 | 0.87 | 0.87 | 0.87 | 0.87 | 0.86 | 0.85 | 0.83 | 0.85 | 0.86 | 0.90 | 0.92 | 0.96 | 1.02 | 1.11 | 1.22 | 36 | |||||||||||||||||
22 | 0.73 | 0.76 | 0.76 | 0.76 | 0.77 | 0.77 | 0.77 | 0.77 | 0.80 | 0.83 | 0.88 | 0.91 | 0.96 | 1.04 | 1.15 | 1.28 | 37 | |||||||||||||||||
23 | 0.73 | 0.76 | 0.75 | 0.75 | 0.75 | 0.76 | 0.77 | 0.77 | 0.80 | 0.84 | 0.90 | 0.94 | 1.00 | 1.10 | 1.21 | 1.36 | 38 | |||||||||||||||||
24 | 0.73 | 0.74 | 0.73 | 0.73 | 0.74 | 0.76 | 0.77 | 0.78 | 0.82 | 0.87 | 0.93 | 0.97 | 1.05 | 1.17 | 1.29 | 1.45 | 39 | |||||||||||||||||
25 | 0.72 | 0.72 | 0.72 | 0.72 | 0.74 | 0.76 | 0.77 | 0.79 | 0.84 | 0.90 | 0.96 | 1.03 | 1.12 | 1.25 | 1.38 | 1.56 | 40 | |||||||||||||||||
26 | 0.70 | 0.70 | 0.71 | 0.72 | 0.73 | 0.76 | 0.78 | 0.82 | 0.88 | 0.95 | 1.02 | 1.09 | 1.20 | 1.35 | 1.49 | 1.70 | 41 | |||||||||||||||||
27 | 0.68 | 0.68 | 0.70 | 0.71 | 0.73 | 0.77 | 0.81 | 0.86 | 0.92 | 1.01 | 1.08 | 1.17 | 1.30 | 1.47 | 1.63 | 1.87 | 42 | |||||||||||||||||
28 | 0.66 | 0.68 | 0.71 | 0.73 | 0.76 | 0.81 | 0.86 | 0.92 | 1.00 | 1.08 | 1.17 | 1.28 | 1.42 | 1.61 | 1.81 | 2.07 | 43 | |||||||||||||||||
29 | 0.65 | 0.68 | 0.73 | 0.76 | 0.81 | 0.86 | 0.92 | 1.00 | 1.08 | 1.17 | 1.28 | 1.42 | 1.58 | 1.81 | 2.03 | 2.31 | 44 | |||||||||||||||||
30 | 0.64 | 0.68 | 0.76 | 0.81 | 0.86 | 0.92 | 1.00 | 1.08 | 1.17 | 1.28 | 1.42 | 1.58 | 1.81 | 2.03 | 2.26 | 2.58 | 45 | |||||||||||||||||
31 | 0.63 | 0.69 | 0.79 | 0.86 | 0.92 | 1.00 | 1.08 | 1.17 | 1.28 | 1.42 | 1.58 | 1.81 | 2.03 | 2.26 | 2.53 | 2.89 | 46 | |||||||||||||||||
32 | 0.63 | 0.71 | 0.84 | 0.92 | 1.00 | 1.08 | 1.17 | 1.28 | 1.40 | 1.58 | 1.81 | 2.03 | 2.26 | 2.53 | 2.83 | 3.24 | 47 | |||||||||||||||||
33 | 0.63 | 0.72 | 0.88 | 0.98 | 1.08 | 1.17 | 1.28 | 1.40 | 1.58 | 1.78 | 2.01 | 2.25 | 2.53 | 2.83 | 3.17 | 3.61 | 48 | |||||||||||||||||
34 | 0.63 | 0.73 | 0.93 | 1.05 | 1.17 | 1.28 | 1.40 | 1.58 | 1.78 | 2.01 | 2.24 | 2.53 | 2.81 | 3.16 | 3.54 | 4.02 | 49 |
C-1-1 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
35 | 0.63 | 0.76 | 0.99 | 1.14 | 1.28 | 1.40 | 1.58 | 1.78 | 2.01 | 2.24 | 2.53 | 2.80 | 3.13 | 3.52 | 3.94 | 4.45 | 50 | |||||||||||||||||
36 | 0.65 | 0.79 | 1.06 | 1.25 | 1.40 | 1.58 | 1.78 | 2.01 | 2.24 | 2.53 | 2.80 | 3.10 | 3.48 | 3.91 | 4.36 | 4.92 | 51 | |||||||||||||||||
37 | 0.67 | 0.84 | 1.15 | 1.37 | 1.58 | 1.78 | 2.01 | 2.24 | 2.53 | 2.80 | 3.08 | 3.43 | 3.86 | 4.32 | 4.82 | 5.44 | 52 | |||||||||||||||||
38 | 0.70 | 0.89 | 1.23 | 1.47 | 1.70 | 1.91 | 2.16 | 2.41 | 2.72 | 3.04 | 3.35 | 3.76 | 4.25 | 4.28 | 5.33 | 6.00 | 53 | |||||||||||||||||
39 | 0.74 | 0.95 | 1.33 | 1.59 | 1.83 | 2.07 | 2.33 | 2.60 | 2.93 | 3.27 | 3.64 | 4.10 | 4.67 | 5.28 | 5.88 | 6.61 | 54 | |||||||||||||||||
40 | 0.79 | 1.02 | 1.45 | 1.73 | 2.00 | 2.23 | 2.51 | 2.79 | 3.13 | 3.51 | 3.94 | 4.47 | 5.13 | 5.82 | 6.48 | 7.27 | 55 | |||||||||||||||||
41 | 0.85 | 1.11 | 1.59 | 1.90 | 2.17 | 2.42 | 2.70 | 2.98 | 3.33 | 3.75 | 4.24 | 4.86 | 5.62 | 6.41 | 7.12 | 8.01 | 56 | |||||||||||||||||
42 | 0.92 | 1.22 | 1.76 | 2.09 | 2.37 | 2.62 | 2.89 | 3.18 | 3.52 | 3.99 | 4.57 | 5.28 | 6.15 | 7.05 | 7.85 | 8.82 | 57 | |||||||||||||||||
43 | 0.99 | 1.37 | 1.92 | 2.30 | 2.61 | 2.88 | 3.18 | 3.47 | 3.83 | 4.33 | 4.96 | 5.71 | 6.63 | 7.61 | 8.50 | 9.73 | 58 | |||||||||||||||||
44 | 1.08 | 1.53 | 2.11 | 2.52 | 2.86 | 3.17 | 3.47 | 3.79 | 4.17 | 4.70 | 5.37 | 6.16 | 7.16 | 8.20 | 9.22 | 10.75 | 59 | |||||||||||||||||
45 | 1.17 | 1.72 | 2.31 | 2.75 | 3.13 | 3.47 | 3.79 | 4.14 | 4.56 | 5.08 | 5.80 | 6.66 | 7.73 | 8.85 | 10.02 | 11.89 | 60 | |||||||||||||||||
46 | 1.28 | 1.94 | 2.51 | 3.00 | 3.40 | 3.78 | 4.14 | 4.56 | 4.91 | 5.48 | 6.28 | 7.19 | 8.35 | 9.56 | 10.89 | 13.17 | 61 | |||||||||||||||||
47 | 1.39 | 2.17 | 2.73 | 3.25 | 3.69 | 4.13 | 4.56 | 4.89 | 5.31 | 5.93 | 6.79 | 7.78 | 9.03 | 10.34 | 11.85 | 14.57 | 62 | |||||||||||||||||
48 | 1.49 | 2.27 | 2.84 | 3.40 | 3.90 | 4.38 | 4.87 | 5.28 | 5.80 | 6.49 | 7.53 | 8.64 | 9.94 | 11.30 | 12.79 | 16.07 | 63 | |||||||||||||||||
49 | 1.60 | 2.35 | 2.95 | 3.54 | 4.09 | 4.62 | 5.18 | 5.70 | 6.33 | 7.12 | 8.36 | 9.60 | 10.96 | 12.32 | 13.75 | 17.71 | 64 | |||||||||||||||||
50 | 1.70 | 2.42 | 3.04 | 3.66 | 4.29 | 4.87 | 5.51 | 6.15 | 6.93 | 7.83 | 9.30 | 10.69 | 12.06 | 13.40 | 14.77 | 19.50 | 65 | |||||||||||||||||
51 | 1.80 | 2.48 | 3.12 | 3.77 | 4.47 | 5.12 | 5.86 | 6.65 | 7.59 | 8.61 | 10.35 | 11.89 | 13.24 | 14.56 | 15.83 | 21.47 | 66 | |||||||||||||||||
52 | 1.90 | 2.52 | 3.17 | 3.85 | 4.65 | 5.38 | 6.23 | 7.20 | 8.32 | 9.48 | 11.51 | 13.18 | 14.52 | 15.80 | 16.96 | 23.65 | 67 | |||||||||||||||||
53 | 2.06 | 2.75 | 3.46 | 4.23 | 5.08 | 5.90 | 6.84 | 7.89 | 9.11 | 10.43 | 12.63 | 14.52 | 15.80 | 16.96 | 19.16 | 26.05 | 68 | |||||||||||||||||
54 | 2.23 | 2.99 | 3.78 | 4.64 | 5.57 | 6.47 | 7.52 | 8.66 | 9.96 | 11.44 | 13.85 | 15.80 | 16.96 | 19.16 | 21.62 | 28.69 | 69 | |||||||||||||||||
55 | 2.41 | 3.27 | 4.12 | 5.10 | 6.11 | 7.11 | 8.27 | 9.50 | 10.86 | 12.54 | 15.17 | 16.96 | 19.16 | 21.62 | 24.39 | 31.57 | 70 | |||||||||||||||||
56 | 2.61 | 3.56 | 4.51 | 5.61 | 6.71 | 7.83 | 9.09 | 10.38 | 11.83 | 13.73 | 16.62 | 19.16 | 21.62 | 24.39 | 27.47 | 34.68 | 71 | |||||||||||||||||
57 | 2.82 | 3.89 | 4.94 | 6.18 | 7.38 | 8.60 | 9.96 | 11.33 | 12.87 | 15.03 | 18.21 | 21.36 | 24.39 | 27.15 | 30.87 | 38.00 | 72 | |||||||||||||||||
58 | 2.96 | 4.13 | 5.44 | 6.74 | 8.10 | 9.20 | 10.59 | 12.05 | 13.66 | 15.94 | 19.22 | 22.43 | 25.64 | 28.58 | 32.76 | 41.60 | 73 | |||||||||||||||||
59 | 3.10 | 4.37 | 6.00 | 7.34 | 8.87 | 9.82 | 11.23 | 12.79 | 14.47 | 16.88 | 20.25 | 23.49 | 26.85 | 29.94 | 34.70 | 45.54 | 74 | |||||||||||||||||
60 | 3.23 | 4.63 | 6.61 | 7.97 | 9.71 | 10.46 | 11.89 | 13.57 | 15.32 | 17.85 | 21.28 | 24.48 | 27.97 | 31.28 | 36.71 | 49.90 | 75 | |||||||||||||||||
61 | 3.37 | 4.89 | 7.26 | 8.64 | 10.46 | 11.59 | 12.58 | 14.38 | 16.18 | 18.82 | 22.26 | 25.39 | 29.04 | 32.61 | 38.82 | 54.71 | 76 | |||||||||||||||||
62 | 3.50 | 5.14 | 7.97 | 9.36 | 11.59 | 11.83 | 13.29 | 15.21 | 17.05 | 19.77 | 23.18 | 26.21 | 30.06 | 33.93 | 41.03 | 60.03 | 77 | |||||||||||||||||
63 | 3.89 | 5.77 | 8.74 | 10.48 | 11.83 | 13.29 | 15.21 | 17.05 | 20.11 | 22.42 | 25.79 | 28.87 | 33.14 | 37.75 | 44.66 | 65.85 | 78 | |||||||||||||||||
64 | 4.32 | 6.47 | 9.57 | 11.73 | 13.29 | 15.21 | 17.05 | 20.11 | 22.42 | 25.79 | 28.69 | 32.93 | 36.55 | 42.02 | 48.60 | 72.18 | 79 | |||||||||||||||||
65 | 4.80 | 7.26 | 10.50 | 13.13 | 15.21 | 17.05 | 20.11 | 22.42 | 25.79 | 28.69 | 32.93 | 35.12 | 40.34 | 46.75 | 52.83 | 79.02 | 80 | |||||||||||||||||
66 | 5.32 | 8.14 | 11.51 | 14.69 | 17.05 | 20.11 | 22.42 | 25.79 | 28.69 | 32.93 | 34.69 | 38.78 | 44.51 | 51.97 | 57.68 | 86.36 | 81 | |||||||||||||||||
67 | 5.91 | 9.12 | 12.62 | 16.42 | 20.11 | 22.42 | 25.79 | 28.69 | 32.93 | 34.47 | 38.42 | 42.80 | 49.08 | 57.68 | 62.18 | 94.12 | 82 | |||||||||||||||||
68 | 6.51 | 10.04 | 13.89 | 18.04 | 22.04 | 24.54 | 28.23 | 31.44 | 34.47 | 37.82 | 42.14 | 46.91 | 53.73 | 62.18 | 67.77 | 102.35 | 83 | |||||||||||||||||
69 | 7.17 | 11.05 | 15.25 | 19.76 | 24.12 | 26.87 | 30.94 | 34.47 | 37.82 | 41.49 | 46.20 | 51.36 | 58.72 | 67.77 | 73.69 | 111.41 | 84 |
C-1-2 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
70 | 7.89 | 12.14 | 16.72 | 21.64 | 26.41 | 29.44 | 33.92 | 37.82 | 41.49 | 45.48 | 50.57 | 56.13 | 64.00 | 73.69 | 80.22 | 121.31 | 85 | |||||||||||||||||
71 | 9.53 | 14.60 | 19.60 | 24.97 | 29.44 | 34.32 | 41.78 | 48.80 | 57.45 | 65.58 | 74.61 | 84.52 | 95.47 | 107.84 | 121.31 | 132.05 | 86 | |||||||||||||||||
72 | 11.40 | 16.64 | 22.87 | 28.77 | 34.15 | 39.89 | 48.34 | 56.16 | 65.58 | 74.61 | 84.52 | 95.39 | 107.67 | 121.31 | 132.05 | 143.63 | 87 | |||||||||||||||||
73 | 13.52 | 19.13 | 26.61 | 33.20 | 39.52 | 46.21 | 55.72 | 64.40 | 74.61 | 84.52 | 95.39 | 107.62 | 121.31 | 132.05 | 143.63 | 156.05 | 88 | |||||||||||||||||
74 | 15.94 | 22.46 | 30.70 | 38.25 | 45.60 | 53.35 | 64.01 | 73.58 | 84.52 | 95.39 | 107.62 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 89 | |||||||||||||||||
75 | 18.71 | 26.26 | 35.35 | 43.95 | 52.45 | 61.35 | 73.23 | 83.67 | 95.39 | 107.62 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 90 | |||||||||||||||||
76 | 21.88 | 30.62 | 40.61 | 50.35 | 60.12 | 70.26 | 83.39 | 94.78 | 107.62 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 91 | |||||||||||||||||
77 | 25.51 | 34.90 | 46.52 | 57.51 | 68.66 | 80.09 | 94.57 | 107.29 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 92 | |||||||||||||||||
78 | 29.63 | 40.42 | 53.12 | 65.47 | 78.04 | 90.90 | 107.18 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 93 | |||||||||||||||||
79 | 34.65 | 46.62 | 60.45 | 74.20 | 88.36 | 103.10 | 121.31 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 94 | |||||||||||||||||
80 | 40.30 | 53.54 | 68.50 | 83.78 | 99.99 | 116.79 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 95 | |||||||||||||||||
81 | 46.63 | 61.18 | 77.33 | 94.56 | 113.02 | 132.05 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 272.37 | 96 | |||||||||||||||||
82 | 53.65 | 69.60 | 87.27 | 106.64 | 127.54 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 272.37 | 288.80 | 97 | |||||||||||||||||
83 | 61.41 | 79.10 | 98.40 | 120.07 | 143.63 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 272.37 | 288.80 | 305.65 | 98 | |||||||||||||||||
84 | 72.42 | 89.77 | 110.78 | 134.94 | 156.05 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 272.37 | 288.80 | 305.65 | 322.92 | 99 | |||||||||||||||||
85 | 84.92 | 104.82 | 124.48 | 151.33 | 169.12 | 182.61 | 196.52 | 210.85 | 225.60 | 240.77 | 256.36 | 272.37 | 288.80 | 305.65 | 322.92 | 340.61 | 100 |
C-1-3 |
SCHEDULE C
US 75-80, BASIC SELECT & ULTIMATE, AGGREGATE AGE NEAREST BIRTHDAY, GENDER DISTINCT MORTALITY TABLES
PART 2 | - | FEMALE RATES |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
0 | 0.93 | 0.34 | 0.30 | 0.27 | 0.24 | 0.22 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 02.1 | 0.24 | 0.27 | 0.32 | 0.36 | 15 | |||||||||||||||||
1 | 0.34 | 0.30 | 0.27 | 0.24 | 0.22 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 02.4 | 0.27 | 0.32 | 0.36 | 0.40 | 16 | |||||||||||||||||
2 | 0.28 | 0.27 | 0.24 | 0.22 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 17 | |||||||||||||||||
3 | 0.24 | 0.24 | 0.22 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 18 | |||||||||||||||||
4 | 0.22 | 0.22 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 19 | |||||||||||||||||
5 | 0.20 | 0.20 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 20 | |||||||||||||||||
6 | 0.19 | 0.18 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 21 | |||||||||||||||||
7 | 0.17 | 0.18 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 22 | |||||||||||||||||
8 | 0.16 | 0.18 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 23 | |||||||||||||||||
9 | 0.16 | 0.19 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 24 | |||||||||||||||||
10 | 0.16 | 0.21 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 25 | |||||||||||||||||
11 | 0.17 | 0.24 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 26 | |||||||||||||||||
12 | 0.18 | 0.27 | 0.32 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 27 | |||||||||||||||||
13 | 0.21 | 0.31 | 0.35 | 0.38 | 0.42 | 0.45 | 0.47 | 0.49 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 28 | |||||||||||||||||
14 | 0.25 | 0.33 | 0.37 | 0.40 | 0.43 | 0.45 | 0.47 | 0.48 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 29 | |||||||||||||||||
15 | 0.28 | 0.35 | 0.39 | 0.41 | 0.43 | 0.45 | 0.46 | 0.48 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 0.55 | 30 | |||||||||||||||||
16 | 0.32 | 0.37 | 0.39 | 0.41 | 0.42 | 0.43 | 0.45 | 0.46 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 0.55 | 0.58 | 31 | |||||||||||||||||
17 | 0.36 | 0.37 | 0.39 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 0.55 | 0.58 | 0.61 | 32 | |||||||||||||||||
18 | 0.36 | 0.37 | 0.39 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.51 | 0.52 | 0.53 | 0.54 | 0.55 | 0.58 | 0.61 | 0.65 | 33 | |||||||||||||||||
19 | 0.36 | 0.37 | 0.39 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.50 | 0.50 | 0.54 | 0.55 | 0.58 | 0.61 | 0.65 | 0.70 | 34 | |||||||||||||||||
20 | 0.35 | 0.36 | 0.38 | 0.39 | 0.41 | 0.41 | 0.43 | 0.44 | 0.48 | 0.50 | 0.55 | 0.58 | 0.61 | 0.65 | 0.70 | 0.77 | 35 | |||||||||||||||||
21 | 0.34 | 0.36 | 0.37 | 0.39 | 0.40 | 0.41 | 0.43 | 0.44 | 0.47 | 0.49 | 0.58 | 0.61 | 0.65 | 0.70 | 0.77 | 0.84 | 36 | |||||||||||||||||
22 | 0.32 | 0.34 | 0.36 | 0.38 | 0.40 | 0.41 | 0.43 | 0.45 | 0.46 | 0.50 | 0.61 | 0.65 | 0.70 | 0.77 | 0.84 | 0.93 | 37 | |||||||||||||||||
23 | 0.32 | 0.34 | 0.37 | 0.39 | 0.41 | 0.42 | 0.45 | 0.46 | 0.50 | 0.55 | 0.65 | 0.70 | 0.77 | 0.84 | 0.93 | 1.03 | 38 | |||||||||||||||||
24 | 0.31 | 0.34 | 0.38 | 0.40 | 0.42 | 0.45 | 0.46 | 0.50 | 0.55 | 0.59 | 0.70 | 0.77 | 0.84 | 0.93 | 1.03 | 1.15 | 39 | |||||||||||||||||
25 | 0.31 | 0.35 | 0.39 | 0.41 | 0.44 | 0.46 | 0.50 | 0.55 | 0.59 | 0.63 | 0.77 | 0.84 | 0.93 | 1.03 | 1.15 | 1.29 | 40 | |||||||||||||||||
26 | 0.30 | 0.35 | 0.39 | 0.43 | 0.46 | 0.30 | 0.55 | 0.59 | 0.63 | 0.69 | 0.84 | 0.93 | 1.03 | 1.15 | 1.29 | 1.45 | 41 | |||||||||||||||||
27 | 0.30 | 0.35 | 0.41 | 0.45 | 0.50 | 0.55 | 0.59 | 0.63 | 0.66 | 0.76 | 0.93 | 1.03 | 1.15 | 1.29 | 1.45 | 1.62 | 42 | |||||||||||||||||
28 | 0.31 | 0.36 | 0.42 | 0.48 | 0.53 | 0.59 | 0.63 | 0.66 | 0.76 | 0.86 | 1.03 | 1.15 | 1.29 | 1.45 | 1.62 | 1.79 | 43 | |||||||||||||||||
29 | 0.32 | 0.37 | 0.44 | 0.51 | 0.57 | 0.63 | 0.66 | 0.76 | 0.86 | 0.97 | 1.15 | 1.29 | 1.45 | 1.62 | 1.79 | 1.96 | 44 | |||||||||||||||||
30 | 0.33 | 0.39 | 0.47 | 0.54 | 0.62 | 0.66 | 0.76 | 0.86 | 0.97 | 1.08 | 1.29 | 1.45 | 1.62 | 1.79 | 1.96 | 2.14 | 45 | |||||||||||||||||
31 | 0.35 | 0.41 | 0.50 | 0.59 | 0.66 | 0.76 | 0.86 | 0.97 | 1.08 | 1.19 | 1.45 | 1.62 | 1.79 | 1.96 | 2.14 | 2.33 | 46 | |||||||||||||||||
32 | 0.38 | 0.44 | 0.54 | 0.65 | 0.76 | 0.86 | 0.97 | 1.08 | 1.19 | 1.31 | 1.62 | 1.79 | 1.96 | 2.14 | 2.33 | 2.52 | 47 | |||||||||||||||||
33 | 0.39 | 0.46 | 0.57 | 0.69 | 0.82 | 0.93 | 1.07 | 1.19 | 1.31 | 1.48 | 1.77 | 1.94 | 2.12 | 2.33 | 2.52 | 2.72 | 48 | |||||||||||||||||
34 | 0.41 | 0.49 | 0.60 | 0.74 | 0.88 | 1.02 | 1.18 | 1.31 | 1.48 | 1.64 | 1.92 | 2.10 | 2.30 | 2.51 | 2.72 | 2.93 | 49 |
C-2-1 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
35 | 0.43 | 0.51 | 0.63 | 0.79 | 0.95 | 1.12 | 1.30 | 1.48 | 1.64 | 1.81 | 2.07 | 2.27 | 2.46 | 2.71 | 2.92 | 3.17 | 50 | |||||||||||||||||
36 | 0.45 | 0.54 | 0.67 | 0.85 | 1.04 | 1.23 | 1.43 | 1.63 | 1.81 | 2.00 | 2.23 | 2.43 | 2.64 | 2.92 | 3.16 | 3.43 | 51 | |||||||||||||||||
37 | 0.48 | 0.58 | 0.71 | 0.92 | 1.13 | 1.35 | 1.56 | 1.77 | 1.98 | 2.19 | 2.39 | 2.60 | 2.82 | 3.15 | 3.42 | 3.71 | 52 | |||||||||||||||||
38 | 0.51 | 0.64 | 0.80 | 1.04 | 1.26 | 1.49 | 1.70 | 1.92 | 2.14 | 2.35 | 2.56 | 2.78 | 3.02 | 3.38 | 3.66 | 4.04 | 53 | |||||||||||||||||
39 | 0.55 | 0.72 | 0.89 | 1.16 | 1.39 | 1.63 | 1.85 | 2.08 | 2.30 | 2.52 | 2.74 | 2.98 | 3.23 | 3.62 | 3.94 | 4.40 | 54 | |||||||||||||||||
40 | 0.60 | 0.80 | 1.00 | 1.28 | 1.52 | 1.78 | 2.01 | 2.24 | 2.46 | 2.69 | 2.94 | 3.19 | 3.46 | 3.91 | 4.25 | 4.80 | 55 | |||||||||||||||||
41 | 0.65 | 0.89 | 1.10 | 1.41 | 1.66 | 1.94 | 2.17 | 2.41 | 2.63 | 2.89 | 3.15 | 3.42 | 3.72 | 4.23 | 4.58 | 5.23 | 56 | |||||||||||||||||
42 | 0.70 | 0.98 | 1.20 | 1.54 | 1.80 | 2.10 | 2.33 | 2.58 | 2.83 | 3.10 | 3.38 | 3.69 | 4.01 | 4.57 | 4.94 | 5.70 | 57 | |||||||||||||||||
43 | 0.76 | 1.05 | 1.29 | 1.63 | 1.90 | 2.20 | 2.45 | 2.74 | 3.01 | 3.31 | 3.64 | 3.98 | 4.34 | 4.94 | 5.37 | 6.22 | 58 | |||||||||||||||||
44 | 0.81 | 1.12 | 1.39 | 1.71 | 2.00 | 2.30 | 2.59 | 2.90 | 3.21 | 3.55 | 3.92 | 4.30 | 4.69 | 5.37 | 5.85 | 6.78 | 59 | |||||||||||||||||
45 | 0.86 | 1.19 | 1.48 | 1.79 | 2.10 | 2.42 | 2.73 | 3.07 | 3.43 | 3.82 | 4.23 | 4.64 | 5.07 | 5.83 | 6.36 | 7.37 | 60 | |||||||||||||||||
46 | 0.91 | 1.26 | 1.58 | 1.86 | 2.22 | 2.53 | 2.88 | 3.28 | 3.67 | 4.11 | 4.55 | 5.01 | 5.49 | 6.32 | 6.89 | 8.00 | 61 | |||||||||||||||||
47 | 0.96 | 1.33 | 1.68 | 1.95 | 2.34 | 2.65 | 3.06 | 3.49 | 3.94 | 4.41 | 4.90 | 5.41 | 5.94 | 6.84 | 7.46 | 8.67 | 62 | |||||||||||||||||
48 | 1.00 | 1.39 | 1.76 | 2.04 | 2.45 | 2.82 | 3.27 | 3.76 | 4.20 | 4.70 | 5.23 | 5.77 | 6.31 | 7.25 | 7.88 | 9.38 | 63 | |||||||||||||||||
49 | 1.05 | 1.46 | 1.83 | 2.13 | 2.58 | 3.00 | 3.50 | 4.04 | 4.48 | 5.02 | 5.57 | 6.13 | 6.70 | 7.67 | 8.30 | 10.15 | 64 | |||||||||||||||||
50 | 1.10 | 1.53 | 1.91 | 2.24 | 2.72 | 3.20 | 3.74 | 4.35 | 4.78 | 5.34 | 5.92 | 6.50 | 7.09 | 8.09 | 8.75 | 10.99 | 65 | |||||||||||||||||
51 | 1.15 | 1.60 | 2.01 | 2.35 | 2.86 | 3.40 | 4.00 | 4.68 | 5.09 | 5.67 | 6.28 | 6.88 | 7.49 | 8.53 | 9.21 | 11.91 | 66 | |||||||||||||||||
52 | 1.20 | 1.68 | 2.10 | 2.47 | 3.01 | 3.61 | 4.28 | 5.03 | 5.40 | 6.01 | 6.64 | 7.27 | 7.91 | 9.00 | 9.70 | 12.92 | 67 | |||||||||||||||||
53 | 1.26 | 1.76 | 2.22 | 2.65 | 3.23 | 3.87 | 4.57 | 5.34 | 5.77 | 6.41 | 7.05 | 7.75 | 8.47 | 9.68 | 10.50 | 14.03 | 68 | |||||||||||||||||
54 | 1.32 | 1.85 | 2.35 | 2.84 | 3.47 | 4.15 | 4.87 | 5.65 | 6.15 | 6.81 | 7.49 | 8.26 | 9.07 | 10.43 | 11.37 | 15.25 | 69 | |||||||||||||||||
55 | 1.38 | 1.93 | 2.48 | 3.05 | 3.72 | 4.43 | 5.18 | 5.97 | 6.55 | 7.25 | 7.96 | 8.81 | 9.72 | 11.24 | 12.33 | 16.63 | 70 | |||||||||||||||||
56 | 1.45 | 2.02 | 2.62 | 3.27 | 3.97 | 4.72 | 5.50 | 6.29 | 6.97 | 7.71 | 8.46 | 9.40 | 10.43 | 12.13 | 13.41 | 18.21 | 71 | |||||||||||||||||
57 | 1.51 | 2.11 | 2.76 | 3.49 | 4.24 | 5.02 | 5.82 | 6.62 | 7.42 | 8.21 | 9.00 | 10.04 | 11.20 | 13.13 | 14.65 | 20.04 | 72 | |||||||||||||||||
58 | 1.63 | 2.29 | 2.99 | 3.76 | 4.54 | 5.34 | 6.18 | 7.03 | 7.88 | 8.71 | 9.76 | 10.86 | 12.11 | 14.18 | 15.84 | 22.17 | 73 | |||||||||||||||||
59 | 1.75 | 2.48 | 3.24 | 4.04 | 4.85 | 5.69 | 6.57 | 7.46 | 8.36 | 9.25 | 10.60 | 11.79 | 13.14 | 15.40 | 17.21 | 24.65 | 74 | |||||||||||||||||
60 | 1.88 | 2.68 | 3.50 | 4.34 | 5.18 | 6.06 | 6.98 | 7.93 | 8.89 | 9.83 | 11.55 | 12.85 | 14.33 | 16.80 | 18.78 | 27.53 | 75 | |||||||||||||||||
61 | 2.01 | 2.90 | 3.77 | 4.66 | 5.54 | 6.45 | 7.42 | 8.43 | 9.45 | 10.47 | 12.64 | 14.08 | 15.70 | 18.42 | 20.59 | 30.86 | 76 | |||||||||||||||||
62 | 2.15 | 3.12 | 4.07 | 5.01 | 5.93 | 6.88 | 7.90 | 8.97 | 10.07 | 11.19 | 13.90 | 15.50 | 17.30 | 20.28 | 22.64 | 34.96 | 77 | |||||||||||||||||
63 | 2.27 | 3.27 | 4.26 | 5.24 | 6.21 | 7.22 | 8.30 | 9.49 | 10.75 | 12.11 | 15.04 | 16.80 | 18.79 | 22.08 | 24.73 | 39.07 | 78 | |||||||||||||||||
64 | 2.40 | 3.43 | 4.46 | 5.48 | 6.50 | 7.57 | 8.75 | 10.07 | 11.53 | 13.17 | 16.34 | 18.28 | 20.47 | 20.49 | 27.05 | 44.00 | 79 | |||||||||||||||||
65 | 2.59 | 3.59 | 4.66 | 5.73 | 6.80 | 7.95 | 9.24 | 10.72 | 12.43 | 14.38 | 17.83 | 19.94 | 22.34 | 26.30 | 29.55 | 49.48 | 80 | |||||||||||||||||
66 | 2.67 | 3.76 | 4.88 | 5.99 | 7.12 | 8.37 | 9.80 | 11.47 | 13.45 | 15.78 | 19.51 | 21.81 | 24.41 | 28.69 | 32.20 | 55.51 | 81 | |||||||||||||||||
67 | 2.82 | 3.94 | 5.10 | 6.27 | 7.48 | 8.85 | 10.43 | 12.32 | 14.61 | 17.37 | 21.40 | 23.87 | 26.64 | 31.21 | 34.98 | 62.09 | 82 | |||||||||||||||||
68 | 3.06 | 4.28 | 5.56 | 6.87 | 8.23 | 9.79 | 11.60 | 13.76 | 16.38 | 19.53 | 23.87 | 26.64 | 29.96 | 34.98 | 39.13 | 69.22 | 83 | |||||||||||||||||
69 | 3.33 | 4.67 | 6.09 | 7.56 | 9.11 | 10.89 | 12.95 | 15.42 | 18A1 | 21.99 | 26.64 | 29.96 | 33.61 | 39.13 | 43.62 | 76.90 | 84 |
C-2-2 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
70 | 3.63 | 5.11 | 6.70 | 8.36 | 10.13 | 12.16 | 14.52 | 17.34 | 20.73 | 24.77 | 29.96 | 33.61 | 37.59 | 43.62 | 48.46 | 85.18 | 85 | |||||||||||||||||
71 | 5.01 | 7.70 | 10.44 | 13.52 | 16.24 | 19.36 | 24.15 | 28.95 | 35.02 | 41.07 | 47.96 | 55.76 | 64.57 | 74.44 | 85.13 | 93.91 | 86 | |||||||||||||||||
72 | 6.01 | 8.87 | 12.38 | 15.87 | 19.26 | 23.05 | 28.68 | 34.23 | 41.07 | 47.96 | 55.76 | 64.51 | 74.32 | 85.13 | 93.91 | 103.24 | 87 | |||||||||||||||||
73 | 7.20 | 10.35 | 14.68 | 18.73 | 22.84 | 27.42 | 33.97 | 40.33 | 47.96 | 55.76 | 64.51 | 74.28 | 85.13 | 93.91 | 103.24 | 113.12 | 88 | |||||||||||||||||
74 | 8.63 | 12.39 | 17.32 | 22.10 | 27.06 | 32.52 | 40.08 | 47.30 | 55.76 | 64.51 | 74.28 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 89 | |||||||||||||||||
75 | 10.32 | 14.81 | 20.43 | 26.07 | 31.97 | 38.41 | 47.07 | 55.20 | 64.51 | 74.28 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 90 | |||||||||||||||||
76 | 12.34 | 17.69 | 24.09 | 30.69 | 37.65 | 45.16 | 55.01 | 64.10 | 74.28 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 91 | |||||||||||||||||
77 | 14.74 | 20.71 | 28.36 | 36.01 | 44.13 | 52.83 | 63.96 | 74.06 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 92 | |||||||||||||||||
78 | 17.58 | 24.64 | 33.26 | 42.08 | 51.48 | 61.48 | 73.98 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 93 | |||||||||||||||||
79 | 21.12 | 29.19 | 38.86 | 48.95 | 59.76 | 71.17 | 85.13 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 94 | |||||||||||||||||
80 | 25.23 | 32.42 | 45.19 | 56.66 | 69.02 | 81.96 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 95 | |||||||||||||||||
81 | 29.98 | 40.36 | 52.30 | 65.27 | 79.31 | 93.91 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 211.96 | 96 | |||||||||||||||||
82 | 35.39 | 47.07 | 60.24 | 74.83 | 90.70 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 211.96 | 226.79 | 97 | |||||||||||||||||
83 | 41.53 | 54.60 | 69.05 | 85.39 | 103.24 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 211.96 | 226.79 | 242.17 | 98 | |||||||||||||||||
84 | 49.99 | 63.00 | 78.78 | 97.00 | 113.12 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 211.96 | 226.79 | 242.17 | 258.10 | 99 | |||||||||||||||||
85 | 59.59 | 74.19 | 89.47 | 109.70 | 123.55 | 134.53 | 146.06 | 158.14 | 170.77 | 183.95 | 197.68 | 211.96 | 226.79 | 242.17 | 258.10 | 274.58 | 100 |
C-2-3 |
SCHEDULE
D
US 75-80, BASIC SELECT & ULTIMATE, AGGREGATE AGE LAST BIRTHDAY, GENDER DISTINCT MORTALITY TABLES
PART 1 | - | MALE RATES |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Last Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
0 | 1.12 | 0.70 | 0.47 | 0.37 | 0.32 | 0.31 | 0.28 | 0.27 | 0.27 | 0.28 | 0.33 | 0.38 | 0.46 | 0.66 | 0.85 | 0.85 | 15 | |||||||||||||||||
1 | 0.46 | 0.43 | 0.38 | 0.27 | 0.23 | 0.23 | 0.23 | 0.25 | 0.28 | 0.33 | 0.38 | 0.46 | 0.66 | 0.80 | 1.08 | 1.08 | 16 | |||||||||||||||||
2 | 0.34 | 0.35 | 0.31 | 0.23 | 0.23 | 0.23 | 0.25 | 0.28 | 0.33 | 0.38 | 0.46 | 0.62 | 0.80 | 1.04 | 1.18 | 1.18 | 17 | |||||||||||||||||
3 | 0.33 | 0.28 | 0.25 | 0.23 | 0.21 | 0.25 | 0.28 | 0.33 | 0.38 | 0.46 | 0.61 | 0.74 | 1.04 | 1.17 | 1.27 | 1.27 | 18 | |||||||||||||||||
4 | 0.28 | 0.24 | 0.23 | 0.21 | 0.25 | 0.28 | 0.33 | 0.38 | 0.44 | 0.61 | 0.74 | 0.95 | 1.11 | 1.26 | 1.34 | 1.34 | 19 | |||||||||||||||||
5 | 0.23 | 0.23 | 0.23 | 0.25 | 0.28 | 0.33 | 0.38 | 0.43 | 0.61 | 0.74 | 0.95 | 1.08 | 1.17 | 1.32 | 1.39 | 1.39 | 20 | |||||||||||||||||
6 | 0.22 | 0.22 | 0.21 | 0.28 | 0.33 | 0.38 | 0.43 | 0.58 | 0.74 | 0.95 | 1.08 | 1.15 | 1.21 | 1.36 | 1.41 | 1.41 | 21 | |||||||||||||||||
7 | 0.19 | 0.21 | 0.25 | 0.33 | 0.38 | 0.43 | 0.57 | 0.72 | 0.91 | 1.08 | 1.15 | 1.20 | 1.23 | 1.38 | 1.41 | 1.41 | 22 | |||||||||||||||||
8 | 0.19 | 0.21 | 0.26 | 0.37 | 0.43 | 0.57 | 0.72 | 0.91 | 1.06 | 1.15 | 1.20 | 1.23 | 1.28 | 1.37 | 1.39 | 1.39 | 23 | |||||||||||||||||
9 | 0.20 | 0.23 | 0.30 | 0.43 | 0.57 | 0.72 | 0.91 | 1.06 | 1.14 | 1.20 | 1.23 | 1.28 | 1.32 | 1.34 | 1.36 | 1.36 | 24 | |||||||||||||||||
10 | 0.21 | 0.27 | 0.34 | 0.57 | 0.72 | 0.91 | 1.06 | 1.14 | 1.19 | 1.23 | 1.28 | 1.32 | 1.33 | 1.30 | 1.32 | 1.32 | 25 | |||||||||||||||||
11 | 0.26 | 0.32 | 0.40 | 0.72 | 0.91 | 1.06 | 1.14 | 1.19 | 1.23 | 1.28 | 1.32 | 1.33 | 1.28 | 1.25 | 1.27 | 1.27 | 26 | |||||||||||||||||
12 | 0.31 | 0.40 | 0.57 | 0.90 | 1.06 | 1.14 | 1.19 | 1.22 | 1.28 | 1.32 | 1.33 | 1.28 | 1.23 | 1.19 | 1.22 | 1.22 | 27 | |||||||||||||||||
13 | 0.38 | 0.57 | 0.72 | 1.02 | 1.12 | 1.18 | 1.21 | 1.22 | 1.26 | 1.28 | 1.28 | 1.23 | 1.18 | 1.15 | 1.19 | 1.19 | 28 | |||||||||||||||||
14 | 0.55 | 0.72 | 0.90 | 1.08 | 1.16 | 1.20 | 1.21 | 1.20 | 1.22 | 1.22 | 1.22 | 1.17 | 1.14 | 1.13 | 1.16 | 1.16 | 29 | |||||||||||||||||
15 | 0.72 | 0.90 | 1.02 | 1.13 | 1.17 | 1.20 | 1.19 | 1.17 | 1.17 | 1.16 | 1.16 | 1.12 | 1.11 | 1.11 | 1.13 | 1.13 | 30 | |||||||||||||||||
16 | 0.90 | 1.02 | 1.08 | 1.17 | 1.17 | 1.18 | 1.15 | 1.13 | 1.11 | 1.10 | 1.09 | 1.08 | 1.09 | 1.09 | 1.12 | 1.12 | 31 | |||||||||||||||||
17 | 1.02 | 1.08 | 1.13 | 1.16 | 1.14 | 1.14 | 1.11 | 1.08 | 1.05 | 1.03 | 1.05 | 1.04 | 1.06 | 1.09 | 1.12 | 1.12 | 32 | |||||||||||||||||
18 | 1.01 | 1.06 | 1.09 | 1.10 | 1.07 | 1.07 | 1.04 | 1.01 | 0.99 | 0.99 | 1.01 | 1.00 | 1.04 | 1.09 | 1.13 | 1.13 | 33 | |||||||||||||||||
19 | 0.97 | 1.01 | 1.02 | 1.02 | 1.00 | 0.99 | 0.96 | 0.95 | 0.95 | 0.96 | 0.97 | 0.98 | 1.03 | 1.09 | 1.16 | 1.16 | 34 | |||||||||||||||||
20 | 0.91 | 0.94 | 0.94 | 0.94 | 0.93 | 0.91 | 0.89 | 0.90 | 0.91 | 0.93 | 0.95 | 0.98 | 1.03 | 1.12 | 1.20 | 1.20 | 35 | |||||||||||||||||
21 | 0.83 | 0.85 | 0.85 | 0.86 | 0.85 | 0.83 | 0.86 | 0.86 | 0.87 | 0.91 | 0.94 | 0.97 | 1.05 | 1.16 | 1.25 | 1.25 | 36 | |||||||||||||||||
22 | 0.73 | 0.75 | 0.75 | 0.77 | 0.77 | 0.77 | 0.78 | 0.81 | 0.85 | 0.90 | 0.94 | 0.99 | 1.08 | 1.20 | 1.32 | 1.32 | 37 | |||||||||||||||||
23 | 0.73 | 0.74 | 0.74 | 0.76 | 0.77 | 0.77 | 0.78 | 0.82 | 0.87 | 0.92 | 0.98 | 1.04 | 1.14 | 1.27 | 1.41 | 1.41 | 38 | |||||||||||||||||
24 | 0.73 | 0.73 | 0.73 | 0.76 | 0.77 | 0.78 | 0.80 | 0.84 | 0.90 | 0.96 | 1.03 | 1.10 | 1.22 | 1.36 | 1.51 | 1.51 | 39 | |||||||||||||||||
25 | 0.71 | 0.71 | 0.72 | 0.75 | 0.77 | 0.80 | 0.82 | 0.87 | 0.95 | 1.01 | 1.09 | 1.18 | 1.33 | 1.47 | 1.63 | 1.63 | 40 | |||||||||||||||||
26 | 0.70 | 0.69 | 0.71 | 0.75 | 0.78 | 0.82 | 0.85 | 0.92 | 1.00 | 1.07 | 1.16 | 1.29 | 1.44 | 1.59 | 1.79 | 1.79 | 41 | |||||||||||||||||
27 | 0.68 | 0.68 | 0.71 | 0.76 | 0.80 | 0.85 | 0.90 | 0.97 | 1.07 | 1.15 | 1.26 | 1.40 | 1.58 | 1.75 | 1.97 | 1.97 | 42 | |||||||||||||||||
28 | 0.66 | 0.68 | 0.72 | 0.80 | 0.84 | 0.90 | 0.97 | 1.06 | 1.15 | 1.26 | 1.38 | 1.53 | 1.74 | 1.94 | 2.19 | 2.19 | 43 | |||||||||||||||||
29 | 0.65 | 0.68 | 0.75 | 0.84 | 0.90 | 0.97 | 1.06 | 1.15 | 1.26 | 1.38 | 1.52 | 1.70 | 1.94 | 2.17 | 2.45 | 2.45 | 44 | |||||||||||||||||
30 | 0.63 | 0.68 | 0.78 | 0.90 | 0.97 | 1.06 | 1.15 | 1.25 | 1.38 | 1.52 | 1.70 | 1.94 | 2.17 | 2.42 | 2.74 | 2.74 | 45 | |||||||||||||||||
31 | 0.63 | 0.70 | 0.82 | 0.97 | 1.06 | 1.15 | 1.25 | 1.38 | 1.52 | 1.70 | 1.94 | 2.17 | 2.42 | 2.71 | 3.07 | 3.07 | 46 | |||||||||||||||||
32 | 0.63 | 0.72 | 0.87 | 1.06 | 1.15 | 1.25 | 1.38 | 1.51 | 1.70 | 1.94 | 2.17 | 2.42 | 2.71 | 3.03 | 3.43 | 3.43 | 47 | |||||||||||||||||
33 | 0.63 | 0.74 | 0.91 | 1.14 | 1.25 | 1.36 | 1.50 | 1.67 | 1.87 | 2.14 | 2.41 | 2.69 | 3.03 | 3.39 | 3.82 | 3.82 | 48 | |||||||||||||||||
34 | 0.64 | 0.76 | 0.96 | 1.24 | 1.36 | 1.49 | 1.66 | 1.86 | 2.10 | 2.37 | 2.67 | 3.00 | 3.38 | 3.77 | 4.24 | 4.24 | 49 |
D-1-1 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Last Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
35 | 0.65 | 0.79 | 1.03 | 1.20 | 1.35 | 1.49 | 1.66 | 1.86 | 2.10 | 2.33 | 2.63 | 2.96 | 3.34 | 3.75 | 4.19 | 4.69 | 50 | |||||||||||||||||
36 | 0.67 | 0.83 | 1.12 | 1.31 | 1.49 | 1.66 | 1.86 | 2.10 | 2.33 | 2.63 | 2.92 | 3.28 | 3.70 | 4.16 | 4.63 | 5.18 | 51 | |||||||||||||||||
37 | 0.70 | 0.88 | 1.21 | 1.44 | 1.66 | 1.86 | 2.10 | 2.33 | 2.63 | 2.92 | 3.23 | 3.62 | 4.09 | 4.59 | 5.12 | 5.72 | 52 | |||||||||||||||||
38 | 0.74 | 0.94 | 1.29 | 1.55 | 1.78 | 2.01 | 2.27 | 2.52 | 2.84 | 3.16 | 3.52 | 3.96 | 4.49 | 5.06 | 5.64 | 6.31 | 53 | |||||||||||||||||
39 | 0.78 | 1.00 | 1.40 | 1.68 | 1.93 | 2.18 | 2.45 | 2.72 | 3.06 | 3.41 | 3.82 | 4.31 | 4.92 | 5.37 | 6.22 | 6.94 | 54 | |||||||||||||||||
40 | 0.83 | 1.09 | 1.53 | 1.83 | 2.11 | 2.36 | 2.65 | 2.93 | 3.27 | 3.67 | 4.12 | 4.69 | 5.39 | 6.13 | 6.82 | 7.64 | 55 | |||||||||||||||||
41 | 0.89 | 1.20 | 1.68 | 2.01 | 2.29 | 2.56 | 2.86 | 3.14 | 3.49 | 3.92 | 4.45 | 5.09 | 5.90 | 6.72 | 7.50 | 8.42 | 56 | |||||||||||||||||
42 | 0.97 | 1.32 | 1.86 | 2.21 | 2.50 | 2.77 | 3.06 | 3.35 | 3.70 | 4.18 | 4.79 | 5.53 | 6.44 | 7.38 | 8.25 | 9.28 | 57 | |||||||||||||||||
43 | 1.05 | 1.46 | 2.02 | 2.41 | 2.74 | 3.04 | 3.35 | 3.66 | 4.03 | 4.55 | 5.21 | 5.99 | 6.96 | 7.97 | 8.93 | 10.24 | 58 | |||||||||||||||||
44 | 1.14 | 1.62 | 2.20 | 2.63 | 2.98 | 3.32 | 3.66 | 3.98 | 4.39 | 4.94 | 5.66 | 6.30 | 7.54 | 8.60 | 9.67 | 11.32 | 59 | |||||||||||||||||
45 | 1.23 | 1.81 | 2.39 | 2.85 | 3.24 | 3.61 | 3.98 | 4.34 | 4.77 | 5.35 | 6.15 | 7.06 | 8.16 | 9.30 | 10.49 | 12..53 | 60 | |||||||||||||||||
46 | 1.33 | 2.00 | 2.58 | 3.08 | 3.51 | 3.92 | 4.34 | 4.73 | 5.17 | 5.80 | 6.68 | 7.66 | 8.83 | 10.06 | 11.39 | 13.87 | 61 | |||||||||||||||||
47 | 1.44 | 2.21 | 2.77 | 3.31 | 3.79 | 4.26 | 4.73 | 5.12 | 5.61 | 6.29 | 7.26 | 8.32 | 9.58 | 10.89 | 12.36 | 15.32 | 62 | |||||||||||||||||
48 | 1.55 | 2.32 | 2.90 | 3.48 | 4.02 | 4.53 | 5.06 | 5.54 | 6.13 | 6.89 | 8.04 | 9.23 | 10.57 | 11.94 | 13.41 | 16.89 | 63 | |||||||||||||||||
49 | 1.66 | 2.42 | 3.03 | 3.64 | 4.24 | 4.81 | 5.41 | 5.99 | 6.69 | 7.55 | 8.91 | 10.26 | 11.67 | 13.06 | 14.53 | 18.61 | 64 | |||||||||||||||||
50 | 1.77 | 2.51 | 3.15 | 3.80 | 4.46 | 5.09 | 5.78 | 6.48 | 7.31 | 8.30 | 9.90 | 11.41 | 12.85 | 14.25 | 15.72 | 20.49 | 65 | |||||||||||||||||
51 | 1.88 | 2.59 | 3.26 | 3.94 | 4.69 | 5.39 | 6.18 | 7.02 | 8.01 | 9.13 | 10.99 | 12.65 | 14.12 | 15.54 | 16.98 | 22.56 | 66 | |||||||||||||||||
52 | 1.99 | 2.66 | 3.35 | 4.08 | 4.92 | 5.70 | 6.60 | 7.61 | 8.78 | 10.04 | 12.18 | 14.00 | 15.51 | 16.94 | 18.35 | 24.85 | 67 | |||||||||||||||||
53 | 2.15 | 2.89 | 3.66 | 4.47 | 5.38 | 6.22 | 7.22 | 8.32 | 9.57 | 10.98 | 13.29 | 15.31 | 16.94 | 18.35 | 20.53 | 27.37 | 68 | |||||||||||||||||
54 | 2.31 | 3.13 | 4.00 | 4.90 | 5.89 | 6.81 | 7.90 | 9.09 | 10.42 | 11.98 | 14.48 | 16.73 | 18.35 | 20.53 | 22.96 | 30.13 | 69 | |||||||||||||||||
55 | 2.49 | 3.40 | 4.37 | 5.37 | 6.47 | 7.46 | 8.65 | 9.91 | 11.31 | 13.06 | 15.77 | 18.29 | 20.53 | 22.85 | 25.67 | 33.13 | 70 | |||||||||||||||||
56 | 2.68 | 3.70 | 4.78 | 5.91 | 7.10 | 8.16 | 9.44 | 10.78 | 12.26 | 14.23 | 17.18 | 19.99 | 22.70 | 25.23 | 28.65 | 36.34 | 71 | |||||||||||||||||
57 | 2.89 | 4.02 | 5.24 | 6.50 | 7.80 | 8.92 | 10.29 | 11.72 | 13.29 | 15.50 | 18.71 | 21.85 | 24.96 | 27.83 | 31.89 | 39.80 | 72 | |||||||||||||||||
58 | 3.05 | 4.30 | 5.78 | 7.12 | 8.58 | 9.62 | 11.05 | 12.58 | 14.24 | 16.56 | 19.88 | 23.10 | 26.39 | 29.47 | 33.93 | 43.57 | 73 | |||||||||||||||||
59 | 3.22 | 4.60 | 6.37 | 7.78 | 9.42 | 10.36 | 11.84 | 13.48 | 15.26 | 17.68 | 21.09 | 24.35 | 27.80 | 31.11 | 36.05 | 47.72 | 74 | |||||||||||||||||
60 | 3.40 | 4.91 | 7.01 | 8.49 | 10.34 | 11.15 | 12.69 | 14.45 | 16.34 | 18.85 | 22.31 | 25.55 | 29.18 | 32.79 | 38.29 | 52.31 | 75 | |||||||||||||||||
61 | 3.57 | 5.22 | 7.69 | 9.25 | 11.15 | 12.44 | 13.59 | 15.48 | 17.47 | 20.04 | 23.51 | 26.72 | 30.56 | 34.52 | 40.66 | 57.37 | 76 | |||||||||||||||||
62 | 3.74 | 5.54 | 8.44 | 10.07 | 12.44 | 12.89 | 14.54 | 16.56 | 18.64 | 21.24 | 24.70 | 27.87 | 31.96 | 36.31 | 43.15 | 62.94 | 77 | |||||||||||||||||
63 | 4.15 | 6.18 | 9.21 | 11.19 | 12.89 | 14.50 | 16.42 | 18.63 | 21.03 | 23.56 | 27.15 | 30.60 | 35.16 | 40.29 | 47.22 | 69.02 | 78 | |||||||||||||||||
64 | 4.59 | 6.88 | 10.04 | 12.43 | 14.50 | 16.29 | 18.52 | 20.91 | 23.56 | 26.17 | 29.85 | 33.67 | 38.70 | 44.72 | 51.64 | 75.60 | 79 | |||||||||||||||||
65 | 5.08 | 7.66 | 10.96 | 13.82 | 16.29 | 18.27 | 20.82 | 23.41 | 26.17 | 29.29 | 33.67 | 36.95 | 42.60 | 49.60 | 56.42 | 82.69 | 80 | |||||||||||||||||
66 | 5.63 | 8.53 | 11.96 | 15.34 | 18.27 | 20.62 | 23.35 | 26.17 | 29.29 | 33.67 | 36.18 | 40.63 | 46.88 | 54.95 | 61.55 | 90.24 | 81 | |||||||||||||||||
67 | 6.23 | 9.50 | 13.04 | 17.02 | 20.62 | 22.82 | 26.17 | 29.29 | 33.67 | 35.69 | 39.85 | 44.66 | 51.53 | 60.78 | 66.99 | 98.24 | 82 | |||||||||||||||||
68 | 6.86 | 10.46 | 14.34 | 18.67 | 22.58 | 24.98 | 28.66 | 32.11 | 35.69 | 39.16 | 43.70 | 48.92 | 56.36 | 66.33 | 72.93 | 106.88 | 83 | |||||||||||||||||
69 | 7.55 | 11.50 | 15.73 | 20.45 | 24.72 | 27.36 | 31.42 | 35.21 | 39.16 | 42.94 | 47.87 | 53.51 | 61.51 | 72.21 | 79.34 | 116.36 | 84 |
D-1-2 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Male Aggregate | Age Last Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
70 | 8.31 | 12.61 | 17.23 | 22.38 | 27.08 | 29.99 | 34.46 | 38.63 | 42.94 | 47.03 | 52.35 | 58.39 | 66.96 | 78.56 | 86.38 | 126.68 | 85 | |||||||||||||||||
71 | 10.47 | 15.62 | 21.23 | 26.87 | 31.79 | 37.10 | 45.06 | 52.48 | 61.52 | 70.10 | 79.36 | 89.95 | 101.57 | 114.38 | 126.68 | 137.84 | 86 | |||||||||||||||||
72 | 12.46 | 17.88 | 24.74 | 30.99 | 36.83 | 43.05 | 52.03 | 60.28 | 70.10 | 79.56 | 89.95 | 101.50 | 114.49 | 126.68 | 137.84 | 149.84 | 87 | |||||||||||||||||
73 | 14.73 | 20.79 | 28.66 | 35.72 | 42.56 | 49.78 | 59.87 | 68.99 | 79.56 | 89.95 | 101.50 | 114.47 | 126.68 | 137.84 | 149.84 | 162.59 | 88 | |||||||||||||||||
74 | 17.32 | 24.36 | 33.02 | 41.10 | 49.03 | 57.35 | 68.62 | 78.63 | 89.95 | 101.50 | 114.47 | 126.68 | 137.84 | 149.84 | 162.59 | 175.87 | 89 | |||||||||||||||||
75 | 20.30 | 28.44 | 37.98 | 47.15 | 56.29 | 65.81 | 78.31 | 89.23 | 101.50 | 114.47 | 126.68 | 137.84 | 149.84 | 162.59 | 175.87 | 18937 | 90 | |||||||||||||||||
76 | 23.70 | 32.76 | 43.56 | 53.93 | 64.39 | 75.18 | 88.98 | 101.03 | 114.47 | 126.68 | 137.84 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 91 | |||||||||||||||||
77 | 27.57 | 37.66 | 49.82 | 61.49 | 73.35 | 85.50 | 100.87 | 114.30 | 126.68 | 137.84 | 149.84 | 16239 | 175.87 | 189.57 | 203.69 | 218.23 | 92 | |||||||||||||||||
78 | 32.14 | 43.52 | 56.79 | 69.83 | 83.20 | 97.00 | 114.24 | 126.68 | 137.84 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 93 | |||||||||||||||||
79 | 37.47 | 50.08 | 64.48 | 78.99 | 94.18 | 109.95 | 126.68 | 137.84 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 94 | |||||||||||||||||
80 | 43.47 | 57.36 | 72.91 | 89.17 | 106.51 | 124.42 | 137.84 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 95 | |||||||||||||||||
81 | 50.14 | 65.39 | 82.30 | 100.60 | 120.28 | 137.84 | 149:84 | 16239 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 280.59 | 96 | |||||||||||||||||
82 | 57.53 | 74.35 | 92.83 | 113.35 | 135.58 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 280.59 | 297.23 | 97 | |||||||||||||||||
83 | 66.91 | 84.44 | 104.59 | 127.51 | 149.84 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 280.39 | 297.23 | 314.29 | 98 | |||||||||||||||||
84 | 78.67 | 97.04 | 117.63 | 143.14 | 162.59 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 280.59 | 297.23 | 314.29 | 331.77 | 99 | |||||||||||||||||
85 | 91.98 | 111.05 | 132.03 | 160.23 | 175.87 | 189.57 | 203.69 | 218.23 | 233.19 | 248.57 | 264.37 | 280.59 | 297.23 | 314.29 | 331.77 | 349.67 | 100 |
D-1-3 |
SCHEDULE D
US 75-80, BASIC SELECT & ULTIMATE,
AGGREGATE AGE LAST BIRTHDAY,
GENDER DISTINCT MORTALITY TABLES
PART 2 | - | FEMALE RATES |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
0 | 0.84 | 0.33 | 0.30 | 0.27 | 0.24 | 0.22 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 15 | |||||||||||||||||
1 | 0.32 | 0.29 | 0.26 | 0.23 | 0.22 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.42 | 16 | |||||||||||||||||
2 | 0.27 | 0.26 | 0.23 | 0.22 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.42 | 0.46 | 17 | |||||||||||||||||
3 | 0.23 | 0.23 | 0.22 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 18 | |||||||||||||||||
4 | 0.21 | 0.21 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 0.50 | 19 | |||||||||||||||||
5 | 0.20 | 0.20 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 0.49 | 0.52 | 20 | |||||||||||||||||
6 | 0.18 | 0.18 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 0.49 | 0.51 | 0.53 | 21 | |||||||||||||||||
7 | 0.17 | 0.19 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.48 | 0.49 | 0.51 | 0.52 | 0.53 | 22 | |||||||||||||||||
8 | 0.17 | 0.19 | 0.21 | 0.23 | 0.26 | 0.29 | 0.34 | 0.38 | 0.41 | 0.45 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 23 | |||||||||||||||||
9 | 0.17 | 0.21 | 0.23 | 0.25 | 0.28 | 0.33 | 0.38 | 0.41 | 0.45 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 24 | |||||||||||||||||
10 | 0.18 | 0.23 | 0.25 | 0.28 | 0.33 | 0.37 | 0.41 | 0.45 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 25 | |||||||||||||||||
11 | 0.18 | 0.25 | 0.28 | 0.33 | 0.37 | 0.41 | 0.45 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 26 | |||||||||||||||||
12 | 0.20 | 0.28 | 0.33 | 0.36 | 0.40 | 0.44 | 0.47 | 0.49 | 0.51 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 0.53 | 27 | |||||||||||||||||
13 | 0.22 | 0.32 | 0.35 | 0.38 | 0.42 | 0.44 | 0.47 | 0.49 | 0.52 | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 | 0.54 | 0.54 | 28 | |||||||||||||||||
14 | 0.26 | 0.34 | 0.38 | 0.40 | 0.42 | 0.45 | 0.47 | 0.49 | 0.52 | 0.52 | 0.53 | 0.53 | 0.53 | 0.54 | 0.54 | 0.55 | 29 | |||||||||||||||||
15 | 0.30 | 0.36 | 0.39 | 0.40 | 0.42 | 0.45 | 0.47 | 0.47 | 0.52 | 0.53 | 0.53 | 0.53 | 0.34 | 0.54 | 0.56 | 0.57 | 30 | |||||||||||||||||
16 | 0.33 | 0.37 | 0.39 | 0.40 | 0.42 | 0.44 | 0.45 | 0.46 | 0.32 | 0.53 | 0.53 | 0.54 | 0.54 | 0.56 | 0.57 | 0.60 | 31 | |||||||||||||||||
17 | 0.36 | 0.37 | 0.39 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.52 | 0.53 | 0.54 | 0.54 | 0.56 | 0.57 | 0.61 | 0.63 | 32 | |||||||||||||||||
18 | 0.36 | 0.37 | 0.40 | 0.40 | 0.41 | 0.42 | 0.43 | 0.44 | 0.51 | 0.52 | 0.54 | 0.55 | 0.57 | 0.60 | 0.64 | 0.68 | 33 | |||||||||||||||||
19 | 0.36 | 0.37 | 0.40 | 0.40 | 0.41 | 0.42 | 0.43 | 0.45 | 0.49 | 0.51 | 0.55 | 0.57 | 0.60 | 0.64 | 0.69 | 0.74 | 34 | |||||||||||||||||
20 | 0.35 | 0.37 | 0.39 | 0.40 | 0.41 | 0.42 | 0.44 | 0.45 | 0.48 | 0.51 | 0.57 | 0.60 | 0.64 | 0.69 | 0.75 | 0.81 | 35 | |||||||||||||||||
21 | 0.34 | 0.35 | 0.38 | 0.39 | 0.41 | 0.42 | 0.44 | 0.46 | 0.48 | 0.52 | 0.60 | 0.64 | 0.69 | 0.75 | 0.82 | 0.89 | 36 | |||||||||||||||||
22 | 0.32 | 0.34 | 0.37 | 0.39 | 0.41 | 0.42 | 0.45 | 0.47 | 0.48 | 0.53 | 0.64 | 0.69 | 0.75 | 0.82 | 0.90 | 0.98 | 37 | |||||||||||||||||
23 | 0.32 | 0.34 | 0.38 | 0.40 | 0.42 | 0.44 | 0.47 | 0.48 | 0.53 | 0.58 | 0.69 | 0.75 | 0.82 | 0.90 | 1.00 | 1.09 | 38 | |||||||||||||||||
24 | 0.32 | 0.35 | 0.38 | 0.41 | 0.44 | 0.46 | 0.48 | 0.53 | 0.58 | 0.63 | 0.75 | 0.82 | 0.90 | 1.00 | 1.11 | 1.22 | 39 | |||||||||||||||||
25 | 0.31 | 0.35 | 0.39 | 0.43 | 0.46 | 0.48 | 0.53 | 0.58 | 0.63 | 0.68 | 0.82 | 0.90 | 1.00 | 1.11 | 1.23 | 1.37 | 40 | |||||||||||||||||
26 | 0.31 | 0.35 | 0.41 | 0.44 | 0.48 | 0.53 | 0.58 | 0.63 | 0.68 | 0.74 | 0.90 | 1.00 | 1.11 | 1.23 | 1.38 | 1.34 | 41 | |||||||||||||||||
27 | 0.31 | 0.36 | 0.42 | 0.47 | 0.53 | 0.58 | 0.63 | 0.68 | 0.71 | 0.82 | 1.00 | 1.11 | 1.23 | 1.38 | 1.54 | 1.71 | 42 | |||||||||||||||||
28 | 0.32 | 0.37 | 0.43 | 0.50 | 0.56 | 0.63 | 0.68 | 0.71 | 0.80 | 0.91 | 1.11 | 1.23 | 1.38 | 1.34 | 1.71 | 1.88 | 43 | |||||||||||||||||
29 | 0.33 | 0.38 | 0.46 | 0.52 | 0.60 | 0.68 | 0.71 | 0.80 | 0.91 | 1.03 | 1.23 | 1.38 | 1.54 | 1.71 | 1.88 | 2.05 | 44 | |||||||||||||||||
30 | 0.35 | 0.40 | 0.48 | 0.57 | 0.66 | 0.71 | 0.80 | 0.91 | 1.03 | 1.15 | 1.38 | 1.54 | 1.71 | 1.88 | 2.05 | 2.24 | 45 | |||||||||||||||||
31 | 0.37 | 0.42 | 0.52 | 0.62 | 0.71 | 0.80 | 0.91 | 1.03 | 1.15 | 1.27 | 1.54 | 1.71 | 1.88 | 2.05 | 2.24 | 2.43 | 46 | |||||||||||||||||
32 | 0.39 | 0.45 | 0.56 | 0.68 | 0.80 | 0.91 | 1.03 | 1.15 | 1.27 | 1.40 | 1.70 | 1.87 | 2.05 | 2.24 | 2.44 | 2.62 | 47 | |||||||||||||||||
33 | 0.41 | 0.48 | 0.59 | 0.73 | 0.86 | 0.99 | 1.14 | 1.27 | 1.40 | 1.56 | 1.85 | 2.02 | 2.22 | 2.43 | 2.62 | 2.83 | 48 | |||||||||||||||||
34 | 0.43 | 0.51 | 0.63 | 0.77 | 0.93 | 1.09 | 1.25 | 1.40 | 1.56 | 1.73 | 2.00 | 2.19 | 2.39 | 2.62 | 2.83 | 3.05 | 49 |
D-2-1 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
35 | 0.45 | 0.54 | 0.66 | 0.83 | 1.01 | 1.20 | 1.39 | 1.56 | 1.73 | 1.90 | 2.17 | 2.36 | 2.36 | 2.82 | 3.05 | 3.30 | 50 | |||||||||||||||||
36 | 0.47 | 0.58 | 0.71 | 0.90 | 1.10 | 1.32 | 1.52 | 1.71 | 1.90 | 2.09 | 2.33 | 2.53 | 2.75 | 3.04 | 3.30 | 3.57 | 5I | |||||||||||||||||
37 | 0.50 | 0.62 | 0.76 | 0.98 | 1.20 | 1.43 | 1.64 | 1.85 | 2.07 | 2.28 | 2.49 | 2.71 | 2.94 | 3.29 | 3.57 | 3.88 | 52 | |||||||||||||||||
38 | 0.54 | 0.69 | 0:85 | 1.10 | 1.33 | 1.57 | 1.78 | 2.01 | 2.23 | 2.44 | 2.67 | 2.89 | 3.15 | 3.53 | 3.84 | 4.22 | 53 | |||||||||||||||||
39 | 0.58 | 0.76 | 0.95 | 1.22 | 1.45 | 1.70 | 1.93 | 2.17 | 2.39 | 2.62 | 2.85 | 3.10 | 3.37 | 3.80 | 4.13 | 4.60 | 54 | |||||||||||||||||
40 | 0.63 | 0.85 | 1.05 | 1.33 | 1.58 | 1.86 | 2.08 | 2.32 | 2.56 | 2.80 | 3.06 | 3.33 | 3.62 | 4.10 | 4.46 | 5.02 | 55 | |||||||||||||||||
41 | 0.68 | 0.94 | 1.15 | 1.45 | 1.71 | 2.01 | 2.23 | 2.49 | 2.74 | 3.01 | 3.28 | 3.58 | 3.90 | 4.44 | 4.81 | 5.47 | 56 | |||||||||||||||||
42 | 0.73 | 1.02 | 1.25 | 1.58 | 1.85 | 2.16 | 2.40 | 2.67 | 2.94 | 3.23 | 3.53 | 3.86 | 4.20 | 4.80 | 5.19 | 5.96 | 57 | |||||||||||||||||
43 | 0.78 | 1.09 | 1.35 | 1.67 | 1.95 | 2.27 | 2.53 | 2.83 | 1.13 | 3.46 | 3.79 | 4.16 | 4.54 | 5.19 | 5.62 | 6.50 | 58 | |||||||||||||||||
44 | 0.83 | 1.16 | 1.44 | 1.74 | 2.26 | 2.37 | 2.67 | 3.01 | 3.34 | 3.70 | 4.08 | 4.49 | 4.89 | 5.61 | 6.09 | 7.08 | 59 | |||||||||||||||||
45 | 0.89 | 1.23 | 1.53 | 1.83 | 2.16 | 2.49 | 2.83 | 3.20 | 3.57 | 3.97 | 4.39 | 4.83 | 5.28 | 6.07 | 6.60 | 7.69 | 60 | |||||||||||||||||
46 | 0.93 | 1.30 | 1.62 | 1.91 | 2.28 | 2.61 | 3.00 | 3.41 | 3.82 | 4.26 | 4.72 | 5.20 | 5.70 | 6.55 | 7.12 | 8.34 | 61 | |||||||||||||||||
47 | 0.98 | 1.37 | 1.72 | 2.00 | 2.41 | 2.75 | 3.18 | 3.64 | 4.09 | 4.57 | 5.07 | 5.60 | 6.14 | 7.06 | 7.68 | 9.03 | 62 | |||||||||||||||||
48 | 1.03 | 1.43 | 1.80 | 2.10 | 2.54 | 2.92 | 3.40 | 3.91 | 4.36 | 4.87 | 5.41 | 5.97 | 6.53 | 7.50 | 8.14 | 9.77 | 63 | |||||||||||||||||
49 | 1.07 | 1.50 | 1.88 | 2.21 | 2.68 | 3.11 | 3.64 | 4.20 | 4.65 | 5.20 | 5.77 | 6.35 | 6.94 | 7.94 | 8.61 | 10.57 | 64 | |||||||||||||||||
50 | 1.12 | 1.56 | 1.97 | 2.32 | 2.82 | 3.32 | 3.89 | 4.51 | 4.96 | 5.54 | 6.13 | 6.74 | 7.36 | 8.41 | 9.10 | 11.45 | 65 | |||||||||||||||||
51 | 1.17 | 1.64 | 2.07 | 2.44 | 2.98 | 3.53 | 4.15 | 4.84 | 5.28 | 5.88 | 6.50 | 7.14 | 7.79 | 8.89 | 9.63 | 12.42 | 66 | |||||||||||||||||
52 | 1.23 | 1.72 | 2.17 | 2.57 | 3.13 | 3.75 | 4.43 | 5.19 | 5.60 | 6.23 | 6.88 | 7.55 | 8.24 | 9.41 | 10.20 | 13.48 | 67 | |||||||||||||||||
53 | 1.29 | 1.81 | 2.30 | 2.76 | 3.36 | 4.02 | 4.73 | 5.51 | 5.98 | 6.63 | 7.33 | 8.06 | 8.84 | 10.14 | 11.03 | 14.64 | 68 | |||||||||||||||||
54 | 1.36 | 1.91 | 2.44 | 2.96 | 3.61 | 4.31 | 5.04 | 5.83 | 6.37 | 7.06 | 7.81 | 8.62 | 9.49 | 10.93 | 11.94 | 15.94 | 69 | |||||||||||||||||
55 | 1.43 | 2.01 | 2.58 | 3.18 | 3.87 | 4.60 | 5.36 | 6.16 | 6.78 | 7.50 | 8.33 | 9.23 | 10.20 | 11.80 | 12.96 | 17.42 | 70 | |||||||||||||||||
56 | 1.50 | 2.11 | 2.74 | 3.41 | 4.13 | 4.90 | 5.69 | 6.51 | 7.22 | 7.99 | 8.89 | 9.88 | 10.96 | 12.76 | 14.12 | 19.13 | 71 | |||||||||||||||||
57 | 1.57 | 2.21 | 2.89 | 3.64 | 4.41 | 5.21 | 6.03 | 6.86 | 7.69 | 8.51 | 9.49 | 10.59 | 11.81 | 13.85 | 15.45 | 21.11 | 72 | |||||||||||||||||
58 | 1.69 | 2.39 | 3.12 | 3.91 | 4.71 | 5.54 | 6.40 | 7.28 | 8.17 | 9.05 | 10.28 | 11.45 | 12.76 | 14.97 | 16.71 | 23.41 | 73 | |||||||||||||||||
59 | 1.82 | 2.58 | 3.36 | 4.19 | 5.02 | 5.88 | 6.79 | 7.74 | 8.69 | 9.63 | 11.16 | 12.42 | 13.25 | 16.25 | 18.16 | 26.09 | 74 | |||||||||||||||||
60 | 1.94 | 2.77 | 3.61 | 4.48 | 5.35 | 6.25 | 7.21 | 8.22 | 9.24 | 10.27 | 12.16 | 13.55 | 15.11 | 17.72 | 19.83 | 29.20 | 75 | |||||||||||||||||
61 | 2.08 | 2.98 | 3.28 | 4.80 | 5.70 | 6.65 | 7.67 | 8.74 | 9.84 | 10.99 | 13.31 | 14.84 | 16.55 | 19.42 | 21.73 | 32.78 | 76 | |||||||||||||||||
62 | 2.22 | 3.20 | 4.17 | 5.14 | 6.09 | 7.08 | 8.15 | 9.31 | 10.52 | 11.81 | 14.65 | 16.34 | 18.23 | 21.37 | 23.87 | 36.88 | 77 | |||||||||||||||||
63 | 2.36 | 3.38 | 4.40 | 5.42 | 6.42 | 7.47 | 8.61 | 9.88 | 14.24 | 12.74 | 15.86 | 17.73 | 19.83 | 23.30 | 26.11 | 41.54 | 78 | |||||||||||||||||
64 | 2.51 | 3.58 | 4.65 | 5.72 | 6.77 | 7.89 | 9.12 | 10.52 | 12.06 | 13.80 | 17.25 | 19.31 | 21.63 | 25.45 | 28.57 | 46.74 | 79 | |||||||||||||||||
65 | 2.67 | 3.79 | 4.91 | 6.03 | 7.15 | 8.35 | 9.70 | 1124 | 13.00 | 15.01 | 18.83 | 21.08 | 23.62 | 27.79 | 31.21 | 52.50 | 80 | |||||||||||||||||
66 | 2.84 | 4.01 | 5.19 | 6.37 | 7.57 | 8.88 | 10.36 | 12.07 | 14.06 | 16.40 | 20.61 | 23.04 | 25.79 | 30.30 | 34.00 | 58.80 | 81 | |||||||||||||||||
67 | 3.03 | 4.24 | 5.49 | 6.75 | 8.04 | 9.48 | 11.10 | 13.00 | 15.26 | 17.95 | 22.58 | 25.19 | 28.11 | 32.93 | 36.89 | 65.66 | 82 | |||||||||||||||||
68 | 3.29 | 4.62 | 6.00 | 7.41 | 8.87 | 10.51 | 12.37 | 14.55 | 17.13 | 20.20 | 25.19 | 28.11 | 31.57 | 36.88 | 41.19 | 73.06 | 83 | |||||||||||||||||
69 | 3.58 | 5.05 | 6.59 | 8.18 | 9.84 | 11.72 | 13.85 | 16.33 | 19.27 | 22.75 | 28.11 | 31.57 | 35.36 | 41.18 | 45.84 | 81.02 | 84 |
D-2-2 |
Extended Basic US 1975-80 Select and Ultimate Automatic YRT Rates
Female Aggregate | Age Nearest Birthday |
Policy Year | Att. | |||||||||||||||||||||||||||||||||
Age | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16+ | Age | |||||||||||||||||
70 | 3.92 | 5.54 | 7.27 | 9.07 | 10.97 | 13.11 | 15.54 | 18.38 | 21.71 | 25.59 | 31.57 | 35.36 | 39.49 | 45.83 | 50.83 | 89.52 | 85 | |||||||||||||||||
71 | 5.51 | 8.28 | 11.4I | 14.70 | 17.75 | 21.20 | 26.41 | 31.59 | 38.04 | 44.51 | 51.86 | 60.13 | 69.44 | 79.78 | 89.52 | 98.58 | 86 | |||||||||||||||||
72 | 6.61 | 9.61 | 13.53 | 17.30 | 21.05 | 25.24 | 31.32 | 37.28 | 44.51 | 51.86 | 60.13 | 69.40 | 79.72 | 89.52 | 98.58 | 108.18 | 87 | |||||||||||||||||
73 | 7.92 | 11.37 | 16.00 | 20.42 | 24.95 | 29.97 | 37.02 | 43.81 | 51.86 | 60.13 | 69.40 | 79.71 | 89.52 | 98.58 | 108.18 | 118.34 | 88 | |||||||||||||||||
74 | 9.47 | 13.60 | 18.87 | 24.09 | 29.51 | 35.47 | 43.58 | 51.25 | 60.13 | 69.40 | 79.71 | 89.52 | 98.58 | 108.18 | 118.34 | 129.04 | 89 | |||||||||||||||||
75 | 11.33 | 16.25 | 22.26 | 28.38 | 34.81 | 41.79 | 51.04 | 59.65 | 69.40 | 79.71 | 89.52 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 90 | |||||||||||||||||
76 | 13.54 | 19.20 | 26.22 | 33.35 | 40.89 | 49.00 | 59.49 | 69.08 | 79.71 | 89.52 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 91 | |||||||||||||||||
77 | 16.16 | 22.67 | 30.81 | 39.05 | 47.81 | 57.16 | 68.97 | 79.59 | 89.52 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 92 | |||||||||||||||||
78 | 1935 | 26.92 | 36.06 | 45.51 | 55.62 | 66.32 | 79.55 | 89.52 | 98.58 | 108.18 | 11834 | 129.04 | 14030 | 152.10 | 164.46 | 17736 | 93 | |||||||||||||||||
79 | 23.18 | 31.80 | 42.02 | 52.80 | 64.39 | 76.56 | 89.52 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 94 | |||||||||||||||||
80 | 27.61 | 37.39 | 48.74 | 60.97 | 74.17 | 87.93 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 204.82 | 95 | |||||||||||||||||
81 | 32.68 | 43.71 | 56.27 | 70.05 | 85.01 | 98.58 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 20412 | 219.38 | 96 | |||||||||||||||||
82 | 38.46 | 50.83 | 64.64 | 80.11 | 96.97 | 108.18 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 204.82 | 219.38 | 234.48 | 97 | |||||||||||||||||
83 | 45.76 | 58.80 | 73.91. | 91.19 | 108.18 | 11834 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 204.82 | 219.38 | 234.48 | 250.14 | 98 | |||||||||||||||||
84 | 54.79 | 68.59 | 84.13 | 103.35 | 118.34 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 204.82 | 219.38 | 234.48 | 250.14 | 266.34 | 99 | |||||||||||||||||
85 | 65.01 | 79.42 | 95.33 | 116.62 | 129.04 | 140.30 | 152.10 | 164.46 | 177.36 | 190.82 | 204.82 | 219.38 | 234.48 | 250.14 | 26634 | 283.10 | 100 |
D-2-3 |
SCHEDULE E
IN-FORCE LIST OF LEVEL TERM POLICIES
Exhibit 10.5
STANDBY STOCK PURCHASE AGREEMENT
This STANDBY STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of March 8, 2018, is entered into by and among Federal Life Group, Inc., a Pennsylvania corporation (the “Company”), Federal Life Insurance Company, an Illinois insurance company (“Federal Life”), Federal Life Mutual Holding Company, an Illinois corporation (“FLMHC”), and Insurance Capital Group, LLC (the “Standby Purchaser”).
WITNESSETH:
WHEREAS, the Board of Directors of FLMHC has adopted a Plan of Conversion (the “Plan of Conversion”) pursuant to which FLMHC will convert from a mutual holding company to a stock holding company in accordance with Illinois law (the “Conversion”); and
WHEREAS, in accordance with the Plan of Conversion, FLMHC proposes, as soon as practicable after the Registration Statement, as defined herein, becomes effective, to distribute to Eligible Members, as defined herein, non-transferable rights (the “Rights”) to subscribe for and purchase shares of Common Stock of the Company (the “Shares”) at a subscription price (the “Subscription Price”) of $10.00 per share (such offering, the “Subscription Offering”); and
WHEREAS, contemporaneously with the Subscription Offering, the Company will offer the Shares to a limited group of persons at the Subscription Price (the “Community Offering”); and
WHEREAS, the Standby Purchaser is purchasing from FLMHC a promissory note of FLMHC in the form of Exhibit A hereto in the principal amount of up to $2,000,000 that will be exchanged for Common Stock of the Company upon the effective date of the Conversion at a price per share equal to the Subscription Price (the “Exchangeable Note”); and
WHEREAS, the Company has requested the Standby Purchaser to agree to purchase from the Company in the Community Offering any shares remaining after completion of the Subscription Offering and any orders accepted in the Community Offering by persons other than the Standby Purchaser, and the Standby Purchaser is willing to purchase Shares in the Community Offering on the terms and conditions provided herein.
NOW THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and intending to be legally bound, the parties hereto hereby agree as follows:
Section 1. Certain Other Definitions. The following terms used herein shall have the meanings set forth below:
“90-Day Limit” shall have the meaning given to such term in Section 9(c)(i) hereof.
“Adjusted Stockholders’ Equity” shall mean stockholders’ equity as determined in accordance with GAAP (excluding the fixed income component of accumulated other comprehensive income).
1 |
“Affiliate” shall have the meaning set forth in Rule 12b-2 under the Exchange Act and shall include Persons who become Affiliates of any Person subsequent to the date hereof. In the case of the Standby Purchaser, its “Affiliates” shall include entities which are controlled by a principal of the Standby Purchaser.
“Agreement” shall have the meaning given to such term in the preamble hereof.
“ASE Event” shall mean, that, in any fiscal quarter, the Company’s consolidated GAAP financial statements for such fiscal quarter includes an Adjusted Stockholders’ Equity that is less than 85% of the Company’s Adjusted Stockholders’ Equity as of the Closing (as shown in the Company’s consolidated GAAP financial statements for the most recent fiscal quarter as of Closing).
“Associate” shall have the meaning set forth in Rule 12b-2 under the Exchange Act and shall include Persons who become Associates of any Person subsequent to the date hereof.
“Bankruptcy and Equity Exception” shall have the meaning given to such term in Section 3(b) hereof.
“Board” shall mean the board of directors of the Company.
“Burdensome Condition” shall have the meaning given to such term in Section 6(c) hereof.
“Business Day” shall mean any day that is not a Saturday, a Sunday or a day on which banks are required or permitted to be closed in the Commonwealth of Pennsylvania.
“Change of Control” shall mean any transaction or series of transactions (as a result of a tender offer, merger, consolidation or otherwise) that results in, or that is in connection with (a) any Third Party Purchaser or “group” (within the meaning of Section 13(d)(3) of the Exchange Act) of Third Party Purchasers acquiring beneficial ownership, directly or indirectly, of a majority of the then issued and outstanding Common Stock or (b) the sale, lease, exchange, conveyance, transfer, or other disposition (for cash, shares of stock, securities or other consideration) of all or substantially all of the property and assets of the Company and its Subsidiaries, on a consolidated basis, to any Third Party Purchaser or “group” (within the meaning of Section 13(d)(3) of the Exchange Act) of Third Party Purchasers (including any liquidation, dissolution, or winding up of the affairs of the Company, or any other distribution made in connection therewith).
“Closing” shall mean the closing of the purchase described in Section 2 hereof, which shall be held at 10:00 a.m. Eastern Time on the Closing Date at the offices of Stevens & Lee, 620 Freedom Business Center, King of Prussia, Pennsylvania 19406, or such other time and place as may be agreed to by the parties hereto.
“Closing Date” shall mean the date on which the closing of the sale of the Shares pursuant to the Offerings takes place.
2 |
“Commission” shall mean the United States Securities and Exchange Commission, or any successor agency thereto.
“Common Stock” shall mean the common stock of the Company, par value $0.01 per share.
“Common Stock Equivalent” shall mean any convertible debt instrument, option, warrant or other right to acquire Common Stock and shall include the number of shares of Common Stock that may be acquired upon exercise or conversion of such Common Stock Equivalent.
“Company” shall have the meaning given to such term in the preamble hereof.
“Company Contracts” shall have the meaning given to such term in Section 3(f) hereof.
“Company Offer Notice” shall have the meaning given to such term in Section 13(a) hereof.
“Conversion Plan Approval” shall mean the approval of the Plan of Conversion by the Department and the requisite vote of the Voting Members.
“Department” shall mean the Illinois Insurance Department.
“Designated Securities” shall have the meaning given to such term in Section 11(b) hereof.
“Drag-along Notice” shall have the meaning given to such term in Section 14(b) hereof.
“Drag-along Sale” shall have the meaning given to such term in Section 14(a) hereof.
“Drag-along Stockholder” shall have the meaning given to such term in Section 14(a) hereof.
“Dragging Stockholder” shall have the meaning given to such term in Section 14(a) hereof.
“Eligible Members” shall mean the members of FLMHC eligible to purchase Shares in the Subscription Offering.
“Equity Securities” shall include (i) with respect to the Company, (a) any Common Stock, (b) any security convertible into or exercisable or exchangeable for, with or without consideration, shares of Common Stock (including any option to purchase such a convertible security), (c) any security carrying any warrant or right to subscribe to or purchase any shares of Common Stock, and (d) any such warrant or right and (ii) with respect to any Subsidiary of the Company, (a) any equity ownership interests, (b) any security convertible into or exercisable or exchangeable for, with or without consideration, equity ownership interests (including any option to purchase such a convertible security), (c) any security carrying any warrant or right to subscribe to or purchase any shares of equity ownership interests, and (d) any such warrant or right.
3 |
“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated by the Commission thereunder.
“Federal Life” shall have the meaning given to such term in the recitals hereof.
“FLMHC” shall have the meaning given to such term in the recitals hereof.
“Financial Statements” shall have the meaning given to such term in Section 3(g) hereof.
“First Offer Termination Event” shall mean the earliest to occur of (a) the fifth (5th) anniversary of the Closing Date, (b) the first date upon which the Standby Purchaser no longer beneficially owns shares of the Common Stock representing more than five percent (5%) of the issued and outstanding shares of the Common Stock, or (c) the occurrence of a Standstill Termination Event.
“GAAP” shall mean accounting principles generally accepted in the United States of America, consistently applied by the Company with prior practice.
“Griffin” shall mean Griffin Financial Group, LLC.
“Governmental Entity” shall mean any federal or state court, administrative agency or commission or other governmental authority or instrumentality, other than the Department.
“Gross Up Right” shall have the meaning given to such term in Section 11(a) hereof.
“Including” shall mean including, without limitation.
“Indebtedness” means, with respect to any Person, (a) all obligations for borrowed money, (b) any other obligations owed by such Person under any credit agreement or facility, or evidenced by any note, bond, debenture or other debt security or instrument made or issued by such Person, (c) all obligations for the deferred purchase price of property or services with respect to which such Person is liable, contingently or otherwise, as obligor or otherwise, (d) all capitalized lease obligations, synthetic lease obligations and sale leaseback obligations, whether secured or unsecured, (e) all obligations under interest rate cap, swap, collar or similar transactions or currency or commodity hedging transactions (valued at the termination value thereof), (f) all obligations under conditional sale or other title retention agreements relating to any purchased property, (g) all letters of credit or performance bonds issued for the account of such Person, (h) all guarantees of such Person with respect to any of the foregoing of any other Person, (i) all interest, premium and prepayment penalties due and payable in respect of any of the foregoing and (j) all indebtedness referred to in clauses (a) through (i) above secured by (or for which the holder of such indebtedness has an existing right, contingent or otherwise, to be secured by) any encumbrance upon or in property (including accounts and contract rights) owned by such Person, even though such Person may not have assumed or become liable for the payment of such indebtedness, and including in clauses (a) through (i) above any accrued and unpaid interest or penalties thereon.
4 |
“Law” shall have the meaning given to such term in Section 6(d) hereof.
“Liability” means any liability, debt, expense, claim, demand, loss, commitment, damage, deficiency, obligation or actions of any kind, character or description, whether asserted or not asserted, disputed or undisputed, known or unknown, joint or several, fixed or unfixed, liquidated or unliquidated, secured or unsecured, accrued or unaccrued, matured or unmatured, absolute, contingent, determined, determinable or otherwise, whenever or however arising (including, whether arising out of any contract or tort based on negligence or strict liability) and whether or not the same would be required by SAP to be reflected in financial statements or disclosed in the notes thereto, including all costs and expenses related thereto.
“Liens” means all pledges, liens (statutory or other), encumbrances, charges, claims, community property interests, conditions, deeds of trust, equitable interests, options, hypothecations, mortgages, easements, encroachments, burdens, rights of others, rights of way, rights of first refusal, rights of first offer, title defects, title retention agreements, leases, subleases, licenses, occupancy agreements, covenants, voting trust agreements, interests, negotiations or refusals, security interests of any kind, proxies or restrictions of any kind, including any restriction on use, voting, transfer, receipt of income or exercise of any other attribute of ownership or any applicable insurance Laws.
“Material Action” shall mean (a) incurring Indebtedness or any other material Liability or contracting for the extension or ability to incur Indebtedness (even if not yet incurred), (b) modifying or amending Company Contracts, (c) adopting of a plan of complete or partial liquidation, rehabilitation or entering into any merger agreement, (d) creating or acquiring of Subsidiaries, (e) undertaking or committing to make any capital expenditures, (f) mortgaging, pledging or otherwise encumbering or subjecting to a Lien any material assets or properties, tangible or intangible, other than Permitted Liens, (g) defaulting under any Indebtedness, or cancelling or compromising any Indebtedness or waiving any material rights with respect thereto without receiving a realizable benefit of similar or greater value, (h) paying or prepaying any Liability, or discharging or satisfying any Lien, or settling any Liability, claim, dispute, proceeding, suit or appeal, pending or threatened against it or any of its assets or properties, other than short-term liabilities which have been paid prior to the contractual due date therefor in the ordinary course of business, (i) effecting any employee profit-sharing, stock option, stock purchase, pension, bonus, incentive, retirement, medical reimbursement, life insurance, deferred compensation, severance or termination agreements, (j) entering into any new line of business, introduced any new products or services or changed in any material respect existing products or services, except as may be required by applicable Law, (k) abandoning, modifying, failing to renew, waiving, terminating or letting lapse any Permits or failing to timely file with any Governmental Entity all required annual and quarterly statutory financial statements and other insurance regulatory reports, statements, documents, registrations, filings or submissions or (l) entering into any agreement or commitment, whether in writing or otherwise, to do any of the forgoing.
5 |
“Material Adverse Effect” shall mean (a) a material adverse effect on the financial condition, or on the earnings, operations, assets, business or prospects of the Company, Federal Life and their respective subsidiaries taken as a whole, or (b) the failure of either Joseph D. Austin or William S. Austin to serve as Chief Executive Officer of the Company; provided, however, that in determining whether a Material Adverse Effect has occurred under clause (a), there shall be excluded any effect to the extent resulting from (i) actions or omissions of the Company or Federal Life expressly required or contemplated by the terms of this Agreement, (ii) changes after the date hereof in general economic conditions in the United States, including financial market volatility or downturn, (iii) changes after the date hereof affecting generally the life insurance business in the United States, (iv) acts of war, sabotage or terrorism, military actions or the escalation thereof, or outbreak of hostilities, (v) any changes after the date hereof in applicable laws or accounting rules or principles, including changes in GAAP, or (vi) the announcement or pendency of the transactions contemplated by this Agreement; provided further, however, that any circumstance, event, change, development or effect referred to in clauses (ii), (iii), (iv) and (v) shall be taken into account in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur to the extent that such circumstance, event, change, development or effect has a disproportionate effect on the Company and Federal Life compared to other participants in the industries or markets in which the Company and Federal Life operate.
“Maximum of the Valuation Range” has the meaning given to such term in the Plan of Conversion.
“Minimum of the Valuation Range” has the meaning given to such term in the Plan of Conversion.
“Non-public information” shall have the meaning given to such term in Section 6(d) hereof.
“Offer Period” shall have the meaning given to such term in Section 11(b) hereof.
“Offered Shares” shall have the meaning given to such term in Section 9(d) hereof.
“Offerings” shall mean, collectively, the Subscription Offering and the Community Offering.
“Offering Expiration Date” shall mean the date on which the Offerings expire.
“Organizational Documents” of a Person means, as applicable, the declaration and charter, certificate of incorporation, articles of incorporation, certificate of designation, bylaws, certificate of formation, operating agreement or any similar organizational or governing document or instrument of a Person.
“Permits” shall have the meaning given to such term in Section 3(f) hereof.
6 |
“Permitted Liens” means (a) Liens for taxes that are not yet due and payable or are not delinquent and are being contested in good faith by appropriate proceedings for which adequate reserves are maintained, or (b) mechanics’, materialmens’, carriers’, workmens’, repairmens’, contractors’ and warehousemens’ Liens imposed by applicable Law, arising or incurred in the ordinary course of business.
“Person” shall mean individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization and a Governmental Entity.
“Plan of Conversion” shall mean the plan of conversion adopted by FLMHC in connection with its conversion from a mutual insurance holding company to a stock insurance holding company pursuant to Section 59.1 of the Illinois Insurance Code, 215 ILCS 5/59.1.
“Potential Sale Notice” shall have the meaning given to such term in Section 13(a) hereof.
“Proposed Transferee” shall have the meaning given to such term in Section 15(a).
“Prospectus” shall mean the final Prospectus included in the Registration Statement for use in connection with the Offerings.
“Public Sale Notice” shall have the meaning given to such term in Section 9(d) hereof.
“Purchased Shares” shall have the meaning given to such term in Section 2(b) hereof.
“Qualifying Offer” shall have the meaning given to such term in Section 13(c) hereof.
“Registration Statement” shall mean the Company’s Registration Statement on Form S-1 or such other appropriate form under the Securities Act, pursuant to which the shares of Common Stock to be issued in the Offerings will be registered pursuant to the Securities Act.
“Rights” shall have the meaning given to such term in the recitals hereof.
“ROFO Termination Date” shall mean (a) if the Standstill Period terminates as scheduled on the fifth (5th) anniversary of the Closing Date, the date that is two (2) years following the end of the Standstill Period and (b) if the Standstill Period terminates for any other reason, the date of the occurrence of a Standstill Termination Event.
“Sale Notice” has the meaning given to such term in Section 15(b) hereof.
“SAP” shall mean the accounting practices prescribed or permitted by the Department.
“Securities Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations promulgated by the Commission thereunder.
“Selling Stockholder” shall have the meaning given to such term in Section 15(a) hereof.
“Senior Management Shareholders” shall mean the Executive Chairman, the Chief Executive Officer, the President, the Chief Financial Officer and any Executive Vice President.
7 |
“Shares” shall have the meaning given to such term in the recitals hereof.
“Standby Purchaser” shall have the meaning given to such term in the preamble hereof.
“Standstill Period” means the period commencing on the Closing Date and ending on the occurrence of a Standstill Termination Event.
“Standstill Termination Event” shall mean the earliest to occur of (a) the fifth (5th) anniversary of the Closing Date, (b) the failure of either Joseph D. Austin or William S. Austin to serve as Chief Executive Officer of the Company unless a new Chief Executive Officer acceptable to the Standby Purchaser is appointed by the Board within a reasonable time thereafter, or (c) the occurrence of an ASE Event.
“Statutory Financial Statements” shall have the meaning given to such term in Section 3(h) hereof.
“Stockholder” shall mean any Person who is a record holder of Common Stock or any Common Stock Equivalent.
“Strategic Direction” shall have the meaning given to such term in Section 13(d) hereof.
“Strategic Investor” shall have the meaning given to such term in the Plan of Conversion.
“Subscription Agent” shall have the meaning given to such term in Section 6(a)(vi) hereof.
“Subscription Offering” shall have the meaning given to such term in the recitals hereof.
“Subscription Price” shall have the meaning given to such term in the recitals hereof.
“Subsidiary” means, with respect to any Person, any corporation, limited liability company, general or limited partnership, limited liability partnership, joint venture, association or other Person that is a business entity, trust or estate of which (a) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof or (b) if a limited liability company, partnership, association or other business entity (other than a corporation), a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof and for this purpose, a Person or Persons own a majority ownership interest in such a business entity (other than a corporation) if such Person or Persons shall be allocated a majority of such business entity’s gains or losses or shall be or control any managing director or general partner of such business entity (other than a corporation). The term “Subsidiary” shall include all Subsidiaries of such Subsidiary.
“Tag-along Notice” shall have the meaning given to such term in Section 15(c) hereof.
8 |
“Tag-along Period” shall have the meaning given to such term in Section 15(c) hereof.
“Tag-along Sale” shall have the meaning given to such term in Section 15(a) hereof.
“Tag-along Stockholder” shall have the meaning given to such term in Section 15(a) hereof.
“Third Party Purchaser” shall mean any Person who, immediately prior to the contemplated transaction does not directly or indirectly own or have the right to acquire any outstanding Common Stock.
“Transfer” shall have the meaning given to such term in Section 9(a) hereof.
“Unsubscribed Shares” shall mean the number of Shares not purchased in connection with the Subscription Offering.
“Voting Members” shall mean the members of FLMHC eligible to vote to adopt and approve the Plan of Conversion.
“VWAP Price” shall mean the average of daily volume weighted average price of the Common Stock on the NASDAQ Stock Market for the 20 trading days immediately preceding the date of the Public Sale Notice.
Section 2. Standby Purchase Commitment.
(a) On the date of the filing of the Registration Statement, the Standby Purchaser shall purchase from FLMHC at a price of up to $2,000,000, and FLMHC shall issue to the Standby Purchaser, the Exchangeable Note, and FLMHC shall deliver to the Standby Purchaser the original Exchangeable Note executed by FLMHC. The Standby Purchaser shall pay the purchase price for the Exchangeable Note to FLMHC by a wire transfer of immediately available funds as and when Advances (as defined in the Exchangeable Note) are requested in accordance with the terms thereof, to an account designated by FLMHC.
(b) Subject to the terms, conditions and limitations of this Agreement and to the availability of Shares after purchases made in the Subscription Offering, the Standby Purchaser agrees to purchase from the Company in the Community Offering, at the Subscription Price, the greater of (i) such number of Shares as shall result in the sale of Shares in the Offering equal to the number of Shares at the Minimum of the Valuation Range, or (ii) at least the lesser of: (A) 2,800,000 Shares (including any Shares issued as a result of the exchange of the Exchangeable Note), or (B) such number of Shares, that when added to (x) any Shares for which subscriptions have been accepted in the Subscription Offering, plus (y) any Shares for which orders have been accepted in the Community Offering from other than the Standby Purchaser, shall equal the number of Shares at the Maximum of the Valuation Range in the Offering. With the consent of the Company, the Standby Purchaser may purchase such additional Shares above the maximum number of Shares offered in the Offering as shall result in the Standby Investor owning 2,800,000 Shares (the number of Shares purchased by the Standby Purchaser are referred to herein as the “Purchased Shares”).
9 |
(c) Payment of the purchase price for the Purchased Shares shall be made by the Standby Purchaser, on the Closing Date, against delivery of certificates or a book entry statement evidencing the Purchased Shares, in United States dollars by means of a wire transfer of immediately available funds to the escrow account for the Offerings.
Section 3. Representations and Warranties of the Company. The Company, Federal Life, and FLMHC represent and warrant as of the date hereof and as of the Closing Date (except for the representations and warranties that are as of a specific date, which shall be made as of such date) to the Standby Purchaser as follows:
(a) The Company is a corporation duly organized, validly existing and in good standing under the laws of the Commonwealth of Pennsylvania and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted. Federal Life is a stock insurance company duly organized, validly existing and in good standing under the laws of the State of Illinois and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted. FLMHC is a corporation duly organized, validly existing and in good standing under the laws of the State of Illinois and has all requisite corporate power and authority to carry on its business as now conducted and as proposed to be conducted. The copies of the Organizational Documents of the Company, FLMHC, and Federal Life that have been provided to the Standby Purchaser are complete and correct and in full force and effect. The Company has no joint venture or similar arrangement, no subsidiaries, no significant assets or liabilities, and it is not engaged in any business.
(b) This Agreement has been duly and validly authorized, executed and delivered by each of the Company, Federal Life and FLMHC and constitutes a binding obligation of each of the Company, Federal Life, and FLMHC enforceable against each of them in accordance with its terms, subject to (i) the application of bankruptcy, receivership, conservatorship, reorganization, insolvency and similar laws affecting creditors’ rights generally and (ii) equitable principles being applied at the discretion of a court before which any proceeding may be brought (clauses (i) and (ii) collectively, the “Bankruptcy and Equity Exception”).
(c) The authorized capital of the Company consists of (i) 10,000,000 shares of Common Stock, none of which shares were issued and outstanding as of the date of this Agreement, and (ii) 1,000,000 shares of preferred stock, none of which preferred stock has been issued, as of the date hereof. Except for equity awards to be granted to management upon completion of the Offerings as described in the Registration Statement, there are no options, warrants, subscriptions, calls, rights, convertible securities or other agreements or commitments obligating the Company to issue, transfer, sell, redeem, repurchase or otherwise acquire any shares of its capital stock. The authorized capital stock of Federal Life consists of 25,000,000 shares of common stock, of which 2,500,000 shares are issued and outstanding. FLMHC owns all of the outstanding shares of capital stock of Federal Life. As of the date of this Agreement there are no authorized shares of capital stock of FLMHC. At the Closing Date, all of the authorized capital stock of FLMHC will be issued to and will be owned by the Company. There are no options, warrants, subscriptions, calls, rights, convertible securities or other agreements or commitments obligating either Federal Life or FLMHC to issue, transfer, sell, redeem, repurchase or otherwise acquire any shares of its capital stock.
10 |
(d) At the time the Registration Statement becomes effective, the Registration Statement will comply in all material respects with the requirements of the Securities Act and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus, at the time the Registration Statement becomes effective and at the Closing Date, will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading; provided, however, that the representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement or the Prospectus made in reliance upon and in conformity with the information furnished to the Company in writing by the Standby Purchaser for use in the Registration Statement or in the Prospectus.
(e) All of the Shares, including the Purchased Shares, will have been duly authorized for issuance prior to the Closing (assuming the Conversion Plan Approval has been obtained), and, when issued and distributed as set forth in the Prospectus, will be validly issued, fully paid and non-assessable; and none of the Shares will have been issued in violation of the preemptive rights of any security holders of the Company arising as a matter of law or under or pursuant to the Company’s Articles of Incorporation, the Company’s bylaws, or any agreement or instrument to which the Company is a party or by which it is bound.
(f) Neither the execution, delivery or performance of this Agreement or the Plan of Conversion by the Company, FLMHC or Federal Life, nor the consummation by the Company, Federal Life or FLMHC of the transactions contemplated hereby or thereby, will: (i) conflict with or result in any breach of any provisions of the Organizational Documents of the Company, FLMHC or Federal Life; (ii) result in a violation or breach of, or constitute (with or without due notice or lapse of time or both) a default (or give rise to any right of termination, cancellation, vesting, payment, exercise, acceleration, suspension or revocation) under, any of the terms, conditions or provisions of any note, bond, mortgage, deed of trust, security interest, indenture, license, contract, agreement, plan or other instrument or obligation to which the Company, FLMHC or Federal Life is a party or by which it or any of their properties or assets may be bound (collectively, the “Company Contracts”); (iii) violate any order, writ, injunction, decree, statute, rule or regulation applicable to the Company, FLMHC, Federal Life or any of their properties or assets; (iv) result in the creation or imposition of any Lien on any asset of the Company, FLMHC or Federal Life; or (v) cause the suspension or revocation of any permit, license, governmental authorization, consent or approval necessary for the Company, FLMHC or Federal Life to conduct its business as currently conducted (collectively, the “Permits”), except in the case of clauses (ii), (iii), (iv) and (v) for violations, breaches, defaults, terminations, cancellations, accelerations, creations, impositions, suspensions or revocations which would not individually or in the aggregate have or be reasonably likely to result in a Material Adverse Effect. Except for the Conversion Plan Approval, no vote of any member or holder of any other interest in FLMHC or Federal Life (equity or otherwise), is required to consummate the transactions contemplated by this Agreement or the Plan of Conversion.
11 |
(g) Federal Life has delivered to the Standby Purchaser complete and correct copies of the Financial Statements. The Financial Statements have been derived from the accounting books and records of FLMHC and Federal Life and have been prepared on a basis consistent with GAAP, subject, in the case of interim unaudited Financial Statements, only to normal recurring year-end adjustments. The Financial Statements present fairly in all material respects the consolidated financial position of FLMHC and Federal Life as at the respective dates thereof, and the consolidated statements of income, cash flow and equity included in the Financial Statements present fairly in all material respects the consolidated results of operations, cash flows and consolidated equity of FLMHC and Federal Life, as applicable, for the respective periods indicated. The term “Financial Statements” means the unaudited consolidated financial statements of FLMHC and Federal Life as at and for the nine-month period ended September 30, 2017 and the audited consolidated financial statements of FLMHC and Federal Life as at and for the year ended December 31, 2016, including in each case a consolidated balance sheet and consolidated statements of income, cash flow and equity, as previously made available to the Standby Purchaser.
(h) The annual statements of Federal Life for the years ended December 31, 2017, December 31, 2016 and December 31, 2015 and the quarterly statements of Federal Life for the quarters ended March 31, June 30, and September 30, 2017 as filed with the Department (collectively, together with all exhibits and schedules thereto, the “Statutory Financial Statements”) have been prepared in accordance with SAP, and such accounting practices have been applied on a consistent basis throughout the periods involved, except to the extent permitted by the Department and as expressly set forth in the notes, exhibits or schedules thereto, and the Statutory Financial Statements present fairly in all material respects the financial position and the results of operations for Federal Life as of the dates and for the periods therein in accordance with such accounting practices. Federal Life has made available to the Standby Purchaser true and complete copies of all examination reports of the Department and any insurance regulatory agencies since January 1, 2014, relating to Federal Life. Federal Life has delivered to the Standby Purchaser true and complete copies of the Statutory Financial Statements.
(i) As of the date of this Agreement, since December 31, 2017 , there has been no event or condition that, individually or in the aggregate, has had (or is reasonably likely to result in) a Material Adverse Effect, and Federal Life and FLMHC have in all material respects conducted their respective businesses in the ordinary course consistent with past practice. Except (x) for actions taken in the ordinary course of business (including the settlement of undisputed claims) and (y) for such actions as are necessary for the completion of the Offerings and the transactions contemplated by this Agreement and the Plan of Conversion, since December 31, 2017, none of the Company, Federal Life or FLMHC has taken any Material Action that resulted, or could reasonably result, in the payment of an amount, or the incurrence of a liability of, more than $100,000.
(j) Except for insurance claims litigation arising in the ordinary course of business for which adequate reserves have been established, there is no suit, action, proceeding or investigation (whether at law or equity, before or by any Government Entity or before any arbitrator) pending or, to the knowledge of Federal Life, FLMHC or the Company, threatened against or affecting any of them, the outcome of which would individually or in the aggregate have or be reasonably likely to result in a Material Adverse Effect, nor is there any judgment, decree, injunction, rule or order of any Government Entity or arbitrator outstanding against Federal Life, FLMHC or the Company that would individually or in the aggregate have or be reasonably likely to result in a Material Adverse Effect.
12 |
(k) The aggregate reserves of Federal Life as recorded in the Financial Statements and Statutory Financial Statements have been determined in accordance with generally accepted actuarial principles consistently applied or the requirements of the State of Illinois (except as permitted by the State of Illinois and as set forth therein). The insurance reserving practices and policies of Federal Life have not changed, in any material respect, since December 31, 2017, and the results of the application of such practices and policies are reflected in the Financial Statements and Statutory Financial Statements. All reserves of Federal Life set forth in the Financial Statements and Statutory Financial Statements are fairly stated in accordance with sound actuarial principles and meet the requirements of the insurance laws of the State of Illinois, except where the failure to so state such reserves or meet such requirements would not have or be reasonably likely to result in a Material Adverse Effect.
Section 4. Representations and Warranties of the Standby Purchaser. The Standby Purchaser represents and warrants as of the date hereof and as of the Closing Date (except for the representations and warranties that are as of a specific date, which shall be made as of such date) to the Company as follows:
(a) The Standby Purchaser is duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is organized and has the requisite organizational power and authority to enter into and perform its obligations under this Agreement and to consummate the transactions contemplated hereby. Assuming the correctness of the representations and warranties made by the Company in Section 3 hereof, the execution and delivery of this Agreement by the Standby Purchaser and performance by the Standby Purchaser of the transactions contemplated hereby have been duly authorized by all necessary limited liability company action on the part of the Standby Purchaser, and no further consent or authorization in connection therewith is required by the Standby Purchaser, its board of directors or its members. This Agreement has been duly executed by the Standby Purchaser, and when delivered by the Standby Purchaser in accordance with the terms of this Agreement and thereof, will constitute the legal, valid and binding obligations of the Standby Purchaser, enforceable against it in accordance with its respective terms, subject to the Bankruptcy and Equity Exception.
(b) The Standby Purchaser was contacted by the Company or Griffin with respect to a potential investment in the Shares. The Standby Purchaser understands that the Standby Purchaser is acquiring the Purchased Shares in the ordinary course of its business directly from the Company (and not from Griffin), as principal for its own account, with no present intention of dividing its participation with others or reselling or otherwise distributing the same in violation of the Securities Act or any applicable state securities laws. The Standby Purchaser does not presently have any agreement or understanding, directly or indirectly, with any Person to: (i) distribute any of the Purchased Shares; (ii) hold or to dispose of the Purchased Shares; or (iii) acquire any Shares from any other Person other than from the Company pursuant to this Agreement. Notwithstanding the foregoing, except as otherwise set forth in this Agreement, by making the representations herein, the Standby Purchaser does not agree to hold any of the Purchased Shares for any minimum or other specific term.
13 |
(c) The Standby Purchaser is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D. The Standby Purchaser is not a registered broker-dealer under Section 15 of the Exchange Act, or an unregistered broker-dealer engaged in the business of being a broker-dealer. The Standby Purchaser is an experienced institutional investor, is knowledgeable regarding the life insurance industry, and has experience in investing in life insurance companies and life insurance holding companies.
(d) The Standby Purchaser is not purchasing the Purchased Shares as a result of any advertisement, article, notice or other communication regarding the Purchased Shares published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general advertisement. The Standby Purchaser did not learn about Federal Life or the Offerings as a result of the Registration Statement.
(e) The Standby Purchaser understands that the Purchased Shares Shares are being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and regulations.
Section 5. Deliveries at Closing.
(a) At the Closing, the Company shall deliver to the Standby Purchaser the following:
(i) a certificate or certificates or a book entry statement representing the number of shares of Common Stock issued to the Standby Purchaser pursuant to Section 2 hereof; and
(ii) a certificate of an officer of the Company certifying on its behalf to the effect that the conditions set forth in Sections 8(a) and 8(c) have been satisfied on and as of the Closing Date.
(b) At the Closing, the Standby Purchaser shall deliver to the Company the following:
(i) payment of the Subscription Price of the Shares purchased by the Standby Purchaser, as set forth in Section 2(b) hereof; and
(ii) a certificate of the Standby Purchaser certifying to the effect that the conditions set forth in Sections 8(b) and 8(c) have been satisfied on and as of the Closing Date.
Section 6. Covenants.
(a) The Company, Federal Life and FLMHC, as applicable, agree as follows between the date hereof and the Closing Date:
(i) to as soon as reasonably practical file with the Commission the Registration Statement;
14 |
(ii) to use reasonable best efforts to cause the Registration Statement and any amendments thereto to become effective as promptly as practical;
(iii) to use reasonable best efforts to effectuate the Offerings;
(iv) as soon as reasonably practical after the Company is advised or obtains knowledge thereof, to advise the Standby Purchaser with a confirmation in writing, of (A) the time when the Registration Statement or any amendment thereto has been filed or declared effective or the Prospectus or any amendment or supplement thereto has been filed, (B) the issuance by the Commission of any stop order, or of the initiation or threatening of any proceeding suspending the effectiveness of the Registration Statement or any amendment thereto or any order preventing or suspending the use of any preliminary prospectus or the Prospectus or any amendment or supplement thereto, (C) the issuance by any state securities commission of any notice of any proceedings for the suspension of the qualification of the Shares for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose, (D) the receipt of any comments from the Commission, and (E) any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or for additional information. The Company will use its reasonable best efforts to prevent the issuance of any such order or the imposition of any such suspension and, if any such order is issued or suspension is imposed, to obtain the withdrawal thereof as promptly as practical;
(v) to operate the business of Federal Life, the Company and FLMHC in the ordinary course of business consistent with past practice;
(vi) to notify, or to cause the subscription agent for the Subscription Offering (the “Subscription Agent”) to notify, the Standby Purchaser on each Friday during the exercise period of the Rights, or more frequently if reasonably requested by the Standby Purchaser, of the aggregate number of Shares known by the Company or the Subscription Agent to have been subscribed for or ordered in the Subscription Offering as of the close of business on the preceding Business Day or the most recent practical time before such request, as the case may be;
(vii) not to issue any shares of capital stock of the Company, or options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, securities convertible into or exchangeable for capital stock of the Company, or other agreements or rights to purchase or otherwise acquire capital stock of the Company, except for the Exchangeable Note, shares of Common Stock issuable in the Offerings, and equity awards to management as described in the Registration Statement;
(viii) not to authorize any stock split, stock dividend, stock combination or similar transaction affecting the number of issued and outstanding shares of Common Stock or shares of the Company’s preferred stock;
15 |
(ix) except for dividends payable to FLMHC or Federal Life, not to declare or pay any dividends or repurchase any shares of Common Stock or shares of the Company’s preferred stock;
(x) except for the Exchangeable Note, not to incur any Indebtedness other than (A) trade payables or other similar Indebtedness incurred in the ordinary course of business consistent with past practice and (B) other Indebtedness not in excess of $1,000,000 in the aggregate;
(xi) to discuss the orders received in the Community Offering (other than, for avoidance of doubt, any orders from the Standby Purchaser) with the Standby Purchaser and only accept such orders and in such amounts as are agreed to by both the Standby Purchaser, on the one hand, and the Company and FLMHC, on the other hand;
(xii) to not, without the prior written consent of the Standby Purchaser exercise the Company’s right to increase or decrease the purchase limitations set forth in the Plan of Conversion pursuant to Section 10.01(f) thereof;
(xiii) to not exercise the Company’s or FLMHC’s right under Section 11.02 of the Plan of Conversion to reject order for Shares placed by the Standby Purchaser in accordance with the terms of this Agreement and the Plan of Conversion; and
(xiv) to not enter into any other Standby Purchase Agreement (as defined in the Plan of Conversion) with any other Standby Purchaser (as defined in the Plan of Conversion).
(b) The Standby Purchaser agrees as follows between the date hereof and the Closing Date:
(i) it shall be a condition precedent to the obligations of the Company to complete the registration or qualification pursuant to Section 6(a) hereof that the Standby Purchaser shall timely furnish to the Company in writing such information regarding itself as shall be reasonably requested by the Company and as shall be required to effect such registration or qualification and shall timely execute such documents in connection with such registration as the Company may reasonably request; and
(ii) to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of the Registration Statement and the qualification of the Shares offered for sale in the Offerings under applicable “blue sky” laws hereunder.
16 |
(c) Each of the Standby Purchaser and the Company will cooperate with the other and use commercially reasonable efforts to promptly prepare all necessary documentation, to effect all necessary filings and to obtain all necessary permits, consents, waivers, approvals and authorizations of the Commission, the Department and any other third parties or Governmental Entities, necessary or desirable to consummate the purchase of the Shares by the Standby Purchaser contemplated by this Agreement. The Standby Purchaser and the Company will furnish each other and each other’s counsel with all information concerning themselves, their subsidiaries, directors, officers and shareholders and such other matters as may be necessary or advisable in connection with any application, petition or any other statement or application made by or on behalf of the Standby Purchaser or the Company to the Department or any Governmental Entity in connection with the purchase of the Shares by the Standby Purchaser contemplated by this Agreement. The Standby Purchaser shall notify the Company promptly of the receipt of any comments of the Department or any Governmental Entity with respect to such filings. Notwithstanding anything to the contrary contained herein, between the date of this Agreement and the Closing Date, the Standby Purchaser shall not be obligated to take or refrain from taking or to agree to it or its Affiliates taking or refraining from any action or to suffer to exist any condition, limitation, restriction or requirement that, individually or in the aggregate with any other actions, conditions, limitations, restrictions or requirements, would or would reasonably be likely to result in a Burdensome Condition, and the Standby Purchaser shall not be required to seek review by a court, administrative or regulatory authority, agency, commission, board, tribunal or similar adjudicative body of any determination of any insurance regulatory authority, including in their capacity as a rehabilitator, conservator, liquidator or similar capacity. As used herein, “Burdensome Condition” means any condition that would: (A) have a material negative effect on the business or the Permits, assets, liabilities, properties, operations, results of operations or condition (financial or otherwise) of the Standby Purchaser, its Affiliates or the Company; (B) impose any material requirement relating to the contribution of capital, keep-well or capital maintenance arrangements or maintaining risk-based capital level or any material restrictions on dividends or distributions or the ability of the Company to operate its business, in each case, excluding any changes in applicable Law or the effects of any actions, conditions, limitations, restrictions or requirements that are customary for the applicable Governmental Entity to impose in transactions of the type of transaction contemplated hereby; or (C) impose any requirement to modify this Agreement, the Plan of Conversion or other agreement entered or to be entered into in connection herewith or therewith in any manner that materially changes the rights, liabilities or obligations of the parties hereto or thereto.
17 |
(d) After the Closing, if and for so long as the Standby Purchaser beneficially owns more than five percent (5.0%) of the issued and outstanding shares of the Common Stock, the Company shall provide the Standby Purchaser with reasonable opportunities upon reasonable notice and during regular business hours to discuss with the senior management of the Company at least on a quarterly basis, the business and operations of the Company, with at least one of those meetings each year to be held, if requested by the Standby Purchaser, in-person at the Company’s offices or such other mutually agreeable location. The Standby Purchaser hereby acknowledges that it is aware, and it agrees that it will advise its representatives, agents, advisors, Affiliates and Associates who are informed as to the matters which are the subject of this provision (collectively, its “Representatives”), that the United States securities laws prohibit any Person who has received material, non-public information concerning the Company or the matters which are the subject of this provision from purchasing or selling securities of the Company or from communicating such information to any other Person. The Standby Purchaser agrees, and shall instruct its Representatives, to (i) keep such non-public information provided by the Company strictly confidential, (ii) use the same degree of care to protect such non-public information as each would use to protect its own non-public information of a similar nature, but in no event with less than reasonable care, and (iii) not disclose the non-public information in any manner whatsoever to any Person, except with the specific prior written consent of the Company. As used in this Section 6(d), “non-public information” shall not include information which (a) is or becomes public knowledge other than as a result of a breach of the obligations of the Standby Purchaser or its Representatives; (b) was known to the Standby Purchaser prior to the date of this Agreement, except as provided to the Standby Purchaser pursuant to a confidentiality agreement with Federal Life; (c) becomes available without restriction from a third party not known by the Standby Purchaser to be under any confidentiality obligation to the Company with respect thereto; or (d) is developed by the Standby Purchaser or its Representatives without use of the Company’s non-public information. In the event that the Standby Purchaser or any of its Representatives are requested or required by law, regulation, deposition, interrogatory, request for documents, subpoena, civil investigative demand, administrative regulatory requirement, order, decree or the rules of any applicable stock exchange or similar legal process (collectively, “Law”) to disclose any of the foregoing non-public information, the Standby Purchaser shall (or will direct its Representatives to) provide the Company with prompt prior written notice of such requirement to the extent permissible under applicable Law and reasonably practicable under the circumstances in order to enable the Company to (A) seek, at its own cost, an appropriate protective order or other remedy or (B) waive compliance, in whole or in part, with the terms of this Agreement; and the Standby Purchaser or such Representative shall consult and reasonably cooperate with the Company, at the Company’s expense and upon its written request, with respect to taking steps to resist or narrow the scope of such request or requirement. If, in the absence of a protective order, the Standby Purchaser or such Representative are nonetheless, on the advice of counsel of such Standby Purchaser or such Representative, as applicable, required by applicable Law to disclose the foregoing non-public information, the Standby Purchaser or such Representative shall (I) furnish only that portion of the foregoing non-public information that, based upon advice of legal counsel, is legally required, (II) give advance notice to the Company of the information to be disclosed as far in advance as is legally permissible and practical, and (III) exercise commercially reasonable efforts, at the Company’s expense and upon its written request, to obtain reliable assurance that confidential treatment will be accorded such non-public information. Notwithstanding anything to the contrary herein, without satisfying the other obligations of this paragraph, Standby Purchaser and its Representative may disclose such non-public information to the extent such disclosure is requested or required in connection with routine audits or examinations by, or blanket document requests from, a Governmental Entity that does not specifically target the other parties, this Agreement or the transactions contemplated hereby.
(e) The Company shall at all times reserve and hold available sufficient number of shares of Common Stock to satisfy its obligations under this Agreement.
(f) After the Closing, if and for so long as the Standby Purchaser beneficially owns more than five percent (5.0%) of the issued and outstanding shares of the Common Stock and a Standstill Termination Event has not occurred, the Company and Federal Life shall nominate election to the Board of Directors of the Company and Federal Life either (i) Matthew T. Popoli and Jay Novik or either of them, to the extent that the Standby Purchaser notifies the Company that such individuals are to be elected to the Board or (ii) if either Mr. Popoli or Mr. Novick are not selected by the Standby Purchaser, such individuals who are mutually and reasonably acceptable to the Company and the Standby Purchaser.
18 |
(g) As soon as eligible to register Shares for resale on a Form S-3 registration statement, or, if earlier, upon the occurrence of a Standstill Termination Event, the Company shall register the Purchased Shares and the Common Stock held by the Senior Management Shareholders for resale under the Securities Act in accordance with the provisions of Exhibit B attached hereto, at which time the legend described in Section 9(b) hereof shall be removed from the Purchased Shares and the Common Stock held by the Senior Management Shareholders and the restrictions set forth in Section 9(b) hereof shall be of no further force or effect.
Section 7. Public Statements. Neither the Company nor the Standby Purchaser shall issue any public announcement, statement or other disclosure with respect to this Agreement or the transactions contemplated hereby without the prior consent of the other party hereto, which consent shall not be unreasonably withheld or delayed, except if such public announcement, statement or other disclosure is required by applicable law or applicable stock market rules, in which case the disclosing party shall consult in advance with respect to such disclosure with the other parties to the extent reasonably practicable.
Section 8. Conditions to Closing.
(a) The obligations of the Standby Purchaser to consummate the transactions contemplated hereunder are subject to the fulfillment, prior to or on the Closing Date, of the following conditions:
(i) the representations and warranties of the Company, FLMHC, and Federal Life in Section 3 shall be true and correct in all respects as of the date hereof and at and as of the Closing Date as if made on such date, except where the failure to be true and correct (without regard to any materiality or Material Adverse Effect qualifications contained therein), would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (and except that (1) representations and warranties made as of a specified date shall be true and correct as of such date and (2) the representations and warranties of the Company set forth in Sections 3(a), 3(b), 3(c), 3(e), 3(f)(i) and 3(i) shall be true and correct in all respects);
(ii) the Company, FLMHC, and Federal Life shall have performed in all material respects all of their respective obligations under this Agreement required to be performed on or prior to the Closing Date;
(iii) as of the Closing Date, none of the following events shall have occurred and be continuing: (A) trading in the Common Stock shall have been suspended by the Commission or trading in securities generally on The New York Stock Exchange or The Nasdaq Stock Market shall have been suspended or limited or minimum prices shall have been established on either such exchange, (B) a banking moratorium shall have been declared either by U.S. federal or New York State authorities, or (C) there shall have occurred any material outbreak or material escalation of hostilities, declaration by the United States of a national emergency or war or other calamity or crisis which has a material adverse effect on the U.S. financial markets;
19 |
(iv) the gross proceeds from the Offerings, including the purchase of the Purchased Shares by the Standby Purchaser, is equal to at least the Minimum of the Valuation Range;
(v) since the date of this Agreement, a Material Adverse Effect shall not have occurred and no change or other event shall have occurred that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; and
(vi) Senior Management Shareholders shall have agreed to be bound by transfer restrictions on Shares of Common Stock of the Company held by such Persons which are no less restrictive than the restrictions set forth in Section 9 hereof, and to be bound by tag along rights no less restrictive than those set forth in Section 15 hereof, in each case, pursuant to an agreement in form and substance satisfactory to Standby Purchaser; provided, however, that the Senior Management Shareholders shall be permitted to make transfers (x) for estate planning purposes, (y) of shares that in the aggregate are less than 50% of the number of shares owned by Senior Management Shareholders immediately after the Closing Date, or (z) to pay the exercise price upon the exercise of any stock options held by one of the Senior Management Shareholders.
(b) The obligations of the Company to consummate the transactions contemplated hereunder are subject to the fulfillment, prior to or on the Closing Date, of the following conditions:
(i) The representations and warranties of the Standby Purchaser in Section 4 shall be true and correct in all material respects as of the date hereof and at and as of the Closing Date as if made as of such date (except for representations and warranties made as of a specified date, which shall be true and correct in all material respects as of such specified date); and
(ii) the Standby Purchaser shall have performed in all material respects all of its obligations under this Agreement required to be performed on or prior to the Closing Date.
(c) The obligations of each of the Company and the Standby Purchaser to consummate the transactions contemplated hereunder in connection with the Offerings are subject to the fulfillment, prior to or on the Closing Date, of the following conditions:
(i) no judgment, injunction, decree or other legal restraint shall be outstanding, nor shall any action, suit, claim, investigation or other legal proceeding be pending that would reasonably be expected to prohibit, or have the effect of rendering unachievable, the consummation of the Offerings or the transactions contemplated by this Agreement;
(ii) the Registration Statement shall have been filed with the Commission and declared effective; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; and any request of the Commission for inclusion of additional information in the Registration Statement or otherwise shall have been complied with;
20 |
(iii) at least two-thirds of the votes cast by the Voting Members voting at the meeting of the Voting Members called for such purpose shall have voted to adopt and approve the Plan of Conversion and the transactions contemplated thereunder;
(iv) all consents and approvals of the Department and any other regulatory body or agency necessary to consummate the transactions contemplated by this Agreement shall have been obtained and all notice and waiting periods required by law to pass after receipt of such approvals or consents shall have passed; and
(v) the Shares shall have been authorized for listing on the Nasdaq Capital Market.
Section 9. Restrictions on Transfer.
(a) Except as set forth in Section 9(c), the Standby Purchaser shall not, and shall ensure that its Affiliates do not, directly or indirectly, purchase, sell, transfer, assign, lend, convey, gift, mortgage, pledge, encumber, hypothecate or otherwise dispose of, directly or indirectly (“Transfer”), any shares of Common Stock. Any purported Transfers of shares of Common Stock in violation of this Section 9 shall be null and void and no right, title or interest in or to such shares shall be Transferred to the purported transferee, buyer, donee, assignee or encumbrance holder. The Company will not give, and will not permit the Company’s transfer agent to give, any effect to such purported Transfer in its stock records.
(b) The Standby Purchaser understands and agrees that the Purchased Shares will bear a legend substantially similar to the legend set forth below in addition to any other legend that may be required by applicable law or by any agreement between the Company and the Standby Purchaser. The legend shall be removed to permit Transfers made in accordance with Sections 9(c)(i), 9(c)(ii) and 9(c)(iii) unless prohibited by the Securities Act. Alternatively, upon receipt of certifications from the Standby Purchaser reasonably satisfactory to the Company’s counsel, the Company shall cause the legend to be removed in accordance with, and pursuant to, Rule 144 promulgated under the Securities Act and any other applicable federal and state securities laws.
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR REGISTERED AND/OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE TRANSFERRED EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND REGISTRATION AND/OR QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS, (B) IN A TRANSACTION WHICH IS EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND REGISTRATION AND/OR QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS PROVIDED THAT AT THE ISSUER’S REQUEST, THE TRANSFEROR THEREOF SHALL HAVE DELIVERED TO THE ISSUER AN OPINION OF COUNSEL (WHICH OPINION SHALL BE IN FORM, SUBSTANCE AND SCOPE REASONABLY SATISFACTORY TO THE ISSUER) TO THE EFFECT THAT SUCH SECURITIES MAY BE SOLD OR TRANSFERRED PURSUANT TO AN EXEMPTION FROM SUCH REGISTRATION, OR (C) SUCH SECURITIES MAY BE SOLD PURSUANT TO RULE 144 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
21 |
(c) The provisions of Section 9(a) hereof shall not apply to any of the following Transfers by the Standby Purchaser of any shares of Common Stock:
(i) beginning on the third anniversary of the Closing Date, by offering or selling to Persons (other than to Persons party hereto or pursuant to clause (iii) below) shares of Common Stock pursuant to Section 9(d) hereof not more than six and one-quarter percent (6-1/4%) of the number equal to the Purchased Shares every ninety (90) days (the “90-Day Limit”);
(ii) pursuant to a tender or exchange offer to an acquiror seeking to acquire 100% of the Common Stock of the Company that has been approved by the Board prior to such sale;
(iii) to one or more members or Affiliates of the Standby Purchaser, provided that such member or Affiliate executes a written agreement in a form reasonably satisfactory to the Company to be bound by the terms and conditions hereof; and
(iv) occurring after the occurrence of a Standstill Termination Event.
(d) If and for so long as the Standby Purchaser beneficially owns any shares of the Common Stock and a First Offer Termination Event has not occurred, the Standby Purchaser shall provide the Company with not less than fifteen (15) Business Days prior written notice (the “Public Sale Notice”) on each occasion before offering to sell to Persons (other than to Persons party hereto or pursuant to Section 9(c)(ii) or 9(c)(iii) above) any shares of Common Stock that it is permitted to sell under the Securities Act (the “Offered Shares”). The Company shall have a right to notify the Standby Purchaser of the Company’s intent to purchase on or before the expiration of such fifteen (15) Business Days, all or any portion of such Offered Shares at a price per share equal to the greater of (i) the VWAP Price, or (ii) 95% times the Company’s then book value as calculated in accordance with GAAP (determined without regard to its accumulated other comprehensive income) for the most recent quarter preceding the date of the Public Sale Notice by at least forty-five (45) days.
If the Company fails (A) to exercise the foregoing right with respect to such Offered Shares within fifteen (15) Business Days after receipt of the Public Sale Notice and (B) to complete the purchase of such Offered Shares within ten (10) Business Days after receipt of all required regulatory approvals, the Standby Purchaser may sell such Offered Shares in the market in accordance with Section 9(c)(i) hereof.
Any repurchase by the Company pursuant to this Section 9(d) is subject to the prior approval of the Department, to the extent required under applicable Illinois law governing mutual-to-stock conversions or distributions by Federal Life. In the event that the Company exercises its right to purchase the Shares pursuant to this Section 9(d), (i) the Company shall use commercially reasonable efforts to obtain all required regulatory approvals of the purchase of the Shares as soon as practical and (ii) closing upon the purchase of the Shares will occur within ten (10) Business Days after all required regulatory approvals have been received.
22 |
(e) If, at any time while the Common Stock is listed on any public exchange, the per share price of the Common Stock exceeds 250% of the per share price as of Closing, the Company shall, at the written request of the Standby Purchaser, register the Offered Shares for resale under the Securities Act in accordance with the provisions of Exhibit B attached hereto, following which registration the restrictions of Section 9(a) through Section 9(d) shall terminate and be of no further force or effect.
(f) If the Standby Purchaser sells more than 5% of the outstanding shares of Common Stock to any Person prior to the occurrence of a Standstill Termination Event,, then such Person must enter into a standstill agreement reasonably acceptable to the Company containing provisions similar to those in Section 9(f), Section 10 and Section 12(a) of this Agreement.
Section 10. Post-Closing Standstill Provision. If and for so long as the Standby Purchaser beneficially owns more than five percent (5.0%) of the issued and outstanding shares of the Common Stock and a Standstill Termination Event has not occurred, the Standby Purchaser agrees that, without the prior written consent of the Board as specifically expressed in a resolution adopted by a majority of the entire membership of the Board (other than a designee of the Standby Purchaser), neither the Standby Purchaser, nor any of its Affiliates or Associates nor any Person acting at their direction or on their behalf, will, directly or indirectly:
(a) with respect to the Company or Common Stock, make, engage or in any way participate in, directly or indirectly, any “solicitation” (as such term is used in the proxy rules of the Commission) of proxies or consents (whether or not relating to the election or removal of directors); seek to advise, encourage or influence any Person with respect to the voting of any Common Stock (other than Affiliates or Associates); initiate, propose or otherwise “solicit” (as such term is used in the proxy rules of the Commission) shareholders of the Company for the approval of shareholder proposals whether made pursuant to Rule 14a-8 or Rule 14a-4 under the Exchange Act, or otherwise, or cause or encourage or attempt to cause or encourage any other Person to initiate any such shareholder proposal; otherwise communicate with the Company’s shareholders or others pursuant to Rule 14a-1(l)(2)(iv) under the Exchange Act; or participate in, or take any action pursuant to, any “shareholder access” proposal which may be adopted by the Commission, whether in accordance with previously proposed Rule 14a-11 or otherwise;
(b) take any action to cause the Company or any of its subsidiaries to be merged with or into or otherwise acquired (including any purchase of all of the stock or substantially all of the assets of the Company or any of its subsidiaries or any loss portfolio transfer involving any subsidiary of the Company) by Prosperity Life Insurance Company or any other insurance company or affiliate of an insurance company owned or controlled by the Standby Purchaser or any affiliate of the Standby Purchaser.
23 |
(c) seek, propose, or make any statement with respect to any merger, consolidation, business combination, tender or exchange offer, sale or purchase of assets, sale or purchase of securities, dissolution, liquidation, restructuring, recapitalization or similar transactions of or involving the Company or any of its Affiliates or Associates;
(d) except as otherwise permitted by this Agreement, acquire, offer or propose to acquire, or agree to acquire (except by way of stock dividends, stock splits, reverse stock splits or other distributions or offerings made available to holders of any shares of Common Stock generally), directly or indirectly, whether by purchase, tender or exchange offer, through the acquisition of control of another Person, by joining a partnership, limited partnership, syndicate or other “group” (within the meaning of Section 13(d)(3) of the Exchange Act) or otherwise, any shares of Common Stock, Equity Securities, or any loans, debt securities, or assets of the Company or any of its subsidiaries, or rights or options to acquire interests in any of the loans, debt securities, equity securities or assets of the Company or any of its subsidiaries;
(e) form, join or in any way participate in a “group” (within the meaning of Section 13(d)(3) of the Exchange Act) with respect to any shares of Common Stock;
(f) deposit any shares of Common Stock in any voting trust or subject any shares of Common Stock to any arrangement or agreement with respect to the voting of any shares of Common Stock;
(g) act alone or in concert with others to control or seek to control, or influence or seek to influence, the management, the Board or policies of the Company;
(h) make any demand or request for any shareholder list, or any related material, or for the books and records of the Company or its Affiliates;
(i) seek, alone or in concert with others, election or appointment to or representation on, or nominate or propose the nomination of any candidate to, the Board, or seek the removal of any member of the Board, in a manner inconsistent with this Agreement;
(j) have any discussions or communications, or enter into any arrangements, understanding or agreements (whether written or oral) with, or knowingly instigate, advise, finance, assist or encourage, any other Person in connection with any of the foregoing (including by granting any waiver to any legal, financial, public relations, proxy solicitation or other firm that represented or was engaged by the Standby Purchaser, its Affiliates, Associates or any of their legal counsel with respect to the Company, which waiver would permit any such firm to represent any Person in connection with matters relating to the Company), or make any investment in or enter into any arrangement with any other Person that engages, or offers or proposes to engage, in any of the foregoing;
(k) make or disclose any statement regarding any intent, purpose, plan or proposal with respect to the Board, the Company, its management, policies or affairs or any of its securities or assets or this Agreement that is inconsistent with the provisions of this Agreement, including any intent, purpose, plan or proposal that is conditioned on, or would require waiver, amendment, nullification or invalidation of, any provision of this Agreement or take any action that could require the Company to make any public disclosure relating to any such intent, purpose, plan, proposal or condition; or
24 |
(l) otherwise take, or solicit, cause or encourage others to take, any action inconsistent with any of the foregoing; provided, however, that the act of requesting that the Board consider any of the foregoing acts or actions taken in preparation of a privatization of the Company shall not constitute a breach of this Section 10.
Section 11. Post-Closing Pre-Emptive Rights.
(a) Subject to applicable securities laws, other than the Offerings, following the Closing Date, the Standby Purchaser shall have the right to purchase (its “Gross Up Right”) its pro rata share of all Equity Securities that the Company or any Subsidiary of the Company may, from time to time, propose to sell and issue after the date of this Agreement, other than the Equity Securities excluded by Sections 11(d) and 11(e) hereof. The Standby Purchaser’s pro rata share is equal to the ratio of (i) the total number of outstanding shares of the Common Stock that the Standby Purchaser is deemed to be a holder of immediately prior to the issuance of such Equity Securities to (ii) the total number of shares of the outstanding Common Stock (including all shares of the Common Stock issued or issuable upon conversion of any securities convertible into the Common Stock or upon the exercise of any outstanding warrants or options) immediately prior to the issuance of the Equity Securities.
(b) If the Company or a Subsidiary of the Company proposes to issue any Equity Securities, the Company shall give the Standby Purchaser written notice of its intention, describing the Equity Securities and the price and the terms and conditions upon which the Company or such Subsidiary proposes to issue the same. The Standby Purchaser shall have twenty (20) days from the receipt of such notice (the “Offer Period”) to notify the Company in writing that it intends to exercise its Gross Up Right and as to the amount of Equity Securities the Standby Purchaser intends to purchase, up to the maximum calculated in accordance with Section 11(a) hereof (the “Designated Securities”); provided, however, that if providing the Standby Purchaser twenty (20) days’ notice to respond is not practicable, the Company may provide an earlier deadline for the Standby Purchaser to respond to such notice by giving the Standby Purchaser the maximum number of days to respond as is practicable but in any event no fewer than five (5) days’ notice. Such notice from the Standby Purchaser shall constitute a non-binding indication of interest of the Standby Purchaser to purchase the amount of Designated Securities specified by the Standby Purchaser (or a proportionately lesser amount if the amount of Equity Securities to be offered if such offering of Equity Securities is subsequently reduced) at the price (or range of prices) and other terms set forth in the Company’s notice to it. The failure to respond during the Offer Period constitutes a waiver of its Gross Up Right in respect of such offering. The Standby Purchaser shall execute a binding agreement to purchase any such Equity Securities within thirty (30) days after expiration of the Offer Period, and any Equity Securities that the Standby Purchaser indicated it would purchase but that are not covered by a binding purchase agreement at such time may be sold to other Persons, unless the failure to execute such an agreement is attributable to actions of the Company or a Subsidiary of the Company, in which case the Company or such Subsidiary shall have the right to sell the Equity Securities to other Persons if the Standby Purchaser shall not have executed such an agreement within the later of (i) five (5) Business Days after the reason for such delay has been resolved or (ii) thirty (30) days after expiration of the Offer Period. Notwithstanding the foregoing, neither the Company nor such Subsidiary shall be required to offer or sell such Equity Securities to the Standby Purchaser if it would cause the Company or such Subsidiary to be in violation of applicable federal securities or insurance regulatory laws by virtue of such offer or sale.
25 |
(c) The Company or such Subsidiary shall have 90 days after expiration of the Offer Period to sell any Equity Securities in respect of which the Standby Purchaser’s Gross Up Rights were not exercised, at a price and upon general terms and conditions not materially more favorable to the purchasers thereof than specified in the Company’s notice to the Standby Purchaser pursuant to Section 11(b) hereof. If the Company or such Subsidiary has not sold such Equity Securities within such 90-day period, neither the Company nor such Subsidiary shall thereafter issue or sell any Equity Securities without first offering such Equity Securities to the Standby Purchaser in the manner provided above.
(d) The Gross Up Rights provided by this Section 11 shall not apply to, and shall terminate upon the earlier of (a) the first date upon which the Standby Purchaser no longer beneficially owns shares of the Common Stock representing more than five percent (5%) of the issued and outstanding shares of the Common Stock immediately prior to an issuance contemplated under Section 11(a) hereof, (b) the date of any breach by the Standby Purchaser of any material obligation under this Agreement that remains uncured after thirty (30) days’ notice thereof, or (c) the end of the Standstill Period.
(e) The provisions in this Section 11 shall not apply to any issuance of Equity Securities by the Company (i) to employees, consultants, officers or directors of the Company or any of its subsidiaries for the primary purpose of soliciting or retaining their employment or services or in a transaction or pursuant to management or employee agreements, incentive programs or stock purchase or equity compensation plans approved by the Board (including any such programs or plans in existence on the date hereof), (ii) to a third party as consideration in connection with (but not in connection with raising capital to fund) (A) a strategic business combination or other merger, acquisition or disposition transaction, partnership, joint venture, strategic alliance or investment by the Company or similar non-capital raising transaction approved by the Board, or (B) an investment by the Company or its subsidiaries approved by the Board in any party which is not prior to such transaction an Affiliate of the Company (whether by merger, consolidation, sale or exchange of stock, sale of assets or securities, or otherwise), (iii) as part of any offering registered under the Securities Act; provided, that the Standby Purchaser shall not be precluded by the Company, its underwriter(s) or its agent(s) in connection with such offering from purchasing in such offering, and the Company shall use commercially reasonable efforts to cause its underwriter(s) or agent(s) engaged in connection with such offering to allocate shares, on the same terms and conditions offered to the public, a sufficient number of Designated Securities, so as to maintain the Standby Purchaser’s pro rata share of all Equity Securities, (iv) upon the exercise, conversion or exchange of options, warrants or similar rights or other convertible securities, (v) the issuance of Equity Securities by a Subsidiary of the Company to the Company or one of its direct or indirect Subsidiaries and (vi) in connection with any stock split, stock dividend paid on a proportionate basis to all holders of the affected class of capital stock or recapitalization approved by the Board.
26 |
Section 12. Post-Closing Voting. If and for so long as the Standby Purchaser beneficially owns more than five percent (5.0%) of the shares of the Common Stock outstanding and a Standstill Termination Event has not occurred:
(a) subject to the final proviso of this paragraph, the Standby Purchaser shall vote and cause to be voted all shares of Common Stock beneficially owned by the Standby Purchaser (i) for persons nominated and recommended by the Board for election as directors of the Board and against any Person nominated for election as a director by any other Person and (ii) as directed or recommended by the Board with respect to any proposal presented at any meeting of the Company’s shareholders, including, but not limited to (A) the entire slate of directors recommended for election by the Board to the shareholders of the Company at any meeting of the Company’s shareholders at which any directors are elected, (B) any shareholder proposal submitted for a vote at any meeting of the Company’s shareholders, and (C) any proposal submitted by the Company for a vote at any meeting of the Company’s shareholders relating (x) to the appointment of the Company’s accountants or (y) an equity compensation plan of the Company and/or any material revisions thereto; provided, however, that the Standby Purchaser shall not be bound to vote in accordance with the foregoing provisions if the Company is in violation of a material obligation of this Agreement that remains uncured after fifteen (15) days’ notice thereof or if such proposal (1) would have a disproportionate effect on the Standby Purchaser compared to all of the other holders of the Common Stock as a group, (2) (other than the matters specified in clause (i)) requires approval of a related party transaction between the Company and one or more of its Affiliates other than as set forth in clauses (i), (ii)(A) and (ii)(C)(y), or (3) would result in nominees of the Standby Purchaser being removed from the Board.
(b) Notwithstanding the foregoing, so long as the Standby Purchaser owns 25% or more of the outstanding shares of Common Stock, without the affirmative vote or written approval of the Standby Purchaser, none of the Company, Federal Life, or FLMHC shall cause or permit, take or decide, or agree or commit to take any of the actions set forth on Exhibit C, and the Standby Purchaser shall have the right to vote its shares (or provide or withhold its written approval) with respect to such actions in its sole and absolute discretion.
Section 13. Exit Provisions.
(a) If, at any time prior to the ROFO Termination Date, the Standby Purchaser provides a written notice to the Company that the Standby Purchaser and those of its Affiliates who own Common Stock desire to sell the Common Stock held by such Persons (a “Potential Sale Notice”) the Company or its designee may, by written notice to the Standby Purchaser (a “Company Offer Notice”) delivered by the date that is the earlier of (i) the date that is six (6) months following the date of the Potential Sale Notice and (ii) the ROFO Termination Date, make a Qualifying Offer to purchase all, but not less than all, of the Common Stock held by the Standby Purchaser and its Affiliates. If the Standby Purchaser or such Affiliate accepts the Qualifying Offer contained in the Company Offer Notice, the Standby Purchaser shall notify the Company of such acceptance within ten (10) Business Days of receipt of such Company Offer Notice, and the closing of the sale of the Offered Shares to the Company or such designee shall occur on the later to occur of (x) thirty (30) days of such election and (y) ten (10) Business Days after any required regulatory approvals for such sale are received.
27 |
(b) If either (i) the Company confirms in writing that the Company will not provide a Company Offer Notice, (ii) the Company does not deliver a Company Offer Notice to the Standby Purchaser in the manner set forth in Section 13(a), (iii) the Company delivers a Company Offer Notice to the Standby Purchaser and fails to close on the purchase described in such Company Offer Notice for reasons other than the default by the Standby Purchaser or its Affiliates, or (iv) the Standby Purchaser or its applicable Affiliate does not accept the offer contained in the Company Offer Notice, then the Standby Purchaser and its Affiliates may (A) sell all or any portion of the Common Stock held by the Standby Purchaser or its Affiliates to a third party (subject to applicable Law) or (B) require the Company to register such Common Stock for resale under the Securities Act in accordance with the provisions of Exhibit B attached hereto; provided, that until the ROFO Termination Date, if the Company has delivered a Company Offer Notice to the Standby Purchaser, any such sale must be for a price that is not less than the price contained in the Company Offer Notice.
(c) For the purposes of this Section 13, a “Qualifying Offer” shall mean an offer for all but not less than all of the Common Stock owned by the Standby Purchaser and its Affiliates which (i) provides payment of the purchase price at closing in immediately available funds, (ii) is not subject to any contingency except receipt by the buyer of all required regulatory approvals, and (iii) is accompanied by commitment letters or other evidence, in each case, in form and substance reasonably acceptable to the Standby Purchaser, that the proposed buyer for such Common Stock will have the funds available to purchase such Common Stock in accordance with the terms set forth in the applicable Company Offer Notice.
(d) If (x) the Standby Purchaser disagrees with any material corporate action taken or proposed to be taken by the Company or Federal Life or (y) the Company or Federal Life fails to take any material corporate action proposed by the Standby Purchaser (either, a “Strategic Direction”) and the Standby Purchaser gives written notice thereof to the Company, the Company shall have ninety (90) days to rescind or terminate such Strategic Direction that is proposed to be taken, if such action is capable of being terminated or rescinded or, upon a failure to take action proposed by the Standby Purchaser, to take the action which is the subject of such Strategic Direction within one year after receipt of such written notice from the Standby Purchaser. If the Company fails to rescind or terminate such Strategic Direction or take the action which is the subject of such Strategic Direction within the applicable time period, upon receipt by the Company of written notice from the Standby Purchaser, then within six (6) months after receipt by the Company of such written notice from the Standby Purchaser, the Company shall either:
(i) Purchase or cause another Person to offer to purchase all of the Shares using the price set forth in Section 9(d) hereof; or
28 |
(ii) if such Shares have not been registered previously, register the Shares owned by the Standby Purchaser for resale under the Securities Act in accordance with the provisions of Exhibit B attached hereto, following which registration the restrictions of Section 9(a) through Section 9(d) shall terminate and be of no further force or effect.
In the event that the Company exercises its right to purchase the Shares pursuant to Section 13(d)(i) above, (i) the Company or its applicable designee shall use commercially reasonable efforts to obtain all required regulatory approvals of the purchase of the Shares as soon as practical and (ii) closing upon the purchase the Shares will occur within ten (10) Business Days after all required regulatory approvals have been received.
(e) On the occurrence of an ASE Event, (i) the Company shall, promptly upon the request of the Standby Purchaser, remove any restrictive legend on the shares of Common Stock owned by the Standby Purchaser, (ii) the restrictions on transfer in Section 9 hereof (other than the provisions of Section 9(f) hereof) shall terminate and be of no further force or effect, and (iii) the Standby Purchaser shall be permitted to sell such shares at any time and from time to time without any notice to the Company.
Section 14. Drag Along Rights.
(a) After the occurrence of a Standstill Termination Event, if a Stockholder who holds no less than 51% of the outstanding Common Stock of the Company (a “Dragging Stockholder”), receives a bona fide offer from a non-affiliated Third Party Purchaser to consummate, in one transaction, or a series of related transactions, a Change of Control (a “Drag-along Sale”), the Dragging Stockholder shall have the right to require that each other Stockholder (each, a “Drag-along Stockholder”) participate in such Transfer in the manner set forth in this Section 14, provided, however, that no Drag-along Stockholder shall be required to participate in the Drag-along Sale if the consideration for the Drag-along Sale is other than cash or registered securities listed on an established U.S. securities exchange or traded on the NASDAQ Stock Market. Notwithstanding anything to the contrary in this Agreement, each Drag-along Stockholder shall vote in favor of the transaction and take all actions to waive any dissenters, appraisal or other similar rights.
(b) The Dragging Stockholder shall exercise its rights pursuant to this Section 14 by delivering a written notice (the “Drag-along Notice”) to the Company and each Drag-along Stockholder no later than 20 Business Days prior to execution of an agreement to effect a Drag-along Sale. The Drag-along Notice shall make reference to the Dragging Stockholder’s rights and obligations hereunder and shall describe in reasonable detail:
(i) the number of shares of Common Stock to be sold by the Dragging Stockholder, if the Drag-along Sale is structured as a Transfer of Common Stock;
(ii) the identity of the Third Party Purchaser;
(iii) the proposed date, time and location of the closing of the Drag-along Sale;
29 |
(iv) the per share purchase price and the other material terms and conditions of the Transfer, including a description of any non-cash consideration in sufficient detail to permit the valuation thereof; and
(v) a copy of any form of agreement proposed to be executed in connection therewith.
(c) If the Drag-along Sale is structured as a Transfer of Common Stock, then, subject to Section 14(d), the Dragging Stockholder and each Drag-along Stockholder shall Transfer the number of shares equal to the product of (x) the aggregate number of shares of Common Stock the Third Party Purchaser proposes to buy as stated in the Drag-along Notice and (y) a fraction (A) the numerator of which is equal to the number of shares of Common Stock and Common Stock Equivalents then held by such Dragging Stockholder or Drag-along Stockholder, as the case may be, and (B) the denominator of which is equal to the number of shares of Common Stock and Common Stock Equivalents then held by all of the Stockholders (including, for the avoidance of doubt, the Dragging Stockholder).
(d) The consideration to be received by a Drag-along Stockholder shall be the same form and amount of consideration per share of Common Stock to be received by the Dragging Stockholder (or, if the Dragging Stockholder is given an option as to the form and amount of consideration to be received, the same option shall be given) and the terms and conditions of such Transfer shall, except as otherwise provided in the immediately succeeding sentence, be the same as those upon which the Dragging Stockholder Transfers its Common Stock. Each Drag-along Stockholder shall make or provide the same representations, warranties, covenants, and agreements as the Dragging Stockholder makes or provides in connection with the Drag-along Sale (except that in the case of representations, warranties, covenants, and agreements pertaining specifically to the Dragging Stockholder, the Drag-along Stockholder shall make the comparable representations, warranties, covenants, and agreements pertaining specifically to itself); provided, that all representations, warranties, covenants and indemnities shall be made by the Dragging Stockholder and each Drag-along Stockholder severally and not jointly and further provided that no Drag-along Stockholder shall be required to provide any indemnification to the Third Party Purchaser other than in respect of actions taken or defaults caused by such Drag-along Stockholder.
(e) The fees and expenses of the Dragging Stockholder incurred in connection with a Drag-along Sale shall be paid by the Dragging Stockholder to the extent not paid or reimbursed by the Company or the Third Party Purchaser.
(f) Each Drag-along Stockholder shall take all actions as may be reasonably necessary to consummate the Drag-along Sale, including entering into agreements and delivering certificates and instruments, in each case consistent with the agreements being entered into and the certificates being delivered by the Dragging Stockholder.
30 |
(g) The Dragging Stockholder shall have 120 days following the date of the Drag-along Notice in which to consummate the Drag-along Sale, on the terms set forth in the Drag-along Notice (which such 120 day period may be extended for a reasonable time not to exceed 180 days to the extent reasonably necessary to obtain any Government Approvals). If at the end of such period, the Dragging Stockholder has not completed the Drag-along Sale, the Dragging Stockholder may not then effect a transaction subject to this Section 14 without again fully complying with the provisions of this Section 14.
Section 15. Tag Along Rights.
(a) After the occurrence a Standstill Termination Event, except for transfers effected on an Exchange, if a Senior Management Shareholder or a Stockholder who holds no less than 51% of the outstanding Common Stock of the Company (the “Selling Stockholder”) proposes to Transfer any shares of its Common Stock to a Third Party Purchaser (the “Proposed Transferee”) and the Selling Stockholder cannot or has not elected to exercise its drag-along rights set forth in Section 14, each other Stockholder (each, a “Tag-along Stockholder”) shall be permitted to participate in such Transfer (a “Tag-along Sale”) on the terms and conditions set forth in this Section 15.
(b) Prior to the consummation of any such Transfer of Common Stock described in Section 15(a), the Selling Stockholder shall deliver to the Company and each other Stockholder a written notice (a “Sale Notice”) of the proposed Tag-along Sale subject to this Section 15 no later than 10 Business Days prior to the execution of an agreement for a Tag-along Sale. The Sale Notice shall make reference to the Tag-along Stockholders’ rights hereunder and shall describe in reasonable detail:
(i) the aggregate number of shares of Common Stock the Proposed Transferee has offered to purchase.
(ii) the identity of the Proposed Transferee;
(iii) the proposed date, time and location of the closing of the Tag-along Sale;
(iv) the per share purchase price and the other material terms and conditions of the Transfer, including a description of any non-cash consideration in sufficient detail to permit the valuation thereof; and
(v) a copy of any form of agreement proposed to be executed in connection therewith.
(c) Each Tag-along Stockholder shall exercise its right to participate in a Transfer of Common Stock by the Selling Stockholder subject to this Section 15 by delivering to the Selling Stockholder a written notice (a “Tag-along Notice”) stating its election to do so and specifying the number of shares of Common Stock to be Transferred by it no later than five Business Days after receipt of the Sale Notice (the “Tag-along Period”). The offer of each Tag-along Stockholder set forth in a Tag-along Notice shall be irrevocable, and, to the extent such offer is accepted, such Tag-along Stockholder shall be bound and obligated to Transfer in the proposed Transfer on the terms and conditions set forth in this Section 15. The Selling Stockholder and each Tag-along Stockholder shall have the right to Transfer in a Transfer subject to this Section 15 the number of shares of Common Stock equal to the product of (x) the aggregate number of shares of Common Stock the Proposed Transferee proposes to buy as stated in the Sale Notice and (y) a fraction (A) the numerator of which is equal to the number of shares of Common Stock and Common Stock Equivalents then held by the Selling Stockholder or such Tag-along Stockholder, as the case may be, and (B) the denominator of which is equal to the number of shares of Common Stock and Common Stock Equivalents then held by all of the Stockholders (including, for the avoidance of doubt, the Selling Stockholder).
31 |
(d) Each Tag-along Stockholder who does not deliver a Tag-along Notice in compliance with Section 15(c) above shall be deemed to have waived all of such Tag-along Stockholder’s rights to participate in such Transfer, and the Selling Stockholder shall (subject to the rights of any participating Tag-along Stockholder) thereafter be free to Transfer to the Proposed Transferee its shares of Common Stock at a per share price that is no greater than the per share price set forth in the Sale Notice and on terms and conditions which are not materially more favorable to the Selling Stockholder than those set forth in the Sale Notice without any further obligation to the non-accepting Tag-along Stockholders.
(e) Each Tag-along Stockholder participating in a Transfer pursuant to this Section 15 shall receive the same consideration per share as the Selling Stockholder after deduction of such Tag-along Stockholder’s proportionate share of the related expenses in accordance with Section 15(g) below.
(f) Each Tag-along Stockholder shall make or provide the same representations, warranties, covenants, and agreements as the Selling Stockholder makes or provides in connection with the Tag-along Sale (except that in the case of representations, warranties, covenants, and agreements pertaining specifically to the Selling Stockholder, the Tag-along Stockholder shall make the comparable representations, warranties, covenants, indemnities and agreements pertaining specifically to itself); provided, that all representations, warranties, and covenants shall be made by the Selling Stockholder and each Tag-along Stockholder severally and not jointly and provided further that no Tag-along Stockholder shall have any indemnification obligation to the Proposed Transferee other than in respect of actions taken or defaults caused by such Tag-along Stockholder.
(g) The Selling Stockholder and each Tag-along Stockholder shall be responsible for its own expenses.
(h) Each Tag-along Stockholder shall take all actions as may be reasonably necessary to consummate the Tag-along Sale, including entering into agreements and delivering certificates and instruments, in each case consistent with the agreements being entered into and the certificates being delivered by the Selling Stockholder.
(i) The Selling Stockholder shall have 120 Business Days following the expiration of the Tag-along Period in which to Transfer the shares of Common Stock described in the Sale Notice, on the terms set forth in the Sale Notice (which such 120 Business Day period may be extended for a reasonable time not to exceed 180 Business days to the extent reasonably necessary to obtain any Government Approvals). If at the end of such 120 Business day period, the Selling Stockholder has not completed such Transfer, the Selling Stockholder may not then effect a Transfer of Common Stock subject to this Section 15 without again fully complying with the provisions of this Section 15.
32 |
(j) If the Selling Stockholder Transfers to the Proposed Transferee any of its shares of Common Stock in breach of this Section 15, then each Tag-along Stockholder shall have the right to Transfer to the Selling Stockholder, and the Selling Stockholder undertakes to purchase from each Tag-along Stockholder, the number of shares of Common Stock that such Tag-along Stockholder would have had the right to Transfer to the Proposed Transferee pursuant to this Section 15, for a per share amount and form of consideration and upon the terms and conditions on which the Proposed Transferee bought such Common Stock from the Selling Stockholder, and without indemnity being granted by any Tag-along Stockholder to the Selling Stockholder; provided, that, nothing contained in this Section 15 shall preclude any Stockholder from seeking alternative remedies against such Selling Stockholder as a result of its breach of this Section 15. The Selling Stockholder shall also reimburse each Tag-along Stockholder for any and all reasonable and documented out-of-pocket fees and expenses, including reasonable legal fees and expenses, incurred pursuant to the exercise or the attempted exercise of the Tag-along Stockholder’s rights.
Section 16. Termination.
(a) This Agreement may be terminated at any time prior to the Closing Date:
(i) by the Company on one hand or the Standby Purchaser on the other hand by written notice to the other party hereto, if there is a material breach of this Agreement by the other party that is not cured within fifteen (15) days after receipt of written notice of such breach by such breaching party;
(ii) if, by action of FLMHC’s board of directors, FLMHC shall have decided to abandon the Plan of Conversion;
(iii) if the Plan of Conversion shall have been proposed for approval and adoption at a meeting of the Voting Members and shall have failed to receive approval at such meeting or any adjournment thereof or if the Department shall have stated in writing that it does not approve or intend to approve the Plan of Conversion;
(iv) the Closing has not occurred by December 31, 2018 (the “Outside Date”), provided that the party seeking to terminate this Agreement pursuant to this clause (iv) shall not have failed to perform the covenants, agreements and conditions to be performed by it which has been the primary cause of, or resulted in, the failure of the Closing to occur by the Outside Date, and further provided that if any approvals necessary to proceed with or complete the Conversion or the Offerings have not been received by December 1, 2018, either the Company or the Standby Purchaser may extend the Outside Date for up to six months by giving written notice thereof to the other party, so long as, in the case of an extension sought by the Company, each of the Company, FLMHC and Federal Life shall have performed the covenants, agreements and conditions to be performed by it; or
33 |
(v) if any Governmental Entity shall have issued an order, decree or ruling or taken any other action permanently restraining, enjoining or otherwise prohibiting the transactions contemplated by this Agreement and such order, decree, ruling or other action shall have become final and nonappealable or if the removal or reversal of such order, decree, ruling or other action should constitute a Burdensome Condition.
(b) In the event of termination of this Agreement pursuant to Section 16(a), written notice thereof shall as promptly as practicable be given to the other parties to this Agreement and this Agreement shall terminate and the transactions contemplated hereby shall be abandoned, without further action by any of the parties hereto. If this Agreement is terminated pursuant to Section 16(a):
(i) there shall be no liability or obligation on the part of the parties hereto or their respective officers and directors, and all obligations of the parties hereto shall terminate, except for (A) the obligations of the parties pursuant to this Section 17(b), and the provisions of Sections 17 through 23 and Section 25, and (B) any liabilities for any breach by the parties of the terms and conditions of this Agreement prior to such termination; and
(ii) all filings, applications and other submissions made pursuant to the transactions contemplated by this Agreement shall, to the extent practicable, be withdrawn from any Governmental Entity to which made.
Section 17. Survival. The representations and warranties of the Company and the Standby Purchaser contained in this Agreement or in any certificate delivered hereunder shall survive the Closing hereunder.
Section 18. Notices. All notices, communications and deliveries required or permitted by this Agreement shall be made in writing signed by the party making the same, shall specify the Section of this Agreement pursuant to which it is given or being made and shall be deemed given or made (i) on the date delivered if delivered by hand, (ii) on the third (3rd) Business Day after it is mailed if mailed by United States registered or certified mail (return receipt requested) (with postage and other fees prepaid), or (iii) on the day after it is delivered, prepaid, to an overnight express delivery service promising next business day delivery that confirms to the sender delivery to the recipient on such day, as follows:
(a) If to the Company, at: |
Federal Life Insurance Company 3750 Deerfield Road Riverwoods, Illinois 60015 Attention: William Austin, President |
(b) If to the Standby Purchaser, at: |
Insurance Capital Group, LLC 767 5th Avenue New York, New York 10153 Attention: Matthew T. Popoli |
34 |
or to such other representative or at such other address of a party as such party hereto may furnish to the other parties in writing in accordance with this Section 18. If notice is given pursuant to this Section 18 of any assignment to a permitted successor or assign of a party hereto, the notice shall be given as set forth above to such successor or permitted assign of such party.
Section 19. Assignment. This Agreement will be binding upon, and will inure to the benefit of and be enforceable by, the parties hereto and their respective successors and assigns. No party to this Agreement may assign this Agreement or any of its rights or obligations under this Agreement without the prior written consent of the other party hereto; provided that the Standby Purchaser may assign its rights and obligations hereunder to an Affiliate of the Standby Purchaser (excluding Prosperity Life Insurance Group or any subsidiary thereof) if the Standby Purchaser gives written notice of such assignment to the Company within five (5) Business Days thereof and the Standby Purchaser guarantees performance by such Affiliate of the Standby Purchaser’s obligations under this Agreement.
Section 20. Entire Agreement. This Agreement embodies the entire agreement and understanding between the parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, warranties, or undertakings, other than those set forth or referred to herein, with respect to the transactions contemplated by this Agreement. This Agreement supersedes all prior agreements and understandings between the parties with respect to the subject matter of this Agreement.
Section 21. Governing Law; Venue. This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania (other than its rules of conflict of laws to the extent the application of the laws of another jurisdiction would be required thereby). The state courts of the County of Philadelphia, Pennsylvania and the United States District Court for the Eastern District of Philadelphia shall have the exclusive jurisdiction over any and all claims, lawsuits and litigation relating to or arising out of this Agreement, the subject matter hereof or the transactions contemplated hereby. Each party hereto hereby irrevocably (a) submits to the personal jurisdiction of such courts over such party in connection with any litigation, proceeding or other legal action arising out of or in connection with this Agreement, and (b) waives to the fullest extent permitted by law any objection to the venue of any such litigation, proceeding or action which is brought in any such court.
Section 22. Severability. If any provision of this Agreement or the application thereof to any Person or circumstances is determined by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions hereof, or the application of such provision to Persons or circumstances other than those as to which it has been held invalid or unenforceable, shall remain in full force and effect and shall in no way be affected, impaired or invalidated thereby, so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner adverse to any party. Upon such determination, the parties shall negotiate in good faith in an effort to agree upon a suitable and equitable substitute provision to effect the original intent of the parties.
35 |
Section 23. Extension or Modification of Rights Offering. Without the prior written consent of the Standby Purchaser, the Company may (a) waive irregularities in the manner of exercise of the Rights, and (b) waive conditions relating to the method (but not the timing) of the exercise of the Rights.
Section 24. Most Favored Nation. Except as disclosed or set forth herein, during the period from the date of this Agreement through the Closing Date, neither the Company nor its subsidiaries shall enter into any additional, or modify any existing, agreements with any existing or future investors in the Company or any of its subsidiaries that have the effect of establishing rights, imposing restrictions or otherwise benefiting such investor in a manner more favorable in any material respect to such investor than the rights, restrictions and benefits established with respect to the Standby Purchaser in this Agreement, unless, in any such case, this Agreement has been amended to provide the Standby Purchaser with such additional rights and benefits or reduced restrictions.
Section 25. Miscellaneous.
(a) The obligations of the Company, FLMHC, and Federal Life under this Agreement shall be joint and several.
(b) The Company shall not after the date of this Agreement enter into any agreement with respect to its securities which is inconsistent with or violates the rights granted to the Standby Purchaser in this Agreement.
(c) The headings in this Agreement are for purposes of reference only and shall not limit or otherwise affect the meaning of this Agreement.
(d) This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which, when taken together, shall constitute one and the same instrument. In the event that any signature is delivered by facsimile transmission, or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof.
[Remainder of this page intentionally left blank.]
36 |
IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered as of the date first above written.
FEDERAL LIFE GROUP, INC. |
By: | /s/ William S. Austin | |
William S. Austin | ||
President |
FEDERAL LIFE MUTUAL HOLDING COMPANY |
By: | /s/ William S. Austin | |
William S. Austin | ||
President |
FEDERAL LIFE INSURANCE COMPANY |
By: | /s/ William S. Austin | |
William S. Austin | ||
President |
INSURANCE CAPITAL GROUP, LLC |
By: | /s/ Matthew T. Popoli | |
Matthew T. Popoli | ||
Senior Managing Director |
37 |
EXHIBIT A
Proposed Note Terms:
Issuer: FLMHC
Advances: The Note will be structured as a line of credit facility and the Standby Purchaser will make advances to the Issuer within five (5) days after the Issuer has made a written request to the Standby Purchaser for such advance, provided that the outstanding aggregate balance of all advances shall not exceed $2,000,000.
Maturity: 24 months from issuance
Rate: Interest shall accrue on the outstanding principal balance of the Note at a fixed rate of 3.75% per annum for the first 12 months (provided that such 12-month period shall be extended for up to six additional months if the Closing has been delayed in the manner described in the second proviso to Section 16(a)(iv)), and then a fixed rate of 10% per annum thereafter
Default Rate: Fixed rate of 10% per annum
Interest payment: Interest accrued each quarter will be paid on the last day of each quarter
Defaults: Non-payment, bankruptcy, non-compliance with covenants in Standby Purchase Agreement
Other terms: To be assumed by the Company upon closing of the Offerings, and the principal converted into shares of Common Stock on the completion of the Conversion at the Subscription Price.
38 |
EXHIBIT B
1. Definitions.
Capitalized terms used in this Exhibit B that are not defined in this Exhibit B shall have the meaning given to such terms in the Standby Stock Purchase Agreement. As used in this Agreement, the following capitalized defined terms shall have the following meanings:
“1933 Act” shall mean the Securities Act of 1933, as amended from time to time.
“1934 Act” shall mean the Securities Exchange Act of 1934, as amended from time to time.
“Company” shall mean Federal Life Group, Inc. and shall also include the Company’s successors.
“Depositary” shall mean The Depository Trust Company, or any other depositary appointed by the Company, provided, however, that such depositary must have an address in the Borough of Manhattan, in the City of New York.
“Person” shall mean an individual, partnership (general or limited), corporation, limited liability company, trust or unincorporated organization, or a government or agency or political subdivision thereof.
“Prospectus” shall mean the prospectus included in a Registration Statement, including any preliminary prospectus, and any such prospectus as amended or supplemented by any prospectus supplement, including any such prospectus supplement with respect to the terms of the offering of any portion of the Shares covered by a Shelf Registration Statement, and by all other amendments and supplements to a prospectus, including post-effective amendments, and in each case including all material incorporated by reference therein.
“Registration Expenses” shall mean any and all expenses incident to performance of or compliance by the Company with this Agreement, including without limitation: (i) all SEC, stock exchange or Financial Industry Regulatory Authority (“FINRA”) registration and filing fees, (ii) all fees and expenses incurred in connection with compliance with state securities or blue sky laws and compliance with the rules of FINRA (including reasonable fees and disbursements of counsel for any underwriters or the Standby Purchaser in connection with blue sky qualification of any of the Shares and any filings with FINRA), (iii) all expenses of any Persons in preparing or assisting in preparing, word processing, printing and distributing any Registration Statement, any Prospectus, any amendments or supplements thereto, any underwriting agreements, securities sales agreements and other documents relating to the performance of and compliance with this Agreement, (iv) all fees and expenses incurred in connection with the listing, if any, of any of the Shares on any securities exchange or exchanges, (v) the fees and disbursements of counsel for the Company and the fees and expenses of the independent registered public accounting firm of the Company, including the expenses of any special audits or “comfort” letters required by or incident to such performance and compliance, and (vi) any fees and disbursements of the underwriters customarily required to be paid by issuers or sellers of securities and the fees and expenses of any special experts retained by the Company in connection with any Registration Statement, but excluding underwriting discounts and commissions and transfer taxes, if any, relating to the sale or disposition of Shares by the Standby Purchaser.
39 |
“SEC” shall mean the United States Securities and Exchange Commission or any successor agency or government body performing the functions currently performed by the United States Securities and Exchange Commission.
“Shares” shall mean all shares of common stock owned by the Standby Purchaser that were acquired in the Community Offering.
“Shelf Registration” shall mean a registration effected pursuant to Section 2.1 of this Agreement.
“Shelf Registration Statement” shall mean a “shelf” registration statement of the Company pursuant to the provisions of Section 2.1 of this Agreement which covers all of the Shares on an appropriate form under Rule 415 under the 1933 Act, or any similar rule that may be adopted by the SEC, and all amendments and supplements to such registration statement, including post-effective amendments, in each case including the Prospectus contained therein, all exhibits thereto and all material incorporated by reference therein.
2. Registration Under the 1933 Act.
2.1 Registration of Shares. The Company shall, for the benefit of the Standby Purchaser, at the Company’s cost, (A) prepare and file with the SEC a Shelf Registration Statement within 120 days after receipt of a written request of the Standby Purchaser on or after the end of the Solicitation Period, on an appropriate form under the 1933 Act with respect to offers and sales of the Shares, and (B) use all commercially reasonable efforts to cause the Shelf Registration Statement to be declared effective under the 1933 Act within 120 days of the date of filing of the Shelf Registration Statement. The Company will:
(a) Use all commercially reasonable efforts to keep the Shelf Registration Statement continuously effective in order to permit the Prospectus forming part thereof to be usable by the Standby Purchaser for a period of two years from the date the Shelf Registration Statement becomes effective under the 1933 Act, or for such shorter period that will terminate when all Shares covered by the Shelf Registration Statement have been sold pursuant to the Shelf Registration Statement or cease to be owned by the Standby Purchaser (the “Effectiveness Period”); provided, however, that the Effectiveness Period in respect of the Shelf Registration Statement shall be extended to the extent required to permit dealers to comply with the applicable prospectus delivery requirements of Rule 174 under the 1933 Act and as otherwise provided herein.
40 |
(b) Notwithstanding any other provisions hereof, use all commercially reasonable efforts to ensure that (i) any Shelf Registration Statement and any amendment thereto and any Prospectus forming part thereof and any supplement thereto complies in all material respects with the 1933 Act and the rules and regulations thereunder, (ii) any Shelf Registration Statement and any amendment thereto does not, when it becomes effective, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading and (iii) any Prospectus forming part of any Shelf Registration Statement, and any supplement to such Prospectus (as amended or supplemented from time to time), does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements, in light of the circumstances under which they were made, not misleading.
The Company shall not permit any securities other than the Shares to be included in the Shelf Registration Statement. The Company further agrees, if necessary, to supplement or amend the Shelf Registration Statement, as required by Section 3(b) below, and to furnish to the Standby Purchaser copies of any such supplement or amendment promptly after its being used or filed with the SEC.
2.2 Expenses. The Company shall pay all Registration Expenses in connection with the registration pursuant to Section 2.1. The Standby Purchaser shall pay all underwriting discounts and commissions and transfer taxes, if any, relating to the sale or disposition of the Shares pursuant to the Shelf Registration Statement.
2.3 Effectiveness. (a) The Company will be deemed not to have used all commercially reasonable efforts to cause the Shelf Registration Statement to become, or to remain, effective during the requisite period if the Company voluntarily takes any action that would, or omits to take any action which omission would, result in any such Registration Statement not being declared or becoming effective or in the Standby Purchaser not being able to offer and sell the Shares during that period as and to the extent contemplated hereby, unless such action is required by applicable law.
(b) A Shelf Registration Statement pursuant to Section 2.1 hereof will not be deemed to have become effective unless it has been declared effective by the SEC or has otherwise become effective under the 1933 Act; provided, however, that if, after it has been declared or has otherwise become effective, the offering of Shares pursuant to a Shelf Registration Statement is interfered with by any stop order, injunction or other order or requirement of the SEC or any other governmental agency or court, such Registration Statement will be deemed not to have become effective during the period of such interference, until the offering of the Shares pursuant to such Registration Statement may legally resume.
3. Registration Procedures.
In connection with the obligations of the Company pursuant to Section 2.1, the Company shall:
(a) prepare and file with the SEC a Registration Statement on the appropriate form under the 1933 Act, which form (i) shall be selected by the Company, (ii) shall be available for the sale of the Shares by the Standby Purchaser, (iii) shall comply as to form in all material respects with the requirements of the applicable form and include or incorporate by reference all financial statements required by the SEC to be filed therewith or incorporated by reference therein, and (iv) shall comply in all material respects with the requirements of Regulation S-T under the 1933 Act, and use all commercially reasonable efforts to cause such Registration Statement to become effective and remain effective in accordance with Section 2 hereof;
41 |
(b) prepare and file with the SEC such amendments and post-effective amendments to such Registration Statement as may be necessary under applicable law to keep such Registration Statement effective for the applicable period; and cause the Prospectus to be supplemented by any required prospectus supplement, and as so supplemented to be filed pursuant to Rule 424 (or any similar provision then in force) under the 1933 Act and comply with the provisions of the 1933 Act, the 1934 Act and the rules and regulations thereunder applicable to them with respect to the disposition of all Shares covered by such Registration Statement during the applicable period in accordance with the intended method or methods of distribution by the Standby Purchaser;
(c) (i) notify the Standby Purchaser at least ten business days prior to filing, that a Shelf Registration Statement with respect to the Shares is being filed and advising the Standby Purchaser that the distribution of such Shares will be made in accordance with the method selected by Standby Purchaser; (ii) furnish to the Standby Purchaser and to each underwriter of an underwritten offering of such Shares, if any, without charge, as many copies of each Prospectus, including each preliminary Prospectus, and any amendment or supplement thereto and such other documents as the Standby Purchaser or underwriter may reasonably request, including financial statements and schedules and, if the Standby Purchaser so requests, all exhibits in order to facilitate the public sale or other disposition of such Shares; and (iii) hereby consents to the use of the Prospectus or any amendment or supplement thereto by the Standby Purchaser in connection with the offering and sale of the Shares covered by the Prospectus or any amendment or supplement thereto;
(d) use all commercially reasonable efforts to register or qualify the Shares under all applicable state securities or “blue sky” laws of such jurisdictions as the Standby Purchaser and each underwriter of an underwritten offering of Shares shall reasonably request by the time the applicable Registration Statement is declared effective by the SEC, and do any and all other acts and things which may be reasonably necessary or advisable to enable the Standby Purchaser and each underwriter to consummate the disposition in each such jurisdiction of the Shares; provided, however, that the Company shall not be required to (i) qualify as a foreign corporation or as a dealer in securities in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(d), or (ii) take any action which would subject it to general service of process or taxation in any such jurisdiction where it is not then so subject;
42 |
(e) notify promptly the Standby Purchaser and, if requested by the Standby Purchaser, confirm such advice in writing promptly (i) when a Registration Statement has become effective and when any post-effective amendments and supplements thereto become effective, (ii) of any request by the SEC or any state securities authority for post-effective amendments and supplements to a Registration Statement and Prospectus or for additional information after the Registration Statement has become effective, (iii) of the issuance by the SEC or any state securities authority of any stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose, (iv) if, between the effective date of a Registration Statement and the closing of any sale of Shares covered thereby, the representations and warranties of the Company contained in any underwriting agreement, securities sales agreement or other similar agreement, if any, relating to the offering cease to be true and correct in all material respects, (v) of the happening of any event or the discovery of any facts during the period a Registration Statement is effective which makes any statement made in such Registration Statement untrue in any material respect or which requires the making of any changes in such Registration Statement in order to make the statements therein not misleading, (vi) of the happening of any event or the discovery of any facts during the period a Registration Statement is effective which makes any statement in the related Prospectus untrue in any material respect or which requires the making of any changes in such Prospectus in order to make the statements therein, in light of the circumstances under which they were made, not misleading, (vii) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose and (viii) of any determination by the Company that a post-effective amendment to such Registration Statement would be appropriate;
(f) use all commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of a Registration Statement at the earliest possible moment;
(g) furnish to the Standby Purchaser, and each underwriter, if any, without charge, at least one conformed copy of each Registration Statement and any post-effective amendment thereto, including financial statements and schedules (without documents incorporated therein by reference and all exhibits thereto, unless requested);
(h) cooperate with the Standby Purchaser to facilitate the timely preparation and delivery of certificates representing such Shares (or statements of Shares owned, if the Company’s shares of common stock are issued in book entry only form) to be sold and not bearing any restrictive legends and registered in such names as the Standby Purchaser or the underwriters, if any, may reasonably request at least three business days prior to the closing of any sale of Shares;
(i) upon the occurrence of any event or the discovery of any facts, each as contemplated by Sections 3(e)(v), 3(e)(vi) and 3(e)(vii) hereof, as promptly as practicable after the occurrence of such an event, use all commercially reasonable efforts to prepare a supplement or post-effective amendment to the Registration Statement or the related Prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter delivered to the purchasers of the Shares, such Prospectus will not contain at the time of such delivery any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading or will remain so qualified. At such time as such public disclosure is otherwise made or the Company determines that such disclosure is not necessary, in each case to correct any misstatement of a material fact or to include any omitted material fact, the Company agrees promptly to notify the Standby Purchaser of such determination and to furnish the Standby Purchaser such number of copies of the Prospectus as amended or supplemented, as the Standby Purchaser may reasonably request;
43 |
(j) a reasonable time prior to the filing of any Registration Statement, any Prospectus, any amendment to a Registration Statement or amendment or supplement to a Prospectus or any document which is to be incorporated by reference into a Registration Statement or a Prospectus after initial filing of a Registration Statement, provide copies of such document to the Standby Purchaser; and make representatives of the Company as shall be reasonably requested by the Standby Purchaser available for discussion of such document;
(k) if not previously received, obtain a CUSIP number for all Shares not later than the effective date of a Registration Statement;
(l) enter into agreements (including underwriting agreements) and take all other customary and appropriate actions in order to expedite or facilitate the disposition of such Shares and in such connection whether or not an underwriting agreement is entered into and whether or not the registration is an underwritten registration:
(i) make such representations and warranties to the Standby Purchaser and the underwriters, if any, in form, substance and scope as are customarily made by issuers to underwriters in similar underwritten offerings as may be reasonably requested by them;
(ii) obtain opinions of counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the managing underwriters, if any, and the Standby Purchaser) addressed to the Standby Purchaser and the underwriters, if any, covering the matters customarily covered in opinions requested in sales of securities or underwritten offerings and such other matters as may be reasonably requested by the Standby Purchaser and underwriters;
(iii) obtain “comfort” letters and updates thereof from the Company’s independent registered public accounting firm (and, if necessary, any other independent registered public accounting firm of any subsidiary of the Company or of any business acquired by the Company for which financial statements are, or are required to be, included in the Registration Statement) addressed to the underwriters, if any, and use all commercially reasonable efforts to have such letter addressed to the Standby Purchaser (in accordance with AS 6101: Letters for Underwriters and Certain other Requesting Parties of the Public Company Accounting Oversight Board), such letters to be in customary form and covering matters of the type customarily covered in “comfort” letters to underwriters in connection with similar underwritten offerings;
(iv) enter into a securities sales agreement with the Standby Purchaser and an agent of the Standby Purchaser providing for, among other things, the appointment of such agent for the Standby Purchaser for the purpose of soliciting purchases of Shares, which agreement shall be in form, substance and scope customary for similar offerings;
44 |
(v) if an underwriting agreement is entered into, cause the same to set forth indemnification provisions and procedures substantially equivalent to the indemnification provisions and procedures set forth in Section 4 hereof with respect to the underwriters and all other parties to be indemnified pursuant to said Section or, at the request of any underwriters, in the form customarily provided to such underwriters in similar types of transactions; and
(vi) deliver such documents and certificates as may be reasonably requested and as are customarily delivered in similar offerings to the Standby Purchaser and the managing underwriters, if any.
The above shall be done at (i) the effectiveness of such Registration Statement (and each post-effective amendment thereto) and (ii) each closing under any underwriting or similar agreement as and to the extent required thereunder;
(m) make available for inspection by representatives of the Standby Purchaser, any underwriters participating in any disposition pursuant to a Shelf Registration Statement, and any counsel or accountant retained by any of the foregoing, all financial and other records, pertinent corporate documents and properties of the Company reasonably requested by any such persons, and cause the respective officers, directors, employees, and any other agents of the Company to supply all information reasonably requested by any such representative, underwriter, special counsel or accountant in connection with a Registration Statement, and make such representatives of the Company available for discussion of such documents as shall be reasonably requested by any such representative, underwriter, special counsel or accountant; provided that information which the Company determines in good faith, to be confidential and which it notifies such parties is confidential shall not be disclosed by such parties unless (i) such parties reasonably determine that the disclosure of such information is necessary to avoid or correct a material misstatement or omission in the applicable Registration Statement or the related Prospectus, (ii) such party reasonably determines, based on the advice of counsel, that disclosure of such information is required pursuant to a subpoena or other order for a court of competent jurisdiction or any other administrative agency or is otherwise required by applicable law, in which case each such party shall promptly notify, if permitted by applicable law, the Company, or (iii) such information has been made generally available to the public;
(n) a reasonable time prior to filing any Shelf Registration Statement, any Prospectus forming a part thereof, any amendment to such Shelf Registration Statement or amendment or supplement to such Prospectus, provide copies of such document to the Standby Purchaser, to counsel for the Standby Purchaser and to the underwriter or underwriters of an underwritten offering of Shares, if any, make such changes in any such document prior to the filing thereof as the counsel to the Standby Purchaser the underwriter or underwriters reasonably request and not file any such document in a form to which the Standby Purchaser, counsel for the Standby Purchaser or any underwriter shall not have previously been advised and furnished a copy of or to which the Standby Purchaser, counsel to the Standby Purchaser or any underwriter shall reasonably object, and make the representatives of the Company available for discussion of such document as shall be reasonably requested by the Standby Purchaser, counsel for the Standby Purchasers of Purchaser or any underwriter;
45 |
(o) use all commercially reasonable efforts to cause all Shares to be listed on any securities exchange on which shares of common stock of the Company are then listed if requested by the Standby Purchaser, or if requested by the underwriter or underwriters of an underwritten offering of Shares, if any;
(p) otherwise comply with all applicable rules and regulations of the SEC and make available to its security the Standby Purchasers, as soon as reasonably practicable, an earnings statement covering at least 12 months which shall satisfy the provisions of Section 11(a) of the 1933 Act and Rule 158 thereunder;
(q) cooperate and assist in any filings required to be made with FINRA and in the performance of any due diligence investigation by any underwriter and its counsel (including any “qualified independent underwriter” that is required to be retained in accordance with the rules and regulations of FINRA); and
(r) the Company may (as a condition to the Standby Purchaser’s participation in the Shelf Registration) require the Standby Purchaser to furnish to the Company such information regarding the Standby Purchaser and the proposed distribution by the Standby Purchaser of the Shares as the Company may from time to time reasonably request in writing.
The Standby Purchaser agrees that, upon receipt of any notice from the Company of (i) the happening of any event or the discovery of any facts, each of the kind described in Section 3(e)(v) or 3(e)(vi) hereof, or (ii) the good faith determination of the Board of Directors or the Chief Executive Officer and Chief Financial Officer of the Company that the continued effectiveness of the applicable Registration Statement and use of the Prospectus would require disclosure of confidential information related to a material acquisition or divestiture of assets or a material corporate transaction, event or development, the Standby Purchaser will forthwith discontinue disposition of Shares pursuant to a Registration Statement until the Standby Purchaser’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 3(k) hereof, and, if so directed by the Company, the Standby Purchaser will deliver to the Company (at its expense) all copies in the Standby Purchaser’s possession, other than permanent file copies then in the Standby Purchaser’s possession, of the Prospectus covering Shares current at the time of receipt of such notice; provided that the Company shall not allow the applicable Registration Statement to fail or cease to be effective or allow the Prospectus to be unusable pursuant to the provisions of this paragraph for more than 45 days during any year of effectiveness contemplated by Section 2 hereof. It is understood and agreed that the provisions of this paragraph shall not affect the Company’s obligations under Section 2.5 of this Agreement.
The Standby Purchaser hereby agrees with the Company that the Standby Purchaser of will not participate in any underwritten offering hereunder unless the Standby Purchaser completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents required under the terms of such underwriting arrangements.
46 |
4. Indemnification; Contribution.
(a) With respect to the Securities, the Company agrees to indemnify and hold harmless the Standby Purchaser, each Person who participates as an underwriter (any such Person being an “Underwriter”) and each Person, if any, who controls any such Person within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act with respect to the Securities as follows:
(i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement (or any amendment or supplement thereto) pursuant to which Shares were registered under the 1933 Act, including all documents incorporated therein by reference, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact contained in any Prospectus (or any amendment or supplement thereto) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
(ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to Section 4(d) below) any such settlement is effected with the written consent of the Company; and
(iii) against any and all expense whatsoever, as incurred (including the reasonable fees and disbursements of counsel chosen by any indemnified party), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under subparagraph (i) or (ii) above; provided, however, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information furnished to the Company by the Standby Purchaser or Underwriter expressly for use in a Registration Statement (or any amendment thereto) or any Prospectus (or any amendment or supplement thereto).
(b) The Standby Purchaser agrees to indemnify and hold harmless the Company, each Underwriter, and each of their respective directors and officers, and each Person, if any, who controls the Company or any Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act, against any and all loss, liability, claim, damage and expense described in the indemnity contained in Section 4(a) hereof, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Shelf Registration Statement (or any amendment thereto) or any Prospectus included therein (or any amendment or supplement thereto) in reliance upon and in conformity with written information with respect to such the Standby Purchaser furnished to the Company by such the Standby Purchaser expressly for use in the Shelf Registration Statement (or any amendment thereto) or such Prospectus (or any amendment or supplement thereto); provided, however, that the Standby Purchaser shall not be liable for any claims hereunder in excess of the amount of net proceeds received by the Standby Purchaser from the sale of Shares pursuant to such Shelf Registration Statement.
47 |
(c) Each indemnified party shall give notice as promptly as reasonably practicable to each indemnifying party of any action or proceeding commenced against it in respect of which indemnity may be sought hereunder, but failure so to notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement. An indemnifying party may participate at its own expense in the defense of such action; provided, however, that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to the indemnified party. No indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect of which indemnification or contribution could be sought under this Section 4 (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.
(d) If at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section 4(a)(ii) effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.
(e) If the indemnification provided for in this Section 4 is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, in such proportion as is appropriate to reflect the relative fault of the Company on the one hand and the Standby Purchaser, and Underwriters on the other hand in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable considerations.
48 |
The relative fault of the Company on the one hand and the Standby Purchaser, and Underwriters on the other hand shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company, the Standby Purchasers, or Underwriters and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
The Company, the Standby Purchasers, and Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 4 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 4. The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this Section 4 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged omission.
Notwithstanding the provisions of this Section 4, neither the Standby Purchaser nor any Underwriter shall be required to contribute any amount in excess of the amount by which the net proceeds received by the Standby Purchaser from the sale of the Shares exceeds the amount of any damages which the Standby Purchaser or Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission with respect to the Shares from the sale of the Shares.
No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.
For purposes of this Section 4, each Person, if any, who controls the Standby Purchaser or any Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as the Standby Purchaser or Underwriter and each director of the Company, and each Person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as the Company.
5. Miscellaneous.
5.1 Rule 144 and Rule 144A. For so long as the Company is subject to the reporting requirements of Section 13 or 15 of the 1934 Act, the Company covenants that it will file the reports required to be filed by it under the 1933 Act and Section 13(a) or 15(d) of the 1934 Act and the rules and regulations adopted by the SEC thereunder. If the Company ceases to be so required to file such reports, the Company covenants that it will upon the request of the Standby Purchaser (a) make publicly available such information as is necessary to permit sales pursuant to Rule 144 under the 1933 Act, (b) deliver such information to a prospective purchaser as is necessary to permit sales pursuant to Rule 144A under the 1933 Act and it will take such further action as the Standby Purchaser may reasonably request, and (c) take such further action that is reasonable in the circumstances, in each case, to the extent required from time to time to enable the Standby Purchaser to sell its Shares without registration under the 1933 Act within the limitation of the exemptions provided by (i) Rule 144 under the 1933 Act, as such Rule may be amended from time to time, (ii) Rule 144A under the 1933 Act, as such Rule may be amended from time to time, or (iii) any similar rules or regulations hereafter adopted by the SEC. Upon the request of the Standby Purchaser, the Company will deliver to the Standby Purchaser a written statement as to whether it has complied with such requirements.
49 |
5.2 Notices. All notices and other communications provided for or permitted hereunder shall be made in writing by hand delivery, registered first-class mail, email, or any courier guaranteeing overnight delivery (a) if to Standby Purchaser, initially at the Standby Purchaser’s address set forth in the Agreement, and thereafter at the most current address given by Standby Purchaser to the Company by means of a notice given in accordance with the provisions of this Section 5.4; and (b) if to the Company, initially at the Company’s address set forth in the Agreement, and thereafter at such other address of which notice is given in accordance with the provisions of this Section 5.4.
All such notices and communications shall be deemed to have been duly given: at the time delivered by hand, if personally delivered; two business days after being deposited in the mail, postage prepaid, if mailed; when receipt is acknowledged, if emailed; and on the next business day if timely delivered to an air courier guaranteeing overnight delivery.
Copies of all such notices, demands, or other communications shall be concurrently delivered by the person giving the same to the Trustee under the Indenture, at the address specified in such Indenture.
5.3 Specific Enforcement. Without limiting the remedies available to the Standby Purchaser, the Company acknowledges that any failure by the Company to comply with its obligations under Sections 2.1 through 2.4 hereof may result in material irreparable injury to the Standby Purchaser for which there is no adequate remedy at law, that it would not be possible to measure damages for such injuries precisely and that, in the event of any such failure, the Standby Purchaser may obtain such relief as may be required to specifically enforce the Company’s obligations under Sections 2.1 through 2.4 hereof.
50 |
EXHIBIT C
Major Decisions
· | Use of Proceeds – making use of the net proceeds of the Offerings (including the contribution or loan of such net proceeds to Federal Life or FLMHC); other than a contribution of at least $12,500,000 of such net proceeds, which shall be contributed to Federal Life immediately after the Closing. |
· | Merger, Consolidation, Sale of Assets or Sale of a Controlling Stake in the Company – the merger or consolidation of the Company or Federal Life with any Person or the sale, lease or other transfer of all or substantially all of the Company’s or Federal Life’s assets to any Person, or entry into any agreement to do any of the foregoing. |
· | Material Affiliate transactions - the entry into any material transaction with any Affiliate of the Company, FLMHC or Federal Life. |
51 |
AMENDMENT TO STANDBY STOCK PURCHASE AGREEMENT
THIS AMENDMENT TO STANDBY PURCHASE AGREEMENT (“Amendment”) is made effective as of September 12, 2018, by and among by and among Federal Life Group, Inc., a Pennsylvania corporation (the “Company”), Federal Life Insurance Company, an Illinois insurance company (“Federal Life”), Federal Life Mutual Holding Company, an Illinois corporation (“FLMHC”), and Insurance Capital Group, LLC (the “Standby Purchaser”).
BACKGROUND
A. The parties have entered into a Standby Stock Purchase Agreement dated as of March 8, 2018 (the “Agreement”), pursuant to which, among other things, the Standby Purchaser agreed to purchase Shares of the Company’s Common Stock in the Offerings.
B. The Parties desire to modify and amend the provisions of Section 2 of the Agreement.
NOW, THEREFORE, the parties hereto, each intending to be legally bound, hereby covenant and agree as follows:
1. Background. The Background provisions set forth above (including, but not limited to, the defined terms set forth therein) are hereby incorporated by reference into this Amendment and made a part hereof as if set forth in their entirety in this Section 1. Capitalized terms used in this Amendment which are not otherwise defined herein, but which are defined in the Agreement, shall have the respective meanings given to such terms in the Agreement.
2. Amendment to Section 2 of the Agreement. Section 2(b) of the Agreement shall be amended by deleting such section in its entirety and replacing the same with the following:
(b) Subject to the terms, conditions and limitations of this Agreement and to the availability of Shares after purchases made in the Subscription Offering, the Standby Purchaser agrees to purchase from the Company in the Community Offering, at the Subscription Price, such number of Shares which, when added to any Shares issued as a result of the exchange of the Exchangeable Note, shall result in the sale of Shares in the Offering equal to the number of Shares at the Minimum of the Valuation Range. In addition, the Standby Purchaser may purchase such number of additional Shares as will result in the total number of Shares issued to the Purchaser (including those issued in connection with the Exchangeable Note) equaling 2,800,000 Shares, provided that such purchase does not result in the total number of shares being issued in the Offering and upon conversion of the Exchangeable Note exceeding the maximum number of Shares offered in the Offering (the number of Shares purchased by the Standby Purchaser are referred to herein as the “Purchased Shares”)
3. Ratification of Agreement. The Agreement, as modified and amended hereby, and all of the respective liabilities, obligations, covenants, conditions, representations, and warranties set forth therein are hereby ratified and affirmed by each of the parties.
IN WITNESS WHEREOF, the parties hereto have executed this Amendment to Standby Stock Purchase Agreement.
FEDERAL LIFE GROUP, INC. | ||
By: | /s/ William S. Austin | |
WilliamS. Austin | ||
President | ||
FEDERAL LIFE MUTUAL HOLDING COMPANY | ||
By: | /s/ William S. Austin | |
WilliamS. Austin | ||
President | ||
FEDERAL LIFE INSURANCE COMPANY | ||
By: | /s/ William S. Austin | |
WilliamS. Austin | ||
President | ||
INSURANCE CAPITAL GROUP, LLC | ||
By: ICG Management, LLC, its managing member | ||
By: | /s/ Craig A. Huff | |
Name: | Craig A. Huff | |
Title: | Co-Managing Member | |
By: | /s/ Matthew T. Popoli | |
Name: | Matthew T. Popoli | |
Title: | Co-Managing Member |
Exhibit 10.6
EXECUTIVE AGREEMENT
Agreement made this 3rd day of March 2010 between FEDERAL LIFE INSURANCE COMPANY (MUTUAL), an Illinois mutual life insurance company (hereinafter referred to as the “Company”), and JOSEPH D. AUSTIN (hereinafter sometimes referred to as the “Chairman”).
Joseph D. Austin is presently employed by the Company as its Chairman and Chief Executive Officer.
The Board of Directors of the Company recognizes that his contribution to the growth and success of the Company since his election as Chief Executive Officer of the Company on June 21, 1977 has been most substantial. The Board desires to provide for the continued employment of the Chairman which the Board has determined will be in the best interests of the Company and its policyholders and will enforce and encourage the continued attention and dedication to the Company of the Chairman as its Chief Executive Officer. The Chairman is willing to commit himself to continue to serve the Company on the terms and conditions herein provided.
In order to effect the foregoing, the Company and the Chairman wish to enter into an agreement on the terms and conditions set forth below.
Accordingly, in consideration of the promises and the respective covenants and agreements herein contained, in further consideration of services performed and to be performed by the Chairman and intending to be legally bound, the parties hereto agree as follows:
1. Employment.
A. The Company agrees to employ the Chairman as Chief Executive Officer of the Company and the Chairman agrees to serve as the Chief Executive Officer of the Company during the term of employment as set forth in this Agreement. The Chairman shall report only to the Board of Directors of the Company and his powers and authority shall be superior to those of any officers or employees of the Company or of any subsidiaries thereof. The Chairman agrees to serve as a Director and as Chairman of the Board of Directors of the Company as well as serving as chairman or as a member of various committees of the Board of Directors as provided in the Company's By-Laws.
B. If at any time during the term of employment, the Board of Directors of the Company fails to re-elect the Chairman as the Chief Executive Officer and the policyholders fail to elect him as a Director of the Company, or removes the Chairman from such office or from such directorship, or if at any time during the term of this agreement, the Chairman shall fail to be vested by the Company with the powers and authority of the Chief Executive Officer of the Company, except in connection with a termination for material breach or just cause as hereinafter set forth in this Agreement, or if the ownership or control of the Company, including illustratively the power and right to elect a majority of the Board of Directors of the Company becomes vested directly or indirectly in persons other than persons who currently, as of the effective date hereof, have such power and right, the Chairman shall have the right, by written notice to the Company, to terminate his services hereunder effective as of the last day of the month following the receipt by the Company of any such written notice and the Chairman shall have no other obligations under this Agreement. The Chairman's termination of services under this Paragraph shall be treated as a termination of employment by the Company other than for material breach or just cause on the Chairman's part and, accordingly, shall be governed by the provisions of Paragraph 7A of this Agreement.
1
2. Term of Employment.
The initial term of employment, as this phrase is used throughout this Agreement, shall be for the period beginning on the date of this Agreement and ending three (3) years thereafter consistent with the provisions of Chapter 215 ILCS 5/245, as it exists at the time this Agreement is executed. This agreement is automatically extended each day for an additional day except that a notice of non-extension may be given at any time by the Board of Directors in which case the term of employment will expire at the end of its then current term.
3. Chairman's Duties During Term of Employment.
The Chairman shall devote his full business time (with allowances for vacations and sick leave) and attention and best efforts to the affairs of the Company and its subsidiaries and affiliates during the term of employment; provided, however, that he may serve as a director of other corporations and entities and may engage in other activities to the extent that they do not inhibit the performance of his duties hereof or conflict with the business of the Company or its subsidiaries and affiliates.
4. Compensation.
The Chairman's base salary will be determined each year by the Board of Directors at its annual meeting and will be paid in substantially equal monthly installments plus a bonus determined annually by the Board of Directors based upon the Board of Director's determination as to the Performance of the Chairman.
5. Other Benefits.
In addition to the compensation provided for herein, the Chairman shall be entitled to participate in any and all employee benefit programs of the Company as currently in effect. Further, the Chairman shall be entitled to receive prompt reimbursement for all expenses which he deems reasonably incurred by him in performing services hereunder provided such expenses are incurred and accounted for in accordance with the policies and procedures presently established by the Company.
6. Counsel Fees and Indemnification.
A. In the event that: (1) the Company terminates or seeks to terminate this Agreement alleging as justification for such termination a material breach by the Chairman or causes hereinafter set forth; the Chairman disputes such termination or attempted termination; and/or (2) the Chairman elects to terminate his services hereunder pursuant to Paragraph 1B of this Agreement; the Company disputes its obligations to pay to the Chairman that portion of his compensation as hereinafter provided; the Company shall pay or reimburse to the Chairman all reasonable costs incurred by him in such dispute, including attorney's fees and costs providing the Chairman shall prevail in such action.
2
B. The Company further represents and warrants: (1) that the Chairman is and shall continue to be covered and insured up to the maximum limits provided by all insurance that the Company maintains to indemnify its directors and officers (and to indemnify the Company for any obligations which it incurs as a result of its undertaking to indemnify its officers and directors) and (2) that the Company will exert its best efforts to maintain such insurance at least at its present limits in effect throughout the term of the Chairman's employment.
C. The Company hereby warrants and represents that the undertakings of payment indemnification and maintenance of such insurance coverage for the Chairman set out above are not in conflict with the charter of the Company or its By-Laws or with any validly existing agreement or other proper corporate action of the Company.
7. Termination.
A. Termination by the Company other than for Material or Just Cause.
If the Company shall terminate the Chairman's employment during the term of employment for other than a material breach of this Agreement or “just cause”, as herein defined, the Chairman shall have no obligation to seek other employment in mitigation of damages in respect of any period following the date of such termination and the Chairman shall be entitled to receive from the Company $515,000 per annum which shall be payable to the Chairman in monthly installments without regard to, or reduction because of, any other compensation or income which the Chairman receives or is entitled to receive whether from the Company or otherwise. It is stipulated that any payments made in accordance with the foregoing shall be paid to and received by the Chairman as liquidated damages for the unwarranted termination of his employment and not as penalties and he shall be entitled to receive no further sums under this Agreement except as such that have accrued as of the date of termination or as otherwise specifically provided in this Agreement. In view of the fact that the term of this Agreement is for three (3) years pursuant to the provisions of the aforesaid described Chapter 215 ILCS 5/245, it is contemplated that the payments provided to be made by virtue of this provision shall be completed at the expiration of three (3) years from the date of such termination.
B. Termination by the Company for Material Breach or for Just Cause.
“Just cause” shall mean willful misconduct, dishonesty, conviction of a felony, habitual drunkenness or excessive absenteeism not related to illness. Should the Chairman's employment be terminated for a material breach of this Agreement or for “just cause”, the Company shall be obligated to pay the Chairman his then base salary only through the end of the month during which such termination occurs plus such other sums as are payable to the Chairman under this Agreement and which have accrued as of the end of such month.
3
C. Termination by the Chairman.
Without prejudice to the provisions of Paragraph 1B of this Agreement, it is agreed that if during the term of employment the Chairman concludes because of changes in the composition of the Board of Directors of the Company or of other events or occurrences of material effect that he can no longer properly and effectively discharge his responsibilities as Chief Executive Officer of the Company, he may at any time resign as Director of the Company and from his position as Chairman and Chief Executive Officer of the Company after giving the Company not less than sixty (60) days prior written notice of the effective date of his resignation. Any such resignation shall not be deemed to be a material breach by the Chairman of this Agreement.
It is further agreed that upon such resignation, except for obligations of either party to the other which have accrued as of the date of the Chairman's resignation or as otherwise specifically provided in this Agreement, the Chairman shall be entitled to receive the compensation provided under Paragraph 7A of this Paragraph 7 as if such termination was by the Company other than for material breach or other just cause. It is provided, however, that the Chairman's obligation of non-disclosure as provided in Paragraph 11 of this Agreement shall remain undiminished and in full force and effect and the obligation of the Chairman under Paragraph 8 of this Agreement not to compete shall continue for the period during which payments continue to be made to the Chairman under the provisions of Paragraph 7A.
8. Non-Competition.
A. Except as is otherwise provided in Paragraph 7C, it is agreed that during the term of employment and during any period in which the Chairman is receiving compensation as provided in Paragraphs 4 and 7, the Chairman will not without the prior approval of the Board of Directors of the Company become an officer, employee, agent, partner or director of any business enterprise which is in substantial direct competition (as defined below) with the Company or any subsidiary or affiliate of the Company, as the business of the Company or any subsidiary or affiliate may be constituted during the term of employment or at the termination thereof.
B. If the Chairman's employment by the Company is terminated by the Chairman during the term of employment, the Chairman shall not during the period in which he is compensated under the provisions of Paragraphs 7A and 7C following such termination become an officer, employee, agent, partner or director of any business enterprise in substantial direct competition with the Company or any subsidiaries of the Company as the business of the Company or any said subsidiaries may be constituted at the time of such termination.
C. For the purpose of this Paragraph 8, a business enterprise with which the Chairman becomes associated as an officer, employee, agent, partner or director shall be considered in “substantial direct competition” if during a year when such competition is prohibited its sales of any product or service which is competitive with a product or service furnished by the Company or any subsidiary of the Company amount to more than ten percent (10%) of the Company's and subsidiaries' total combined sales of its product or services. This provision shall be effective during the period in which the Chairman is receiving payments from the Company under the provisions of Paragraphs 7A and 7C.
4
9. Effect of Death and Disability.
A. In the event of death of the Chairman during the period of employment, the legal representative of the Chairman shall be entitled to $515,000 to be paid in twelve (12) equal monthly installments beginning at the end of the month in which death occurs. These payments are in lieu of any other life insurance provided by the Company for the Chairman at the Company's expense. If other life insurance is provided to the Chairman at the Company's expense the payments provided for in this Paragraph will be reduced by the amount of the other life insurance. The period of employment shall be deemed to have ended as of the close of business on the last day of the month in which death shall have occurred but without prejudice to any payments due in respect to the Chairman's death.
B. If, as a result of the Chairman's incapacity due to physical or mental illness, the Chairman shall have been absent from his duties hereunder on a full-time basis for the entire period of nine (9) consecutive months, the period of employment shall be deemed to have ended as of the close of business on the last day of such nine (9) month period but without prejudice to any payments due to the Chairman in respect to disability.
In the event of disability of the Chairman during the period of employment, the Chairman shall be entitled to the base salary provided of in Paragraph 4 above at the rate being paid at the time of the commencement of disability for the first nine (9) month period of such disability. Thereafter, the President shall receive fifty percent (50%) of such rate being paid at the time of the commencement of disability for the remaining term provided for in this Agreement; provided however, that this Agreement after the expiration of the nine (9) month period shall be reduced by any payments to which the Chairman may be entitled for the payment period because of disability under any disability plan of the Company or of any subsidiary or affiliate thereof.
10. Successors or Assigns.
Any successor or assign (whether direct or indirect by purchase, merger, consolidation or change of control) shall absolutely and unconditionally assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no succession or assignment had taken place. The Company agrees that it will require any successor, or assign, under the circumstances herein above set forth, to expressly, absolutely and unconditionally assume and agree to perform this Agreement. Any failure of the Company to obtain such agreement prior to the effectiveness of any such succession or assignment shall be a material breach of this Agreement and shall entitle the Chairman to terminate under the provisions of Paragraph 7A. As used in this Paragraph, Company shall mean the Company as herein before defined and any successor of its business and/or assets as aforesaid which executes and delivers the agreement provided for in this Paragraph or which otherwise becomes bound by the terms and conditions of this Agreement by operation of law.
This Agreement shall inure to the benefit of and be enforceable by the Chairman's legal representative, executors, administrators, successors, heirs, devisees, designees and legatees. If the Chairman should die while any amounts are still payable to him hereunder such amounts unless otherwise provided for herein shall be paid in accordance with the terms of this Agreement to the Chairman's devisees, legatees, or other designees, or, if there be no such designees, to the Chairman's estate.
5
11. Non-Disclosure.
The Chairman agrees that he shall not at any time during or following his employment with the Company disclose or use, except in the course of his employment with the Company in the pursuit of the business of the Company or any of its subsidiaries and affiliates, any confidential information or proprietary data of the Company or any of its subsidiaries and affiliates whether such information or proprietary data is in his memory or embodied in writing or other physical form.
12. Conflicts.
Any paragraph, sentence, phrase or other provision of this Executive Agreement which is in conflict with any applicable statute, rule or other law shall be deemed, if possible, to be modified or altered to conform thereto or, if not possible, to be omitted herefrom. The invalidity of any portion hereof shall not affect the form and effect of the remaining valid portions hereof. Paragraph headings are included herein for convenience and are not intended to affect in any way the interpretation of any remaining paragraphs of this Agreement.
13. Governing Law.
This Executive Agreement is governed by and is to be construed in accordance with the laws of the State of Illinois.
14. Notice.
All notices shall be in writing and shall be deemed effective when delivered in person, or 48 hours after deposit thereof in the U.S. mails, postage pre-paid, for delivery as registered mail, return-receipt requested, addressed in the case of the Chairman to his last known address as carried on the personnel records of the Company and in the case of the Company to the corporate headquarters to the attention of the Secretary or to such other address as the parties to be notified may specify by notice to the other party.
15. Arbitration.
A. Any controversy or claim arising out of or relating to this Agreement or any breach thereof shall be settled by arbitration before three (3) arbitrators, as provided below, and judgment of the award rendered which the arbitrators, or at least a majority of the arbitrators, may be entered in any court having jurisdiction thereof,
B. Each party shall appoint a disinterested and neutral arbitrator and the two thus appointed shall appoint a third disinterested and neutral arbitrator. If the two arbitrators so chosen cannot agree on the appointment of a third arbitrator then such arbitrator shall be appointed by the then Chief Judge of the United States District Court of Illinois,
6
16. Modification.
Wherever necessary this Agreement will be modified to comply with IRS Code Section 409A.
Otherwise, no provision of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is agreed to in writing signed by the Chairman and the Company. No waiver by either party hereto at any time by any breach of any part hereto of any compliance with any conditions or provisions of this Agreement to be performed by such party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.
IN WITNESS WHEREOF, the Company, by order of its Board of Directors, has caused this Agreement, consisting of seven (7) pages, to be signed in its corporate name by its duly authorized Director and impressed with its corporate seal, attested by its Secretary and the Director has hereunto set his hand on the day and year first above written.
FEDERAL LIFE INSURANCE COMPANY (MUTUAL) | ||
By: | /s/ James H. Stacke | |
Director - Authorized |
[corporate seal]
ATTEST:
/s/ Judy A. Manning | /s/ Joseph D. Austin | |
Secretary | Joseph D. Austin |
7
Exhibit 10.7
EXECUTIVE AGREEMENT
Agreement made this 30th day of November 2017 between FEDERAL LIFE INSURANCE COMPANY, an Illinois stock life insurance company (hereinafter referred to as the “Company”), and WILLIAM S. AUSTIN (hereinafter sometimes referred to as the “President”).
William S. Austin is presently employed by the Company as its President and Chief Operating Officer.
The Board of Directors of the Company desires to provide for the continued employment of the President which the Board has determined will be in the best interests of the Company and its policyholders and will enforce and encourage the continued attention and dedication to the Company of the President. The President is willing to commit himself to continue to serve the Company on the terms and conditions herein provided.
In order to effect the foregoing, the Company and the President wish to enter into an agreement on the terms and conditions set forth below.
Accordingly, in consideration of the promises and the respective covenants and agreements herein contained, in further consideration of services performed and to be performed by the President and intending to be legally bound, the parties hereto agree as follows:
1. Employment.
A. The Company agrees to employ the President as President and Chief Operating Officer of the Company or in a capacity whose functions require an equivalent level of knowledge and responsibility to those now being performed. If at any time Joseph D. Austin retires, or otherwise terminates his employment then William S. Austin will be elected Chairman and Chief Executive Officer of the Company.
B. If at any time William S. Austin is not in employed as an officer as provided in Paragraph 1A, he shall have the right, by written notice to the Company, to terminate his services hereunder effective as of the last day of the month following the receipt by the Company of any such written notice and the he shall have no other obligations under this Agreement. His termination of services under this Paragraph shall be treated as a termination of employment by the Company other than for material breach or just cause on his part and accordingly, shall be governed by the provisions of Paragraph 7A of this Agreement.
2. Term of Employment.
The initial term of employment, as this phrase is used throughout this Agreement, shall be for the period beginning on the date of this Agreement and ending three (3) years thereafter consistent with the provisions of Chapter 215 ILCS 5/245, as it exists at the time this Agreement is executed. This agreement is automatically extended each day for an additional day except that a notice of non-extension may be given at any time by the Board of Directors in which case the term of employment will expire at the end of its then current term.
1
3. President's Duties During Term of Employment.
The President shall devote his full business time (with allowances for vacations and sick leave) and attention and best efforts to the affairs of the Company and its subsidiaries and affiliates during the term of employment; provided, however, that he may serve as a director of other corporations and entities and may engage in other activities to the extent that they do not inhibit the performance of his duties hereof or conflict with the business of the Company or its subsidiaries and affiliates.
4. Compensation.
The President’s base salary will be determined each year by the Board of Directors at its annual meeting and will be paid in substantially equal monthly installments plus a bonus determined annually by the Board of Directors based upon the Board of Directors’ determination as to the performance of the President.
5. Other Benefits.
In addition to the compensation provided for herein, the President shall be entitled to participate in any and all employee benefit programs of the Company as currently in effect. Further, the President shall be entitled to receive prompt reimbursement for all expenses which he deems reasonably incurred by him in performing services hereunder provided such expenses are incurred and accounted for in accordance with the policies and procedures presently established by the Company.
6. Counsel Fees and Indemnification.
A. In the event that: (1) the Company terminates or seeks to terminate this Agreement alleging as justification for such termination a material breach by the President or causes hereinafter set forth; the President disputes such termination or attempted termination; and/or (2) the President elects to terminate his services hereunder pursuant to Paragraph 1B of this Agreement; the Company disputes its obligations to pay to the President that portion of his base salary as hereinafter provided; the Company shall pay or reimburse to the President all reasonable costs incurred by him in such dispute, including attorney's fees and costs providing the President shall prevail in such action.
B. The Company further represents and warrants: (1) that the President is and shall continue to be covered and insured up to the maximum limits provided by all insurance that the Company maintains to indemnify its directors and officers (and to indemnify the Company for any obligations which it incurs as a result of its undertaking to indemnify its officers and directors) and (2) that the Company will exert its best efforts to maintain such insurance at least at its present limits in effect throughout the term of the President's employment.
C. The Company hereby warrants and represents that the undertakings of payment indemnification and maintenance of such insurance coverage for the President set out above are not in conflict with the charter of the Company or its By-Laws or with any validly existing agreement or other proper corporate action of the Company.
2
7. Termination.
A. Termination by the Company other than for Material or Just Cause.
If the Company shall terminate the President's employment during the term of employment for other than a material breach of this Agreement or “just cause”, as herein defined, the President shall have no obligation to seek other employment in mitigation of damages in respect of any period following the date of such termination and the President shall be entitled to receive from the Company the full base salary to which he is then entitled to the end of the term of employment which shall be payable to the President in monthly installments without regard to, or reduction because of, any other compensation or income which the President receives or is entitled to receive whether from the Company or otherwise. It is stipulated that any payments made in accordance with the foregoing shall be paid to and received by the President as liquidated damages for the unwarranted termination of his employment and not as penalties and he shall be entitled to receive no further sums under this Agreement except as such that have accrued as of the date of termination or as otherwise specifically provided in this Agreement. In view of the fact that the term of this Agreement is for three (3) years pursuant to the provisions of the aforesaid described Chapter 215 ILCS 5/245, it is contemplated that the payments provided to be made by virtue of this provision shall be completed at the expiration of three (3) years from the date of such termination.
It is further understood that coverage under the Home Office Employees’ Group Health Plan during the period when payments are being made under this Paragraph or Paragraph 7C will continue at the same price as if employment had continued.
B. Termination by the Company for Material Breach or for Just Cause.
“Just cause” shall mean willful misconduct, dishonesty, conviction of a felony, habitual drunkenness or excessive absenteeism not related to illness. Should the President's employment be terminated for a material breach of this Agreement or for “just cause”, the Company shall be obligated to pay the President his then base salary only through the end of the month during which such termination occurs plus such other sums as are payable to the President under this Agreement and which have accrued as of the end of such month.
C. Termination by the President.
Without prejudice to the provisions of Paragraph 1B of this Agreement, it is agreed that if during the term of employment the President’s duties are materially diminished he may at any time resign from his position as President and Chief Operating Officer of the Company after giving the Chief Executive Officer not less than sixty (60) days prior written notice of the effective date of his resignation. Any such resignation shall not be deemed to be a material breach by the President of this Agreement.
It is further agreed that upon such resignation, except for obligations of either party to the other which have accrued as of the date of the President's resignation or as otherwise specifically provided in this Agreement, the President shall be entitled to receive the compensation provided under Paragraph 7A of this Paragraph 7 as if such termination was by the Company other than for material breach or other just cause. It is provided, however, that the President's obligation of non-disclosure as provided in Paragraph 11 of this Agreement shall remain undiminished and in full force and effect and the obligation of the President under Paragraph 8 of this Agreement not to compete shall continue for the period during which payments continue to be made to the President under the provisions of Paragraph 7A.
3
8. Non-Competition.
A. Except as is otherwise provided in Paragraph 7C, it is agreed that during the term of employment and during any period in which the President is receiving compensation as provided in Paragraphs 4 and 7, the President will not without the prior approval of the Chairman of the Board become an officer, employee, agent, partner or director of any business enterprise which is in substantial direct competition (as defined below) with the Company or any subsidiary or affiliate of the Company, as the business of the Company or any subsidiary or affiliate may be constituted during the term of employment or at the termination thereof.
B. If the President's employment by the Company is terminated by the President during the term of employment, the President shall not during the period in which he is compensated under the provisions of Paragraphs 7A and 7C following such termination become an officer, employee, agent, partner or director of any business enterprise in substantial direct competition with the Company or any subsidiaries of the Company as the business of the Company or any said subsidiaries may be constituted at the time of such termination.
C. For the purpose of this Paragraph 8, a business enterprise with which the President becomes associated as an officer, employee, agent, partner or director shall be considered in “substantial direct competition” if during a year when such competition is prohibited its sales of any product or service which is competitive with a product or service furnished by the Company or any subsidiary of the Company amount to more than ten percent (10%) of the Company's and subsidiaries' total combined sales of its product or services. This provision shall be effective during the period in which the President is receiving payments from the Company under the provisions of Paragraphs 7A and 7C.
9. Effect of Death and Disability.
A. In the event of death of the President during the period of employment, the legal representative of the President shall be entitled to the base salary provided for in Paragraph 4 for the month in which death shall have taken place at the rate being paid at the time of death and the period of employment shall be deemed to have ended as of the close of business on the last day of the month in which death shall have occurred but without prejudice to any payments due in respect to the President's death.
It is further understood that the foregoing shall not foreclose the Board of Directors from voting to continue the compensation of the President to his widow for a reasonable period after his death.
4
B. If, as a result of the President's incapacity due to physical or mental illness, the President shall have been absent from his duties hereunder on a full-time basis for the entire period of nine (9) consecutive months, the period of employment shall be deemed to have ended as of the close of business on the last day of such nine (9) month period but without prejudice to any payments due to the President in respect to disability.
In the event of disability of the President during the period of employment, the President shall be entitled to the base salary provided of in Paragraph 4 above at the rate being paid at the time of the commencement of disability for the first nine (9) month period of such disability. Thereafter, the President shall receive fifty percent (50%) of such rate being paid at the time of the commencement of disability for the remaining term provided for in this Agreement; provided, however, that this Agreement after the expiration of the nine (9) month period shall be reduced by any payments to which the President may be entitled for the payment period because of disability under any disability plan of the Company or of any subsidiary or affiliate thereof.
10. Successors or Assigns.
Any successor or assign (whether direct or indirect by purchase, merger, consolidation or change of control) shall absolutely and unconditionally assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no succession or assignment had taken place. The Company agrees that it will require any successor, or assign, under the circumstances herein above set forth, to expressly, absolutely and unconditionally assume and agree to perform this Agreement. Any failure of the Company to obtain such agreement prior to the effectiveness of any such succession or assignment shall be a material breach of this Agreement and shall entitle the President to terminate under the provisions of Paragraph 7A. As used in this Paragraph, Company shall mean the Company as herein before defined and any successor of its business and/or assets as aforesaid which executes and delivers the agreement provided for in this Paragraph or which otherwise becomes bound by the terms and conditions of this Agreement by operation of law.
This Agreement shall inure to the benefit of and be enforceable by the President's legal representative, executors, administrators, successors, heirs, devisees, designees and legatees. If the President should die while any amounts are still payable to him hereunder such amounts unless otherwise provided for herein shall be paid in accordance with the terms of this Agreement to the President's devisees, legatees, or other designees, or, if there be no such designees, to the President's estate.
11. Non-disclosure.
The President agrees that he shall not at any time while receiving compensation from the Company disclose or use, except in the course of his employment with the Company in the pursuit of the business of the Company or any of its subsidiaries and affiliates, any confidential information or proprietary data of the Company or any of its subsidiaries and affiliates whether such information or proprietary data is in his memory or embodied in writing or other physical form.
5
12. Conflicts.
Any paragraph, sentence, phrase or other provision of this Executive Agreement which is in conflict with any applicable statute, rule or other law shall be deemed, if possible, to be modified or altered to conform thereto or, if not possible, to be omitted here from. The invalidity of any portion hereof shall not affect the form and effect of the remaining valid portions hereof. Paragraph headings are included herein for convenience and are not intended to affect in any way the interpretation of any remaining Paragraphs of this Agreement.
13. Governing Law.
This Executive Agreement is governed by and is to be construed in accordance with the laws of the State of Illinois.
14. Notice.
All notices shall be in writing and shall be deemed effective when delivered in person, or 48 hours after deposit thereof in the U.S. mails, postage pre-paid, for delivery as registered mail, return-receipt requested, addressed in the case of the President to his last known address as carried on the personnel records of the Company and in the case of the Company to the corporate headquarters to the attention of the Chief Executive Officer or to such other address as the parties to be notified may specify by notice to the other party.
15. Arbitration.
A. Any controversy or claim arising out of or relating to this Agreement or any breach thereof shall be settled by arbitration before three (3) arbitrators, as provided below, and judgment of the award rendered which the arbitrators, or at least a majority of the arbitrators, may be entered in any court having jurisdiction thereof.
B. Each party shall appoint a disinterested and neutral arbitrator and the two thus appointed shall appoint a third disinterested and neutral arbitrator. If the two arbitrators so chosen cannot agree on the appointment of a third arbitrator then such arbitrator shall be appointed by the then Chief Judge of the United States District Court of Illinois.
16. Representation and Warranties.
The Company represents and warrants that the execution of this Agreement by the Company has been duly authorized by resolution of its Board of Directors.
17. Modification.
Wherever necessary this Agreement will be modified to comply with IRS Code Section 409A.
Otherwise, no provision of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is agreed to in writing signed by the President and the Company. No waiver by either party hereto at any time by any breach of any part hereto of any compliance with any conditions or provisions of this Agreement to be performed by such party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.
6
IN WITNESS WHEREOF, the Company, by order of its Board of Directors, has caused this Agreement, consisting of ten (10) pages, to be signed in its corporate name by its duly authorized Director and impressed with its corporate seal, attested by its Secretary and the Director has hereunto set his hand on the day and year first above written.
FEDERAL LIFE INSURANCE COMPANY (MUTUAL) | ||
By: | /s/ James H. Stacke | |
Director - Authorized |
[corporate seal]
ATTEST:
/s/ Judy A. Manning | /s/ William S. Austin | |
Secretary | William S. Austin |
7
Exhibit 10.8
EXECUTIVE AGREEMENT
Agreement made this 3rd day of March 2010 between FEDERAL LIFE INSURANCE COMPANY (MUTUAL), an Illinois mutual life insurance company (hereinafter referred to as the “Company”), and MICHAEL AUSTIN (hereinafter sometimes referred to as the “Executive Vice President”).
Michael Austin is presently employed by the Company as its Executive Vice President and Chief Marketing Officer.
The Board of Directors of the Company desires to provide for the continued employment of the Executive Vice President which the Board has determined will be in the best interests of the Company and its policyholders and will enforce and encourage the continued attention and dedication to the Company of the Executive Vice President. The Executive Vice President is willing to commit himself to continue to serve the Company on the terms and conditions herein provided.
In order to effect the foregoing, the Company and the Executive Vice President wish to enter into an agreement on the terms and conditions set forth below.
Accordingly, in consideration of the promises and the respective covenants and agreements herein contained, in further consideration of services performed and to be performed by the Executive Vice President and intending to be legally bound, the parties hereto agree as follows:
1. Employment.
A. The Company agrees to employ the Executive Vice President as Executive Vice President and Chief Marketing Officer of the Company or in a capacity whose functions require an equivalent level of knowledge and responsibility to those now being performed.
B. If at any time during the term of employment, the Board of Directors of the Company fails to re-elect the Executive Vice President, or removes the Executive Vice President from such office at any time during the term of this agreement, the Executive Vice President shall have the right, by written notice to the Company, to terminate his services hereunder effective as of the last day of the month following the receipt by the Company of any such written notice and the Executive Vice President shall have no other obligations under this Agreement. The Executive Vice President's termination of services under this Paragraph shall be treated as a termination of employment by the Company other than for material breach or just cause on the Executive Vice President's part and, accordingly, shall be governed by the provisions of Paragraph 7A of this Agreement.
2. Term of Employment.
The initial term of employment, as this phrase is used throughout this Agreement, shall be for the period beginning on the date of this Agreement and ending three (3) years thereafter consistent with the provisions of Chapter 215 ILCS 5/245, as it exists at the time this Agreement is executed. This agreement is automatically extended each day for an additional day except that a notice of non-extension may be given at any time by the Board of Directors in which case the term of employment will expire at the end of its then current term.
1
3. Executive Vice President's Duties During Term of Employment.
The Executive Vice President shall devote his full business time (with allowances for vacations and sick leave) and attention and best efforts to the affairs of the Company and its subsidiaries and affiliates during the term of employment; provided, however, that he may serve as a director of other corporations and entities and may engage in other activities to the extent that they do not inhibit the performance of his duties hereof or conflict with the business of the Company or its subsidiaries and affiliates.
4. Compensation.
The Executive Vice President's base salary will be determined each year by the Board of Directors at its annual meeting and will be paid in substantially equal monthly installments plus a bonus determined annually by the Board of Directors based upon the Board of Directors' determination as to the performance of the Executive Vice President.
5. Other Benefits.
In addition to the compensation provided for herein, the Executive Vice President shall be entitled to participate in any and all employee benefit programs of the Company as currently in effect. Further, the Executive Vice President shall be entitled to receive prompt reimbursement for all expenses which he deems reasonably incurred by him in performing services hereunder provided such expenses are incurred and accounted for in accordance with the policies and procedures presently established by the Company.
6. Counsel Fees and Indemnification.
A. In the event that: (1) the Company terminates or seeks to terminate this Agreement alleging as justification for such termination a material breach by the Executive Vice President or causes hereinafter set forth; the Executive Vice President disputes such termination or attempted termination; and/or (2) the Executive Vice President elects to terminate his services hereunder pursuant to Paragraph 1B of this Agreement; the Company disputes its obligations to pay to the Executive Vice President that portion of his base salary as hereinafter provided; the Company shall pay or reimburse to the Executive Vice President all reasonable costs incurred by him in such dispute, including attorney's fees and costs providing the Executive Vice President shall prevail in such action.
B. The Company further represents and warrants: (1) that the Executive Vice President is and shall continue to be covered and insured up to the maximum limits provided by all insurance that the Company maintains to indemnify its directors and officers (and to indemnify the Company for any obligations which it incurs as a result of its undertaking to indemnify its officers and directors) and (2) that the Company will exert its best efforts to maintain such insurance at least at its present limits in effect throughout the term of the Executive Vice President's employment.
2
C. The Company hereby warrants and represents that the undertakings of payment indemnification and maintenance of such insurance coverage for the Executive Vice President set out above are not in conflict with the charter of the Company or its By-Laws or with any validly existing agreement or other proper corporate action of the Company.
7. Termination.
A. Termination by the Company other than for Material or Just Cause.
If the Company shall terminate the Executive Vice President's employment during the term of employment for other than a material breach of this Agreement or “just cause”, as herein defined, the Executive Vice President shall have no obligation to seek other employment in mitigation of damages in respect of any period following the date of such termination and the Executive Vice President shall be entitled to receive from the Company the full base salary to which he is then entitled to the end of the term of employment which shall be payable to the Executive Vice President in monthly installments without regard to, or reduction because of, any other compensation or income which the Executive Vice President receives or is entitled to receive whether from the Company or otherwise. It is stipulated that any payments made in accordance with the foregoing shall be paid to and received by the Executive Vice President as liquidated damages for the unwarranted termination of his employment and not as penalties and he shall be entitled to receive no further sums under this Agreement except as such that have accrued as of the date of termination or as otherwise specifically provided in this Agreement. In view of the fact that the term of this Agreement is for three (3) years pursuant to the provisions of the aforesaid described Chapter 215 ILCS 5/245, it is contemplated that the payments provided to be made by virtue of this provision shall be completed at the expiration of three (3) years from the date of such termination.
It is further understood that coverage under the Home Office Employees' Group Health Plan during the period when payments are being made under this Paragraph or Paragraph 7C will continue at the same price as if employment had continued.
B. Termination by the Company for Material Breach or for Just Cause.
“Just cause” shall mean willful misconduct, dishonesty, conviction of a felony, habitual drunkenness or excessive absenteeism not related to illness. Should the Executive Vice President's employment be terminated for a material breach of this Agreement or for “just cause”, the Company shall be obligated to pay the Executive Vice President his then base salary only through the end of the month during which such termination occurs plus such other sums as are payable to the Executive Vice President under this Agreement and which have accrued as of the end of such month.
C. Termination by the Executive Vice President.
Without prejudice to the provisions of Paragraph 1B of this Agreement, it is agreed that if during the term of employment the Executive Vice President's duties are materially diminished he may at any time resign from his position as Executive Vice President -Marketing of the Company after giving the Chief Executive Officer not less than sixty (60) days prior written notice of the effective date of his resignation. Any such resignation shall not be deemed to be a material breach by the Executive Vice President of this Agreement.
3
It is further agreed that upon such resignation, except for obligations of either party to the other which have accrued as of the date of the Executive Vice President's resignation or as otherwise specifically provided in this Agreement, the Executive Vice President shall be entitled to receive the compensation provided under Paragraph 7A of this Paragraph 7 as if such termination was by the Company other than for material breach or other just cause, It is provided, however, that the Executive Vice President's obligation of non-disclosure as provided in Paragraph 11 of this Agreement shall remain undiminished and in full force and effect and the obligation of the Executive Vice President under Paragraph 8 of this Agreement not to compete shall continue for the period during which payments continue to be made to the Executive Vice President under the provisions of Paragraph 7A.
8. Non-Competition.
A. Except as is otherwise provided in Paragraph 7C, it is agreed that during the term of employment and during any period in which the Executive Vice President is receiving compensation as provided in Paragraphs 4 and 7, the Executive Vice President will not without the prior approval of the Chairman of the Board become an officer, employee, agent, partner or director of any business enterprise which is in substantial direct competition (as defined below) with the Company or any subsidiary or affiliate of the Company, as the business of the Company or any subsidiary or affiliate may be constituted during the term of employment or at the termination thereof.
B. If the Executive Vice President's employment by the Company is terminated by the Executive Vice President during the term of employment, the Executive Vice President shall not during the period in which he is compensated under the provisions of Paragraphs 7A and 7C following such termination become an officer, employee, agent, partner or director of any business enterprise in substantial direct competition with the Company or any subsidiaries of the Company as the business of the Company or any said subsidiaries may be constituted at the time of such termination.
C. For the purpose of this Paragraph 8, a business enterprise with which the Executive Vice President becomes associated as an officer, employee, agent, partner or director shall be considered in “substantial direct competition” if during a year when such competition is prohibited its sales of any product or service which is competitive with a product or service furnished by the Company or any subsidiary of the Company amount to more than ten percent (10%) of the Company's and subsidiaries' total combined sales of its product or services. This provision shall be effective during the period in which the Executive Vice President is receiving payments from the Company under the provisions of Paragraphs 7A and 7C.
9. Effect of Death and Disability.
A. In the event of death of the Executive Vice President during the period of employment, the legal representative of the Executive Vice President shall be entitled to the base salary provided for in Paragraph 4 for the month in which death shall have taken place at the rate being paid at the time of death and the period of employment shall be deemed to have ended as of the close of business on the last day of the month in which death shall have occurred but without prejudice to any payments due in respect to the Executive Vice President's death.
4
It is further understood that the foregoing shall not foreclose the Board of Directors from voting to continue the compensation of the Executive Vice President to his widow for a reasonable period after his death.
B. If, as a result of the Executive Vice President's incapacity due to physical or mental illness, the Executive Vice President shall have been absent from his duties hereunder on a full-time basis for the entire period of nine (9) consecutive months, the period of employment shall be deemed to have ended as of the close of business on the last day of such nine (9) month period but without prejudice to any payments due to the Executive Vice President in respect to disability,
In the event of disability of the Executive Vice President during the period of employment, the Executive Vice President shall be entitled to the base salary provided of in Paragraph 4 above at the rate being paid at the time of the commencement of disability for the first nine (9) month period of such disability. Thereafter, the Executive Vice President shall receive fifty percent (50%) of such rate being paid at the time of the commencement of disability for the remaining term provided for in this Agreement; provided, however, that this Agreement after the expiration of the nine (9) month period shall be reduced by any payments to which the Executive Vice President may be entitled for the payment period because of disability under any disability plan of the Company or of any subsidiary or affiliate thereof.
10. Successors or Assigns,
Any successor or assign (whether direct or indirect by purchase, merger, consolidation or change of control) shall absolutely and unconditionally assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no succession or assignment had taken place. The Company agrees that it will require any successor, or assign, under the circumstances herein above set forth, to expressly, absolutely and unconditionally assume and agree to perform this Agreement. Any failure of the Company to obtain such agreement prior to the effectiveness of any such succession or assignment shall be a material breach of this Agreement and shall entitle the Executive Vice President to terminate under the provisions of Paragraph 7A. As used in this Paragraph, Company shall mean the Company as herein before defined and any successor of its business and/or assets as aforesaid which executes and delivers the agreement Page 7 provided for in this Paragraph or which otherwise becomes bound by the terms and conditions of this Agreement by operation of law.
This Agreement shall inure to the benefit of and be enforceable by the Executive Vice President's legal representative, executors, administrators, successors, heirs, devisees, designees and legatees. If the Executive Vice President should die while any amounts are still payable to him hereunder such amounts unless otherwise provided for herein shall be paid in accordance with the terms of this Agreement to the Executive Vice President's devisees, legatees, or other designees, or, if there be no such designees, to the Executive Vice President's estate.
5
11. Non-Disclosure.
The Executive Vice President agrees that he shall not at any time while receiving compensation from the Company disclose or use, except in the course of his employment with the Company in the pursuit of the business of the Company or any of its subsidiaries and affiliates, any confidential information or proprietary data of the Company or any of its subsidiaries and affiliates whether such information or proprietary data is in his memory or embodied in writing or other physical form.
12. Conflicts.
Any paragraph, sentence, phrase or other provision of this Executive Agreement which is in conflict with any applicable statute, rule or other law shall be deemed, if possible, to be modified or altered to conform thereto or, if not possible, to be omitted here from. The invalidity of any portion hereof shall not affect the form and effect of the remaining valid portions hereof. Paragraph headings are included herein for convenience and are not intended to affect in any way the interpretation of any remaining Paragraphs of this Agreement.
13. Governing Law.
This Executive Agreement is governed by and is to be construed in accordance with the laws of the State of Illinois.
14. Notice.
All notices shall be in writing and shall be deemed effective when delivered in person, or 48 hours after deposit thereof in the U.S. mails, postage pre-paid, for delivery as registered mail, return-receipt requested, addressed in the case of the Executive Vice President to his last known address as carried on the personnel records of the Company and in the case of the Company to the corporate headquarters to the attention of the Chief Executive Officer or to such other address as the parties to be notified may specify by notice to the other party.
15. Arbitration.
A. Any controversy or claim arising out of or relating to this Agreement or any breach thereof shall be settled by arbitration before three (3) arbitrators, as provided below, and judgment of the award rendered which the arbitrators, or at least a majority of the arbitrators, may be entered in any court having jurisdiction thereof.
B. Each party shall appoint a disinterested and neutral arbitrator and the two thus appointed shall appoint a third disinterested and neutral arbitrator. If the two arbitrators so chosen cannot agree on the appointment of a third arbitrator then such arbitrator shall be appointed by the then Chief Judge of the United States District Court of Illinois.
16. Representation and Warranties.
The Company represents and warrants that the execution of this Agreement by the Company has been duly authorized by resolution of its Board of Directors.
6
17. Modification.
Wherever necessary this Agreement will be modified to comply with IRS Code Section 409A.
Otherwise, no provision of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is agreed to in writing signed by the Executive Vice President and the Company. No waiver by either party hereto at any time by any breach of any part hereto of any compliance with any conditions or provisions of this Agreement to be performed by such party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.
IN WITNESS WHEREOF, the Company, by order of its Board of Directors, has caused this Agreement, consisting of ten (10) pages, to be signed in its corporate name by its duly authorized Director and impressed with its corporate seal, attested by its Secretary and the Director has hereunto set his hand on the day and year first above written.
FEDERAL LIFE INSURANCE COMPANY (MUTUAL) | ||
By: | /s/ James H. Stacke | |
Director - Authorized |
[corporate seal]
ATTEST:
/s/ Judy A. Manning | /s/ Michael Austin | |
Secretary | Michael Austin |
7
Exhibit 10.9
ESCROW AGREEMENT
This ESCROW AGREEMENT (as the same may be amended or modified from time to time pursuant hereto, this “Agreement”) is made and entered into as of September 12, 2018, by and among Griffin Financial Group, LLC, a Pennsylvania limited liability company (the “Placement Agent”), Federal Life Group, Inc., a Pennsylvania corporation (the “Company”, and together with the Placement Agent, sometimes referred to individually as “Party” or collectively as the “Parties”), Federal Life Insurance Company (“Federal Life”), and Computershare Trust Company, N.A. (the “Escrow Agent”).
WHEREAS, the Company will offer to sell shares of its common stock, par value $0.01 per share (the “Shares”), to certain persons in a public offering registered under the Securities Act of 1933, as amended, pursuant to a registration statement and prospectus filed with the United States Securities and Exchange Commission (the “Prospectus”); and
WHEREAS, the Company has engaged the Placement Agent to assist the Company in connection with the sale of Shares pursuant to the terms of that certain letter agreement, dated as of July 27, 2017 (the “Engagement Letter”), by and between the Company and the Placement Agent; and
WHEREAS, potential purchasers of the Shares (the “Investors”) will submit subscriptions and orders to purchase Shares together with payment of the purchase price for such Shares; and
WHEREAS, the Company must receive and accept subscriptions and orders for at least 3,400,000 Shares in order to complete the offering;
WHEREAS, the Parties desire to use an escrow agent to provide certain escrow functions in connection with such offer and sale; and
WHEREAS, the Parties wish to engage the Escrow Agent to act, and the Escrow Agent is willing to act, as escrow agent hereunder and, in that capacity, to hold, administer and distribute the amounts deposited in escrow hereunder in accordance with, and subject to, the terms of this Agreement.
NOW THEREFORE, in consideration of the foregoing and of the mutual covenants hereinafter set forth, intending to be legally bound, the parties hereto agree as follows:
1. Appointment. The Parties hereby appoint the Escrow Agent as their escrow agent for the purposes set forth herein, and the Escrow Agent hereby accepts such appointment under the terms and conditions set forth herein.
2. Fund. Pursuant to the Prospectus, the Investors are directed to submit orders and payment for Shares they wish to purchase to the Escrow Agent. The Placement Agent and the Company hereby authorize the Escrow Agent to accept checks, money orders, and wire transfers from the Investors (collectively, the “Escrow Deposit”). The Escrow Agent shall hold the Escrow Deposit and, subject to the terms and conditions hereof, shall invest and reinvest the Escrow Deposit and the proceeds thereof (the “Fund”) as directed in Section 3.
3. Investment of Fund.
(a) If the Escrow Agent shall have received specific written investment instructions from the Placement Agent and the Company (which shall include instruction as to term to maturity, if applicable), on a timely basis, the Escrow Agent shall invest the Fund at one or more of the banks listed in Schedule 4 to this Agreement, each of which shall be a commercial bank with capital exceeding $500,000,000 (each such bank, an “Approved Bank”). Escrow Agent shall be entitled to retain for its own benefit, as partial compensation or benefit for its services hereunder, including reduced bank charges, any amount of interest earned on the Escrow Deposit that is not payable pursuant to this Section 3(b) or herein. If no such instructions are received by the Escrow Agent, then the Fund shall remain uninvested. The Escrow Agent will not provide any investment advice in connection with this Agreement.
(b) The amounts held in custody by the Escrow Agent pursuant to this Agreement are at the sole risk of the Parties and, without limiting the generality of the foregoing, the Escrow Agent shall have no responsibility or liability for any diminution of the Escrow Amount that may result from any deposits made pursuant to this Agreement, including any losses resulting from a default by an Approved Bank or any other credit losses (whether or not resulting from such default) or other losses on any deposit required to be liquidated in order to make a payment required hereunder. The Parties acknowledge and agree that the Escrow Agent is acting prudently and at their direction when depositing the Escrow Amount at any Approved Bank, and the Escrow Agent is not required to make any further inquiries in respect of any Approved Bank.
4. Claims and Payment; Release from Escrow
(a) As soon as the Escrow Agent receives joint written instructions substantially in the form of Schedule 1 as to the disbursement of the Fund (the “Joint Written Instructions”) signed by both an officer of the Company and an officer of the Placement Agent, the Escrow Agent shall transfer the Fund to the Company, the Placement Agent and any third party indicated in such notice, in the amounts specified by the Company and the Placement Agent in such Joint Written Instructions. Except as otherwise provided in this Agreement, the Escrow Agent shall rely conclusively on any Joint Written Instructions and shall have no responsibility to determine whether the information set forth therein, including the amount of the payment of the Fund, is accurate or correct.
(b) Rejection. If at any time prior to the release of an Investor’s subscription or order pursuant to the terms of this Agreement, the Company shall deliver to the Escrow Agent a written notice to the effect that any or all of the subscription or order of such Investor has been rejected (the “Rejected Subscription Amount”) by the Company, the Escrow Agent shall, promptly after receipt of such written notice, return to such Investor the amount of such Rejected Subscription Amount without any interest that may have accrued on such amount.
(c) Failure to Close. If at any time prior to the release of a Investor’s subscription pursuant to the terms of this Agreement, the Placement Agent shall deliver to the Escrow Agent a written notice stating that the closing conditions to the offering contemplated by this Agreement have not been satisfied, then the Escrow Agent shall, promptly after receipt of such written notice, return to each Investor indicated in such notice the amount of its subscription as specified in such notice without any interest that may have accrued on such amount.
2 |
(d) Reporting. The Escrow Agent shall provide the Placement Agent and the Company with an electronic statement on a daily basis showing the amount of funds received and posted, as well as any transfers made by the Escrow Agent. The Escrow Agent shall provide the Company and the Placement Agent with a list of the Investors, including the amount of funds received from each Investor, on a daily basis. After receiving a check or money order from an Investor, the Escrow Agent shall deposit such funds into the Escrow Account as soon as the funds clear. The Placement Agent and the Company shall be entitled to inquire by telephone as to the balance of the Escrow Account from time to time.
(e) Notwithstanding anything to the contrary in this Agreement, if any amount to be released at any time or under any circumstances exceeds the balance in the Fund, the Escrow Agent shall release the balance in the Fund and shall have no liability or responsibility to the Parties for any deficiency.
(f) All Escrow Deposits received by the Escrow Agent are subject to clearance time, and the funds represented cannot be drawn until such time as the same constitutes good and collected funds.
(g) Upon delivery of any and all remaining balance in the Fund by the Escrow Agent, this Agreement shall terminate, subject to the provisions of Section 8.
5. Escrow Agent.
(a) The Escrow Agent represents and warrants to the Parties that the Escrow Agent is a “bank” as defined in Paragraph (A) of Section 3(a)(6) of the Securities Exchange Act of 1934, as amended. The deposit accounts of each Approved Bank is insured by the FDIC to the maximum amount permitted by law.
(b) All funds received from Investors by the Company or the Placement Agent in payment for the Shares (“Investor Funds”) will be delivered to the Escrow Agent by noon Eastern Time on the next business day following the day upon which such Investor Funds are received by the Company or the Placement Agent, and shall, upon receipt of good and collected funds by the Escrow Agent, be retained in the Escrow Account by the Escrow Agent and invested as provided in Section 3(a) hereof. During the term of this Escrow Agreement, the Company and the Placement Agent shall instruct Investors to make all checks payable to the order of “Computershare Trust Company, N.A.as Escrow Agent for Federal Life Group, Inc.” and shall cause all checks received by each of them in payment for the Shares to be endorsed in favor of the Escrow Agent and delivered to the Escrow Agent for deposit in the Escrow Account. Investor Funds also may be wired directly to the Escrow Account using wire instructions provided by the Escrow Agent.
3 |
(c) The Escrow Agent shall have only those duties as are specifically and expressly provided herein, which shall be deemed purely ministerial in nature, and no other duties shall be implied. The Escrow Agent shall neither be responsible for, nor chargeable with, knowledge of, nor have any requirements to comply with, the terms and conditions of any other agreement, instrument or document between the Company, the Placement Agent and the Investors, in connection herewith, if any, nor shall the Escrow Agent be required to determine if any person or entity has complied with any such agreements, nor shall any additional obligations of the Escrow Agent be inferred from the terms of such agreements, even though reference thereto may be made in this Agreement. In the event of any conflict between the terms and provisions of this Agreement, any schedule or exhibit attached to this Agreement, or any other agreement among the Company, the Placement Agent and the Investors, the terms and conditions of this Agreement shall control. The Escrow Agent may rely upon and shall not be liable for acting or refraining from acting upon any written notice, document, instruction or request furnished to it hereunder and believed by it to be genuine and to have been signed or presented by the proper Party or Parties without inquiry and without requiring substantiating evidence of any kind. The Escrow Agent shall not be liable to any Party, any beneficiary or other person for refraining from acting upon any instruction setting forth, claiming, containing, objecting to, or related to the transfer or distribution of the Fund, or any portion thereof, unless such instruction shall have been delivered to the Escrow Agent in accordance with Section 11 below and the Escrow Agent has been able to satisfy any applicable security procedures as may be required hereunder and as set forth in Section 11. The Escrow Agent shall be under no duty to inquire into or investigate the validity, accuracy or content of any such document, notice, instruction or request. The Escrow Agent shall have no duty to solicit any payments which may be due it or the Fund, including, without limitation, the Escrow Deposit nor shall the Escrow Agent have any duty or obligation to confirm or verify the accuracy or correctness of any amounts deposited with it hereunder.
(d) The Escrow Agent shall not be liable for any action taken, suffered or omitted to be taken by it except to the extent that a final adjudication of a court of competent jurisdiction determines that the Escrow Agent’s gross negligence or willful misconduct was the primary cause of any loss to either Party. The Escrow Agent may execute any of its powers and perform any of its duties hereunder directly or through affiliates or agents. The Escrow Agent may consult with counsel, accountants and other skilled persons to be selected and retained by it. The Escrow Agent shall not be liable for any action taken, suffered or omitted to be taken by it in accordance with, or in reliance upon, the advice or opinion of any such counsel, accountants or other skilled persons. In the event that the Escrow Agent shall be uncertain or believe there is some ambiguity as to its duties or rights hereunder or shall receive instructions, claims or demands from any Party hereto which, in its opinion, conflict with any of the provisions of this Agreement, it shall be entitled to refrain from taking any action and its sole obligation shall be to keep safely all property held in escrow until it shall be given a direction in writing by the Parties which eliminates such ambiguity or uncertainty to the satisfaction of Escrow Agent or by a final and non-appealable order or judgment of a court of competent jurisdiction. The Parties agree to pursue any redress or recourse in connection with any dispute without making the Escrow Agent a party to the same. Anything in this Agreement to the contrary notwithstanding, in no event shall the Escrow Agent be liable for special, incidental, punitive, indirect or consequential loss or damage of any kind whatsoever (including but not limited to lost profits), even if the Escrow Agent has been advised of the likelihood of such loss or damage and regardless of the form of action.
4 |
6. Succession.
(a) The Escrow Agent may resign and be discharged from its duties or obligations hereunder by giving thirty (30) days advance notice in writing of such resignation to the Parties specifying a date when such resignation shall take effect. If the Parties have failed to appoint a successor escrow agent prior to the expiration of thirty (30) days following receipt of the notice of resignation, the Escrow Agent may petition any court of competent jurisdiction for the appointment of a successor escrow agent or for other appropriate relief, and any such resulting appointment shall be binding upon all of the Parties hereto. Escrow Agent’s sole responsibility after such thirty (30) day notice period expires shall be to hold the Fund (without any obligation to reinvest the same) and to deliver the same to a designated substitute escrow agent, if any, or in accordance with the directions of a final order or judgment of a court of competent jurisdiction, at which time of delivery Escrow Agent’s obligations hereunder shall cease and terminate, subject to the provisions of Section 8 hereunder.
(b) Any entity into which the Escrow Agent may be merged or converted or with which it may be consolidated, or any entity to which all or substantially all the escrow business may be transferred, shall be the Escrow Agent under this Agreement without further act.
7. Compensation and Reimbursement. Federal Life agrees to (a) pay the Escrow Agent all reasonable compensation for the services to be rendered hereunder as described in Schedule 3 attached hereto, and (b) pay or reimburse the Escrow Agent upon request for all expenses, disbursements and advances, including, without limitation reasonable attorney’s fees and expenses, incurred or made by it in connection with the entry into, performance, modification and termination of this Agreement. The Escrow Agent shall have no lien on, or right to deduct from, the Fund, or proceeds thereof, for any sums owed to it under this Agreement.
8. Indemnity.
(a) Subject to Section 8(c) below, Escrow Agent shall be liable for any losses, damages, claims, liabilities, penalties, judgments, settlements, actions, suits, proceedings, litigations, investigations, costs or expenses (including without limitation, the fees and expenses of outside counsel and experts and their staffs and all expenses of document location, duplication and shipment)(collectively “Losses”) only to the extent such Losses are determined by a court of competent jurisdiction to be a result of Escrow Agent’s gross negligence or willful misconduct; provided, however, that any liability of the Escrow Agent will be limited in the aggregate to the balance of the Escrow Deposit placed with the Escrow Agent at the time of such Losses.
(b) The Company and Federal Life shall jointly and severally indemnify and hold Escrow Agent harmless from and against, and Escrow Agent shall not be responsible for, any and all Losses arising out of or attributable to Escrow Agent’s duties under this Agreement or this appointment, including the reasonable costs and expenses of defending itself against any Losses or enforcing this Agreement, except to the extent of liability described in Section 8(a) above.
5 |
(c) Without limiting the indemnification obligations set forth in Section 8(b) above, none of Federal Life, the Parties, or the Escrow Agent shall be liable for any incidental, indirect, special or consequential damages of any nature whatsoever, including, but not limited to, loss of anticipated profits, occasioned by a breach of any provision of this Agreement even if apprised of the possibility of such damages.
(d) This Section 8 shall survive termination of this Agreement or the resignation, replacement or removal of the Escrow Agent for any reason.
9. Patriot Act Disclosure/Taxpayer Identification Numbers/Tax Reporting.
(a) Patriot Act Disclosure. Section 326 of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (“USA PATRIOT Act”) requires the Escrow Agent to implement reasonable procedures to verify the identity of any person that opens a new account with it. Accordingly, the Parties acknowledge that Section 326 of the USA PATRIOT Act and the Escrow Agent’s identity verification procedures require the Escrow Agent to obtain information which may be used to confirm the Parties identity including without limitation name, address and organizational documents (“identifying information”). The Parties agree to provide the Escrow Agent with and consent to the Escrow Agent obtaining from third parties any such identifying information required as a condition of opening an account with or using any service provided by the Escrow Agent.
(b) Certification and Tax Reporting. The Parties agree to provide the Escrow Agent with their respective fully executed Internal Revenue Service (“IRS”) Form W-8 or Form W-9 upon the execution of this Agreement. The Parties understand that, in the event their tax identification numbers are not certified to the Escrow Agent, the Internal Revenue Code, as amended from time to time, may require withholding of a portion of any interest or other income earned on the investment of the Fund. Each of the Parties agrees to instruct the Escrow Agent in writing with respect to the Escrow Agent’s responsibility for withholding and other taxes, assessments or other governmental charges, and to instruct the Escrow Agent with respect to any certifications and governmental reporting that may be required under any laws or regulations that may be applicable in connection with its acting as Escrow Agent under this Agreement. The Parties hereby represent and warrant to the Escrow Agent that (i) there is no sale or transfer of a United States Real Property Interest as defined under IRC Section 897(c) in the underlying transaction giving rise to this Agreement; and (ii) such underlying transaction does not constitute an installment sale requiring any tax reporting or withholding of imputed interest or original issue discount to the IRS or other taxing authority.
10. Notices. All communications hereunder shall be in writing and except for communications from the Parties setting forth, claiming, containing, objecting to, or in any way related to the transfer or distribution of funds, including but not limited to funds transfer instructions (all of which shall be specifically governed by Section 11 below), shall be deemed to be duly given after it has been received and the receiving party has had a reasonable time to act upon such communication if it is sent or served:
6 |
(a) by facsimile or email;
(b) by overnight courier; or
(c) by prepaid registered mail, return receipt requested;
to the appropriate notice address set forth below or at such other address as any party hereto may have furnished to the other parties in writing by registered mail, return receipt requested.
If to the Company: | Federal Life Group, Inc. |
3750 West Deerfield Road | |
Riverwoods, Illinois 60015 | |
Attention: William S. Austin, President | |
With a copy to: | Stevens & Lee, P.C. |
111 North 6th Street | |
Reading, PA 16103 | |
Attention: Wesley R. Kelso, Esq. | |
If to Placement Agent: | Griffin Financial Group LLC |
620 Freedom Business Center | |
Suite 200 | |
King of Prussia, PA 19406 | |
Attention: Jeffrey P. Waldron | |
If to the Escrow Agent: | Computershare Trust Company, N.A. |
8742 Lucent Boulevard, Suite 225 | |
Highlands Ranch, CO 80129 | |
Attention: Rose Stroud | |
Facsimile No. (303) 262-0608 | |
Email: rose.stroud@computershare.com | |
cc: corporate.trust@computershare.com | |
With a copy to: | Computershare Trust Company, N.A. |
480 Washington Boulevard | |
Jersey City, NJ 07310 | |
Attn: General Counsel | |
Facsimile No.: (201) 680-4610 |
Notwithstanding the above, in the case of communications delivered to the Escrow Agent, such communications shall be deemed to have been given on the date received by an officer of the Escrow Agent or any employee of the Escrow Agent who reports directly to any such officer at the above-referenced office. In the event that the Escrow Agent, in its sole discretion, shall determine that an emergency exists, the Escrow Agent may use such other means of communication as the Escrow Agent deems appropriate. For purposes of this Agreement, “Business Day” shall mean any day other than a Saturday, Sunday or any other day on which the Escrow Agent located at the notice address set forth above is authorized or required by law or executive order to remain closed.
7 |
11. Security Procedures.
(a) Notwithstanding anything to the contrary as set forth in Section 10, any instructions setting forth, claiming, containing, objecting to, or in any way related to the transfer or distribution of funds, including but not limited to the Joint Written Instructions described in Section 4 of this Agreement, may be given to the Escrow Agent only by confirmed facsimile or email and no instruction for or related to the transfer or distribution of the Fund, or any portion thereof, shall be deemed delivered and effective unless the Escrow Agent actually shall have received such instruction by email or by facsimile at the number provided to the Parties by the Escrow Agent in accordance with Section 10 and as further evidenced by a confirmed transmittal to that number.
(b) In the event funds transfer instructions are so received by the Escrow Agent by facsimile or email, the Escrow Agent is authorized to seek confirmation of such instructions by telephone call-back to the person or persons designated on Schedule 2 hereto, and the Escrow Agent may rely upon the confirmation of anyone purporting to be the person or persons so designated. The persons and telephone numbers for call-backs may be changed only in a writing actually received and acknowledged by the Escrow Agent. If the Escrow Agent is unable to contact any of the authorized representatives identified in Schedule 2, the Escrow Agent is hereby authorized both to receive written instructions from and seek confirmation of such instructions by telephone call-back to any one or more of the Parties’ respective executive officers, (“Executive Officers”), as the case may be, which shall include the titles of President, Chief Executive Officer, Controller, General Counsel and Chief Financial Officer, as the Escrow Agent may select. Such Executive Officer shall deliver to the Escrow Agent a fully executed incumbency certificate, and the Escrow Agent may rely upon the confirmation of anyone purporting to be any such officer.
(c) The Parties acknowledge that the security procedures set forth in this Section 11 are commercially reasonable.
12. Compliance with Court Orders. In the event that any escrow property shall be attached, garnished or levied upon by any court order, or the delivery thereof shall be stayed or enjoined by an order of a court, or any order, judgment or decree shall be made or entered by any court order affecting the property deposited under this Agreement, the Escrow Agent is hereby expressly authorized, in its sole discretion, to obey and comply with all writs, orders or decrees so entered or issued, which it is advised by legal counsel of its own choosing is binding upon it, whether with or without jurisdiction, and in the event that the Escrow Agent obeys or complies with any such writ, order or decree it shall not be liable to any of the parties hereto or to any other person, entity, firm or corporation, by reason of such compliance notwithstanding such writ, order or decree be subsequently reversed, modified, annulled, set aside or vacated.
8 |
13. Miscellaneous. The provisions of this Agreement may be waived, altered, amended or supplemented, in whole or in part, only by a writing signed by the Escrow Agent and the Parties. Neither this Agreement nor any right or interest hereunder may be assigned in whole or in part by the Escrow Agent or any Party, except as provided in Section 6, without the prior consent of the Escrow Agent and the other parties. This Agreement shall be governed by and construed under the laws of the Commonwealth of Massachusetts. Each Party and the Escrow Agent irrevocably waives any objection on the grounds of venue, forum non-conveniens or any similar grounds and irrevocably consents to service of process by mail or in any other manner permitted by applicable law and consents to the jurisdiction of any court of the Commonwealth of Massachusetts or United States federal court, in each case, sitting in Massachusetts. The Parties and the Escrow Agent further hereby waive any right to a trial by jury with respect to any lawsuit or judicial proceeding arising or relating to this Agreement. No party to this Agreement is liable to any other party for losses due to, or if it is unable to perform its obligations under the terms of this Agreement because of, acts of God, fire, war, terrorism, floods, strikes, electrical outages, equipment or transmission failure, or other causes reasonably beyond its control. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. All signatures of the parties to this Agreement may be transmitted by facsimile, and such facsimile will, for all purposes, be deemed to be the original signature of such party whose signature it reproduces, and will be binding upon such party. If any provision of this Agreement is determined to be prohibited or unenforceable by reason of any applicable law of a jurisdiction, then such provision shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions thereof, and any such prohibition or unenforceability in such jurisdiction shall not invalidate or render unenforceable such provisions in any other jurisdiction. A person who is not a party to this Agreement shall have no right to enforce any term of this Agreement. The Parties represent, warrant and covenant that each document, notice, instruction or request provided by such Party to Escrow Agent shall comply with applicable laws and regulations. Where, however, the conflicting provisions of any such applicable law may be waived, they are hereby irrevocably waived by the parties hereto to the fullest extent permitted by law, to the end that this Agreement shall be enforced as written. Except as expressly provided in Section 8 above, nothing in this Agreement, whether express or implied, shall be construed to give to any person or entity other than the Escrow Agent and the Parties any legal or equitable right, remedy, interest or claim under or in respect of this Agreement or any funds escrowed hereunder.
* * * * *
9 |
IN WITNESS WHEREOF, the parties hereto have executed this Escrow Agreement as of the date set forth above.
FEDERAL LIFE GROUP, INC. | ||
By: | /s/ William S. Austin | |
Name: William S. Austin | ||
Title: President and Chief Operating Officer | ||
Griffin financial group, llc | ||
By: | /s/ Jeffrey P. Waldron | |
Name: Jeffrey P. Waldron | ||
Title: Senior Managing Director | ||
COMPUTERSHARE TRUST COMPANY, N.A. | ||
as Escrow Agent | ||
By: | /s/ Jaddiel Ramos | |
Name: Jaddiel Ramos | ||
Title: Trust Officer | ||
FEDERAL LIFE INSURANCE COMPANY | ||
By: | /s/ William S. Austin | |
Name: William S. Austin | ||
Title: President and Chief Operating Officer |
[Signature Page to Escrow Agreement]
SCHEDULE 1
JOINT WRITTEN INSTRUCTIONS
FOR RELEASE OF ESCROW FUNDS
Pursuant to Section 4(a) of the Escrow Agreement dated as of September 12, 2018, by and among Griffin Financial Group, LLC (the “Placement Agent”), Federal Life Group, Inc. (the “Company”), Federal Life Insurance Company (“Federal Life”), and Computershare Trust Company, N.A. (the “Escrow Agent”), the Placement Agent and the Company hereby instruct the Escrow Agent to release $[___________] from the Escrow Account in accordance with the following instructions:
Wire Instructions: | ||
Account Name: | ||
Account Number: | ||
Bank Name: | ||
Bank ABA Number: | ||
Bank Address: | ||
For credit to: | ||
Special Instructions: | ||
Bank Check: | ||
Payee Name: | ||
Mailing Address: | ||
Federal Life Group, Inc.
By: | ||
Name: | ||
Title: |
Griffin Financial Group, LLC
By: | ||
Name: | ||
Title: | ||
Date: |
Schedule 2
Telephone Number(s) and authorized signature(s)
for
Person(s) Designated to give and confirm Funds Transfer Instructions
If from the Company:
Name |
Telephone Number | Cell Number | Signature | |||
1. William S. Austin | (847) 520-1900 | |||||
2. Anders Raaum | (847) 520-1900 | |||||
3. __________________ | ||||||
If from Placement Agent: | ||||||
Name | Telephone Number | Cell Number | Signature | |||
1. Jeffrey P. Waldron | (610) 205-6028 | (610) 223-8675 | ||||
2. ___________________ | ||||||
3. ___________________ |
Schedule 3
SCHEDULE 4
APPROVED BANKS
Bank of America
BMO Harris Bank, N.A.
Citibank,N.A.
Bank of the West
PNC Bank NA
Huntington Bank
BB&T
Exhibit 21.1
SUBSIDIARIES OF REGISTRANT
Company |
State of Organization |
Percentage
of Equity Owned Directly or Indirectly | ||
Federal Life Insurance Company | Illinois | 100% | ||
Americana Realty Company | Illinois | 100% | ||
FED Mutual Financial Services, Inc. | Illinois | 100% | ||
FEDHO Holding Company | Illinois | 100% |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the inclusion in this Form S-1 Registration Statement (No. 377-02185) of Federal Life Mutual Holding Company and Subsidiaries filed with the Securities and Exchange Commission of our report dated July 20, 2018 on our audits of the financial statements of Federal Life Mutual Holding Company and Subsidiaries (A Mutual Insurance Company) as of and for the years ended December 31, 2017 and 2016. We also consent to the references to our firm under the caption “Experts.”
Kansas City, Missouri
October 11, 2018
EXHIBIT 23.2
CONSENT OF RP FINANCIAL, LC
We hereby consent to the inclusion of our opinion letter dated December 22, 2017 addressed to the Board of Directors of Federal Life Mutual Holding Company (“FLMHC”) as an Exhibit to the Registration Statement on Form S-1 and related amendments thereto (collectively, the “Form S-1”) of Federal Life Group, Inc. as filed with the Securities and Exchange Commission (the “SEC”) and to the references to such opinion and the quotation or summarization of such opinion contained therein. In giving such consent, we do not admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended (the “Act”), or the rules and regulations of the SEC thereunder (the “Regulations”), nor do we admit that we are experts with respect to any part of the Registration Statement within the meaning of the term “experts” as used in the Act or the Regulations.
/s/ RP FINANCIAL, LC |
RP FINANCIAL, LC |
Arlington, VA |
October 10, 2018 |
Exhibit 99.1
STOCK ORDER FORM For Internal Use Only Named Insured Address Policy or Annuity Number Federal Life Group, Inc. Stock Information Center 620 Freedom Business Center Suite 200 King of Prussia, Pennsylvania 19406 Call us at 1-610-205-6005 BATCH #__________ ORDER #__________ CATEGORY __________REC’D ___________________________ O __________ C __________ORDER DEADLINE & DELIVERY: A Stock Order Form, properly completed and with full payment, must be received (not postmarked) by 12:00 noon, Central Time, on _____________, 2018. Subscription rights cannot be exercised after this time. Stock Order Forms can be delivered by using the enclosed Order Reply Envelope, or by hand or overnight delivery to the Stock Information Center address on this form. Stock Order Forms will only be accepted at this address. Faxes or copies of this form will not be accepted. PLEASE PRINT CLEARLY AND COMPLETE ALL APPLICABLE SHADED AREAS - READ THE ENCLOSED STOCK ORDER FORM INSTRUCTIONS (BLUE SHEET) AS YOU COMPLETE THIS FORM (1) NUMBER OF SHARES SUBSCRIPTION PRICE PER SHARE (2) TOTAL PAYMENT DUE (3) METHOD OF PAYMENT CHECK OR MONEY ORDER Enclosed is a personal check, bank check or money order made payable to: Computershare Trust Company, N.A. on behalf of Federal Life Group, Inc. in the amount of:Cash, wire transfers and third party checks will not be accepted for this purchase. Checks and money orders will be cashed upon receipt. X $10.00 =Minimum Number of Shares: 50 ($500). Maximum Number of Shares: 50,000 ($500,000). See Stock Order Form instructions for more information regarding maximum number of shares. (4) PURCHASER INFORMATION SUBSCRIPTION OFFERING (descending order of priority) a. ? Check here if you were a policyholder or annuity holder of Federal Life Mutual Holding Company (“Federal Life”) as of March 8, 2018. (List policy and annuity information below.) b. ? Check here if you are a director or officer of Federal Life. Named Insured or Annuity Owner Policy or Annuity Number(s) PLEASE NOTE: FAILURE TO LIST YOUR POLICIES OR ANNUITIES, OR PROVIDING INCORRECT OR INCOMPLETE INFORMATION, COULD RESULT IN THE LOSS OF PART OR ALL OF YOUR SHARE ALLOCATION. ATTACH A SEPARATE PAGE IF ADDITIONAL SPACE IS NEEDED. (5) PURCHASER INFORMATION COMMUNITY OFFERING c. ? Check here if you are an employee of Federal Life. d. ? Check here if you do not qualify to check box a, b, or c.(6) MAXIMUM PURCHASER IDENTIFICATION ? Not applicable(7) ASSOCIATES/AFFILIATES/ACTION IN CONCERT ? Check here if you, or any affiliates and associates or persons acting in concert with you, have submitted other orders for shares. If you check the box, list below all other orders submitted by you or your affiliates and associates or by persons acting in concert with you. Name(s) listed in Section 8 on other Stock Order Forms Number of shares ordered Name(s) listed in Section 8 on other Stock Order Forms Number of shares ordered(8) STOCK REGISTRATION The name(s) and address that you provide below will be reflected on your stock registration, and will be used for communications related to this order. Please PRINT clearly and use full first and last name(s), not initials. You may not add the names of other persons who are not named insureds on your insurance policy or who are not annuity holders if you are purchasing in the Subscription Offering unless the person is a permitted transferee as described in the Prospectus. See Stock Order Form Instructions for further guidance. First Name, Middle Initial, Last Name Reporting SSN/Tax ID No. First Name, Middle Initial, Last Name SSN/Tax ID No. Street Daytime Phone Number (important) City State Zip Evening Phone Number (important)(9) FORM OF STOCK OWNERSHIP Check the applicable box. See Stock Order Form Instructions for ownership definitions ? Individual ? Joint Tenants ? Tenants in Common ? Uniform Transfer to Minors Act ? Corporation/Partnership ? Other ___________ (for reporting SSN, use minor’s) FOR BROKER USE ONLYIRA SSN of Beneficial Owner: _____-____-_____ (10) ACKNOWLEDGMENT AND SIGNATURE(S) I (we) understand that, to be effective, this form, properly completed, together with full payment, must be received by Federal Life Group, Inc. no later than 12:00 noon Central Time, on __________, 2018, otherwise my (our) subscription rights in the Subscription Offering cannot be exercised. (continued on reverse side of this form) ORDER NOT VALID UNLESS SIGNED BY ALL PURCHASERS
STOCK ORDER FORM - SIDE 2 (10) ACKNOWLEDGMENT AND SIGNATURES (continued from front of Stock Order Form) I/we certify that, if signing on behalf of a company registering common stock in Section 8, or otherwise signing in a fiduciary capacity, I/we am/are legally authorized to do so. I (we) agree that after receipt by Federal Life Group, Inc., this Stock Order Form may not be modified or canceled without Federal Life Group, Inc.’s consent. Subscription rights pertain to those eligible to subscribe in the Subscription Offering. Illinois law prohibits any person from transferring or entering into any agreement, directly or indirectly, to transfer the legal or beneficial ownership of subscription rights, or the underlying securities to the account of another, except as described in the Prospectus. Under penalty of perjury, I (we) certify that (1) the Social Security or Tax ID information and all other information provided hereon are true, correct and complete, (2) I am the owner of any subscription rights being exercised or a permitted transferee of such rights as described in the Prospectus, and (3) I am (we are) purchasing shares solely for my (our) own account and that there is no agreement or understanding regarding the sale or transfer of such shares, or the right to subscribe for shares. I (WE) ACKNOWLEDGE THAT THE SHARES OF COMMON STOCK ARE NOT INSURED, AND ARE NOT GUARANTEED BY FEDERAL LIFE GROUP, INC. OR ANY OF ITS AFFILIATES OR BY THE FEDERAL OR STATE GOVERNMENT. I (we) further certify that, before purchasing the common stock of Federal Life Group, Inc., I (we) received the Prospectus dated _______, 2018, which contains disclosures concerning, among other things, the nature of the security being offered and the risks involved in the investment. See the “Risk Factors” section beginning on page ___ of the Prospectus. By executing this form the investor is not waiving any rights under the Federal securities laws, including the Securities Act of 1933 and the Securities and Exchange Act of 1934 .Signature: ___________________________________________________Signature: ___________________________________________________IF YOU PURCHASE SHARES OF FEDERAL LIFE GROUP, INC. YOU MUST COMPLETE AND SIGN THE FORM W-9 ON THE LAST PAGE OF THIS ORDER FORM AND SUBMIT THIS FORM TO FEDERAL LIFE GROUP, INC. IN ORDER TO AVOID BACKUP WITHHOLDING TAX ON ANY FUTURE DIVIDENDS.
FEDERAL LIFE GROUP, INC. STOCK ORDER FORM INSTRUCTIONS Sections (1) and (2) Number of Shares and Total Payment Due. Indicate the Number of Shares that you wish to subscribe for and the Total Payment Due. Calculate the Total Payment Due by multiplying the number of shares by the $10.00 price per share. The minimum purchase is 50 shares ($500). Except as described in the Prospectus, the maximum allowable purchase for any person or entity, together with associates, affiliates or persons acting in concert with such person or entity, is 50,000 shares. Please see the Prospectus section entitled “The Conversion and Offering Limitations on Purchase of Common Stock,” beginning on Page ____ of the Prospectus. By signing this form, you are certifying that your order does not conflict with these purchase limitations. Section (3) Payment by Check or Money Order. Payment must be made by including with this form a personal check, bank check or money order payable to ”Computershare Trust Company, N. A. on behalf of Federal Life Group, Inc.” These will be cashed upon receipt; the funds remitted by personal check, must be available within the account when your Stock Order Form is received. Indicate the amount remitted. Please do not remit cash, wire transfers or third party checks for this purchase. Section (4) Purchaser Information (Subscription Offering). Please check the box that reflects the highest eligibility priority of the purchasers listed in Section 4 or 5 of the Stock Order Form. If you checked box (a), please list all names and policy and annuity numbers that the purchaser(s) had with Federal Life at March 8, 2018 (an “Eligible Member”). Include all policies and annuities held individually or jointly. If purchasing shares for a minor, list only the minor’s policies or annuities. If purchasing shares for a corporation or partnership, list only the entity’s policies and annuities. Attach a separate page, if necessary. Box (b) refers to any director or officer of Federal Life. A director or officer of Federal Life Mutual Holding Company who is also an Eligible Member should check both boxes (a) and (b). Failure to complete this section, or providing incorrect or incomplete information, could result in a loss of part or all of our share allocation in the event of an oversubscription. Orders placed in the Subscription Offering will take preference over orders placed in the Community Offering. See “The Conversion and Offering” section of the Prospectus for further details about the Subscription Offering and Community Offering, and the method for allocating shares in the event of an oversubscription. Section (5) Purchaser Information (Community Offering). Orders placed in the Subscription Offering will take preference over orders placed in the Community Offering. See “The Conversion and Offering” section of the Prospectus for further details about the Subscription Offering and Community Offering, and the method for allocating shares in the event of an oversubscription. Section (6) Maximum Purchaser Identification. Not Applicable Section (7) Associates/Affiliates/Acting in Concert. Check the box, if applicable, and provide the requested information. Attach a separate page, if necessary. Please see the Prospectus section entitled “The Conversion and Offering Limitations on Purchases of Common Stock” for the definition of “associate,” “affiliate” and “acting in concert.” Section (8) Stock Registration. Clearly PRINT the name(s) in which you want the shares registered and the mailing address for all correspondence related to your order, including the notice of the shares issued to you. Each Stock Order Form will generate one notice of the shares issued to you, subject to the stock allocation provisions described in the Prospectus. IMPORTANT: Except as described in the Prospectus, subscription rights are non-transferable. If placing an order in the Subscription Offering, you may include the names of one or more named insureds on the policy or one or more holders of an annuity, but you may not add the names of persons who are not named insureds on your policy or an annuity holder unless such person is a permitted transferee. NOTE FOR FINRA MEMBERS: If you are a member of the Financial Industry Regulatory Authority (“FINRA”), or a person affiliated or associated with a FINRA member, you may have additional reporting requirements. Please report this subscription in writing to the applicable FINRA member within one day of payment thereof. Section (9) Form of Stock Ownership. For reasons of clarity and standardization, the stock transfer industry has developed uniform stockholder registrations for securities. Beneficiaries may not be named on stock registrations. If you have any questions on wills, estates, beneficiaries, etc., please consult your legal advisor. When registering stock, do not use two initials use the full first name, middle initial and last name. Omit words that do not affect ownership such as “Dr.” or “Mrs.” Check the one box that applies. Buying Stock Individually Used when shares are registered in the name of only one owner. To qualify in the Subscription Offering, the purchaser named in Section 8 of the Stock Order Form must have been a named insured or annuity holder of Federal Life as of March 8, 2018, a director or officer of Federal Life, or a permitted transferee. Buying Stock Jointly To qualify in the Subscription Offering, the persons named in Section 8 of the Stock Order Form must have been a named insured or annuity holder of Federal Life as of March 8, 2018, a director or officer of Federal Life, or a permitted transferee. Joint Tenants Joint Tenancy (with Right of Survivorship) may be specified to identify two or more owners where ownership is intended to pass automatically to the surviving tenant(s). All owners must agree to the sale of shares. Tenants in Common May be specified to identify two or more owners where, upon the death of one co-tenant, ownership of the stock will be held by the surviving co tenant(s) and by the heirs of the deceased co-tenant. All owners must agree to the sale of shares. Buying Stock for a Minor Shares may be held in the name of a custodian for a minor under the Uniform Transfer to Minors Act. To qualify in the Subscription Offering, the minor (not the custodian) named in Section 8 of the Stock Order Form must have been a named insured or annuity holder of Federal Life as of March 8, 2018, a director or officer of Federal Life, or a permitted transferee. The standard abbreviation for custodian is “CUST.” The Uniform Transfer to Minors Act is “UTMA.” Include the state abbreviation. For example, stock held by John Smith, as custodian for Susan Smith under the PA Uniform Transfer to Minors Act, should be registered as John Smith CUST Susan Smith UTMA PA (list only the minor’s social security number). Buying Stock for a Corporation/Partnership On the first name line, indicate the name of the corporation or partnership and indicate that entity’s Tax ID Number for reporting purposes. To qualify in the Subscription Offering, the corporation or partnership named in Section 8 of the Stock Order Form must have been a named insured or annuity holder of Federal Life as of March 8, 2018. Buying Stock in a Trust/Fiduciary Capacity Indicate the name of the fiduciary and the capacity under which they are acting (for example, “Executor”), or name of the trust, the trustees and the date of the trust. Indicate the Tax ID Number to be used for reporting purposes. To qualify in the Subscription Offering, the entity named in Section 8 of the Stock Order Form must have been a named insured or annuity holder of Federal Life as of March 8, 2018, a director or officer of Federal Life, or a permitted transferee. Buying Stock in a Self-Directed IRA (for trustee/broker use only) Stock may be purchased using self-directed individual retirement accounts which have the ability to hold the securities, such as at a brokerage firm. The purchase of shares using such funds can only be made through a self-directed retirement account, not through retirement accounts which are not self-directed. Registration should reflect the custodian or trustee firm’s registration requirements. For example, on the first name line indicate the name of the brokerage firm, followed by CUST or TRUSTEE. On the second name line, indicate the name of the beneficial owner (for example, “FBO JOHN SMITH IRA”). You can indicate an account number or other underlying information, and the custodian or trustee firm’s address and department to which all correspondence should be mailed related to this order, including the notice of shares issued. Indicate the Tax ID Number under which the IRA account should be reported for tax purposes. Section (10) Acknowledgment and Signature(s). Sign and date the Stock Order Form where indicated. All persons listed in Section 8 of the Stock Order Form must sign the form. If signing on behalf of a company registering common stock in Section 8, or otherwise signing in a fiduciary capacity, you must be legally authorized to do so. Before you sign, please carefully review the information you provided and read the acknowledgment. Verify that you have printed clearly, and completed all applicable shaded areas on the Stock Order Form. Please review the Prospectus carefully before making an investment decision. Deliver your completed Stock Order Form, with full payment, so that it is received (not postmarked) by Federal Life Group, Inc. by 12:00 noon, Central Time, on _________, 2018. Stock Order Forms can be delivered by using the enclosed postage paid Order Reply Envelope, or by hand or overnight delivery to the Stock Information Center at 620 Freedom Business Center, Suite 200, King of Prussia, Pennsylvania 19406. Stock Order Forms will only be accepted at this address. We are not required to accept Stock Order Forms that are found to be deficient or incorrect, or that do not include proper payment or the required signature. OVERNIGHT DELIVERY can be made to the Stock Information Center address provided on the front of the Stock Order Form. QUESTIONS? Call our Stock Information Center at 1 610 205 6005, Monday through Friday from 10:00 a.m. to 4:00 p.m. Central Time. The Stock Information Center is not open on weekends or bank holidays.
Form W-9 (Rev. December 2014) Department of the Treasury Internal Revenue Service Request for Taxpayer Identification Number and Certification Give Form to the requester. Do not send to the IRSPrint or Type See Specific Instructions on page 2 1 Name (as shown on your income tax return). Name is required on this line; do not leave this line blank. 2 Business name/disregarded entity name, if different from above 3 Check appropriate box for federal tax classification; check only one of the following seven boxes: 4 Exemptions (codes apply only to certain entities, not individuals; see page 3 of instructions): Exempt payee code (if any) _______ Exemption from FATCA reporting code (if any) __________________ (Applies to accounts maintained outside the U.S.) ? Individual/sole proprietor or single-member LLC ? C Corporation ? S Corporation ? Partnership ? Trust/estate? Limited Liability company. Enter the tax classification (C=C corporation, S=S corporation, P=partnership) ?_________Note. For a single-member LLC that is disregarded, do not check LLC; check the appropriate box in the line above for the tax classification of the single-member owner. ? Other (see instructions) ?5 Address (number, street, and apt. or suite no.) Requester’s name and address (optional) 6 City, state, and ZIP code7 List account number(s) here (optional) Part I Taxpayer Identification Number (TIN) Enter your TIN in the appropriate box. The TIN provided must match the name given on line 1 to avoid backup withholding. For individuals, this is generally your social security number (SSN). However, for a resident alien, sole proprietor, or disregarded entity, see the Part I instructions on page 3. For other entities, it is your employer identification number (EIN). If you do not have a number, see How to get a TIN on page 3. Note. If the account is in more than one name, see the instructions for line 1 and the chart on page 4 of the instructions for guidelines on whose number to enter. Social security number– – or Employer identification number– Part II Certification Under penalties of perjury, I certify that: 1. The number shown on this form is my correct taxpayer identification number (or I am waiting for a number to be issued to me); and 2. I am not subject to backup withholding because: (a) I am exempt from backup withholding, or (b) I have not been notified by the Internal Revenue Service (IRS) that I am subject to backup withholding as a result of a failure to report all interest or dividends, or (c) the IRS has notified me that I am no longer subject to backup withholding; and 3. I am a U.S. citizen or other U.S. person (defined below); and 4. The FATCA code(s) entered on this form (if any) indicating that I am exempt from FATCA reporting is correct. Certification instructions. You must cross out item 2 above if you have been notified by the IRS that you are currently subject to backup withholding because you have failed to report all interest and dividends on your tax return. For real estate transactions, item 2 does not apply. For mortgage interest paid, acquisition or abandonment of secured property, cancellation of debt, contributions to an individual retirement arrangement (IRA), and generally, payments other than interest and dividends, you are not required to sign the certification, but you must provide your correct TIN. See the instructions on page 3. Sign Here Signature of U.S. person ? Date ? General Instructions Section references are to the Internal Revenue Code unless otherwise noted. Future developments. Information about developments affecting Form W 9 (such as legislation enacted after we release it) is at www.irs.gov/fw9. Purpose of Form An individual or entity (Form W 9 requester) who is required to file an information return with the IRS must obtain your correct taxpayer identification number (TIN) which may be your social security number (SSN), individual taxpayer identification number (ITIN), adoption taxpayer identification number (ATIN), or employer identification number (EIN), to report on an information return the amount paid to you, or other amount reportable on an information return. Examples of information returns include, but are not limited to, the following: • Form 1099 INT (interest earned or paid) • Form 1099 DIV (dividends, including those from stocks or mutual funds) • Form 1099 MISC (various types of income, prizes, awards, or gross proceeds) • Form 1099 B (stock or mutual fund sales and certain other transactions by brokers) • Form 1099 S (proceeds from real estate transactions) • Form 1099 K (merchant card and third party network transactions) • Form 1098 (home mortgage interest), 1098 E (student loan interest), 1098 T (tuition) • Form 1099 C (canceled debt) • Form 1099 A (acquisition or abandonment of secured property) Use Form W 9 only if you are a U.S. person (including a resident alien), to provide your correct TIN. If you do not return Form W-9 to the requester with a TIN, you might be subject to backup withholding. See What is backup withholding? on page 2. By signing the filled-out form, you: 1. Certify that the TIN you are giving is correct (or you are waiting for a number to be issued), 2. Certify that you are not subject to backup withholding, or 3. Claim exemption from backup withholding if you are a U.S. exempt payee. If applicable, you are also certifying that as a U.S. person, your allocable share of any partnership income from a U.S. trade or business is not subject to the withholding tax on foreign partners' share of effectively connected income, and 4. Certify that FATCA code(s) entered on this form (if any) indicating that you are exempt from the FATCA reporting, is correct. See What is FATCA reporting? on page 2 for further information.
Exhibit 99.2
[ FEDERAL LIFE LOGO ]
QUESTIONS AND
ANSWERS
ABOUT OUR CONVERSION
AND STOCK OFFERING
This pamphlet answers questions about the mutual to stock conversion of Federal Life Mutual Holding Company and the related common stock offering of Federal Life Group, Inc.
ABOUT THE PLAN OF CONVERSION
The board of directors of Federal Life Mutual Holding Company (“Federal Life Mutual”) adopted a Plan of Conversion on March 8, 2018 (the “Plan of Conversion”), whereby Federal Life Mutual will convert from a mutual holding company to a stock company. In connection with the conversion, Federal Life Group, Inc. (“Federal Life Group”), a corporation newly formed by Federal Life Mutual, is conducting an initial public offering of up to 4,600,000 shares of common stock at a purchase price of $10.00 per share. Such shares will constitute all of the outstanding shares of Federal Life Group following completion of the conversion and the stock offering. Immediately following the conversion, all of the outstanding shares of common stock of Federal Life Mutual, as converted to a stock company, will be issued to Federal Life Group. As a result of the conversion, policyholders of Federal Life Insurance Company will no longer be members of Federal Life Mutual.
There will be no change in your premium or in the rights of policyholders to insurance coverage under their existing policies of insurance with Federal Life Insurance Company as a result of the conversion.
The Plan of Conversion has been approved by the Illinois Insurance Commissioner, subject to approval of the Plan of Conversion by the members of Federal Life Mutual. In order to complete the conversion, it is necessary for the Plan of Conversion to receive the affirmative vote of at least two-thirds of the votes cast by the voting members of Federal Life Mutual, so YOUR VOTE IS VERY IMPORTANT. Please return your proxy in the enclosed [COLOR] postage-paid envelope marked “PROXY RETURN.”
THE BOARD OF DIRECTORS OF FEDERAL LIFE MUTUAL URGES MEMBERS TO VOTE “FOR” THE PLAN OF CONVERSION. PLEASE PROMPTLY VOTE, SIGN AND MAIL YOUR PROXY(S).
MUTUAL TO STOCK CONVERSION
Q: Why is Federal Life Mutual converting from mutual to stock form?
A: Federal Life Mutual’s conversion from mutual to stock form and the related stock offering will provide Federal Life Group with additional capital that will enable it to take advantage of anticipated future growth opportunities and provide a source of additional capital for Federal Life Insurance Company. The additional capital raised will also permit Federal Life Insurance Company to develop and offer new insurance and annuity products.
Q: Will the conversion affect my coverage with Federal Life Insurance Company?
A: No. Neither the premium you pay nor the insurance coverage under any Federal Life Insurance Company policy that you own will be affected by the conversion.
Q: Will any policy or annuity that I hold with Federal Life Insurance Company be converted to stock?
A: No. All policies and annuities will remain as they were prior to the conversion. Eligible members of Federal Life Mutual have a right to purchase shares of common stock of Federal Life Group during the subscription offering. Eligible members of Federal Life Mutual consist of named insureds under issued and in force Federal Life Insurance Company policies and owners of annuities in force as of the close of business on March 8, 2018. These rights to purchase stock cannot be transferred.
ABOUT VOTING RIGHTS
Q: Who is eligible to vote on the conversion?
A: The members of Federal Life Mutual of record as of March 8, 2018 (“Eligible Voting Members”) are eligible to vote on the conversion.
Q: Am I required to vote?
A: No. Eligible Voting Members are not required to vote. However, because the conversion will produce a fundamental change in Federal Life Mutual’s corporate structure and the rights of the members of Federal Life Mutual, the board of directors of Federal Life Mutual encourages all Eligible Voting Members to vote.
Q: How can I vote?
A: You may vote by mailing your signed proxy(s) in the [COLOR] postage-paid envelope marked “PROXY RETURN.” Should you choose to attend the special meeting of members or you decide to change your vote, you may do so by revoking any previously signed proxy.
Q: Why did I receive more than one proxy?
A: Each life insurance policyholder is entitled to cast one vote for each $1,000 of life insurance, and each accident and health policyholder is entitled to cast one vote for each $25 of annual premium on each proposal considered at the Special Meeting. If you have more than one policy, you may have received more than one proxy depending upon who is named as an insured on your policy. PLEASE VOTE, SIGN AND RETURN ALL PROXYS THAT YOU RECEIVED.
Q: Does my vote for the Plan of Conversion require me to buy common stock of Federal Life Group, Inc.?
A: No. Voting for the Plan of Conversion does not obligate you to buy shares of common stock of Federal Life Group. You can also vote against the Plan of Conversion and still elect to buy shares of Federal Life Group common stock in the offering. However, if a quorum is not obtained for the special meeting of members or if sufficient votes in favor of approving the Plan of Conversion are not cast at the special meeting, the conversion will not occur and no stock of Federal Life Group will be sold.
ABOUT THE STOCK OFFERING AND PURCHASING SHARES
Investment in our common stock involves certain risks. For a discussion of certain of such risks and other factors, you are urged to read the accompanying Prospectus.
Q: How many shares are being offered and at what price?
A: In the stock offering, Federal Life Group is offering up to 4,600,000 shares of common stock for sale at $10.00 per share. All shares will be sold at the same price, and no sales commission will be charged to purchasers in the stock offering.
Q: Who is eligible to purchase stock in the Offering?
A: Pursuant to the Plan of Conversion, the right to purchase shares of common stock at $10.00 per share in a subscription offering has been granted in the following order of priority:
Priority #1 – Eligible members of Federal Life Mutual, who consist of named insureds under an issued and in force Federal Life Insurance Company policy as of the close of business on March 8, 2018 and holders of annuities issued by Federal Life in force as of the close of business on March 8, 2018; and
Priority #2 – Directors and officers of Federal Life Mutual who are not eligible members.
Common stock that is not sold in the subscription offering is expected to be sold to employees of Federal Life Insurance Company, to a limited number of strategic investors, and to Insurance Capital Group LLC, which has agreed to act as the standby purchaser for the offering at $10.00 per share. Unlike the subscription offering, there are no rights to purchase common stock in the community offering. We have the right to accept or reject any order received in the community offering.
In the event that orders are received for more shares than are available for sale in the stock offering, shares will be allocated as described in the Prospectus.
Q: How can I buy shares during the Offering?
A: Shares may be purchased by completing a Stock Order Form and returning it, with full payment, so that it is received (not postmarked) by 12:00 noon, Central Time, on ______, 2018, unless the offering is extended as described in the Prospectus. Delivery of a Stock Order Form may be made in one of the following ways: (1) by mail, using the Order Reply Envelope provided, or (2) by overnight delivery to the Stock Information Center address noted on the Stock Order Form.
Q: How many shares of common stock can I purchase?
A: The minimum purchase is 50 shares ($500). The maximum allowable purchase for any person or entity, together with associates, affiliates or persons acting in concert with such person or entity, is 50,000 shares ($500,000). Please review the section in the prospectus entitled “The Offering – Limitations on Purchases of Common Stock” for more information regarding purchase limitations.
Q: How can I pay for the shares?
A: Payment for shares can be remitted by personal check, bank check or money order in U.S. dollars, payable to “_____________ on behalf of Federal Life Group, Inc.” These will be cashed upon receipt. Cash, wire transfers and third party checks will not be accepted.
Q: What is the deadline for purchasing shares in the Subscription and Community Offerings?
A: An executed Stock Order Form, with full payment, must be received by us, using an accepted method of delivery as described above, by no later than 12:00 noon, Central Time, on _____, 2018, unless the offering is extended as described in the Prospectus.
Q: Is it possible that I will not receive any or all of the shares I ordered?
A: Yes. If we receive orders in the offering for more shares than we have available to sell, we will allocate shares as described in the Prospectus. If we are unable to fill your order, in whole or in part, you will receive a refund check.
Q: Will payments for common stock earn interest?
A: No. Payments that you submit will not earn interest.
Q: May I change my mind after I place an order to subscribe for stock?
A: No. After receipt, your order cannot be modified or withdrawn unless the offering is extended beyond _____, 2018, or the offering range is amended to below 3,400,000 shares or above 4,600,000 shares.
Q: I am eligible to subscribe for shares of common stock in the Subscription Offering, but I am not interested in purchasing any shares. May I allow someone else to use my Stock Order Form to take advantage of my Subscription Offering priority?
A: No, you cannot transfer any of your subscription rights, and any attempted transfer will be void and not recognized.
On occasion, people attempt to persuade eligible members to transfer subscription rights, or to purchase shares in the offering based on an understanding that the shares will be subsequently transferred to others. Participation in such schemes is against the law and may subject involved parties to prosecution. If you become aware of any such activities, we ask that you notify us promptly so that we can take the necessary steps to protect subscription rights.
Q: Will my common stock be insured?
A: No. Like all stock, the common stock cannot be insured or guaranteed by any government agency, nor will it be insured or guaranteed by Federal Life Group.
Q: Will dividends be paid on the stock?
A: We have not yet determined whether or not we will pay any cash dividends, the amount that may be paid, or when the payment of dividends may begin. Our dividend policy will depend upon our financial condition, results of operations and future prospects, as well as that of our subsidiaries.
Q: How will Federal Life Group shares trade?
A: Upon completion of the offering, Federal Life Group expects the stock to be traded on the NASDAQ Capital Market under the symbol “FLF.” Once the shares have begun trading, you may contact a firm offering investment services in order to buy or sell Federal Life Group shares in the future. Upon completion of the offering, a statement setting forth the number of Federal Life Group shares owned will be mailed to purchasers in the stock offering. Shareholders may not be able to sell their shares of common stock until such statement is delivered to them, even though the common stock will have begun trading. Shares will be issued in book entry form only, and you will not receive a stock certificate representing the shares you purchase in the offering.
Q: Are officers and directors planning to purchase stock?
A: Yes. Our executive officers and directors, together with their affiliates and associates, plan to purchase approximately 372,000 shares of common stock in the offering.
WHERE TO GET MORE INFORMATION
Q: How can I get more information?
A: A Stock Information Center has been established to process orders to purchase stock and to answer any questions related to the conversion and the offering. You may call the Stock Information Center at (610) 205-6005 from 10:00 a.m. to 4:00 p.m., Central Time, Monday through Friday or email us at federallife@griffinfingroup.com. The Stock Information Center is not open on weekends or bank holidays.
This brochure is neither an offer to sell nor a solicitation of an offer to buy shares of common stock. The offer is made only by means of the Prospectus.
The shares of common stock are not insured and are not guaranteed by Federal Life Group, Inc. or any of its affiliates or by any Federal or state government or agency.
Exhibit 99.3
[Griffin Financial Group, LLC]
_________ [●], 2018
Dear Member of Federal Life Mutual Holding Company:
At the request of Federal Life Mutual Holding Company (“Federal Life Mutual”), we have enclosed materials regarding the offering of common stock in connection with the conversion of Federal Life Mutual from a mutual insurance holding company to a stock insurance holding company. As part of this conversion, Federal Life Mutual will form Federal Life Group, Inc. (“Federal Life Group”), which will become the parent holding company of Federal Life Mutual and Federal Life Insurance Company.
The enclosed materials include a prospectus and a stock order form, which offer you the opportunity to subscribe for shares of common stock of Federal Life Group. We are also enclosing a questions and answers brochure containing answers to commonly asked questions about the conversion and the offering. You are not obligated to invest in Federal Life Group and there will be no change in your premium or your insurance coverage as a result of this transaction.
Please read the prospectus carefully before making an investment decision. If you decide to subscribe for shares of common stock, you must mail the properly completed and signed stock order form, along with full payment for the shares, to the Stock Information Center in the accompanying postage-paid envelope marked “STOCK ORDER RETURN.” Your order must be physically received by the Stock Information Center no later than 12:00 noon, Central Time, on ________, [●], 2018. If you have any questions after reading the enclosed materials, please call the Stock Information Center at (610) 205-6005, Monday through Friday, between the hours of 10:00 a.m. and 4:00 p.m. Central Time, and ask for a Griffin Financial representative or email us at federallife@griffinfingroup.com.
We have been asked to forward these documents to you in view of certain requirements of the securities laws of your jurisdiction. We are not recommending or soliciting in any way any action by you with regard to the enclosed material.
Sincerely,
Griffin Financial Group, LLC
This letter is neither an offer to sell nor a solicitation of an offer to buy shares of common stock. The offer is made only by means of the Prospectus.
The shares of common stock are not insured and are not guaranteed by Federal Life Group, Inc. or any of its affiliates or by any Federal or state government or agency.
[INSERT FEDERAL LIFE MUTUAL HOLDING COMPANY LETTERHEAD]
January __, 2017
[INSERT MEMBER NAME]
[INSERT MEMBER ADDRESS]
Dear Member:
We are pleased to inform you that the Board of Directors of Federal Life Mutual Holding Company (“Federal Life Mutual”) has approved a Plan of Conversion (the “Plan”). Under the Plan, a new holding company called Federal Life Group, Inc. (“Federal Life Group”) was formed that will hold all of the outstanding shares of Federal Life Mutual after its conversion from a mutual insurance company to a stock insurance company. Federal Life Group is offering shares of its common stock for sale in a public offering in connection with the conversion. You are not obligated to invest in Federal Life Group, and there will be no change in your premium or your insurance coverage as a result of this transaction.
Upon the conversion of Federal Life, up to 4,600,000 shares of common stock of Federal Life Group will be sold in a public offering. As a member of Federal Life Mutual, your offer to purchase stock in the offering will be preferred over all other purchasers. Under the Plan, a subscription offering will be made in the following priorities to: (i) holders of insurance policies and holders of annuities issued by Federal Life Insurance Company that are in force as of March 8, 2018 and (ii) the directors and officers of Federal Life Mutual.
All shares not subscribed for in the subscription offering will be offered for sale in a community offering. In the community offering, Federal Life Group may, in its discretion, give preference to employees of Federal Life Mutual and a limited number of strategic investors. Insurance Capital Group LLC has agreed to purchase such number of shares as is necessary to ensure that at least the 3,400,000 minimum number of shares is sold in the offering.
The mutual to stock conversion of Federal Life Mutual contemplated by the Plan is subject to the approval of the Illinois Insurance Department and the members of Federal Life Mutual, which are the policyholders of Federal Life Insurance Company.
The common stock will be offered at a price of $10.00 per share. We have applied for listing on the NASDAQ Capital Market, and if listed the common stock will trade under the symbol “FLF.”
Griffin Financial Group LLC is serving as our placement agent and will use its best efforts to assist us in selling stock in the offering. After the payment of commissions and offering expenses, the proceeds from the offering will be used to provide capital for our future growth, which may include the introduction of new products and the acquisition of other life insurance companies and related businesses.
Enclosed with this letter is a prospectus regarding the offering. Please read the prospectus carefully before making an investment decision. If you decide to subscribe for shares of common stock, you must mail the properly completed and signed stock order form, along with full payment for the shares, to the Stock Information Center in the accompanying postage-paid envelope marked “STOCK ORDER RETURN.” Your order must be physically received by the Stock Information Center no later than 12:00 noon, Central Time, on December [●], 2018.
If you have any questions after reading the enclosed materials, please contact our Stock Information Center at (______) ____- ______, which is open from 10:00 am to 4:00 pm, Central Time, Monday through Friday or email us at ______________________@griffinfingroup.com. The Stock Information Center is closed on weekends and bank holidays.
Your business is important to us and we appreciate the opportunity to keep our members up to date regarding our recent business developments.
Very truly yours,
Joseph D. Austin
Chairman and Chief Executive Officer of Federal Life Mutual Holding Company
|
FOR
|
| |
AGAINST
|
|
|
☐
|
| |
☐
|
|
| SIGNATURE | | |
|
| | DATE | | | ____/____/____ | |
| | | |
OF PERSON WHOSE NAME APPEARS ABOVE
|
| | |
Exhibit 99.5
PRO FORMA VALUATION APPRAISAL REPORT
Federal Life Group, Inc. │Riverwoods, Illinois
PROPOSED HOLDING COMPANY FOR:
Federal Life Insurance Company
Dated as of December 22, 2017
1100 North Glebe Road Suite 600
Arlington, Virginia 22201
703.528.1700
rpfinancial.com
December 22, 2017
Board of Directors
Federal Life Mutual Holding Company
Federal Life Insurance Company
3750 West Deerfield Road
Riverwoods, Illinois 60015
Members of the Board:
At your request, we have completed and hereby provide an independent appraisal (“Appraisal”) of the estimated pro forma market value of the Common Stock which is to be offered in connection with the conversion transaction described below (hereinafter referred to as the “Conversion”).
This Appraisal is furnished pursuant to the requirements stipulated in Section 59.1 of the Illinois Insurance Code. In accordance with Section 59.1(6)(f) of the Illinois Insurance Code, the aggregate price of the capital stock shall be equal to the estimated pro forma market value of the converted stock company based upon an independent evaluation by a qualified person. Furthermore, as permitted by Section 59.1(6)(f), the pro forma market value may be the value that is estimated to be necessary to attract full subscription for the shares as indicated by the independent evaluation. Pursuant to the requirement in Section 59.1(3)(b)(i)(A), the Appraisal must be filed with the Illinois Department of Insurance (the “Department”).
Description of Conversion and Stock Issuance
We understand that Federal Life Mutual Insurance Holding Company (“FLMHC” or the “MHC”), the mutual insurance holding company for Federal Life Insurance Company (“Federal Life” or the “Company”) will reorganize into a stock insurance holding company. Pursuant to the Plan of Conversion (the “Plan”), upon completion of the Conversion, all of the outstanding shares of common stock of FLMHC will be issued to Federal Life Group (“FLG”). FLG will be the first tier parent of FLMHC which will wholly-own Federal Life. The Conversion will be effected only if subscriptions and orders are received for at least the minimum shares of common stock as indicated by the Valuation Range and the members of the MHC approve the Plan of Conversion. Federal Life Group, Inc. (“FLG”) which will offer its common stock in a subscription offering first to eligible members, and second, to the directors and officers.
The Standby Purchase Agreement
Insurance Capital Group, LLC. (“ICG” or the “Standby Purchaser”), has entered into a Standby Purchase Agreement (the “Agreement”) with FLG, FLMHC and Federal Life. Pursuant to the Agreement, the Standby Purchaser agrees to purchase at least the number of shares equal to (i) the number of shares that would be issued at the minimum of the valuation range minus (ii) the sum of any shares for which subscriptions have been accepted in the Subscription Offering, plus any shares for which orders have been accepted in the Community Offering (such number of shares purchased being the “Purchased Shares”). The Standby Purchaser has also been guaranteed the right but not the obligation to purchase 2,800,000 shares issued in the conversion, subject to other requirements of the Agreement. Any order submitted by Standby Purchaser in the Community Offering may be accepted by FLG prior to accepting any other order received in the Community Offering. In addition, the Company and the Standby Purchaser have agreed to certain other operating and management provisions including board representation by the Standby Purchaser. In addition, the Standby Purchaser has agreed that it will not seek to acquire or otherwise control the Company for a period of least 5 years subject to certain conditions.
Washington Headquarters | |
Three Ballston Plaza | |
1100 North Glebe Road, Suite 600 | Telephone: (703) 528-1700 |
Arlington, VA 22201 | Fax No.: (703) 528-1788 |
E-Mail: mail@rpfinancial.com | Toll-Free No.: (866) 723-0594 |
Board of Directors
December 22, 2017
Page 2
RP Financial, LC.
RP Financial, LC. (“RP Financial”) is a financial consulting firm serving the financial services industry nationwide that, among other things, specializes in financial valuations and analyses of business enterprises and securities, including the pro forma valuation for companies undertaking the demutualization process, including insurance companies and savings institutions. RP Financial is a nationally recognized valuation expert in stock conversion transactions for mutually owned financial services companies. The background and experience of RP Financial is detailed in Exhibit V-1. We believe that, except for the fee we will receive for our appraisal services, we are independent of FLMHC, FLG and Federal Life and the other parties engaged by the Company to assist in the conversion process.
Valuation Methodology
In preparing our appraisal, we have reviewed the Plan of Conversion to be filed with the Department. We have conducted a financial analysis of the Company that has included a review of its financial information for fiscal years ended December 31, 2015 through 2016 and through September 30, 2017, all unaudited but prepared in accordance with generally accepted accounting principles (“GAAP”). We have conducted due diligence related discussions with the Company’s management, Stevens & Lee, the Company’s counsel, and Griffin Financial Group, LLC, the Company’s financial and marketing advisor in connection with the stock offering. All conclusions set forth in the Appraisal were reached independently from such discussions. In addition, where appropriate, we have considered information based on other available published sources that we believe are reliable. While we believe the information and data gathered from all these sources are reliable, we cannot guarantee the accuracy and completeness of such information.
We have investigated the competitive environment within which the Company operates and have assessed the Company’s relative strengths and weaknesses. We have kept abreast of the changing regulatory and legislative environment for insurance companies, including those with broadly similar lines of business, and analyzed the potential impact on the Company and the industry as a whole. We have analyzed the potential effects of the Conversion and stock offering on the Company’s operating characteristics and financial performance as they relate to the pro forma market value. We have reviewed the economy in the Company’s primary market area and have compared the Company’s financial performance and condition with publicly-traded insurance companies sharing similar lines of business. We have reviewed conditions in the securities markets in general and in the market for insurance company stocks in particular, including the market for existing insurance companies, the market for the newly issued stock offered by demutualized insurance companies, and the market for mutual thrift institutions converting to stock form. We have also considered the expected market for FLG including the post-transaction illiquidity of the shares in view of the large insider ownership and shares purchased by ICG.
Board of Directors
December 22, 2017
Page 3
Our Appraisal is based on the Company’s representation that the information contained in the regulatory applications and additional information furnished to us by the Company, its independent auditors and actuaries, legal counsel and other authorized agents are truthful, accurate and complete. We did not independently verify the financial statements and other information provided by the Company, its independent auditors and actuaries, legal counsel and other authorized agents nor did we independently value the assets or liabilities of the Company. The valuation considers the Company only as a going concern and should not be considered as an indication of the Company’s liquidation value.
Our appraised value is predicated on a continuation of the current operating environment for the Company and for all insurance companies and their holding companies. Changes in the local, state and national economy, the legislative and regulatory environment for insurance companies and legal professional liability insurers, the stock market, interest rates, and other external forces (such as natural disasters or significant world events) may occur from time to time, often with great unpredictability, and may materially impact the value of insurers as a whole or FLG’s value alone. To the extent that such factors can be foreseen, they have been factored into our analysis.
Pro forma market value is defined as the price at which FLG’s stock, immediately upon completion of the Offering, would change hands between a willing buyer and a willing seller, neither being under any compulsion to buy or sell and both having reasonable knowledge of relevant facts.
Valuation Conclusion
It is our opinion that, as of December 22, 2017 (the “Valuation Date”), the estimated pro forma market value of the Company was $40,000,000 with a range (the “Valuation Range”) of $34,000,000 to $46,000,000. The Valuation Range was based upon a 15% decrease from the midpoint of $40,000,000 to determine the minimum and a 15% increase from the midpoint to establish the maximum. Based on an assumed offering price of $10.00 per share, the number of shares of common stock offered for sale will range from 3,400,000 shares at the minimum to 4,600,000 shares at the maximum with a midpoint of 4,000,000 shares.
Limiting Factors and Considerations
Our valuation is not intended, and must not be construed, as a recommendation of any kind as to the advisability of purchasing shares of the Common Stock. Moreover, because such valuation is necessarily based upon estimates and projections of a number of matters, all of which are subject to change from time to time, no assurance can be given that persons who purchase shares of common stock in the offering will thereafter be able to buy or sell such shares at prices related to the foregoing valuation of the pro forma market value thereof.
Our valuation conclusion reflects our opinion as to the fair market value of the shares issued in the Offering assuming a full distribution of the shares to eligible subscribers. This valuation conclusion does not express an opinion as to the pro forma impact to the subscribers. Furthermore, this valuation is based on offering and transaction terms set forth in the draft documents which set forth the terms and structure of the offering on a preliminary basis. Changes in the transaction terms and structure could have a material impact on the valuation conclusion set forth herein.
Board of Directors
December 22, 2017
Page 4
RP Financial’s valuation was determined based on the financial condition and operations of the Company as of September 30, 2017.
RP Financial is not a seller of securities within the meaning of any federal and state securities laws and any report prepared by RP Financial shall not be used as an offer or solicitation with respect to the purchase or sale of any securities. RP Financial maintains a policy which prohibits the company, its principals or employees from purchasing stock of its client institutions.
Respectfully submitted, | |
RP FINANCIAL, LC. | |
James P. Hennessey | |
Director |
RP® Financial, LC. | TABLE OF CONTENTS |
i |
TABLE OF CONTENTS
Federal Life Insurance Company
Riverwoods, Illinois
PAGE | ||
DESCRIPTION | NUMBER | |
CHAPTER ONE OVERVIEW AND FINANCIAL ANALYSIS | ||
Company Overview | 1.1 | |
Business Strategies | 1.2 | |
Product Description | 1.4 | |
Marketing and Distribution | 1.8 | |
Underwriting | 1.10 | |
Reinsurance | 1.10 | |
Claims Management | 1.11 | |
Executive Officers | 1.12 | |
Plan of Conversion | 1.13 | |
Financial Overview | 1.14 | |
Income and Expense Trends | 1.19 | |
Potential Off Balance Sheet Value | 1.22 | |
Legal Proceedings | 1.23 | |
CHAPTER TWO EXTERNAL ENVIRONMENT | ||
Introduction | 2.1 | |
National Economic Factors | 2.1 | |
Life Insurance Trends | 2.3 | |
Regulatory Environment | 2.5 | |
Competition | 2.6 | |
CHAPTER THREE PEER GROUP ANALYSIS | ||
Peer Group Selection | 3.1 | |
Financial Condition | 3.8 | |
Income and Expense Components | 3.10 | |
Summary | 3.13 |
RP® Financial, LC. | TABLE OF CONTENTS |
ii |
TABLE OF CONTENTS
Federal Life Insurance Company
Riverwoods, Illinois
(continued)
PAGE | |||||
DESCRIPTION | NUMBER | ||||
CHAPTER FOUR VALUATION ANALYSIS | |||||
Introduction | 4.1 | ||||
Pro Forma Approach to the Valuation | 4.1 | ||||
Valuation Analysis | 4.2 | ||||
1. | Financial Considerations | 4.2 | |||
2. | Operating Considerations | 4.3 | |||
3. | Dividends | 4.4 | |||
4 | Liquidity of the Shares | 4.4 | |||
5. | Marketing of the Issue | 4.5 | |||
A. | The Public Market | 4.5 | |||
B. | The New Issue Market | 4.8 | |||
6. | Organization | 4.11 | |||
7. | Regulatory Environment | 4.11 | |||
Summary of Adjustments | 4.12 | ||||
Valuation Approaches | 4.12 | ||||
1. | Price-to-Earnings ("P/E") | 4.14 | |||
2. | Price-to-Book ("P/B") | 4.16 | |||
3. | P/Revenues | 4.16 | |||
Comparison to Recent Demutualizations | 4.16 | ||||
Valuation Conclusion | 4.17 |
RP® Financial, LC. | LIST OF TABLES |
iii |
LIST OF TABLES
Federal Life Insurance Company
Riverwoods, Illinois
TABLE | ||||
NUMBER | DESCRIPTION | PAGE | ||
1.1 | Direct Premium by Product Type | 1.6 | ||
1.2 | Number of Policies by Type | 1.7 | ||
1.3 | Summary of Life Insurance in Force | 1.7 | ||
1.4 | Geographic Distribution of Premium Income | 1.9 | ||
1.5 | Reinsurance Ceded by Reinsurer | 1.11 | ||
1.6 | Historical Balance Sheets | 1.15 | ||
1.7 | Historical Income Statements as a Percent Average Assets | 1.20 | ||
2.1 | Market Shares | 2.7 | ||
3.1 | Peer Group of Publicly-Traded Insurance Companies | 3.3 | ||
3.2 | Comparative Financial Condition Data | 3.9 | ||
3.3 | Comparative Operating Performance Data | 3.12 | ||
4.1 | Stock Market Pricing Trends | 4.7 | ||
4.2 | Demutualization Transaction – Subscription Rights Offerings | 4.9 | ||
4.3 | Public Market Pricing | 4.15 | ||
4.4 | Valuation Range and Offering Characteristics | 4.17 |
RP Financial, LC.
Page 1.1
I. OVERVIEW AND FINANCIAL ANALYSIS
Company Overview
Federal Life Insurance Company (“Federal Life” or the “Company” is an Illinois chartered stock insurance company whose primary business activity is the marketing and underwriting of quality life insurance and annuity products. The Company was incorporated in 1899 and conducts operations through its headquarters office in Riverwoods, Illinois, a suburb approximately thirty miles north of Chicago. The Company is licensed to do business in all states except: Maine, Massachusetts, New Hampshire, New York, and Vermont. Moreover, the Company markets its products through independent agents located across the United States. Federal Life is focused on the underwriting of various life and annuity products and does not offer property, casualty or health insurance.
For more than 100 years, Federal Life has provided quality whole life and term life insurance products as well as various savings products including annuities. Federal Life’s products and services have evolved over time in keeping with changing consumer needs and preferences. In this regard, Federal Life was a pioneer in the variable annuity business when it formed a relationship with Wellington Management Company. In 1976, Federal Life introduced a Variable Annuity that was unique at that time having Wellington Management Funds as investment option as well as a Fixed Annuity with Federal Life. Other innovative product offerings include the 2015 introduction by Federal Life of Market Shield Plus, an Index-Linked Annuity which offers the opportunity to participate in stock market growth on a tax-deferred basis, with downside protection.
In June 2016, the Company was reorganized into a mutual holding company structure whereby the Company converted to the stock form of ownership and became a wholly-owned subsidiary of FedHo Holding Company, Inc., which is a wholly-owned subsidiary of Federal Life Mutual Holding Company (“FLMHC” or the “MHC”).
Federal Life Group, Inc. (“FLG”) will be a newly created Pennsylvania corporation organized to be the stock holding company for Federal Life following the conversion to the stock form of ownership (the “Conversion”). In the Conversion, FLG will become the sole shareholder of FLMHC which will own 100% of Federal Life. Federal Life is subject to examination and comprehensive regulation by the Illinois Department of Insurance. Federal Life is also a member of the Chicago Federal Home Loan Bank.
RP Financial, LC.
Page 1.2
Business Strategies
Federal Life states that its mission is to offer competitive products that are beneficial to customers, create a culture of service that strives to “do the right thing”, and maintain operations that support long term financial strength to ensure the promises of the Company will be kept.
The Company’s vision is to offer products, service and security that will enable people to achieve their goals now and in the future while providing security for future generations. The Company has trademarked the following tagline with the U.S. Patent and Trademark Office to promote this vision: “Live your dreams. Leave a legacy.”
Federal Life offers a variety of annuity, life insurance and had previously but does not currently offer Medicare supplement plans. Federal Life administers and sells a variety of variable, fixed, index-linked and income annuities designed to address contract holders’ needs for protected wealth accumulation on a tax-deferred basis, wealth transfer and income security. The life segment offers insurance products and services, including term, whole, universal and variable life products designed to address policyholders’ needs for financial security and protected wealth transfer, which may be provided on a tax-advantaged basis. Most of the Company’s offerings are marketed through independent agent relationships but Federal Life is increasingly emphasizing direct marketing through the Internet and social media platforms.
Importantly, Federal Life has reported operating losses for over a decade, which management attributes to serval factors. In this regard, the economic environment following the financial crisis in 2007, has resulted in a long period of falling and or very low interest rates which have had a significant impact on the financial results of the Company in recent years. Despite taking proactive steps to mitigate the interest rate risk by significantly diversifying the investment portfolio, and closely monitoring crediting rates, diminished investment income on the Company’s investment securities portfolio has resulted in lower net income.
Like most of the life insurance industry, the Company also suffered significant capital losses in 2008 and 2009 due to the global financial crisis. Many of the losses were on investment grade bonds which under normal conditions would not be considered high credit risks.
Accordingly, the financial results of the Company over the last 10 years have reflected the effects of the low interest rate environment, the global economic crisis and the limited marketing growth due to the changing niche market. The Company sought to preserve capital through this difficult operating environment while also managing expense levels while maintaining an infrastructure with capacity for future growth.
RP Financial, LC.
Page 1.3
In response to the challenging operating environment, Federal Life has developed a growth oriented business plan designed to reverse the recent operating losses. Management believes that growth in underwriting supported by the capital provided by the conversion and facilitated by relationships and partnerships fostered by the standby investor in the offering (the “Standby Investor”) will facilitate the reversal of the current operating losses and provide a future return for investors in the conversion offering. In view of the foregoing, the management of Federal Life has developed the following key business strategies for achieving its vision and mission.
1. | Undertake growth to expand revenues and achieve economies of scale. The Company will be implementing a marketing plan based on the formation of strategic partnerships to improve the Company’s distribution capabilities which will enable significant growth in products that the Company identifies as having unique market opportunities. A portion of this growth will be achieved through the Standby Investor who has longstanding experience and relationships within the insurance industry. The strategic partnership will leverage national distribution systems with existing relationships with the partner to enhance the current marketing program of the Company. |
2. | Maximize the use of the existing infrastructure capacity in growth plans to create a competitive advantage. The Company has maintained an administrative infrastructure capacity which can be utilized efficiently in the future growth plans. The Company is able to make modest incremental investments in infrastructure to create a companywide digital transformation that will allow it to adapt to the technological demands of the industry with a competitive advantage for service. The digital transformation over the next several years is targeted to result a full suite of digital distribution and service business applications. Existing programs and applications will be improved, which will increase the speed with which new products are released and existing products are updated. This will eliminate time-consuming, manual processes and allows employees and agents to focus on higher priority tasks, increasing efficiency. |
3. | Promote a performance oriented culture within the organization to ensure financial strength. The Company has sought to develop a performance oriented culture which emphasizes execution and accountability. The highest priority goal of the plan will be to maintain operations that support long term financial strength. Areas requiring improvement will be identified and modified as appropriate. Projections and forecasts will be continuously updated, and the strategic plans will be dynamically changed to ensure the operations support this goal. This will include reviewing that expenses and staff levels are appropriate for actual growth rates achieved. |
4. | Identify potential internal opportunities to increase regulatory surplus to support growth and risk levels. The Company is currently exploring internal resources to improve surplus levels separate from operations. The Company owns several assets which currently have market values significantly in excess of the statutory book values, and also has other avenues it is exploring to improve surplus levels. These opportunities include: |
RP Financial, LC.
Page 1.4
· | The Company’s home office building which is located on 10 acres of property in a sought after location in Riverwoods, Illinois. The current market value is estimated to be materially in excess of the current book value under both STAT and GAAP accounting; |
· | The Company owns oil and gas mineral rights leases that are at market values materially above the current book values. The Company will continue to explore additional opportunities to utilize these assets to benefit operations or raise surplus levels. |
· | FHLB – As a member of the Federal Home Loan Bank of Chicago, Federal Life has access to low-cost, flexible advances that can be used for funding, liquidity and yield enhancement. |
· | Reinsurance – The Company has entered into new reinsurance treaties that will stabilize the operations of the Company, and provide surplus relief to assist in growth plans. The increase in capital resulting from the Conversion transaction will facilitate Federal Life’s flexibility with respect to its reinsurance arrangements. |
5. | Complete the conversion to capitalize future growth and provide enhanced access to capital markets in the future to support growth and risk levels. The Company is currently pursuing a plan to raise enough capital to support the future growth plans by offering common stock investments in a full subscription rights demutualization. The current plan is to offer subscription rights to invest in the Company to policyholders, directors, officers, employees and other stakeholders such as agents. The Company will also sell stock to the Standby Investor which will facilitate growth objectives through referrals and industry relationships of the Standby Investor. |
Product Description
Federal life offers a variety of life insurance and annuity/savings.
Life Insurance.
The Company offers a variety of term and whole life policies. Term life policies are offered for terms of up to 30 years and for a minimum benefit amount of $50,000. The Company has policies with the ability to change the coverage based on changing circumstances of the policyholder including the ability to add a spouse as an additional insured to this plan, instead of having to purchase a second plan. Whole life policies offered by the Company include traditional level premium insurance products and single premium plans. The Company’s insurance products include the following:
RP Financial, LC.
Page 1.5
Current Interest Tradition - Interest Sensitive Whole Life. Current Interest Tradition provides whole life coverage, with level premiums and a level death benefit. A variety of optional riders are available for an additional charge.
The Level Term Series – 10, 15, 20 and 30-year periods - Level Premium Term Life. The Level Term Series provides term life coverage for a specific period, with level premiums and a level death benefit. These plans are renewable and convertible, and also feature a variety of optional riders for an additional charge.
Ultra Flex-Life – Universal Life. Ultra Flex-Life provides flexible premiums, a choice of death benefit options (level or increasing), and a variety of optional riders available for an additional charge. This plan also allows an additional insured to be added to the base plan.
The Estate Builder – Single Premium Whole Life. The Estate Builder provides permanent whole life coverage by locking in a guaranteed death benefit purchased with a one-time premium payment. This plan also features a built-in accelerated death benefit, free of charge.
Express Plan – Final Expense Coverage. The Express Plan provides permanent whole life coverage, with level premiums and lower face amounts ($2,500-$25,000), available via simplified underwriting.
Graded Benefit Whole Life – Final Expense Coverage. The Graded Benefit Whole Life plan provides permanent whole life coverage, with level premiums and lower face amounts ($2,500-$25,000), with a graded benefit during the first two policy years. This plan is offered as an alternative for individuals who may not qualify for the Express Plan.
Annuities
The Company offers a variety of annuities that can be used for both primary and supplemental retirement savings, and can provide either an immediate or future stream of guaranteed income. These retirement plans can also be setup as Traditional or Roth IRAs and include the following products:
Market Shield Plus - Single Premium Deferred Annuity with Fixed and Index-Linked Options. Market Shield Plus allows the customer to build long-term savings by earning interest as the market increases, while protecting principal during periods of decline. This product earns interest on a tax-deferred basis and features three allocation options. There are two annual point- to-point index-linked allocation options which earn interest based on the S&P500®, and one fixed allocation option that earns interest based on a current competitive rate. Interest is credited on an annual basis. Additionally, Market Shield Plus features a built-in Nursing Home Rider, which is included free of charge, and an optional Income Benefit Rider (Income Security Shield).
RP Financial, LC.
Page 1.6
Flexi/Saver – Flexible Premium Deferred Annuity. Flexi/Saver features a guaranteed principal, death benefit, and minimum interest rate. Additionally, this product earns interest on a tax-deferred basis, and offers a variety of annuitization payout options.
Maxi/Saver – Single Premium Deferred Annuity. Maxi/Saver features a guaranteed principal, death benefit, and minimum interest rate. Additionally, this product earns interest on a tax-deferred basis and offers a variety of annuitization payout options.
Income Security Shield – Single Premium Immediate Annuity. Income Security Shield requires a one-time initial premium payment. The customer can then choose to begin receiving guaranteed income payments within the first contract year at regularly scheduled intervals (i.e. monthly, quarterly, semi-annually, or annually). A variety of payout options, including Life Income with Cash Refund, are available.
Table 1.1 below shows the gross direct premiums by product type.
Table 1.1
Federal Life Insurance Company
Direct Premium by Product Type
(Dollars In Thousands)
Nine Months | ||||||||||||
Fiscal Year Ended | Ended | |||||||||||
12/31/2015 | 12/31/2016 | 9/30/2017 | ||||||||||
Whole Life Premium | $ | 10,156 | $ | 9,655 | $ | 6,197 | ||||||
Term life Premium | $ | 4,684 | $ | 4,571 | $ | 3,448 | ||||||
FEGLI Premium | $ | 2,926 | $ | 2,908 | $ | 2,181 | ||||||
Total Life Insurance Premiums | $ | 17,766 | $ | 17,134 | $ | 11,827 | ||||||
Fixed Annuity Premium | $ | 3,098 | $ | 7,376 | $ | 9,519 | ||||||
Variable Annuity Premium | 0 | 0 | 0 | |||||||||
Total Annuity Premiums | $ | 3,098 | $ | 7,376 | $ | 9,519 |
Source: Internal Financial Reports
RP Financial, LC.
Page 1.7
Table 1.2 below shows the number of policies by type of policy as of the end of the last two fiscal years and as of September 30, 2017 which reflects the historical focus on writing whole life insurance policies.
Table 1.2
Federal Life Insurance Company
Number of Policies by Type
Nine Months | ||||||||||||
Fiscal Year Ended | Ended | |||||||||||
12/31/2015 | 12/31/2016 | 9/30/2017 | ||||||||||
Whole life | 18,901 | 18,710 | 18,270 | |||||||||
Term life | 9,180 | 9,080 | 9,016 | |||||||||
Group life | 1,146 | 1,079 | 1,034 | |||||||||
FEGLI | 4,929 | 4,422 | 4,422 | |||||||||
Fixed annuities | 1,740 | 1,773 | 1,840 | |||||||||
Variable annuities | 176 | 149 | 142 | |||||||||
Total | 36,072 | 35,213 | 34,724 |
Source: Internal Financial Reports.
Table 1.3 shows the total value of life Insurance in force by type of policy as of the end of the last two fiscal years and as of September 30, 2017.
Table 1.3
Federal Life Insurance Company
Summary of Life Insurance In Force
(Dollars in Thousands)
As of the Fiscal Year Ended | As of | |||||||||||
12/31/2015 | 12/31/2016 | 9/30/2017 | ||||||||||
Whole Life | $ | 721,213 | $ | 719,135 | $ | 705,797 | ||||||
Term Life | 1,026,524 | 1,019,717 | 1,007,992 | |||||||||
FEGLI | 624,615 | 559,752 | 559,752 | |||||||||
Total | $ | 2,372,352 | $ | 2,298,604 | $ | 2,273,541 |
Source: Internal Financial Reports.
RP Financial, LC.
Page 1.8
Marketing and Distribution
The Company historically distributed life, health and annuity products through financial institutions such as banks, mortgage companies and savings and loans. This strategy was highly successful and the Company had significant capital increases for many years creating a heavily capitalized balance sheet. Changes in the regulatory environment and the resulting consolidation of financial institutions led to the elimination of many smaller banks, mortgage companies and savings and loans. These events had the direct effect of significantly reducing new premium production for the Company and limiting balance sheet growth.
The Company made a strategic decision to emphasize the senior market in 2011 with the introduction a new single premium whole life plan. This program enabled the Company to develop relationships with many producers in the senior market who were also major producers of other products which were not being offered by the Company, including index annuities. In an effort to expand further into the senior market the Company developed an index annuity which was introduced in the 4th quarter of 2015.
Federal Life maintains a network of independent agents and agencies for distribution. The Company offers competitive commission schedules and personalized sales training and development programs. The Company is currently upgrading its digital distribution and service system to enhance the sales process for contracted agents. Currently, Federal Life maintains relationships with approximately 1,000 independent agents, with a compensation system structured to encourage production and long-term persistency. Agents receive commissions for new life insurance and annuity sales and renewal commissions on premium payments in subsequent years. Production bonuses are paid based on the premium level of new life business written each quarter and the persistency of the business written by the agent. (Persistency is a commonly used industry benchmark that gauges business quality based on the consistency of premium payments.)
Table 1.4 below reflects that while Federal Life has a concentration of agents and premium income derived from Illinois residents (42.5% of total premiums year-to-date through September 30, 2017), the agent network is widely dispersed and more than one-half of the premium income is derived from out-of-state policyholders.
RP Financial, LC.
Page 1.9
Table 1.4
Geographic Distribution of Premium Income
As of September 30, 2017
(Dollars in Thousands)
Life | Accident & | |||||||||||||||||||
Insurance | Annuity | Health | ||||||||||||||||||
State | Premiums | Considerations | Premiums | Total | ||||||||||||||||
($000) | ($000) | ($000) | ($000) | (%) | ||||||||||||||||
Illinois | $ | 3,436 | $ | 4,752 | $ | 24 | $ | 8,212 | 42.5 | % | ||||||||||
Ohio | 253 | 1,790 | 1 | 2,044 | 10.6 | % | ||||||||||||||
Michigan | 251 | 1,567 | 1 | 1,819 | 9.4 | % | ||||||||||||||
California | 1,468 | 22 | 13 | 1,503 | 7.8 | % | ||||||||||||||
Florida | 755 | 428 | 10 | 1,193 | 6.2 | % | ||||||||||||||
Wisconsin | 494 | 376 | 17 | 887 | 4.6 | % | ||||||||||||||
Texas | 804 | 30 | 3 | 837 | 4.3 | % | ||||||||||||||
New Jersey | 300 | 303 | 3 | 605 | 3.1 | % | ||||||||||||||
Pennsylvania | 263 | 3 | 4 | 270 | 1.4 | % | ||||||||||||||
Georgia | 229 | 9 | 3 | 242 | 1.3 | % | ||||||||||||||
All Other States | 1,470 | 239 | 15 | 1,724 | 8.9 | % | ||||||||||||||
Total | $ | 9,723 | $ | 9,519 | $ | 95 | $ | 19,336 | 100.0 | % |
Source: Internal financial reports.
RP Financial, LC.
Page 1.10
Underwriting
Federal Life follows industry underwriting standards and procedures, designed to assess, qualify, and rate life applicants before issuing the policies. To implement these procedures, the Company employs an experienced underwriting staff.
The underwriting process involves a multi-step review process for each application, which is supported by any required testing and records, including: blood, urine, or oral fluid testing, paramedical/physicians’ examinations, and/or motor vehicle, pharmacological, and medical inspection reports and records. The Company’s non-medical limit is $150,000, which means that blood and urine testing is generally required for face amounts exceeding that amount. Other factors may affect table and premium rates, such as the proposed insured’s tobacco/nicotine use. Tobacco/nicotine use within the 2-year period prior to application may result in a higher mortality charge. Additional underwriting requirements and inspection reports may be required when the face amount of the policy and/or the age of the proposed insured increases. Based on the results of these tests, Federal Life may adjust the mortality charge or decline coverage completely.
Reinsurance
Federal Life reinsures a portion of its life insurance exposure with unaffiliated insurance companies under traditional indemnity reinsurance agreements, which assists in diversifying risk and limiting its maximum loss on risks that exceed the Company’s policy retention limits. The current maximum retention limit on an insured’s life is $250,000. New sales of life products are reinsured above prescribed limits and do not require the reinsurer’s prior approval within certain guidelines.
Reinsurance contracts do not fully discharge Federal Life’s obligation to pay claims on the reinsured business. As the ceding insurer, Federal Life remains responsible for policy claims to the extent the reinsurer fails to pay claims. No reinsurer of business ceded by Federal Life has failed to pay any material policy claims (either individually or in the aggregate) with respect to the ceded business. The management of Federal Life continually evaluates the financial strength of its reinsurers and monitors concentrations of credit risk. If for any reason reinsurance coverages would need to be replaced, Federal Life believes that replacement coverages from financially responsible reinsurers would be available.
Table 1.5 below reflects that the majority of the reinsurance has been placed with Optimum Re, Inc.
RP Financial, LC.
Page 1.11
Table 1.5
Federal Life Insurance Company
Reinsurance Ceded By Reinsurer
9/30/2017 | ||||||||
Amount Ceded | Reserve Ceded | |||||||
($000) | ($000) | |||||||
Swiss RE (Cigna) | $ | 57 | $ | 1 | ||||
Optimum RE (LNL) | 4 | 1 | ||||||
Optimum RE | 645,804 | 2,035 | ||||||
Swiss RE | 238 | 5 | ||||||
Prudential | 799 | 3 | ||||||
SCOR | 37,742 | 448 | ||||||
Total | $ | 684,644 | $ | 2,493 |
Source: Internal Financial Reports.
Claims Management
Federal Life processed approximately $7.9 million and $7.7 million of life insurance benefit claims in the fiscal year ended December 31, 2016 and the nine months ended September 30, 2017, on policies underwritten by the Company. The Company provides a high level of customer service and is committed to paying all valid claims. The claim may be reported by an agent, a beneficiary, an interested party, or in the case of a qualifying disability or terminal illness, the policyholder. Claims may also be initiated by us as a result of a search of the Social Security Death Master File or other database. Through the claims administration system, Federal Life records, processes and pays the appropriate benefit for any reported claim. The claims administrative staff orders medical and investigative reports from third-party providers. The claims administrative staff determines the benefit payable based upon the Cyberlife system, calculations from the Actuarial Department, and other amounts such as post mortem interest. The claims administrative staff reports and recovers reinsurance payments from the appropriate reinsurance providers.
The Company as an Illinois domestic insurer regularly consults the Social Security Administration’s Death Master File (“Death Master File”) in accordance with applicable state requirements. These processes help identify potential deceased insureds for whom claims have not been presented in the normal course of business. If unreported deaths are identified, Federal Life determines the validity of claims, locates beneficiaries, and pays benefits accordingly.
RP Financial, LC.
Page 1.12
Executive Officers
Federal Life is managed by an experienced group of executives led by Joseph D. Austin, Chief Executive Officer and Chairman of the Board and William S. Austin, its President and Chief Operating Officer (“COO”). Current management has longstanding experience both at Federal Life and within the insurance industry. Summary biographies of the Company’s executive officers are included below:
Joseph D. Austin has been employed with the Company since 1972 and a member of the Board of Directors since 1973. He was elected Chairman of the Board, President and Chief Executive Officer in June 1977. Since 2002 he has served as Chairman of the Board and Chief Executive Officer. Mr. Austin holds a B.A. degree from the University of Scranton and is a Fellow of the Society of Actuaries and a Member of the American Academy of Actuaries. Prior to joining Federal Life, Mr. Austin served in actuarial, administrative and marketing positions and on the Board of Directors of several other life insurance companies as well as serving as an expert consultant to the U.S. Post Office Department.
William S. Austin has been employed with the Company since 1990 and a member of the Board of Directors since 1992. He has served as President and Chief Operating Officer since 2002. Mr. Austin is a graduate of Marquette University and has an M.B.A. degree in Finance, Investments and Banking from the University of Wisconsin-Madison. Mr. Austin is a Chartered Life Underwriter and a member of the Society of Financial Services Professionals.
Michael Austin has been employed with the Company since 1982 and a member of the Board of Directors since 1992. He has served as Executive Vice President and Chief Marketing Officer since 2000. Mr. Austin attended Western Illinois University. He holds a FINRA Series 6 and Broker-Dealer Agency license with FED Mutual Financial Services, Inc. (a subsidiary of Federal Life Insurance Company) and also holds a producer's license for life and casualty insurance in the State of Illinois. Mr. Austin is responsible for marketing of the Company.
Anders Raaum has been employed with the Company since 1994 and has served as Chief Financial Officer since 2011. Mr. Raaum has a B.A. degree in Business Administration from the University of Oregon and an M.B.A. degree in Finance, Investments and Banking from the University of Wisconsin-Madison and is a Chartered Financial Analyst and a Chartered Life Underwriter. He is also a registered FINRA Full Registration/General Securities Representative and a General Securities Principal with FED Mutual Financial Services, Inc. (a subsidiary of Federal Life Insurance Company. Mr. Raaum is responsible for overseeing the invested assets of Federal Life and well as all accounting functions and regulatory reporting for the Company.
Paul R. Murphy has been employed with the Company since 2002 as its Actuary. He has a B.S. degree in Mathematics Education and a Master of Science degree in Mathematics from the University of Illinois and is a Fellow of the Society of Actuaries, a Member of the American Academy of Actuaries and a Fellow of the Life Management Institute. Mr. Murphy is responsible for actuarial functions for Federal Life and serves as the Appointed Actuary and Illustration Actuary for the Company.
RP Financial, LC.
Page 1.13
Plan of Conversion
As a mutual insurance holding company, FLMHC does not have shareholders. It has members. The members of the FLMHC are the policyholders of Federal Life. On March 8, 2018, the Board of Directors of the FLMHC unanimously adopted the Plan of Conversion, subject to the approval of the Illinois Department of Insurance and the members of FLMHC.
The Plan of Conversion provides for the conversion of Federal Life Mutual Holding Company, a mutual holding company organized under the laws of Illinois (such entity, both before and after the Conversion, being referred to as “FLMHC”), from a mutual holding company into a stock company, and the issuance by FLMHC of newly-issued shares of common stock of FLMHC to FLG pursuant to the Illinois Insurance Code. The Plan of Conversion provides that FLG will offer shares of its common stock for sale in a subscription offering to eligible members of FLMHC, and the directors, officers, and employees of FLMHC. In addition, the Company may elect to offer the shares of common stock not subscribed for in the subscription offering, if any, for sale in a community offering commencing during or upon completion of the subscription offering and in a subsequent syndicated community offering. An identified standby investor, Insurance Capital Group, LLC. (“ICG”) has entered into a Standby Purchase Agreement (the “Agreement”), to purchase in the community offering all unsold shares in the offering up to at least the minimum of the valuation range subject to certain restrictions on their acquisition, sale, and voting of the common stock.
Upon completion of the Conversion, all of the outstanding shares of common stock of FLMHC will be issued to FLG. FLG will be the first-tier parent of FLMHC which will wholly-own Federal Life. The Conversion will be effected only if the orders received in the subscription and community offerings equal or exceed at least the minimum of the Valuation Range and the members of the MHC approve the Plan of Conversion. The Conversion will be accounted for as a simultaneous reorganization, recapitalization, and share offering that will not change the historical accounting basis of FLMHC’s consolidated financial statements.
After paying its expenses and commissions related to the Conversion, FLG will retain a majority of the proceeds of the Offering after downstreaming $12.5 million of the proceeds to Federal Life. The net proceeds infused into Federal Life will supply additional capital that Federal Life needs to support future premium growth, including the expansion of the Company’s producer networks and the marketing of its products. On a short-term basis, the net proceeds will be invested primarily in U.S. Government securities, other federal agency securities, and other corporate and asset-backed securities consistent with the Company’s investment policy.
RP Financial, LC.
Page 1.14
The principal purpose of the Conversion as articulated in the Plan is to create a stock holding company to enhance its strategic and financial flexibility and to provide the Eligible Members with the right to acquire an equity interest in FLG. The Board has indicated its belief that the additional capital resulting from the Conversion would result in the following:
· | Support further organic growth in life insurance premiums written and annuity deposits; |
· | Provide the capital necessary to permit increased sales of life insurance and annuities by Federal Life; |
· | Enable FLG to attract institutional investors and engage in strategic transactions advantageous to FLG and its subsidiaries; and |
· | The Board further believes that the transaction is fair and equitable, is consistent with the purpose and intent of Section 59.1 and will not prejudice the interests of the Members. |
Financial Overview
This valuation analysis is based on Federal Life’s historical financial statements and operations up through September 30, 2017. The financial data presentation for Federal Life in the tables below and incorporated by reference in Exhibit I-1 is based on United States generally accepted accounting principles (“GAAP”). Statutory financial data for Federal Life is included in Exhibit I-2 to provide a more lengthy presentation of the Company’s operating trends, notwithstanding the significant differences between GAAP and the statutory financial presentation. Table 1.6 presents Federal Life’s balance sheet for the fiscal years ended December 31, 2015 and 2016, and as of September 30, 2017, presented in accordance with GAAP.
Growth Trends
The Company balance sheet has remained relatively stable reflecting limited change in Federal’s Life’s operations as the Company has restricted growth in the face of on-going operating losses. Fixed maturity investment securities, which comprise the majority of the asset base, increased from $173.2 million as of December 31, 2015, to $182.9 million as of September 30, 2017, which was partially offset by a reduction in equity securities from $10.2 million as of December 31, 2015, to $7.5 million as of September 30, 2017. The remaining balance of non- invested assets, consisted of various insurance and non-insurance related accruals, the largest of which were deferred policy acquisition costs and assets held in separate accounts, both of which increased modestly through the one and three-quarter year period ended September 30, 2017.
RP Financial, LC.
Page 1.15
Table 1.6
Federal Life Insurance Company
Historical Balance Sheets
As of the Fiscal Year Ended December 31, | As of | |||||||||||||||||||||||
2015 | 2016 | September 30, 2017 | ||||||||||||||||||||||
% of | % of | % of | ||||||||||||||||||||||
Amount | Assets | Amount | Assets | Amount | Assets | |||||||||||||||||||
($000) | (%) | ($000) | (%) | ($000) | (%) | |||||||||||||||||||
ASSETS | ||||||||||||||||||||||||
INVESTMENTS: | ||||||||||||||||||||||||
Available-for-sale | ||||||||||||||||||||||||
Fixed maturities, at fair value | $ | 173,161 | 71.87 | % | $ | 173,102 | 70.64 | % | $ | 182,937 | 71.01 | % | ||||||||||||
Equity securities, at fair value | 10,199 | 4.23 | % | 7,927 | 3.23 | % | 7,526 | 2.92 | % | |||||||||||||||
Policy loans | 10,129 | 4.20 | % | 10,059 | 4.11 | % | 9,937 | 3.86 | % | |||||||||||||||
Other invested assets | - | 0.00 | % | 2,059 | 0.84 | % | 2,208 | 0.86 | % | |||||||||||||||
Short-term investments | 4,987 | 2.07 | % | 5,548 | 2.26 | % | 4,868 | 1.89 | % | |||||||||||||||
Total investments | $ | 198,476 | 82.37 | % | $ | 198,695 | 81.09 | % | $ | 207,476 | 80.53 | % | ||||||||||||
OTHER ASSETS: | ||||||||||||||||||||||||
Cash | $ | 1,567 | 0.65 | % | $ | 2,719 | 1.11 | % | $ | 1,602 | 0.62 | % | ||||||||||||
Real Estate | 1,882 | 0.78 | % | 1,987 | 0.81 | % | 1,915 | 0.74 | % | |||||||||||||||
Accrued investment income | 1,951 | 0.81 | % | 1,827 | 0.75 | % | 1,905 | 0.74 | % | |||||||||||||||
Accounts receivable | 552 | 0.23 | % | 575 | 0.23 | % | 2,722 | 1.06 | % | |||||||||||||||
Reinsurance recoverable | 411 | 0.17 | % | 3,526 | 1.44 | % | 3,680 | 1.43 | % | |||||||||||||||
Prepaid reinsurance premiums | 103 | 0.04 | % | 924 | 0.38 | % | 1,097 | 0.43 | % | |||||||||||||||
Deferred policy acquisition costs, net | 11,605 | 4.82 | % | 11,938 | 4.87 | % | 12,048 | 4.68 | % | |||||||||||||||
Deferred sales inducement costs | 13 | 0.01 | % | 314 | 0.13 | % | 754 | 0.29 | % | |||||||||||||||
Income taxes recoverable | - | 0.00 | % | - | 0.00 | % | - | 0.00 | % | |||||||||||||||
Deferred tax asset | 487 | 0.20 | % | 457 | 0.19 | % | 460 | 0.18 | % | |||||||||||||||
Property and equipment | 343 | 0.14 | % | 310 | 0.13 | % | 229 | 0.09 | % | |||||||||||||||
Other Assets | 227 | 0.09 | % | 254 | 0.10 | % | 196 | 0.08 | % | |||||||||||||||
Assets held in separate accounts | 23,335 | 9.68 | % | 21,513 | 8.78 | % | 23,554 | 9.14 | % | |||||||||||||||
TOTAL ASSETS | $ | 240,952 | 100.00 | % | $ | 245,039 | 100.00 | % | $ | 257,638 | 100.00 | % | ||||||||||||
LIABILITIES & EQUITY | ||||||||||||||||||||||||
LIABILITIES: | ||||||||||||||||||||||||
Policy liabilities and accruals: | ||||||||||||||||||||||||
Policyholder account balance | $ | 94,691 | 39.30 | % | $ | 99,440 | 40.58 | % | $ | 107,090 | 41.57 | % | ||||||||||||
Future life policy benefits | 72,760 | 30.20 | % | 73,097 | 29.83 | % | 72,155 | 28.01 | % | |||||||||||||||
Future life and accident and health policy benefits | 146 | 0.06 | % | 90 | 0.04 | % | 89 | 0.03 | % | |||||||||||||||
Resrve for deposit type contracts | 10,039 | 4.17 | % | 10,529 | 4.30 | % | 10,726 | 4.16 | % | |||||||||||||||
Other policyholder funds | 1,806 | 0.75 | % | 1,889 | 0.77 | % | 5,243 | 2.04 | % | |||||||||||||||
Unearned premium | 1,234 | 0.51 | % | 1,396 | 0.57 | % | 1,383 | 0.54 | % | |||||||||||||||
Taxes payable | 64 | 0.03 | % | 5 | 0.00 | % | 5 | 0.00 | % | |||||||||||||||
Deferrred tax liability | 5 | 0.00 | % | 6 | 0.00 | % | 7 | 0.00 | % | |||||||||||||||
Other liabilities | 1,380 | 0.57 | % | 1,137 | 0.46 | % | 1,145 | 0.44 | % | |||||||||||||||
Separate accounts | 23,335 | 9.68 | % | 21,513 | 8.78 | % | 23,554 | 9.14 | % | |||||||||||||||
TOTAL LIABILITIES | $ | 205,460 | 85.27 | % | $ | 209,102 | 85.33 | % | $ | 221,397 | 85.93 | % | ||||||||||||
Equity | ||||||||||||||||||||||||
Common stock | $ | 0 | 0.00 | % | $ | 2,500 | 1.02 | % | $ | 2,500 | 0.97 | % | ||||||||||||
Retained earnings | $ | 29,576 | 12.27 | % | $ | 27,924 | 11.40 | % | $ | 26,779 | 10.39 | % | ||||||||||||
Accumulated other comprehensive income | 5,916 | 2.46 | % | 5,513 | 2.25 | % | 6,962 | 2.70 | % | |||||||||||||||
TOTAL EQUITY | $ | 35,492 | 14.73 | % | $ | 35,937 | 14.67 | % | $ | 36,241 | 14.07 | % | ||||||||||||
TOTAL LIABILITIES & EQUITY | $ | 240,952 | 100.00 | % | $ | 245,039 | 100.00 | % | $ | 257,638 | 100.00 | % |
Source: Federal Life's and subsidiaries unaudited GAAP adjusted financial statements.
RP Financial, LC.
Page 1.16
Liabilities have remained between 85% and 86% of assets since the end of fiscal 2015. Policyholder account balances have increased reflecting in part, the normal variances typically observed in the accounts. Other liabilities including reserves for future policy benefits and liabilities related to annuities sold remained relatively stable.
Total equity remained relatively stable since the end of fiscal 2015 as retained earnings diminished because of the ongoing operating losses as well as the mutual holding company restructuring which resulted in the upstreaming of capital to the MHC which was subsequently down streamed to the Company as a credit to common stock. Stability of the capital base in the face of operating losses reported by Federal Life was supported by increases in the value of the investment portfolio, which positively impacted the balance of accumulated other comprehensive income (“AOCI”).
The following discussion addresses the major balance sheet items in terms of characteristics, composition and trends.
Investment Securities
Investment decisions for the fixed income portfolio are made by management. Investment management advisory services are provided by Deutsche Asset Management (“Deutsche”) with respect to structured products such as residential mortgage backed securities, commercial mortgage backed securities, asset backed securities, and non-investment grade corporate bonds. Deutsche Asset Management is a leading global asset manager that offers investment services across all asset classes to a variety of individual and institutional clients, including insurance companies. Investment purchases and sales for the defined sectors are made by Deutsche within the parameters established by the Company’s investment guidelines and with prior notification of the Company’s management team. Other investments, primarily exchange traded stock fund investments (“ETFs”), are managed by the Company’s senior management with the assistance of Alley Company, LLC.
RP Financial, LC.
Page 1.17
Federal Life’s investment policy is conservative and has placed primary emphasis on capital preservation and the maintenance of liquidity appropriate for the current and long-term requirements of the Company. The Company’s primary investment objective is to earn a sustainable positive risk-adjusted, after-tax total rate of return on invested assets. Specifically, the structure and composition of the portfolio will seek to complement all aspects of the insurance operations including, but not limited to, liquidity requirements, cash flow, taxation, risk tolerance, and the applicable regulatory directives governing investment activity. The process of policy implementation is meant to be flexible so that the assets of the Company can be invested in a prudent manner under any normal business cycle or market condition which can be reasonably anticipated.
In conforming with the Company’s investment policy, fixed income securities must be rated BB- or higher by Standard & and Poor’s at the time of purchase, with such securities subject to issuer specific limitations by rating category, and overall limitations on investment amounts by rating category. There are various other requirements with respect to management of the investment portfolio detailed in the investment policy pertaining to issuer diversification, sector limitations, etc.
The composition of the investment portfolio is set forth below as of September 30, 2017. As reflected in the data, more than 80% of the portfolio is comprised of corporate and mortgage-backed securities. The average yield and duration of the portfolio as of September 30, 2017, was 3.11% and 6.24 years, respectively.
Type | Market Value | Market Yield | Duration | Market Value / Book Value | Unrealized Gain / Loss | |||||||||||||||
ABS | $ | 1,026 | 3.46 | % | 3.36 | 0.10 | % | $ | 6 | |||||||||||
MBS-Commercial | 4,914 | 3.43 | % | 7.02 | 0.10 | % | (22 | ) | ||||||||||||
MBS-Residential | 39,107 | 3.25 | % | 9.07 | 0.10 | % | 1,487 | |||||||||||||
Municipal | 16,846 | 3.23 | % | 7.24 | 0.10 | % | 763 | |||||||||||||
Corporate | 109,694 | 3.02 | % | 5.24 | 0.10 | % | 3,565 | |||||||||||||
Government Agy | 8,933 | 3.39 | % | 4.38 | 0.10 | % | (65 | ) | ||||||||||||
U. S. Treasury | 2,417 | 2.03 | % | 6.07 | 0.11 | % | 213 | |||||||||||||
Total Bonds | $ | 182,937 | 3.11 | % | 6.24 | 0.10 | % | $ | 5,946 |
RP Financial, LC.
Page 1.18
Historically, fixed-income investments have accounted for the majority of the Company’s investments portfolio. As of September 30, 2017, the was a small balance of equity securities investments ($7.5 million or 2.92% of assets) which consisted primarily of exchange- traded funds (“ETFs”).
Other Assets
Other assets totaled $50.1 million or 19.46% of assets. The largest component of other assets is investments underlying annuities sold by Federal Life, which are held in separate accounts. Deferred policy acquisition costs are also material and reflect the commissions paid to agents on long term insurance policies which are deferred and expensed over the estimated term of the policies. The remaining balance of other assets include operating and trade related accounts such as cash, reinsurance recoverables, prepaid reinsurance premiums and accounts receivable. These balances fluctuate based on typical fluctuations in the Company’s insurance business and internal operations.
Policyholder Account Balances and Policy Benefits
The majority of the Company’s liabilities are comprised of obligations to policyholders. In this regard, policyholder account balances representing the cash surrender value of the policies, totaled $107.1 million, or 41.57% of assets, as of September 30, 2017. Reserves for future life insurance benefits of policy holders was also material, totaling $72.2 million, equal to 28.01% of total assets.
Other Liabilities
Other liabilities consisted primarily of reserves for deposit-type contracts and liabilities for funds due to annuity holders. The remaining balance of other liabilities include operating and trade related accounts such as liabilities for separate accounts, policyholder funds and various accrued liabilities. These balances fluctuate based on typical fluctuations in the Company’s insurance business and internal operations.
Equity
The balance of GAAP equity has remained relatively stable in a range of $35.5 million to $36.2 million since December 31, 2015. A portion of retained earnings was reallocated as a result of the MHC reorganization to common stock while AOCI has increased to offset the impact of operating losses. The conversion and issuance of stock will substantially bolster the Company’s capital position and provide the capital resources required for the Company to implement a growth oriented business plan. In this regard, the infusion of the conversion proceeds will bolster the Company’s capital resources on both a GAAP and statutory basis.
RP Financial, LC.
Page 1.19
Income and Expense Trends
The Company has been reporting operating losses on a GAAP basis for more than a decade, which management attributes to a high level of competition in the traditional markets for life insurance and annuity products. Specifically, Federal Life’s small size and resulting high cost structure have resulted in operating losses for the last decade. Moreover, the erosion of the statutory surplus has eroded the ability to introduce products and services which, while entailing a significant upfront cost to develop and market, could provide enhanced revenues and earnings over the long term. Additionally, the low interest rate environment has diminished net investment income on investment assets used to provide guaranteed benefits to policyholders.
The Company’s losses are reflected in Table 1.7, which provides historical income statements for fiscal 2016 and for the nine months ended September 30, 2017. The ratios presented reflect revenues and expenses as a percent of both average assets and revenues for the periods depicted, with the ratios expressed as a percent of asset reflecting annualized nine month results for the period ended September 30, 2017.
Overall, the Company reported a loss equal to $2.0 million in fiscal 2016, and $1.1 million for the nine months ended September 30, 2017. The fiscal 2016 loss equaled 0.81 percent of assets and 7.7 percent of revenues. Over the nine months ended September 30, 2017, losses equaled 0.56 percent of assets on an annualized basis and 6.2% of revenues for the corresponding period.
Net Premiums Earned
Premiums on life insurance policies comprise the largest component of revenues, and equaled $14.9 million (58.03% of revenues) in fiscal 2016 and $9.7 million (54.3% of revenues) for the first nine months of fiscal 2017. The substantial majority of the Company’s premium revenues is derived through the sale of Federal Life’s insurance and annuity products.
RP Financial, LC.
Page 1.20
Table 1.7
Federal Life Insurance Company
Historical Income Statements as a Percent of Average Assets
For the Fiscal Year Ended | For the Nine Months Ended | |||||||||||||||||||||||
December 31, 2016 | September 30, 2017 | |||||||||||||||||||||||
% of Avg | % of | % of Avg. | % of | |||||||||||||||||||||
Amount | Assets | Revenues | Amount | Assets (1) | Revenues | |||||||||||||||||||
($000) | (%) | (%) | ($000) | (%) | (%) | |||||||||||||||||||
REVENUES: | ||||||||||||||||||||||||
Premiums | $ | 14,879 | 6.12 | % | 58.03 | % | $ | 9,698 | 4.86 | % | 54.30 | % | ||||||||||||
Net investment income | 8,797 | 3.62 | % | 34.31 | % | 6,326 | 3.17 | % | 35.42 | % | ||||||||||||||
Net realized capital gains | 1,783 | 0.73 | % | 6.95 | % | 1,697 | 0.85 | % | 9.50 | % | ||||||||||||||
Miscellaneous income | 179 | 0.07 | % | 0.70 | % | 138 | 0.07 | % | 0.77 | % | ||||||||||||||
Total revenues | $ | 25,638 | 10.55 | % | 100.00 | % | $ | 17,859 | 8.94 | % | 100.00 | % | ||||||||||||
EXPENSES: | ||||||||||||||||||||||||
Policyholder benefits | $ | 18,645 | 7.67 | % | 72.72 | % | $ | 12,577 | 6.30 | % | 70.42 | % | ||||||||||||
Interest credited to policyholders | 315 | 0.13 | % | 1.23 | % | 330 | 0.17 | % | 1.85 | % | ||||||||||||||
Operating Costs and expenses | 7,809 | 3.21 | % | 30.46 | % | 5,441 | 2.72 | % | 30.47 | % | ||||||||||||||
Taxes, licenses and fees | 722 | 0.30 | % | 2.82 | % | 554 | 0.28 | % | 3.10 | % | ||||||||||||||
Total Benefits and Expenses | 27,491 | 11.31 | % | 107.23 | % | 18,902 | 9.46 | % | 105.84 | % | ||||||||||||||
INCOME (LOSS) BEFORE DIVIDENDS TO POLICY HOLDERS AND INCOME TAXES | $ | (1,853 | ) | -0.76 | % | -7.23 | % | $ | (1,043 | ) | -0.52 | % | -5.84 | % | ||||||||||
DIVIDENDS TO POLICY HOLDERS | 86 | 0.04 | % | 0.34 | % | 49 | 0.02 | % | 0.27 | % | ||||||||||||||
INCOME (LOSS) BEFORE INCOME TAXES | $ | (1,939 | ) | -0.80 | % | -7.56 | % | $ | (1,092 | ) | -0.55 | % | -6.11 | % | ||||||||||
INCOME TAX (BENEFIT) PROVISION: | $ | 32 | 0.01 | % | 0.12 | % | $ | 18 | 0.01 | % | 0.10 | % | ||||||||||||
NET INCOME | $ | (1,971 | ) | -0.81 | % | -7.69 | % | $ | (1,110 | ) | -0.56 | % | -6.22 | % |
(1) Reflects annualized ratio.
Source: Federal Life's and subsidiaries unaudited GAAP adjusted financial statements.
RP Financial, LC.
Page 1.21
Investment Income
Investment income consists of dividends and interest earned on invested assets. As previously noted, investment income has been declining over time as the higher yielding investments have matured with the proceeds reinvested into securities with relatively low interest rates consistent with the prevailing market. Investment income equaled $8.8 million (34.3% of revenues) in fiscal 2016 and $6.3 million (35.4% of revenues) for the first nine months of fiscal 2017.
Other Income
Other income, outside of policies revenues and investment income, has been a relatively minor contributor to the earnings of the Company for the period of time shown in Table 1.7 and primarily consisted of realized capital gains on the sale of investments and other miscellaneous revenue sources.
Policyholder Benefits
Benefit expenses related to policyholder claims represent the largest component of expenses, equaling $12.6 million, or 70.4% of revenues. Life and annuity policy liabilities are developed by actuarial methods and are intended to provide, in the aggregate, reserves that are greater than, or equal to, the minimum or guaranteed policy cash values or the amounts required by law.
Operating Costs and Expenses
Operating and administrative expenses consist of the administrative expenses directly related to underwriting insurance and the ancillary activities of the Company. Federal Life has sought to limit the growth of operating expenses with the objective of stemming the recent operating losses. In this regard, the Company has reduced staffing and sought to minimize other controllable costs without impacting revenues. Additionally, the Company has held off on revenue producing initiatives, such as introducing alternative variable annuity products given their upfront costs. Operating costs and expenses totaled $7.8 million (30.5% of revenues) in fiscal 2016, and $5.4 million (30.5% of revenues) for the nine months ended September 30, 2017.
RP Financial, LC.
Page 1.22
Income Taxes
As of September 30, 2017, Federal Life had net operating loss carryforwards (“NOLs”) available to offset future taxable income totaling $28.6 million with expirations extending out for 15 years through 2032. As of September 30, 2017 the Company had a deferred tax asset (“DTA”) related to the NOL equal to $9.7 million, but only carried a net deferred tax asset of $0.5 million as an admitted asset on its balance sheet. The value of the DTA will be affected by any future changes in the corporate tax rate and could be further limited by IRS rules related to change in ownership. Management has indicated that the ability of the Company to utilize NOL’s to offset taxable income in the future might be subject to an annual “382 limitation” of approximately $0.7 million, depending on the pre-sale value of the Company. Moreover, the ability to utilize the NOLs will be subject to the Company’s plans to implement a growth oriented business plan and generate taxable income.
Potential Off Balance Sheet Value
The Company has several assets that management estimates may have value beyond the historical cost as reflected on the balance sheet. In this regard, Federal Life’s headquarters office in Riverwoods, Illinois had a de minimus net book value as the building was fully depreciated as of September 30, 2017. The tax value is in the range of $5.5 million, and management has indicated that the value could be higher in a market sale transaction. Alternatively, the office could be divided with a portion of the spaced leased to a tenant.
In addition to the foregoing, the Company’s wholly owned subsidiary Americana Realty Company owns mineral rights on land primarily in Texas and Oklahoma that has generated an average of approximately $875,000 in annual bonus and royalty payments over the past five years. These mineral rights have been fully depleted and have a zero book value on Americana’s balance sheet. Management believes that the sale of these mineral rights could yield significant value.
Importantly, management has indicated no current intent to undertake any of the foregoing strategies to monetize the unrealized value in the main office building or the mineral rights it owns. Additionally, some of the benefits of such unrealized values are realized through operations, in terms of the relatively low occupancy costs and revenues from the mineral rights.
RP Financial, LC.
Page 1.23
Legal Proceedings
Other than the routine legal proceedings that occur in the Company’s ordinary course of business, the Company is not involved in litigation that is expected to have a material impact on financial condition or operations.
RP Financial, LC.
Page 2.1
II. EXTERNAL ENVIRONMENT
Introduction
As the U.S. economy continues its steady post-recession recovery, the gap between small and large insurance companies is projected to widen. Many segments of the insurance industry are highly cyclical and subject to intense competition, particularly in Federal Life’s more significant markets in the Midwest and in the life and annuity insurance product segments. While life insurance ownership amongst U.S. households has increased steadily over the years, the mix has shifted towards employer-based plans in recent years, driven by population growth, reductions in unemployment and increased corporate profitability. Going forward, industry analysts expect that many life insurers will see greater demand for simple products, particularly whole life insurance, as individuals flee to greater levels of safety in today’s volatile financial environment. Another important external factor critical to Federal Life’s business is the current low interest rate environment that has caused bond yields to plummet to historical lows and limited investment income for all insurers. Other factors impacting life insurers include the changing regulatory landscape, evolving customer expectations and the looming threat of technology start-ups entering the life insurance market. In summary, the major factors that will influence Federal Life’s business during 2017-2018 include: national economic factors, customer expectations, regulatory matters, and competition. These topics are further discussed below.
National Economic Trends
Profitability for Federal Life and the life insurance industry will be significantly affected by investment returns and the strength and health of the economy, which may impact demand for insurance products. In assessing national economic trends over the past quarter, manufacturing activity decelerated in July 2017, based on readings of 56.3 and 53.9, respectively. The U.S. economy added 209,000 jobs in July and the July unemployment rate fell to 4.3%. Housing starts for July declined 4.8%, while new and existing home sales also fell in July decreasing by 9.4% and 1.3%, respectively. Durable-goods orders declined 6.8% in July, which was driven by a drop in aircraft orders. Excluding aircraft orders, July durable-goods orders were up 0.5%. Economic activity in the manufacturing and service sectors expanded at faster rates in August, based on respective readings of 58.8 and 55.3. The U.S. economy added 156,000 jobs in August and the August unemployment rate ticked up to 4.4%. Housing data for August showed a slight slowdown compared to July, as August housing starts fell 0.8%, existing home sales slipped 1.7% and new home sales decreased 3.4%. Manufacturing activity for September reached a 13-year high, with a reading of 60.8. Similarly, the September service sector activity reading of 59.8 was a 12-year high. The U.S. economy lost 33,000 jobs in September, reflecting the impact of hurricanes Harvey and Irma. The September unemployment rate fell to a post-crisis low of 4.2%. Sales of existing homes edged up 0.7% in September, while new home sales for September surged 18.9%. Indications that the U.S. economy was gaining momentum was provided by a 2.2% increase in September durable- goods orders and GDP increased at a 3.0% annual rate in the third quarter.
RP Financial, LC.
Page 2.2
Manufacturing activity for October 2017 expanded at a slightly lower rate compared to September, with a reading of 58.7. Comparatively, service sector activity accelerated in October to a reading of 60.1, its highest reading since August 2005. The unemployment rate for October declined to a 17-year low of 4.1%, as U.S. employers added 261,000 jobs in October.
The upward trend in long-term Treasury yields continued at the start of the third quarter of 2017, which was followed by a slight decline in long-term Treasury yields in the second half of July. The Federal Reserve elected to hold rates steady following its late-July policy meeting and signaled readiness to begin shrinking its bond holdings as soon as September 2017. Following a period of relatively stable interest rates through most of August, long-term Treasury yields trended lower in late-August through the first part of September. Factors contributing to the rally in Treasury bonds included warnings from Federal Reserve officials regarding low inflation and its impact on further rate increases, as well as a flight to safe-haven investments fueled by escalating tensions between the U.S. and North Korea. Long-term Treasury yields edged higher ahead of the Federal Reserve’s September meeting. The Federal Reserve concluded its September policy meeting leaving interest rates unchanged and indicated that it was on track to raise short-term interest rates later in 2017. The upward trend in long-term Treasury yields continued through the end of the third quarter.
Strong reports for September manufacturing and service sector activity contributed to sustaining the upward trend in long-term Treasury yields at the start of the fourth quarter of 2017. Comparatively, soft inflation data contributed to a rally in Treasury bonds in mid-October. Long-term Treasury yields moved higher during the second half of October, with the 10-year Treasury yield closing above 2.4% for the time in five months. Investors preparing for the Federal Reserve to back away from years of stimulus efforts was a noted factor contributing to the rise in Treasury yields. At the start of November, the Federal Reserve concluded its policy meeting leaving its target rate unchanged as expected. Treasury yields eased lower in early- November, as the nomination of Jerome Powell as the next Federal Reserve chairman eased some investors’ fears. As of November 8, 2017, the bond equivalent yields for U.S. Treasury bonds with terms of one and ten years equaled 1.53% and 2.32%, respectively, versus comparable year ago yields of 0.71% and 1.88%. Exhibit II-2 provides historical interest rate trends.
RP Financial, LC.
Page 2.3
Based on the consensus outlook of economists surveyed by The Wall Street Journal in October 2017, GDP growth was projected to increase to 2.4% in 2018. The unemployment rate was forecasted to equal 4.2% in December 2017 and then decline slightly to equal 4.1% in June 2018. An average of 161,000 jobs were projected to be added per month during 2017. On average, the economists forecasted an increase in the federal funds rate to 1.37% in December 2017 and then increase to 1.72% in June 2018. On average, the economists forecasted that the 10-year Treasury yield would increase to 2.46% in December 2017 and then increase to 2.76% in June 2017. The surveyed economists also forecasted home prices would rise 4.8% in 2018 and housing starts would continue to trend slightly higher in 2018.
Life Insurance Trends
Since 2010, the number of Americans with life insurance coverage has increased by approximately 0.5% to 172 million or approximately 53% the U.S. population. Coverage growth over this period can be attributed to enrollment in employer-based life insurance plans, which increased by 9 million persons from 2010 through 2016 (see chart below)
RP Financial, LC.
Page 2.4
Source: LIMRA
Despite the increase in persons with life insurance coverage, coverage amounts continue to be an issue. The mean life insurance coverage amount is currently $168,000, which translates to 3.4 years of income replacement – falling short of the industry recommended 7 years of income replacement. The observed shortfall in insurance coverage amounts is due in part, to relatively low coverage limits imposed by employer-based insurance plans, and a general lack of education regarding life insurance products. Among the 102 million Americans without life insurance coverage at the end of 2016, the primary reasons for not purchasing coverage include a belief that life insurance products are too expensive, and that other financial priorities such as living expenses, establishing savings, managing debt and/or saving for retirement take precedence. In addition, more than a quarter of Americans believe that they would not qualify for insurance, with almost half of millennial respondents without insurance coverage surveyed by LIMR, stating that they have never been approached by a life insurance agent.
The confluence of the aforementioned findings highlights the market opportunity for life insurers in the U.S. According to studies by LIMRA, a financial services consulting and research organization, a consumer centric approach will be key to growth for successful life insurance underwriters, with an emphasis on education and attentive customer service. With more than half of consumers surveyed by the LIMRA, stating that they would have immediate or near immediate trouble paying living expenses if their primary wage earner died, life insurance agents must seek to counsel consumers on the benefits of life insurance as a source of income to cover final expenses, supplement wages and/or retirement income. As millennials age and establish families, their propensity for life insurance products increase accordingly. Winning the business of persons from this segment of the population, characterized by their prevalent use of smartphones and the internet, desire for transparency and instant gratification, will require higher levels of service that may include product innovation, increased focus on social media, and the use of mobile applications and online platforms.
RP Financial, LC.
Page 2.5
Technology will continue to shape the future of the industry, as innovators seek to develop new applications, thereby driving innovation and efficiencies. Industry advances include the use of artificial intelligence in process automation and underwriting decisions, in turn providing consumers with rapid policy approval. Companies leveraging enterprise data will be better positioned to drive product innovation, as such technologies will allow insurers to optimize product offerings to better suit consumer needs, in addition to generating cross-sales.
Regulatory Environment
The current regulatory environment and pending legislation have the potential to impact the life insurance industry as well as Federal Life on many different levels. The Department of Labor fiduciary rules, issued on April 2016, are changing the way in which insurance companies and their agent networks operate. The rule demands that financial professionals, specifically those recommending or soliciting retirement plans or products (defined-contribution plans, defined-benefit plans and IRAs), work in the best interest of their clients. Importantly, the fiduciary standard outlined in the rule indicates a level of accountability beyond the suitability standard previously required of agents and advisors. The suitability standard of old required that an investment recommendation be made to meet a client’s defined need and objectives. The fiduciary standard however, means that agents and advisors would be legally obligated to find and recommend the best possible investment for their clients based on their overall profile. In addition, agents or advisors seeking to continue working on commission will need to provide clients with a disclosure agreement, known as a Best Interest Contract Exemption (“BICE”), thereby clearly outlining all possible conflicts of interest that may exist, such as higher bonuses and commissions for specific product sales. In addition, all compensation received by agents or advisors must be quantified.
RP Financial, LC.
Page 2.6
The impact of the rule on the insurance industry is twofold, an increase in costs stemming from heightened compliance (the rule stipulates that BICE be supervised by a “Financial Institution”), and investment in due diligence efforts required of fiduciaries, along with a possible elimination of the commission-based compensation structure agents and advisors. Following an initial assessment of the rule, many insurance companies, have already begun moving towards a fee based compensation structure for their agents and advisors. Implementation of the rule however, has been delayed until June 2019 by the Trump Administration, to allow for a legal and economic review.
An increased national focus on cybersecurity, following several high-profile security breaches in recent months, is likely to attract government action at both the state and federal level. Recently proposed cybersecurity regulations from New York State, the Federal Reserve, the Office of the Comptroller of the Currency and the Federal Deposit Insurance Corporation serve as early indicators of the Trump Administration’s regulatory agenda. This will spell higher compliance costs for insurers, stemming from cyber risk audits, enterprise-wide training, and penetration testing, as digital transformation continues to gain hold within the industry, thereby increasing exposure to cybercrime.
Competition
Federal Life faces notable competition, including direct competition with insurers that primarily have a local, regional or national presence. The slow growth/declining population of Federal Life’s primary market area of Illinois, over the last several years has naturally had an effect on the economic and business environment, increasing competition for life insurers in the market.
Importantly the impact of the local market conditions is limited as Federal Life operates nationwide with the exception of the New England states. In addition, Federal Life, like many other life insurers, has a significant focus on annuities, a space in which many asset managers. Table 2.1 lists the largest competitors by market share in Federal Life’s top 5 markets, based on 2016 direct premiums written.
RP Financial, LC.
Page 2.7
Table 2.1
Federal Life
Market Share
2016 | 2016 | |||||||||||
Institution | Rank | State Direct Premiums & Annuity Considerations ($000) | Market Share (%) | |||||||||
Illinois - Total Life | ||||||||||||
Prudential Financial Inc. (SNL Life Group) | 1 | 1,696,732 | 8.0 | |||||||||
Massachusetts Mutl Life Ins Co (SNL Life Group) | 2 | 1,106,999 | 5.3 | |||||||||
Northwestern Mutl Life Ins Co. (SNL Life Group) | 3 | 912,527 | 4.3 | |||||||||
Principal Financial Group Inc. (SNL Life Group) | 4 | 838,287 | 4.0 | |||||||||
Jackson (SNL Life Group) | 5 | 815,382 | 3.9 | |||||||||
John Hancock (SNL Life Group) | 6 | 802,241 | 3.8 | |||||||||
Voya Financial Inc. (SNL Life Group) | 7 | 760,166 | 3.6 | |||||||||
New York Life (SNL Life Group) | 8 | 727,242 | 3.5 | |||||||||
American International Group (SNL Life Group) | 9 | 708,066 | 3.4 | |||||||||
AEGON (SNL Life Group) | 10 | 703,337 | 3.3 | |||||||||
Federal Life Insurance Co. | 94 | 9,906 | 0.1 | |||||||||
Total Life Premiums in Market | 21,100,314 | |||||||||||
Ohio - Total Life | ||||||||||||
Western & Southern Financial (SNL Life Group) | 1 | 3,257,094 | 15.1 | |||||||||
Prudential Financial Inc. (SNL Life Group) | 2 | 1,130,026 | 5.3 | |||||||||
Nationwide Mutual Group (SNL Life Group) | 3 | 1,037,672 | 4.8 | |||||||||
Voya Financial Inc. (SNL Life Group) | 4 | 856,789 | 4.0 | |||||||||
Jackson (SNL Life Group) | 5 | 822,454 | 3.8 | |||||||||
Massachusetts Mutl Life Ins Co (SNL Life Group) | 6 | 729,614 | 3.4 | |||||||||
New York Life (SNL Life Group) | 7 | 707,685 | 3.3 | |||||||||
Lincoln Financial (SNL Life Group) | 8 | 654,177 | 3.0 | |||||||||
John Hancock (SNL Life Group) | 9 | 619,977 | 2.9 | |||||||||
American International Group (SNL Life Group) | 10 | 618,054 | 2.9 | |||||||||
Federal Life Insurance Co. | 118 | 2,370 | 0.0 | |||||||||
Total Life Premiums in Market | 21,522,121 | |||||||||||
California - Total Life | ||||||||||||
Prudential Financial Inc. (SNL Life Group) | 1 | 3,986,735 | 7.8 | |||||||||
AEGON (SNL Life Group) | 2 | 3,060,243 | 6.0 | |||||||||
New York Life (SNL Life Group) | 3 | 2,862,496 | 5.6 | |||||||||
John Hancock (SNL Life Group) | 4 | 2,365,467 | 4.6 | |||||||||
American International Group (SNL Life Group) | 5 | 2,316,407 | 4.5 | |||||||||
Massachusetts Mutl Life Ins Co (SNL Life Group) | 6 | 2,158,317 | 4.2 | |||||||||
Voya Financial Inc. (SNL Life Group) | 7 | 2,011,980 | 3.9 | |||||||||
Jackson (SNL Life Group) | 8 | 1,954,043 | 3.8 | |||||||||
Lincoln Financial (SNL Life Group) | 9 | 1,925,509 | 3.8 | |||||||||
Nationwide Mutual Group (SNL Life Group) | 10 | 1,748,029 | 3.4 | |||||||||
Federal Life Insurance Co. | 132 | 2,003 | 0.0 | |||||||||
Total Life Premiums in Market | 51,315,483 | |||||||||||
Florida - Total Life | ||||||||||||
American International Group (SNL Life Group) | 1 | 2,115,923 | 6.3 | |||||||||
AEGON (SNL Life Group) | 2 | 2,046,986 | 6.1 | |||||||||
Prudential Financial Inc. (SNL Life Group) | 3 | 1,846,866 | 5.5 | |||||||||
Nationwide Mutual Group (SNL Life Group) | 4 | 1,723,117 | 5.1 | |||||||||
Lincoln Financial (SNL Life Group) | 5 | 1,620,467 | 4.8 | |||||||||
New York Life (SNL Life Group) | 6 | 1,370,578 | 4.1 | |||||||||
Massachusetts Mutl Life Ins Co (SNL Life Group) | 7 | 1,305,471 | 3.9 | |||||||||
Jackson (SNL Life Group) | 8 | 1,225,869 | 3.6 | |||||||||
John Hancock (SNL Life Group) | 9 | 1,209,279 | 3.6 | |||||||||
Voya Financial Inc. (SNL Life Group) | 10 | 1,073,527 | 3.2 | |||||||||
Federal Life Insurance Co. | 142 | 1,254 | 0.0 | |||||||||
Total Life Premiums in Market | 33,634,825 | |||||||||||
Texas - Total Life | ||||||||||||
American International Group (SNL Life Group) | 1 | 3,012,599 | 9.0 | |||||||||
New York Life (SNL Life Group) | 2 | 1,642,642 | 4.9 | |||||||||
Prudential Financial Inc. (SNL Life Group) | 3 | 1,368,211 | 4.1 | |||||||||
Voya Financial Inc. (SNL Life Group) | 4 | 1,247,832 | 3.7 | |||||||||
Lincoln Financial (SNL Life Group) | 5 | 1,234,451 | 3.7 | |||||||||
Allianz Group (SNL Life Group) | 6 | 1,189,602 | 3.6 | |||||||||
Jackson (SNL Life Group) | 7 | 1,160,386 | 3.5 | |||||||||
AEGON (SNL Life Group) | 8 | 1,141,780 | 3.4 | |||||||||
John Hancock (SNL Life Group) | 9 | 1,109,000 | 3.3 | |||||||||
Massachusetts Mutl Life Ins Co (SNL Life Group) | 10 | 1,102,403 | 3.3 | |||||||||
Federal Life Insurance Co. | 168 | 1,087 | 0.0 | |||||||||
Total Life Premiums in Market | 33,555,061 |
RP Financial, LC.
Page 3.1
III. PEER GROUP ANALYSIS
The applicable valuation technique is the pro forma market value approach, whereby the pro forma market value of Federal Life is derived from the market pricing of a group of publicly- traded insurance companies sharing reasonably comparable characteristics. This section presents an analysis of Federal Life’s operations versus a group of comparable companies (the “Peer Group”) selected from the universe of all publicly-traded insurance companies which share reasonably comparable characteristics with the Company. Factors affecting the Company’s pro forma market value, such as financial condition and operating performance, and liquidity of the stock, can be assessed in relation to the Peer Group. Current market pricing of the Peer Group, subject to adjustments to account for fundamental differences between Federal Life and the Peer Group, will then be used as a basis for the valuation of Federal Life’s to-be- issued common stock.
Peer Group Selection
We consider the appropriate Peer Group to be of publicly-traded companies with established markets for common stock (NASDAQ, NYSE, AMEX and OTC Bulletin Board/Pink Sheets). We believe companies trading outside of these markets are frequently highly irregular in terms of frequency of trading and/or pricing and as a result, the trading activity may not be a reliable indicator of market value. We have excluded from the Peer Group those companies under acquisition and/or those companies whose market prices appear to be distorted by speculative factors or unusual operating conditions.
Ideally, the Peer Group should be comprised of similarly-sized publicly-traded insurance companies that have reasonably comparable financial characteristics and strategies as the Company. While there are many insurance companies with relatively small asset bases, smaller companies are usually not exchange-listed or are in mutual form. Thus, the peer group of publicly-traded companies selected for this analysis are generally significantly larger and more diversified than Federal Life. We also attempted to select Peer Group members whose business focus was on life insurance and annuity/savings products as these companies are subject to the same general market dynamics and pricing trends as the Company, which influences their stock prices and investor perceptions of value.
RP Financial, LC.
Page 3.2
Of the 24 companies composing the Public Life Insurance Group as of December 22, 2017, there were only seven insurers with a total market capitalization under $1 billion. The median market capitalization of the overall Public Life Insurance Group was $4.3 billion and the average size was even larger at $10.5 billion, skewed by such large and well known life insurers as MetLife, Prudential and AFLAC. We applied the following specific selection criteria and focused principally on companies with market capitalization of less than $1 billion and total assets less than $5 billion, which were thus the most comparable to Federal Life:
· | Publicly traded – stock-form insurance company whose shares are traded on New York Stock Exchange, NYSE MKT, or NASDAQ Stock Market or in one of the over the counter markets. |
· | Market segment – Insurance underwriter whose primary market segment is listed as life insurance by SNL Financial. |
· | Not subject to acquisition |
· | Operations – We sought to include companies with either modest losses or earnings on a trailing 12 month basis; and |
· | Market capitalization – Less than $10 billion. |
Table 3.1 lists certain key characteristics of the Peer Group companies.
RP Financial, LC.
Page 3.3
Table 3.1
General Characteristics
Peer Group of Publicly-Traded Insurance Companies
Corporate | Primarily | |||||||
Ticker | Company | Headquarters | Exchange | Lines of Business | ||||
Federal Life Insurance Company | Riverwoods, IL | NA | Asset Accumulation, Life | |||||
AEL | American Equity Investment Life Holding Company | West Des Moines, IA | NYSE | Asset Accumulation, Life | ||||
CIA | Citizens, Inc. | Austin, TX | NYSE | Health, Life, Multi-Peril, Other P&C | ||||
CNO | CNO Financial Group, Inc. | Carmel, IN | NYSE | Asset Accumulation, Asset Management, Health, Life, Manage | ||||
FFG | FBL Financial Group, Inc. | West Des Moines, IA | NYSE | Asset Accumulation, Asset Management, Health, Life | ||||
IHC | Independence Holding Company | Stamford, CT | NYSE | Asset Accumulation, Health, Life, Managed Care | ||||
KCLI | Kansas City Life Insurance Company | Kansas City, MO | OTCQX | Accident & Health, Asset Accumulation, Life, Managed Care | ||||
NWLI | National Western Life Group, Inc. | Austin, TX | NASDAQ | Asset Accumulation, Life, Other L&H | ||||
SNFCA | Security National Financial Corporation | Salt Lake City, UT | NASDAQ | Asset Accumulation, Health, Life | ||||
UTGN | UTG, Inc. | Springfield, IL | OTC Pink | Asset Accumulation, Health, Life |
Source: S&P Global Market Intelligence and Federal Life's internal financials, as of September 30, 2017 for Federal Life and all other Companies.
RP Financial, LC.
Page 3.4
Table 3.1
General Characteristics
Peer Group of Publicly-Traded Insurance Companies
Trailing | ||||||||||||||||||||||
12 Months | As of 12/22/2017 | |||||||||||||||||||||
Total | Policy | Total | Common | Market | ||||||||||||||||||
Ticker | Company | Assets | Revenues | Revenues | Stock Price | Value | ||||||||||||||||
($Mil) | ($Mil) | ($Mil) | ($) | ($Mil) | ||||||||||||||||||
Federal Life Insurance Company (1) | $ | 258 | $ | 13 | $ | 24 | NA | NA | ||||||||||||||
AEL | American Equity Investment Life Holding Company | $ | 60,380 | $ | 230 | $ | 3,275 | $ | 32.13 | $ | 2,863 | |||||||||||
CIA | Citizens, Inc. | $ | 1,651 | $ | 199 | $ | 253 | $ | 7.48 | $ | 375 | |||||||||||
CNO | CNO Financial Group, Inc. | $ | 32,705 | $ | 2,641 | $ | 4,212 | $ | 24.87 | $ | 4,172 | |||||||||||
FFG | FBL Financial Group, Inc. | $ | 9,892 | $ | 311 | $ | 737 | $ | 71.80 | $ | 1,790 | |||||||||||
IHC | Independence Holding Company | $ | 1,039 | $ | 278 | $ | 317 | $ | 27.95 | $ | 415 | |||||||||||
KCLI | Kansas City Life Insurance Company | $ | 4,511 | $ | 292 | $ | 450 | $ | 45.10 | $ | 437 | |||||||||||
NWLI | National Western Life Group, Inc. | $ | 12,138 | $ | 181 | $ | 811 | $ | 337.03 | $ | 1,158 | |||||||||||
SNFCA | Security National Financial Corporation | $ | 1,008 | $ | 69 | $ | 288 | $ | 5.40 | $ | 82 | |||||||||||
UTGN | UTG, Inc. | $ | 405 | $ | 6 | $ | 21 | $ | 25.00 | $ | 83 |
(1) Revenues are annualized nine month results.
Source: S&P Global Market Intelligence and Federal Life's internal financials, as of September 30, 2017 for Federal Life and all other Companies.
RP Financial, LC.
Page 3.5
American Equity Investment Life Holding Company (“AEL”), based in West Des Moines, IA, issues fixed annuity and life insurance products through its wholly-owned life insurance subsidiaries, American Equity Investment Life Insurance Company, American Equity Investment Life Insurance Company of New York and Eagle Life Insurance Company. AEL has one business segment which represents its core business comprised of the sale of fixed index and fixed rate annuities and AEL business strategy is focused on growing policyholder funds and earning predictable returns by managing investment spreads and investment risk. AEL is licensed to sell its annuity products in 50 states and the District of Columbia, and marketing of the products is undertaken through a variable cost distribution network including, independent agents through national marketing organizations, broker/dealers, banks and registered investment advisors.
· | Citizens, Inc. (“CIA”) is an insurance holding company incorporated in Colorado serving the life insurance needs of individuals in the United States since 1969 and internationally since 1975. Through CIA’s insurance subsidiaries, CIA pursues a strategy of offering traditional insurance products in niche markets where its believes it is able to achieve competitive advantages. CIA’s core insurance operations include issuing and servicing: |
· | U.S. Dollar-denominated ordinary whole life insurance and endowment policies predominantly sold to foreign residents, located principally in Latin America and the Pacific Rim, through independent marketing consultants; |
· | Ordinary whole life insurance policies to middle income households concentrated in the Midwest, Mountain West and southern United States through independent marketing consultants; and |
· | Final expense and limited liability property policies to middle and lower income households in Louisiana, Mississippi and Arkansas through employee and independent agents in our home service distribution channel and funeral homes |
· | CNO Financial Group (“CNO”), based in Carmel, Indiana, is an insurance holding company. CNO’s insurance subsidiaries - principally Bankers Life and Casualty Company, Colonial Penn Life Insurance Company and Washington National Insurance Company - primarily serve middle-income pre-retiree and retired Americans by helping them protect against financial adversity and provide for a more secure retirement. CNO’s insurance subsidiaries develop, market and administer health insurance, annuity, individual life insurance and other insurance products with these products sold through three primary distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing. CNO’s insurance subsidiaries collectively hold licenses to market our insurance products in all fifty states, the District of Columbia, and certain protectorates of the United States. |
RP Financial, LC.
Page 3.6
· | FBL Financial Group, Inc. (“FFG”) is an insurance holding company whose primary operating subsidiary, Farm Bureau Life Insurance Company, underwrites and markets a broad range of life insurance and annuities to individuals and businesses, which are distributed by multiline exclusive Farm Bureau agents. In addition, FBL Financial Group manages all aspects of two Farm Bureau affiliated property-casualty insurance companies for a management fee. Sales through the principal distribution channels are currently conducted in 15 states. FFG’s target market is Farm Bureau members and "Middle America." FFG has traditionally have been very strong in rural and small-town markets while having a growing presence in small and mid-metro markets. The financial needs of FFG’s target market/customer tend to focus on security, insurance needs and retirement savings. FBL Financial Group, is headquartered in West Des Moines, Iowa. |
· | Independence Holding Company (“IHC”), Stamford, CT is an insurance holding company that is principally engaged in underwriting, administering and/or distributing group and individual specialty benefit products, including disability, supplemental health, pet, and group life insurance through its subsidiaries since 1980. The IHC Group owns three insurance companies (Standard Security Life Insurance Company of New York, Madison National Life Insurance Company, Inc. and Independence American Insurance Company), and IHC Specialty Benefits, Inc., a technology-driven insurance sales and marketing company that creates value for insurance producers, carriers and consumers (both individuals and small businesses) through a suite of proprietary tools and products (including ACA plans and small group medical stop-loss). |
· | Kansas City Life Insurance Company (“KCLI”), was established in 1895 and is based in Kansas City, Missouri. KCLI’s primary business is providing financial protection through the sale of life insurance and annuities. Kansas City Life’s Individual Insurance segment provides financial security to consumers in 48 states. Life insurance products are distributed through two channels: the Company’s field force and through third-party marketing arrangements. The Individual Insurance segment consists of individual insurance products for both Kansas City Life and Sunset Life. Kansas City Life offers several insurance products in the Group Insurance segment, including dental, life, accident, vision, and short and long term disability. These offerings encompass both traditional, employer-funded group insurance, as well as voluntary, employee-paid products. The Group Insurance segment markets products primarily to small and mid-size organizations. Marketing is conducted through through sales representatives who target a nationwide network of independent general agents and group brokers, along with the Company’s career general agents. This sales network is this segment’s core distribution system. The Company also markets insurance products through third party alliances and marketing arrangements. |
· | National Western Life Group, Inc. (“NWLI”) is the insurance holding company of National Western Life Insurance Company (NWLIC). Founded in 1956, NWLIC is a stock life insurance company offering a broad portfolio of individual whole life, universal life and term insurance plans, and annuities, including supplementary riders. Products are offered to meet the financial needs of its customers in 49 states as well as residents of various international countries. NWLIC has 277 employees and approximately 30,100 contracted independent agents, brokers, and consultants. |
RP Financial, LC.
Page 3.7
· | Security National Financial Corporation (“SNFCA”) is based in Salt Lake City, Utah, and operates three main business segments: life insurance, funeral service and mortgage loans. SNFCA is designed and structured so each segment relates to the others, and contributes to the profitability of the whole. For example, the cemetery and mortuary operations enjoy a high level of public awareness, assisting in the sales and marketing of SNFCA’s insurance and preneed cemetery and funeral products. Security National Life Insurance Company in turn invests its assets in high quality mortgage loans. Thus, while each segment is a stand-alone profit center, this horizontal integration is strategically planned to improve profitability. Additionally, SNFCA actively pursues growth through acquisitions of life insurance companies and mortuaries, and through expanding its mortgage operations. |
The majority of domestic sales are SNFCA’s annuities. National Western markets and distributes its domestic products primarily through independent national marketing organizations ("NMOs"). These NMOs assist the company in recruiting, contracting, and managing independent agents. International applications are submitted on behalf of their clients by independent contractors, consultants and broker-agents, many of whom have been submitting policy applications to National Western for twenty or more years.
· | UTG, Inc (“UTGN”), a Delaware corporation, is a life insurance holding UTGN. UTGN’s dominant business is individual life insurance, which includes the servicing of existing insurance policies in force, the acquisition of other companies in the life insurance business and the administration and processing of life insurance business for other entities. UTGN’s product portfolio consists of a limited number of life insurance product offerings. All of the products are individual life insurance products, with design variations from each other to provide choices to the customer. These variations generally center around the length of the premium paying period, length of the coverage period and whether the product accumulates cash value or not. In recent years, UTGN has not placed an emphasis on new business production. Current sales primarily represent sales to existing customers through additional insurance needs or conservation efforts. The UTGN currently encourages policy retention as opposed to new sales in an attempt to maintain or improve current persistency levels. UTGN also performs administrative work as a third-party administrator (“TPA”) for unaffiliated life insurance companies seeking business process outsourcing solutions. |
RP Financial, LC.
Page 3.8
The following sections present a comparison of Federal Life’s financial condition and income and expense trends versus the latest financial data reported data by the Peer Group companies. The conclusions drawn from the comparative analysis are then factored into the valuation analysis discussed in the final chapter.
Financial Condition
Overall, the balance sheet composition of Federal Life and the Peer Group was relatively comparable (see Table 3.2). Federal Life’s financial data reflects financial data as of September 30, 2017. The Peer Group data is as of the latest available date for which information is publicly available, which is generally as of September 30, 2017, as well, and is based on their respective public company financial reports which are solely reported on a GAAP basis.
Cash and investments comprised the bulk of assets for both the Company (80.5% of assets) and the Peer Group (83.0% of assets based on the median). The Company’s and the Peer Group’s cash and investments portfolio is dominated by fixed-income securities (75% of cash and investments for the Company and 78% at the median for the Peer Group). The higher level of cash and investments for Federal Life is reflective of the Company’s focus on insurance underwriting, small size, and lower level of diversification of business into non-insurance activities.
Other assets for the Company consisted primarily of deferred policy acquisition costs and assets held in separate accounts. Likewise, the Peer Group companies had a similar composition in other assets. On balance, while the Company is very small and is much less diversified than the majority of the Peer Group members, the composition of its asset base is relatively similar.
RP Financial, LC.
Page 3.9
Table 3.2
Comparative Financial Condition Data
Federal Life Insurance Company and the Peer Group
Policy | Cash and | |||||||||||||||||||||||||||||||||||
Total | Policy | Total | LTM | Reserves/ | Investments/ | Total Equity/ | Tangible Equity/ | |||||||||||||||||||||||||||||
Company Name | City, State | Ticker | Assets | Reserves | Equity | Asset Growth | Equity | Assets | Assets | Assets | ||||||||||||||||||||||||||
($Mil) | ($Mil) | ($Mil) | (%) | (x) | (%) | (%) | (%) | |||||||||||||||||||||||||||||
Federal Life | ||||||||||||||||||||||||||||||||||||
- As of September 30, 2017 | Riverwoods, IL | NA | $ | 258 | $ | 195 | $ | 36 | 6.86 | % | 5.40 | x | 80.53 | % | 14.07 | % | 14.07 | % | ||||||||||||||||||
All Publicly Traded Life and Health Companies | ||||||||||||||||||||||||||||||||||||
Average | 126,634 | 63,220 | 9,913 | 2.13 | % | 6.16 | x | 65.58 | % | 15.23 | % | 14.37 | % | |||||||||||||||||||||||
Median | 27,849 | 18,522 | 3,822 | 1.52 | % | 5.21 | x | 74.13 | % | 13.81 | % | 13.69 | % | |||||||||||||||||||||||
Peer Group | ||||||||||||||||||||||||||||||||||||
Average | $ | 13,748 | $ | 11,346 | $ | 1,373 | 2.42 | % | 6.02 | x | 78.25 | % | 17.52 | % | 16.93 | % | ||||||||||||||||||||
Median | $ | 4,511 | $ | 3,213 | $ | 704 | 2.17 | % | 4.77 | x | 83.04 | % | 14.93 | % | 14.93 | % | ||||||||||||||||||||
Peer Group Companies | ||||||||||||||||||||||||||||||||||||
American Equity Investment Life Holding | West Des Moines, IA | AEL | $ | 60,380 | $ | 55,220 | $ | 2,763 | 8.11 | % | 19.99 | x | 83.04 | % | 4.58 | % | 4.58 | % | ||||||||||||||||||
Citizens, Inc. | Austin, TX | CIA | $ | 1,651 | $ | 1,276 | $ | 264 | 5.42 | % | 4.83 | x | 80.55 | % | 16.00 | % | 15.06 | % | ||||||||||||||||||
CNO Financial Group, Inc. | Carmel, IN | CNO | $ | 32,705 | $ | 23,270 | $ | 4,882 | 0.88 | % | 4.77 | x | 85.39 | % | 14.93 | % | 14.93 | % | ||||||||||||||||||
FBL Financial Group, Inc. | West Des Moines, IA | FFG | $ | 9,892 | $ | 7,576 | $ | 1,279 | 2.31 | % | 5.93 | x | 87.47 | % | 12.93 | % | 12.84 | % | ||||||||||||||||||
Independence Holding Company | Stamford, CT | IHC | $ | 1,039 | $ | 549 | $ | 423 | -16.92 | % | 1.30 | x | 47.87 | % | 40.69 | % | 36.69 | % | ||||||||||||||||||
Kansas City Life Insurance Company | Kansas City, MO | KCLI | $ | 4,511 | $ | 3,213 | $ | 704 | -0.04 | % | 4.56 | x | 78.20 | % | 15.62 | % | 15.62 | % | ||||||||||||||||||
National Western Life Group, Inc. | Austin, TX | NWLI | $ | 12,138 | $ | 10,129 | $ | 1,803 | 2.17 | % | 5.62 | x | 90.13 | % | 14.85 | % | 14.85 | % | ||||||||||||||||||
Security National Financial Corporation | Salt Lake City, UT | SNFCA | $ | 1,008 | $ | 605 | $ | 139 | 20.34 | % | 4.34 | x | 62.86 | % | 13.83 | % | 13.59 | % | ||||||||||||||||||
UTG, Inc. | Springfield, IL | UTGN | $ | 405 | $ | 280 | $ | 98 | -0.50 | % | 2.85 | x | 88.77 | % | 24.24 | % | 24.24 | % |
Source: S&P Global Market Intelligence and Federal Life's audited and unaudited financial statements as of September 30, 2017.
RP Financial, LC.
Page 3.10
Liabilities
Various types of policyholder-liabilities comprised the majority of liabilities for both the Company and the Peer Group. In this regard, the policy reserves, which primarily consisted of reserves for future policy benefits and the policyholder account balances (i.e., cash surrender value of whole life policies), comprised the largest segment of liabilities and totaled $195 million, or 75.8 percent of assets.
The peer Group’s policy-related reserves were $3.2 billion based on the median equal to 71.2 percent of assets. Based on the average, policy reserves totaled $11.3 billion for the Peer Group, equal to 82.5 percent of the average Peer Group assets of $13.7 billion.
Equity
Federal Life’s pre-offering equity base of 14.07% of assets as measured on a GAAP basis was modestly below the Peer Group’s median equity ratio of 14.93% of assets. Federal Life operates with no intangible assets while the Peer Group possesses a moderate level on intangibles, resulting in similar tangible equity to asset ratios for the Company and Peer Group equal to 14.1% and 14.9% based on the median. As a result of the similarity of the capital levels and the composition of liabilities, the ratios of policy reserves/equity for Federal Life, equal to 5.40x fell within the range of the Peer Group average and median equal to 6.02x and 4.77x, respectively.
As a result of the conversion offering, Federal Life’s GAAP and statutory capital ratios will be substantially bolstered to levels in excess of the Peer Group average and median ratios. The increased capitalization will facilitate the adoption of a growth-oriented business plan designed to restore the Company’s operations to profitability.
Income and Expense Components
Federal Life’s recent operating performance versus the Peer Group is reflected in Table 3.3. The earnings data for Federal Life is based on annualized GAAP financial data for the nine months ended September 30, 2017. The Peer Group’s financial data is as of or for the most recent twelve months for which data is publicly available and is based on their respective public company reports which reflect GAAP financial reporting.
RP Financial, LC.
Page 3.11
As noted in Section One of the valuation, Federal Life has been reporting operating losses in recent years which has eroded capital. Management has attributed the ongoing losses to several factors including a high level of competition in the traditional markets for life insurance and annuity products. Specifically, Federal Life’s small size and resulting high cost structure have resulted in operating losses for the last decade. Moreover, the erosion of the statutory surplus has eroded the ability to introduce products and services which, while entailing a significant upfront cost to develop and market, could provide enhanced revenues and earnings over the long term. Additionally, the low interest rate environment has diminished net investment income on investment assets used to provide guaranteed benefits to policyholders.
The Company’s small size in comparison to the Peer Group is reflected in the revenues data, including both total revenues and policy revenues. In this regard, total revenues equaled $18 million for Federal Life ($24 million on an annualized basis versus the Peer Group median of $450 million). Federal Life’s modest revenues reflect its comparatively more limited line of insurance products in comparison to the Peer Group companies.
Overall, Federal Life reported ongoing losses from operations, with a loss equal to 0.56 percent of assets on an annualized basis and a negative return on equity equal to 4.10%. In contrast, the Peer Group reported positive earnings equal to 0.62 percent of assets based on the median and 5.38 percent of equity.
Revenues
Policy revenues (i.e., net premiums earned) represented the largest revenue source for both the Company and the Peer Group, equal to 54.3% and 42.3% of total revenues, respectively, based on the median for the Peer Group. Given their focus on underwriting long term life insurance policies, investment income is significant for both the Company and the Peer Group, equal to 35.5 percent and 36.3 percent of total revenues, respectively. Accordingly, policy revenues and investment income, both of which are primarily related to the respective insurance operations of the Company and the Peer Group totaled 89.7 percent and 78.5% of revenues, respectively.
RP Financial, LC.
Page 3.12
Table 3.3
Comparative Operating Performance Data
Federal Life Insurance Company and the Peer Group
Policy | ||||||||||||||||||||||||||||||||||||
Total | Policy | Revenues/ | Portfolio Rev./ | Policy Exp. | G&A Exp./ | |||||||||||||||||||||||||||||||
Company Name | City, State | Ticker | Revenue | Revenues | Revenues | Revenues | Revenues | Revenues | ROAA | ROAE | ||||||||||||||||||||||||||
($Mil) | ($Mil) | ($Mil) | (%) | (%) | (%) | (%) | (%) | |||||||||||||||||||||||||||||
Federal Life | ||||||||||||||||||||||||||||||||||||
- Annualized For the Nine Months Ended September 30, 2017 (1) | Riverwoods, IL | NA | $ | 24 | $ | 13 | 54.30 | % | 35.42 | % | 72.29 | % | 30.47 | % | -0.56 | % | -4.10 | % | ||||||||||||||||||
All Publicly Traded Life and Health Companies | ||||||||||||||||||||||||||||||||||||
Average | $ | 9,539 | $ | 6,547 | 58.58 | % | 27.91 | % | 57.75 | % | 39.46 | % | 1.03 | % | 1.61 | % | ||||||||||||||||||||
Median | $ | 3,675 | $ | 1,784 | 63.52 | % | 24.95 | % | 58.78 | % | 28.45 | % | 0.59 | % | 8.35 | % | ||||||||||||||||||||
Peer Group | ||||||||||||||||||||||||||||||||||||
Average | $ | 1,152 | $ | 468 | 46.39 | % | 41.24 | % | 54.27 | % | 36.61 | % | 0.88 | % | 5.65 | % | ||||||||||||||||||||
Median | $ | 450 | $ | 230 | 42.26 | % | 36.27 | % | 58.66 | % | 32.60 | % | 0.62 | % | 5.38 | % | ||||||||||||||||||||
Peer Group Companies | ||||||||||||||||||||||||||||||||||||
American Equity Investment Life Holding Company | West Des Moines, IA | AEL | $ | 3,275 | $ | 230 | 7.03 | % | 59.61 | % | 51.24 | % | 35.29 | % | 0.45 | % | 10.18 | % | ||||||||||||||||||
Citizens, Inc. | Austin, TX | CIA | $ | 253 | $ | 199 | 78.61 | % | 20.85 | % | 65.11 | % | 32.60 | % | 0.39 | % | 2.42 | % | ||||||||||||||||||
CNO Financial Group, Inc. | Carmel, IN | CNO | $ | 4,212 | $ | 2,641 | 62.71 | % | 36.27 | % | 58.66 | % | 25.57 | % | 1.48 | % | 10.36 | % | ||||||||||||||||||
FBL Financial Group, Inc. | West Des Moines, IA | FFG | $ | 737 | $ | 311 | 42.26 | % | 55.67 | % | 58.90 | % | 20.35 | % | 1.16 | % | 9.15 | % | ||||||||||||||||||
Independence Holding Company | Stamford, CT | IHC | $ | 317 | $ | 278 | 87.68 | % | 5.63 | % | 43.83 | % | 47.25 | % | 3.02 | % | 7.69 | % | ||||||||||||||||||
Kansas City Life Insurance Company | Kansas City, MO | KCLI | $ | 450 | $ | 292 | 64.94 | % | 33.57 | % | 62.75 | % | 30.22 | % | 0.51 | % | 3.31 | % | ||||||||||||||||||
National Western Life Group, Inc. | Austin, TX | NWLI | $ | 811 | $ | 181 | 22.34 | % | 75.37 | % | 54.77 | % | 27.21 | % | 0.79 | % | 5.38 | % | ||||||||||||||||||
Security National Financial Corporation | Salt Lake City, UT | SNFCA | $ | 288 | $ | 69 | 24.09 | % | 14.42 | % | 21.08 | % | 73.80 | % | 0.62 | % | 4.39 | % | ||||||||||||||||||
UTG, Inc. | Springfield, IL | UTGN | $ | 21 | $ | 6 | 27.85 | % | 69.77 | % | 72.10 | % | 37.18 | % | -0.49 | % | -2.06 | % |
(1) Reflects annualized 9 month result for Federal Life.
Source: S&P Global Market Intelligence and Federal Life's internal financials, for the nine months ended September 30, 2017 for Federal Life and the twelve months ended September 30, 2017 for Peers.
RP Financial, LC.
Page 3.13
Expenses
The Company operated with a relatively high level of policy expenses reflecting its small size, as policy expenses totaled 72.3 percent of revenues, which was well above the Peer Group median of 58.7 percent. Coupled with a similar level of G&A expense which totaled 30.5 percent of revenues for the Company versus a median of 32.6 percent for the Peer Group, the Company’s overhead and policy expenses totaled 102.8% of revenues, and with the ratio in excess of 100% reflective of Federal Life’s recent operating losses. In comparison, the Peer Group’s median G&A and policy expenses combined to equal 91.3 percent of revenues reflecting their generally profitable operations from underwriting life insurance and other insurance-related operations.
Taxes
As of September 30, 2017, Federal Life had net operating loss carryforwards (“NOLs”) available to offset future taxable income totaling $28.6 million with expirations extending out for 15 years through 2032. As of September 30, 2017, the Company had a deferred tax asset (“DTA”) related to the NOL equal to $9.7 million, but only carried a net deferred tax asset of $0.5 million as an admitted asset on its balance sheet. The value of the DTA will be affected by any future changes in the corporate tax rate and could be further limited by IRS rules related to change in ownership. In contrast, the majority of the Peer Group companies are in a fully taxable position. While the ability to utilize a portion of the tax loss carryforwards may benefit the Company’s future operations, the value of such tax benefits will be subject to Federal Life’s ability to reverse the recent operating losses and generate taxable income.
Summary
Based on the above analysis, RP Financial concluded that the Peer Group forms a reasonable basis for determining the pro forma market value of Federal Life. Areas where substantial differences exist will be further addressed in the valuation section to follow, which will lead to valuation adjustments.
RP Financial, LC.
Page 4.1
IV. VALUATION ANALYSIS
Introduction
This section of the valuation report presents the valuation analysis and methodology used to determine Federal Life’s estimated pro forma market value. The valuation utilizes the market value approach to value incorporating the selection of the Peer Group, fundamental and technical analysis on both the Company and the Peer Group, and determination of the Company’s pro forma market value utilizing the pro forma market value approach.
Pro Forma Approach to the Valuation
Employing the principles embodied in the pro forma market value approach, the valuation incorporates a detailed analysis based on the Peer Group, discussed in Section III, which constitutes a “fundamental analysis”. The valuation also incorporates a “technical analysis”, incorporating recently completed stock offerings of other demutualized insurance companies. It should be noted that these valuation analyses, based on either the Peer Group or recent insurance company demutualizations, cannot possibly fully account for all the market forces which impact trading activity and pricing characteristics of a stock on a given day.
The appraised value determined herein is based on the current market and operating environment for the Company and for all insurance companies. Subsequent changes in the local and national economy, the legislative and regulatory environment, the stock market, interest rates, and other external forces (such as natural disasters or major world events), which may occur from time to time (often with great unpredictability) may materially impact the market value of all insurance company stocks, including Federal Life, the market value of the stocks of life insurers, or Federal Life’s value alone.
The basis of the appraised value determined herein is that of a minority stock issuance in keeping with standard conversion valuation guidelines and the Company’s Plan of Conversion, whereby all of the shares will be issued at the same stock price. We made no valuation adjustment to account for ICG’s ownership position, which could acquire up to 80 percent of the outstanding shares.
RP Financial, LC.
Page 4.2
Valuation Analysis
The following sections summarize the key differences between the Company and the Peer Group addressed in Section III and how those differences affect the pro forma valuation. Emphasis is placed on the specific strengths and weaknesses of the Company relative to the Peer Group in such key areas as financial considerations, operating considerations, risk assessment, primary market and growth, dividends, liquidity of the shares, marketing of the issue, management, and the effect of government regulations and/or regulatory reform. We have also considered the market for insurance company stocks, in particular new issues, in evaluating the impact of the new issue market on the value of Federal Life coming to market at this time. Finally, we have considered the overall market for common stocks generally with particular focus on the market for the common stock of life insurance underwriters.
1. | Financial Considerations |
The financial condition of a company is an important determinant in pro forma market value, because investors typically look to such factors as liquidity, capital and balance sheet composition in assessing investment attractiveness. In assessing comparative strengths and weaknesses, we have considered the Company on a pro forma basis, that is raising the equity capital and infusing the majority of the proceeds into Federal Life. The similarities and differences in the financial condition are noted below:
· | Balance Sheet Composition and Liquidity. Federal Life’s balance sheet composition was broadly similar to the Peer Group company’s balance sheets with a comparable level of invested assets which comprised the majority of assets for both the Company and the Peer Group. Other assets for the Company consisted primarily of deferred policy acquisition costs and assets held in separate accounts. Likewise, the Peer Group companies had a similar composition in other assets which were primarily insurance-related assets. On balance, while the Company is very small and is much less diversified than the majority of the Peer Group members, the composition of its asset base is relatively similar. |
· | Equity Capital. The Company operates with a similar pre-offering tangible equity ratio in comparison to the Peer Group median. The Company capital position will be enhanced with the conversion as up to $12.5 million of the net conversion proceeds are infused into Federal Life to support its insurance underwriting operations. The remaining balance of the proceeds will be retained by FLG for general corporate purposes. On a pro forma basis, the Company’s tangible GAAP equity to assets ratio is projected to be in the range of 23% to 26% based on the valuation set forth herein, which will be well in excess of the Peer Group averages and medians. |
RP Financial, LC.
Page 4.3
· | Potential Unrealized Off Balance Sheet Value. As described in Section One (Overview and Financial Analysis), the Company has several assets with significant value beyond the historical cost as reflected on the balance sheet. These may potentially include Federal Life’s headquarters office and the Company’s ownership of mineral rights on land in Texas and Oklahoma. Importantly, management has indicated no current intent to undertake any of the foregoing strategies to monetize the unrealized value in the main office building or the mineral rights it owns. Additionally, some of the benefits of such unrealized values are realized through operations, in terms of the relatively low occupancy costs and revenues from the mineral rights. It is our belief that the Peer Group companies do not have similar elements of potential unrealized value. |
· | Potential Value of the Deferred Tax Asset (“DTA”). The Company currently has a 100% valuation allowance established against the DTA. To the extent Federal Life can utilize NOLs on a post-conversion basis, a portion of the value of the DTA may be recognized through the reversal of the valuation allowance. The Peer Group companies are generally fully taxable with regard to state and federal income taxes and thus, do not have the potential to realize such tax benefits. At the same time, any benefit which the Company may realize is contingent upon its achieving profitable operations in the future. |
On balance, we believe an upward adjustment is warranted for the Company’s higher pro forma capitalization and potential unrealized value in fixed assets and the ownership of mineral rights.
2. | Operating Considerations |
Earnings are a key factor in determining pro forma market value, as the level and risk characteristics of an insurance company’s earnings stream and the prospects and ability to generate future earnings heavily influence the multiple the investment community will pay for pro forma earnings. The major factors considered in the valuation are described below.
· | Reported Profitability. Federal Life has reported operating losses since fiscal 2002 and losses equaled 0.56% of assets on an annualized basis for the nine months ended September 30, 2017, and a negative return on equity equal to 4.10%. By comparison, eight of the nine Peer Group companies reported positive net income. |
· | Earnings Growth Potential. Several factors were considered in assessing earnings growth potential. In general, we believe that the Company’s earnings growth potential is limited in the near term due to a number of factors. |
Ø | First, it remains a challenging investing environment to reinvest the conversion proceeds as intermediate to longer term interest rates remain near their historical lows. Accordingly, the reinvestment benefit of the proceeds will be modest initially. |
RP Financial, LC.
Page 4.4
Ø | The conversion proceeds will provide substantial additional statutory capital with which Federal Life intends to implement a growth oriented business plan which may include the following: |
- | The Company will be implementing a marketing plan based on the formation of strategic partnerships to improve the Company’s distribution capabilities which will enable significant growth in products that the Company identifies as having unique market opportunities. A portion of the growth is expected to be derived from the marketing of a variable annuity product. |
- | The Standby Investor who has longstanding experience and relationships within the insurance industry is expected to facilitate the expansion. |
- | In addition to the foregoing, the Company may seek to diversify into other financial services businesses and/or seek potential acquisition opportunities as a stock company. |
Overall, primarily in view of the history of operating losses and execution risk in the growth- oriented business plan, we concluded a significant downward valuation adjustment for the foregoing operating considerations was appropriate.
3. | Dividends |
Management has indicated that it will not pay a cash dividend initially. Federal Life’s pro forma capitalization will improve the dividend paying capacity of the Company. At the same time, the post-conversion growth objectives will require earnings retention, to the extent the Company can reverse the operating losses which have eroded the Company’s capital in recent years.
A total of six out of the nine companies in the Peer Group currently pays a cash dividend, with an average dividend yield of 1.3%. On balance, we believe that in view of the stated intent that the Company will not pay a dividend coupled with the recent history of operating losses and the need to retain capital for future growth will limit the Company’s dividend paying capacity.
On balance, we have applied a downward adjustment for this factor.
4. | Liquidity of the Shares |
The Peer Group is by definition composed of companies that are traded in the public markets, and 7 of the nine of the Peer Group members trade on either the New York exchange or the NASDAQ system while two trade in the over the counter market. Typically, the number of shares outstanding and market capitalization provides an indication of how much liquidity there will be in a stock. The market capitalization of the Peer Group companies ranged from $82 million to $4.2 billion as of December 22, 2017, with average and median market values of $436 million and $1.3 billion, respectively. The shares issued and outstanding to shareholders of the Peer Group members ranged from approximately 3.3 to 167.8 million, with average and median shares outstanding of approximately 15.3 million and 42.1 million, respectively. The Company’s stock offering is expected to result in shares outstanding and market capitalization which will be far below the range exhibited by the Peer Group average and median, and the pro forma market capitalization at the midpoint of the offering range will be less than half of the smallest Peer Group companies. In addition, the majority of the stock will be held by the Standby Purchaser and insiders who are long term holders of the stock.
RP Financial, LC.
Page 4.5
At the same time, the Company expects that its shares will be traded on NASDAQ and there will be at least several market makers in the issue. Overall, we concluded that a downward adjustment was warranted for this factor.
5. | Marketing of the Issue |
Two separate markets exist for insurance company stocks: (1) the after-market for public companies in which trading activity is regular and investment decisions are made based upon financial condition, earnings, capital, ROE, dividends and prospects; and (2) the new issue market in which demutualizing insurers are evaluated based on the same factors but on a pro forma basis without the benefit of prior operations as a publicly-held company and stock trading history. Both markets were considered in the valuation of the Company’s to-be-issued stock.
A. | The Public Market |
The value of publicly-traded insurance company stocks, i.e., those which are listed on an exchange or on NASDAQ, is easily measurable, and is tracked by investment firms, related organizations and by electronic means. In general, the stocks of insurance companies react to market stimuli such as interest rates, inflation, perceived industry health, projected rates of economic growth, regulatory issues and stock market conditions in general.
Table 4.1 shows the recent performance of various insurance stock indexes along with broader market indexes. In terms of assessing general stock market conditions, the broad stock market rallied strongly over the last 12 months. The general market for stocks has been supported by strong underlying fundamentals. Consumer confidence hit 122.1 in December, slightly below the 17-year high set in November of 128.6, according to the Conference Board's index. Confidence has been fueled by a few factors including: the strong job market, the stock market rally and Republicans' tax reforms.
RP Financial, LC.
Page 4.6
The U.S. job market is very strong with the national unemployment rate at 4.1%, the lowest level since 2000. Job openings are abundant too as the U.S. economy has gained jobs for 86 consecutive months, the longest streak in history, according to Labor Department figures going back to 1939. Balanced growth in the global economy has also supported some U.S. employment levels in the last several years.
Strong underlying economic fundamentals have supported a surging stock market. The stock market's surge has also been another reflection of consumer confidence. The Dow ended 2017 just below 25,000 points which reflects a nearly 25 percent increase on a year over year basis. Stock market gains have been supported by corporate earnings growth and the passage of tax reform by the Republican congress in late 2017. In addition, while the Federal Reserve has raised the targeted short-term interest rates and indicated that it anticipates three rate increases in 2018, interest rates remain low by historical standards, which has also supported stock prices.
Insurance company stocks have participated in the ongoing bull market with the SNL Insurance Underwriter Index increasing by 21 percent in 2017 and by nearly 47% over the prior three years. While the performance of the Life and Health sector has lagged the broader index for all insurance underwriters, the stocks of the public life and health insurers have nonetheless participated in the broader stock market rally as indicated by appreciation of the SNL U.S. Life and Health Insurance index of 12 percent over the last year and nearly 26% over the prior three years.
RP Financial, LC.
Page 4.7
Table 4.1
Stock Market Pricing Trends
Through January 2, 2018
Index | Percent Change | |||||||||||
Value | 1 Year | 3 Year | ||||||||||
SNL Insurance Indexes | ||||||||||||
SNL U.S. Insurance | 1,032.09 | 20.56 | 45.82 | |||||||||
SNL U.S. Insurance Underwriter | 1,023.03 | 20.73 | 46.67 | |||||||||
S&P 500 Insurance | 397.03 | 12.39 | 29.62 | |||||||||
NASDAQ Insurance | 8,494.84 | 1.69 | 26.49 | |||||||||
S&P 500 Insurance Brokers | 630.39 | 18.96 | 34.57 | |||||||||
S&P 500 Multi-line Insurance | 116.38 | (1.37 | ) | 12.78 | ||||||||
SNL Sector Indexes | ||||||||||||
SNL U.S. Insurance Multiline | 225.51 | 29.87 | 32.69 | |||||||||
SNL U.S. Insurance L&H | 1,027.49 | 11.59 | 25.98 | |||||||||
S&P 500 L&H | 421.66 | 13.47 | 25.78 | |||||||||
SNL U.S. Insurance P&C | 921.77 | 11.31 | 32.83 | |||||||||
S&P 500 P&C | 539.61 | 16.97 | 42.07 | |||||||||
SNL U.S. Reinsurance | 1,103.46 | (3.41 | ) | 24.27 | ||||||||
SNL U.S. Managed Care | 3,296.10 | 43.44 | 103.47 | |||||||||
SNL U.S. Title Insurer | 1,766.97 | 22.77 | 25.65 | |||||||||
SNL U.S. Mortgage & Finl Guaranty | 103.08 | 14.21 | 30.78 | |||||||||
SNL Global Reinsurance | 181.19 | NA | NA | |||||||||
SNL Asset Size Indexes | ||||||||||||
SNL U.S. Insurance < $250M | 1,258.14 | 27.43 | 91.45 | |||||||||
SNL U.S. Insurance $250M-$500M | 641.97 | 10.06 | (9.12 | ) | ||||||||
SNL U.S. Insurance $500M-$1B | 1,072.15 | 20.89 | 43.90 | |||||||||
SNL U.S. Insurance $1B-$2.5B | 2,094.80 | 10.27 | 36.99 | |||||||||
SNL U.S. Insurance $2.5B-$10B | 1,290.02 | 14.79 | 44.69 | |||||||||
SNL U.S. Insurance > $10B | 971.74 | 21.10 | 46.85 | |||||||||
SNL U.S. Insurance > $1B | 1,063.13 | 20.69 | 46.64 | |||||||||
SNL U.S. Insurance < $1B | 1,326.38 | 21.20 | 44.17 | |||||||||
SNL Market Cap Indexes | ||||||||||||
SNL Micro Cap U.S. Insurance | 261.10 | (11.09 | ) | (26.17 | ) | |||||||
SNL Small Cap U.S. Insurance | 970.41 | 8.90 | 20.49 | |||||||||
SNL Mid Cap U.S. Insurance | 717.06 | 9.19 | 30.55 | |||||||||
SNL Large Cap U.S. Insurance | 969.53 | 24.23 | 50.85 | |||||||||
Broad Market Indexes | ||||||||||||
DJIA | 24,824.01 | 25.61 | 39.20 | |||||||||
S&P 500 | 2,695.81 | 20.41 | 30.98 | |||||||||
S&P Mid-Cap | 1,917.36 | 15.46 | 32.11 | |||||||||
S&P Small-Cap | 942.97 | 12.53 | 36.63 | |||||||||
S&P 500 Financials | 463.66 | 19.95 | 39.07 | |||||||||
NASDAQ | 7,006.90 | 30.16 | 48.24 | |||||||||
NASDAQ Financial | 4,500.97 | 12.60 | 43.95 |
Source: S&P Global Market Intelligence.
RP Financial, LC.
Page 4.8
B. | The New Issue Market |
In addition to stock market conditions for insurers in general, the new issue market for demutualizing insurers is also an important consideration in determining the Company’s pro forma market value. The new issue market is separate and distinct from the market for seasoned stock insurers in that the pricing ratios (primarily price/book and price/earnings) for demutualizing issues are computed on a pro forma basis, specifically: (1) the numerator and denominator are both impacted by the stock offering amount, unlike existing stock issues in which price change affects only the numerator; and (2) the pro forma pricing ratio incorporates assumptions regarding source and use of proceeds, effective tax rates, stock plan purchases, etc. which impact pro forma financials, whereas pricing for existing issues are based on reported financials. The distinction between pricing of demutualizing and existing issues is perhaps no clearer than in the case of the price/tangible book (“P/TB”) ratio in that the P/TB ratio of a demutualizing insurer, particularly those employing the thrift subscription method, will typically result in a discount to tangible book value whereas the P/TB in the current market for the Peer Group reflects a premium to tangible book value, on average. Therefore, it is appropriate to also consider the market for new issues, both at the time of the demutualization and in the aftermarket.
The number of demutualized insurance company issues which are publicly traded is relatively limited, and while there were no demutualization transactions completed pursuant to the subscription rights method between 2010 and 2017, there were two such transactions completed in March 2017. Table 4.2 shows the financial and pricing characteristics of selected demutualized insurers completing their demutualization transactions since 1997. The average and median pro forma P/TB ratios for the ten insurance companies completing demutualizations were 63.0% and 58.1%, respectively. The average and median pro forma price/core earnings (“P/Core”) equaled 17.0 times and 15.1 times, respectively.
Perhaps the most comparable of the offerings was by ICC Holdings, which is also based in Illinois, which completed its offering on March 24, 2017, raising gross proceeds of $35 million, which is comparable in size to the Company’s proposed offering. The transaction was completed at a pro forma P/TB ratio of 56.3% while the pro forma P/E multiple was 17.0x. The fact that ICC Holdings was profitable on pre-conversion basis represents a significant difference from Federal Life’s history of operating losses. At the same time, the bull market environment has continued and Federal Life has developed a growth oriented business plan which is dependent on the capital raised in the offering.
RP Financial, LC.
Page 4.9
Table 4.2
Demutualization Transactions: Subscription Rights Offerings
AM | Demutual | Aggregate Value | Shares Issued | |||||||||||||||||||||||||||||||
Best | Deal Structure | Demut | Initial | Shrs. Dist | Exrcs | |||||||||||||||||||||||||||||
Rating | Main | IPO | Closing | Mkt | Gross | To | Offering | Over- | Issue | |||||||||||||||||||||||||
Ticker | Company | @ IPO | Lines | Form | Struct. | Date | Cap | Prcds | Insureds(6) | Shares | allot. | Price | ||||||||||||||||||||||
($Mil) | ($Mil) | (000) | (000) | ($) | ||||||||||||||||||||||||||||||
NODK | NI Holdings Inc. | A | P/C-Mix | MHC/ | Subscr | 03/13/17 | $ | 104 | $ | 104 | - | 103,500 | - | $ | 10.00 | |||||||||||||||||||
Minority | ||||||||||||||||||||||||||||||||||
ICCH | ICC Holdings | B++ | P/C - Mix | Full | Subscr | 03/24/17 | $ | 35 | $ | 35 | - | 3,500 | - | $ | 10.00 | |||||||||||||||||||
PMIC | Penn Millers Holding Corp. | A- | P/C-Mix | Full | Subscr | 10/16/09 | $ | 54 | $ | 54 | - | 5,444 | - | $ | 10.00 | |||||||||||||||||||
EIHI | Eastern Insurance Holdings, Inc. | B++ | Life/Pc | Full | Subscr | 06/19/06 | 114 | (5) | 75 | (5) | - | 7,475 | - | $ | 10.00 | |||||||||||||||||||
FMMH.OB | Fremont Michigan Insuracorp, MI | B++ | P/C-Mix | Full | Subscr | 10/18/04 | $ | 9 | $ | 9 | - | 862 | - | $ | 10.00 | |||||||||||||||||||
MIGP | Mercer Insurance Group, PA | A | P/C-Mix | Full | Subscr | 12/15/03 | $ | 69 | $ | 59 | - | 5,884 | - | $ | 10.00 | |||||||||||||||||||
NCRI | NCRIC Group, Inc., DC(2) | A- | Med Liab | 2nd Step MHC | Subscr | 06/25/03 | $ | 69 | $ | 41 | - | 4,144 | - | $ | 10.00 | |||||||||||||||||||
PFLD.OB | Professionals Direct, MI | B++ | Attny. Liab | Full | Subscr | 07/01/01 | $ | 3 | $ | 3 | - | 334 | - | $ | 10.00 | |||||||||||||||||||
ACAP | AP Capital, Inc., MI (3) | A- | Med Liab | Full | Subscr | 12/08/00 | $ | 155 | $ | 155 | - | 11,450 | Yes | $ | 13.50 | |||||||||||||||||||
OGGI | Old Guard Grp, Inc., PA | A- | P/C-Mix | Full | Subscr | 02/01/97 | N.A. | $ | 40 | - | 3,955 | No | $ | 10.00 |
(1) | Reflects the impact of a simultaneous merger with Eastern Holding Company. |
(2) | Reflects second step offering by NCRIC Group's mutual holding company. NCRIC completed an initial MHC offering prior to the second step conversion. |
(3) | Core earnings and ROA and ROE ratios reflect adjustment to exclude a significant one-time income tax recovery. |
(4) | None for subscription rights transactions. |
(5) | Includes 3.9 million shares issued connection with a merger with Eastern Holding Co. and 7.5 million shares sold in a subscription offering. |
RP Financial, LC.
Page 4.10
Table 4.2 (continued)
Demutualization Transactions: Subscription Rights Offerings
After-Market | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Price Change | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Pro Forma Financial Ratios | Pro Forma Pricing Ratios | Vs. IPO Price | ||||||||||||||||||||||||||||||||||||||||||||||||||
Company | E/A | Tg. E/A | ROA | ROE | P/E | P/CE | P/B | P/TB | P/Rev | P/A | 1 day | 1 wk | 1 mo | |||||||||||||||||||||||||||||||||||||||
(%) | (%) | (%) | (%) | (x) | (x) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | ||||||||||||||||||||||||||||||||||||||||
NI Holdings Inc. (3) | 64.3 | % | 63.8 | % | 2.37 | % | 3.68 | % | 18.1 | x | 18.1 | x | 66.9 | % | 67.3 | % | 141.5 | % | 42.9 | % | 48 | % | 44 | % | 57 | % | ||||||||||||||||||||||||||
ICC Holdings | 21.7 | % | 21.7 | % | 1.24 | % | 2.99 | % | 17.0 | x | 17.0 | x | 56.3 | % | 56.3 | % | 94.8 | % | 22.3 | % | 44 | % | 53 | % | 52 | % | ||||||||||||||||||||||||||
Penn Millers Holding Corp. | 44.5 | % | 44.5 | % | 0.88 | % | 1.98 | % | 27.0 | x | 27.0 | x | 53.5 | % | 53.5 | % | 119.3 | % | 20.0 | % | 8 | % | 2 | % | 2 | % | ||||||||||||||||||||||||||
Eastern Insurance Holdings, Inc. | 47.1 | % | 44.7 | % | 3.46 | % | 7.36 | % | 8.6 | x | 8.6 | x | 66.7 | % | 74.4 | % | 84.9 | % | 31.4 | % | 14 | % | 21 | % | 29 | % | ||||||||||||||||||||||||||
Fremont Michigan Insuracorp, MI | 25.0 | % | 25.0 | % | 1.00 | % | 4.00 | % | 13.4 | x | 13.4 | x | 53.3 | % | 53.3 | % | 44.7 | % | 13.3 | % | N.A. | N.A. | N.A. | |||||||||||||||||||||||||||||
Mercer Insurance Group, PA | 65.3 | % | 62.1 | % | 1.46 | % | 2.24 | % | 31.7 | x | 31.7 | x | 70.9 | % | 74.5 | % | 160.9 | % | 46.3 | % | 22 | % | 24 | % | 34 | % | ||||||||||||||||||||||||||
NCRIC Group, Inc., DC(1) | 35.3 | % | 32.3 | % | 0.63 | % | 1.78 | % | 46.0 | x | 28.9 | x | 82.1 | % | 89.9 | % | 141.0 | % | 25.9 | % | 5 | % | 3 | % | 10 | % | ||||||||||||||||||||||||||
Professionals Direct, MI | 20.4 | % | 19.2 | % | 3.03 | % | 14.99 | % | 3.7 | x | 4.6 | x | 53.7 | % | 57.2 | % | 43.8 | % | 11.0 | % | N.A. | N.A. | N.A. | |||||||||||||||||||||||||||||
AP Capital, Inc., MI (2) | 38.1 | % | 36.3 | % | 1.80 | % | 4.74 | % | 3.6 | x | 8.9 | x | 42.9 | % | 45.0 | % | 69.7 | % | 16.1 | % | 1 | % | 13 | % | 26 | % | ||||||||||||||||||||||||||
Old Guard Grp, Inc., PA | 39.4 | % | 39.4 | % | 1.89 | % | 4.78 | % | N.M. | 12.3 | x | 59.0 | % | 59.0 | % | 61.7 | % | 40.6 | % | 44 | % | 39 | % | 46 | % |
(1) | Reflects second step offering by NCRIC Group's mutual holding company. NCRIC completed an initial MHC offering prior to the second step conversion. |
(2) | Core earnings and ROA and ROE ratios reflect adjustment to exclude a significant one-time income tax recovery. |
(3) | Reflects pricing ratios on a fully converted basis. |
RP Financial, LC.
Page 4.11
* * * * * * * * * * *
In determining the valuation adjustment for marketing of the issue, we considered trends in both the overall market for insurance companies and the new issue market. Taking these factors and trends into account, RP Financial concluded that a downward adjustment was appropriate in the valuation analysis for purposes of marketing of the issue.
6. | Organization |
By its relatively small level of total assets and revenues, Federal Life’s management team is constrained relative to the resources available relative to other larger insurers. At the same time, the Company has indicated that the management infrastructure in place can manage targeted growth with little or no additions at the senior executive level. On balance we have applied a downward adjustment for Organization as Federal Life’s management depth is limited by the smaller size.
7. | Regulatory Environment |
Both Federal Life and the Peer Group companies operate in a regulated industry with oversight typically provided by state insurance regulators, generally within the framework of guidelines established by state law and the National Association of Insurance Commissioners. Federal Life appears to maintain good relations with its regulators and we believe the Peer Group companies are not subject to operating restrictions. On balance, we believe no adjustment is warranted for this factor.
RP Financial, LC.
Page 4.12
Summary of Adjustments
Overall, based on the factors discussed above, we concluded that the Company’s pro forma market value should be discounted relative to the Peer Group as follows:
Key Valuation Parameters | Valuation Adjustment | |
Financial Considerations | Upward Adjustment | |
Operating Considerations | Significant Downward Adj. | |
Dividends | Downward Adjustment | |
Liquidity of the Shares | Downward Adjustment | |
Marketing of the Issue | Downward Adjustment | |
Organization | Downward Adjustment | |
Regulatory Environment | No Adjustment |
Valuation Approaches
In applying the pro forma market value approach, we considered the three key pricing ratios in valuing Federal Life’s to-be-issued stock – price/earnings (“P/E”), price/book value (“P/B” and price/revenue (“P/Rev”) — all performed on a pro forma basis including the effects of the stock offering proceeds. In computing the pro forma impact of the demutualization and the related pricing ratios, we have incorporated the valuation parameters as provided by management on a preliminary basis (see Exhibit IV-2 and IV-3).
Pursuant to the stock offering, we have also incorporated the valuation parameters as estimated by management for offering expenses. The assumptions utilized in the pro forma analysis in calculating the Company’s value pursuant to the conversion is described more fully below.
Ø | Offering Expenses. Total fixed offering expenses were assumed to be fixed at $1,500,00 based on management’s preliminary estimates. In addition, there will be a variable component in the offering costs paid to the marketing agent as follows: |
Ø | A 2.0% commission on all shares sold in the subscription offering and to an identified list of individuals, customers, etc. developed by Federal Life’s management preliminarily estimated to total $10.0 million: and |
Ø | A 6.5% common on all shares sold to the Public and Standby Investor |
Ø | Based on the foregoing, total offering expenses at the midpoint of the offering range are estimated at $3.65 million. |
RP Financial, LC.
Page 4.13
· | Reinvestment Rate. A 3.10 percent reinvestment rate on the net offering proceeds has been assumed, which is consistent with the current weighted average yield on the investment portfolio as of September 30, 2017. Management has indicated that the offering proceeds will be invested in a laddered portfolio of investment securities relatively consistent with the current investment securities portfolio composition. |
· | Effective Tax Rate. Assumes the current non-taxable status continues owing to NOLs. While the conversion transaction is expected to limit the future ability to utilize NOLs, the annual usage limitation is expected to be in the range of range of $700,000 of taxable income annually. Coupled with the recent reduction in the federal corporate tax rate, it appears that the Company will not be taxable for the short to intermediate term. |
In our estimate of value, we assessed the relationship of the pro forma pricing ratios relative to the Peer Group and the recent demutualizations.
RP Financial’s valuation placed an emphasis on the following:
· | P/E Approach. The P/E approach is historically the preferred valuation approach. Important with respect to Federal Life however, the recent history of operating losses renders the P/E approach to valuation less meaningful relative to P/B and P/Revenue approaches. |
· | P/B Approach. P/B ratios have generally served as a useful benchmark in the valuation of the equity securities of financial securities companies in recent years, including insurance companies, particularly in the context of an initial public offering. RP Financial considered the P/B approach to be a reliable indicator of value given current market conditions, particularly the market for recent demutualizations. RP Financial also considered price/tangible book, which adjusts for intangible assets, particularly goodwill. |
It is important to stress that the P/B ratios of the Peer Group companies are not subject to capital raising – the denominator (reported stockholders’ equity) is relatively stable quarter whereas the numerator (stock price) tends to be more volatile based on prevailing market conditions. In comparison, the Company’s P/B ratio must mathematically be discounted to book value as the denominator (pro forma equity) will always be less than the numerator (the price, the offering amount) since the pro forma equity incorporates both pre-offering equity as well as the net proceeds raised in the offering.
· | P/Revenues Approach. P/Revenue ratios have also been considered a benchmark of trading value. A benefit of the revenues approach is that it is not significantly impacted by the offering proceeds, unlike the earnings and book value approaches. In addition, given the lack of a history of core earnings, we have given the Price/Revenues approach more weight in the valuation conclusion. |
RP Financial, LC.
Page 4.14
Based on the application of the pro forma valuation approaches described above, taking into consideration the valuation adjustments discussed above, RP Financial concluded that the pro forma market value of the shares to be offered by Federal Life was $40.0 million at the midpoint of the offering range. Table 4.3 sets forth details regarding the offering range for the Company and the Company’s pro forma pricing relative to the Peer Group based on stock prices as of December 22, 2017.
In developing the pro forma valuation estimate, RP Financial considered the potential for restoration of positive earnings within the first two or three years following the completion of the conversion transaction. In this regard, the major elements of the business plan to reverse the recent operating losses include:
1. | Undertake growth to expand revenues and achieve economies of scale. |
2. | Maximize the use of the existing infrastructure capacity in growth plans to create a competitive advantage. |
3. | Promote a performance oriented culture within the organization to ensure financial strength. |
4. | Identify potential internal opportunities to increase regulatory surplus to support growth and risk levels. |
5. | Complete the conversion to capitalize future growth and provide enhanced access to capital markets in the future to support growth and risk levels. |
6. | The realization of the foregoing elements of the strategic plan is expected to be facilitated by efforts of the Standby Purchaser to assist in the Company in implementing the foregoing elements of the Strategic Plan. |
1. P/E. The application of the P/E valuation method requires calculating the Company’s pro forma market value by applying a valuation P/E multiple to the pro forma earnings base. In applying this technique, we considered both reported earnings and a recurring earnings base, that is, earnings adjusted to exclude any one-time non-operating items, plus the estimated after-tax earnings benefit of the reinvestment of the net proceeds. As discussed in the financial analysis in Section One, Federal Life reported a net loss equal to $1.110 million for the nine months ended September 30, 2017, equal to $1.480 million on an annualized basis. Based on these net losses, the application of the P/E approach was deemed “not meaningful” and no analysis was performed.
RP Financial, LC.
Page 4.15
Table 4.3
Public Market Pricing
Federal Life Insurance Company and the Peer Group
Prices as of December 22, 2017
Financial Data as of September 30, 2017 | Key Pricing Ratios as of December 22, 2017 | |||||||||||||||||||||||||||||||||||||||||||||
Price/ | Price/ | Price/ | ||||||||||||||||||||||||||||||||||||||||||||
Closing | Market | Equity/ | Price/ | Tangible | TTM | TTM | ||||||||||||||||||||||||||||||||||||||||
Company Name | City, State | Ticker | Exchange | Price | Value | Assets | Assets | ROAA | ROAE | Book | Book | Earnings | Revenue | |||||||||||||||||||||||||||||||||
($) | ($Mil) | ($Mil) | (%) | (%) | (%) | (%) | (%) | (x) | (x) | |||||||||||||||||||||||||||||||||||||
Federal Life Insurance Company | Riverwods, IL | |||||||||||||||||||||||||||||||||||||||||||||
Maximum | $ | 10.00 | $ | 46.00 | $ | 300 | 26.10 | % | -0.06 | % | -0.22 | % | 58.8 | % | 58.8 | % | NM | 1.83 | x | |||||||||||||||||||||||||||
Midpoint | $ | 10.00 | $ | 40.00 | $ | 294 | 24.69 | % | -0.12 | % | -0.48 | % | 55.1 | % | 55.1 | % | NM | 1.60 | x | |||||||||||||||||||||||||||
Minimum | $ | 10.00 | $ | 34.00 | $ | 288 | 23.23 | % | -0.18 | % | -0.78 | % | 50.8 | % | 50.8 | % | NM | 1.37 | x | |||||||||||||||||||||||||||
All Public Life Insurance Companies | ||||||||||||||||||||||||||||||||||||||||||||||
Average | $ | 66.40 | $ | 10,482.5 | $ | 130,630 | 12.98 | % | 0.42 | % | 1.29 | % | 112.3 | % | 119.8 | % | 17.51 | x | 1.35 | x | ||||||||||||||||||||||||||
Median | $ | 51.48 | $ | 4,373.7 | $ | 45,699 | 13.36 | % | 0.59 | % | 8.35 | % | 98.6 | % | 117.9 | % | 12.81 | x | 1.16 | x | ||||||||||||||||||||||||||
Peer Group | ||||||||||||||||||||||||||||||||||||||||||||||
Average | $ | 64.08 | $ | 1,264.1 | $ | 13,748 | 17.52 | % | 0.88 | % | 5.65 | % | 93.9 | % | 97.4 | % | 19.56 | x | 1.52 | x | ||||||||||||||||||||||||||
Median | $ | 27.95 | $ | 436.7 | $ | 4,511 | 14.93 | % | 0.62 | % | 5.38 | % | 85.8 | % | 85.8 | % | 14.16 | x | 1.31 | x | ||||||||||||||||||||||||||
Peer Group Companies | ||||||||||||||||||||||||||||||||||||||||||||||
American Equity Investment Life Holding Company | West Des Moines, IA | AEL | NYSE | $ | 32.13 | $ | 2,863.5 | $ | 60,380 | 4.58 | % | 0.45 | % | 10.18 | % | 103.4 | % | 103.4 | % | 11.16 | x | 0.87 | x | |||||||||||||||||||||||
Citizens, Inc. | Austin, TX | CIA | NYSE | $ | 7.48 | $ | 374.6 | $ | 1,651 | 16.00 | % | 0.39 | % | 2.42 | % | 141.8 | % | 152.3 | % | 60.49 | x | 1.48 | x | |||||||||||||||||||||||
CNO Financial Group, Inc. | Carmel, IN | CNO | NYSE | $ | 24.87 | $ | 4,172.2 | $ | 32,705 | 14.93 | % | 1.48 | % | 10.36 | % | 85.5 | % | 85.5 | % | 8.98 | x | 0.99 | x | |||||||||||||||||||||||
FBL Financial Group, Inc. | West Des Moines, IA | FFG | NYSE | $ | 71.80 | $ | 1,790.2 | $ | 9,892 | 12.93 | % | 1.16 | % | 9.15 | % | 140.3 | % | 141.4 | % | 15.99 | x | 2.43 | x | |||||||||||||||||||||||
Independence Holding Company | Stamford, CT | IHC | NYSE | $ | 27.95 | $ | 415.4 | $ | 1,039 | 40.69 | % | 3.02 | % | 7.69 | % | 99.2 | % | 117.6 | % | 14.12 | x | 1.31 | x | |||||||||||||||||||||||
Kansas City Life Insurance Company | Kansas City, MO | KCLI | OTCQX | $ | 45.10 | $ | 436.7 | $ | 4,511 | 15.62 | % | 0.51 | % | 3.31 | % | 62.0 | % | 62.0 | % | 18.95 | x | 0.97 | x | |||||||||||||||||||||||
National Western Life Group, Inc. | Austin, TX | NWLI | NASDAQ | $ | 337.03 | $ | 1,158.1 | $ | 12,138 | 14.85 | % | 0.79 | % | 5.38 | % | 68.0 | % | 68.0 | % | 12.62 | x | 1.43 | x | |||||||||||||||||||||||
Security National Financial Corporation | Salt Lake City, UT | SNFCA | NASDAQ | $ | 5.40 | $ | 82.4 | $ | 1,008 | 13.83 | % | 0.62 | % | 4.39 | % | 59.2 | % | 60.4 | % | 14.21 | x | 0.29 | x | |||||||||||||||||||||||
UTG, Inc. | Springfield, IL | UTGN | OTC Pink | $ | 25.00 | $ | 83.4 | $ | 405 | 24.24 | % | -0.49 | % | -2.06 | % | 85.8 | % | 85.8 | % | NM | 3.88 | x |
(1) Financial information is on a pro forma basis for Federal Life. Peer Group data is as of September 30, 2017.
Source: S&P Global Market Intelligence and Federal Life's internal f inancials, as of September 30, 2017 for Federal Lif e and September 30, 2017 for all other Companies.
RP Financial, LC.
Page 4.16
2. P/B. The application of the P/B valuation method requires calculating the Company’s pro forma market value by applying a valuation P/B ratio to Federal Life’s pro forma book value. In applying the P/B approach, we relied most heavily on tangible book value (i.e., book value net of intangible assets) because historically the market has not generally given credit for intangible assets.
At the estimated midpoint of the offering range, Federal Life exhibited a pro forma reported and tangible P/B ratios equal 55.1% (the ratios are the same for Federal Life because the Company has no intangible assets on its balance sheet). The Peer Group’s median reported and tangible P/B median ratios were both 85.8%. Accordingly, the Company’s pro forma reported and tangible P/B ratios are both discounted by 36%. RP Financial considered these discounts to be appropriate considering the downward adjustments indicated above, including the Company’s history of operating losses and the more limited liquidity of the stock in the aftermarket coupled with Federal Life’s status as a new issue. These discounts were mitigated to an extent by various positive considerations including the potential ability of the Standby Purchaser to assist the Company in restoring profitability through its industry relationships and related ability to facilitate the Company’s implementation of a growth-oriented business plan.
3. P/Revenues. The P/Revenues valuation methodology determines market value by applying a valuation P/Revenue ratio to the Company’s pro forma revenues. At the estimated midpoint value, Federal Life’s value equaled 1.60x pro forma revenues, which is at a premium of 5.3 percent to the Peer Group average of 1.52x and at a premium of 22.1% to the Peer Group median of 1.31x. A benefit of the revenues approach is that it is not significantly impacted by the offering proceeds, unlike the earnings and book value approaches. At the same time, we believe that investors tend to focus more heavily on overall net earnings levels rather than the magnitude of overall revenues.
Comparison to Recent Demutualizations
We also considered the conversion offering by ICC Holdings, an Illinois-domiciled insurance company, which completed its offering on March 24, 2017, raising gross proceeds of $40 million, which is comparable in size to the Company’s proposed offering size. The transaction was completed at a pro forma P/TB ratio of 56.3% while the pro forma P/E multiple was 17.0x. The fact that ICC Holdings was profitable on pre-conversion basis represents a significant difference from Federal Life’s history of operating losses. At the same time, we considered that the bull market environment has continued, both with respect to the broad market and insurance underwriters, and that Federal Life has developed a growth oriented business plan which is dependent on the capital raised in the offering.
RP Financial, LC.
Page 4.17
Valuation Conclusion
Based on the foregoing, it is our opinion that, based on stock prices as of December 22, 2017, and financial statements through September 30, 2017, the estimated aggregate pro forma market value of the shares to be issued immediately following the offering, was $40,000,000 (the “midpoint value”). A range of value will be established based on the midpoint value to be responsive to moderate changes in market conditions. The resulting range of value pursuant to regulatory guidelines, and the corresponding number of shares based on the Board determined $10.00 per share offering price, is set forth below.
Table 4.4
Federal Life Insurance Company
Valuation Range and Offering Characteristics
Aggregate | ||||||||
Shares | Value | Shares (1) | ||||||
Maximum | $ | 46,000,000 | 4,600,000 | |||||
Midpoint | $ | 40,000,000 | 4,000,000 | |||||
Minimum | $ | 34,000,000 | 3,400,000 | |||||
(1) Based on offering price of $10.00 per share. |
EXHIBITS
LIST OF EXHIBITS
Exhibit | ||
Number | Description | |
I-1 | Federal Life’s Unaudited Financial Statements | |
I-2 | Financial Data based on Statutory Accounting Principles | |
IV-1 | Pricing and Financial Characteristics of Public Life Insurance Companies | |
IV-2 | Pro Forma Analysis Sheet | |
IV-3 | Pro Forma Effect of Offering Proceeds | |
V-1 | Firm Qualifications Statement |
EXHIBIT I-1
Federal Life Insurance Company Unaudited
Financial Statements
[Incorporated by Reference]
EXHIBIT I-2
Federal Life Insurance Company
Financial Statements Based on Statutory Accounting Data
Federal Life Insurance Company | Life Balance Sheet
MI STAT ENTITY KEY: C2347
Periods Last Five Years
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Period Ended | 12/31/2012 | 12/31/2013 | 12/31/2014 | 12/31/2015 | 12/31/2016 | |||||||||||||||
Data displayed in $000 unless otherwise noted | ||||||||||||||||||||
Assets | ||||||||||||||||||||
Investments: | ||||||||||||||||||||
Bonds | 163,926 | 165,160 | 166,181 | 168,725 | 168,634 | |||||||||||||||
Preferred Stocks | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Common Stocks | 12,152 | 13,037 | 11,568 | 10,667 | 8,468 | |||||||||||||||
Mortgage Loans | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Real Estate | 1,966 | 1,873 | 1,826 | 1,882 | 1,987 | |||||||||||||||
Contract Loans | 10,145 | 10,461 | 10,322 | 10,129 | 10,059 | |||||||||||||||
Derivatives | 0 | 0 | 0 | 0 | 60 | |||||||||||||||
Cash & Short Term Investments | 3,228 | 4,348 | 6,293 | 5,687 | 7,080 | |||||||||||||||
Other Investments | 0 | 0 | 0 | 0 | 2,000 | |||||||||||||||
Total Cash & Investments | 191,417 | 194,879 | 196,189 | 197,090 | 198,287 | |||||||||||||||
Premiums and Considerations Due | 4,500 | 4,412 | 4,060 | 4,219 | 4,497 | |||||||||||||||
Reinsurance Recoverable | 2 | 0 | 50 | 0 | 0 | |||||||||||||||
Receivable from Parent, Subsidiary or Affiliates | 34 | 4 | 0 | 0 | 0 | |||||||||||||||
All Other Admitted Assets | 2,654 | 2,874 | 2,744 | 3,045 | 3,223 | |||||||||||||||
Total Assets without Separate Account | 198,607 | 202,169 | 203,044 | 204,355 | 206,006 | |||||||||||||||
Separate Account Assets | 21,536 | 26,068 | 26,651 | 23,335 | 21,513 | |||||||||||||||
Total Assets | 220,144 | 228,237 | 229,695 | 227,690 | 227,519 | |||||||||||||||
Liabilities | ||||||||||||||||||||
Net Policy Reserves - Life | 162,403 | 166,454 | 169,171 | 171,775 | 173,876 | |||||||||||||||
Net Policy Reserves - A&H | 563 | 491 | 491 | 422 | 351 | |||||||||||||||
Liability for Deposit-Type Contracts | 9,679 | 9,379 | 9,603 | 10,039 | 10,529 | |||||||||||||||
Total Policy Reserves plus Deposits | 172,645 | 176,325 | 179,265 | 182,236 | 184,756 | |||||||||||||||
Contract Claims | 1,906 | 2,248 | 1,490 | 1,806 | 1,889 | |||||||||||||||
Interest Maintenance Reserve | 847 | 918 | 733 | 869 | 686 | |||||||||||||||
Asset Valuation Reserve | 2,922 | 3,230 | 2,928 | 2,765 | 2,822 | |||||||||||||||
Reinsurance Liabilities | 0 | 0 | 0 | 0 | 0 |
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Commissions, expenses, and tax due | 705 | 815 | 673 | 637 | 663 | |||||||||||||||
Payable to Parent, Subs or Affiliates | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Derivatives | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
All Other Liabilities | 173,243 | 176,971 | 179,932 | 182,979 | 185,231 | |||||||||||||||
Total Liabilities without Sep Accounts | 179,623 | 184,182 | 185,757 | 189,056 | 191,290 | |||||||||||||||
From Separate Account Statements | 21,536 | 26,068 | 26,651 | 23,335 | 21,513 | |||||||||||||||
Total Liabilities incl Sep Accounts | 201,160 | 210,250 | 212,408 | 212,392 | 212,803 | |||||||||||||||
Capital and Surplus | ||||||||||||||||||||
Common Capital Stock | 0 | 0 | 0 | 0 | 2,500 | |||||||||||||||
Preferred Capital Stock | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Surplus Notes | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Unassigned Surplus | 18,584 | 17,588 | 16,887 | 14,899 | 14,316 | |||||||||||||||
Other Including Gross Contributed | 400 | 400 | 400 | 400 | (2,100 | ) | ||||||||||||||
Capital & Surplus | 18,984 | 17,988 | 17,287 | 15,299 | 14,716 | |||||||||||||||
Total Liabilities and C&S | 220,144 | 228,237 | 229,695 | 227,690 | 227,519 | |||||||||||||||
Memo: Affiliated Investments | ||||||||||||||||||||
Bonds | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Preferred Stocks | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Common Stocks | 5,195 | 6,186 | 550 | 572 | 578 | |||||||||||||||
Mortgage Loans | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Cash & Short Term Investments | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
All Other Investments | 0 | 0 | 0 | 0 | 2,000 | |||||||||||||||
Total Affiliated Investments | 5,195 | 6,186 | 550 | 572 | 2,578 | |||||||||||||||
Total Cash & Investments, Excl Affiliated | 186,221 | 188,693 | 195,639 | 196,519 | 195,708 |
Site content and design Copyright © 2018, S&P Global Market Intelligence
Usage of this product is governed by the SNL Master Subscription Agreement or separate S&P Agreement, as applicable.
S&P Global Market Intelligence, 55 Water Street, New York, NY 10041,
Federal Life Insurance Company | Life Income Statement
MI STAT ENTITY KEY: C2347
Periods Last Five Years
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Period Ended | 12/31/2012 | 12/31/2013 | 12/31/2014 | 12/31/2015 | 12/31/2016 | |||||||||||||||
Data displayed in $000 unless otherwise noted | ||||||||||||||||||||
Revenue | ||||||||||||||||||||
Life Insurance Premiums | 20,179 | 19,472 | 18,386 | 17,535 | 15,262 | |||||||||||||||
Annuity Premiums & Deposits | 1,997 | 3,522 | 2,065 | 3,098 | 7,376 | |||||||||||||||
Accident & Health Premiums | 220 | 199 | 176 | 153 | 139 | |||||||||||||||
Credit Life & Credit A&H Premiums | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Other Premiums & Considerations | 0 | 71 | 0 | 40 | 223 | |||||||||||||||
Premiums, Consideration and Deposits | 22,396 | 23,264 | 20,627 | 20,826 | 23,001 | |||||||||||||||
Net Investment Income | 10,431 | 10,629 | 10,281 | 9,747 | 9,586 | |||||||||||||||
Reinsurance Allowance | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Separate Accounts Revenue | 171 | 199 | 218 | 220 | 183 | |||||||||||||||
Other Income | 282 | 326 | 334 | 383 | 410 | |||||||||||||||
Total Revenue | 33,280 | 34,419 | 31,460 | 31,176 | 33,181 | |||||||||||||||
Expense | ||||||||||||||||||||
Life Benefits | 12,198 | 13,725 | 11,685 | 10,424 | 10,386 | |||||||||||||||
Annuity Benefits | 7,061 | 5,895 | 5,938 | 4,176 | 6,481 | |||||||||||||||
Accident & Health Benefits | 168 | 184 | 198 | 118 | 92 | |||||||||||||||
Credit Life & Credit A&H Benefits | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Other Benefits | 248 | 234 | 239 | 215 | 220 | |||||||||||||||
Total Benefits | 19,675 | 20,039 | 18,059 | 14,933 | 17,178 | |||||||||||||||
Life Surrenders | 2,563 | 2,294 | 3,262 | 3,415 | 3,367 | |||||||||||||||
Annuity Surrenders | 0 | 0 | 0 | 2,750 | 3,758 | |||||||||||||||
Accident & Health Surrenders | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Credit Life & Credit A&H Surrenders | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Other Surrenders | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Total Surrenders | 2,563 | 2,294 | 3,262 | 6,165 | 7,125 | |||||||||||||||
Life Inc. in Reserves | 3,495 | 3,438 | 3,048 | 2,707 | (517 | ) |
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Annuity Inc. in Reserves | (2,504 | ) | 863 | 18 | 1,012 | 2,723 | ||||||||||||||
Accident & Health Inc. in Reserves | (250 | ) | (72 | ) | 0 | (69 | ) | (71 | ) | |||||||||||
Credit Life & Credit A&H Inc. in Reserves | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Other Inc. in Reserves | (56 | ) | 17 | (89 | ) | 31 | 210 | |||||||||||||
Total Inc. in Reserves | 685 | 4,246 | 2,977 | 3,680 | 2,345 | |||||||||||||||
Life Trsfrs. to Sep. Accts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Annuity Trsfrs. to Sep. Accts | (146 | ) | (779 | ) | (1,840 | ) | (2,714 | ) | (3,733 | ) | ||||||||||
Accident & Health Trsfrs. to Sep. Accts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Credit Life & Credit A&H Trsfrs. to Sep. Accts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Other Trsfrs. to Sep. Accts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Total Trsfrs. to Sep. Accts | (146 | ) | (779 | ) | (1,840 | ) | (2,714 | ) | (3,733 | ) | ||||||||||
Commissions | 1,700 | 1,759 | 1,538 | 1,656 | 1,925 | |||||||||||||||
General & Administrative Expenses | 9,926 | 8,904 | 8,689 | 8,838 | 9,026 | |||||||||||||||
Insurance Taxes, Licenses and Fees | 909 | 863 | 791 | 766 | 722 | |||||||||||||||
Other Expenses | (15 | ) | (67 | ) | (99 | ) | 66 | (99 | ) | |||||||||||
Total Expenses | 35,298 | 37,259 | 33,378 | 33,390 | 34,490 | |||||||||||||||
Net Income | ||||||||||||||||||||
Policyholder Dividends | 287 | 284 | 271 | 253 | 86 | |||||||||||||||
Net Gain from Operations before FIT | (2,305 | ) | (3,124 | ) | (2,189 | ) | (2,467 | ) | (1,395 | ) | ||||||||||
Federal Income Tax | (156 | ) | (424 | ) | (335 | ) | (245 | ) | (310 | ) | ||||||||||
Net Income before Cap Gains | (2,149 | ) | (2,700 | ) | (1,854 | ) | (2,222 | ) | (1,085 | ) | ||||||||||
Net Realized Capital Gains (Losses) | 410 | 299 | 1,234 | (55 | ) | 1,021 | ||||||||||||||
Net Income | (1,739 | ) | (2,402 | ) | (620 | ) | (2,276 | ) | (64 | ) | ||||||||||
Pre-tax Operating Income | (2,305 | ) | (3,124 | ) | (2,189 | ) | (2,467 | ) | (1,395 | ) | ||||||||||
Change In Capital and Surplus | ||||||||||||||||||||
Capital & Surplus, Beginning of Period | 20,462 | 18,984 | 17,988 | 17,287 | 15,299 | |||||||||||||||
Net Income | (1,739 | ) | (2,402 | ) | (620 | ) | (2,276 | ) | (64 | ) | ||||||||||
Net Unrealized Capital Gains (Losses) | 638 | 1,679 | (433 | ) | 252 | (403 | ) | |||||||||||||
Change in Surplus Notes | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Capital Changes & Surplus Adj | 0 | 0 | 0 | 0 | 0 |
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Dividends to Stockholders | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
All Other Changes in Surplus | (378 | ) | (274 | ) | 352 | 36 | (116 | ) | ||||||||||||
Capital & Surplus, Current Period Ended | 18,984 | 17,988 | 17,287 | 15,299 | 14,716 |
Site content and design Copyright © 2018, S&P Global Market Intelligence
Usage of this product is governed by the SNL Master Subscription Agreement or separate S&P Agreement, as applicable.
S&P Global Market Intelligence, 55 Water Street, New York, NY 10041,
Federal Life Insurance Company | Life Financial Highlights
MI STAT ENTITY KEY: C2347
Periods Last Five Years
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Period Ended | 12/31/2012 | 12/31/2013 | 12/31/2014 | 12/31/2015 | 12/31/2016 | |||||||||||||||
Data displayed in $000 unless otherwise noted | ||||||||||||||||||||
Balance Sheet | ||||||||||||||||||||
Total Cash and Investments | 191,417 | 194,879 | 196,189 | 197,090 | 198,287 | |||||||||||||||
Separate Account Assets | 21,536 | 26,068 | 26,651 | 23,335 | 21,513 | |||||||||||||||
Total Assets | 220,144 | 228,237 | 229,695 | 227,690 | 227,519 | |||||||||||||||
Affiliated Investments (incl above) | 5,195 | 6,186 | 550 | 572 | 2,578 | |||||||||||||||
Net Policy Reserves - Life | 162,403 | 166,454 | 169,171 | 171,775 | 173,876 | |||||||||||||||
Net Policy Reserves - A&H | 563 | 491 | 491 | 422 | 351 | |||||||||||||||
Total Policy Reserves | 162,966 | 166,946 | 169,662 | 172,197 | 174,227 | |||||||||||||||
Interest Maintenance Reserve | 847 | 918 | 733 | 869 | 686 | |||||||||||||||
Asset Valuation Reserve | 2,922 | 3,230 | 2,928 | 2,765 | 2,822 | |||||||||||||||
Total Liabilities | 201,160 | 210,250 | 212,408 | 212,392 | 212,803 | |||||||||||||||
Surplus Notes | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Capital and Surplus | 18,984 | 17,988 | 17,287 | 15,299 | 14,716 | |||||||||||||||
C&S / Assets (%) | 9.56 | 8.90 | 8.51 | 7.49 | 7.14 | |||||||||||||||
Total Reserves & Deposits / C&S (%) | 909.41 | 980.25 | 1,037.00 | 1,191.19 | 1,255.46 | |||||||||||||||
Income Statement | ||||||||||||||||||||
Premiums, Consideration & Deposits | 22,396 | 23,264 | 20,627 | 20,826 | 23,001 | |||||||||||||||
Net Investment Income | 10,431 | 10,629 | 10,281 | 9,747 | 9,586 | |||||||||||||||
Separate Accounts Revenue | 171 | 199 | 218 | 220 | 183 | |||||||||||||||
Total Revenue | 33,280 | 34,419 | 31,460 | 31,176 | 33,181 | |||||||||||||||
Benefits | 19,675 | 20,039 | 18,059 | 14,933 | 17,178 | |||||||||||||||
Surrenders | 2,563 | 2,294 | 3,262 | 6,165 | 7,125 | |||||||||||||||
Increase in Reserves and Deposits | 685 | 4,246 | 2,977 | 3,680 | 2,345 | |||||||||||||||
Commissions | 1,700 | 1,759 | 1,538 | 1,656 | 1,925 | |||||||||||||||
General & Administrative Expense | 9,926 | 8,904 | 8,689 | 8,838 | 9,026 | |||||||||||||||
Net transfers to Separate Accounts | (146 | ) | (779 | ) | (1,840 | ) | (2,714 | ) | (3,733 | ) | ||||||||||
Policyholder Dividends | 287 | 284 | 271 | 253 | 86 | |||||||||||||||
Income Tax | (156 | ) | (424 | ) | (335 | ) | (245 | ) | (310 | ) | ||||||||||
Net Realized Capital Gains (Losses) | 410 | 299 | 1,234 | (55 | ) | 1,021 | ||||||||||||||
Net Income | (1,739 | ) | (2,402 | ) | (620 | ) | (2,276 | ) | (64 | ) | ||||||||||
Pre-tax Operating Income | (2,305 | ) | (3,124 | ) | (2,189 | ) | (2,467 | ) | (1,395 | ) | ||||||||||
Premiums & Annuity Considerations By Major Segment (%) | ||||||||||||||||||||
Life | 90.10 | 83.70 | 89.13 | 84.20 | 66.35 | |||||||||||||||
Annuities | 8.92 | 15.14 | 10.01 | 14.88 | 32.07 | |||||||||||||||
Accident & Health | 0.98 | 0.86 | 0.85 | 0.73 | 0.61 | |||||||||||||||
Credit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
Other | 0.00 | 0.30 | 0.00 | 0.19 | 0.97 | |||||||||||||||
Operating Ratios (%) | ||||||||||||||||||||
Growth Rate - Direct Premium & Annuity Cnsdrtns | (7.11 | ) | 9.03 | (6.63 | ) | 6.43 | 20.18 | |||||||||||||
Growth Rate - Premium & Annuity Cnsdrtns | (12.75 | ) | 3.88 | (11.34 | ) | 0.97 | 10.44 | |||||||||||||
Growth Rate - Operating Income | NM | NM | NM | NM | NM | |||||||||||||||
Growth Rate - Revenue | (10.08 | ) | 3.42 | (8.60 | ) | (0.90 | ) | 6.43 | ||||||||||||
Benefit Ratio (Premiums) | 87.85 | 86.14 | 87.55 | 71.70 | 74.68 | |||||||||||||||
Commission Ratio | 7.59 | 7.56 | 7.46 | 7.95 | 8.37 | |||||||||||||||
Expense Ratio (Premiums) | 44.32 | 38.27 | 42.12 | 42.44 | 39.24 |
2012 Y | 2013 Y | 2014 Y | 2015 Y | 2016 Y | ||||||||||||||||
Change in Policyholder Dividend | (7.64 | ) | (1.16 | ) | (4.55 | ) | (6.61 | ) | (65.90 | ) | ||||||||||
Effective Tax Rate | NM | NM | NM | NM | NM | |||||||||||||||
Net Yield on Avg. Invested Assets | 5.43 | 5.50 | 5.28 | 4.97 | 4.87 | |||||||||||||||
Pre-Tax Operating Margin | (6.93 | ) | (9.08 | ) | (6.96 | ) | (7.91 | ) | (4.20 | ) | ||||||||||
Return on Average Equity | (8.86 | ) | (13.35 | ) | (3.53 | ) | (14.17 | ) | (0.45 | ) | ||||||||||
Pre-Tax Operating ROAE | (11.74 | ) | (17.36 | ) | (12.47 | ) | (15.35 | ) | (9.84 | ) | ||||||||||
Return on Average Assets | (0.78 | ) | (1.06 | ) | (0.27 | ) | (0.99 | ) | (0.03 | ) | ||||||||||
Capital, Leverage & Liquidity (%) | ||||||||||||||||||||
RBC - Total Adjusted Capital | 22,053 | 21,360 | 20,350 | 18,192 | 17,581 | |||||||||||||||
ACL Risk Based Capital | 3,471 | 3,373 | 3,095 | 3,052 | 2,906 | |||||||||||||||
Risk Based Capital Ratio(TAC/ACL RBC) | 635.32 | 633.27 | 657.47 | 595.98 | 604.91 | |||||||||||||||
Net Premiums Written / C&S | 114.11 | 129.28 | 117.53 | 129.63 | 162.27 | |||||||||||||||
Affiliated Investments / C&S | 27.37 | 34.39 | 3.18 | 3.74 | 17.52 | |||||||||||||||
Dividends to Stockholders ($000) | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Reserve Analysis | ||||||||||||||||||||
Total Reserves including Separate Accounts | 194,181 | 202,393 | 205,916 | 205,571 | 206,270 | |||||||||||||||
Growth Rate Total Reserves incl. SA (%) | 1.46 | 4.23 | 1.74 | (0.17 | ) | 0.34 | ||||||||||||||
Investments (%) | ||||||||||||||||||||
Net Yield on Invested Assets | 5.43 | 5.50 | 5.28 | 4.97 | 4.87 | |||||||||||||||
Unaff. Bonds / Unaff. Investments | 88.03 | 87.53 | 84.94 | 85.86 | 86.17 | |||||||||||||||
Unaff. Preferred Stocks / Unaff. Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
Unaff. Common Stocks / Unaff. Investments | 3.74 | 3.63 | 5.63 | 5.14 | 4.03 | |||||||||||||||
Affiliated Investments / Total Investments | 2.71 | 3.17 | 0.28 | 0.29 | 1.30 | |||||||||||||||
Gross Yield - Bonds (excl affiliates) | 5.44 | 5.16 | 5.04 | 4.77 | 4.63 | |||||||||||||||
Bond Average Asset Quality (1-6) (#) | 1.49 | 1.44 | 1.43 | 1.46 | 1.45 | |||||||||||||||
Bonds Rated 3-6 / Total Bonds | 7.46 | 5.32 | 5.35 | 5.23 | 4.90 | |||||||||||||||
Bonds < 1 Year / Total Bonds | 11.51 | 11.94 | 16.56 | 15.21 | 9.94 | |||||||||||||||
Reinsurance Analysis ($000) | ||||||||||||||||||||
Reinsurance Ceded - Premiums & Annuity Considerations | ||||||||||||||||||||
Life | 218 | 237 | 224 | 230 | 1,872 | |||||||||||||||
Annuities | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Accident and Health | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Reinsurance Ceded - Reserve Credits Taken | ||||||||||||||||||||
Life & Annuities General Accounts | 375 | 378 | 401 | 411 | 2,378 | |||||||||||||||
Life & Annuities Separate Accounts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Accident & Health (incl Unearned Prem) | 32 | 0 | 0 | 0 | 0 | |||||||||||||||
Reinsurance Ceded - Outstanding Surplus Relief | ||||||||||||||||||||
Life & Annuities General Accounts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Life & Annuities Separate Accounts | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Accident and Health | 0 | 0 | 0 | 0 | 0 |
Site content and design Copyright © 2018, S&P Global Market Intelligence
Usage of this product is governed by the SNL Master Subscription Agreement or separate S&P Agreement, as applicable.
S&P Global Market Intelligence, 55 Water Street, New York, NY 10041,
EXHIBIT IV-1
Pricing and Financial Characteristics of Public Life Insurance Companies
Exhibit IV-1
Public Life Insurance Market Pricing
As of December 22, 2017
Market Capitalization | Dividends(4) | Financial Characteristics(6) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Price/ | Market | Pricing Ratios(3) | Amount/ | Payout | Total | Equity/ | Tang. Eq./ | Reported | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Share(1) | Value | P/E | P/B | P/TB | P/TTM Rev | Share | Yield | Ratio(5) | Assets | Assets | T. Assets | ROAA | ROAE | |||||||||||||||||||||||||||||||||||||||||||||||
($) | ($Mil) | (x) | (%) | (%) | (x) | ($) | (%) | (%) | ($Mil) | (%) | (%) | (%) | (%) | |||||||||||||||||||||||||||||||||||||||||||||||
Comparable Group | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Averages | $ | 70.29 | $ | 11,360.62 | 16.86 | x | 118.22 | % | 127.07 | % | 1.43 | x | $ | 0.82 | 1.11 | % | 18.09 | % | $ | 137,723 | 13.04 | % | 12.62 | % | 0.43 | % | 1.13 | % | ||||||||||||||||||||||||||||||||
Medians | $ | 53.31 | $ | 5,853.27 | 12.81 | x | 101.30 | % | 118.49 | % | 1.27 | x | $ | 0.48 | 0.79 | % | 16.01 | % | $ | 45,699 | 13.36 | % | 13.21 | % | 0.70 | % | 9.08 | % | ||||||||||||||||||||||||||||||||
Comparable Group | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AFL | Aflac Incorporated | GA | $ | 87.21 | $ | 34,286.58 | 12.64 | x | 156.30 | % | NA | 1.54 | x | $ | 1.80 | 2.06 | % | 26.09 | % | $ | 136,083 | 16.15 | % | NA | 2.06 | % | 13.09 | % | ||||||||||||||||||||||||||||||||
AEL | American Equity Investment Life Holding Compa | IA | $ | 32.13 | $ | 2,863.48 | 11.16 | x | 103.43 | % | 103.43 | % | 0.87 | x | $ | 0.26 | 0.81 | % | 9.03 | % | $ | 60,380 | 4.58 | % | 4.58 | % | 0.45 | % | 10.18 | % | ||||||||||||||||||||||||||||||
ATH | Athene Holding Ltd. | $ | 51.82 | $ | 10,361.74 | NA | 119.53 | % | 119.53 | % | 1.75 | x | $ | 0.00 | 0.00 | % | NA | $ | 96,061 | 9.02 | % | 9.02 | % | 1.49 | % | 17.64 | % | |||||||||||||||||||||||||||||||||
BHF | Brighthouse Financial, Inc. | NC | $ | 59.54 | $ | 7,131.29 | NA | 51.80 | % | 51.80 | % | 1.62 | x | $ | 0.00 | 0.00 | % | NA | $ | 223,279 | 6.19 | % | 6.19 | % | -1.25 | % | -18.01 | % | ||||||||||||||||||||||||||||||||
CIA | Citizens, Inc. | TX | $ | 7.48 | $ | 374.61 | 60.49 | x | 141.78 | % | 152.28 | % | 1.48 | x | $ | 0.00 | 0.00 | % | 0.00 | % | $ | 1,651 | 16.00 | % | 15.06 | % | 0.39 | % | 2.42 | % | ||||||||||||||||||||||||||||||
CNO | CNO Financial Group, Inc. | IN | $ | 24.87 | $ | 4,172.25 | 8.98 | x | 85.47 | % | 85.47 | % | 0.99 | x | $ | 0.36 | 1.45 | % | 13.00 | % | $ | 32,705 | 14.93 | % | 14.93 | % | 1.48 | % | 10.36 | % | ||||||||||||||||||||||||||||||
FFG | FBL Financial Group, Inc. | IA | $ | 71.80 | $ | 1,790.23 | 15.99 | x | 140.34 | % | 141.45 | % | 2.43 | x | $ | 1.76 | 2.45 | % | 39.20 | % | $ | 9,892 | 12.93 | % | 12.84 | % | 1.16 | % | 9.15 | % | ||||||||||||||||||||||||||||||
IHC | Independence Holding Company | CT | $ | 27.95 | $ | 415.40 | 14.12 | x | 99.16 | % | 117.56 | % | 1.31 | x | $ | 0.12 | 0.43 | % | 6.06 | % | $ | 1,039 | 40.69 | % | 36.69 | % | 3.02 | % | 7.69 | % | ||||||||||||||||||||||||||||||
KCLI | Kansas City Life Insurance Company | MO | $ | 45.10 | $ | 436.72 | 18.95 | x | 62.00 | % | 62.00 | % | 0.97 | x | $ | 1.08 | 2.39 | % | 45.38 | % | $ | 4,511 | 15.62 | % | 15.62 | % | 0.51 | % | 3.31 | % | ||||||||||||||||||||||||||||||
LNC | Lincoln National Corporation | PA | $ | 77.75 | $ | 17,013.99 | 12.17 | x | 104.63 | % | 121.57 | % | 1.23 | x | $ | 1.32 | 1.70 | % | 20.66 | % | $ | 276,785 | 5.89 | % | 5.11 | % | 0.54 | % | 9.42 | % | ||||||||||||||||||||||||||||||
MET | MetLife, Inc. | NY | $ | 50.76 | $ | 53,414.71 | NM | 97.99 | % | 118.77 | % | 0.91 | x | $ | 1.60 | 3.15 | % | NA | $ | 720,515 | 7.90 | % | 6.67 | % | -0.05 | % | -0.65 | % | ||||||||||||||||||||||||||||||||
MDWT | Midwest Holding Inc. | NE | $ | 0.06 | $ | 1.39 | NM | 74.52 | % | 118.21 | % | 0.32 | x | $ | 0.00 | 0.00 | % | NA | $ | 48 | 4.92 | % | 3.50 | % | -10.16 | % | -123.48 | % | ||||||||||||||||||||||||||||||||
NWLI | National Western Life Group, Inc. | TX | $ | 337.03 | $ | 1,158.09 | 12.62 | x | 67.98 | % | 67.98 | % | 1.43 | x | $ | 0.36 | 0.11 | % | 1.35 | % | $ | 12,138 | 14.85 | % | 14.85 | % | 0.79 | % | 5.38 | % | ||||||||||||||||||||||||||||||
PRI | Primerica, Inc. | GA | $ | 103.40 | $ | 4,575.25 | 20.12 | x | 358.36 | % | 373.64 | % | 2.79 | x | $ | 0.80 | 0.77 | % | 15.56 | % | $ | 12,207 | 10.49 | % | 10.10 | % | 2.04 | % | 19.14 | % | ||||||||||||||||||||||||||||||
PFG | Principal Financial Group, Inc. | IA | $ | 71.26 | $ | 20,576.66 | 11.68 | x | 171.37 | % | 213.56 | % | 1.43 | x | $ | 1.96 | 2.75 | % | 32.13 | % | $ | 247,934 | 4.87 | % | 3.95 | % | 0.77 | % | 16.66 | % | ||||||||||||||||||||||||||||||
PRU | Prudential Financial, Inc. | NJ | $ | 116.16 | $ | 49,251.84 | 11.67 | x | 97.94 | % | NA | 0.87 | x | $ | 3.00 | 2.58 | % | 30.15 | % | $ | 821,131 | 6.16 | % | NA | 0.55 | % | 9.01 | % | ||||||||||||||||||||||||||||||||
RGA | Reinsurance Group of America, Incorporated | MO | $ | 155.07 | $ | 9,987.14 | 12.76 | x | 123.27 | % | 123.38 | % | 0.81 | x | $ | 2.00 | 1.29 | % | 16.46 | % | $ | 58,694 | 13.80 | % | 13.79 | % | 1.43 | % | 10.42 | % | ||||||||||||||||||||||||||||||
SNFCA | Security National Financial Corporation | UT | $ | 5.40 | $ | 82.43 | 14.21 | x | 59.16 | % | 60.36 | % | 0.29 | x | $ | 0.00 | 0.00 | % | 0.00 | % | $ | 1,008 | 13.83 | % | 13.59 | % | 0.62 | % | 4.39 | % | ||||||||||||||||||||||||||||||
TMK | Torchmark Corporation | TX | $ | 90.69 | $ | 10,469.87 | 19.30 | x | 202.45 | % | 221.36 | % | 2.57 | x | $ | 0.60 | 0.66 | % | 12.77 | % | $ | 22,994 | 22.47 | % | 20.96 | % | 2.54 | % | 11.55 | % | ||||||||||||||||||||||||||||||
UNM | Unum Group | TN | $ | 54.79 | $ | 12,294.28 | 12.86 | x | 130.10 | % | 134.93 | % | 1.09 | x | $ | 0.92 | 1.68 | % | 21.60 | % | $ | 63,806 | 14.81 | % | 14.35 | % | 1.55 | % | 10.60 | % | ||||||||||||||||||||||||||||||
UTGN | UTG, Inc. | IL | $ | 25.00 | $ | 83.44 | NM | 85.84 | % | 85.84 | % | 3.88 | x | $ | 0.00 | 0.00 | % | NA | $ | 405 | 24.24 | % | 24.24 | % | -0.49 | % | -2.06 | % | ||||||||||||||||||||||||||||||||
VOYA | Voya Financial, Inc. | NY | $ | 51.14 | $ | 9,192.25 | NM | 67.33 | % | 68.31 | % | 0.93 | x | $ | 0.04 | 0.08 | % | NA | $ | 226,644 | 6.45 | % | 6.37 | % | -0.09 | % | -1.39 | % | ||||||||||||||||||||||||||||||||
Under Acquisition | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GNW | Genworth Financial, Inc. | VA | $ | 3.20 | $ | 1,597.31 | 4.78 | x | 12.22 | % | 12.52 | % | 0.18 | x | $ | 0.00 | 0.00 | % | NA | $ | 104,629 | 14.42 | % | 14.16 | % | 0.57 | % | 3.99 | % | |||||||||||||||||||||||||||||||
IHRC | Investors Heritage Capital Corporation | KY | $ | 44.00 | $ | 48.88 | 40.64 | x | 82.54 | % | 82.54 | % | 0.77 | x | $ | 0.01 | 0.57 | % | 23.09 | % | $ | 580 | 10.20 | % | 10.20 | % | 0.20 | % | 2.05 | % |
(1) | Core income, on a diluted per-share basis. Core income is net income after taxes and before extraordinary items, less net income attributable to noncontrolling interest, gain on the sale of securities, amortization of intangibles, goodwill and nonrec |
(2) | P/E = Price to earnings; P/B = Price to book; P/A = Price to assets; P/TB = Price to tangible book value; and P/Core = Price to core earnings. P/E and P/Core =NM if the ratio is negative or above 35x. |
(3) | Indicated 12 month dividend, based on last quarterly dividend declared. |
(4) | Indicated 12 month dividend as a percent of trailing 12 month earnings. |
(5) | ROAA (return on average assets) and ROAE (return on average equity) are indicated ratios based on trailing 12 month earnings and average equity and assets balances. |
(6) | Excludes from averages and medians those companies the subject of actual or rumored acquisition activities or unusual operating characteristics. |
Source: S&P Global Market Intelligence and RP Financial, LC. calculations. The information provided in this report has been obtained from sources we believe are reliable, but we cannot guarantee the accuracy or completeness of such information.
Copyright (c) 2017 by RP® Financial, LC.
EXHIBIT IV-2
Pro Forma Analysis Sheet
RP Financial, LC.
Financial Services Industry Consultants
Exhibit IV-2
Pro Forma Analysis Sheet
Federal Life Insurance Company
Peer Group Aggregate | ||||||||||||||||||||||
Valuation Midpoint Pricing Multiples | Symbol | Subject (1) | Mean | Median | ||||||||||||||||||
1. Price-earnings multiple | = | P/E | N.M. | 19.56 | x | 14.16 | x | |||||||||||||||
2. Price-book ratio | = | P/B | 55.10 | % | 93.90 | % | 85.80 | % | ||||||||||||||
3. Price-tangible book ratio | = | P/TB | 55.10 | % | 97.40 | % | 85.80 | % | ||||||||||||||
4. Price-revenue ratio | = | P/Rev. | 1.60 | x | 1.52 | x | 1.31 | x | ||||||||||||||
Valuation Parameters | ||||||||||||||||||||||
Pre-Conversion Reported Earnings (Y) | $ | (1,480,000 | ) | 30-Sep-17 | ESOP Stock Purchases (E) | 0.00 | % | (4) | ||||||||||||||
Pre-Conversion Core Earnings (CE) | $ | (1,480,000 | ) | 30-Sep-17 | Cost of ESOP Borrowings (S) | 0.00 | % | |||||||||||||||
Pre-Conversion Book Value (B) | $ | 36,241,000 | 30-Sep-17 | ESOP Amortization (T) | 0.00 | years | ||||||||||||||||
Pre-Conv. Tang. Book Value (TB) | $ | 36,241,000 | 30-Sep-17 | Stock Programs Amount (M) | 0.00 | % | ||||||||||||||||
Pre-Conversion Assets (A) | $ | 257,638,000 | 30-Sep-17 | Stock Programs Vesting (N) | 5.00 | years (4) | ||||||||||||||||
Pre-Conversion Revenues (Rev.) | $ | 23,812,000 | 30-Sep-17 | Percentage Sold (PCT) | 100.00 | % | ||||||||||||||||
Reinvestment Rate (R)(2) | 3.11 | % | Fixed Expenses | $ | 1,500,000 | |||||||||||||||||
Est. Conversion Expenses (X)(3) | 9.13 | % | Commissions Paid on Sales to Friends and Family | |||||||||||||||||||
Tax Rate (TAX) | 0.00 | % | Insiders, Friends and Family | 2.00 | % | |||||||||||||||||
Price/Share | $ | 10.00 | Insider Purchases | $ | 10,000,000 | |||||||||||||||||
Commissions Paid on Sales to Public/Standby Investor | 6.50 | % | ||||||||||||||||||||
Option (O1) | 0.00 | % | ||||||||||||||||||||
Estimated Option Value (O2) | 0.00 | % | ||||||||||||||||||||
Option vesting (O3) | 0.00 | |||||||||||||||||||||
Option pct taxable (O4) | 25.00 | % |
Calculation of Pro Forma Value After Conversion
1. | V= | P/E * Y | V= | N.M. | |||
(1 - P/E * PCT * ((1-X-E-M)*R - (1-TAX)*E/T - (1-TAX)*M/N) - (1-(TAX*O4))*O1*O2/O3) | |||||||
2. | V= | P/BE * (Y) | V= | N.M. | |||
(1 - P/BE * PCT * ((1-X-E-M)*R - (1-TAX)*E/T - (1-TAX)*M/N) - (1-(TAX*O4))*O1*O2/O3) | |||||||
3. | V= | P/B * B | V= | $40,000,000 | |||
1 - P/B * PCT * (1-X-E-M) | |||||||
4. | V= | P/TB * TB | V= | $40,000,000 | |||
1 - P/TB * PCT * (1-X-E-M) | |||||||
5. | V= | P/Rev. * Rev. | V= | $40,000,000 | |||
1 - P/Rev. * PCT * (1-X-E-M)*R |
Shares | Price/ | Gross | Pro Forma | |||||||||||||
Conclusion and Range of Value | Issued | Share | Proceeds | Market Value | ||||||||||||
Minimum | 3,400,000 | 10.00000 | $ | 34,000,000 | $ | 34,000,000 | ||||||||||
Midpoint | 4,000,000 | 10.00000 | $ | 40,000,000 | $ | 40,000,000 | ||||||||||
Maximum | 4,600,000 | 10.00000 | $ | 46,000,000 | $ | 46,000,000 |
(1) | Pricing ratios shown reflect the Midpoint Value. |
(2) | Net return reflects a reinvestment rate of 2.00%, and a tax rate of 0.0%. |
(3) | Estimated offering expenses at midpoint of the offering. |
(4) | Stock benefit plans amortization expenses tax effected at 0.0%. |
EXHIBIT IV-3
Pro Forma Effects of Offering Proceeds
RP Financial, LC.
Financial Services Industry Consultants
Exhibit IV-3
Pro Forma Effect of Conversion
Federal Life Insurance Company
Demutualization Proceeds | Minimum | Midpoint | Maximum | |||||||||
Shares Issued | 3,400,000 | 4,000,000 | 4,600,000 | |||||||||
Price Per Share | $ | 10.00 | $ | 10.00 | $ | 10.00 | ||||||
Gross Offering Proceeds | $ | 34,000,000 | $ | 40,000,000 | $ | 46,000,000 | ||||||
Less: Estimated Offering Expenses | 3,260,000 | 3,650,000 | 4,040,000 | |||||||||
Net Demutualization Proceeds | $ | 30,740,000 | $ | 36,350,000 | $ | 41,960,000 | ||||||
Estimated Additional Income from Demutualization Proceeds | ||||||||||||
Net Demutualization Proceeds | $ | 30,740,000 | $ | 36,350,000 | $ | 41,960,000 | ||||||
Less: Non-Cash Stock Purchases | - | - | - | |||||||||
Net Proceeds Available for Reinvestment | $ | 30,740,000 | $ | 36,350,000 | $ | 41,960,000 | ||||||
Estimated Net Incremental Rate of Return (1) | 3.11 | % | 3.11 | % | 3.11 | % | ||||||
Reinvestment Income | $ | 956,014 | $ | 1,130,485 | $ | 1,304,956 |
Before | ||||||||||||||||
Earnings Pro Forma Impact | Demutualization | Pro Forma After Demutualization | ||||||||||||||
12 Months ended September 30, 2017 | $ | (1,480,000 | ) | $ | (523,986 | ) | $ | (349,515 | ) | $ | (175,044 | ) | ||||
12 Months ended September 30, 2017 | $ | (1,480,000 | ) | $ | (523,986 | ) | $ | (349,515 | ) | $ | (175,044 | ) | ||||
Net Worth Pro Forma Impact | ||||||||||||||||
September 30, 2017 (GAAP Estimated) | $ | 36,241,000 | $ | 66,981,000 | $ | 72,591,000 | $ | 78,201,000 | ||||||||
September 30, 2017 (Tangible GAAP Estimated) | $ | 36,241,000 | $ | 66,981,000 | $ | 72,591,000 | $ | 78,201,000 | ||||||||
Revenues Pro Forma Impact | ||||||||||||||||
12 Months ended September 30, 2017 | $ | 23,812,000 | $ | 24,768,014 | $ | 24,942,485 | $ | 25,116,956 |
(1) | Based on current portfolio mix and anticipated short term use of proceeds. |
EXHIBIT V-1
RP Financial, LC.
Firm Qualifications Statement
FIRM QUALIFICATION STATEMENT |
RP® Financial (“RP®) provides financial and management consulting, merger advisory and valuation services to the financial services industry nationwide. We offer a broad array of services, high quality and prompt service, hands-on involvement by principals and senior staff, careful structuring of strategic initiatives and sophisticated valuation and other analyses consistent with industry practices and regulatory requirements. Our staff maintains extensive background in financial and management consulting, valuation and investment banking. Our clients include commercial banks, thrifts, credit unions, mortgage companies, insurance companies and other financial services companies.
STRATEGIC PLANNING SERVICES |
RP®’s strategic planning services are designed to provide effective feasible plans with quantifiable results. We analyze strategic options to enhance shareholder value, achieve regulatory approval or realize other objectives. Such services involve conducting situation analyses; establishing mission/vision statements, developing strategic goals and objectives; and identifying strategies to enhance franchise and/or market value, capital management, earnings enhancement, operational matters and organizational issues. Strategic recommendations typically focus on: capital formation and management, asset/liability targets, profitability, return on equity and stock pricing. Our proprietary financial simulation models provide the basis for evaluating the impact of various strategies and assessing their feasibility and compatibility with regulations.
MERGER ADVISORY SERVICES |
RP®’s merger advisory services include targeting potential buyers and sellers, assessing acquisition merit, conducting due diligence, negotiating and structuring merger transactions, preparing merger business plans and financial simulations, rendering fairness opinions, preparing mark-to-market analyses, valuing intangible assets and supporting the implementation of post-acquisition strategies. Our merger advisory services involve transactions of financially healthy companies and failed bank deals. RP® is also expert in de novo charters and shelf charters. Through financial simulations, comprehensive data bases, valuation proficiency and regulatory familiarity, RP®’s merger advisory services center on enhancing shareholder returns.
VALUATION SERVICES |
RP®’s extensive valuation practice includes bank and thrift mergers, thrift mutual-to-stock conversions, goodwill impairment, insurance company demutualizations, ESOPs, subsidiary companies, merger accounting and other purposes. We are highly experienced in performing appraisals which conform to regulatory guidelines and appraisal standards. RP® is the nation’s leading valuation firm for thrift mutual-to-stock conversions, with appraised values ranging up to $4 billion.
OTHER CONSULTING SERVICES |
RP® offers other consulting services including evaluating the impact of regulatory changes (TARP, etc.), branching and diversification strategies, feasibility studies and special research. We assist banks/thrifts in preparing CRA plans and evaluating wealth management activities on a de novo or merger basis. Our other consulting services are facilitated by proprietary valuation and financial simulation models.
KEY PERSONNEL (Years of Relevant Experience & Contact Information) |
Ronald S. Riggins, Managing Director (37) | (703) 647-6543 | rriggins@rpfinancial.com |
William E. Pommerening, Managing Director (33) | (703) 647-6546 | wpommerening@rpfinancial.com |
Marcus Faust, Managing Director (29) | (703) 647-6553 | mfaust@rpfinancial.com |
Gregory E. Dunn, Director (34) | (703) 647-6548 | gdunn@rpfinancial.com |
James P. Hennessey, Director (30) | (703) 647-6544 | jhennessey@rpfinancial.com |
James J. Oren, Director (30) | (703) 647-6549 | joren@rpfinancial.com |
Carla Pollard, Senior Vice President (27) | (703) 647-6556 | cpollard@rpfinancial.com |
Washington Headquarters | |
Three Ballston Plaza | Telephone: (703) 528-1700 |
1100 North Glebe Road, Suite 600 | Fax No.: (703) 528-1788 |
Arlington, VA 22201 | Toll-Free No.: (866) 723-0594 |
www.rpfinancial.com | E-Mail: mail@rpfinancial.com |
Exhibit 99.6
RP® FINANCIAL, LC. Advisory | Planning | Valuation |
December 22, 2017
Board of Directors
Federal Life Group, Inc.
3750 West Deerfield Road
Riverwoods, Illinois 60015
Members of the Board:
We understand that the Board of Directors of Federal Life Mutual Holding Company (the “Company”), has adopted a Plan of Conversion (the “Plan”). In connection with the Plan, the Company will convert from the mutual to stock form of organization, issue all of its capital stock to a newly formed holding company, Federal Life Group, Inc. (“Federal Life Group”), and Federal Life Group will offer shares of its common stock for sale in a subscription offering to all eligible subscribers. Any shares of common stock that remain unsubscribed for in the subscription offering will be offered by Federal Life Group for sale in a community offering to Insurance Capital Group LLC, employees, officers and directors of the Company and certain strategic investors.
Based solely upon our observation that the subscription rights will be available to such parties without cost, will be legally non-transferable and of short duration, and will afford such parties the right only to purchase shares of common stock at the same price as will be paid by members of the general public in the community offering but without undertaking any independent investigation of state or federal law or the position of the Internal Revenue Service with respect to this issue, we are of the belief that, as a factual matter:
(1) | the subscription rights will have no economic fair market value; and, |
(2) | the price at which the subscription rights are exercisable will not be more or less than the pro forma market value of the shares upon issuance. |
Changes in the local and national economy, the legislative and regulatory environment, the stock market, interest rates, and other external forces (such as natural disasters or significant world events) may occur from time to time, often with great unpredictability and may materially impact the value of stocks of life insurers as a whole or the Company’s value alone. Accordingly, no assurance can be given that persons who subscribe to shares of common stock in the subscription offering will thereafter be able to buy or sell such shares at the same price paid in the subscription offering.
Sincerely | |
RP Financial, LC. |
4250 North Fairfax Drive | Telephone: (703) 528-1700 |
Suite 600 | Fax No.: (703) 528-1788 |
Arlington, VA 22203 | Toll-Free No.: (866) 723-0594 |
www.rpfinancial.com | E-Mail: mail@rpfinancial.com |